data_1t3v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1t3v _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.406 ' HA ' ' OE2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.513 0.197 . . . . 0.0 110.841 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 mt -115.3 153.25 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 165.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 mt -134.51 105.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.132 2.173 . . . . 0.0 105.812 -164.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.438 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.52 145.59 31.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.191 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.3 mt -145.94 114.59 4.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.35 129.42 15.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.574 1.516 . . . . 0.0 108.372 171.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.88 150.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 118.739 0.7 . . . . 0.0 109.185 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -68.1 -27.06 66.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.318 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.59 156.1 39.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.648 1.579 . . . . 0.0 107.91 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -85.73 95.59 9.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -125.8 39.64 3.91 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 108.582 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.19 -127.88 29.94 Favored Glycine 0 C--N 1.34 0.76 0 O-C-N 120.775 -1.203 . . . . 0.0 111.434 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -58.4 -45.79 87.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.182 1.393 . . . . 0.0 111.665 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -1.87 4.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.774 2.43 . . . . 0.0 114.304 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.3 m -52.99 109.01 1.24 Allowed Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.975 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.92 135.47 14.11 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.357 1.371 . . . . 0.0 108.964 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.47 134.37 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.047 0.939 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.38 169.9 12.5 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.876 1.27 . . . . 0.0 107.876 166.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -88.1 -55.32 3.8 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 121.472 -0.768 . . . . 0.0 110.554 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.63 85.57 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 -152.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -37.49 -47.17 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.411 1.484 . . . . 0.0 112.908 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.42 -14.34 41.18 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 118.7 -1.055 . . . . 0.0 115.276 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.59 48.02 1.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.09 2.156 . . . . 0.0 108.74 173.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.65 137.77 54.77 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 167.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.74 -25.29 28.83 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.454 2.103 . . . . 0.0 114.494 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -146.27 158.17 43.86 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.29 103.9 8.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.51 1.524 . . . . 0.0 107.896 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.11 79.02 6.72 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.526 1.53 . . . . 0.0 107.585 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.438 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.31 3.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.08 164.15 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.034 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.874 -1.141 . . . . 0.0 108.97 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.18 147.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 161.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.54 113.71 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 173.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t30 54.58 -86.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.718 1.207 . . . . 0.0 111.687 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.94 12.24 2.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.685 1.594 . . . . 0.0 111.969 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.11 156.36 38.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.784 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.26 -32.32 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.096 1.758 . . . . 0.0 112.932 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 59.13 -51.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 115.497 -168.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.68 161.98 16.05 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.06 0.944 . . . . 0.0 110.8 -160.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mm -135.74 140.45 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.226 1.81 . . . . 0.0 107.73 -176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.79 88.5 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.734 2.013 . . . . 0.0 107.714 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.7 t -89.8 93.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 164.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.69 152.6 19.47 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 mp0 -56.88 152.87 11.93 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.448 1.099 . . . . 0.0 110.496 168.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -79.77 133.6 58.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 164.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.92 -9.72 26.25 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 CA-C-N 121.12 1.436 . . . . 0.0 112.121 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.78 39.65 0.96 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.023 1.329 . . . . 0.0 110.062 -163.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 O-C-N 120.295 -1.503 . . . . 0.0 112.336 -169.088 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.08 -53.44 48.45 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 119.227 0.921 . . . . 0.0 109.515 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -72.48 -32.05 10.41 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.012 1.808 . . . . 0.0 111.899 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.1 -38.33 73.22 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.052 0.842 . . . . 0.0 110.922 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.75 -65.58 0.61 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.902 1.281 . . . . 0.0 110.991 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 m -61.81 -22.34 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.751 1.16 . . . . 0.0 113.904 -173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.48 -12.36 61.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.304 -1.498 . . . . 0.0 114.002 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -19.01 23.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.809 1.186 . . . . 0.0 109.781 165.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.15 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.171 0 O-C-N 119.87 -1.768 . . . . 0.0 111.239 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.53 20.11 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 127.34 2.4 . . . . 0.0 116.214 161.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.23 176.84 9.3 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -159.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 11.4 mt-10 -144.1 -53.32 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 124.63 1.172 . . . . 0.0 110.642 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.08 157.01 19.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.6 1.16 . . . . 0.0 109.363 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.51 139.65 44.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.386 2.275 . . . . 0.0 105.071 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 94.5 mt -131.47 111.37 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.31 155.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.685 -162.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -95.08 -62.14 1.36 Allowed 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.763 -1.211 . . . . 0.0 111.243 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.85 -54.42 1.3 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.791 -0.568 . . . . 0.0 113.929 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.485 HG12 ' H ' ' A' ' 74' ' ' GLY 0.299 3.7 tt 44.26 -168.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 130.102 3.361 . . . . 0.0 115.14 -173.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.485 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.36 167.19 39.82 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.319 1.914 . . . . 0.0 110.445 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.61 -31.76 73.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -163.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -64.74 -36.33 83.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.198 1.817 . . . . 0.0 109.642 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.73 63.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.265 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.42 -43.96 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 119.764 1.165 . . . . 0.0 109.626 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.23 10.93 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.196 -1.565 . . . . 0.0 114.934 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.16 -58.56 3.09 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.259 1.424 . . . . 0.0 110.453 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -35.62 -56.29 0.67 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 126.953 2.101 . . . . 0.0 109.159 160.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.42 -9.94 55.82 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 117.421 -1.276 . . . . 0.0 111.733 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.9 63.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.725 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.2 14.92 5.66 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.311 0.382 . . . . 0.0 111.504 -163.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.25 26.78 56.84 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.09 -0.381 . . . . 0.0 112.765 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.64 108.15 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -168.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.66 28.49 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.975 1.71 . . . . 0.0 110.336 -170.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.07 95.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.5 139.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.81 154.06 47.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.986 -0.446 . . . . 0.0 110.845 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.12 38.62 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.084 0.85 . . . . 0.0 114.799 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.5 157.53 37.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.427 1.113 . . . . 0.0 110.869 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.2 p -159.46 130.33 5.93 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.127 0.971 . . . . 0.0 108.414 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.65 -130.86 6.28 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.906 -172.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.35 159.61 39.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.041 1.737 . . . . 0.0 111.329 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.71 -45.1 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.861 -1.149 . . . . 0.0 111.272 -166.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.53 -12.01 48.97 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.38 -43.49 5.41 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.007 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.3 t -46.03 -49.8 4.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.432 1.469 . . . . 0.0 110.547 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.47 -38.47 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.478 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -62.01 -50.97 69.93 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 117.329 -1.32 . . . . 0.0 110.307 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.26 -37.22 69.5 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.379 1.445 . . . . 0.0 111.575 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.04 -50.42 41.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.723 1.209 . . . . 0.0 111.94 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.8 mt -62.88 -30.63 71.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.097 0.408 . . . . 0.0 110.139 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.9 m -74.77 -1.09 20.49 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.924 2.09 . . . . 0.0 112.508 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.91 75.0 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 125.39 1.472 . . . . 0.0 112.916 168.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.5 -45.78 51.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.914 0.864 . . . . 0.0 108.705 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.97 134.88 38.74 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.602 1.161 . . . . 0.0 108.373 -166.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.494 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.1 mt -111.7 141.7 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.9 mt -122.41 102.65 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 129.424 3.09 . . . . 0.0 107.246 -168.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.433 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.15 145.74 32.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.985 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mt -138.64 117.97 9.53 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.21 108.63 2.02 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 N-CA-C 107.121 -1.915 . . . . 0.0 107.121 166.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -101.1 158.9 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 119.065 0.848 . . . . 0.0 110.33 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -77.03 -33.11 57.42 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.154 1.782 . . . . 0.0 112.392 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -147.13 146.58 29.96 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -86.54 90.03 8.1 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 167.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -111.62 39.44 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.487 -1.244 . . . . 0.0 110.306 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 25.05 91.36 0.01 OUTLIER Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.581 2.039 . . . . 0.0 115.174 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt 80.19 -45.7 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.791 2.436 . . . . 0.0 112.068 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -20.13 65.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -33.36 102.34 0.21 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.972 2.909 . . . . 0.0 111.974 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.29 137.13 36.05 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 109.349 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 tt -60.78 140.17 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 t -75.83 177.71 6.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.211 1.004 . . . . 0.0 109.039 170.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 -13.94 21.43 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.489 -0.757 . . . . 0.0 112.616 -173.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -142.25 -179.5 6.29 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.888 2.075 . . . . 0.0 108.861 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -119.6 -42.55 2.63 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.424 0.69 . . . . 0.0 111.777 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 -16.3 55.49 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 117.578 -1.679 . . . . 0.0 116.947 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 39.09 1.49 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.999 1.719 . . . . 0.0 109.794 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.39 146.7 97.83 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 37.6 Cg_endo -74.37 -22.22 16.55 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.565 1.51 . . . . 0.0 114.055 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -153.18 153.03 31.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.694 1.134 . . . . 0.0 109.418 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -113.31 109.18 18.31 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.711 0.264 . . . . 0.0 111.711 164.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 96.58 6.52 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.1 m-85 -83.34 96.39 8.5 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 164.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 t -79.64 168.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.82 -164.21 1.32 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.24 -1.537 . . . . 0.0 109.246 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -147.11 133.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 O-C-N 121.74 -0.6 . . . . 0.0 109.768 170.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -105.27 102.09 11.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 168.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.4 t30 55.28 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 111.964 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -140.03 34.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.686 1.595 . . . . 0.0 109.996 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.19 169.89 12.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.518 1.127 . . . . 0.0 108.412 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.11 -23.12 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.573 1.533 . . . . 0.0 113.588 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.4 -68.68 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.367 1.867 . . . . 0.0 114.228 -162.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -168.32 146.38 4.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.752 0.821 . . . . 0.0 110.412 -150.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mm -111.89 126.53 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.005 2.122 . . . . 0.0 107.072 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.37 80.46 1.61 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.55 1.54 . . . . 0.0 107.39 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.266 7.2 p -91.82 75.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.976 0.893 . . . . 0.0 109.012 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.01 160.41 25.88 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.55 -178.44 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.754 1.222 . . . . 0.0 111.437 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.421 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 33.7 p-10 -100.31 85.51 0.54 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.023 3.329 . . . . 0.0 114.671 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.69 -24.79 74.9 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.257 1.972 . . . . 0.0 113.39 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -120.24 56.2 0.98 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 123.593 1.664 . . . . 0.0 107.74 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.484 0 C-N-CA 125.171 1.389 . . . . 0.0 109.904 162.398 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -46.41 -55.15 14.85 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 122.505 2.411 . . . . 0.0 110.288 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.25 -17.11 11.86 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.319 2.013 . . . . 0.0 112.197 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.68 -48.8 68.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -52.95 -66.09 0.45 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.45 1.1 . . . . 0.0 111.278 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.64 -17.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 120.297 -1.502 . . . . 0.0 113.156 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.98 -31.87 61.54 Favored 'General case' 0 N--CA 1.458 -0.049 0 O-C-N 120.922 -1.111 . . . . 0.0 111.746 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -64.51 -26.47 68.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.968 1.258 . . . . 0.0 110.981 170.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -82.48 38.13 0.54 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.859 0.863 . . . . 0.0 111.029 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 62' ' ' GLU . . . 40.55 30.83 0.34 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 129.375 3.369 . . . . 0.0 116.903 165.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.74 175.46 7.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.551 1.175 . . . . 0.0 113.696 -167.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.56 -37.88 0.41 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.281 1.433 . . . . 0.0 110.052 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -132.02 154.76 49.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.698 1.199 . . . . 0.0 109.435 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -148.76 140.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.6 mt -126.0 110.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.55 164.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 109.813 -172.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.36 -100.5 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.31 66.2 0.35 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 125.277 1.417 . . . . 0.0 110.606 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.7 tt -57.96 172.44 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.128 1.771 . . . . 0.0 111.215 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.72 154.2 20.82 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.716 1.151 . . . . 0.0 110.945 169.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -51.57 -35.5 41.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.921 2.089 . . . . 0.0 114.374 -165.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -59.06 -28.4 66.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.624 1.102 . . . . 0.0 112.448 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.03 -31.72 27.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.68 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.6 mm -54.44 -50.13 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.72 -26.78 10.07 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 114.851 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.76 -51.61 11.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.915 0.78 . . . . 0.0 111.29 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -58.51 -35.43 72.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.046 1.339 . . . . 0.0 110.293 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -65.23 -7.77 14.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.029 0.932 . . . . 0.0 113.383 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.69 -25.43 33.01 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.906 1.685 . . . . 0.0 110.942 170.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 ptm -118.28 1.75 11.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.913 1.685 . . . . 0.0 112.648 -167.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.87 76.47 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 118.722 0.692 . . . . 0.0 111.548 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 t -79.74 121.43 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.48 146.51 36.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 p -138.72 93.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.04 124.39 28.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 126.11 1.764 . . . . 0.0 107.161 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 166.94 12.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.603 0.761 . . . . 0.0 110.676 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.25 18.54 73.3 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.003 -0.887 . . . . 0.0 113.31 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.36 170.36 12.03 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.906 1.353 . . . . 0.0 110.913 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 t -161.91 147.93 13.52 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.444 1.098 . . . . 0.0 108.055 172.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.08 -172.53 19.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.156 1.36 . . . . 0.0 112.587 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.5 p -79.86 163.19 24.57 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.441 -1.035 . . . . 0.0 109.26 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.29 -51.38 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.931 0.893 . . . . 0.0 110.049 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.75 -38.41 72.38 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 123.334 0.396 . . . . 0.0 111.268 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -77.54 -54.73 6.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.159 0.984 . . . . 0.0 108.625 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 t -54.52 -46.84 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.109 1.364 . . . . 0.0 110.785 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.65 -51.43 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -56.63 -42.54 79.03 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.69 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -55.86 -39.39 71.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.673 1.124 . . . . 0.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.19 -45.64 47.09 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.092 0.557 . . . . 0.0 112.23 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.6 mp -56.99 -35.07 68.77 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.3 m -86.29 1.73 49.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.356 1.462 . . . . 0.0 113.129 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.64 13.87 61.71 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.494 1.045 . . . . 0.0 114.02 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -74.93 -36.54 62.13 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.823 1.312 . . . . 0.0 110.186 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.21 161.98 23.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.119 0.968 . . . . 0.0 109.041 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 tptt . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 124.755 1.222 . . . . 0.0 108.384 -172.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.443 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.482 HD22 HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.482 HG23 HD22 ' A' ' 45' ' ' ASN . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.443 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.401 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.2 tpt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.2 mt -139.45 141.01 36.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.01 104.33 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 127.561 2.344 . . . . 0.0 107.428 -163.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.448 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -79.73 140.37 36.98 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.7 mt -139.71 107.51 7.05 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 129.32 14.5 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.152 1.901 . . . . 0.0 108.129 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.37 152.06 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.169 0.588 . . . . 0.0 110.132 -170.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -74.32 -13.27 60.73 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.94 170.41 21.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.9 1.227 . . . . 0.0 109.381 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.487 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 37.2 p-10 -82.12 39.67 0.59 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.014 1.326 . . . . 0.0 112.809 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -81.46 41.01 0.6 Allowed 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.631 -1.293 . . . . 0.0 112.285 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.7 124.7 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.396 2.427 . . . . 0.0 114.791 -170.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt 80.32 -67.28 0.13 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.998 2.919 . . . . 0.0 109.984 -165.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -10.61 48.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.592 2.357 . . . . 0.0 112.954 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 m -35.91 99.08 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 130.46 3.504 . . . . 0.0 111.628 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.22 128.68 15.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tt -62.04 131.87 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 170.27 14.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.103 1.361 . . . . 0.0 108.409 170.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -89.92 -56.08 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -99.6 135.41 41.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -67.9 -41.32 82.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.16 -5.24 53.03 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.119 -1.934 . . . . 0.0 115.444 -164.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -144.12 38.73 1.31 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.593 1.697 . . . . 0.0 109.181 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.27 132.67 75.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.29 -19.01 17.65 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.743 1.628 . . . . 0.0 113.502 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 10' ' ' ASN . 96.7 m-85 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.935 1.294 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.17 107.75 10.29 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.684 1.194 . . . . 0.0 108.515 170.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.96 91.63 5.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.4 m-85 -77.98 95.91 4.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 160.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -79.84 164.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -112.42 -170.43 1.66 Allowed 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.851 -1.156 . . . . 0.0 110.017 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -141.56 151.53 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 156.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.74 106.32 15.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 160.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 t30 57.76 -62.63 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.376 2.27 . . . . 0.0 115.754 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.0 12.01 1.6 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.199 1.4 . . . . 0.0 112.791 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.23 -157.58 0.62 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.738 1.615 . . . . 0.0 112.802 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.11 -30.78 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.607 1.163 . . . . 0.0 111.316 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.36 -71.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 113.828 -161.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.04 165.98 32.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.281 1.432 . . . . 0.0 110.42 -160.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.77 147.1 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.5 1.12 . . . . 0.0 110.071 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -129.71 117.7 20.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.009 2.523 . . . . 0.0 105.977 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.97 70.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -79.71 146.2 32.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -62.3 143.31 57.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.963 0.905 . . . . 0.0 109.513 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -81.06 121.04 80.25 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.71 -37.76 34.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.342 2.028 . . . . 0.0 112.666 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.87 39.38 3.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.217 0.917 . . . . 0.0 110.08 -168.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.123 0 CA-C-N 119.01 0.823 . . . . 0.0 110.718 -173.019 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 117.21 -1.376 . . . . 0.0 114.376 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.53 -52.35 44.66 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.397 1.453 . . . . 0.0 108.587 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.2 -30.27 25.14 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.056 1.17 . . . . 0.0 112.962 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -69.33 -22.49 63.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.086 -0.384 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.05 -64.4 0.87 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.078 -0.963 . . . . 0.0 108.973 164.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -60.94 -26.15 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 121.095 1.771 . . . . 0.0 114.472 -170.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -59.75 -26.57 65.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.189 1.359 . . . . 0.0 113.449 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -21.57 60.21 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.457 1.026 . . . . 0.0 110.324 172.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -84.56 38.19 0.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.252 0.933 . . . . 0.0 110.302 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 28.77 42.33 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 129.901 3.619 . . . . 0.0 115.042 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 172.48 8.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.394 1.097 . . . . 0.0 112.405 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 18.3 mt-10 -139.0 -27.51 0.82 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.246 -166.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -141.57 154.47 45.46 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.69 0.796 . . . . 0.0 110.827 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -150.17 103.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 120.994 -1.066 . . . . 0.0 110.129 -172.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.6 mt -91.49 100.9 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 119.735 -1.853 . . . . 0.0 107.457 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.7 m -122.08 171.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.747 1.158 . . . . 0.0 111.948 -170.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -114.36 -100.06 0.43 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.49 54.42 4.95 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.806 1.67 . . . . 0.0 113.091 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.429 ' CG1' ' H ' ' A' ' 74' ' ' GLY . 10.3 tt -58.02 -170.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 125.772 1.629 . . . . 0.0 111.603 165.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.429 ' H ' ' CG1' ' A' ' 73' ' ' ILE . . . -154.87 164.81 31.91 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 119.051 -2.281 . . . . 0.0 109.38 171.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -53.28 -46.65 69.37 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.107 0.954 . . . . 0.0 113.554 -168.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -51.42 -21.61 2.45 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.31 -39.79 9.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.739 0.816 . . . . 0.0 110.584 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.7 mm -48.35 -47.6 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 166.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.56 -21.03 36.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.667 1.587 . . . . 0.0 114.672 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.16 -57.44 4.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.223 0.92 . . . . 0.0 108.925 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -60.71 -38.86 86.47 Favored 'General case' 0 N--CA 1.424 -1.767 0 C-N-CA 124.936 1.294 . . . . 0.0 109.403 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.79 -14.14 30.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.683 -1.151 . . . . 0.0 113.962 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.65 64.64 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 121.421 1.919 . . . . 0.0 111.929 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.64 18.6 5.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.108 1.363 . . . . 0.0 112.998 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.14 25.78 60.38 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.81 -1.181 . . . . 0.0 113.001 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 t -78.56 112.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -65.95 148.88 51.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.23 -169.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.36 98.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.0 mt -72.75 134.48 29.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.77 2.028 . . . . 0.0 107.101 166.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.58 174.97 5.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.077 0.551 . . . . 0.0 110.34 169.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.52 -2.98 65.43 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.689 -1.617 . . . . 0.0 115.547 168.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.61 -174.48 0.72 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.025 1.912 . . . . 0.0 112.575 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 p -170.49 153.04 4.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.964 2.106 . . . . 0.0 106.455 165.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.65 -168.96 22.57 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.814 0.721 . . . . 0.0 111.878 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -82.74 169.29 16.33 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.54 -0.976 . . . . 0.0 110.393 166.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.18 -53.99 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 123.56 0.744 . . . . 0.0 109.817 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.01 -17.09 36.12 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -99.28 -52.06 3.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.275 1.43 . . . . 0.0 108.678 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.7 t -55.33 -40.04 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.631 1.572 . . . . 0.0 111.714 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.37 -59.4 2.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -60.95 -41.09 95.62 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.517 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.27 -37.15 66.92 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.314 1.416 . . . . 0.0 110.584 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -77.12 -50.04 13.92 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.253 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.74 -25.64 65.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.816 0.697 . . . . 0.0 111.044 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -27.93 40.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.814 -0.613 . . . . 0.0 111.749 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.96 3.31 19.89 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.644 1.116 . . . . 0.0 113.693 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -42.67 65.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.171 1.486 . . . . 0.0 110.445 -173.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.47 147.93 52.6 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 122.957 0.503 . . . . 0.0 110.245 -172.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.7 tptt . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 124.366 1.066 . . . . 0.0 110.671 -172.772 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mt -138.59 150.33 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.039 2.136 . . . . 0.0 105.971 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.7 mt -132.39 105.3 8.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 128.745 2.818 . . . . 0.0 108.112 -163.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.1 145.84 32.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 118.525 0.602 . . . . 0.0 110.401 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 53.4 mt -143.41 111.36 5.44 Favored Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.77 123.1 10.06 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 N-CA-C 106.715 -2.071 . . . . 0.0 106.715 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.86 158.85 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.784 0.72 . . . . 0.0 109.514 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.4 m -74.45 -34.9 63.3 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -146.52 154.06 41.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -80.21 115.32 19.7 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -138.34 39.64 2.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.399 0.545 . . . . 0.0 110.214 170.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.87 73.96 0.1 OUTLIER Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.326 -1.263 . . . . 0.0 115.058 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt 77.86 -28.35 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 130.6 3.56 . . . . 0.0 113.46 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.81 -8.3 53.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.502 0.721 . . . . 0.0 109.304 167.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -42.1 108.36 0.6 Allowed Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 130.224 3.41 . . . . 0.0 110.124 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.71 135.47 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.47 2.114 . . . . 0.0 109.102 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -58.53 146.38 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 118.854 0.752 . . . . 0.0 109.535 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 t -81.57 171.28 14.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 122.636 1.208 . . . . 0.0 109.159 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.62 -39.25 37.71 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.846 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -131.82 -174.03 3.3 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.792 -1.193 . . . . 0.0 108.6 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -119.83 -41.87 2.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.482 0.713 . . . . 0.0 110.208 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.39 64.79 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.936 -0.925 . . . . 0.0 113.739 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.43 72.68 1.44 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.26 1.824 . . . . 0.0 107.196 168.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.43 138.52 19.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 165.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.73 -20.97 8.82 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.641 2.894 . . . . 0.0 113.313 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -151.94 138.43 18.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.166 1.786 . . . . 0.0 107.038 -165.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.86 98.95 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.357 1.863 . . . . 0.0 107.953 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.41 78.0 5.94 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.204 1.402 . . . . 0.0 108.841 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -71.34 94.66 1.24 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.737 1.215 . . . . 0.0 109.285 174.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.98 167.88 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.528 1.531 . . . . 0.0 109.404 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -122.88 -171.53 2.31 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.694 -1.253 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.72 136.74 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 166.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.28 126.71 18.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 127.413 2.285 . . . . 0.0 105.759 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 52.75 42.38 31.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.145 0.978 . . . . 0.0 111.324 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.09 9.23 5.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.63 1.972 . . . . 0.0 113.729 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.05 167.89 10.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.659 1.184 . . . . 0.0 109.072 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.99 -26.21 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 113.673 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 57.78 -54.52 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.393 2.277 . . . . 0.0 115.937 -167.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -170.6 158.05 6.07 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.309 1.444 . . . . 0.0 108.787 -157.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.7 mt -138.82 137.87 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 125.303 1.441 . . . . 0.0 107.972 171.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 m -111.07 144.42 40.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.434 2.294 . . . . 0.0 105.855 160.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 16.0 t -140.74 68.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 167.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -80.18 136.65 36.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.14 150.04 49.69 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -88.85 107.74 19.28 Favored Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.199 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.17 -8.51 22.11 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.163 1.909 . . . . 0.0 112.083 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -128.41 37.75 4.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.11 0.964 . . . . 0.0 109.769 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.416 0 C-N-CA 126.146 1.778 . . . . 0.0 111.793 177.054 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -36.53 -51.19 1.9 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.162 2.185 . . . . 0.0 112.193 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.14 -24.64 12.41 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.257 1.485 . . . . 0.0 112.519 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -68.68 -38.36 80.3 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 119.874 1.215 . . . . 0.0 109.551 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.71 -65.62 0.54 Allowed 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.896 0.747 . . . . 0.0 109.557 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 m -59.91 -37.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 117.134 -1.412 . . . . 0.0 112.192 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -58.74 -17.56 24.06 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.02 2.191 . . . . 0.0 114.322 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -26.04 49.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.5 -1.375 . . . . 0.0 110.303 167.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -84.71 37.9 0.67 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.153 1.381 . . . . 0.0 111.164 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.06 26.63 1.32 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 128.287 2.851 . . . . 0.0 118.112 165.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.87 171.17 11.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.904 1.852 . . . . 0.0 115.21 -171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -144.88 -27.24 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.042 1.737 . . . . 0.0 112.019 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp -132.18 156.21 46.84 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.378 1.471 . . . . 0.0 108.745 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.8 146.6 21.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 170.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.0 mt -130.6 113.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.08 177.02 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.445 1.098 . . . . 0.0 109.542 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.9 ttt-85 -112.55 -90.83 0.5 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.9 64.68 0.26 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.139 1.828 . . . . 0.0 112.37 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.48 176.62 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 125.639 1.576 . . . . 0.0 111.747 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.89 159.67 23.06 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.09 1.805 . . . . 0.0 111.141 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -60.01 -34.77 73.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -164.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -56.08 -40.76 74.11 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.267 1.394 . . . . 0.0 110.826 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.945 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.0 mm -61.47 -48.56 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 167.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.14 -20.49 58.67 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.71 -57.78 7.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.049 -1.032 . . . . 0.0 111.518 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -62.39 -37.86 87.41 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 126.438 1.895 . . . . 0.0 109.399 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.46 -30.0 59.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.53 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.29 -8.46 55.95 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.473 1.033 . . . . 0.0 112.297 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -134.97 12.82 3.62 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.175 1.79 . . . . 0.0 111.783 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.46 33.99 33.66 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 121.382 -0.824 . . . . 0.0 112.408 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.49 117.7 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 146.39 52.89 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.102 -0.998 . . . . 0.0 108.372 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' ' HE2' ' A' ' 90' ' ' LYS . 2.5 p -133.69 110.17 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.467 0.651 . . . . 0.0 110.919 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mt -81.18 140.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.324 1.85 . . . . 0.0 106.135 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 88' ' ' VAL . 23.4 mtmt -124.48 174.07 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.727 1.211 . . . . 0.0 109.965 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.24 10.64 74.53 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.485 171.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 172.28 5.15 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.538 1.669 . . . . 0.0 111.345 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.0 p -159.38 153.91 24.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.054 1.742 . . . . 0.0 107.895 161.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.49 -166.52 25.8 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.759 0.709 . . . . 0.0 113.404 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 p -83.57 171.97 12.81 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.227 -1.16 . . . . 0.0 109.297 162.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.25 -55.1 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.341 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.18 -33.36 72.1 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.956 -173.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -71.57 -50.88 26.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.84 0.856 . . . . 0.0 110.388 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 38.0 t -58.99 -42.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.262 1.025 . . . . 0.0 110.218 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.62 -54.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -56.71 -42.04 78.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.004 0.82 . . . . 0.0 112.357 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -61.03 -32.85 72.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.266 0.939 . . . . 0.0 111.792 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -79.87 -42.13 24.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.414 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.53 -28.89 67.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.377 0.99 . . . . 0.0 110.754 173.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.2 m -74.12 -13.16 60.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.216 1.406 . . . . 0.0 112.896 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.8 12.77 65.19 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.946 1.26 . . . . 0.0 113.2 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -68.68 -50.84 47.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.131 1.466 . . . . 0.0 107.817 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.61 135.98 55.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.089 1.356 . . . . 0.0 110.109 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.259 0 C-N-CA 125.32 1.448 . . . . 0.0 109.373 171.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.436 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.146 0.022 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 mt -113.49 148.55 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 162.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.45 104.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 128.715 2.806 . . . . 0.0 105.604 -165.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.436 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.43 140.18 36.1 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.3 mt -131.94 118.59 16.53 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 167.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.9 121.22 8.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 107.099 -1.923 . . . . 0.0 107.099 168.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 m -116.13 147.6 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 119.013 0.824 . . . . 0.0 109.999 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -70.02 -30.93 68.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.993 -1.004 . . . . 0.0 111.429 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -146.4 156.33 43.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.429 1.892 . . . . 0.0 106.194 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -90.46 106.86 18.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -132.72 39.15 3.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.88 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.6 -76.12 0.01 OUTLIER Glycine 0 N--CA 1.469 0.864 0 C-N-CA 126.712 2.101 . . . . 0.0 115.849 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -110.33 -50.96 2.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.012 1.725 . . . . 0.0 107.069 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.88 -6.41 1.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 129.32 3.048 . . . . 0.0 113.77 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 m -47.95 109.7 1.2 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 129.864 3.266 . . . . 0.0 111.745 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.04 137.21 21.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.102 1.868 . . . . 0.0 110.317 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.14 137.26 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.643 1.211 . . . . 0.0 111.422 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -74.54 170.16 16.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.429 1.892 . . . . 0.0 109.614 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -109.87 -24.66 10.72 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.83 -1.169 . . . . 0.0 113.059 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -121.43 89.25 3.09 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.259 1.024 . . . . 0.0 109.897 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -39.86 -49.64 2.4 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.3 1.44 . . . . 0.0 113.23 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -15.07 48.38 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.22 52.48 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 173.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.93 153.36 69.74 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 161.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.62 -22.53 0.9 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.782 2.988 . . . . 0.0 113.955 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.11 160.93 39.25 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.793 1.237 . . . . 0.0 107.981 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -127.5 110.53 12.83 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.19 86.93 5.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.436 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -76.63 100.06 5.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 t -88.52 141.97 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 125.328 1.451 . . . . 0.0 107.847 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -93.18 -172.48 2.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.801 0.728 . . . . 0.0 109.277 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.2 t -145.42 134.31 17.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 34' ' ' ASN . 6.8 ttpt -133.0 118.52 18.92 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 126.061 1.744 . . . . 0.0 106.713 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.401 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 80.6 m-20 40.45 56.93 2.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.218 1.407 . . . . 0.0 112.62 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 39.93 62.81 1.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 112.985 -167.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.75 171.0 15.4 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.617 1.967 . . . . 0.0 107.968 159.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.63 -20.61 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.62 1.568 . . . . 0.0 112.985 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.37 -59.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.737 2.415 . . . . 0.0 115.912 -165.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -170.88 164.29 7.76 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.718 2.407 . . . . 0.0 108.8 -164.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.02 129.05 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -173.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 m -124.35 89.03 3.0 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 127.177 2.191 . . . . 0.0 108.298 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 3.7 t -92.17 81.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.6 147.33 32.12 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.42 149.61 33.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.05 0.453 . . . . 0.0 110.115 162.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -95.51 107.98 36.65 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 117.802 -1.094 . . . . 0.0 108.61 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.27 -6.96 17.55 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.164 1.909 . . . . 0.0 113.372 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.46 38.18 4.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.157 1.783 . . . . 0.0 109.479 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.395 0 O-C-N 120.605 -1.309 . . . . 0.0 111.675 175.623 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -50.06 -48.28 79.38 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 120.48 1.491 . . . . 0.0 110.051 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.62 -29.61 5.63 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.847 1.698 . . . . 0.0 111.652 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.37 -40.59 71.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.325 0.966 . . . . 0.0 109.516 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.88 -71.74 0.09 Allowed 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.219 1.007 . . . . 0.0 110.516 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.9 m -60.31 -14.47 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 O-C-N 119.542 -1.974 . . . . 0.0 114.549 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -80.26 -18.26 49.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.878 1.671 . . . . 0.0 112.867 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.07 -27.82 61.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.775 1.17 . . . . 0.0 111.037 164.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -87.65 37.65 0.8 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.535 -0.728 . . . . 0.0 110.672 -162.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.03 27.09 4.87 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.717 2.103 . . . . 0.0 115.157 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.76 166.89 22.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.627 1.214 . . . . 0.0 112.89 -167.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 7.4 mt-10 -141.85 -28.37 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.906 0.882 . . . . 0.0 111.69 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -134.71 160.94 36.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.629 1.172 . . . . 0.0 109.444 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.24 148.84 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.606 1.562 . . . . 0.0 106.902 169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.41 113.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.2 m -135.08 -175.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.343 1.057 . . . . 0.0 110.264 -170.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -118.01 -100.35 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.37 -24.17 59.49 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.565 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.302 2.4 tt 44.2 -97.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.577 2.351 . . . . 0.0 113.696 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.13 124.01 2.22 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 127.449 2.452 . . . . 0.0 109.93 -174.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.35 -40.73 17.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.726 1.61 . . . . 0.0 112.472 -169.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -58.05 -34.64 70.31 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.506 1.503 . . . . 0.0 112.69 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.79 -22.52 46.21 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.453 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.6 mm -54.72 -46.79 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.93 -11.76 14.8 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.56 -1.337 . . . . 0.0 114.311 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -57.09 4.76 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 121.26 1.846 . . . . 0.0 111.163 167.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -53.56 1.68 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.655 1.582 . . . . 0.0 110.659 167.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.47 -13.88 62.43 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.528 1.142 . . . . 0.0 111.49 -170.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.71 -22.45 40.3 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 119.212 0.915 . . . . 0.0 110.517 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.48 10.69 7.93 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.144 0.429 . . . . 0.0 111.856 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.66 23.62 58.78 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.399 0.999 . . . . 0.0 112.99 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.85 94.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.71 1.204 . . . . 0.0 110.909 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 127.99 34.55 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.567 . . . . 0.0 110.55 -166.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.63 103.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 122.57 1.176 . . . . 0.0 108.321 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.5 mt -85.67 134.38 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -118.56 179.42 4.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.83 0.452 . . . . 0.0 111.568 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.28 20.33 76.62 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.682 0.614 . . . . 0.0 112.106 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.93 175.04 6.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.224 1.012 . . . . 0.0 109.522 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.8 p -166.96 156.51 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.57 1.548 . . . . 0.0 107.323 166.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.57 -169.67 12.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -80.48 168.83 18.48 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.598 -0.942 . . . . 0.0 109.88 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.85 -49.96 76.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 O-C-N 121.752 -0.592 . . . . 0.0 109.592 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.1 -30.74 62.49 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -75.76 -64.44 1.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.31 -44.24 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.746 1.618 . . . . 0.0 111.119 -171.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.1 t -59.15 -49.74 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.65 -33.67 76.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.565 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -60.76 -46.33 90.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.21 1.368 . . . . 0.0 110.426 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -59.14 -52.17 66.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.586 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -32.15 66.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.543 0.611 . . . . 0.0 110.856 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 m -76.98 -2.43 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.385 0.674 . . . . 0.0 111.882 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.8 8.92 87.21 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.911 -1.118 . . . . 0.0 112.718 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -75.33 -44.76 43.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.104 1.452 . . . . 0.0 110.405 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.53 151.81 37.88 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.852 1.261 . . . . 0.0 110.031 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 tptt . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 123.943 0.897 . . . . 0.0 111.949 -178.122 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 CA--C 1.507 -0.704 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 mt -142.42 142.98 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.8 104.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 0.0 106.867 -170.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.45 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -81.39 140.27 34.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.307 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.18 113.14 9.56 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.54 108.09 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.493 2.129 . . . . 0.0 108.009 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -100.57 158.22 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.309 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.9 m -81.49 -25.62 35.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.503 -0.761 . . . . 0.0 111.524 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -152.29 157.83 41.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.567 1.076 . . . . 0.0 109.675 -174.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -95.23 84.25 4.03 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.841 1.257 . . . . 0.0 108.578 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -107.81 38.62 2.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 116.803 -1.57 . . . . 0.0 110.383 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 32.43 79.56 0.02 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 125.299 1.428 . . . . 0.0 112.958 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 78.08 -36.12 0.21 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 128.633 2.773 . . . . 0.0 113.249 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.35 -7.87 35.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.756 0.707 . . . . 0.0 110.549 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -39.55 106.6 0.4 Allowed Pre-proline 0 N--CA 1.448 -0.557 1 C-N-CA 131.845 4.058 . . . . 0.0 111.051 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.77 133.78 15.85 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.99 2.46 . . . . 0.0 110.778 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -64.44 127.16 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.493 0.663 . . . . 0.0 110.174 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -63.19 168.45 4.24 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.423 1.089 . . . . 0.0 109.321 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.78 -15.37 34.83 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.198 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -131.02 -177.72 4.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -120.36 -55.78 2.02 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.648 1.179 . . . . 0.0 108.531 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.02 -6.21 12.0 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 117.424 -1.764 . . . . 0.0 116.324 -166.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.8 39.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.799 2.3 . . . . 0.0 109.869 163.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 144.96 97.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.3 -18.47 20.6 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.203 1.936 . . . . 0.0 114.23 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.15 160.63 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.146 1.378 . . . . 0.0 109.811 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -133.56 104.75 6.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.945 1.698 . . . . 0.0 108.473 170.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.77 93.3 6.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.45 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.3 m-85 -81.98 101.34 10.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 167.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.2 160.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -111.14 -166.9 1.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.393 0.997 . . . . 0.0 108.518 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -157.07 144.44 10.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 164.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.0 124.22 23.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 128.401 2.68 . . . . 0.0 105.19 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 36.73 61.53 0.85 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.786 2.034 . . . . 0.0 111.729 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 64.95 11.16 6.82 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 128.458 2.703 . . . . 0.0 115.335 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.14 164.7 18.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 120.165 1.348 . . . . 0.0 109.639 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.36 -28.0 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 113.792 -162.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.45 -56.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.912 2.485 . . . . 0.0 114.398 -165.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -162.6 155.19 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.454 1.502 . . . . 0.0 110.34 -165.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mm -128.09 117.02 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.038 2.535 . . . . 0.0 106.088 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -109.7 98.39 7.75 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 165.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.54 86.81 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -93.55 153.71 18.28 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -64.91 167.44 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 109.329 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.22 109.97 29.65 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 158.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.13 -7.29 19.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.632 1.554 . . . . 0.0 112.946 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.38 39.39 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.722 1.209 . . . . 0.0 109.985 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.434 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -172.623 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.216 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -48.61 -50.9 56.73 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.439 1.018 . . . . 0.0 110.441 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -75.98 -19.96 15.4 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.347 1.365 . . . . 0.0 112.844 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -66.98 -40.59 87.44 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 119.421 1.01 . . . . 0.0 109.254 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -53.1 -64.4 0.83 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.039 0.936 . . . . 0.0 110.265 168.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.7 m -63.21 -29.22 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 119.952 1.251 . . . . 0.0 113.447 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -64.12 -23.28 67.26 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.76 -1.212 . . . . 0.0 112.791 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -24.71 61.23 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 121.245 1.839 . . . . 0.0 110.798 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.71 38.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.853 1.261 . . . . 0.0 111.102 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 38.63 37.09 0.51 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.735 2.588 . . . . 0.0 116.799 165.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.6 175.29 10.62 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.04 -31.56 0.54 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.792 1.637 . . . . 0.0 112.922 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.8 tp -134.46 159.83 39.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.305 1.05 . . . . 0.0 109.552 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.9 130.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.4 mt -114.45 112.42 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.92 170.34 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.556 1.542 . . . . 0.0 109.277 -172.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -99.64 -93.64 0.26 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.32 -19.98 53.53 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.51 -1.161 . . . . 0.0 114.661 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.336 2.7 tt 29.55 -129.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 127.724 2.41 . . . . 0.0 112.978 -172.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.22 -162.99 20.27 Favored Glycine 0 CA--C 1.541 1.698 1 C-N-CA 131.227 4.251 . . . . 0.0 106.822 176.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -37.69 9.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 121.145 2.472 . . . . 0.0 111.106 165.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -60.84 -20.79 62.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.98 -4.49 17.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.383 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -56.18 -41.26 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 157.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.26 -18.27 15.62 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.64 7.09 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 120.811 -1.181 . . . . 0.0 108.826 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.02 -40.22 95.84 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 125.789 1.636 . . . . 0.0 109.054 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -56.49 -27.6 57.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.72 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.16 -11.95 61.24 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.186 1.357 . . . . 0.0 111.738 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.5 ptp -130.81 6.38 4.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.867 1.667 . . . . 0.0 111.851 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.56 37.15 66.28 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 120.653 -1.279 . . . . 0.0 110.906 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 121.01 34.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -59.08 147.87 33.23 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.878 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.57 126.21 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.03 119.87 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -113.4 158.78 20.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.935 1.294 . . . . 0.0 108.794 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 11.33 74.25 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.538 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.71 174.37 1.05 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.362 1.581 . . . . 0.0 113.322 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -161.74 148.61 14.2 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.663 -1.273 . . . . 0.0 109.768 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.06 -163.77 12.17 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 124.011 0.819 . . . . 0.0 112.618 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.9 p -81.1 174.73 11.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.936 0.894 . . . . 0.0 109.81 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.47 -54.92 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 O-C-N 121.028 -1.045 . . . . 0.0 109.756 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.78 -37.98 69.28 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.94 -49.87 40.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.508 0.723 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.54 -40.51 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.631 1.172 . . . . 0.0 110.513 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.21 -51.84 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -62.0 -44.88 95.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.028 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -52.91 -39.24 62.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.305 0.957 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -76.01 -43.2 45.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mp -62.31 -28.49 69.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.687 0.795 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.5 m -80.61 -37.44 31.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.38 1.072 . . . . 0.0 109.833 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.13 10.42 22.38 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.158 0.885 . . . . 0.0 112.986 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -61.72 -44.03 97.71 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.182 0.991 . . . . 0.0 108.664 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 137.74 57.19 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.123 1.369 . . . . 0.0 110.626 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tptm . . . . . 0 CA--C 1.518 -0.281 0 C-N-CA 124.635 1.174 . . . . 0.0 112.67 -170.081 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 2.1 ttm . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.152 0.025 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.7 142.8 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.75 107.41 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 129.779 3.232 . . . . 0.0 107.42 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.444 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -83.61 150.19 26.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.158 0.435 . . . . 0.0 111.367 175.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -142.77 120.01 7.02 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.19 123.17 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 108.75 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 m -118.54 156.89 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.158 0.583 . . . . 0.0 110.31 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -81.73 -21.49 37.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.524 -0.75 . . . . 0.0 112.123 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -142.77 161.36 38.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.621 1.1 . . . . 0.0 109.534 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -91.96 98.63 11.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -139.98 39.19 1.97 Allowed 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.77 -0.581 . . . . 0.0 110.473 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.02 -140.77 26.35 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-N 119.074 0.852 . . . . 0.0 112.347 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -16.75 6.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.93 -2.7 55.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.535 1.534 . . . . 0.0 110.755 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.4 m -50.57 122.49 16.1 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.984 1.714 . . . . 0.0 110.991 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.91 130.99 15.09 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 123.021 2.481 . . . . 0.0 109.703 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.3 140.11 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.52 175.48 9.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.098 0.951 . . . . 0.0 108.906 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.72 -21.65 21.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 118.356 -0.83 . . . . 0.0 111.126 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -130.93 -175.14 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.118 2.167 . . . . 0.0 108.277 -173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.31 -48.13 2.33 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.527 1.131 . . . . 0.0 109.77 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -19.71 59.28 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -165.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.7 38.55 3.05 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.629 1.214 . . . . 0.0 110.57 168.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.49 129.2 89.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.62 -21.69 45.33 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.308 2.005 . . . . 0.0 114.888 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -145.33 164.37 31.66 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 119.359 0.981 . . . . 0.0 109.191 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -134.17 103.98 6.0 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.168 1.387 . . . . 0.0 108.608 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.75 91.15 5.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.444 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.5 m-85 -82.95 94.61 7.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.2 155.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -98.16 -172.2 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.819 -1.175 . . . . 0.0 110.475 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 t -138.79 157.18 29.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 153.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -154.12 142.09 20.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.45 2.3 . . . . 0.0 104.969 162.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 47.62 47.8 17.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.727 1.149 . . . . 0.0 111.128 170.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.18 41.19 1.98 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.556 1.542 . . . . 0.0 115.029 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.6 169.09 18.4 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.283 0.633 . . . . 0.0 109.534 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.98 -31.38 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 113.484 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.69 -62.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.045 2.138 . . . . 0.0 114.789 -161.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.93 167.16 30.67 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.985 1.314 . . . . 0.0 111.525 -162.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.28 147.86 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.454 2.301 . . . . 0.0 107.86 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -145.21 97.51 3.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 p -105.09 65.89 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -89.1 150.26 22.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -170.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.78 148.67 49.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -80.1 122.28 82.85 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.297 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.98 -13.28 39.35 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.768 2.312 . . . . 0.0 114.789 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -134.05 39.91 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.499 1.52 . . . . 0.0 108.531 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 O-C-N 120.432 -1.417 . . . . 0.0 110.98 -179.757 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.51 -52.86 16.17 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.843 0.747 . . . . 0.0 109.989 172.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -75.67 -27.51 8.91 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.478 1.206 . . . . 0.0 113.199 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -55.82 -45.37 78.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.77 -66.48 0.49 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.185 0.994 . . . . 0.0 110.962 170.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 m -61.18 -21.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.871 1.668 . . . . 0.0 113.296 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.39 -23.86 62.85 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.814 1.246 . . . . 0.0 112.187 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -79.81 -18.64 50.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.642 1.11 . . . . 0.0 112.079 168.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -85.88 39.32 0.8 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.459 1.104 . . . . 0.0 111.084 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.9 16.85 41.14 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 160.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.53 165.67 24.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.909 1.354 . . . . 0.0 114.552 -161.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.417 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -133.94 -34.16 1.01 Allowed 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.942 1.297 . . . . 0.0 111.189 173.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -137.34 154.19 50.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -171.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -149.14 141.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 67.2 mt -132.91 111.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.15 -178.39 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.453 0.644 . . . . 0.0 110.592 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -114.0 -100.45 0.43 Allowed 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.3 61.96 1.25 Allowed Glycine 0 C--N 1.329 0.171 0 C-N-CA 125.688 1.613 . . . . 0.0 111.441 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.0 tt -59.96 172.46 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 125.462 1.505 . . . . 0.0 110.988 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 152.53 17.92 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -42.3 52.8 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 124.952 1.301 . . . . 0.0 112.418 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -56.95 -22.69 39.87 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.61 -31.71 13.15 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.311 1.045 . . . . 0.0 111.909 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.7 -45.77 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.1 -11.13 5.29 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.19 -57.14 3.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.551 1.069 . . . . 0.0 109.632 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -58.41 -39.15 78.95 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.008 1.723 . . . . 0.0 109.148 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -55.43 -29.26 58.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.526 1.131 . . . . 0.0 112.842 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.61 -6.53 55.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.696 1.135 . . . . 0.0 111.081 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -130.99 -0.78 4.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.13 1.372 . . . . 0.0 112.059 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.91 38.94 93.39 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.996 -1.065 . . . . 0.0 110.501 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.44 127.79 38.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 167.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -78.08 142.0 38.42 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 p -131.1 101.56 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 56.3 mt -74.36 149.27 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 125.829 1.652 . . . . 0.0 107.399 171.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.41 176.17 7.93 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.62 19.21 77.74 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.34 -0.7 . . . . 0.0 113.295 165.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 179.78 6.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.279 1.04 . . . . 0.0 110.329 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 p -164.8 154.54 13.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.313 2.245 . . . . 0.0 107.091 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.86 -168.02 13.22 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 123.55 0.531 . . . . 0.0 112.885 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.7 p -79.68 173.38 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.775 -0.838 . . . . 0.0 109.966 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.58 -57.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.003 0.921 . . . . 0.0 108.955 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.08 -32.36 72.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.418 -173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.93 -54.23 20.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.21 1.404 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.4 t -57.33 -30.05 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.695 1.198 . . . . 0.0 111.139 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.8 -53.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -54.29 -44.59 72.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.617 0.767 . . . . 0.0 109.963 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -53.81 -38.8 64.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.544 0.738 . . . . 0.0 111.073 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.36 -39.44 32.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.927 0.891 . . . . 0.0 112.503 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.25 -26.29 68.3 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.402 1.456 . . . . 0.0 111.275 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -1.86 57.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.514 1.126 . . . . 0.0 111.802 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.64 69.25 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.328 -1.483 . . . . 0.0 113.226 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -78.13 -27.48 48.27 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.804 1.302 . . . . 0.0 110.538 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.55 152.88 22.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.099 0.96 . . . . 0.0 110.667 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 C-N-CA 124.413 1.085 . . . . 0.0 110.514 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 tpp . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 mt -139.05 142.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 mt -132.96 104.39 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 127.217 2.207 . . . . 0.0 105.9 -161.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.01 142.3 35.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.808 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.3 115.14 11.7 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.1 116.73 4.64 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.368 2.045 . . . . 0.0 106.878 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 m -114.28 152.2 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 118.258 0.481 . . . . 0.0 109.843 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -77.34 -26.38 52.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.871 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -145.08 150.96 37.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.262 0.937 . . . . 0.0 109.516 -172.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.45 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 48.4 t-20 -85.78 64.75 8.79 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.239 1.816 . . . . 0.0 108.779 -168.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -111.2 39.24 2.33 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.495 -0.753 . . . . 0.0 109.319 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.88 -108.05 0.07 OUTLIER Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.462 1.982 . . . . 0.0 112.953 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -20.53 46.51 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.69 -6.85 58.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.934 2.494 . . . . 0.0 110.674 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.0 m -51.7 119.93 14.63 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.622 1.969 . . . . 0.0 112.28 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.39 135.28 20.1 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.864 2.376 . . . . 0.0 110.893 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.02 139.55 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.951 0.5 . . . . 0.0 109.771 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.38 177.05 6.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.747 1.219 . . . . 0.0 110.032 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -96.06 -42.12 8.4 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.71 -0.619 . . . . 0.0 111.634 -171.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -100.18 178.49 4.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -120.43 -47.36 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.564 1.146 . . . . 0.0 109.672 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -12.03 34.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.69 1.138 . . . . 0.0 114.127 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.04 38.93 3.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.078 1.439 . . . . 0.0 110.848 168.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.71 130.18 82.02 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.3 -23.58 20.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.361 2.041 . . . . 0.0 113.338 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 69.3 m-85 -145.75 153.38 40.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.099 1.36 . . . . 0.0 107.761 -176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -126.49 110.31 13.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.84 89.79 5.27 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -81.72 93.02 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -79.74 153.73 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -103.14 -168.27 1.49 Allowed 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.646 -0.659 . . . . 0.0 109.769 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.29 138.69 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 163.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.16 96.43 6.22 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 164.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 71.02 -50.11 0.68 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.33 2.252 . . . . 0.0 114.328 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.91 -1.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.212 2.605 . . . . 0.0 112.543 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.84 178.22 4.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.257 1.423 . . . . 0.0 108.211 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.87 -18.76 23.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 120.206 1.366 . . . . 0.0 113.438 -162.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.22 -79.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.72 1.145 . . . . 0.0 110.383 -159.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -154.07 168.02 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 109.791 -168.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.9 mm -100.49 162.5 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 127.038 2.135 . . . . 0.0 106.691 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 m -148.61 84.66 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.677 1.591 . . . . 0.0 107.426 157.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.33 84.11 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 175.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -93.38 158.33 15.78 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -78.94 145.45 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -84.59 108.8 16.08 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.34 -17.26 59.22 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.23 1.287 . . . . 0.0 111.929 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -120.2 38.75 3.88 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.398 1.079 . . . . 0.0 110.258 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.323 0 O-C-N 120.851 -1.155 . . . . 0.0 110.918 -178.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.823 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.38 -55.71 17.67 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 110.077 174.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.48 -20.93 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.963 1.776 . . . . 0.0 110.581 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.67 -44.67 85.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.296 0.638 . . . . 0.0 109.907 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -55.72 -66.91 0.34 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.274 1.43 . . . . 0.0 110.422 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.71 -22.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -0.94 8.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 113.374 171.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 -19.08 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.837 -1.165 . . . . 0.0 110.667 168.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -84.61 37.25 0.63 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.613 0.642 . . . . 0.0 111.375 -174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 41.58 33.94 1.07 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.238 2.351 . . . . 0.0 114.492 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.19 166.73 15.65 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.613 1.707 . . . . 0.0 112.875 -168.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -139.14 -40.69 0.47 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.916 1.286 . . . . 0.0 110.923 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp -127.98 156.25 42.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.296 1.038 . . . . 0.0 108.664 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.56 142.88 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 94.4 mt -134.54 114.09 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 m -131.24 170.34 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.226 0.61 . . . . 0.0 110.065 -171.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -60.84 1.97 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.331 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.86 4.38 0.64 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 117.484 1.754 . . . . 0.0 117.484 -173.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 74' ' ' GLY 0.274 4.4 tt 31.83 -123.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 127.031 2.132 . . . . 0.0 114.994 162.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 156.75 155.76 7.58 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 128.039 2.733 . . . . 0.0 109.004 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -59.62 -31.96 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -164.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -30.32 71.16 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.466 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.66 -22.87 24.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.496 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.55 -42.61 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 121.005 1.73 . . . . 0.0 108.61 160.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.95 -10.6 22.24 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 120.453 -1.404 . . . . 0.0 113.118 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.66 -62.4 1.46 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 119.855 1.207 . . . . 0.0 111.333 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.403 ' CD2' HG13 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -30.99 -57.88 0.22 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 128.027 2.531 . . . . 0.0 109.61 161.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.02 -13.17 62.29 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.959 0.787 . . . . 0.0 112.57 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.46 59.23 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.824 0.738 . . . . 0.0 111.759 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -137.12 7.6 2.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.018 0.372 . . . . 0.0 111.811 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.35 28.5 35.68 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.626 1.584 . . . . 0.0 112.39 -170.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.06 99.52 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 124.341 1.057 . . . . 0.0 108.44 -172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -64.34 128.44 35.8 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.392 -163.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.403 HG13 ' CD2' ' A' ' 81' ' ' PHE . 7.0 p -110.77 112.25 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.0 mt -88.13 147.61 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -179.41 5.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.24 13.84 73.65 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-O 119.116 -0.824 . . . . 0.0 114.163 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.52 162.48 28.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.085 1.442 . . . . 0.0 109.936 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -146.14 160.1 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.053 2.141 . . . . 0.0 106.527 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.49 -161.06 17.95 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.469 0.577 . . . . 0.0 113.793 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -92.99 171.38 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 163.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -53.17 -54.97 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.883 0.873 . . . . 0.0 109.273 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.38 -31.0 71.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.047 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.458 ' HG2' HE21 ' A' ' 102' ' ' GLN . 42.4 tt0 -70.87 -55.57 8.18 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.08 -44.87 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.363 1.065 . . . . 0.0 110.599 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.59 -46.91 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -59.86 -42.14 93.02 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.887 0.767 . . . . 0.0 111.296 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.458 HE21 ' HG2' ' A' ' 98' ' ' GLU . 72.3 mt-30 -58.76 -52.5 65.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.863 0.865 . . . . 0.0 109.801 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.05 -46.66 83.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.11 -25.5 67.75 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.065 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 m -90.59 7.86 37.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 112.957 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.24 -1.28 88.96 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.177 1.37 . . . . 0.0 115.184 168.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -71.25 -44.06 66.04 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.367 1.084 . . . . 0.0 111.831 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.62 141.75 37.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.644 1.178 . . . . 0.0 108.473 -166.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 CA-C-O 123.482 1.61 . . . . 0.0 112.937 -173.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.412 ' HA ' ' OE2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.521 0.201 . . . . 0.0 110.772 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 mt -115.31 153.13 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 165.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.48 105.29 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 127.16 2.184 . . . . 0.0 105.797 -164.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.438 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.47 145.56 31.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 118.623 -0.704 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.2 mt -145.93 114.59 4.66 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.38 129.55 16.05 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.523 1.482 . . . . 0.0 108.318 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.02 150.15 26.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.3 m -68.07 -27.02 66.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.337 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.63 156.07 39.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.663 1.585 . . . . 0.0 107.937 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -85.71 95.52 9.41 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.69 39.67 3.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.072 0.949 . . . . 0.0 108.616 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.2 -127.96 30.08 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 120.751 -1.218 . . . . 0.0 111.464 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -58.29 -45.83 87.2 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.153 1.381 . . . . 0.0 111.736 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -1.87 4.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.751 2.42 . . . . 0.0 114.307 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.1 m -53.05 109.03 1.26 Allowed Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 125.201 1.4 . . . . 0.0 110.955 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.89 135.37 14.08 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.42 1.414 . . . . 0.0 108.932 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.43 134.37 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.978 0.911 . . . . 0.0 111.288 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.37 169.87 12.53 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.869 1.267 . . . . 0.0 107.91 166.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -88.09 -55.26 3.83 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 121.454 -0.779 . . . . 0.0 110.577 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.7 85.59 2.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -152.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -37.49 -47.22 0.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 112.908 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.35 40.98 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.773 -1.015 . . . . 0.0 115.341 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 47.96 1.56 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 108.737 173.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.63 137.79 54.84 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.76 -25.28 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.482 2.121 . . . . 0.0 114.457 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -146.3 158.18 43.86 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.28 103.92 8.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.523 1.529 . . . . 0.0 107.904 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 78.99 6.66 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.543 1.537 . . . . 0.0 107.624 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.438 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.28 3.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 170.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 t -83.05 164.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 123.682 0.793 . . . . 0.0 109.055 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.87 2.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.94 -1.1 . . . . 0.0 108.946 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.19 147.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.65 113.76 19.08 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 173.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.8 t30 54.61 -86.86 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.716 1.206 . . . . 0.0 111.627 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.9 12.22 2.89 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.605 1.562 . . . . 0.0 111.917 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 156.32 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.821 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.21 -32.32 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.137 1.775 . . . . 0.0 112.938 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 59.17 -51.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.309 2.244 . . . . 0.0 115.48 -168.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.72 162.03 15.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 110.768 -160.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mm -135.75 140.48 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.205 1.802 . . . . 0.0 107.683 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.84 88.55 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.741 2.016 . . . . 0.0 107.704 165.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.7 t -89.86 93.46 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 164.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.76 152.63 19.47 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -56.92 152.97 11.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.427 1.091 . . . . 0.0 110.439 168.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -79.86 133.66 58.09 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.94 -9.72 26.24 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 CA-C-N 121.128 1.439 . . . . 0.0 112.136 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.81 39.73 0.96 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.042 1.337 . . . . 0.0 110.082 -163.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.205 0 O-C-N 120.275 -1.516 . . . . 0.0 112.367 -169.135 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.06 -53.45 48.27 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 119.237 0.926 . . . . 0.0 109.515 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.43 -32.09 10.48 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.02 1.814 . . . . 0.0 111.925 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.09 -38.35 73.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.063 0.847 . . . . 0.0 110.884 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.77 -65.59 0.61 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.922 1.289 . . . . 0.0 110.971 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 m -61.74 -22.34 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 119.776 1.171 . . . . 0.0 113.952 -173.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.59 -12.34 61.51 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.368 -1.457 . . . . 0.0 113.946 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.78 -18.93 24.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.848 1.204 . . . . 0.0 109.813 165.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.22 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 119.84 -1.787 . . . . 0.0 111.221 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.51 20.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.337 2.398 . . . . 0.0 116.264 161.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.2 176.85 9.29 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -159.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 11.3 mt-10 -144.09 -53.31 0.33 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 110.661 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.02 157.03 19.73 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.618 1.167 . . . . 0.0 109.373 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.56 139.61 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 127.387 2.275 . . . . 0.0 105.084 172.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 94.5 mt -131.43 111.4 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.35 155.38 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.85 0.86 . . . . 0.0 110.657 -162.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -95.14 -62.1 1.36 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.66 -1.275 . . . . 0.0 111.195 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.82 -54.46 1.3 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 121.757 -0.589 . . . . 0.0 113.977 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.489 HG12 ' H ' ' A' ' 74' ' ' GLY 0.301 3.7 tt 44.38 -168.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 130.143 3.377 . . . . 0.0 115.093 -173.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.489 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.35 167.21 39.86 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.289 1.9 . . . . 0.0 110.42 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.8 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -64.74 -36.28 83.8 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 121.201 1.819 . . . . 0.0 109.638 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.66 -40.7 63.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.256 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.44 -43.89 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 119.732 1.151 . . . . 0.0 109.622 168.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.75 -11.25 11.32 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.131 -1.606 . . . . 0.0 114.89 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.18 -58.53 3.1 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.208 1.403 . . . . 0.0 110.441 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -35.63 -56.33 0.67 Allowed 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 126.958 2.103 . . . . 0.0 109.153 160.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.32 -10.05 56.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 117.441 -1.266 . . . . 0.0 111.763 -167.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.98 63.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.714 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.13 14.94 5.7 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.379 0.424 . . . . 0.0 111.476 -163.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.2 26.8 56.75 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.101 -0.374 . . . . 0.0 112.819 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.67 108.21 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -168.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.68 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.929 1.692 . . . . 0.0 110.349 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.05 95.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.51 139.47 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.87 154.06 47.68 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 -171.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.8 11.04 38.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.08 0.848 . . . . 0.0 114.751 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.48 157.58 37.58 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.48 1.14 . . . . 0.0 110.85 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.1 p -159.52 130.3 5.87 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.64 -130.77 6.25 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.95 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.41 159.55 39.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.044 1.738 . . . . 0.0 111.344 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.7 t -63.68 -45.1 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 120.909 -1.119 . . . . 0.0 111.304 -166.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.54 -11.91 48.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.43 -43.55 5.38 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 117.356 -1.307 . . . . 0.0 108.972 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.1 t -45.93 -49.88 4.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 120.412 1.46 . . . . 0.0 110.569 169.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.42 -38.48 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.471 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -61.99 -51.01 69.78 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 117.352 -1.309 . . . . 0.0 110.314 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.22 -37.26 69.46 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.374 1.443 . . . . 0.0 111.589 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.0 -50.38 42.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.724 1.21 . . . . 0.0 112.005 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.86 -30.72 71.72 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.128 0.422 . . . . 0.0 110.086 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.4 m -74.72 -1.13 20.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.884 2.074 . . . . 0.0 112.483 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 -8.9 74.98 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.356 1.455 . . . . 0.0 112.966 168.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.51 -45.79 51.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.95 134.85 38.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.34 -166.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.558 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 ttp . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.707 0.289 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -137.66 145.47 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.53 111.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 128.423 2.689 . . . . 0.0 106.827 -162.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.411 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -84.02 147.67 27.29 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.289 0.95 . . . . 0.0 111.599 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.4 mt -141.64 113.82 6.6 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.47 110.01 2.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.343 2.696 . . . . 0.0 108.824 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 m -106.82 146.26 13.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.496 0.718 . . . . 0.0 111.409 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.418 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -141.53 149.08 40.38 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.582 1.083 . . . . 0.0 109.389 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.68 100.04 11.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.95 39.02 1.8 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 27.23 80.89 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 126.76 2.124 . . . . 0.0 114.884 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 80.66 -29.78 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 1 C-N-CA 131.821 4.049 . . . . 0.0 113.445 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.5 -8.46 54.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.03 1.286 . . . . 0.0 110.263 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.4 m -45.82 108.64 0.83 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 128.401 2.681 . . . . 0.0 110.086 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.55 131.66 12.74 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.209 2.606 . . . . 0.0 110.104 -172.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.0 tt -62.11 140.75 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.404 1.002 . . . . 0.0 109.708 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -94.62 -173.32 2.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.982 1.313 . . . . 0.0 110.699 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -101.05 -42.72 6.28 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.729 1.212 . . . . 0.0 111.584 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -122.13 104.4 9.46 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.986 1.314 . . . . 0.0 109.901 -173.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -44.43 -44.57 8.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.126 1.37 . . . . 0.0 111.585 166.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.12 -3.09 51.14 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 117.943 -1.476 . . . . 0.0 116.233 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -148.16 63.16 1.1 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.03 124.31 32.53 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.69 1.996 . . . . 0.0 108.276 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.21 -23.71 24.13 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 CA-C-N 122.181 1.815 . . . . 0.0 114.214 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -148.68 151.7 35.39 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.814 0.734 . . . . 0.0 109.041 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -122.31 106.21 10.89 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.717 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.74 81.52 6.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.6 1.16 . . . . 0.0 107.94 169.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.411 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 2.6 m-85 -70.36 141.1 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 161.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.44 150.44 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -96.55 -169.83 1.97 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.374 0.67 . . . . 0.0 109.512 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.4 115.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.681 -0.637 . . . . 0.0 110.102 165.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.82 91.94 6.59 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.39 -67.33 0.15 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.279 1.432 . . . . 0.0 112.69 174.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -145.71 12.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.138 1.775 . . . . 0.0 112.636 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.63 173.33 6.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.602 1.561 . . . . 0.0 109.389 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.91 -25.74 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 121.068 1.758 . . . . 0.0 114.229 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.53 -69.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.304 1.411 . . . . 0.0 112.989 -158.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -166.09 170.84 13.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.097 0.959 . . . . 0.0 112.071 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.2 mm -116.01 145.18 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.774 2.43 . . . . 0.0 106.56 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 m -147.35 68.36 1.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.025 2.53 . . . . 0.0 109.815 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.06 93.33 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -96.33 161.95 13.71 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.003 1.321 . . . . 0.0 109.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -71.5 149.36 45.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.66 1.584 . . . . 0.0 109.689 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.1 129.82 65.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 118.242 -0.885 . . . . 0.0 108.849 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.86 -27.26 26.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.168 1.246 . . . . 0.0 111.436 168.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.32 45.76 2.59 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.524 -1.36 . . . . 0.0 109.473 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.427 0 O-C-N 120.441 -1.412 . . . . 0.0 110.578 167.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 117.849 2.537 . . . . 0.0 117.849 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -51.49 -55.25 30.89 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 120.372 1.442 . . . . 0.0 109.254 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.62 -22.74 37.51 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 120.304 1.144 . . . . 0.0 110.36 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.82 -37.08 85.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.736 1.153 . . . . 0.0 110.485 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -61.42 -61.64 2.39 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.45 -27.72 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 120.603 -1.311 . . . . 0.0 113.674 -174.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -60.54 -22.63 63.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.199 1.0 . . . . 0.0 111.352 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.9 -18.64 58.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.945 1.702 . . . . 0.0 111.417 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -95.03 37.13 1.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.27 1.395 . . . . 0.0 112.195 -164.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 46.78 26.09 2.59 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.07 1.319 . . . . 0.0 115.357 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.32 171.8 13.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.112 1.456 . . . . 0.0 112.422 -168.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -143.89 -28.77 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.188 0.995 . . . . 0.0 112.965 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -139.42 154.66 47.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.08 143.36 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.2 mt -133.22 115.93 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.62 175.43 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.468 1.107 . . . . 0.0 110.251 -172.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -99.43 0.18 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.89 -28.26 24.1 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 121.143 1.792 . . . . 0.0 116.217 -170.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.499 HG12 ' H ' ' A' ' 74' ' ' GLY 0.311 7.2 tt 39.9 -135.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 127.9 2.48 . . . . 0.0 113.41 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.499 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.28 154.99 18.09 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 127.78 2.609 . . . . 0.0 109.647 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -39.92 85.71 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.792 1.296 . . . . 0.0 111.645 -171.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -53.32 -38.22 63.0 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.793 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.87 -35.4 38.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 117.097 -1.43 . . . . 0.0 112.373 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.9 -48.07 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 120.604 1.547 . . . . 0.0 108.471 164.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 -10.02 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.281 -1.342 . . . . 0.0 114.479 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.08 -53.35 9.03 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 121.227 1.83 . . . . 0.0 109.904 167.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -60.86 -35.05 75.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.458 1.103 . . . . 0.0 110.385 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -60.32 -20.28 58.65 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.37 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.27 -10.77 57.03 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.665 1.575 . . . . 0.0 111.53 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.0 ptp -134.45 13.65 3.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.37 1.068 . . . . 0.0 112.782 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.2 33.08 44.88 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.628 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -79.45 113.0 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -71.95 146.44 47.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t -127.07 112.27 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -94.61 133.25 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.879 1.672 . . . . 0.0 106.624 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -129.28 167.98 16.9 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.982 1.713 . . . . 0.0 108.183 -172.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 12.45 67.21 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.765 -1.02 . . . . 0.0 113.781 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 171.89 10.38 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.05 1.425 . . . . 0.0 110.6 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 p -160.85 152.9 20.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 109.456 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.76 -173.13 16.52 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.381 0.515 . . . . 0.0 112.808 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p -82.43 172.94 12.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.621 -0.929 . . . . 0.0 109.752 168.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -60.81 -49.13 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 O-C-N 121.156 -0.965 . . . . 0.0 110.54 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -58.62 -37.5 76.0 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.499 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.42 -58.32 3.48 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.052 1.741 . . . . 0.0 107.867 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.4 -44.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.762 1.625 . . . . 0.0 110.636 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.59 -35.72 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.68 -40.6 88.64 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.788 1.176 . . . . 0.0 111.797 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -59.46 -44.26 93.04 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.013 0.824 . . . . 0.0 110.05 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.0 -45.33 74.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.961 0.905 . . . . 0.0 113.139 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.17 -28.02 69.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.85 0.75 . . . . 0.0 110.377 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.9 m -77.07 -3.23 38.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.36 56.08 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.141 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 -49.75 58.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.94 131.54 43.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.482 1.113 . . . . 0.0 110.743 -171.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttm . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.3 mt -127.45 135.72 62.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -132.85 101.59 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 127.001 2.12 . . . . 0.0 107.031 -156.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.04 144.22 33.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.078 0.399 . . . . 0.0 111.131 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.3 mt -134.54 115.87 12.69 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.51 114.59 4.07 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.15 2.567 . . . . 0.0 109.079 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.34 157.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.08 . . . . 0.0 112.699 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -74.46 -25.33 59.34 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.865 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -150.57 152.16 33.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.134 1.374 . . . . 0.0 107.819 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -85.12 110.95 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 164.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -126.37 39.46 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.473 166.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.07 -102.39 0.58 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 125.368 1.461 . . . . 0.0 109.532 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -98.49 -31.68 11.86 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.875 1.27 . . . . 0.0 110.628 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.78 -10.07 54.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.305 1.442 . . . . 0.0 111.445 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.6 m -40.71 106.44 0.42 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 129.911 3.284 . . . . 0.0 111.892 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 135.82 19.97 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.899 2.4 . . . . 0.0 110.927 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.43 138.65 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -77.67 -160.16 0.17 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 108.265 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.54 -52.81 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.977 1.37 . . . . 0.0 109.697 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.4 179.13 6.04 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.894 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 54.5 t80 -121.0 -46.7 2.32 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.843 -1.16 . . . . 0.0 110.889 159.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.14 -42.22 16.38 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 41.47 2.21 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.833 1.253 . . . . 0.0 111.825 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.29 118.01 65.11 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-O 115.927 -1.987 . . . . 0.0 106.373 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.25 -17.67 50.12 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 113.717 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -149.1 158.92 44.57 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.738 1.215 . . . . 0.0 108.782 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.409 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 25.1 m-85 -126.22 128.9 47.95 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.318 1.847 . . . . 0.0 107.485 170.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.42 89.13 3.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 65' ' ' ALA . 2.7 m-85 -75.43 92.02 2.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.26 162.23 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -117.28 -167.64 1.35 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.81 -1.182 . . . . 0.0 108.714 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.33 136.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 120.872 -1.143 . . . . 0.0 109.751 165.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.05 91.82 3.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 168.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 56.68 -69.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.383 2.273 . . . . 0.0 114.345 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.25 11.81 3.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.555 1.542 . . . . 0.0 112.752 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.72 173.36 8.61 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.115 1.366 . . . . 0.0 110.207 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.45 -23.25 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.464 1.106 . . . . 0.0 112.994 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.05 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.593 1.557 . . . . 0.0 114.02 -162.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -162.24 167.16 24.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.367 1.467 . . . . 0.0 109.836 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 mm -124.28 138.6 53.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.897 2.079 . . . . 0.0 105.835 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 m -119.79 96.91 5.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.86 77.69 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 123.467 1.603 . . . . 0.0 107.523 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.6 127.99 32.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.585 1.554 . . . . 0.0 106.943 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -60.61 162.63 6.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.793 1.179 . . . . 0.0 108.681 158.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -78.2 153.38 79.59 Favored Pre-proline 0 N--CA 1.438 -1.059 0 O-C-N 121.496 -0.753 . . . . 0.0 109.428 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.12 -52.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.721 0.948 . . . . 0.0 110.916 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.24 38.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.332 -0.855 . . . . 0.0 111.278 -163.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.231 0 O-C-N 120.939 -1.101 . . . . 0.0 110.271 -160.293 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -46.98 -48.52 52.52 Favored Pre-proline 0 CA--C 1.556 1.204 0 CA-C-N 119.232 0.923 . . . . 0.0 110.398 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.73 -20.04 17.94 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.188 1.925 . . . . 0.0 112.385 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -64.96 -42.46 94.59 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -59.79 -62.14 2.1 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -63.91 -21.11 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.638 1.563 . . . . 0.0 112.545 -173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -64.1 -13.21 46.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 116.862 -1.542 . . . . 0.0 112.654 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -11.19 32.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 121.237 1.835 . . . . 0.0 112.488 173.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -90.56 37.29 0.91 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.956 0.798 . . . . 0.0 111.647 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.77 28.05 5.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.836 1.684 . . . . 0.0 114.179 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -63.48 152.82 37.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.662 1.731 . . . . 0.0 112.796 -173.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -144.4 -21.84 0.54 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 111.738 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.3 166.39 23.23 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 109.019 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.31 150.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 165.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.6 mt -134.19 112.04 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.89 176.81 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.469 1.508 . . . . 0.0 109.679 -167.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -103.26 -97.19 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.237 -1.363 . . . . 0.0 107.838 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.12 -12.94 40.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 120.731 1.605 . . . . 0.0 115.638 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.498 ' CG1' ' H ' ' A' ' 74' ' ' GLY . 2.3 tt 38.51 -130.17 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.527 1.931 . . . . 0.0 114.159 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.498 ' H ' ' CG1' ' A' ' 73' ' ' ILE . . . 168.82 158.46 12.79 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 129.437 3.398 . . . . 0.0 110.812 166.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -47.35 33.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.475 1.51 . . . . 0.0 112.492 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -55.9 -6.01 0.2 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.38 -40.45 3.64 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 116.785 -1.578 . . . . 0.0 110.235 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -42.44 -46.96 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.698 1.135 . . . . 0.0 108.958 161.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.36 -19.1 63.03 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.9 2.0 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -57.52 -44.52 85.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 124.013 0.925 . . . . 0.0 109.915 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.95 -14.14 59.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.495 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.98 72.62 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.015 1.734 . . . . 0.0 109.021 168.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -19.15 33.66 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.111 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.71 20.23 37.96 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.094 -1.004 . . . . 0.0 112.496 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.8 t -78.91 121.23 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -63.95 146.31 54.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.703 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 p -139.93 89.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.65 1.18 . . . . 0.0 107.989 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.12 131.58 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.21 171.86 7.35 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.012 1.325 . . . . 0.0 111.494 -173.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.76 4.05 38.1 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.003 1.287 . . . . 0.0 114.483 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.74 164.47 23.46 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.89 1.345 . . . . 0.0 110.324 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.3 p -162.17 124.87 2.91 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -159.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.29 -169.68 25.32 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 123.399 0.437 . . . . 0.0 112.618 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.3 p -79.92 170.56 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.929 0.865 . . . . 0.0 109.723 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.2 t -53.6 -59.83 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 C-N-CA 123.591 0.756 . . . . 0.0 109.425 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.01 -27.75 69.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.04 -54.26 8.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.812 1.645 . . . . 0.0 109.399 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 t -56.35 -43.45 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.837 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 t -52.88 -58.35 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 107.993 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.61 -44.05 95.07 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.009 -0.996 . . . . 0.0 111.939 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.96 -46.01 78.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.347 0.976 . . . . 0.0 110.0 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -62.87 -52.64 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.034 0.534 . . . . 0.0 112.152 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 110.812 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.5 m -74.29 -39.56 62.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.68 35.23 1.09 Allowed Glycine 0 C--N 1.333 0.365 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.145 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.15 -35.12 10.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.068 0.934 . . . . 0.0 112.257 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.53 146.52 31.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.978 1.311 . . . . 0.0 108.871 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 tptm . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 123.409 0.684 . . . . 0.0 110.315 -159.143 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptm . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.8 mt -124.38 132.24 71.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.21 104.46 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 129.012 2.925 . . . . 0.0 106.079 -164.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.468 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -82.08 133.9 35.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mt -127.8 118.26 21.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.89 127.21 17.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 106.8 -2.039 . . . . 0.0 106.8 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.13 157.51 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 119.538 1.063 . . . . 0.0 110.691 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.86 -34.45 60.03 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.991 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -146.16 169.35 18.91 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.183 0.993 . . . . 0.0 108.545 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -84.03 89.79 7.32 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 130.579 3.552 . . . . 0.0 108.599 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -128.67 38.91 3.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.717 -0.615 . . . . 0.0 110.794 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.41 -80.29 0.11 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 126.033 1.778 . . . . 0.0 113.351 167.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -120.93 -33.54 3.73 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.775 1.63 . . . . 0.0 111.393 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.67 -5.23 11.0 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.769 2.427 . . . . 0.0 112.177 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.24 109.62 1.28 Allowed Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 127.896 2.478 . . . . 0.0 108.318 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -83.04 137.37 8.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.181 1.92 . . . . 0.0 109.159 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.3 tt -58.92 133.99 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.012 0.91 . . . . 0.0 110.947 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 t -73.68 167.84 20.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.387 1.475 . . . . 0.0 109.137 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -90.82 -20.75 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.44 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -133.75 -176.7 4.26 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -120.33 -49.51 2.27 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 110.64 -176.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.6 -5.69 24.98 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 46.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.666 2.386 . . . . 0.0 106.852 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.04 143.4 94.31 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 162.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.76 -16.31 13.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.207 1.938 . . . . 0.0 113.089 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -149.51 155.88 41.08 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.903 -1.123 . . . . 0.0 109.72 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.64 114.3 17.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 126.265 1.826 . . . . 0.0 107.684 170.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.95 88.49 5.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 161.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -75.19 92.42 2.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 160.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.94 148.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -97.23 -167.69 1.58 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -144.74 136.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 164.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.491 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.55 -139.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.31 1.844 . . . . 0.0 106.95 167.389 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.491 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 20.1 t-20 -59.34 -54.11 50.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.712 -1.242 . . . . 0.0 109.398 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.27 11.42 0.71 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.296 1.039 . . . . 0.0 112.701 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.08 171.35 7.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.336 1.455 . . . . 0.0 108.543 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.13 -22.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 126.375 1.87 . . . . 0.0 112.664 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.15 -70.9 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.943 1.697 . . . . 0.0 112.052 -162.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -159.1 162.05 36.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.244 1.818 . . . . 0.0 109.25 -155.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mm -126.87 126.03 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -173.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -112.87 94.76 5.06 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 163.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -91.65 88.83 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -97.55 136.37 38.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.825 1.25 . . . . 0.0 109.655 -169.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -75.91 143.57 41.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.338 1.055 . . . . 0.0 108.235 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.59 116.46 60.93 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.118 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.92 -22.9 30.69 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.834 1.69 . . . . 0.0 112.312 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.85 39.86 3.86 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.534 1.134 . . . . 0.0 109.356 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 123.518 0.727 . . . . 0.0 110.693 -179.819 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -43.2 -54.06 9.98 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 120.8 1.636 . . . . 0.0 111.456 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.1 -31.24 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.969 2.446 . . . . 0.0 111.497 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -62.65 -41.55 99.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.924 -0.56 . . . . 0.0 109.559 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.16 -66.28 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.758 0.823 . . . . 0.0 109.679 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 m -60.56 -6.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.83 -20.03 17.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.502 -1.374 . . . . 0.0 112.432 175.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -64.3 -25.22 67.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.976 0.807 . . . . 0.0 110.753 158.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 36.25 0.74 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.306 0.957 . . . . 0.0 110.716 -165.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.69 4.39 0.04 OUTLIER Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.446 2.45 . . . . 0.0 116.741 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.427 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.78 158.46 25.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.086 -1.832 . . . . 0.0 112.736 -158.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.65 -20.35 2.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.745 0.818 . . . . 0.0 111.852 -165.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -134.36 152.84 52.04 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.671 0.607 . . . . 0.0 109.558 -174.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.49 139.0 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.55 111.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -131.05 -178.5 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.698 1.199 . . . . 0.0 111.685 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.31 -100.48 0.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.53 55.63 3.48 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 125.962 1.744 . . . . 0.0 112.503 -169.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.47 167.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 O-C-N 121.681 -0.893 . . . . 0.0 109.231 169.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.45 166.74 23.31 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.424 1.012 . . . . 0.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -36.31 46.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.302 1.441 . . . . 0.0 113.414 -166.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.82 -31.37 64.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.324 1.42 . . . . 0.0 112.449 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.18 -35.88 15.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.695 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -41.75 -54.29 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.981 1.264 . . . . 0.0 107.884 158.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.75 -14.21 42.04 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.52 -53.42 6.29 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.107 1.322 . . . . 0.0 110.566 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -57.78 -35.52 70.91 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.228 1.011 . . . . 0.0 110.807 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -49.76 -33.08 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.186 2.194 . . . . 0.0 114.043 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -18.94 64.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.172 0.896 . . . . 0.0 111.861 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.22 1.11 4.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.089 1.356 . . . . 0.0 113.551 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.05 39.16 97.23 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.052 -1.03 . . . . 0.0 112.246 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.64 117.79 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -74.15 139.47 44.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.593 -0.692 . . . . 0.0 110.175 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.05 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.208 1.403 . . . . 0.0 109.295 -168.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.06 131.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -150.91 144.15 24.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.322 -0.861 . . . . 0.0 112.198 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.19 11.91 22.96 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.749 1.166 . . . . 0.0 112.073 -169.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.33 177.65 3.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.169 1.485 . . . . 0.0 110.043 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.2 p -162.2 156.72 22.11 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 119.806 1.184 . . . . 0.0 110.032 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.63 -153.26 21.95 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 121.643 0.579 . . . . 0.0 111.792 172.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.73 153.4 26.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.791 0.837 . . . . 0.0 111.154 -171.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 t -61.24 -45.56 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 122.932 0.493 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.83 -28.24 65.86 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.433 0.561 . . . . 0.0 111.939 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.28 -57.04 3.79 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 127.347 2.259 . . . . 0.0 109.008 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.6 t -52.95 -45.37 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.791 1.237 . . . . 0.0 110.72 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.1 -50.38 79.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -55.88 -47.88 76.58 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.419 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -54.07 -38.2 65.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.123 1.329 . . . . 0.0 112.102 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -71.29 -51.29 25.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.506 0.723 . . . . 0.0 112.114 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.16 -38.92 68.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.5 m -78.98 -5.66 54.4 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.839 1.656 . . . . 0.0 112.025 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.8 4.28 82.61 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.848 1.214 . . . . 0.0 114.736 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -81.18 -35.16 31.76 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.765 1.283 . . . . 0.0 111.431 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.7 161.38 31.07 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.716 0.806 . . . . 0.0 110.845 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tptm . . . . . 0 C--O 1.232 0.173 0 C-N-CA 124.292 1.037 . . . . 0.0 109.821 -173.345 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.441 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 14.2 ttp . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 mt -140.17 147.05 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.7 mt -132.56 103.1 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 127.38 2.272 . . . . 0.0 106.265 -162.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.461 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.09 154.42 28.1 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 119.61 -0.233 . . . . 0.0 110.845 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -146.18 115.89 4.7 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.22 123.4 9.91 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.497 2.131 . . . . 0.0 108.225 169.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.81 157.93 21.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.448 0.567 . . . . 0.0 110.364 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.4 m -78.79 -27.84 44.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.078 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -148.75 148.94 30.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.111 0.869 . . . . 0.0 108.838 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -82.68 45.33 0.97 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.233 2.213 . . . . 0.0 112.987 -170.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -88.78 39.67 0.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.96 -1.713 . . . . 0.0 111.461 -167.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.51 -125.47 13.78 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.539 -1.35 . . . . 0.0 112.504 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -52.47 -45.82 66.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.648 1.579 . . . . 0.0 110.609 174.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -7.37 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.839 2.456 . . . . 0.0 111.834 -169.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -47.53 109.37 1.08 Allowed Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.151 1.78 . . . . 0.0 110.997 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.46 131.85 15.48 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.182 1.921 . . . . 0.0 109.975 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.94 142.93 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.488 1.115 . . . . 0.0 109.762 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.06 173.7 8.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.897 1.279 . . . . 0.0 108.735 174.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.34 -48.3 8.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 122.4 1.095 . . . . 0.0 109.196 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -86.88 166.39 15.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.486 -171.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -119.38 -52.27 2.27 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 123.862 0.865 . . . . 0.0 109.959 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -17.4 49.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.044 -0.864 . . . . 0.0 113.645 -172.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -139.2 39.3 2.1 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.283 1.833 . . . . 0.0 110.124 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.75 130.64 91.64 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 160.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.14 -17.87 35.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.445 1.43 . . . . 0.0 114.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -146.69 156.34 43.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.516 1.126 . . . . 0.0 109.541 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -134.18 106.42 7.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.039 1.736 . . . . 0.0 109.343 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.17 100.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.397 1.079 . . . . 0.0 108.662 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.461 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 4.5 m-85 -89.98 100.95 13.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 t -82.64 154.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 168.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -102.67 -165.04 1.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.41 132.6 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 163.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.85 87.23 3.25 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 170.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 70.31 -75.01 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.125 1.37 . . . . 0.0 110.445 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -137.51 15.27 2.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.04 1.336 . . . . 0.0 112.197 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.34 174.79 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.981 1.313 . . . . 0.0 109.508 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.88 -22.87 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 121.217 1.826 . . . . 0.0 114.346 -166.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.76 -64.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.629 1.971 . . . . 0.0 115.084 -162.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.45 169.88 19.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.588 1.155 . . . . 0.0 108.823 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.2 mm -131.18 139.69 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 127.749 2.42 . . . . 0.0 105.32 -172.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.67 70.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.044 -1.035 . . . . 0.0 108.262 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.17 88.72 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 106.831 167.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.33 155.65 22.75 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.582 1.153 . . . . 0.0 108.25 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -82.34 166.34 19.56 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.994 -0.441 . . . . 0.0 109.991 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.9 110.77 37.83 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.203 173.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.44 -6.06 18.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.506 2.137 . . . . 0.0 113.275 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -134.99 38.17 3.0 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.06 0.944 . . . . 0.0 109.504 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 119.04 0.836 . . . . 0.0 110.475 -172.224 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.52 -53.09 38.63 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 119.467 1.03 . . . . 0.0 108.301 168.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.99 -28.19 24.44 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.571 1.514 . . . . 0.0 111.88 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.14 -42.69 99.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.05 1.295 . . . . 0.0 108.984 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.505 ' CZ ' ' HE2' ' A' ' 63' ' ' LYS . 4.6 t80 -53.39 -63.05 1.27 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.256 0.622 . . . . 0.0 110.256 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 m -61.91 -30.65 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.276 -0.89 . . . . 0.0 113.154 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -65.13 -17.52 64.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -30.88 66.31 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.089 165.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.505 ' HE2' ' CZ ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -86.27 37.32 0.72 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.912 1.687 . . . . 0.0 113.378 -167.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 36.6 42.36 0.66 Allowed Glycine 0 CA--C 1.541 1.683 0 C-N-CA 127.694 2.569 . . . . 0.0 117.208 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 29' ' ' PHE . . . -63.79 168.9 4.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.63 1.715 . . . . 0.0 113.789 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.441 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.4 mt-10 -139.73 -25.98 0.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.031 1.732 . . . . 0.0 111.046 172.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 tp -142.53 150.22 40.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.379 0.99 . . . . 0.0 110.603 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 t -147.71 123.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 87.9 mt -111.54 112.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.61 -177.1 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.76 1.224 . . . . 0.0 110.272 -172.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -112.14 -87.08 0.55 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.428 -0.795 . . . . 0.0 108.919 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.51 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 124.365 0.983 . . . . 0.0 113.65 -167.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.461 HG12 ' H ' ' A' ' 74' ' ' GLY 0.257 4.6 tt 43.56 -153.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 126.876 2.07 . . . . 0.0 112.883 -176.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.461 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -168.66 156.55 28.04 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.606 2.527 . . . . 0.0 109.329 176.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -38.38 70.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.511 1.155 . . . . 0.0 111.547 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -55.69 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 175.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.44 12.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.261 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.63 -48.1 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 165.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.02 50.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.9 -51.06 17.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.265 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.68 -36.59 76.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 126.149 1.779 . . . . 0.0 110.123 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -61.62 -17.02 53.51 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.133 -0.979 . . . . 0.0 113.589 170.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.78 -13.63 53.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.478 1.49 . . . . 0.0 111.821 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -125.64 12.25 7.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.642 1.977 . . . . 0.0 110.854 -172.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 15.02 58.45 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 123.658 0.647 . . . . 0.0 112.924 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.26 113.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -67.85 147.71 52.16 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.31 108.45 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.106 0.962 . . . . 0.0 109.774 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.4 128.41 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 128.511 2.724 . . . . 0.0 106.868 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -108.21 179.54 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 108.812 169.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.72 8.08 87.28 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 115.079 0.791 . . . . 0.0 115.079 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 -176.73 1.58 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.544 1.172 . . . . 0.0 110.65 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.5 t -163.33 168.31 20.64 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 128.362 2.665 . . . . 0.0 106.588 164.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.82 -170.83 21.27 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 118.023 0.374 . . . . 0.0 113.804 168.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.5 p -79.52 163.0 25.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.453 -1.028 . . . . 0.0 111.337 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.09 -55.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.374 1.07 . . . . 0.0 110.164 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.19 -20.79 66.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.81 -54.07 4.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.871 1.668 . . . . 0.0 107.207 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.3 t -52.49 -46.37 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.216 1.806 . . . . 0.0 110.886 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.38 -53.28 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -62.44 -37.68 86.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.15 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -59.88 -46.79 88.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.042 1.292 . . . . 0.0 110.259 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -61.28 -53.93 50.45 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -56.23 -31.3 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.609 0.64 . . . . 0.0 110.426 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.3 m -76.08 -22.31 55.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 112.726 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.23 8.99 58.43 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.408 1.004 . . . . 0.0 113.236 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -80.92 -22.6 39.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.426 1.613 . . . . 0.0 112.067 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.91 145.18 27.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 109.202 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.553 0 C-N-CA 124.27 1.028 . . . . 0.0 109.065 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttm . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.28 138.91 52.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 mt -125.66 105.42 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 127.586 2.354 . . . . 0.0 106.27 -159.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.413 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -79.65 144.09 34.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.365 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.9 mt -143.18 116.4 6.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 171.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.13 119.43 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.62 141.91 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.789 1.177 . . . . 0.0 110.21 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -69.28 -21.85 63.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 117.442 -1.266 . . . . 0.0 112.849 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -148.0 156.72 42.96 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.451 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 38.7 t-20 -90.42 97.75 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -132.24 38.21 3.5 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.25 -109.24 1.09 Allowed Glycine 0 C--N 1.342 0.891 0 C-N-CA 124.022 0.82 . . . . 0.0 112.487 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -80.62 -41.17 24.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.764 1.626 . . . . 0.0 109.603 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.27 -16.05 59.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.061 1.744 . . . . 0.0 112.408 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 m -39.26 104.56 0.32 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.685 2.794 . . . . 0.0 112.416 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.37 135.94 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.056 1.837 . . . . 0.0 109.328 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -61.77 148.2 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.612 0.72 . . . . 0.0 110.338 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -78.47 178.35 7.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.905 2.482 . . . . 0.0 110.054 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -108.21 -30.22 8.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.816 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -133.88 90.59 2.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.694 1.134 . . . . 0.0 110.645 -164.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -43.32 -42.69 4.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.649 1.18 . . . . 0.0 112.986 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -1.53 40.02 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.023 -1.431 . . . . 0.0 115.925 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.45 46.86 1.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.442 1.621 . . . . 0.0 108.775 166.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 133.26 88.77 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 116.618 -1.658 . . . . 0.0 109.38 172.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -73.22 -22.55 18.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.756 2.304 . . . . 0.0 113.575 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 99.0 m-85 -147.1 154.04 40.66 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.022 0.929 . . . . 0.0 109.459 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.67 104.16 7.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 91.8 5.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.252 1.821 . . . . 0.0 108.913 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.413 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.6 m-85 -84.71 96.35 9.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.22 160.78 4.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -110.99 -170.08 1.57 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 119.993 -1.692 . . . . 0.0 108.798 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.1 144.24 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 162.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.536 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -80.05 -138.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.357 2.263 . . . . 0.0 105.598 167.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 21.4 t-20 -59.28 -62.63 1.74 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.471 1.908 . . . . 0.0 109.644 174.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -142.09 20.03 2.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.839 1.256 . . . . 0.0 111.678 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.91 161.71 26.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.117 1.367 . . . . 0.0 109.71 -170.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.75 -23.84 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.368 1.894 . . . . 0.0 112.608 -165.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.73 -65.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.032 2.133 . . . . 0.0 114.208 -166.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.24 165.88 21.53 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.069 0.948 . . . . 0.0 111.682 -165.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 152.07 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 127.229 2.212 . . . . 0.0 107.716 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.64 73.04 1.3 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.67 1.588 . . . . 0.0 109.467 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.256 8.3 p -90.63 84.77 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -96.66 154.46 17.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.707 1.203 . . . . 0.0 108.334 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.69 148.81 42.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.416 1.487 . . . . 0.0 110.564 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -92.19 115.08 64.05 Favored Pre-proline 0 CA--C 1.516 -0.345 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.806 -173.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 -21.97 53.59 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.989 1.793 . . . . 0.0 112.557 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -123.66 38.63 4.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.3 1.409 . . . . 0.0 111.049 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.339 0 CA-C-N 119.513 1.051 . . . . 0.0 110.693 175.208 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.8 -53.5 12.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.656 1.982 . . . . 0.0 109.501 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.31 -30.73 5.14 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 120.581 1.243 . . . . 0.0 111.04 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.0 -24.97 67.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.06 0.544 . . . . 0.0 110.348 -177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -69.12 -73.2 0.16 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 124.472 1.109 . . . . 0.0 109.502 162.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 m -59.38 -28.76 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -58.82 -42.63 89.63 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.076 1.307 . . . . 0.0 108.836 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -17.86 54.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.761 0.824 . . . . 0.0 112.479 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -86.58 37.17 0.73 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.747 0.703 . . . . 0.0 109.853 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 29.27 44.27 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 128.688 3.042 . . . . 0.0 114.832 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.73 174.37 8.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.012 1.406 . . . . 0.0 113.635 -172.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -145.13 -28.09 0.46 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.024 0.93 . . . . 0.0 112.194 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.05 157.9 44.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.859 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -150.77 143.6 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.811 1.644 . . . . 0.0 106.999 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 61.8 mt -131.59 113.38 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.61 -177.23 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.748 1.219 . . . . 0.0 110.418 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -104.05 -100.5 0.31 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 117.515 -1.231 . . . . 0.0 107.808 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.8 -18.27 32.83 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 120.355 1.434 . . . . 0.0 114.849 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.431 HG12 ' H ' ' A' ' 74' ' ' GLY 0.309 4.9 tt 41.22 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 126.98 2.112 . . . . 0.0 112.786 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.431 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -152.91 -138.74 2.76 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.977 2.227 . . . . 0.0 109.822 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.62 -31.6 4.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.748 1.274 . . . . 0.0 111.18 163.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -36.84 68.08 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.345 -1.472 . . . . 0.0 113.135 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 -31.71 43.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.219 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.23 -47.92 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.55 -12.74 34.97 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.07 -58.9 3.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.796 1.18 . . . . 0.0 109.403 172.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -58.49 -42.31 87.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.06 -20.87 66.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.53 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.43 -9.1 58.27 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.808 1.185 . . . . 0.0 112.222 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.49 -5.69 6.48 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.054 0.942 . . . . 0.0 112.434 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.39 28.87 69.0 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 119.589 1.086 . . . . 0.0 111.228 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.42 115.47 20.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -72.65 139.05 47.09 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.453 -0.779 . . . . 0.0 109.216 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.16 92.94 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 122.612 1.196 . . . . 0.0 109.637 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.9 147.48 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.173 1.789 . . . . 0.0 107.537 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -155.34 173.02 17.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.15 0.98 . . . . 0.0 109.38 -160.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.21 18.61 60.75 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.435 -0.647 . . . . 0.0 112.715 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.32 178.68 7.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.28 1.032 . . . . 0.0 109.784 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -158.27 160.4 37.03 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 106.05 -1.834 . . . . 0.0 106.05 160.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.37 -162.41 25.39 Favored Glycine 0 N--CA 1.463 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 112.665 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 p -84.93 165.33 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.65 -0.912 . . . . 0.0 109.134 165.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.2 t -53.74 -54.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.94 -22.52 62.57 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -89.63 -52.47 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.825 1.65 . . . . 0.0 107.658 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -55.16 -35.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 111.552 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.29 -53.99 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -54.91 -43.01 72.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.134 0.574 . . . . 0.0 111.214 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -58.86 -41.8 87.87 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.854 0.835 . . . . 0.0 111.005 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -72.5 -43.63 63.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.376 1.071 . . . . 0.0 111.778 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.26 -29.87 67.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.972 0.806 . . . . 0.0 110.601 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 m -78.33 -2.96 40.66 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.844 1.258 . . . . 0.0 113.138 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.68 20.65 68.39 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.534 1.061 . . . . 0.0 113.205 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -81.16 -56.18 4.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.344 1.072 . . . . 0.0 108.952 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.02 146.63 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 110.806 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 tptt . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 122.489 1.137 . . . . 0.0 112.379 -175.803 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 C--O 1.235 0.342 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.411 HG12 ' HE3' ' A' ' 31' ' ' LYS . 3.9 mt -137.35 148.38 26.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 mt -128.79 106.62 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 129.373 3.069 . . . . 0.0 105.561 -170.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -82.66 150.2 26.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.378 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.06 118.67 10.23 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.72 116.54 4.29 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 107.221 -1.876 . . . . 0.0 107.221 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -116.79 157.08 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.699 0.799 . . . . 0.0 110.488 -174.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 p -72.6 -35.45 67.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -142.2 156.44 45.33 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 120.355 1.434 . . . . 0.0 109.049 -167.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.52 88.88 6.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -132.41 38.41 3.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 109.719 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.26 -105.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 127.438 2.447 . . . . 0.0 111.25 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -79.92 -37.21 35.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.24 1.016 . . . . 0.0 110.216 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.66 -18.58 64.99 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.348 1.859 . . . . 0.0 112.175 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -37.97 105.06 0.31 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.42 2.288 . . . . 0.0 111.894 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -68.87 132.64 25.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.578 1.519 . . . . 0.0 110.615 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.4 tt -62.13 142.0 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 119.781 -1.825 . . . . 0.0 110.67 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -81.03 -173.79 4.49 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.245 1.418 . . . . 0.0 108.977 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -109.12 -45.03 3.83 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.045 -1.034 . . . . 0.0 111.608 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -120.41 100.68 7.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.017 1.327 . . . . 0.0 107.851 -163.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -42.47 -45.35 4.4 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.141 1.376 . . . . 0.0 112.16 171.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.81 -20.2 59.46 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 117.888 -1.507 . . . . 0.0 114.303 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.32 38.91 3.58 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.415 1.608 . . . . 0.0 109.495 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.06 130.58 93.81 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.598 -1.192 . . . . 0.0 107.845 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.72 -20.74 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.605 2.203 . . . . 0.0 113.127 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -148.03 160.99 42.27 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.41 1.484 . . . . 0.0 108.378 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -126.94 112.11 14.9 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.68 88.41 7.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -78.12 98.6 5.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 108.179 169.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.42 136.82 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.465 1.106 . . . . 0.0 108.055 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HE3' HG12 ' A' ' 2' ' ' ILE . 9.6 mtpt -80.45 -164.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.13 -0.982 . . . . 0.0 109.549 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -156.25 147.86 11.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -146.06 122.08 10.72 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 53.96 34.46 19.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.079 0.952 . . . . 0.0 112.541 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 73.7 12.85 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.325 2.65 . . . . 0.0 114.337 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.06 172.49 7.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.0 108.402 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.85 -27.23 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 125.15 1.38 . . . . 0.0 112.436 -159.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.99 -67.42 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 C-N-CA 127.156 2.183 . . . . 0.0 112.753 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -164.86 157.17 16.02 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.751 -0.593 . . . . 0.0 112.011 -164.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.32 131.4 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.171 1.788 . . . . 0.0 106.848 -172.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.0 m -129.4 117.94 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 107.153 166.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 t -131.39 79.45 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -82.02 168.81 17.43 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -105.97 132.52 51.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 107.68 -168.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -79.59 123.73 84.04 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.591 -150.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.35 -10.77 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.427 2.752 . . . . 0.0 114.982 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.35 38.84 2.28 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.147 1.779 . . . . 0.0 109.895 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 O-C-N 120.599 -1.313 . . . . 0.0 112.429 -178.008 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -43.45 -52.02 14.1 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 121.404 1.911 . . . . 0.0 111.314 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.86 -27.39 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.277 1.985 . . . . 0.0 111.761 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.38 -41.79 90.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.729 1.149 . . . . 0.0 109.889 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.17 -68.15 0.2 Allowed 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 123.683 0.793 . . . . 0.0 109.654 167.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 m -64.47 -12.1 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -72.71 -22.26 60.92 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.59 1.156 . . . . 0.0 111.553 170.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.55 -12.95 50.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.838 0.745 . . . . 0.0 112.044 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -93.1 37.02 1.03 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.173 -0.954 . . . . 0.0 111.18 -164.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.28 18.27 34.95 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.796 1.188 . . . . 0.0 113.835 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -64.39 158.75 22.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.929 1.365 . . . . 0.0 112.422 -171.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -137.77 -19.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.327 1.451 . . . . 0.0 110.893 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.65 159.24 42.62 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.315 1.846 . . . . 0.0 109.042 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 t -137.62 139.82 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 158.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.5 mt -112.74 117.85 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 173.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.81 138.85 48.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 O-C-N 121.773 -0.58 . . . . 0.0 110.974 -164.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -77.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.598 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.87 -36.69 1.22 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.577 1.081 . . . . 0.0 115.459 -170.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.492 HG12 ' H ' ' A' ' 74' ' ' GLY 0.252 6.2 tt 44.5 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 128.828 2.851 . . . . 0.0 113.971 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.492 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.85 169.67 40.61 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.296 1.903 . . . . 0.0 110.759 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -48.45 64.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.401 1.481 . . . . 0.0 114.007 -161.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.67 -24.03 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.02 -31.12 13.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.518 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mm -52.49 -46.95 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.25 54.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.62 -50.06 14.73 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.066 1.303 . . . . 0.0 111.279 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -38.09 -56.19 1.19 Allowed 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.806 1.643 . . . . 0.0 109.831 161.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -12.24 61.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 124.609 1.193 . . . . 0.0 112.081 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.8 -18.29 48.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.251 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.59 13.32 3.75 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.293 0.951 . . . . 0.0 113.3 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.98 27.54 59.76 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 121.347 -0.845 . . . . 0.0 111.847 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.67 110.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -57.16 151.85 14.73 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.863 0.465 . . . . 0.0 110.095 -168.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.78 89.59 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-O 121.447 0.641 . . . . 0.0 110.543 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . 0.258 36.7 mt -76.52 85.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 123.365 1.555 . . . . 0.0 109.591 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -80.75 142.01 34.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.896 2.079 . . . . 0.0 112.148 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.9 22.15 7.77 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.873 1.225 . . . . 0.0 112.484 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.78 165.98 24.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.567 1.683 . . . . 0.0 112.058 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -151.66 165.25 34.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.924 2.89 . . . . 0.0 105.136 158.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 125.36 175.45 14.22 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.953 0.797 . . . . 0.0 113.487 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 p -79.83 156.35 27.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.99 -47.87 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -54.69 -29.73 53.72 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.49 -45.84 8.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.651 1.981 . . . . 0.0 110.389 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 56.3 t -50.65 -45.69 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.977 1.311 . . . . 0.0 109.822 172.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.32 -48.39 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.756 0.822 . . . . 0.0 108.918 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.892 0.769 . . . . 0.0 111.188 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -54.9 -42.61 72.37 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.895 0.878 . . . . 0.0 110.272 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -69.48 -49.39 55.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.646 0.778 . . . . 0.0 113.067 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.71 -21.69 66.08 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.252 0.478 . . . . 0.0 111.121 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -81.25 -30.43 34.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.197 0.599 . . . . 0.0 109.72 171.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.37 2.0 17.98 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.48 1.514 . . . . 0.0 113.945 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -82.84 -30.31 28.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.83 0.815 . . . . 0.0 110.401 -165.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.94 136.74 45.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.823 1.249 . . . . 0.0 109.886 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 125.464 1.506 . . . . 0.0 112.279 -166.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.452 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 58.3 ttm . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.3 mt -131.59 143.67 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 172.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.2 mt -128.78 100.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 127.395 2.278 . . . . 0.0 106.844 -166.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.515 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -81.81 127.21 32.74 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.784 0.434 . . . . 0.0 110.71 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.0 mt -130.24 116.82 17.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.83 127.01 9.82 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.262 1.975 . . . . 0.0 107.745 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 m -127.74 148.08 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.7 m -76.25 -22.01 55.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.526 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.48 171.75 13.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.218 1.407 . . . . 0.0 108.056 -173.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -113.69 40.4 2.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.818 1.647 . . . . 0.0 113.412 -165.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -86.0 39.01 0.79 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.982 0.513 . . . . 0.0 111.026 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.86 -95.82 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.954 2.216 . . . . 0.0 113.694 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -41.37 22.31 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.527 1.164 . . . . 0.0 112.315 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.56 -3.25 14.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.39 1.476 . . . . 0.0 111.205 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -49.68 117.63 7.43 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.603 1.961 . . . . 0.0 110.57 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.2 135.69 11.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.741 2.294 . . . . 0.0 111.655 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.59 129.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.485 0.659 . . . . 0.0 111.118 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.81 164.29 15.29 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.16 1.784 . . . . 0.0 108.979 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.37 -52.99 5.76 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 121.075 -1.016 . . . . 0.0 110.488 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -97.39 94.99 7.37 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -161.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -42.91 -52.41 5.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.586 0.63 . . . . 0.0 111.573 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.58 9.91 40.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.577 -176.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 -149.1 56.11 1.0 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.4 137.81 20.04 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.12 -20.25 19.29 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.939 1.759 . . . . 0.0 113.294 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -149.58 165.05 33.43 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.604 1.093 . . . . 0.0 109.558 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.02 106.76 8.23 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.368 1.467 . . . . 0.0 108.65 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 88.83 5.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -80.54 91.85 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.183 1.393 . . . . 0.0 108.298 166.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.49 155.5 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -99.69 -170.68 1.93 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.907 -1.121 . . . . 0.0 109.242 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 t -146.59 146.93 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 114.86 8.14 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 127.844 2.458 . . . . 0.0 105.311 169.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 m120 43.4 60.46 2.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.472 1.109 . . . . 0.0 111.03 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 64.95 6.25 3.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.465 1.906 . . . . 0.0 115.171 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.36 173.78 6.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.863 1.665 . . . . 0.0 108.879 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.1 -23.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 124.884 1.273 . . . . 0.0 113.597 -164.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.82 -77.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.715 1.206 . . . . 0.0 111.903 -155.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.54 172.17 19.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.881 2.072 . . . . 0.0 110.23 -161.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 mm -126.21 141.11 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 m -138.44 121.02 16.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.954 2.102 . . . . 0.0 106.296 166.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -137.02 79.14 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -88.28 158.21 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.41 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.88 162.7 15.79 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 167.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -100.17 99.84 10.38 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.46 -0.781 . . . . 0.0 108.926 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.91 -11.02 29.08 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.646 2.231 . . . . 0.0 114.444 -170.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.56 38.57 4.13 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.787 -1.196 . . . . 0.0 110.489 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 124.592 1.157 . . . . 0.0 110.477 168.624 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 116.72 -1.61 . . . . 0.0 114.906 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -46.51 -48.52 47.37 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 121.672 2.033 . . . . 0.0 110.989 161.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.17 -18.26 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 120.52 1.222 . . . . 0.0 113.081 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -68.34 -26.97 65.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.828 0.74 . . . . 0.0 111.15 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.01 -69.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.278 1.031 . . . . 0.0 108.849 165.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 m -62.02 -29.02 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -166.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -63.87 -35.99 82.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.292 1.405 . . . . 0.0 110.729 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -15.54 62.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.27 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -86.05 37.07 0.7 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.191 1.36 . . . . 0.0 110.856 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.46 25.72 4.64 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.841 2.163 . . . . 0.0 116.957 165.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.22 173.78 8.13 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -164.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 19.9 mt-10 -142.4 -33.62 0.47 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.768 1.627 . . . . 0.0 111.657 -178.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -138.14 156.19 47.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.461 1.104 . . . . 0.0 109.065 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -148.7 144.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.714 1.205 . . . . 0.0 108.587 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.45 115.48 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.96 177.14 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.116 0.966 . . . . 0.0 109.923 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.6 -80.45 0.39 Allowed 'General case' 0 C--O 1.226 -0.135 0 O-C-N 120.888 -1.133 . . . . 0.0 108.046 167.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.77 -19.01 8.47 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -164.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 74' ' ' GLY 0.289 5.5 tt 35.84 -126.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 127.517 2.327 . . . . 0.0 113.708 175.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 153.82 140.68 3.1 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.306 1.908 . . . . 0.0 109.461 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -48.51 -44.09 35.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 116.987 -1.482 . . . . 0.0 113.44 -166.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -31.18 55.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.756 1.616 . . . . 0.0 112.463 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.57 -25.57 22.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.712 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.93 -51.69 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 167.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.42 -26.63 13.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.557 1.543 . . . . 0.0 113.132 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.52 -57.15 4.38 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.649 0.659 . . . . 0.0 111.454 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -59.17 -34.6 72.3 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.003 1.321 . . . . 0.0 110.985 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -54.62 -32.5 59.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.949 0.899 . . . . 0.0 111.793 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.4 -10.65 59.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.77 0.714 . . . . 0.0 112.452 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 ptm -124.4 10.2 8.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.508 1.523 . . . . 0.0 111.026 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.05 21.94 64.31 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 118.584 0.629 . . . . 0.0 112.182 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -80.83 119.66 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.06 146.56 49.23 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 119.123 -0.465 . . . . 0.0 110.308 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 t -133.71 107.93 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.808 1.186 . . . . 0.0 111.545 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -96.52 147.76 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.871 1.668 . . . . 0.0 108.608 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -172.6 2.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.072 1.349 . . . . 0.0 110.316 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.25 9.87 73.24 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 163.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -167.87 2.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.793 1.796 . . . . 0.0 111.442 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.32 159.01 14.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.492 1.917 . . . . 0.0 106.845 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 117.24 -169.67 13.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 112.618 170.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 p -79.89 167.85 20.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.0 t -56.96 -54.03 35.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 123.718 0.807 . . . . 0.0 110.289 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -50.96 -40.81 58.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 -175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.85 -49.9 13.35 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.13 1.772 . . . . 0.0 109.307 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.3 t -50.44 -32.61 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.57 1.148 . . . . 0.0 110.867 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.2 t -82.98 -41.36 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -52.42 -48.89 65.48 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -58.71 -41.96 87.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.399 0.679 . . . . 0.0 111.693 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -65.37 -51.66 58.93 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.516 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -60.74 -26.71 67.39 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.944 0.778 . . . . 0.0 111.01 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.95 0.47 56.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 110.977 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.12 6.51 88.07 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 120.835 -1.165 . . . . 0.0 113.347 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -72.3 -48.71 40.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.77 1.285 . . . . 0.0 109.425 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 tp -81.52 134.69 35.55 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.11 1.364 . . . . 0.0 109.491 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 tptm . . . . . 0 C--N 1.33 -0.259 0 C-N-CA 124.453 1.101 . . . . 0.0 111.086 -176.778 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.479 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 24.2 ttm . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.969 0.89 . . . . 0.0 112.07 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 mt -140.3 144.0 28.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.18 104.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.346 2.658 . . . . 0.0 105.981 -163.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.44 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -82.16 143.95 31.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.108 0.163 . . . . 0.0 111.091 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 mt -145.38 106.77 4.41 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.61 117.84 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.351 2.034 . . . . 0.0 107.929 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -112.18 159.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.719 1.608 . . . . 0.0 109.439 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -85.25 -11.55 54.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 117.548 -1.215 . . . . 0.0 112.389 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -150.88 170.16 19.96 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.701 1.201 . . . . 0.0 108.296 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -98.77 103.1 15.02 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -137.76 38.57 2.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.378 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.09 -123.78 2.68 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.695 -1.253 . . . . 0.0 111.516 -174.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -35.93 63.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.956 1.378 . . . . 0.0 113.7 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -6.27 50.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.531 1.133 . . . . 0.0 111.311 -175.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 m -52.6 111.33 2.49 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 120.302 1.41 . . . . 0.0 110.166 -175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -67.38 134.3 32.99 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.595 2.197 . . . . 0.0 108.541 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tt -64.75 142.82 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.161 0.437 . . . . 0.0 110.309 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -81.2 -173.79 4.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.826 0.85 . . . . 0.0 108.967 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.14 -46.97 6.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.469 1.128 . . . . 0.0 108.737 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -99.41 165.56 11.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.671 1.189 . . . . 0.0 109.436 -159.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -120.42 -49.41 2.26 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.264 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 16.72 5.06 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.177 0.894 . . . . 0.0 114.593 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.74 39.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 129.073 2.949 . . . . 0.0 107.863 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.48 150.88 82.72 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 170.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.63 -22.5 12.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.802 2.335 . . . . 0.0 114.359 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -145.84 172.28 13.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.431 1.892 . . . . 0.0 109.074 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -133.96 110.29 9.59 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.665 1.186 . . . . 0.0 108.034 162.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.72 101.75 8.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 165.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.44 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.3 m-85 -88.72 104.72 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.17 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -98.88 -165.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.006 -1.059 . . . . 0.0 108.637 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.12 147.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 162.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 123.08 15.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 161.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.94 20.5 11.58 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 t30 86.83 9.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.437 2.695 . . . . 0.0 112.27 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.59 170.22 8.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.54 -22.77 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.202 1.801 . . . . 0.0 112.304 -163.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 50.5 -72.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.48 1.912 . . . . 0.0 112.766 -160.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -157.06 156.45 32.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.135 0.574 . . . . 0.0 112.472 -166.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mm -121.68 127.81 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.141 1.777 . . . . 0.0 108.0 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 t -120.57 97.28 5.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.254 13.0 p -106.72 61.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 122.743 1.258 . . . . 0.0 108.636 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.6 149.62 31.28 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.48 163.34 16.09 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.0 115.63 60.89 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.85 -7.02 19.5 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.419 2.079 . . . . 0.0 112.515 -175.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mt -135.45 39.85 2.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.931 2.093 . . . . 0.0 107.687 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.372 0 O-C-N 120.857 -1.152 . . . . 0.0 111.605 -173.803 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.69 -49.18 27.56 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 126.131 1.772 . . . . 0.0 108.289 164.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.8 -25.0 17.4 Favored 'Trans proline' 0 C--N 1.359 1.096 0 CA-C-N 121.349 1.518 . . . . 0.0 111.367 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.415 ' HA ' ' HE3' ' A' ' 61' ' ' LYS . 10.2 t30 -71.36 -28.71 64.25 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 119.854 1.207 . . . . 0.0 111.237 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -60.85 -70.99 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 162.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -62.57 -21.9 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 58' ' ' ASN . 6.3 mtmp? -66.12 -22.9 66.41 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.555 -1.341 . . . . 0.0 112.746 170.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -26.33 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 120.267 1.394 . . . . 0.0 109.614 172.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -85.74 38.6 0.76 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.975 0.91 . . . . 0.0 111.118 -165.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.08 14.6 39.89 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.725 2.107 . . . . 0.0 116.017 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -69.32 167.64 16.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.242 1.521 . . . . 0.0 114.395 -160.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.479 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 32.3 mt-10 -142.68 -21.86 0.66 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.197 0.999 . . . . 0.0 112.486 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -142.47 155.03 45.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.73 1.212 . . . . 0.0 107.853 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -152.16 138.61 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.01 110.72 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 m -133.45 156.01 41.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.615 1.566 . . . . 0.0 108.931 -167.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -99.3 -52.4 3.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.199 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.97 -49.17 0.59 Allowed Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.542 1.068 . . . . 0.0 113.036 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.482 HG12 ' H ' ' A' ' 74' ' ' GLY 0.255 4.9 tt 41.42 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 127.077 2.151 . . . . 0.0 112.626 -173.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.482 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.74 158.18 21.69 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 127.153 2.311 . . . . 0.0 109.356 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -45.03 -40.0 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 128.793 2.837 . . . . 0.0 114.511 -168.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -58.81 -34.02 71.03 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.001 -1.062 . . . . 0.0 112.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.84 -31.58 22.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.312 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.8 -51.66 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 166.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 0.66 1.98 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.31 -51.95 5.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 119.983 -1.698 . . . . 0.0 111.736 163.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -60.9 -37.3 81.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.684 1.194 . . . . 0.0 110.02 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -63.06 -15.87 58.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.062 0.945 . . . . 0.0 112.675 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.32 -15.81 61.38 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.436 -1.415 . . . . 0.0 110.97 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.7 ptp -131.81 5.75 4.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.583 1.953 . . . . 0.0 112.519 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.34 41.62 55.21 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -79.1 119.64 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -66.47 136.73 56.12 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.453 -0.779 . . . . 0.0 109.09 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.82 110.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.0 mt -93.69 116.42 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 127.927 2.491 . . . . 0.0 106.126 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -117.04 135.12 53.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.785 0.434 . . . . 0.0 111.335 -173.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.04 2.29 13.94 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.671 1.605 . . . . 0.0 114.603 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 -177.96 5.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.458 1.629 . . . . 0.0 111.128 -168.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.4 p -164.61 153.76 13.18 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.925 -1.109 . . . . 0.0 108.383 -172.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.28 -144.65 15.43 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 112.106 -0.397 . . . . 0.0 112.106 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.7 p -105.94 173.0 6.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.194 1.398 . . . . 0.0 109.629 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.11 -57.82 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.59 -35.11 76.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.733 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.29 -51.7 41.91 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.64 1.176 . . . . 0.0 108.136 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.2 t -63.31 -29.5 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.186 0.995 . . . . 0.0 111.739 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.4 t -68.85 -51.34 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -56.22 -43.2 78.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.041 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -57.18 -51.21 70.22 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.708 1.14 . . . . 0.0 109.868 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.87 -43.64 57.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.124 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.43 -31.72 68.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.51 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 m -78.24 -12.66 60.01 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 113.271 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.6 5.87 68.6 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.272 0.942 . . . . 0.0 113.594 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -70.41 -37.11 74.4 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.792 1.296 . . . . 0.0 110.676 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mt -82.56 165.77 19.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.022 1.329 . . . . 0.0 112.432 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 tptm . . . . . 0 C--N 1.345 0.412 0 C-N-CA 125.578 1.551 . . . . 0.0 111.91 175.705 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptm . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.16 141.15 47.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.5 mt -125.14 100.58 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.764 2.826 . . . . 0.0 106.384 -161.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.439 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -83.86 145.61 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.856 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.37 126.68 21.41 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 166.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -75.43 110.2 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 N-CA-C 106.252 -2.249 . . . . 0.0 106.252 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.98 161.73 8.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 122.465 1.126 . . . . 0.0 110.99 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -93.24 -22.91 18.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.848 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.1 165.21 32.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.661 1.119 . . . . 0.0 108.797 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -92.44 77.3 5.09 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.245 1.018 . . . . 0.0 109.475 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -124.01 57.7 1.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.77 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -24.72 119.52 0.02 OUTLIER Glycine 0 N--CA 1.47 0.931 0 C-N-CA 126.064 1.792 . . . . 0.0 112.655 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt 80.14 -58.02 0.34 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.779 3.232 . . . . 0.0 110.909 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.38 -6.23 9.6 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.627 1.171 . . . . 0.0 113.105 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 m -47.92 102.84 0.33 Allowed Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 130.3 3.44 . . . . 0.0 110.379 -167.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.23 123.62 7.31 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.203 1.936 . . . . 0.0 110.677 -170.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.3 tt -56.71 143.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 122.111 0.957 . . . . 0.0 109.406 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.08 168.77 9.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.79 1.236 . . . . 0.0 109.411 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.6 -40.49 18.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.779 -0.576 . . . . 0.0 111.899 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -101.05 172.51 6.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.765 1.226 . . . . 0.0 108.575 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -120.2 -51.79 2.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 173.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -7.05 7.57 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.132 171.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ttp-105 -144.32 39.43 1.3 Allowed 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 126.011 1.724 . . . . 0.0 109.625 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.91 123.95 87.46 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 163.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.95 -19.72 34.84 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 120.801 1.322 . . . . 0.0 112.669 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -148.04 161.49 41.28 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.153 0.888 . . . . 0.0 109.697 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -135.77 106.46 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 108.287 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.92 93.68 5.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.439 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -82.16 95.64 7.57 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 171.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -79.65 151.86 4.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.72 -174.37 2.53 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.694 -1.254 . . . . 0.0 110.16 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.19 137.69 19.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.53 -0.731 . . . . 0.0 109.098 165.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -142.68 125.97 16.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 53.06 39.61 29.8 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.836 0.744 . . . . 0.0 112.586 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.93 12.41 1.74 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.008 2.123 . . . . 0.0 114.487 -174.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.24 168.77 8.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.118 1.367 . . . . 0.0 108.223 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.42 -19.04 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.233 1.413 . . . . 0.0 112.076 -164.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 52.61 -66.71 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.16 2.184 . . . . 0.0 113.835 -167.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.79 178.72 9.5 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.977 1.311 . . . . 0.0 111.387 174.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.36 142.71 41.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.816 0.846 . . . . 0.0 108.798 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -113.18 88.92 2.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.875 2.47 . . . . 0.0 107.311 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.35 72.92 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 122.947 1.356 . . . . 0.0 107.626 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.67 151.0 22.72 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -73.77 150.74 40.91 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.099 1.359 . . . . 0.0 109.848 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -82.62 116.6 64.8 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.48 -8.8 24.14 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.722 2.281 . . . . 0.0 114.668 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.86 39.78 2.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.235 1.814 . . . . 0.0 109.464 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.382 0 O-C-N 119.655 -1.903 . . . . 0.0 111.934 -179.42 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -51.02 80.87 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 119.131 0.878 . . . . 0.0 109.775 170.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -72.64 -28.54 14.03 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.426 2.084 . . . . 0.0 111.688 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.84 -45.26 70.85 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.277 0.631 . . . . 0.0 109.675 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -57.97 -68.23 0.27 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.706 0.803 . . . . 0.0 111.274 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 m -61.41 -18.79 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 120.118 -1.614 . . . . 0.0 113.755 -171.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -68.68 -26.6 65.38 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.18 1.355 . . . . 0.0 111.766 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -23.32 62.91 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.809 1.186 . . . . 0.0 111.124 171.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -85.11 38.93 0.74 Allowed 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.949 -1.094 . . . . 0.0 111.408 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.53 28.32 4.84 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.891 2.186 . . . . 0.0 115.686 163.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.19 168.32 20.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.038 0.919 . . . . 0.0 113.054 -160.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -143.2 -33.35 0.44 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.323 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.1 152.66 45.58 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.203 0.91 . . . . 0.0 108.878 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.57 139.39 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 161.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.1 mt -115.66 121.79 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 172.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.31 162.6 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.823 1.249 . . . . 0.0 109.892 -170.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -91.65 -75.05 0.49 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.67 -27.17 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.187 -1.341 . . . . 0.0 114.849 -171.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.484 HG12 ' H ' ' A' ' 74' ' ' GLY 0.265 4.5 tt 37.27 -143.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.392 2.277 . . . . 0.0 112.603 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.484 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.44 156.01 20.1 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 127.785 2.612 . . . . 0.0 109.875 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.29 82.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.205 1.002 . . . . 0.0 112.081 -172.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -32.99 60.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.521 175.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.98 -40.59 16.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.99 -1.481 . . . . 0.0 111.193 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -44.82 -46.84 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 119.589 1.086 . . . . 0.0 108.886 166.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.73 -11.73 13.46 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 119.861 -1.774 . . . . 0.0 114.951 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.48 -32.88 14.72 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.123 1.329 . . . . 0.0 113.459 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.432 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -46.64 -55.94 6.9 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.748 -1.22 . . . . 0.0 109.07 154.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -69.66 -3.17 13.98 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 124.577 1.173 . . . . 0.0 110.294 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -10.16 48.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 119.507 1.049 . . . . 0.0 110.853 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.2 5.69 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.29 33.55 84.85 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.856 0.753 . . . . 0.0 111.767 -168.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 4.9 t -80.41 96.86 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.14 -1.212 . . . . 0.0 110.606 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -49.92 145.79 5.23 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.727 1.611 . . . . 0.0 111.94 -169.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' CG2' ' CD2' ' A' ' 81' ' ' PHE . 1.2 t -125.89 107.55 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.082 0.468 . . . . 0.0 111.283 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.8 mt -93.05 99.47 9.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -83.69 165.82 18.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.195 0.521 . . . . 0.0 110.119 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.86 17.77 69.37 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-O 118.522 -1.155 . . . . 0.0 114.044 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.44 166.61 19.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.609 1.205 . . . . 0.0 110.106 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -152.64 159.04 43.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.87 1.668 . . . . 0.0 106.917 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 -175.62 15.82 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.349 0.976 . . . . 0.0 113.093 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.1 p -79.68 160.67 26.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.622 -0.928 . . . . 0.0 109.029 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -46.67 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -171.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -27.35 67.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.29 -60.98 2.15 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.4 t -46.52 -56.06 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.306 1.443 . . . . 0.0 109.419 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.14 -52.87 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 125.334 1.454 . . . . 0.0 109.045 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -54.71 -42.84 71.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.893 0.77 . . . . 0.0 111.548 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -60.97 -44.54 97.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 112.285 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -63.79 -45.12 91.12 Favored 'General case' 0 CA--C 1.519 -0.219 0 O-C-N 121.333 -0.854 . . . . 0.0 113.273 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.5 -32.23 70.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.3 0.955 . . . . 0.0 110.498 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -74.79 -9.91 59.0 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.22 0.608 . . . . 0.0 111.707 174.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.98 3.84 87.48 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.386 1.469 . . . . 0.0 113.074 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -71.0 -50.49 33.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.743 1.772 . . . . 0.0 109.488 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.04 145.31 56.11 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.972 1.709 . . . . 0.0 110.618 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.459 ' HA ' ' OE2' ' A' ' 66' ' ' GLU . 3.8 ptp . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 mt -136.03 148.06 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.5 mt -125.65 109.75 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 129.049 2.94 . . . . 0.0 106.271 -168.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.44 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -82.27 148.15 28.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.288 169.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 87.4 mt -140.47 116.71 7.78 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 167.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.33 125.25 12.14 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.269 1.979 . . . . 0.0 108.496 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.51 157.9 24.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 119.247 0.931 . . . . 0.0 111.541 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -90.8 -20.74 22.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 116.69 -1.624 . . . . 0.0 113.325 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -147.99 150.01 33.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.199 1.399 . . . . 0.0 107.67 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -80.55 39.35 0.47 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.128 1.771 . . . . 0.0 113.694 -166.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 -82.87 39.83 0.65 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.561 -1.337 . . . . 0.0 112.94 -166.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.74 -137.27 35.91 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 120.44 1.473 . . . . 0.0 111.493 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -28.66 29.31 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -4.86 57.37 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 112.482 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.9 m -51.72 115.14 6.04 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.082 1.353 . . . . 0.0 111.681 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.19 134.96 18.12 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.629 2.219 . . . . 0.0 110.318 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.22 141.56 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.272 1.029 . . . . 0.0 110.819 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.15 156.56 17.26 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.784 1.233 . . . . 0.0 110.195 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -70.14 -39.98 75.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.857 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -133.58 117.2 16.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.677 2.035 . . . . 0.0 109.706 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -41.82 -53.75 3.61 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 112.42 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.69 63.57 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.645 -164.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.55 38.99 2.23 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 120.504 2.152 . . . . 0.0 108.161 162.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.81 125.95 91.57 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.492 ' HA ' HD21 ' A' ' 45' ' ' ASN . 30.2 Cg_endo -63.51 -16.42 54.52 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.281 1.321 . . . . 0.0 113.017 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -150.39 149.03 29.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.283 1.033 . . . . 0.0 108.955 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.44 103.69 9.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.071 0.949 . . . . 0.0 108.643 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.82 106.8 13.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.44 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.7 m-85 -95.15 89.46 5.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.954 1.302 . . . . 0.0 107.532 171.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.69 147.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -89.2 -170.6 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.327 -0.858 . . . . 0.0 108.722 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -142.92 128.37 16.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 162.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -94.88 104.45 16.34 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.0 t30 59.25 -81.4 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.064 . . . . 0.0 110.533 -171.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -135.7 -0.27 2.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 130.449 3.5 . . . . 0.0 113.325 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.9 -179.29 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.049 1.74 . . . . 0.0 108.953 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.31 -22.18 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 121.413 1.915 . . . . 0.0 113.946 -169.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.22 -74.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.247 1.385 . . . . 0.0 112.331 -160.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -163.36 153.34 15.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.323 1.049 . . . . 0.0 110.302 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.0 mm -78.39 155.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.081 1.353 . . . . 0.0 107.854 168.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -127.73 154.88 44.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 141.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 70.53 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 122.8 1.286 . . . . 0.0 108.546 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.0 131.59 35.83 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.085 1.354 . . . . 0.0 108.759 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.12 162.65 27.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.375 0.607 . . . . 0.0 111.616 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.492 HD21 ' HA ' ' A' ' 25' ' ' PRO . 39.7 p-10 -78.42 95.39 0.17 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 131.461 3.904 . . . . 0.0 114.733 -168.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.89 -25.18 23.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.385 1.39 . . . . 0.0 114.307 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.24 39.64 3.24 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.881 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.335 0 C-N-CA 125.007 1.323 . . . . 0.0 111.501 -171.906 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.489 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -57.45 -51.67 80.0 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.69 -28.99 51.86 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.37 1.38 . . . . 0.0 112.416 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -32.54 74.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.584 1.084 . . . . 0.0 110.323 178.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -65.41 -61.99 1.79 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.4 m -61.87 -23.92 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 120.383 1.447 . . . . 0.0 113.261 -174.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -21.14 63.87 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 120.848 -1.158 . . . . 0.0 112.809 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.18 -19.36 54.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 120.665 1.575 . . . . 0.0 111.537 170.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -85.07 37.9 0.69 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.16 21.14 5.36 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.601 2.524 . . . . 0.0 115.735 169.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.05 167.47 13.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.011 1.405 . . . . 0.0 114.548 -163.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 9.5 mt-10 -137.96 -31.13 0.78 Allowed 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.504 1.122 . . . . 0.0 111.902 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.63 152.77 51.96 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.623 1.169 . . . . 0.0 108.783 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 t -139.11 146.5 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 168.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.4 mt -131.65 118.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -134.61 169.49 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 111.356 -168.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -112.69 -42.34 3.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.501 -1.374 . . . . 0.0 113.439 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.93 42.48 0.78 Allowed Glycine 0 N--CA 1.469 0.836 0 C-N-CA 125.197 1.38 . . . . 0.0 111.648 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.2 tt -58.97 166.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.744 1.217 . . . . 0.0 111.087 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.58 161.51 13.25 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.679 1.133 . . . . 0.0 110.744 170.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -30.09 59.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.275 1.43 . . . . 0.0 113.486 -174.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -53.63 -43.45 68.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 111.127 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.98 29.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.235 -1.364 . . . . 0.0 112.047 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.07 -49.48 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 120.337 1.426 . . . . 0.0 107.328 164.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -13.64 50.61 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.46 -60.77 2.12 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 110.07 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.77 -38.73 72.88 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.8 2.04 . . . . 0.0 109.553 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.92 -19.76 53.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.542 0.737 . . . . 0.0 112.944 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.85 -12.58 61.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.025 -1.672 . . . . 0.0 112.491 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.81 7.29 6.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.638 1.175 . . . . 0.0 114.064 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.15 24.76 74.68 Favored Glycine 0 C--O 1.241 0.558 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.972 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.11 116.33 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -69.99 141.76 52.91 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.78 97.82 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.7 mt -75.64 144.85 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.636 1.174 . . . . 0.0 108.363 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -125.38 173.19 9.03 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.075 1.75 . . . . 0.0 109.054 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.37 57.78 16.95 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.899 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.14 165.53 12.81 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 124.368 0.687 . . . . 0.0 110.788 165.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.3 p -146.49 164.07 33.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.361 1.864 . . . . 0.0 108.436 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.38 -166.8 24.44 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 118.794 0.725 . . . . 0.0 113.486 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.4 p -85.18 165.7 17.19 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 121.547 -0.972 . . . . 0.0 111.7 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -50.41 -56.25 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 C-N-CA 124.523 1.129 . . . . 0.0 110.081 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -59.8 -27.46 66.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -82.83 -53.39 5.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.519 1.528 . . . . 0.0 107.893 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.84 -43.99 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.416 1.486 . . . . 0.0 110.145 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.07 -53.24 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.03 -39.66 90.63 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.301 -0.874 . . . . 0.0 111.91 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.46 -39.39 94.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.343 0.974 . . . . 0.0 110.645 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -64.32 -52.0 60.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.42 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -56.46 -36.03 68.6 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.006 0.922 . . . . 0.0 109.14 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.8 m -77.18 0.96 19.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.656 1.182 . . . . 0.0 112.697 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.5 9.91 84.59 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.894 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -80.0 -43.64 21.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 119.355 1.578 . . . . 0.0 109.84 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.32 141.38 48.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.175 0 C-N-CA 127.538 2.335 . . . . 0.0 108.198 177.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.566 0.209 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.0 mt -109.34 151.36 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 160.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.81 108.48 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 C-N-CA 130.011 3.324 . . . . 0.0 105.16 -169.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.433 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -79.68 153.73 29.11 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.272 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.9 mt -146.4 113.93 4.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.58 124.95 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 N-CA-C 106.852 -2.018 . . . . 0.0 106.852 170.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.43 155.47 15.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 -19.84 30.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 -177.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -149.43 153.37 37.22 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 -177.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -93.7 64.22 3.48 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.956 0.884 . . . . 0.0 111.537 -169.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -106.48 42.03 1.34 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.598 -166.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 24.38 80.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.701 1.619 . . . . 0.0 115.481 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 80.67 -46.26 0.26 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.153 2.981 . . . . 0.0 112.604 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -0.06 0.63 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.015 0.825 . . . . 0.0 112.169 162.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -51.0 107.97 0.94 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.713 2.805 . . . . 0.0 111.769 169.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.94 130.62 5.77 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.996 2.464 . . . . 0.0 110.209 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.41 134.35 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.951 1.301 . . . . 0.0 112.052 -175.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -70.15 169.42 13.6 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.85 1.66 . . . . 0.0 109.274 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -92.48 -23.11 19.24 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.324 -0.86 . . . . 0.0 111.12 174.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -108.48 171.23 7.53 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -170.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -120.76 -57.57 1.88 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.35 -3.14 11.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.731 -169.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -143.49 38.51 1.38 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.415 1.607 . . . . 0.0 108.703 169.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.86 152.57 96.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.96 -20.73 7.33 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.779 2.319 . . . . 0.0 113.606 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -152.85 157.1 40.23 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.868 1.267 . . . . 0.0 109.489 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -123.07 108.36 12.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.036 1.334 . . . . 0.0 107.893 174.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.42 87.5 5.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 165.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 2.2 m-85 -70.86 142.9 51.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 157.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -84.71 -168.48 2.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.102 0.865 . . . . 0.0 109.523 -179.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.63 143.12 26.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 162.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -139.45 133.91 31.61 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 127.428 2.291 . . . . 0.0 105.38 169.268 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 32.47 57.24 0.4 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.241 1.817 . . . . 0.0 112.702 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.53 12.98 5.83 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.982 2.513 . . . . 0.0 116.769 -178.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.03 -179.6 4.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.243 1.817 . . . . 0.0 109.586 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.33 -23.46 31.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 125.222 1.409 . . . . 0.0 113.611 -164.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.05 -74.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.105 1.32 . . . . 0.0 112.48 -160.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.17 160.25 39.71 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.533 1.933 . . . . 0.0 111.049 -160.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mm -124.87 134.62 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.507 1.923 . . . . 0.0 106.788 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 m -138.95 72.14 1.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.608 2.763 . . . . 0.0 106.941 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 2.2 t -77.22 97.75 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -96.27 159.84 14.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.886 173.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -57.41 163.51 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 110.848 167.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.33 95.93 3.28 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 159.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.51 3.46 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.217 2.612 . . . . 0.0 113.098 -176.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.26 39.11 2.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.016 1.326 . . . . 0.0 109.003 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.582 0 O-C-N 120.751 -1.218 . . . . 0.0 111.489 -171.508 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 118.318 -0.848 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -50.13 -52.69 51.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 119.521 1.055 . . . . 0.0 109.665 173.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -71.05 -29.99 17.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.521 2.147 . . . . 0.0 111.974 178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.4 -32.78 74.59 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.428 -0.795 . . . . 0.0 110.596 -177.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -58.66 -65.69 0.62 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 109.925 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.81 -27.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -171.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -63.83 -19.96 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.984 0.913 . . . . 0.0 112.65 173.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -20.68 44.91 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.084 0.856 . . . . 0.0 111.984 169.131 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -86.83 38.03 0.78 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.677 -1.264 . . . . 0.0 111.419 -170.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.27 19.83 8.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.329 1.919 . . . . 0.0 115.918 166.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 168.43 19.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.185 1.492 . . . . 0.0 113.278 -163.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -143.38 -27.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.442 1.097 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 68' ' ' VAL . 41.9 tp -135.88 158.64 43.9 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.963 0.801 . . . . 0.0 110.241 176.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.421 ' H ' HD13 ' A' ' 67' ' ' LEU . 2.8 t -150.66 122.87 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -174.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 82.4 mt -114.59 107.67 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 108.628 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.43 176.07 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.729 2.012 . . . . 0.0 111.966 -174.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -96.5 -94.36 0.21 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 164.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.97 -40.52 8.03 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.588 -0.562 . . . . 0.0 114.072 -167.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.493 ' CG1' ' H ' ' A' ' 74' ' ' GLY 0.281 3.0 tt 44.55 -138.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.939 1.696 . . . . 0.0 112.537 -176.423 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.493 ' H ' ' CG1' ' A' ' 73' ' ' ILE . . . -179.42 155.37 15.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 129.61 3.481 . . . . 0.0 109.219 174.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.56 -34.15 73.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.989 1.394 . . . . 0.0 111.785 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -55.56 -23.41 26.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 171.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.84 13.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.205 0.911 . . . . 0.0 110.857 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.73 -46.35 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 166.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.53 -31.91 25.92 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.533 1.533 . . . . 0.0 114.566 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.5 -55.27 5.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.02 0.827 . . . . 0.0 110.526 -177.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -62.14 -31.45 71.93 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.436 1.094 . . . . 0.0 110.799 177.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -56.56 -32.58 65.31 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.196 -0.94 . . . . 0.0 112.302 170.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -18.69 61.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.713 0.688 . . . . 0.0 111.601 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.75 6.04 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.404 1.482 . . . . 0.0 110.785 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.81 23.67 69.33 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.941 -1.1 . . . . 0.0 111.982 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.0 t -79.4 117.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -58.72 145.12 41.39 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.429 1.492 . . . . 0.0 109.38 174.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.05 128.3 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 mt -115.16 131.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.325 2.65 . . . . 0.0 105.101 -178.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.2 135.86 43.32 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.769 1.228 . . . . 0.0 108.775 -170.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.14 2.95 6.38 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.673 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.78 173.64 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.079 1.44 . . . . 0.0 111.13 -173.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 p -161.99 165.13 27.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.198 1.799 . . . . 0.0 106.65 156.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.62 -163.05 16.42 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 122.264 0.924 . . . . 0.0 112.601 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 162.92 24.78 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.212 -1.169 . . . . 0.0 111.098 -178.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -53.05 -49.74 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 123.007 0.523 . . . . 0.0 109.605 174.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -62.22 -26.67 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -80.65 -54.61 5.49 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 107.828 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -53.84 -45.5 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -178.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.04 -42.8 92.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -58.0 -50.85 72.0 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.284 174.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -57.09 -41.72 79.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.197 0.908 . . . . 0.0 110.772 -172.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.25 -53.73 22.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.246 1.019 . . . . 0.0 112.134 174.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.2 -26.75 68.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.613 0.642 . . . . 0.0 110.822 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -82.54 -3.28 55.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 174.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.07 15.18 75.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 118.126 -1.374 . . . . 0.0 113.691 168.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -87.1 -30.08 21.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.984 1.392 . . . . 0.0 111.613 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 tp -74.86 166.53 23.48 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.152 -0.342 . . . . 0.0 111.347 -163.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.656 0 C-N-CA 124.267 1.027 . . . . 0.0 111.748 -170.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.443 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.482 HD22 HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.482 HG23 HD22 ' A' ' 45' ' ' ASN . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.443 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HA ' ' OE2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.513 0.197 . . . . 0.0 110.841 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 mt -115.3 153.25 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 165.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 mt -134.51 105.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.132 2.173 . . . . 0.0 105.812 -164.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.438 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.52 145.59 31.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.191 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.3 mt -145.94 114.59 4.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.35 129.42 15.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.574 1.516 . . . . 0.0 108.372 171.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.88 150.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 118.739 0.7 . . . . 0.0 109.185 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -68.1 -27.06 66.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.318 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.59 156.1 39.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.648 1.579 . . . . 0.0 107.91 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -85.73 95.59 9.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -125.8 39.64 3.91 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 108.582 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.19 -127.88 29.94 Favored Glycine 0 C--N 1.34 0.76 0 O-C-N 120.775 -1.203 . . . . 0.0 111.434 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -58.4 -45.79 87.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.182 1.393 . . . . 0.0 111.665 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -1.87 4.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.774 2.43 . . . . 0.0 114.304 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.3 m -52.99 109.01 1.24 Allowed Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.975 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.92 135.47 14.11 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.357 1.371 . . . . 0.0 108.964 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.47 134.37 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.047 0.939 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.38 169.9 12.5 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.876 1.27 . . . . 0.0 107.876 166.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -88.1 -55.32 3.8 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 121.472 -0.768 . . . . 0.0 110.554 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.63 85.57 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 -152.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -37.49 -47.17 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.411 1.484 . . . . 0.0 112.908 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.42 -14.34 41.18 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 118.7 -1.055 . . . . 0.0 115.276 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.59 48.02 1.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.09 2.156 . . . . 0.0 108.74 173.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.65 137.77 54.77 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 167.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.74 -25.29 28.83 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.454 2.103 . . . . 0.0 114.494 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -146.27 158.17 43.86 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.29 103.9 8.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.51 1.524 . . . . 0.0 107.896 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.11 79.02 6.72 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.526 1.53 . . . . 0.0 107.585 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.438 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.31 3.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.08 164.15 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.034 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.874 -1.141 . . . . 0.0 108.97 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.18 147.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 161.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.54 113.71 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 173.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t30 54.58 -86.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.718 1.207 . . . . 0.0 111.687 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.94 12.24 2.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.685 1.594 . . . . 0.0 111.969 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.11 156.36 38.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.784 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.26 -32.32 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.096 1.758 . . . . 0.0 112.932 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 59.13 -51.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 115.497 -168.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.68 161.98 16.05 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.06 0.944 . . . . 0.0 110.8 -160.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mm -135.74 140.45 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.226 1.81 . . . . 0.0 107.73 -176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.79 88.5 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.734 2.013 . . . . 0.0 107.714 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.7 t -89.8 93.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 164.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.69 152.6 19.47 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 mp0 -56.88 152.87 11.93 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.448 1.099 . . . . 0.0 110.496 168.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -79.77 133.6 58.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 164.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.92 -9.72 26.25 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 CA-C-N 121.12 1.436 . . . . 0.0 112.121 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.78 39.65 0.96 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.023 1.329 . . . . 0.0 110.062 -163.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.47 85.84 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.295 -1.503 . . . . 0.0 112.336 -169.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.6 63.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 -171.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -144.29 -105.73 0.12 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.563 -161.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -64.93 -32.98 74.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.744 1.611 . . . . 0.0 112.991 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 t 49.97 84.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.626 1.97 . . . . 0.0 111.109 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.88 -176.76 5.65 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.211 -0.931 . . . . 0.0 109.981 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.96 21.39 0.28 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.509 1.052 . . . . 0.0 114.081 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.64 -20.24 17.1 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.602 1.701 . . . . 0.0 113.822 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.08 -53.44 48.45 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 119.227 0.921 . . . . 0.0 109.515 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -72.48 -32.05 10.41 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.012 1.808 . . . . 0.0 111.899 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.1 -38.33 73.22 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.052 0.842 . . . . 0.0 110.922 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.75 -65.58 0.61 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.902 1.281 . . . . 0.0 110.991 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 m -61.81 -22.34 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.751 1.16 . . . . 0.0 113.904 -173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.48 -12.36 61.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.304 -1.498 . . . . 0.0 114.002 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -19.01 23.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.809 1.186 . . . . 0.0 109.781 165.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.15 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.171 0 O-C-N 119.87 -1.768 . . . . 0.0 111.239 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.53 20.11 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 127.34 2.4 . . . . 0.0 116.214 161.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.23 176.84 9.3 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -159.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 11.4 mt-10 -144.1 -53.32 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 124.63 1.172 . . . . 0.0 110.642 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.08 157.01 19.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.6 1.16 . . . . 0.0 109.363 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.51 139.65 44.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.386 2.275 . . . . 0.0 105.071 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 94.5 mt -131.47 111.37 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.31 155.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.685 -162.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -95.08 -62.14 1.36 Allowed 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.763 -1.211 . . . . 0.0 111.243 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.85 -54.42 1.3 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.791 -0.568 . . . . 0.0 113.929 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.485 HG12 ' H ' ' A' ' 74' ' ' GLY 0.299 3.7 tt 44.26 -168.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 130.102 3.361 . . . . 0.0 115.14 -173.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.485 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.36 167.19 39.82 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.319 1.914 . . . . 0.0 110.445 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.61 -31.76 73.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -163.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -64.74 -36.33 83.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.198 1.817 . . . . 0.0 109.642 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.73 63.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.265 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.42 -43.96 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 119.764 1.165 . . . . 0.0 109.626 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.23 10.93 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.196 -1.565 . . . . 0.0 114.934 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.16 -58.56 3.09 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.259 1.424 . . . . 0.0 110.453 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -35.62 -56.29 0.67 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 126.953 2.101 . . . . 0.0 109.159 160.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.42 -9.94 55.82 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 117.421 -1.276 . . . . 0.0 111.733 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.9 63.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.725 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.2 14.92 5.66 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.311 0.382 . . . . 0.0 111.504 -163.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.25 26.78 56.84 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.09 -0.381 . . . . 0.0 112.765 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.64 108.15 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -168.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.66 28.49 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.975 1.71 . . . . 0.0 110.336 -170.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.07 95.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.5 139.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.81 154.06 47.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.986 -0.446 . . . . 0.0 110.845 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.12 38.62 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.084 0.85 . . . . 0.0 114.799 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.5 157.53 37.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.427 1.113 . . . . 0.0 110.869 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.2 p -159.46 130.33 5.93 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.127 0.971 . . . . 0.0 108.414 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.65 -130.86 6.28 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.906 -172.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.35 159.61 39.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.041 1.737 . . . . 0.0 111.329 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.71 -45.1 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.861 -1.149 . . . . 0.0 111.272 -166.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.53 -12.01 48.97 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.38 -43.49 5.41 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.007 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.3 t -46.03 -49.8 4.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.432 1.469 . . . . 0.0 110.547 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.47 -38.47 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.478 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -62.01 -50.97 69.93 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 117.329 -1.32 . . . . 0.0 110.307 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.26 -37.22 69.5 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.379 1.445 . . . . 0.0 111.575 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.04 -50.42 41.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.723 1.209 . . . . 0.0 111.94 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.8 mt -62.88 -30.63 71.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.097 0.408 . . . . 0.0 110.139 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.9 m -74.77 -1.09 20.49 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.924 2.09 . . . . 0.0 112.508 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.91 75.0 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 125.39 1.472 . . . . 0.0 112.916 168.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.5 -45.78 51.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.914 0.864 . . . . 0.0 108.705 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.97 134.88 38.74 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.602 1.161 . . . . 0.0 108.373 -166.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -158.72 178.78 9.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -124.55 14.12 8.78 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.089 2.156 . . . . 0.0 112.469 -162.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 t 49.34 -135.03 1.3 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.809 1.644 . . . . 0.0 111.456 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -146.68 113.95 6.26 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.974 1.71 . . . . 0.0 108.508 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -151.29 14.82 0.7 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -160.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -120.79 34.24 5.29 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.618 -1.302 . . . . 0.0 113.132 -166.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -45.82 137.06 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 125.182 1.393 . . . . 0.0 111.283 169.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -119.73 40.62 3.35 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.951 1.3 . . . . 0.0 111.41 -164.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -117.97 -26.52 6.41 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.614 1.566 . . . . 0.0 112.229 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -142.21 151.93 42.62 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.5 1.52 . . . . 0.0 108.33 -163.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -159.52 -171.25 3.23 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.518 1.527 . . . . 0.0 109.098 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -133.08 48.36 2.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.953 1.301 . . . . 0.0 109.028 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 54.23 173.65 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.092 1.357 . . . . 0.0 110.113 -141.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -71.53 -73.42 0.18 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 158.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 66.42 112.17 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.738 2.015 . . . . 0.0 109.187 -162.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 C--O 1.25 1.117 0 N-CA-C 104.567 -2.382 . . . . 0.0 104.567 160.755 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.1 mt -111.7 141.7 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.9 mt -122.41 102.65 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 129.424 3.09 . . . . 0.0 107.246 -168.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.433 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.15 145.74 32.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.985 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mt -138.64 117.97 9.53 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.21 108.63 2.02 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 N-CA-C 107.121 -1.915 . . . . 0.0 107.121 166.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -101.1 158.9 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 119.065 0.848 . . . . 0.0 110.33 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -77.03 -33.11 57.42 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.154 1.782 . . . . 0.0 112.392 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -147.13 146.58 29.96 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -86.54 90.03 8.1 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 167.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -111.62 39.44 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.487 -1.244 . . . . 0.0 110.306 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 25.05 91.36 0.01 OUTLIER Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.581 2.039 . . . . 0.0 115.174 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt 80.19 -45.7 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.791 2.436 . . . . 0.0 112.068 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -20.13 65.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -33.36 102.34 0.21 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.972 2.909 . . . . 0.0 111.974 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.29 137.13 36.05 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 109.349 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 tt -60.78 140.17 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 t -75.83 177.71 6.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.211 1.004 . . . . 0.0 109.039 170.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 -13.94 21.43 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.489 -0.757 . . . . 0.0 112.616 -173.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -142.25 -179.5 6.29 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.888 2.075 . . . . 0.0 108.861 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -119.6 -42.55 2.63 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.424 0.69 . . . . 0.0 111.777 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 -16.3 55.49 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 117.578 -1.679 . . . . 0.0 116.947 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 39.09 1.49 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.999 1.719 . . . . 0.0 109.794 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.39 146.7 97.83 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 37.6 Cg_endo -74.37 -22.22 16.55 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.565 1.51 . . . . 0.0 114.055 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -153.18 153.03 31.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.694 1.134 . . . . 0.0 109.418 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -113.31 109.18 18.31 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.711 0.264 . . . . 0.0 111.711 164.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 96.58 6.52 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.1 m-85 -83.34 96.39 8.5 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 164.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 t -79.64 168.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.82 -164.21 1.32 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.24 -1.537 . . . . 0.0 109.246 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -147.11 133.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 O-C-N 121.74 -0.6 . . . . 0.0 109.768 170.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -105.27 102.09 11.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 168.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.4 t30 55.28 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 111.964 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -140.03 34.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.686 1.595 . . . . 0.0 109.996 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.19 169.89 12.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.518 1.127 . . . . 0.0 108.412 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.11 -23.12 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.573 1.533 . . . . 0.0 113.588 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.4 -68.68 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.367 1.867 . . . . 0.0 114.228 -162.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -168.32 146.38 4.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.752 0.821 . . . . 0.0 110.412 -150.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mm -111.89 126.53 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.005 2.122 . . . . 0.0 107.072 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.37 80.46 1.61 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.55 1.54 . . . . 0.0 107.39 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.266 7.2 p -91.82 75.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.976 0.893 . . . . 0.0 109.012 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.01 160.41 25.88 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.55 -178.44 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.754 1.222 . . . . 0.0 111.437 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.421 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 33.7 p-10 -100.31 85.51 0.54 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.023 3.329 . . . . 0.0 114.671 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.69 -24.79 74.9 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.257 1.972 . . . . 0.0 113.39 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -120.24 56.2 0.98 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 123.593 1.664 . . . . 0.0 107.74 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.2 -49.49 77.64 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.171 1.389 . . . . 0.0 109.904 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -145.6 5.93 1.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 116.833 -1.556 . . . . 0.0 112.659 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.44 97.6 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 121.558 1.981 . . . . 0.0 113.716 -166.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 41.76 26.53 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.71 2.404 . . . . 0.0 113.61 -166.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 m 33.12 55.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.625 2.77 . . . . 0.0 111.89 -169.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -117.51 -175.98 2.92 Favored 'General case' 0 C--O 1.242 0.683 0 O-C-N 121.49 -0.756 . . . . 0.0 110.491 -171.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.2 72.03 2.88 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 120.913 -1.117 . . . . 0.0 113.38 -163.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.41 -18.6 1.47 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -46.41 -55.15 14.85 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 122.505 2.411 . . . . 0.0 110.288 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.25 -17.11 11.86 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.319 2.013 . . . . 0.0 112.197 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.68 -48.8 68.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -52.95 -66.09 0.45 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.45 1.1 . . . . 0.0 111.278 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.64 -17.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 120.297 -1.502 . . . . 0.0 113.156 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.98 -31.87 61.54 Favored 'General case' 0 N--CA 1.458 -0.049 0 O-C-N 120.922 -1.111 . . . . 0.0 111.746 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -64.51 -26.47 68.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.968 1.258 . . . . 0.0 110.981 170.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -82.48 38.13 0.54 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.859 0.863 . . . . 0.0 111.029 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 62' ' ' GLU . . . 40.55 30.83 0.34 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 129.375 3.369 . . . . 0.0 116.903 165.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.74 175.46 7.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.551 1.175 . . . . 0.0 113.696 -167.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.56 -37.88 0.41 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.281 1.433 . . . . 0.0 110.052 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -132.02 154.76 49.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.698 1.199 . . . . 0.0 109.435 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -148.76 140.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.6 mt -126.0 110.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.55 164.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 109.813 -172.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.36 -100.5 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.31 66.2 0.35 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 125.277 1.417 . . . . 0.0 110.606 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.7 tt -57.96 172.44 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.128 1.771 . . . . 0.0 111.215 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.72 154.2 20.82 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.716 1.151 . . . . 0.0 110.945 169.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -51.57 -35.5 41.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.921 2.089 . . . . 0.0 114.374 -165.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -59.06 -28.4 66.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.624 1.102 . . . . 0.0 112.448 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.03 -31.72 27.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.68 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.6 mm -54.44 -50.13 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.72 -26.78 10.07 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 114.851 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.76 -51.61 11.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.915 0.78 . . . . 0.0 111.29 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -58.51 -35.43 72.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.046 1.339 . . . . 0.0 110.293 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -65.23 -7.77 14.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.029 0.932 . . . . 0.0 113.383 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.69 -25.43 33.01 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.906 1.685 . . . . 0.0 110.942 170.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 ptm -118.28 1.75 11.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.913 1.685 . . . . 0.0 112.648 -167.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.87 76.47 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 118.722 0.692 . . . . 0.0 111.548 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 t -79.74 121.43 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.48 146.51 36.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 p -138.72 93.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.04 124.39 28.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 126.11 1.764 . . . . 0.0 107.161 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 166.94 12.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.603 0.761 . . . . 0.0 110.676 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.25 18.54 73.3 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.003 -0.887 . . . . 0.0 113.31 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.36 170.36 12.03 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.906 1.353 . . . . 0.0 110.913 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 t -161.91 147.93 13.52 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.444 1.098 . . . . 0.0 108.055 172.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.08 -172.53 19.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.156 1.36 . . . . 0.0 112.587 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.5 p -79.86 163.19 24.57 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.441 -1.035 . . . . 0.0 109.26 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.29 -51.38 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.931 0.893 . . . . 0.0 110.049 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.75 -38.41 72.38 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 123.334 0.396 . . . . 0.0 111.268 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -77.54 -54.73 6.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.159 0.984 . . . . 0.0 108.625 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 t -54.52 -46.84 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.109 1.364 . . . . 0.0 110.785 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.65 -51.43 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -56.63 -42.54 79.03 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.69 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -55.86 -39.39 71.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.673 1.124 . . . . 0.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.19 -45.64 47.09 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.092 0.557 . . . . 0.0 112.23 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.6 mp -56.99 -35.07 68.77 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.3 m -86.29 1.73 49.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.356 1.462 . . . . 0.0 113.129 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.64 13.87 61.71 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.494 1.045 . . . . 0.0 114.02 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -74.93 -36.54 62.13 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.823 1.312 . . . . 0.0 110.186 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.21 161.98 23.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.119 0.968 . . . . 0.0 109.041 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -129.61 179.67 5.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.755 1.222 . . . . 0.0 108.384 -172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -153.56 69.8 0.82 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -162.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.1 p -54.09 159.72 1.76 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.226 170.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -142.77 145.67 33.49 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -144.52 163.5 33.66 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.91 1.284 . . . . 0.0 108.782 -163.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -43.58 99.24 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 127.335 2.254 . . . . 0.0 112.165 -164.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.6 t -82.89 58.83 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 170.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -70.05 164.12 24.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 161.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -34.13 98.39 0.01 OUTLIER 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.667 2.387 . . . . 0.0 112.383 -168.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.88 159.72 31.53 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 122.209 -0.307 . . . . 0.0 110.377 170.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -144.99 149.91 35.99 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.022 -1.049 . . . . 0.0 111.838 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -156.9 129.68 7.68 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 125.637 1.575 . . . . 0.0 106.918 163.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.37 -177.54 5.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.095 0.958 . . . . 0.0 108.888 171.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 50.34 71.63 0.4 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.951 1.7 . . . . 0.0 112.261 170.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -162.45 168.7 21.6 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 161.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.902 0 C-N-CA 126.534 1.934 . . . . 0.0 106.866 140.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.482 HD22 HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.06 70.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -145.05 22.53 1.56 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -117.57 129.23 55.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.899 0.772 . . . . 0.0 110.619 -163.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.5 m170 61.06 -40.04 0.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.685 2.794 . . . . 0.0 114.049 -168.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t 56.75 24.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.902 1.681 . . . . 0.0 111.531 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -64.23 -70.48 0.22 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 120.914 -1.116 . . . . 0.0 108.096 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.87 41.35 0.04 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.72 -14.37 14.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.482 HG23 HD22 ' A' ' 45' ' ' ASN . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.443 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.75 158.85 40.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -135.74 45.56 2.41 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 126.48 1.912 . . . . 0.0 108.919 -164.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 m -44.2 152.06 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.498 1.919 . . . . 0.0 112.316 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.13 124.71 16.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -147.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.1 119.93 40.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.298 1.839 . . . . 0.0 110.3 -157.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.6 142.9 53.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 113.089 -173.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t 32.41 58.75 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 128.851 2.86 . . . . 0.0 111.739 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 t60 57.88 -77.09 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.836 2.054 . . . . 0.0 111.306 -170.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.91 -34.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.454 1.102 . . . . 0.0 111.577 171.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 67.97 -4.37 1.03 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.614 1.566 . . . . 0.0 114.993 171.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -82.63 148.36 28.02 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 121.093 1.77 . . . . 0.0 109.942 -171.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.3 m170 57.73 165.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.732 2.413 . . . . 0.0 111.197 -169.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -141.54 161.18 38.54 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.501 1.12 . . . . 0.0 108.728 164.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.75 -28.06 13.02 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 66.19 -24.97 0.1 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.099 2.16 . . . . 0.0 116.099 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 171.108 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.2 tpt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.2 mt -139.45 141.01 36.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.01 104.33 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 127.561 2.344 . . . . 0.0 107.428 -163.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.448 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -79.73 140.37 36.98 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.7 mt -139.71 107.51 7.05 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 129.32 14.5 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.152 1.901 . . . . 0.0 108.129 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.37 152.06 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.169 0.588 . . . . 0.0 110.132 -170.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -74.32 -13.27 60.73 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.94 170.41 21.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.9 1.227 . . . . 0.0 109.381 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.487 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 37.2 p-10 -82.12 39.67 0.59 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.014 1.326 . . . . 0.0 112.809 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -81.46 41.01 0.6 Allowed 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.631 -1.293 . . . . 0.0 112.285 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.7 124.7 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.396 2.427 . . . . 0.0 114.791 -170.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt 80.32 -67.28 0.13 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.998 2.919 . . . . 0.0 109.984 -165.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -10.61 48.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.592 2.357 . . . . 0.0 112.954 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 m -35.91 99.08 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 130.46 3.504 . . . . 0.0 111.628 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.22 128.68 15.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tt -62.04 131.87 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 170.27 14.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.103 1.361 . . . . 0.0 108.409 170.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -89.92 -56.08 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -99.6 135.41 41.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -67.9 -41.32 82.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.16 -5.24 53.03 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.119 -1.934 . . . . 0.0 115.444 -164.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -144.12 38.73 1.31 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.593 1.697 . . . . 0.0 109.181 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.27 132.67 75.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.29 -19.01 17.65 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.743 1.628 . . . . 0.0 113.502 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 10' ' ' ASN . 96.7 m-85 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.935 1.294 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.17 107.75 10.29 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.684 1.194 . . . . 0.0 108.515 170.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.96 91.63 5.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.4 m-85 -77.98 95.91 4.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 160.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -79.84 164.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -112.42 -170.43 1.66 Allowed 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.851 -1.156 . . . . 0.0 110.017 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -141.56 151.53 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 156.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.74 106.32 15.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 160.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 t30 57.76 -62.63 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.376 2.27 . . . . 0.0 115.754 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.0 12.01 1.6 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.199 1.4 . . . . 0.0 112.791 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.23 -157.58 0.62 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.738 1.615 . . . . 0.0 112.802 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.11 -30.78 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.607 1.163 . . . . 0.0 111.316 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.36 -71.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 113.828 -161.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.04 165.98 32.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.281 1.432 . . . . 0.0 110.42 -160.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.77 147.1 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.5 1.12 . . . . 0.0 110.071 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -129.71 117.7 20.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.009 2.523 . . . . 0.0 105.977 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.97 70.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -79.71 146.2 32.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -62.3 143.31 57.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.963 0.905 . . . . 0.0 109.513 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -81.06 121.04 80.25 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.71 -37.76 34.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.342 2.028 . . . . 0.0 112.666 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.87 39.38 3.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.217 0.917 . . . . 0.0 110.08 -168.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.03 87.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.01 0.823 . . . . 0.0 110.718 -173.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -139.8 60.16 1.57 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.252 1.021 . . . . 0.0 108.975 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -135.35 -154.28 0.57 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.229 -0.919 . . . . 0.0 110.545 -173.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -55.91 -16.5 4.78 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.474 1.488 . . . . 0.0 114.564 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.2 t 34.89 48.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 127.955 2.502 . . . . 0.0 113.356 165.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -92.37 41.1 1.06 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 119.705 -1.872 . . . . 0.0 108.336 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.81 30.96 45.87 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.906 -0.941 . . . . 0.0 113.529 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.75 -13.46 13.23 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.292 1.546 . . . . 0.0 114.376 -173.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.53 -52.35 44.66 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.397 1.453 . . . . 0.0 108.587 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.2 -30.27 25.14 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.056 1.17 . . . . 0.0 112.962 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -69.33 -22.49 63.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.086 -0.384 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.05 -64.4 0.87 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.078 -0.963 . . . . 0.0 108.973 164.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -60.94 -26.15 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 121.095 1.771 . . . . 0.0 114.472 -170.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -59.75 -26.57 65.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.189 1.359 . . . . 0.0 113.449 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -21.57 60.21 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.457 1.026 . . . . 0.0 110.324 172.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -84.56 38.19 0.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.252 0.933 . . . . 0.0 110.302 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 28.77 42.33 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 129.901 3.619 . . . . 0.0 115.042 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 172.48 8.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.394 1.097 . . . . 0.0 112.405 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 18.3 mt-10 -139.0 -27.51 0.82 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.246 -166.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -141.57 154.47 45.46 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.69 0.796 . . . . 0.0 110.827 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -150.17 103.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 120.994 -1.066 . . . . 0.0 110.129 -172.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.6 mt -91.49 100.9 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 119.735 -1.853 . . . . 0.0 107.457 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.7 m -122.08 171.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.747 1.158 . . . . 0.0 111.948 -170.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -114.36 -100.06 0.43 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.49 54.42 4.95 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.806 1.67 . . . . 0.0 113.091 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.429 ' CG1' ' H ' ' A' ' 74' ' ' GLY . 10.3 tt -58.02 -170.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 125.772 1.629 . . . . 0.0 111.603 165.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.429 ' H ' ' CG1' ' A' ' 73' ' ' ILE . . . -154.87 164.81 31.91 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 119.051 -2.281 . . . . 0.0 109.38 171.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -53.28 -46.65 69.37 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.107 0.954 . . . . 0.0 113.554 -168.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -51.42 -21.61 2.45 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.31 -39.79 9.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.739 0.816 . . . . 0.0 110.584 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.7 mm -48.35 -47.6 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 166.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.56 -21.03 36.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.667 1.587 . . . . 0.0 114.672 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.16 -57.44 4.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.223 0.92 . . . . 0.0 108.925 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -60.71 -38.86 86.47 Favored 'General case' 0 N--CA 1.424 -1.767 0 C-N-CA 124.936 1.294 . . . . 0.0 109.403 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.79 -14.14 30.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.683 -1.151 . . . . 0.0 113.962 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.65 64.64 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 121.421 1.919 . . . . 0.0 111.929 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.64 18.6 5.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.108 1.363 . . . . 0.0 112.998 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.14 25.78 60.38 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.81 -1.181 . . . . 0.0 113.001 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 t -78.56 112.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -65.95 148.88 51.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.23 -169.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.36 98.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.0 mt -72.75 134.48 29.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.77 2.028 . . . . 0.0 107.101 166.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.58 174.97 5.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.077 0.551 . . . . 0.0 110.34 169.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.52 -2.98 65.43 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.689 -1.617 . . . . 0.0 115.547 168.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.61 -174.48 0.72 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.025 1.912 . . . . 0.0 112.575 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 p -170.49 153.04 4.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.964 2.106 . . . . 0.0 106.455 165.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.65 -168.96 22.57 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.814 0.721 . . . . 0.0 111.878 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -82.74 169.29 16.33 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.54 -0.976 . . . . 0.0 110.393 166.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.18 -53.99 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 123.56 0.744 . . . . 0.0 109.817 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.01 -17.09 36.12 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -99.28 -52.06 3.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.275 1.43 . . . . 0.0 108.678 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.7 t -55.33 -40.04 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.631 1.572 . . . . 0.0 111.714 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.37 -59.4 2.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -60.95 -41.09 95.62 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.517 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.27 -37.15 66.92 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.314 1.416 . . . . 0.0 110.584 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -77.12 -50.04 13.92 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.253 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.74 -25.64 65.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.816 0.697 . . . . 0.0 111.044 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -27.93 40.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.814 -0.613 . . . . 0.0 111.749 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.96 3.31 19.89 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.644 1.116 . . . . 0.0 113.693 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -42.67 65.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.171 1.486 . . . . 0.0 110.445 -173.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.47 147.93 52.6 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 122.957 0.503 . . . . 0.0 110.245 -172.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -111.01 146.19 37.13 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.366 1.066 . . . . 0.0 110.671 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -126.37 56.68 1.44 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.791 1.636 . . . . 0.0 109.808 -166.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.5 t -60.39 163.55 5.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.006 1.322 . . . . 0.0 111.713 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -103.34 115.73 31.1 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.69 1.996 . . . . 0.0 106.988 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -87.89 152.78 21.83 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.431 1.092 . . . . 0.0 109.33 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -77.83 145.5 36.3 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.52 -174.01 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.466 1.506 . . . . 0.0 109.175 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -118.36 -66.56 1.06 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 119.535 -1.978 . . . . 0.0 109.465 -172.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -175.71 -87.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -162.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -160.07 173.03 16.44 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.135 1.774 . . . . 0.0 106.828 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -70.11 94.57 0.9 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 168.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 174.04 0.7 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 125.076 1.35 . . . . 0.0 109.732 172.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -73.94 69.54 1.43 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.029 0.932 . . . . 0.0 109.249 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.87 76.58 1.73 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.345 1.458 . . . . 0.0 107.126 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.86 160.98 17.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 117.645 -1.169 . . . . 0.0 112.124 175.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 128.617 2.767 . . . . 0.0 108.358 -177.43 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mt -138.59 150.33 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.039 2.136 . . . . 0.0 105.971 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.7 mt -132.39 105.3 8.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 128.745 2.818 . . . . 0.0 108.112 -163.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.1 145.84 32.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 118.525 0.602 . . . . 0.0 110.401 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 53.4 mt -143.41 111.36 5.44 Favored Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.77 123.1 10.06 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 N-CA-C 106.715 -2.071 . . . . 0.0 106.715 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.86 158.85 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.784 0.72 . . . . 0.0 109.514 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.4 m -74.45 -34.9 63.3 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -146.52 154.06 41.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -80.21 115.32 19.7 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -138.34 39.64 2.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.399 0.545 . . . . 0.0 110.214 170.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.87 73.96 0.1 OUTLIER Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.326 -1.263 . . . . 0.0 115.058 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt 77.86 -28.35 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 130.6 3.56 . . . . 0.0 113.46 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.81 -8.3 53.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.502 0.721 . . . . 0.0 109.304 167.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -42.1 108.36 0.6 Allowed Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 130.224 3.41 . . . . 0.0 110.124 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.71 135.47 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.47 2.114 . . . . 0.0 109.102 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -58.53 146.38 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 118.854 0.752 . . . . 0.0 109.535 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 t -81.57 171.28 14.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 122.636 1.208 . . . . 0.0 109.159 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.62 -39.25 37.71 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.846 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -131.82 -174.03 3.3 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.792 -1.193 . . . . 0.0 108.6 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -119.83 -41.87 2.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.482 0.713 . . . . 0.0 110.208 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.39 64.79 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.936 -0.925 . . . . 0.0 113.739 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.43 72.68 1.44 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.26 1.824 . . . . 0.0 107.196 168.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.43 138.52 19.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 165.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.73 -20.97 8.82 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.641 2.894 . . . . 0.0 113.313 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -151.94 138.43 18.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.166 1.786 . . . . 0.0 107.038 -165.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.86 98.95 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.357 1.863 . . . . 0.0 107.953 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.41 78.0 5.94 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.204 1.402 . . . . 0.0 108.841 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -71.34 94.66 1.24 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.737 1.215 . . . . 0.0 109.285 174.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.98 167.88 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.528 1.531 . . . . 0.0 109.404 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -122.88 -171.53 2.31 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.694 -1.253 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.72 136.74 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 166.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.28 126.71 18.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 127.413 2.285 . . . . 0.0 105.759 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 52.75 42.38 31.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.145 0.978 . . . . 0.0 111.324 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.09 9.23 5.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.63 1.972 . . . . 0.0 113.729 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.05 167.89 10.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.659 1.184 . . . . 0.0 109.072 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.99 -26.21 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 113.673 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 57.78 -54.52 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.393 2.277 . . . . 0.0 115.937 -167.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -170.6 158.05 6.07 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.309 1.444 . . . . 0.0 108.787 -157.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.7 mt -138.82 137.87 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 125.303 1.441 . . . . 0.0 107.972 171.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 m -111.07 144.42 40.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.434 2.294 . . . . 0.0 105.855 160.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 16.0 t -140.74 68.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 167.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -80.18 136.65 36.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.14 150.04 49.69 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -88.85 107.74 19.28 Favored Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.199 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.17 -8.51 22.11 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.163 1.909 . . . . 0.0 112.083 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -128.41 37.75 4.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.11 0.964 . . . . 0.0 109.769 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.71 -28.19 58.5 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.146 1.778 . . . . 0.0 111.793 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -135.33 3.53 3.1 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.1 0.96 . . . . 0.0 113.365 -167.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -95.8 103.6 15.49 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.935 0.788 . . . . 0.0 109.369 173.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 51.89 -0.56 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.111 2.565 . . . . 0.0 116.399 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 t 53.16 23.04 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 126.135 1.774 . . . . 0.0 111.832 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -151.5 17.74 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.063 -1.648 . . . . 0.0 112.185 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.92 60.54 3.8 Favored Glycine 0 C--O 1.216 -1.012 0 O-C-N 120.4 -1.438 . . . . 0.0 111.291 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 53.05 26.77 5.08 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -36.53 -51.19 1.9 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.162 2.185 . . . . 0.0 112.193 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.14 -24.64 12.41 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.257 1.485 . . . . 0.0 112.519 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -68.68 -38.36 80.3 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 119.874 1.215 . . . . 0.0 109.551 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.71 -65.62 0.54 Allowed 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.896 0.747 . . . . 0.0 109.557 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 m -59.91 -37.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 117.134 -1.412 . . . . 0.0 112.192 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -58.74 -17.56 24.06 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.02 2.191 . . . . 0.0 114.322 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -26.04 49.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.5 -1.375 . . . . 0.0 110.303 167.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -84.71 37.9 0.67 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.153 1.381 . . . . 0.0 111.164 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.06 26.63 1.32 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 128.287 2.851 . . . . 0.0 118.112 165.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.87 171.17 11.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.904 1.852 . . . . 0.0 115.21 -171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -144.88 -27.24 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.042 1.737 . . . . 0.0 112.019 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp -132.18 156.21 46.84 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.378 1.471 . . . . 0.0 108.745 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.8 146.6 21.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 170.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.0 mt -130.6 113.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.08 177.02 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.445 1.098 . . . . 0.0 109.542 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.9 ttt-85 -112.55 -90.83 0.5 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.9 64.68 0.26 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.139 1.828 . . . . 0.0 112.37 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.48 176.62 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 125.639 1.576 . . . . 0.0 111.747 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.89 159.67 23.06 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.09 1.805 . . . . 0.0 111.141 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -60.01 -34.77 73.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -164.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -56.08 -40.76 74.11 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.267 1.394 . . . . 0.0 110.826 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.945 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.0 mm -61.47 -48.56 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 167.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.14 -20.49 58.67 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.71 -57.78 7.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.049 -1.032 . . . . 0.0 111.518 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -62.39 -37.86 87.41 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 126.438 1.895 . . . . 0.0 109.399 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.46 -30.0 59.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.53 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.29 -8.46 55.95 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.473 1.033 . . . . 0.0 112.297 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -134.97 12.82 3.62 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.175 1.79 . . . . 0.0 111.783 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.46 33.99 33.66 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 121.382 -0.824 . . . . 0.0 112.408 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.49 117.7 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 146.39 52.89 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.102 -0.998 . . . . 0.0 108.372 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' ' HE2' ' A' ' 90' ' ' LYS . 2.5 p -133.69 110.17 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.467 0.651 . . . . 0.0 110.919 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mt -81.18 140.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.324 1.85 . . . . 0.0 106.135 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 88' ' ' VAL . 23.4 mtmt -124.48 174.07 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.727 1.211 . . . . 0.0 109.965 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.24 10.64 74.53 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.485 171.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 172.28 5.15 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.538 1.669 . . . . 0.0 111.345 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.0 p -159.38 153.91 24.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.054 1.742 . . . . 0.0 107.895 161.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.49 -166.52 25.8 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.759 0.709 . . . . 0.0 113.404 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 p -83.57 171.97 12.81 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.227 -1.16 . . . . 0.0 109.297 162.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.25 -55.1 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.341 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.18 -33.36 72.1 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.956 -173.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -71.57 -50.88 26.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.84 0.856 . . . . 0.0 110.388 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 38.0 t -58.99 -42.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.262 1.025 . . . . 0.0 110.218 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.62 -54.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -56.71 -42.04 78.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.004 0.82 . . . . 0.0 112.357 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -61.03 -32.85 72.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.266 0.939 . . . . 0.0 111.792 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -79.87 -42.13 24.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.414 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.53 -28.89 67.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.377 0.99 . . . . 0.0 110.754 173.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.2 m -74.12 -13.16 60.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.216 1.406 . . . . 0.0 112.896 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.8 12.77 65.19 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.946 1.26 . . . . 0.0 113.2 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -68.68 -50.84 47.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.131 1.466 . . . . 0.0 107.817 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.61 135.98 55.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.089 1.356 . . . . 0.0 110.109 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.16 163.28 34.84 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.32 1.448 . . . . 0.0 109.373 171.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -80.16 101.57 8.88 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 160.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.8 p -127.51 54.12 1.7 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.447 159.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.01 75.24 1.48 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.17 -0.956 . . . . 0.0 109.714 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -162.61 136.72 6.37 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.951 1.301 . . . . 0.0 108.528 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.03 82.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.959 2.104 . . . . 0.0 109.375 160.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.9 t 62.15 173.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 C-N-CA 125.147 1.379 . . . . 0.0 110.113 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 119.64 0.64 Allowed 'General case' 0 N--CA 1.474 0.765 0 O-C-N 118.925 -2.36 . . . . 0.0 113.77 163.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.63 176.22 5.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.653 1.181 . . . . 0.0 110.79 165.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -167.6 -50.81 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.356 1.462 . . . . 0.0 109.388 162.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -85.37 169.41 13.72 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 161.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -114.44 177.89 4.48 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.584 1.554 . . . . 0.0 108.05 159.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -157.82 167.25 30.55 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.89 1.676 . . . . 0.0 107.325 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 64.71 -174.35 0.17 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.376 1.87 . . . . 0.0 111.205 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 62.41 -178.36 0.13 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.768 1.627 . . . . 0.0 111.25 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 . . . . . 0 C--O 1.239 0.538 0 N-CA-C 103.225 -2.879 . . . . 0.0 103.225 138.605 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.146 0.022 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 mt -113.49 148.55 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 162.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.45 104.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 128.715 2.806 . . . . 0.0 105.604 -165.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.436 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.43 140.18 36.1 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.3 mt -131.94 118.59 16.53 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 167.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.9 121.22 8.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 107.099 -1.923 . . . . 0.0 107.099 168.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 m -116.13 147.6 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 119.013 0.824 . . . . 0.0 109.999 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -70.02 -30.93 68.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.993 -1.004 . . . . 0.0 111.429 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -146.4 156.33 43.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.429 1.892 . . . . 0.0 106.194 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -90.46 106.86 18.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -132.72 39.15 3.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.88 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.6 -76.12 0.01 OUTLIER Glycine 0 N--CA 1.469 0.864 0 C-N-CA 126.712 2.101 . . . . 0.0 115.849 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -110.33 -50.96 2.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.012 1.725 . . . . 0.0 107.069 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.88 -6.41 1.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 129.32 3.048 . . . . 0.0 113.77 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 m -47.95 109.7 1.2 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 129.864 3.266 . . . . 0.0 111.745 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.04 137.21 21.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.102 1.868 . . . . 0.0 110.317 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.14 137.26 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.643 1.211 . . . . 0.0 111.422 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -74.54 170.16 16.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.429 1.892 . . . . 0.0 109.614 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -109.87 -24.66 10.72 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.83 -1.169 . . . . 0.0 113.059 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -121.43 89.25 3.09 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.259 1.024 . . . . 0.0 109.897 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -39.86 -49.64 2.4 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.3 1.44 . . . . 0.0 113.23 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -15.07 48.38 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.22 52.48 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 173.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.93 153.36 69.74 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 161.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.62 -22.53 0.9 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.782 2.988 . . . . 0.0 113.955 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.11 160.93 39.25 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.793 1.237 . . . . 0.0 107.981 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -127.5 110.53 12.83 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.19 86.93 5.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.436 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -76.63 100.06 5.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 t -88.52 141.97 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 125.328 1.451 . . . . 0.0 107.847 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -93.18 -172.48 2.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.801 0.728 . . . . 0.0 109.277 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.2 t -145.42 134.31 17.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 34' ' ' ASN . 6.8 ttpt -133.0 118.52 18.92 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 126.061 1.744 . . . . 0.0 106.713 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.401 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 80.6 m-20 40.45 56.93 2.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.218 1.407 . . . . 0.0 112.62 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 39.93 62.81 1.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 112.985 -167.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.75 171.0 15.4 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.617 1.967 . . . . 0.0 107.968 159.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.63 -20.61 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.62 1.568 . . . . 0.0 112.985 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.37 -59.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.737 2.415 . . . . 0.0 115.912 -165.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -170.88 164.29 7.76 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.718 2.407 . . . . 0.0 108.8 -164.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.02 129.05 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -173.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 m -124.35 89.03 3.0 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 127.177 2.191 . . . . 0.0 108.298 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 3.7 t -92.17 81.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.6 147.33 32.12 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.42 149.61 33.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.05 0.453 . . . . 0.0 110.115 162.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -95.51 107.98 36.65 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 117.802 -1.094 . . . . 0.0 108.61 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.27 -6.96 17.55 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.164 1.909 . . . . 0.0 113.372 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.46 38.18 4.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.157 1.783 . . . . 0.0 109.479 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.75 -27.9 66.32 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.605 -1.309 . . . . 0.0 111.675 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -151.25 80.64 1.31 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.69 1.596 . . . . 0.0 107.714 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -145.4 -90.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 156.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -86.17 -17.13 35.73 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.274 1.03 . . . . 0.0 113.076 -167.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t 68.13 -22.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 128.484 2.714 . . . . 0.0 114.288 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -150.23 168.59 23.56 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.944 2.098 . . . . 0.0 106.374 162.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.82 -85.82 0.4 Allowed Glycine 0 N--CA 1.461 0.304 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -17.78 29.43 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -50.06 -48.28 79.38 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 120.48 1.491 . . . . 0.0 110.051 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.62 -29.61 5.63 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.847 1.698 . . . . 0.0 111.652 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.37 -40.59 71.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.325 0.966 . . . . 0.0 109.516 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.88 -71.74 0.09 Allowed 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.219 1.007 . . . . 0.0 110.516 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.9 m -60.31 -14.47 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 O-C-N 119.542 -1.974 . . . . 0.0 114.549 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -80.26 -18.26 49.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.878 1.671 . . . . 0.0 112.867 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.07 -27.82 61.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.775 1.17 . . . . 0.0 111.037 164.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -87.65 37.65 0.8 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.535 -0.728 . . . . 0.0 110.672 -162.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.03 27.09 4.87 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.717 2.103 . . . . 0.0 115.157 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.76 166.89 22.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.627 1.214 . . . . 0.0 112.89 -167.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 7.4 mt-10 -141.85 -28.37 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.906 0.882 . . . . 0.0 111.69 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -134.71 160.94 36.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.629 1.172 . . . . 0.0 109.444 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.24 148.84 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.606 1.562 . . . . 0.0 106.902 169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.2 mt -132.41 113.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.2 m -135.08 -175.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.343 1.057 . . . . 0.0 110.264 -170.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -118.01 -100.35 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.37 -24.17 59.49 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.565 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.302 2.4 tt 44.2 -97.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.577 2.351 . . . . 0.0 113.696 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.13 124.01 2.22 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 127.449 2.452 . . . . 0.0 109.93 -174.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.35 -40.73 17.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.726 1.61 . . . . 0.0 112.472 -169.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -58.05 -34.64 70.31 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.506 1.503 . . . . 0.0 112.69 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.79 -22.52 46.21 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.453 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.6 mm -54.72 -46.79 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.93 -11.76 14.8 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.56 -1.337 . . . . 0.0 114.311 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -57.09 4.76 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 121.26 1.846 . . . . 0.0 111.163 167.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -53.56 1.68 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.655 1.582 . . . . 0.0 110.659 167.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.47 -13.88 62.43 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.528 1.142 . . . . 0.0 111.49 -170.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.71 -22.45 40.3 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 119.212 0.915 . . . . 0.0 110.517 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.48 10.69 7.93 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.144 0.429 . . . . 0.0 111.856 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.66 23.62 58.78 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.399 0.999 . . . . 0.0 112.99 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.85 94.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.71 1.204 . . . . 0.0 110.909 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 127.99 34.55 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.567 . . . . 0.0 110.55 -166.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.63 103.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 122.57 1.176 . . . . 0.0 108.321 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.5 mt -85.67 134.38 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -118.56 179.42 4.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.83 0.452 . . . . 0.0 111.568 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.28 20.33 76.62 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.682 0.614 . . . . 0.0 112.106 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.93 175.04 6.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.224 1.012 . . . . 0.0 109.522 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.8 p -166.96 156.51 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.57 1.548 . . . . 0.0 107.323 166.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.57 -169.67 12.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -80.48 168.83 18.48 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.598 -0.942 . . . . 0.0 109.88 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.85 -49.96 76.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 O-C-N 121.752 -0.592 . . . . 0.0 109.592 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.1 -30.74 62.49 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -75.76 -64.44 1.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.31 -44.24 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.746 1.618 . . . . 0.0 111.119 -171.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.1 t -59.15 -49.74 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.65 -33.67 76.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.565 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -60.76 -46.33 90.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.21 1.368 . . . . 0.0 110.426 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -59.14 -52.17 66.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.586 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -32.15 66.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.543 0.611 . . . . 0.0 110.856 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 m -76.98 -2.43 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.385 0.674 . . . . 0.0 111.882 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.8 8.92 87.21 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.911 -1.118 . . . . 0.0 112.718 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -75.33 -44.76 43.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.104 1.452 . . . . 0.0 110.405 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.53 151.81 37.88 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.852 1.261 . . . . 0.0 110.031 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -160.22 165.74 30.95 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.943 0.897 . . . . 0.0 111.949 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -105.79 24.7 11.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 129.678 3.191 . . . . 0.0 112.096 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.4 m -78.94 45.52 0.62 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.524 -1.36 . . . . 0.0 113.132 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -141.98 74.23 1.44 Allowed 'General case' 0 C--O 1.239 0.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.145 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -162.29 99.87 1.06 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -158.67 162.14 37.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.442 0.565 . . . . 0.0 109.792 160.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.273 8.9 m 45.77 5.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 130.676 3.59 . . . . 0.0 118.681 173.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -62.25 -64.88 0.79 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.968 1.258 . . . . 0.0 112.168 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -166.07 141.05 4.63 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.037 0.535 . . . . 0.0 109.697 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -111.63 114.06 26.86 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.494 1.518 . . . . 0.0 107.517 167.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -152.19 151.0 30.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 164.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.5 175.54 13.48 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.6 m80 62.67 163.54 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.433 2.293 . . . . 0.0 111.594 -170.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.67 -173.83 3.34 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 128.112 2.565 . . . . 0.0 107.154 169.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -148.02 52.11 1.03 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 130.71 3.604 . . . . 0.0 109.064 174.785 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 CA--C 1.507 -0.704 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 mt -142.42 142.98 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.8 104.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 0.0 106.867 -170.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.45 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -81.39 140.27 34.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.307 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.18 113.14 9.56 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.54 108.09 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.493 2.129 . . . . 0.0 108.009 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -100.57 158.22 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.309 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.9 m -81.49 -25.62 35.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.503 -0.761 . . . . 0.0 111.524 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -152.29 157.83 41.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.567 1.076 . . . . 0.0 109.675 -174.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -95.23 84.25 4.03 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.841 1.257 . . . . 0.0 108.578 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -107.81 38.62 2.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 116.803 -1.57 . . . . 0.0 110.383 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 32.43 79.56 0.02 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 125.299 1.428 . . . . 0.0 112.958 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 78.08 -36.12 0.21 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 128.633 2.773 . . . . 0.0 113.249 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.35 -7.87 35.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.756 0.707 . . . . 0.0 110.549 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -39.55 106.6 0.4 Allowed Pre-proline 0 N--CA 1.448 -0.557 1 C-N-CA 131.845 4.058 . . . . 0.0 111.051 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.77 133.78 15.85 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.99 2.46 . . . . 0.0 110.778 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -64.44 127.16 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.493 0.663 . . . . 0.0 110.174 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -63.19 168.45 4.24 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.423 1.089 . . . . 0.0 109.321 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.78 -15.37 34.83 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.198 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -131.02 -177.72 4.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -120.36 -55.78 2.02 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.648 1.179 . . . . 0.0 108.531 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.02 -6.21 12.0 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 117.424 -1.764 . . . . 0.0 116.324 -166.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.8 39.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.799 2.3 . . . . 0.0 109.869 163.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 144.96 97.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.3 -18.47 20.6 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.203 1.936 . . . . 0.0 114.23 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.15 160.63 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.146 1.378 . . . . 0.0 109.811 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -133.56 104.75 6.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.945 1.698 . . . . 0.0 108.473 170.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.77 93.3 6.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.45 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.3 m-85 -81.98 101.34 10.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 167.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.2 160.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -111.14 -166.9 1.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.393 0.997 . . . . 0.0 108.518 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -157.07 144.44 10.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 164.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.0 124.22 23.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 128.401 2.68 . . . . 0.0 105.19 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 36.73 61.53 0.85 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.786 2.034 . . . . 0.0 111.729 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 64.95 11.16 6.82 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 128.458 2.703 . . . . 0.0 115.335 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.14 164.7 18.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 120.165 1.348 . . . . 0.0 109.639 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.36 -28.0 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 113.792 -162.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.45 -56.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.912 2.485 . . . . 0.0 114.398 -165.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -162.6 155.19 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.454 1.502 . . . . 0.0 110.34 -165.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mm -128.09 117.02 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.038 2.535 . . . . 0.0 106.088 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -109.7 98.39 7.75 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 165.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.54 86.81 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -93.55 153.71 18.28 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -64.91 167.44 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 109.329 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.22 109.97 29.65 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 158.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.13 -7.29 19.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.632 1.554 . . . . 0.0 112.946 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.38 39.39 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.722 1.209 . . . . 0.0 109.985 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.89 90.62 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.47 19.56 0.94 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.206 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -95.16 90.55 5.93 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 122.879 0.472 . . . . 0.0 110.488 -171.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 53.24 29.93 9.21 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.534 1.134 . . . . 0.0 111.649 172.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.69 117.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.581 1.152 . . . . 0.0 112.26 -145.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -143.21 97.55 3.11 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.574 1.149 . . . . 0.0 110.219 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.15 14.34 79.05 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.419 -1.211 . . . . 0.0 115.931 158.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.78 -17.71 7.3 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.858 1.829 . . . . 0.0 114.376 -172.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -48.61 -50.9 56.73 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.439 1.018 . . . . 0.0 110.441 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -75.98 -19.96 15.4 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.347 1.365 . . . . 0.0 112.844 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -66.98 -40.59 87.44 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 119.421 1.01 . . . . 0.0 109.254 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -53.1 -64.4 0.83 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.039 0.936 . . . . 0.0 110.265 168.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.7 m -63.21 -29.22 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 119.952 1.251 . . . . 0.0 113.447 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -64.12 -23.28 67.26 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.76 -1.212 . . . . 0.0 112.791 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -24.71 61.23 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 121.245 1.839 . . . . 0.0 110.798 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.71 38.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.853 1.261 . . . . 0.0 111.102 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 38.63 37.09 0.51 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.735 2.588 . . . . 0.0 116.799 165.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.6 175.29 10.62 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.04 -31.56 0.54 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.792 1.637 . . . . 0.0 112.922 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.8 tp -134.46 159.83 39.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.305 1.05 . . . . 0.0 109.552 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.9 130.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.4 mt -114.45 112.42 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.92 170.34 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.556 1.542 . . . . 0.0 109.277 -172.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -99.64 -93.64 0.26 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.32 -19.98 53.53 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.51 -1.161 . . . . 0.0 114.661 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.336 2.7 tt 29.55 -129.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 127.724 2.41 . . . . 0.0 112.978 -172.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.22 -162.99 20.27 Favored Glycine 0 CA--C 1.541 1.698 1 C-N-CA 131.227 4.251 . . . . 0.0 106.822 176.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -37.69 9.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 121.145 2.472 . . . . 0.0 111.106 165.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -60.84 -20.79 62.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.98 -4.49 17.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.383 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -56.18 -41.26 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 157.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.26 -18.27 15.62 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.64 7.09 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 120.811 -1.181 . . . . 0.0 108.826 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.02 -40.22 95.84 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 125.789 1.636 . . . . 0.0 109.054 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -56.49 -27.6 57.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.72 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.16 -11.95 61.24 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.186 1.357 . . . . 0.0 111.738 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.5 ptp -130.81 6.38 4.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.867 1.667 . . . . 0.0 111.851 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.56 37.15 66.28 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 120.653 -1.279 . . . . 0.0 110.906 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 121.01 34.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -59.08 147.87 33.23 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.878 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.57 126.21 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.03 119.87 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -113.4 158.78 20.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.935 1.294 . . . . 0.0 108.794 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 11.33 74.25 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.538 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.71 174.37 1.05 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.362 1.581 . . . . 0.0 113.322 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -161.74 148.61 14.2 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.663 -1.273 . . . . 0.0 109.768 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.06 -163.77 12.17 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 124.011 0.819 . . . . 0.0 112.618 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.9 p -81.1 174.73 11.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.936 0.894 . . . . 0.0 109.81 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.47 -54.92 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 O-C-N 121.028 -1.045 . . . . 0.0 109.756 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.78 -37.98 69.28 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.94 -49.87 40.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.508 0.723 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.54 -40.51 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.631 1.172 . . . . 0.0 110.513 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.21 -51.84 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -62.0 -44.88 95.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.028 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -52.91 -39.24 62.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.305 0.957 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -76.01 -43.2 45.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mp -62.31 -28.49 69.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.687 0.795 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.5 m -80.61 -37.44 31.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.38 1.072 . . . . 0.0 109.833 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.13 10.42 22.38 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.158 0.885 . . . . 0.0 112.986 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -61.72 -44.03 97.71 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.182 0.991 . . . . 0.0 108.664 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 137.74 57.19 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.123 1.369 . . . . 0.0 110.626 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -115.24 148.7 38.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.635 1.174 . . . . 0.0 112.67 -170.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.71 58.38 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 127.802 2.441 . . . . 0.0 106.392 -169.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.9 t -58.42 150.09 23.27 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 158.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -116.03 169.91 8.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 148.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.64 12.38 2.3 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.249 1.019 . . . . 0.0 113.422 -176.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -94.61 175.81 6.52 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.153 -154.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.2 t -137.34 143.82 33.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -80.51 88.71 5.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 162.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.31 -76.12 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.962 2.105 . . . . 0.0 113.015 -172.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 174.69 -58.94 0.01 OUTLIER 'General case' 0 C--O 1.235 0.322 0 C-N-CA 129.041 2.936 . . . . 0.0 106.764 -168.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -139.68 -40.38 0.45 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.054 0.541 . . . . 0.0 111.968 171.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 44.79 94.21 0.01 OUTLIER 'General case' 0 C--O 1.233 0.192 0 C-N-CA 128.267 2.627 . . . . 0.0 112.863 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 32.1 t60 56.49 160.6 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.849 2.06 . . . . 0.0 110.545 -163.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -80.62 89.04 5.69 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 -163.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -71.13 88.22 0.8 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.965 1.306 . . . . 0.0 109.548 -164.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 . . . . . 0 C--O 1.25 1.113 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 156.528 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 2.1 ttm . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.152 0.025 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.7 142.8 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.75 107.41 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 129.779 3.232 . . . . 0.0 107.42 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.444 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -83.61 150.19 26.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.158 0.435 . . . . 0.0 111.367 175.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -142.77 120.01 7.02 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.19 123.17 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 108.75 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 m -118.54 156.89 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.158 0.583 . . . . 0.0 110.31 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -81.73 -21.49 37.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.524 -0.75 . . . . 0.0 112.123 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -142.77 161.36 38.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.621 1.1 . . . . 0.0 109.534 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -91.96 98.63 11.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -139.98 39.19 1.97 Allowed 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.77 -0.581 . . . . 0.0 110.473 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.02 -140.77 26.35 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-N 119.074 0.852 . . . . 0.0 112.347 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -16.75 6.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.93 -2.7 55.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.535 1.534 . . . . 0.0 110.755 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.4 m -50.57 122.49 16.1 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.984 1.714 . . . . 0.0 110.991 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.91 130.99 15.09 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 123.021 2.481 . . . . 0.0 109.703 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.3 140.11 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.52 175.48 9.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.098 0.951 . . . . 0.0 108.906 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.72 -21.65 21.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 118.356 -0.83 . . . . 0.0 111.126 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -130.93 -175.14 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.118 2.167 . . . . 0.0 108.277 -173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.31 -48.13 2.33 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.527 1.131 . . . . 0.0 109.77 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -19.71 59.28 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -165.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.7 38.55 3.05 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.629 1.214 . . . . 0.0 110.57 168.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.49 129.2 89.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.62 -21.69 45.33 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.308 2.005 . . . . 0.0 114.888 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -145.33 164.37 31.66 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 119.359 0.981 . . . . 0.0 109.191 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -134.17 103.98 6.0 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.168 1.387 . . . . 0.0 108.608 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.75 91.15 5.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.444 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.5 m-85 -82.95 94.61 7.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.2 155.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -98.16 -172.2 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.819 -1.175 . . . . 0.0 110.475 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 t -138.79 157.18 29.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 153.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -154.12 142.09 20.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.45 2.3 . . . . 0.0 104.969 162.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 47.62 47.8 17.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.727 1.149 . . . . 0.0 111.128 170.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.18 41.19 1.98 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.556 1.542 . . . . 0.0 115.029 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.6 169.09 18.4 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.283 0.633 . . . . 0.0 109.534 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.98 -31.38 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 113.484 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.69 -62.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.045 2.138 . . . . 0.0 114.789 -161.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.93 167.16 30.67 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.985 1.314 . . . . 0.0 111.525 -162.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.28 147.86 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.454 2.301 . . . . 0.0 107.86 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -145.21 97.51 3.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 p -105.09 65.89 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -89.1 150.26 22.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -170.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.78 148.67 49.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -80.1 122.28 82.85 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.297 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.98 -13.28 39.35 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.768 2.312 . . . . 0.0 114.789 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -134.05 39.91 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.499 1.52 . . . . 0.0 108.531 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.81 65.86 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 120.432 -1.417 . . . . 0.0 110.98 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -140.95 2.85 1.78 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -167.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 52' ' ' VAL . 3.9 t70 -127.94 154.11 45.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 119.409 1.004 . . . . 0.0 111.055 -156.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.456 ' C ' ' H ' ' A' ' 53' ' ' HIS . 5.6 m170 53.58 -31.11 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 129.583 3.153 . . . . 0.0 114.516 -162.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 50' ' ' ASP 0.265 21.2 m 36.16 3.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.83 1 C-N-CA 134.33 5.052 . . . . 0.0 116.959 -160.718 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' A' ' 51' ' ' HIS . 0.7 OUTLIER -61.18 -21.56 63.91 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.742 2.017 . . . . 0.0 112.345 -173.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.7 66.26 1.01 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -170.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.73 -6.4 19.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.181 154.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.51 -52.86 16.17 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.843 0.747 . . . . 0.0 109.989 172.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -75.67 -27.51 8.91 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.478 1.206 . . . . 0.0 113.199 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -55.82 -45.37 78.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.77 -66.48 0.49 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.185 0.994 . . . . 0.0 110.962 170.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 m -61.18 -21.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.871 1.668 . . . . 0.0 113.296 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.39 -23.86 62.85 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.814 1.246 . . . . 0.0 112.187 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -79.81 -18.64 50.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.642 1.11 . . . . 0.0 112.079 168.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -85.88 39.32 0.8 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.459 1.104 . . . . 0.0 111.084 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.9 16.85 41.14 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 160.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.53 165.67 24.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.909 1.354 . . . . 0.0 114.552 -161.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.417 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -133.94 -34.16 1.01 Allowed 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.942 1.297 . . . . 0.0 111.189 173.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -137.34 154.19 50.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -171.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -149.14 141.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 67.2 mt -132.91 111.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.15 -178.39 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.453 0.644 . . . . 0.0 110.592 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -114.0 -100.45 0.43 Allowed 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.3 61.96 1.25 Allowed Glycine 0 C--N 1.329 0.171 0 C-N-CA 125.688 1.613 . . . . 0.0 111.441 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.0 tt -59.96 172.46 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 125.462 1.505 . . . . 0.0 110.988 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 152.53 17.92 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -42.3 52.8 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 124.952 1.301 . . . . 0.0 112.418 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -56.95 -22.69 39.87 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.61 -31.71 13.15 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.311 1.045 . . . . 0.0 111.909 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.7 -45.77 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.1 -11.13 5.29 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.19 -57.14 3.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.551 1.069 . . . . 0.0 109.632 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -58.41 -39.15 78.95 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.008 1.723 . . . . 0.0 109.148 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -55.43 -29.26 58.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.526 1.131 . . . . 0.0 112.842 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.61 -6.53 55.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.696 1.135 . . . . 0.0 111.081 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -130.99 -0.78 4.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.13 1.372 . . . . 0.0 112.059 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.91 38.94 93.39 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.996 -1.065 . . . . 0.0 110.501 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.44 127.79 38.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 167.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -78.08 142.0 38.42 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 p -131.1 101.56 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 56.3 mt -74.36 149.27 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 125.829 1.652 . . . . 0.0 107.399 171.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.41 176.17 7.93 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.62 19.21 77.74 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.34 -0.7 . . . . 0.0 113.295 165.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 179.78 6.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.279 1.04 . . . . 0.0 110.329 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 p -164.8 154.54 13.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.313 2.245 . . . . 0.0 107.091 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.86 -168.02 13.22 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 123.55 0.531 . . . . 0.0 112.885 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.7 p -79.68 173.38 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.775 -0.838 . . . . 0.0 109.966 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.58 -57.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.003 0.921 . . . . 0.0 108.955 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.08 -32.36 72.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.418 -173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.93 -54.23 20.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.21 1.404 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.4 t -57.33 -30.05 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.695 1.198 . . . . 0.0 111.139 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.8 -53.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -54.29 -44.59 72.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.617 0.767 . . . . 0.0 109.963 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -53.81 -38.8 64.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.544 0.738 . . . . 0.0 111.073 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.36 -39.44 32.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.927 0.891 . . . . 0.0 112.503 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.25 -26.29 68.3 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.402 1.456 . . . . 0.0 111.275 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -1.86 57.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.514 1.126 . . . . 0.0 111.802 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.64 69.25 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.328 -1.483 . . . . 0.0 113.226 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -78.13 -27.48 48.27 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.804 1.302 . . . . 0.0 110.538 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.55 152.88 22.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.099 0.96 . . . . 0.0 110.667 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 161.67 42.02 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.413 1.085 . . . . 0.0 110.514 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -87.65 89.99 8.2 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 167.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 55.9 p -133.55 176.19 8.76 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.977 1.711 . . . . 0.0 109.277 166.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 46.2 t0 74.33 94.24 0.07 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.492 2.717 . . . . 0.0 110.091 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -151.41 146.42 25.95 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.388 1.075 . . . . 0.0 110.66 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -103.67 147.52 27.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.768 1.227 . . . . 0.0 111.909 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -130.07 25.61 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 120.458 -1.401 . . . . 0.0 111.686 -171.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -131.47 24.95 4.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -156.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.74 142.71 49.92 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.49 1.041 . . . . 0.0 110.546 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 24.97 -121.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.388 2.275 . . . . 0.0 112.391 -169.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -172.05 -51.67 0.02 OUTLIER 'General case' 0 C--N 1.342 0.255 0 CA-C-O 117.737 -1.125 . . . . 0.0 110.849 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 24.03 75.94 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.799 2.839 . . . . 0.0 111.937 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -68.48 99.19 0.93 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 51.01 -90.86 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.02 2.128 . . . . 0.0 109.546 -165.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 68.9 73.8 0.26 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.555 1.942 . . . . 0.0 107.697 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.359 1.864 . . . . 0.0 106.564 -175.776 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 tpp . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 mt -139.05 142.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 mt -132.96 104.39 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 127.217 2.207 . . . . 0.0 105.9 -161.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.01 142.3 35.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.808 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.3 115.14 11.7 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.1 116.73 4.64 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.368 2.045 . . . . 0.0 106.878 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 m -114.28 152.2 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 118.258 0.481 . . . . 0.0 109.843 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -77.34 -26.38 52.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.871 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -145.08 150.96 37.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.262 0.937 . . . . 0.0 109.516 -172.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.45 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 48.4 t-20 -85.78 64.75 8.79 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.239 1.816 . . . . 0.0 108.779 -168.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -111.2 39.24 2.33 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.495 -0.753 . . . . 0.0 109.319 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.88 -108.05 0.07 OUTLIER Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.462 1.982 . . . . 0.0 112.953 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -20.53 46.51 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.69 -6.85 58.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.934 2.494 . . . . 0.0 110.674 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.0 m -51.7 119.93 14.63 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.622 1.969 . . . . 0.0 112.28 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.39 135.28 20.1 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.864 2.376 . . . . 0.0 110.893 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.02 139.55 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.951 0.5 . . . . 0.0 109.771 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.38 177.05 6.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.747 1.219 . . . . 0.0 110.032 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -96.06 -42.12 8.4 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.71 -0.619 . . . . 0.0 111.634 -171.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -100.18 178.49 4.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -120.43 -47.36 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.564 1.146 . . . . 0.0 109.672 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -12.03 34.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.69 1.138 . . . . 0.0 114.127 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.04 38.93 3.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.078 1.439 . . . . 0.0 110.848 168.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.71 130.18 82.02 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.3 -23.58 20.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.361 2.041 . . . . 0.0 113.338 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 69.3 m-85 -145.75 153.38 40.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.099 1.36 . . . . 0.0 107.761 -176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -126.49 110.31 13.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.84 89.79 5.27 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -81.72 93.02 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -79.74 153.73 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -103.14 -168.27 1.49 Allowed 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.646 -0.659 . . . . 0.0 109.769 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.29 138.69 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 163.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.16 96.43 6.22 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 164.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 71.02 -50.11 0.68 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.33 2.252 . . . . 0.0 114.328 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.91 -1.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.212 2.605 . . . . 0.0 112.543 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.84 178.22 4.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.257 1.423 . . . . 0.0 108.211 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.87 -18.76 23.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 120.206 1.366 . . . . 0.0 113.438 -162.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.22 -79.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.72 1.145 . . . . 0.0 110.383 -159.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -154.07 168.02 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 109.791 -168.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.9 mm -100.49 162.5 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 127.038 2.135 . . . . 0.0 106.691 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 m -148.61 84.66 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.677 1.591 . . . . 0.0 107.426 157.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.33 84.11 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 175.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -93.38 158.33 15.78 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -78.94 145.45 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -84.59 108.8 16.08 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.34 -17.26 59.22 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.23 1.287 . . . . 0.0 111.929 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -120.2 38.75 3.88 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.398 1.079 . . . . 0.0 110.258 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.58 -21.89 65.4 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.851 -1.155 . . . . 0.0 110.918 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -145.67 -6.57 0.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.88 1.272 . . . . 0.0 112.786 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -69.7 89.4 0.55 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.17 1.388 . . . . 0.0 112.546 -157.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.1 m80 43.45 29.66 0.27 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.285 1.834 . . . . 0.0 112.973 -174.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t 36.11 44.78 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 129.435 3.094 . . . . 0.0 112.04 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -64.45 160.3 19.51 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.17 -1.581 . . . . 0.0 109.215 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.6 30.24 1.03 Allowed Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.714 -1.241 . . . . 0.0 112.946 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.7 -19.01 20.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.823 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.38 -55.71 17.67 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 110.077 174.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.48 -20.93 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.963 1.776 . . . . 0.0 110.581 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.67 -44.67 85.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.296 0.638 . . . . 0.0 109.907 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -55.72 -66.91 0.34 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.274 1.43 . . . . 0.0 110.422 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.71 -22.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -0.94 8.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 113.374 171.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 -19.08 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.837 -1.165 . . . . 0.0 110.667 168.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -84.61 37.25 0.63 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.613 0.642 . . . . 0.0 111.375 -174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 41.58 33.94 1.07 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.238 2.351 . . . . 0.0 114.492 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.19 166.73 15.65 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.613 1.707 . . . . 0.0 112.875 -168.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -139.14 -40.69 0.47 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.916 1.286 . . . . 0.0 110.923 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp -127.98 156.25 42.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.296 1.038 . . . . 0.0 108.664 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.56 142.88 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 94.4 mt -134.54 114.09 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 m -131.24 170.34 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.226 0.61 . . . . 0.0 110.065 -171.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -60.84 1.97 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.331 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.86 4.38 0.64 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 117.484 1.754 . . . . 0.0 117.484 -173.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 74' ' ' GLY 0.274 4.4 tt 31.83 -123.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 127.031 2.132 . . . . 0.0 114.994 162.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 156.75 155.76 7.58 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 128.039 2.733 . . . . 0.0 109.004 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -59.62 -31.96 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -164.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -30.32 71.16 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.466 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.66 -22.87 24.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.496 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.55 -42.61 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 121.005 1.73 . . . . 0.0 108.61 160.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.95 -10.6 22.24 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 120.453 -1.404 . . . . 0.0 113.118 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.66 -62.4 1.46 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 119.855 1.207 . . . . 0.0 111.333 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.403 ' CD2' HG13 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -30.99 -57.88 0.22 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 128.027 2.531 . . . . 0.0 109.61 161.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.02 -13.17 62.29 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.959 0.787 . . . . 0.0 112.57 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.46 59.23 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.824 0.738 . . . . 0.0 111.759 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -137.12 7.6 2.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.018 0.372 . . . . 0.0 111.811 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.35 28.5 35.68 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.626 1.584 . . . . 0.0 112.39 -170.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.06 99.52 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 124.341 1.057 . . . . 0.0 108.44 -172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -64.34 128.44 35.8 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.392 -163.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.403 HG13 ' CD2' ' A' ' 81' ' ' PHE . 7.0 p -110.77 112.25 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.0 mt -88.13 147.61 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -179.41 5.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.24 13.84 73.65 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-O 119.116 -0.824 . . . . 0.0 114.163 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.52 162.48 28.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.085 1.442 . . . . 0.0 109.936 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -146.14 160.1 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.053 2.141 . . . . 0.0 106.527 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.49 -161.06 17.95 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.469 0.577 . . . . 0.0 113.793 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -92.99 171.38 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 163.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -53.17 -54.97 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.883 0.873 . . . . 0.0 109.273 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.38 -31.0 71.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.047 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.458 ' HG2' HE21 ' A' ' 102' ' ' GLN . 42.4 tt0 -70.87 -55.57 8.18 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.08 -44.87 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.363 1.065 . . . . 0.0 110.599 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.59 -46.91 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -59.86 -42.14 93.02 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.887 0.767 . . . . 0.0 111.296 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.458 HE21 ' HG2' ' A' ' 98' ' ' GLU . 72.3 mt-30 -58.76 -52.5 65.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.863 0.865 . . . . 0.0 109.801 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.05 -46.66 83.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.11 -25.5 67.75 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.065 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 m -90.59 7.86 37.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 112.957 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.24 -1.28 88.96 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.177 1.37 . . . . 0.0 115.184 168.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -71.25 -44.06 66.04 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.367 1.084 . . . . 0.0 111.831 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.62 141.75 37.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.644 1.178 . . . . 0.0 108.473 -166.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.71 161.51 41.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 123.482 1.61 . . . . 0.0 112.937 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.09 14.05 2.49 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.002 2.521 . . . . 0.0 112.926 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.7 m -87.14 61.23 6.62 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.972 1.309 . . . . 0.0 112.556 -173.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -157.48 82.45 0.9 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.922 -1.111 . . . . 0.0 108.502 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -124.93 162.25 24.84 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.119 0.968 . . . . 0.0 110.737 -167.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -121.82 163.54 18.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.322 1.449 . . . . 0.0 110.541 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.45 150.67 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 124.494 1.117 . . . . 0.0 108.357 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -160.77 -60.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 166.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 t70 66.03 113.69 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.282 2.633 . . . . 0.0 108.109 -168.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.24 47.23 0.52 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.411 -1.431 . . . . 0.0 112.258 -169.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -159.34 162.39 35.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.237 1.415 . . . . 0.0 108.752 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 61.83 78.5 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.41 2.284 . . . . 0.0 112.968 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.05 -82.63 0.53 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 158.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -51.51 0.65 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.64 1.176 . . . . 0.0 110.451 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -129.79 159.13 37.47 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.478 1.511 . . . . 0.0 108.998 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 p80 . . . . . 0 C--O 1.242 0.662 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 148.799 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HA ' ' OE2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.521 0.201 . . . . 0.0 110.772 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 mt -115.31 153.13 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 165.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.48 105.29 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 127.16 2.184 . . . . 0.0 105.797 -164.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.438 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.47 145.56 31.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 118.623 -0.704 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.2 mt -145.93 114.59 4.66 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.38 129.55 16.05 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.523 1.482 . . . . 0.0 108.318 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.02 150.15 26.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.3 m -68.07 -27.02 66.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.337 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.63 156.07 39.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.663 1.585 . . . . 0.0 107.937 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -85.71 95.52 9.41 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.69 39.67 3.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.072 0.949 . . . . 0.0 108.616 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.2 -127.96 30.08 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 120.751 -1.218 . . . . 0.0 111.464 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -58.29 -45.83 87.2 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.153 1.381 . . . . 0.0 111.736 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -1.87 4.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.751 2.42 . . . . 0.0 114.307 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.1 m -53.05 109.03 1.26 Allowed Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 125.201 1.4 . . . . 0.0 110.955 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.89 135.37 14.08 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.42 1.414 . . . . 0.0 108.932 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.43 134.37 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.978 0.911 . . . . 0.0 111.288 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.37 169.87 12.53 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.869 1.267 . . . . 0.0 107.91 166.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -88.09 -55.26 3.83 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 121.454 -0.779 . . . . 0.0 110.577 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.7 85.59 2.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -152.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -37.49 -47.22 0.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 112.908 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.35 40.98 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.773 -1.015 . . . . 0.0 115.341 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 47.96 1.56 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 108.737 173.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.63 137.79 54.84 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.76 -25.28 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.482 2.121 . . . . 0.0 114.457 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -146.3 158.18 43.86 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.28 103.92 8.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.523 1.529 . . . . 0.0 107.904 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 78.99 6.66 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.543 1.537 . . . . 0.0 107.624 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.438 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.28 3.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 170.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 t -83.05 164.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 123.682 0.793 . . . . 0.0 109.055 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.87 2.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.94 -1.1 . . . . 0.0 108.946 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.19 147.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.65 113.76 19.08 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 173.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.8 t30 54.61 -86.86 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.716 1.206 . . . . 0.0 111.627 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.9 12.22 2.89 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.605 1.562 . . . . 0.0 111.917 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 156.32 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.821 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.21 -32.32 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.137 1.775 . . . . 0.0 112.938 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 59.17 -51.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.309 2.244 . . . . 0.0 115.48 -168.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.72 162.03 15.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 110.768 -160.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mm -135.75 140.48 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.205 1.802 . . . . 0.0 107.683 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.84 88.55 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.741 2.016 . . . . 0.0 107.704 165.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.7 t -89.86 93.46 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 164.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.76 152.63 19.47 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -56.92 152.97 11.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.427 1.091 . . . . 0.0 110.439 168.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -79.86 133.66 58.09 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.94 -9.72 26.24 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 CA-C-N 121.128 1.439 . . . . 0.0 112.136 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.81 39.73 0.96 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.042 1.337 . . . . 0.0 110.082 -163.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.41 85.84 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 120.275 -1.516 . . . . 0.0 112.367 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.63 63.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -171.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -144.32 -105.71 0.12 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.593 -161.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -65.04 -32.88 74.81 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.818 1.644 . . . . 0.0 112.978 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.1 t 49.87 84.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.632 1.973 . . . . 0.0 111.071 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.94 -176.79 5.67 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.026 0.931 . . . . 0.0 109.971 171.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.0 21.45 0.28 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.48 1.038 . . . . 0.0 114.005 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.63 -20.31 17.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.667 1.734 . . . . 0.0 113.813 -174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.06 -53.45 48.27 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 119.237 0.926 . . . . 0.0 109.515 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.43 -32.09 10.48 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.02 1.814 . . . . 0.0 111.925 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.09 -38.35 73.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.063 0.847 . . . . 0.0 110.884 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.77 -65.59 0.61 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.922 1.289 . . . . 0.0 110.971 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 m -61.74 -22.34 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 119.776 1.171 . . . . 0.0 113.952 -173.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.59 -12.34 61.51 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.368 -1.457 . . . . 0.0 113.946 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.78 -18.93 24.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.848 1.204 . . . . 0.0 109.813 165.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.22 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 119.84 -1.787 . . . . 0.0 111.221 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.51 20.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.337 2.398 . . . . 0.0 116.264 161.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.2 176.85 9.29 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -159.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 11.3 mt-10 -144.09 -53.31 0.33 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 110.661 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.02 157.03 19.73 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.618 1.167 . . . . 0.0 109.373 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.56 139.61 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 127.387 2.275 . . . . 0.0 105.084 172.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 94.5 mt -131.43 111.4 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.35 155.38 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.85 0.86 . . . . 0.0 110.657 -162.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -95.14 -62.1 1.36 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.66 -1.275 . . . . 0.0 111.195 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.82 -54.46 1.3 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 121.757 -0.589 . . . . 0.0 113.977 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.489 HG12 ' H ' ' A' ' 74' ' ' GLY 0.301 3.7 tt 44.38 -168.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 130.143 3.377 . . . . 0.0 115.093 -173.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.489 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.35 167.21 39.86 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.289 1.9 . . . . 0.0 110.42 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.8 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -64.74 -36.28 83.8 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 121.201 1.819 . . . . 0.0 109.638 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.66 -40.7 63.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.256 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.44 -43.89 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 119.732 1.151 . . . . 0.0 109.622 168.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.75 -11.25 11.32 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.131 -1.606 . . . . 0.0 114.89 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.18 -58.53 3.1 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.208 1.403 . . . . 0.0 110.441 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -35.63 -56.33 0.67 Allowed 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 126.958 2.103 . . . . 0.0 109.153 160.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.32 -10.05 56.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 117.441 -1.266 . . . . 0.0 111.763 -167.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.98 63.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.714 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.13 14.94 5.7 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.379 0.424 . . . . 0.0 111.476 -163.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.2 26.8 56.75 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.101 -0.374 . . . . 0.0 112.819 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.67 108.21 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -168.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.68 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.929 1.692 . . . . 0.0 110.349 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.05 95.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.51 139.47 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.87 154.06 47.68 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 -171.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.8 11.04 38.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.08 0.848 . . . . 0.0 114.751 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.48 157.58 37.58 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.48 1.14 . . . . 0.0 110.85 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.1 p -159.52 130.3 5.87 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.64 -130.77 6.25 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.95 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.41 159.55 39.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.044 1.738 . . . . 0.0 111.344 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.7 t -63.68 -45.1 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 120.909 -1.119 . . . . 0.0 111.304 -166.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.54 -11.91 48.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.43 -43.55 5.38 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 117.356 -1.307 . . . . 0.0 108.972 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.1 t -45.93 -49.88 4.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 120.412 1.46 . . . . 0.0 110.569 169.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.42 -38.48 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.471 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -61.99 -51.01 69.78 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 117.352 -1.309 . . . . 0.0 110.314 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.22 -37.26 69.46 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.374 1.443 . . . . 0.0 111.589 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.0 -50.38 42.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.724 1.21 . . . . 0.0 112.005 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.86 -30.72 71.72 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.128 0.422 . . . . 0.0 110.086 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.4 m -74.72 -1.13 20.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.884 2.074 . . . . 0.0 112.483 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 -8.9 74.98 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.356 1.455 . . . . 0.0 112.966 168.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.51 -45.79 51.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.95 134.85 38.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.34 -166.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -158.67 178.77 9.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -124.53 14.14 8.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.077 2.151 . . . . 0.0 112.436 -162.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 t 49.29 -134.98 1.3 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.795 1.638 . . . . 0.0 111.454 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -146.74 113.88 6.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.975 1.71 . . . . 0.0 108.575 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -151.23 14.82 0.7 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -160.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -120.79 34.36 5.24 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.603 -1.311 . . . . 0.0 113.146 -166.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.2 m -45.9 137.05 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.248 1.419 . . . . 0.0 111.234 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -119.73 40.67 3.34 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.936 1.294 . . . . 0.0 111.404 -164.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -118.01 -26.48 6.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.609 1.564 . . . . 0.0 112.237 -174.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -142.28 151.96 42.53 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.475 1.51 . . . . 0.0 108.31 -163.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -159.52 -171.32 3.26 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.525 1.53 . . . . 0.0 109.067 172.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -133.02 48.39 2.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.901 1.28 . . . . 0.0 109.052 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 54.25 173.67 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.114 1.366 . . . . 0.0 110.116 -141.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -71.5 -73.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 66.36 112.11 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.661 1.984 . . . . 0.0 109.234 -162.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.251 1.133 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 160.769 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 ttp . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.707 0.289 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -137.66 145.47 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.53 111.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 128.423 2.689 . . . . 0.0 106.827 -162.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.411 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -84.02 147.67 27.29 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.289 0.95 . . . . 0.0 111.599 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.4 mt -141.64 113.82 6.6 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.47 110.01 2.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.343 2.696 . . . . 0.0 108.824 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 m -106.82 146.26 13.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.496 0.718 . . . . 0.0 111.409 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.418 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -141.53 149.08 40.38 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.582 1.083 . . . . 0.0 109.389 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.68 100.04 11.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.95 39.02 1.8 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 27.23 80.89 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 126.76 2.124 . . . . 0.0 114.884 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 80.66 -29.78 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 1 C-N-CA 131.821 4.049 . . . . 0.0 113.445 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.5 -8.46 54.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.03 1.286 . . . . 0.0 110.263 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.4 m -45.82 108.64 0.83 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 128.401 2.681 . . . . 0.0 110.086 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.55 131.66 12.74 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.209 2.606 . . . . 0.0 110.104 -172.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.0 tt -62.11 140.75 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.404 1.002 . . . . 0.0 109.708 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -94.62 -173.32 2.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.982 1.313 . . . . 0.0 110.699 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -101.05 -42.72 6.28 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.729 1.212 . . . . 0.0 111.584 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -122.13 104.4 9.46 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.986 1.314 . . . . 0.0 109.901 -173.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -44.43 -44.57 8.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.126 1.37 . . . . 0.0 111.585 166.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.12 -3.09 51.14 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 117.943 -1.476 . . . . 0.0 116.233 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -148.16 63.16 1.1 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.03 124.31 32.53 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.69 1.996 . . . . 0.0 108.276 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.21 -23.71 24.13 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 CA-C-N 122.181 1.815 . . . . 0.0 114.214 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -148.68 151.7 35.39 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.814 0.734 . . . . 0.0 109.041 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -122.31 106.21 10.89 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.717 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.74 81.52 6.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.6 1.16 . . . . 0.0 107.94 169.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.411 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 2.6 m-85 -70.36 141.1 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 161.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.44 150.44 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -96.55 -169.83 1.97 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.374 0.67 . . . . 0.0 109.512 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.4 115.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.681 -0.637 . . . . 0.0 110.102 165.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.82 91.94 6.59 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.39 -67.33 0.15 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.279 1.432 . . . . 0.0 112.69 174.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -145.71 12.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.138 1.775 . . . . 0.0 112.636 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.63 173.33 6.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.602 1.561 . . . . 0.0 109.389 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.91 -25.74 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 121.068 1.758 . . . . 0.0 114.229 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.53 -69.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.304 1.411 . . . . 0.0 112.989 -158.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -166.09 170.84 13.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.097 0.959 . . . . 0.0 112.071 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.2 mm -116.01 145.18 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.774 2.43 . . . . 0.0 106.56 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 m -147.35 68.36 1.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.025 2.53 . . . . 0.0 109.815 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.06 93.33 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -96.33 161.95 13.71 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.003 1.321 . . . . 0.0 109.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -71.5 149.36 45.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.66 1.584 . . . . 0.0 109.689 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.1 129.82 65.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 118.242 -0.885 . . . . 0.0 108.849 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.86 -27.26 26.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.168 1.246 . . . . 0.0 111.436 168.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.32 45.76 2.59 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.524 -1.36 . . . . 0.0 109.473 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.86 -51.72 68.79 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 120.441 -1.412 . . . . 0.0 110.578 167.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -152.25 70.91 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -164.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -146.88 -95.25 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -26.78 62.92 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.639 1.176 . . . . 0.0 112.487 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t 51.36 101.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 128.987 2.915 . . . . 0.0 109.888 -166.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 75.66 -35.58 0.27 Allowed 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 126.039 1.736 . . . . 0.0 112.99 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.62 154.58 45.54 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 162.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 49.29 -12.06 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 131.202 3.801 . . . . 0.0 117.849 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -51.49 -55.25 30.89 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 120.372 1.442 . . . . 0.0 109.254 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.62 -22.74 37.51 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 120.304 1.144 . . . . 0.0 110.36 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.82 -37.08 85.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.736 1.153 . . . . 0.0 110.485 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -61.42 -61.64 2.39 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.45 -27.72 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 120.603 -1.311 . . . . 0.0 113.674 -174.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -60.54 -22.63 63.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.199 1.0 . . . . 0.0 111.352 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.9 -18.64 58.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.945 1.702 . . . . 0.0 111.417 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -95.03 37.13 1.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.27 1.395 . . . . 0.0 112.195 -164.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 46.78 26.09 2.59 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.07 1.319 . . . . 0.0 115.357 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.32 171.8 13.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.112 1.456 . . . . 0.0 112.422 -168.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -143.89 -28.77 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.188 0.995 . . . . 0.0 112.965 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -139.42 154.66 47.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.08 143.36 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.2 mt -133.22 115.93 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.62 175.43 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.468 1.107 . . . . 0.0 110.251 -172.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -99.43 0.18 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.89 -28.26 24.1 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 121.143 1.792 . . . . 0.0 116.217 -170.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.499 HG12 ' H ' ' A' ' 74' ' ' GLY 0.311 7.2 tt 39.9 -135.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 127.9 2.48 . . . . 0.0 113.41 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.499 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.28 154.99 18.09 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 127.78 2.609 . . . . 0.0 109.647 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -39.92 85.71 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.792 1.296 . . . . 0.0 111.645 -171.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -53.32 -38.22 63.0 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.793 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.87 -35.4 38.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 117.097 -1.43 . . . . 0.0 112.373 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.9 -48.07 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 120.604 1.547 . . . . 0.0 108.471 164.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 -10.02 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.281 -1.342 . . . . 0.0 114.479 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.08 -53.35 9.03 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 121.227 1.83 . . . . 0.0 109.904 167.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -60.86 -35.05 75.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.458 1.103 . . . . 0.0 110.385 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -60.32 -20.28 58.65 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.37 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.27 -10.77 57.03 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.665 1.575 . . . . 0.0 111.53 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.0 ptp -134.45 13.65 3.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.37 1.068 . . . . 0.0 112.782 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.2 33.08 44.88 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.628 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -79.45 113.0 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -71.95 146.44 47.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t -127.07 112.27 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -94.61 133.25 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.879 1.672 . . . . 0.0 106.624 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -129.28 167.98 16.9 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.982 1.713 . . . . 0.0 108.183 -172.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 12.45 67.21 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.765 -1.02 . . . . 0.0 113.781 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 171.89 10.38 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.05 1.425 . . . . 0.0 110.6 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 p -160.85 152.9 20.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 109.456 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.76 -173.13 16.52 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.381 0.515 . . . . 0.0 112.808 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p -82.43 172.94 12.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.621 -0.929 . . . . 0.0 109.752 168.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -60.81 -49.13 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 O-C-N 121.156 -0.965 . . . . 0.0 110.54 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -58.62 -37.5 76.0 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.499 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.42 -58.32 3.48 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.052 1.741 . . . . 0.0 107.867 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.4 -44.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.762 1.625 . . . . 0.0 110.636 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.59 -35.72 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.68 -40.6 88.64 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.788 1.176 . . . . 0.0 111.797 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -59.46 -44.26 93.04 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.013 0.824 . . . . 0.0 110.05 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.0 -45.33 74.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.961 0.905 . . . . 0.0 113.139 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.17 -28.02 69.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.85 0.75 . . . . 0.0 110.377 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.9 m -77.07 -3.23 38.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.36 56.08 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.141 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 -49.75 58.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.94 131.54 43.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.482 1.113 . . . . 0.0 110.743 -171.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.49 149.97 48.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -82.36 29.15 0.43 Allowed 'General case' 0 C--N 1.324 -0.526 1 C-N-CA 132.068 4.147 . . . . 0.0 112.109 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.0 p -54.19 165.34 0.52 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.198 0.999 . . . . 0.0 112.199 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 67.72 86.29 0.13 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.19 1.796 . . . . 0.0 109.587 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -143.88 -177.47 5.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.378 1.071 . . . . 0.0 111.48 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.18 168.83 11.44 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.989 0.423 . . . . 0.0 111.098 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -141.78 -56.67 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.655 0.782 . . . . 0.0 109.897 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -142.49 -149.17 0.26 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.817 1.247 . . . . 0.0 108.429 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -54.21 134.45 44.65 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 120.098 1.317 . . . . 0.0 110.299 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -163.34 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.738 2.015 . . . . 0.0 107.028 170.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -149.14 168.57 22.87 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.871 1.214 . . . . 0.0 110.906 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -128.39 -66.55 0.84 Allowed 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.063 0.945 . . . . 0.0 110.3 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.4 -177.67 0.12 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.367 1.467 . . . . 0.0 110.643 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.253 0.2 OUTLIER 62.09 -71.61 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.322 1.849 . . . . 0.0 111.334 -168.163 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.2 t60 56.09 86.27 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.62 1.968 . . . . 0.0 111.178 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 . . . . . 0 C--O 1.242 0.678 0 C-N-CA 125.596 1.558 . . . . 0.0 108.998 169.439 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttm . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.3 mt -127.45 135.72 62.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -132.85 101.59 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 127.001 2.12 . . . . 0.0 107.031 -156.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.04 144.22 33.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.078 0.399 . . . . 0.0 111.131 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.3 mt -134.54 115.87 12.69 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.51 114.59 4.07 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.15 2.567 . . . . 0.0 109.079 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.34 157.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.08 . . . . 0.0 112.699 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -74.46 -25.33 59.34 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.865 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -150.57 152.16 33.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.134 1.374 . . . . 0.0 107.819 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -85.12 110.95 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 164.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -126.37 39.46 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.473 166.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.07 -102.39 0.58 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 125.368 1.461 . . . . 0.0 109.532 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -98.49 -31.68 11.86 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.875 1.27 . . . . 0.0 110.628 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.78 -10.07 54.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.305 1.442 . . . . 0.0 111.445 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.6 m -40.71 106.44 0.42 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 129.911 3.284 . . . . 0.0 111.892 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 135.82 19.97 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.899 2.4 . . . . 0.0 110.927 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.43 138.65 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -77.67 -160.16 0.17 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 108.265 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.54 -52.81 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.977 1.37 . . . . 0.0 109.697 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.4 179.13 6.04 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.894 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 54.5 t80 -121.0 -46.7 2.32 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.843 -1.16 . . . . 0.0 110.889 159.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.14 -42.22 16.38 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 41.47 2.21 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.833 1.253 . . . . 0.0 111.825 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.29 118.01 65.11 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-O 115.927 -1.987 . . . . 0.0 106.373 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.25 -17.67 50.12 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 113.717 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -149.1 158.92 44.57 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.738 1.215 . . . . 0.0 108.782 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.409 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 25.1 m-85 -126.22 128.9 47.95 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.318 1.847 . . . . 0.0 107.485 170.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.42 89.13 3.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 65' ' ' ALA . 2.7 m-85 -75.43 92.02 2.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.26 162.23 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -117.28 -167.64 1.35 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.81 -1.182 . . . . 0.0 108.714 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.33 136.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 120.872 -1.143 . . . . 0.0 109.751 165.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.05 91.82 3.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 168.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 56.68 -69.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.383 2.273 . . . . 0.0 114.345 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.25 11.81 3.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.555 1.542 . . . . 0.0 112.752 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.72 173.36 8.61 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.115 1.366 . . . . 0.0 110.207 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.45 -23.25 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.464 1.106 . . . . 0.0 112.994 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.05 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.593 1.557 . . . . 0.0 114.02 -162.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -162.24 167.16 24.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.367 1.467 . . . . 0.0 109.836 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 mm -124.28 138.6 53.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.897 2.079 . . . . 0.0 105.835 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 m -119.79 96.91 5.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.86 77.69 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 123.467 1.603 . . . . 0.0 107.523 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.6 127.99 32.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.585 1.554 . . . . 0.0 106.943 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -60.61 162.63 6.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.793 1.179 . . . . 0.0 108.681 158.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -78.2 153.38 79.59 Favored Pre-proline 0 N--CA 1.438 -1.059 0 O-C-N 121.496 -0.753 . . . . 0.0 109.428 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.12 -52.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.721 0.948 . . . . 0.0 110.916 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.24 38.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.332 -0.855 . . . . 0.0 111.278 -163.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.33 97.21 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 120.939 -1.101 . . . . 0.0 110.271 -160.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.89 18.03 7.92 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -50.45 -67.0 0.29 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.616 2.367 . . . . 0.0 111.794 -167.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.26 24.0 1.15 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.581 1.553 . . . . 0.0 109.473 175.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.265 34.4 m 40.93 48.17 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 126.217 1.807 . . . . 0.0 111.656 -159.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -68.66 166.6 16.94 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.406 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.59 23.64 21.44 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.968 1.747 . . . . 0.0 111.624 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.27 -21.36 14.91 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.993 1.396 . . . . 0.0 113.276 -171.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -46.98 -48.52 52.52 Favored Pre-proline 0 CA--C 1.556 1.204 0 CA-C-N 119.232 0.923 . . . . 0.0 110.398 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.73 -20.04 17.94 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.188 1.925 . . . . 0.0 112.385 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -64.96 -42.46 94.59 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -59.79 -62.14 2.1 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -63.91 -21.11 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.638 1.563 . . . . 0.0 112.545 -173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -64.1 -13.21 46.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 116.862 -1.542 . . . . 0.0 112.654 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -11.19 32.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 121.237 1.835 . . . . 0.0 112.488 173.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -90.56 37.29 0.91 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.956 0.798 . . . . 0.0 111.647 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.77 28.05 5.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.836 1.684 . . . . 0.0 114.179 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -63.48 152.82 37.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.662 1.731 . . . . 0.0 112.796 -173.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -144.4 -21.84 0.54 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 111.738 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.3 166.39 23.23 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 109.019 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.31 150.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 165.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.6 mt -134.19 112.04 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.89 176.81 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.469 1.508 . . . . 0.0 109.679 -167.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -103.26 -97.19 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.237 -1.363 . . . . 0.0 107.838 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.12 -12.94 40.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 120.731 1.605 . . . . 0.0 115.638 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.498 ' CG1' ' H ' ' A' ' 74' ' ' GLY . 2.3 tt 38.51 -130.17 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.527 1.931 . . . . 0.0 114.159 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.498 ' H ' ' CG1' ' A' ' 73' ' ' ILE . . . 168.82 158.46 12.79 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 129.437 3.398 . . . . 0.0 110.812 166.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -47.35 33.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.475 1.51 . . . . 0.0 112.492 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -55.9 -6.01 0.2 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.38 -40.45 3.64 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 116.785 -1.578 . . . . 0.0 110.235 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -42.44 -46.96 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.698 1.135 . . . . 0.0 108.958 161.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.36 -19.1 63.03 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.9 2.0 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -57.52 -44.52 85.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 124.013 0.925 . . . . 0.0 109.915 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.95 -14.14 59.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.495 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.98 72.62 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.015 1.734 . . . . 0.0 109.021 168.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -19.15 33.66 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.111 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.71 20.23 37.96 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.094 -1.004 . . . . 0.0 112.496 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.8 t -78.91 121.23 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -63.95 146.31 54.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.703 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 p -139.93 89.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.65 1.18 . . . . 0.0 107.989 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.12 131.58 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.21 171.86 7.35 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.012 1.325 . . . . 0.0 111.494 -173.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.76 4.05 38.1 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.003 1.287 . . . . 0.0 114.483 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.74 164.47 23.46 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.89 1.345 . . . . 0.0 110.324 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.3 p -162.17 124.87 2.91 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -159.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.29 -169.68 25.32 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 123.399 0.437 . . . . 0.0 112.618 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.3 p -79.92 170.56 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.929 0.865 . . . . 0.0 109.723 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.2 t -53.6 -59.83 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 C-N-CA 123.591 0.756 . . . . 0.0 109.425 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.01 -27.75 69.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.04 -54.26 8.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.812 1.645 . . . . 0.0 109.399 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 t -56.35 -43.45 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.837 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 t -52.88 -58.35 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 107.993 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.61 -44.05 95.07 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.009 -0.996 . . . . 0.0 111.939 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.96 -46.01 78.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.347 0.976 . . . . 0.0 110.0 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -62.87 -52.64 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.034 0.534 . . . . 0.0 112.152 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 110.812 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.5 m -74.29 -39.56 62.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.68 35.23 1.09 Allowed Glycine 0 C--N 1.333 0.365 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.145 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.15 -35.12 10.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.068 0.934 . . . . 0.0 112.257 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.53 146.52 31.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.978 1.311 . . . . 0.0 108.871 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -156.52 159.04 38.21 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.409 0.684 . . . . 0.0 110.315 -159.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -103.29 48.03 0.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.954 1.302 . . . . 0.0 109.23 -165.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.51 -4.03 24.51 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -164.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -114.71 88.2 2.81 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -162.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -121.56 153.99 37.29 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.148 0.579 . . . . 0.0 110.702 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.72 67.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.006 1.322 . . . . 0.0 111.244 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.5 t 62.07 -74.34 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 130.231 3.413 . . . . 0.0 112.46 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -162.23 177.38 9.69 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.792 1.178 . . . . 0.0 109.047 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -42.25 -46.59 4.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.13 1.772 . . . . 0.0 113.573 -172.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 38.87 64.86 0.72 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.331 2.252 . . . . 0.0 110.947 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -56.78 100.12 0.04 OUTLIER 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.47 1.508 . . . . 0.0 109.911 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -153.43 145.61 23.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 23.8 m170 77.87 156.09 0.16 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.946 2.098 . . . . 0.0 109.112 -162.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -150.35 -160.39 1.16 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.93 1.292 . . . . 0.0 109.018 -162.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -105.82 -47.09 3.96 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.012 1.725 . . . . 0.0 112.036 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.857 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 164.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptm . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.8 mt -124.38 132.24 71.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.21 104.46 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 129.012 2.925 . . . . 0.0 106.079 -164.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.468 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -82.08 133.9 35.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mt -127.8 118.26 21.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.89 127.21 17.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 106.8 -2.039 . . . . 0.0 106.8 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.13 157.51 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 119.538 1.063 . . . . 0.0 110.691 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.86 -34.45 60.03 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.991 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -146.16 169.35 18.91 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.183 0.993 . . . . 0.0 108.545 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -84.03 89.79 7.32 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 130.579 3.552 . . . . 0.0 108.599 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -128.67 38.91 3.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.717 -0.615 . . . . 0.0 110.794 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.41 -80.29 0.11 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 126.033 1.778 . . . . 0.0 113.351 167.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -120.93 -33.54 3.73 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.775 1.63 . . . . 0.0 111.393 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.67 -5.23 11.0 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.769 2.427 . . . . 0.0 112.177 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.24 109.62 1.28 Allowed Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 127.896 2.478 . . . . 0.0 108.318 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -83.04 137.37 8.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.181 1.92 . . . . 0.0 109.159 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.3 tt -58.92 133.99 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.012 0.91 . . . . 0.0 110.947 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 t -73.68 167.84 20.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.387 1.475 . . . . 0.0 109.137 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -90.82 -20.75 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.44 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -133.75 -176.7 4.26 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -120.33 -49.51 2.27 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 110.64 -176.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.6 -5.69 24.98 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 46.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.666 2.386 . . . . 0.0 106.852 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.04 143.4 94.31 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 162.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.76 -16.31 13.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.207 1.938 . . . . 0.0 113.089 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -149.51 155.88 41.08 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.903 -1.123 . . . . 0.0 109.72 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.64 114.3 17.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 126.265 1.826 . . . . 0.0 107.684 170.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.95 88.49 5.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 161.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -75.19 92.42 2.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 160.457 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.94 148.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -97.23 -167.69 1.58 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -144.74 136.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 164.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.491 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.55 -139.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.31 1.844 . . . . 0.0 106.95 167.389 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.491 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 20.1 t-20 -59.34 -54.11 50.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.712 -1.242 . . . . 0.0 109.398 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.27 11.42 0.71 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.296 1.039 . . . . 0.0 112.701 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.08 171.35 7.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.336 1.455 . . . . 0.0 108.543 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.13 -22.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 126.375 1.87 . . . . 0.0 112.664 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.15 -70.9 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.943 1.697 . . . . 0.0 112.052 -162.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -159.1 162.05 36.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.244 1.818 . . . . 0.0 109.25 -155.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mm -126.87 126.03 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -173.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -112.87 94.76 5.06 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 163.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -91.65 88.83 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -97.55 136.37 38.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.825 1.25 . . . . 0.0 109.655 -169.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -75.91 143.57 41.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.338 1.055 . . . . 0.0 108.235 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.59 116.46 60.93 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.118 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.92 -22.9 30.69 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.834 1.69 . . . . 0.0 112.312 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.85 39.86 3.86 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.534 1.134 . . . . 0.0 109.356 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.19 78.41 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.518 0.727 . . . . 0.0 110.693 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -141.87 18.7 2.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.446 1.098 . . . . 0.0 112.206 -170.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -76.77 73.94 3.42 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 120.98 -1.075 . . . . 0.0 108.675 172.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 53.25 29.96 9.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.686 1.594 . . . . 0.0 112.34 167.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.263 19.4 m 38.82 45.12 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.835 2.054 . . . . 0.0 113.065 -168.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -61.44 161.51 9.3 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.41 -29.5 75.27 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.622 -162.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.99 -1.82 33.98 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 -156.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -43.2 -54.06 9.98 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 120.8 1.636 . . . . 0.0 111.456 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.1 -31.24 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.969 2.446 . . . . 0.0 111.497 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -62.65 -41.55 99.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.924 -0.56 . . . . 0.0 109.559 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.16 -66.28 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.758 0.823 . . . . 0.0 109.679 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 m -60.56 -6.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.83 -20.03 17.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.502 -1.374 . . . . 0.0 112.432 175.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -64.3 -25.22 67.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.976 0.807 . . . . 0.0 110.753 158.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 36.25 0.74 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.306 0.957 . . . . 0.0 110.716 -165.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.69 4.39 0.04 OUTLIER Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.446 2.45 . . . . 0.0 116.741 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.427 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.78 158.46 25.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.086 -1.832 . . . . 0.0 112.736 -158.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.65 -20.35 2.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.745 0.818 . . . . 0.0 111.852 -165.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -134.36 152.84 52.04 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.671 0.607 . . . . 0.0 109.558 -174.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.49 139.0 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.55 111.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -131.05 -178.5 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.698 1.199 . . . . 0.0 111.685 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.31 -100.48 0.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.53 55.63 3.48 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 125.962 1.744 . . . . 0.0 112.503 -169.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.47 167.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 O-C-N 121.681 -0.893 . . . . 0.0 109.231 169.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.45 166.74 23.31 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.424 1.012 . . . . 0.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -36.31 46.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.302 1.441 . . . . 0.0 113.414 -166.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.82 -31.37 64.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.324 1.42 . . . . 0.0 112.449 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.18 -35.88 15.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.695 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -41.75 -54.29 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.981 1.264 . . . . 0.0 107.884 158.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.75 -14.21 42.04 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.52 -53.42 6.29 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.107 1.322 . . . . 0.0 110.566 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -57.78 -35.52 70.91 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.228 1.011 . . . . 0.0 110.807 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -49.76 -33.08 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.186 2.194 . . . . 0.0 114.043 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -18.94 64.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.172 0.896 . . . . 0.0 111.861 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.22 1.11 4.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.089 1.356 . . . . 0.0 113.551 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.05 39.16 97.23 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.052 -1.03 . . . . 0.0 112.246 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.64 117.79 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -74.15 139.47 44.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.593 -0.692 . . . . 0.0 110.175 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.05 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.208 1.403 . . . . 0.0 109.295 -168.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.06 131.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -150.91 144.15 24.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.322 -0.861 . . . . 0.0 112.198 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.19 11.91 22.96 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.749 1.166 . . . . 0.0 112.073 -169.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.33 177.65 3.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.169 1.485 . . . . 0.0 110.043 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.2 p -162.2 156.72 22.11 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 119.806 1.184 . . . . 0.0 110.032 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.63 -153.26 21.95 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 121.643 0.579 . . . . 0.0 111.792 172.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.73 153.4 26.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.791 0.837 . . . . 0.0 111.154 -171.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 t -61.24 -45.56 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 122.932 0.493 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.83 -28.24 65.86 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.433 0.561 . . . . 0.0 111.939 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.28 -57.04 3.79 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 127.347 2.259 . . . . 0.0 109.008 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.6 t -52.95 -45.37 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.791 1.237 . . . . 0.0 110.72 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.1 -50.38 79.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -55.88 -47.88 76.58 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.419 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -54.07 -38.2 65.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.123 1.329 . . . . 0.0 112.102 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -71.29 -51.29 25.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.506 0.723 . . . . 0.0 112.114 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.16 -38.92 68.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.5 m -78.98 -5.66 54.4 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.839 1.656 . . . . 0.0 112.025 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.8 4.28 82.61 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.848 1.214 . . . . 0.0 114.736 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -81.18 -35.16 31.76 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.765 1.283 . . . . 0.0 111.431 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.7 161.38 31.07 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.716 0.806 . . . . 0.0 110.845 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -150.89 152.77 34.15 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.292 1.037 . . . . 0.0 109.821 -173.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -105.25 13.69 30.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.771 1.628 . . . . 0.0 111.442 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.0 t 51.77 -134.44 1.63 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.932 1.293 . . . . 0.0 108.628 176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.23 110.8 15.1 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.843 1.657 . . . . 0.0 107.291 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.48 148.94 49.61 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -65.03 164.68 12.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.7 t -132.98 135.81 56.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 71.75 -164.7 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.636 1.574 . . . . 0.0 109.11 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 41.03 63.14 1.26 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.142 2.177 . . . . 0.0 113.429 -173.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -137.52 65.94 1.47 Allowed 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.622 -1.299 . . . . 0.0 109.303 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.23 158.37 24.33 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 121.373 -0.829 . . . . 0.0 110.743 174.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -149.23 138.5 21.51 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 170.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -168.83 -61.45 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.14 147.9 13.11 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 128.045 2.538 . . . . 0.0 104.787 174.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 161.13 -174.77 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 130.438 3.495 . . . . 0.0 107.411 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 31.1 m80 . . . . . 0 C--O 1.252 1.219 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 161.691 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 14.2 ttp . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 mt -140.17 147.05 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.7 mt -132.56 103.1 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 127.38 2.272 . . . . 0.0 106.265 -162.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.461 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.09 154.42 28.1 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 119.61 -0.233 . . . . 0.0 110.845 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -146.18 115.89 4.7 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.22 123.4 9.91 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.497 2.131 . . . . 0.0 108.225 169.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.81 157.93 21.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.448 0.567 . . . . 0.0 110.364 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.4 m -78.79 -27.84 44.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.078 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -148.75 148.94 30.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.111 0.869 . . . . 0.0 108.838 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -82.68 45.33 0.97 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.233 2.213 . . . . 0.0 112.987 -170.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -88.78 39.67 0.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.96 -1.713 . . . . 0.0 111.461 -167.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.51 -125.47 13.78 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.539 -1.35 . . . . 0.0 112.504 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -52.47 -45.82 66.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.648 1.579 . . . . 0.0 110.609 174.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -7.37 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.839 2.456 . . . . 0.0 111.834 -169.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -47.53 109.37 1.08 Allowed Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.151 1.78 . . . . 0.0 110.997 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.46 131.85 15.48 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.182 1.921 . . . . 0.0 109.975 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.94 142.93 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.488 1.115 . . . . 0.0 109.762 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.06 173.7 8.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.897 1.279 . . . . 0.0 108.735 174.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.34 -48.3 8.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 122.4 1.095 . . . . 0.0 109.196 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -86.88 166.39 15.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.486 -171.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -119.38 -52.27 2.27 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 123.862 0.865 . . . . 0.0 109.959 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -17.4 49.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.044 -0.864 . . . . 0.0 113.645 -172.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -139.2 39.3 2.1 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.283 1.833 . . . . 0.0 110.124 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.75 130.64 91.64 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 160.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.14 -17.87 35.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.445 1.43 . . . . 0.0 114.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -146.69 156.34 43.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.516 1.126 . . . . 0.0 109.541 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -134.18 106.42 7.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.039 1.736 . . . . 0.0 109.343 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.17 100.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.397 1.079 . . . . 0.0 108.662 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.461 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 4.5 m-85 -89.98 100.95 13.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 t -82.64 154.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 168.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -102.67 -165.04 1.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.41 132.6 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 163.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.85 87.23 3.25 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 170.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 70.31 -75.01 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.125 1.37 . . . . 0.0 110.445 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -137.51 15.27 2.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.04 1.336 . . . . 0.0 112.197 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.34 174.79 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.981 1.313 . . . . 0.0 109.508 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.88 -22.87 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 121.217 1.826 . . . . 0.0 114.346 -166.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.76 -64.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.629 1.971 . . . . 0.0 115.084 -162.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.45 169.88 19.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.588 1.155 . . . . 0.0 108.823 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.2 mm -131.18 139.69 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 127.749 2.42 . . . . 0.0 105.32 -172.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.67 70.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.044 -1.035 . . . . 0.0 108.262 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.17 88.72 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 106.831 167.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.33 155.65 22.75 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.582 1.153 . . . . 0.0 108.25 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -82.34 166.34 19.56 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.994 -0.441 . . . . 0.0 109.991 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.9 110.77 37.83 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.203 173.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.44 -6.06 18.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.506 2.137 . . . . 0.0 113.275 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -134.99 38.17 3.0 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.06 0.944 . . . . 0.0 109.504 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.29 -35.62 77.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.04 0.836 . . . . 0.0 110.475 -172.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -144.2 41.17 1.37 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.039 1.335 . . . . 0.0 109.867 -168.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -134.76 -58.26 0.82 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.968 0.507 . . . . 0.0 111.999 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.11 -41.17 8.47 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.283 0.947 . . . . 0.0 111.057 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t 61.74 -71.93 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.848 1.659 . . . . 0.0 110.693 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 128.7 36.71 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.253 -1.529 . . . . 0.0 109.365 162.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.12 -21.41 6.15 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 117.918 -1.49 . . . . 0.0 115.827 159.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.93 -19.25 0.45 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.455 2.127 . . . . 0.0 115.035 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.52 -53.09 38.63 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 119.467 1.03 . . . . 0.0 108.301 168.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.99 -28.19 24.44 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.571 1.514 . . . . 0.0 111.88 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.14 -42.69 99.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.05 1.295 . . . . 0.0 108.984 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.505 ' CZ ' ' HE2' ' A' ' 63' ' ' LYS . 4.6 t80 -53.39 -63.05 1.27 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.256 0.622 . . . . 0.0 110.256 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 m -61.91 -30.65 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.276 -0.89 . . . . 0.0 113.154 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -65.13 -17.52 64.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -30.88 66.31 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.089 165.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' HE2' ' CZ ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -86.27 37.32 0.72 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.912 1.687 . . . . 0.0 113.378 -167.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 36.6 42.36 0.66 Allowed Glycine 0 CA--C 1.541 1.683 0 C-N-CA 127.694 2.569 . . . . 0.0 117.208 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 29' ' ' PHE . . . -63.79 168.9 4.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.63 1.715 . . . . 0.0 113.789 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.441 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.4 mt-10 -139.73 -25.98 0.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.031 1.732 . . . . 0.0 111.046 172.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 tp -142.53 150.22 40.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.379 0.99 . . . . 0.0 110.603 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 t -147.71 123.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 87.9 mt -111.54 112.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.61 -177.1 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.76 1.224 . . . . 0.0 110.272 -172.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -112.14 -87.08 0.55 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.428 -0.795 . . . . 0.0 108.919 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.51 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 124.365 0.983 . . . . 0.0 113.65 -167.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.461 HG12 ' H ' ' A' ' 74' ' ' GLY 0.257 4.6 tt 43.56 -153.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 126.876 2.07 . . . . 0.0 112.883 -176.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.461 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -168.66 156.55 28.04 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.606 2.527 . . . . 0.0 109.329 176.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -38.38 70.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.511 1.155 . . . . 0.0 111.547 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -55.69 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 175.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.44 12.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.261 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.63 -48.1 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 165.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.02 50.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.9 -51.06 17.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.265 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.68 -36.59 76.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 126.149 1.779 . . . . 0.0 110.123 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -61.62 -17.02 53.51 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.133 -0.979 . . . . 0.0 113.589 170.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.78 -13.63 53.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.478 1.49 . . . . 0.0 111.821 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -125.64 12.25 7.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.642 1.977 . . . . 0.0 110.854 -172.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 15.02 58.45 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 123.658 0.647 . . . . 0.0 112.924 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.26 113.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -67.85 147.71 52.16 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.31 108.45 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.106 0.962 . . . . 0.0 109.774 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.4 128.41 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 128.511 2.724 . . . . 0.0 106.868 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -108.21 179.54 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 108.812 169.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.72 8.08 87.28 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 115.079 0.791 . . . . 0.0 115.079 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 -176.73 1.58 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.544 1.172 . . . . 0.0 110.65 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.5 t -163.33 168.31 20.64 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 128.362 2.665 . . . . 0.0 106.588 164.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.82 -170.83 21.27 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 118.023 0.374 . . . . 0.0 113.804 168.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.5 p -79.52 163.0 25.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.453 -1.028 . . . . 0.0 111.337 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.09 -55.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.374 1.07 . . . . 0.0 110.164 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.19 -20.79 66.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.81 -54.07 4.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.871 1.668 . . . . 0.0 107.207 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.3 t -52.49 -46.37 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.216 1.806 . . . . 0.0 110.886 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.38 -53.28 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -62.44 -37.68 86.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.15 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -59.88 -46.79 88.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.042 1.292 . . . . 0.0 110.259 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -61.28 -53.93 50.45 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -56.23 -31.3 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.609 0.64 . . . . 0.0 110.426 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.3 m -76.08 -22.31 55.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 112.726 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.23 8.99 58.43 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.408 1.004 . . . . 0.0 113.236 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -80.92 -22.6 39.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.426 1.613 . . . . 0.0 112.067 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.91 145.18 27.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 109.202 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 165.46 28.27 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.27 1.028 . . . . 0.0 109.065 177.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.08 90.84 7.54 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 173.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.1 m -135.9 88.89 2.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.284 1.833 . . . . 0.0 108.725 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -165.37 101.59 0.72 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.498 1.519 . . . . 0.0 107.931 161.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.76 175.77 12.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 157.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -124.16 136.73 54.4 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 159.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 m -77.28 82.07 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 122.65 1.214 . . . . 0.0 108.757 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.81 174.24 11.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.451 1.5 . . . . 0.0 109.455 166.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.7 t70 62.99 173.92 0.15 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.099 2.56 . . . . 0.0 112.18 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -156.2 57.78 0.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.229 -0.919 . . . . 0.0 110.279 162.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -41.98 130.63 3.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.646 1.579 . . . . 0.0 111.916 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.34 178.12 7.64 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.813 -0.554 . . . . 0.0 111.022 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 65.56 175.87 0.21 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.219 1.408 . . . . 0.0 109.7 -167.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 72.11 111.78 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.701 2.4 . . . . 0.0 110.593 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -155.23 137.46 14.8 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.108 1.363 . . . . 0.0 107.632 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 C--O 1.253 1.282 0 CA-C-N 119.61 1.095 . . . . 0.0 110.662 -163.88 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttm . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.28 138.91 52.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 mt -125.66 105.42 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 127.586 2.354 . . . . 0.0 106.27 -159.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.413 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -79.65 144.09 34.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.365 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.9 mt -143.18 116.4 6.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 171.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.13 119.43 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.62 141.91 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.789 1.177 . . . . 0.0 110.21 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -69.28 -21.85 63.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 117.442 -1.266 . . . . 0.0 112.849 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -148.0 156.72 42.96 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.451 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 38.7 t-20 -90.42 97.75 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -132.24 38.21 3.5 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.25 -109.24 1.09 Allowed Glycine 0 C--N 1.342 0.891 0 C-N-CA 124.022 0.82 . . . . 0.0 112.487 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -80.62 -41.17 24.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.764 1.626 . . . . 0.0 109.603 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.27 -16.05 59.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.061 1.744 . . . . 0.0 112.408 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 m -39.26 104.56 0.32 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.685 2.794 . . . . 0.0 112.416 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.37 135.94 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.056 1.837 . . . . 0.0 109.328 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -61.77 148.2 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.612 0.72 . . . . 0.0 110.338 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -78.47 178.35 7.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.905 2.482 . . . . 0.0 110.054 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -108.21 -30.22 8.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.816 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -133.88 90.59 2.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.694 1.134 . . . . 0.0 110.645 -164.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -43.32 -42.69 4.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.649 1.18 . . . . 0.0 112.986 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -1.53 40.02 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.023 -1.431 . . . . 0.0 115.925 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.45 46.86 1.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.442 1.621 . . . . 0.0 108.775 166.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 133.26 88.77 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 116.618 -1.658 . . . . 0.0 109.38 172.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -73.22 -22.55 18.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.756 2.304 . . . . 0.0 113.575 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 99.0 m-85 -147.1 154.04 40.66 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.022 0.929 . . . . 0.0 109.459 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.67 104.16 7.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 91.8 5.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.252 1.821 . . . . 0.0 108.913 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.413 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.6 m-85 -84.71 96.35 9.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.22 160.78 4.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -110.99 -170.08 1.57 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 119.993 -1.692 . . . . 0.0 108.798 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.1 144.24 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 162.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.536 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -80.05 -138.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.357 2.263 . . . . 0.0 105.598 167.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 21.4 t-20 -59.28 -62.63 1.74 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.471 1.908 . . . . 0.0 109.644 174.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -142.09 20.03 2.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.839 1.256 . . . . 0.0 111.678 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.91 161.71 26.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.117 1.367 . . . . 0.0 109.71 -170.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.75 -23.84 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.368 1.894 . . . . 0.0 112.608 -165.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.73 -65.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.032 2.133 . . . . 0.0 114.208 -166.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.24 165.88 21.53 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.069 0.948 . . . . 0.0 111.682 -165.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 152.07 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 127.229 2.212 . . . . 0.0 107.716 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.64 73.04 1.3 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.67 1.588 . . . . 0.0 109.467 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.256 8.3 p -90.63 84.77 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -96.66 154.46 17.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.707 1.203 . . . . 0.0 108.334 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.69 148.81 42.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.416 1.487 . . . . 0.0 110.564 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -92.19 115.08 64.05 Favored Pre-proline 0 CA--C 1.516 -0.345 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.806 -173.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 -21.97 53.59 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.989 1.793 . . . . 0.0 112.557 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -123.66 38.63 4.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.3 1.409 . . . . 0.0 111.049 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.71 63.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.513 1.051 . . . . 0.0 110.693 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -157.06 29.09 0.3 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.088 1.355 . . . . 0.0 110.448 -175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.48 -72.14 0.53 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.079 -1.013 . . . . 0.0 109.317 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -66.34 -23.37 66.34 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.943 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.7 t 39.0 52.26 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 126.534 1.934 . . . . 0.0 109.419 -174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -152.15 -58.02 0.15 Allowed 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.115 -0.991 . . . . 0.0 109.78 -165.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -176.62 -142.51 4.38 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -172.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.45 -14.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 129.997 3.319 . . . . 0.0 116.71 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.8 -53.5 12.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.656 1.982 . . . . 0.0 109.501 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.31 -30.73 5.14 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 120.581 1.243 . . . . 0.0 111.04 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.0 -24.97 67.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.06 0.544 . . . . 0.0 110.348 -177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -69.12 -73.2 0.16 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 124.472 1.109 . . . . 0.0 109.502 162.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 m -59.38 -28.76 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -58.82 -42.63 89.63 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.076 1.307 . . . . 0.0 108.836 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -17.86 54.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.761 0.824 . . . . 0.0 112.479 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -86.58 37.17 0.73 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.747 0.703 . . . . 0.0 109.853 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 29.27 44.27 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 128.688 3.042 . . . . 0.0 114.832 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.73 174.37 8.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.012 1.406 . . . . 0.0 113.635 -172.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -145.13 -28.09 0.46 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.024 0.93 . . . . 0.0 112.194 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.05 157.9 44.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.859 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -150.77 143.6 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.811 1.644 . . . . 0.0 106.999 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 61.8 mt -131.59 113.38 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.61 -177.23 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.748 1.219 . . . . 0.0 110.418 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -104.05 -100.5 0.31 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 117.515 -1.231 . . . . 0.0 107.808 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.8 -18.27 32.83 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 120.355 1.434 . . . . 0.0 114.849 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.431 HG12 ' H ' ' A' ' 74' ' ' GLY 0.309 4.9 tt 41.22 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 126.98 2.112 . . . . 0.0 112.786 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.431 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -152.91 -138.74 2.76 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.977 2.227 . . . . 0.0 109.822 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.62 -31.6 4.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.748 1.274 . . . . 0.0 111.18 163.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -36.84 68.08 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.345 -1.472 . . . . 0.0 113.135 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 -31.71 43.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.219 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.23 -47.92 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.55 -12.74 34.97 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.07 -58.9 3.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.796 1.18 . . . . 0.0 109.403 172.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -58.49 -42.31 87.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.06 -20.87 66.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.53 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.43 -9.1 58.27 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.808 1.185 . . . . 0.0 112.222 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.49 -5.69 6.48 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.054 0.942 . . . . 0.0 112.434 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.39 28.87 69.0 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 119.589 1.086 . . . . 0.0 111.228 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.42 115.47 20.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -72.65 139.05 47.09 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.453 -0.779 . . . . 0.0 109.216 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.16 92.94 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 122.612 1.196 . . . . 0.0 109.637 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.9 147.48 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.173 1.789 . . . . 0.0 107.537 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -155.34 173.02 17.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.15 0.98 . . . . 0.0 109.38 -160.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.21 18.61 60.75 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.435 -0.647 . . . . 0.0 112.715 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.32 178.68 7.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.28 1.032 . . . . 0.0 109.784 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -158.27 160.4 37.03 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 106.05 -1.834 . . . . 0.0 106.05 160.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.37 -162.41 25.39 Favored Glycine 0 N--CA 1.463 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 112.665 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 p -84.93 165.33 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.65 -0.912 . . . . 0.0 109.134 165.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.2 t -53.74 -54.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.94 -22.52 62.57 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -89.63 -52.47 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.825 1.65 . . . . 0.0 107.658 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -55.16 -35.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 111.552 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.29 -53.99 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -54.91 -43.01 72.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.134 0.574 . . . . 0.0 111.214 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -58.86 -41.8 87.87 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.854 0.835 . . . . 0.0 111.005 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -72.5 -43.63 63.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.376 1.071 . . . . 0.0 111.778 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.26 -29.87 67.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.972 0.806 . . . . 0.0 110.601 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 m -78.33 -2.96 40.66 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.844 1.258 . . . . 0.0 113.138 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.68 20.65 68.39 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.534 1.061 . . . . 0.0 113.205 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -81.16 -56.18 4.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.344 1.072 . . . . 0.0 108.952 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.02 146.63 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 110.806 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -150.4 164.61 35.41 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.489 1.137 . . . . 0.0 112.379 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -99.57 21.48 12.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 128.569 2.747 . . . . 0.0 110.414 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 p -74.52 5.33 4.85 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.685 1.994 . . . . 0.0 115.224 -164.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -123.22 74.1 1.21 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.309 1.528 . . . . 0.0 108.115 -150.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -163.55 86.02 0.5 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.094 -1.412 . . . . 0.0 107.371 -170.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.21 154.74 0.05 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 128.359 2.663 . . . . 0.0 108.882 164.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.9 t -141.43 -87.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 165.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -140.92 -57.04 0.51 Allowed 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 119.373 0.988 . . . . 0.0 112.26 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.41 -44.02 0.06 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.591 1.087 . . . . 0.0 112.177 175.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.49 -170.68 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 110.937 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -41.32 123.38 2.09 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.714 1.606 . . . . 0.0 111.894 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -92.25 119.73 32.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.42 147.05 52.29 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.08 0.854 . . . . 0.0 109.417 168.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -81.31 106.59 13.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.431 2.292 . . . . 0.0 108.212 171.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.19 146.74 25.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 162.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 . . . . . 0 C--O 1.234 0.262 0 O-C-N 126.881 2.613 . . . . 0.0 111.075 172.614 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 C--O 1.235 0.342 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.411 HG12 ' HE3' ' A' ' 31' ' ' LYS . 3.9 mt -137.35 148.38 26.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 mt -128.79 106.62 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 129.373 3.069 . . . . 0.0 105.561 -170.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -82.66 150.2 26.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.378 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.06 118.67 10.23 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.72 116.54 4.29 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 107.221 -1.876 . . . . 0.0 107.221 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -116.79 157.08 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.699 0.799 . . . . 0.0 110.488 -174.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 p -72.6 -35.45 67.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -142.2 156.44 45.33 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 120.355 1.434 . . . . 0.0 109.049 -167.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.52 88.88 6.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -132.41 38.41 3.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 109.719 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.26 -105.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 127.438 2.447 . . . . 0.0 111.25 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -79.92 -37.21 35.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.24 1.016 . . . . 0.0 110.216 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.66 -18.58 64.99 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.348 1.859 . . . . 0.0 112.175 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -37.97 105.06 0.31 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.42 2.288 . . . . 0.0 111.894 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -68.87 132.64 25.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.578 1.519 . . . . 0.0 110.615 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.4 tt -62.13 142.0 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 119.781 -1.825 . . . . 0.0 110.67 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -81.03 -173.79 4.49 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.245 1.418 . . . . 0.0 108.977 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -109.12 -45.03 3.83 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.045 -1.034 . . . . 0.0 111.608 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -120.41 100.68 7.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.017 1.327 . . . . 0.0 107.851 -163.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -42.47 -45.35 4.4 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.141 1.376 . . . . 0.0 112.16 171.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.81 -20.2 59.46 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 117.888 -1.507 . . . . 0.0 114.303 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.32 38.91 3.58 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.415 1.608 . . . . 0.0 109.495 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.06 130.58 93.81 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.598 -1.192 . . . . 0.0 107.845 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.72 -20.74 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.605 2.203 . . . . 0.0 113.127 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -148.03 160.99 42.27 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.41 1.484 . . . . 0.0 108.378 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -126.94 112.11 14.9 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.68 88.41 7.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -78.12 98.6 5.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 108.179 169.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.42 136.82 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.465 1.106 . . . . 0.0 108.055 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HE3' HG12 ' A' ' 2' ' ' ILE . 9.6 mtpt -80.45 -164.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.13 -0.982 . . . . 0.0 109.549 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -156.25 147.86 11.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -146.06 122.08 10.72 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 53.96 34.46 19.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.079 0.952 . . . . 0.0 112.541 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 73.7 12.85 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.325 2.65 . . . . 0.0 114.337 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.06 172.49 7.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.0 108.402 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.85 -27.23 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 125.15 1.38 . . . . 0.0 112.436 -159.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.99 -67.42 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 C-N-CA 127.156 2.183 . . . . 0.0 112.753 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -164.86 157.17 16.02 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.751 -0.593 . . . . 0.0 112.011 -164.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.32 131.4 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.171 1.788 . . . . 0.0 106.848 -172.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.0 m -129.4 117.94 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 107.153 166.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 t -131.39 79.45 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -82.02 168.81 17.43 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -105.97 132.52 51.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 107.68 -168.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -79.59 123.73 84.04 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.591 -150.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.35 -10.77 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.427 2.752 . . . . 0.0 114.982 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.35 38.84 2.28 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.147 1.779 . . . . 0.0 109.895 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.44 68.68 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.599 -1.313 . . . . 0.0 112.429 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -130.14 -19.36 3.19 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.107 1.363 . . . . 0.0 111.869 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -100.28 128.97 46.23 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 60.05 -46.01 0.09 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.34 1.856 . . . . 0.0 113.719 -163.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.5 t 65.28 -80.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 127.49 2.316 . . . . 0.0 108.655 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -75.25 134.72 41.06 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 160.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.31 -151.91 21.29 Favored Glycine 0 C--N 1.322 -0.224 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -164.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.74 -1.1 1.72 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 -170.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -43.45 -52.02 14.1 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 121.404 1.911 . . . . 0.0 111.314 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.86 -27.39 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.277 1.985 . . . . 0.0 111.761 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.38 -41.79 90.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.729 1.149 . . . . 0.0 109.889 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.17 -68.15 0.2 Allowed 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 123.683 0.793 . . . . 0.0 109.654 167.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 m -64.47 -12.1 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -72.71 -22.26 60.92 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.59 1.156 . . . . 0.0 111.553 170.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.55 -12.95 50.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.838 0.745 . . . . 0.0 112.044 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -93.1 37.02 1.03 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.173 -0.954 . . . . 0.0 111.18 -164.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.28 18.27 34.95 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.796 1.188 . . . . 0.0 113.835 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -64.39 158.75 22.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.929 1.365 . . . . 0.0 112.422 -171.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -137.77 -19.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.327 1.451 . . . . 0.0 110.893 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.65 159.24 42.62 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.315 1.846 . . . . 0.0 109.042 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 t -137.62 139.82 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 158.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.5 mt -112.74 117.85 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 173.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.81 138.85 48.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 O-C-N 121.773 -0.58 . . . . 0.0 110.974 -164.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -77.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.598 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.87 -36.69 1.22 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.577 1.081 . . . . 0.0 115.459 -170.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.492 HG12 ' H ' ' A' ' 74' ' ' GLY 0.252 6.2 tt 44.5 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 128.828 2.851 . . . . 0.0 113.971 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.492 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.85 169.67 40.61 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.296 1.903 . . . . 0.0 110.759 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -48.45 64.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.401 1.481 . . . . 0.0 114.007 -161.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.67 -24.03 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.02 -31.12 13.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.518 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mm -52.49 -46.95 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.25 54.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.62 -50.06 14.73 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.066 1.303 . . . . 0.0 111.279 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -38.09 -56.19 1.19 Allowed 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.806 1.643 . . . . 0.0 109.831 161.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -12.24 61.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 124.609 1.193 . . . . 0.0 112.081 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.8 -18.29 48.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.251 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.59 13.32 3.75 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.293 0.951 . . . . 0.0 113.3 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.98 27.54 59.76 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 121.347 -0.845 . . . . 0.0 111.847 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.67 110.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -57.16 151.85 14.73 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.863 0.465 . . . . 0.0 110.095 -168.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.78 89.59 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-O 121.447 0.641 . . . . 0.0 110.543 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . 0.258 36.7 mt -76.52 85.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 123.365 1.555 . . . . 0.0 109.591 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -80.75 142.01 34.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.896 2.079 . . . . 0.0 112.148 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.9 22.15 7.77 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.873 1.225 . . . . 0.0 112.484 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.78 165.98 24.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.567 1.683 . . . . 0.0 112.058 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -151.66 165.25 34.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.924 2.89 . . . . 0.0 105.136 158.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 125.36 175.45 14.22 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.953 0.797 . . . . 0.0 113.487 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 p -79.83 156.35 27.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.99 -47.87 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -54.69 -29.73 53.72 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.49 -45.84 8.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.651 1.981 . . . . 0.0 110.389 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 56.3 t -50.65 -45.69 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.977 1.311 . . . . 0.0 109.822 172.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.32 -48.39 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.756 0.822 . . . . 0.0 108.918 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.892 0.769 . . . . 0.0 111.188 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -54.9 -42.61 72.37 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.895 0.878 . . . . 0.0 110.272 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -69.48 -49.39 55.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.646 0.778 . . . . 0.0 113.067 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.71 -21.69 66.08 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.252 0.478 . . . . 0.0 111.121 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -81.25 -30.43 34.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.197 0.599 . . . . 0.0 109.72 171.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.37 2.0 17.98 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.48 1.514 . . . . 0.0 113.945 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -82.84 -30.31 28.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.83 0.815 . . . . 0.0 110.401 -165.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.94 136.74 45.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.823 1.249 . . . . 0.0 109.886 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.84 162.71 26.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.464 1.506 . . . . 0.0 112.279 -166.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.407 ' C ' ' HG ' ' A' ' 111' ' ' SER . 4.9 p-10 -119.13 14.14 13.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.664 1.585 . . . . 0.0 111.367 -175.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.407 ' HG ' ' C ' ' A' ' 110' ' ' ASP 0.255 35.7 p 53.86 -159.98 0.15 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 126.047 1.739 . . . . 0.0 112.091 175.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.11 114.84 8.98 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -175.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.59 168.64 18.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.489 1.515 . . . . 0.0 109.552 -176.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -70.12 134.52 48.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.291 -163.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -58.61 126.21 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 160.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -46.57 109.58 0.21 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.038 2.135 . . . . 0.0 112.484 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -45.17 -48.43 12.36 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.843 1.657 . . . . 0.0 110.637 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.67 -11.03 6.16 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 28.64 51.76 0.06 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 129.84 3.256 . . . . 0.0 115.477 168.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -60.01 -29.03 68.21 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.887 -1.133 . . . . 0.0 112.623 -173.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 54.68 43.99 29.28 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.216 1.007 . . . . 0.0 110.983 167.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.99 73.76 6.77 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.519 1.128 . . . . 0.0 110.77 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 178.83 -7.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.829 0 N-CA-C 102.728 -3.064 . . . . 0.0 102.728 175.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 58.3 ttm . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.3 mt -131.59 143.67 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 172.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.2 mt -128.78 100.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 127.395 2.278 . . . . 0.0 106.844 -166.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.515 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -81.81 127.21 32.74 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.784 0.434 . . . . 0.0 110.71 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.0 mt -130.24 116.82 17.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.83 127.01 9.82 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.262 1.975 . . . . 0.0 107.745 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 m -127.74 148.08 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.7 m -76.25 -22.01 55.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.526 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.48 171.75 13.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.218 1.407 . . . . 0.0 108.056 -173.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -113.69 40.4 2.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.818 1.647 . . . . 0.0 113.412 -165.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -86.0 39.01 0.79 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.982 0.513 . . . . 0.0 111.026 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.86 -95.82 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.954 2.216 . . . . 0.0 113.694 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -41.37 22.31 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.527 1.164 . . . . 0.0 112.315 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.56 -3.25 14.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.39 1.476 . . . . 0.0 111.205 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -49.68 117.63 7.43 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.603 1.961 . . . . 0.0 110.57 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.2 135.69 11.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.741 2.294 . . . . 0.0 111.655 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.59 129.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.485 0.659 . . . . 0.0 111.118 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.81 164.29 15.29 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.16 1.784 . . . . 0.0 108.979 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.37 -52.99 5.76 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 121.075 -1.016 . . . . 0.0 110.488 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -97.39 94.99 7.37 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -161.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -42.91 -52.41 5.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.586 0.63 . . . . 0.0 111.573 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.58 9.91 40.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.577 -176.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 -149.1 56.11 1.0 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.4 137.81 20.04 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.12 -20.25 19.29 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.939 1.759 . . . . 0.0 113.294 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -149.58 165.05 33.43 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.604 1.093 . . . . 0.0 109.558 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.02 106.76 8.23 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.368 1.467 . . . . 0.0 108.65 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 88.83 5.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -80.54 91.85 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.183 1.393 . . . . 0.0 108.298 166.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.49 155.5 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -99.69 -170.68 1.93 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.907 -1.121 . . . . 0.0 109.242 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 t -146.59 146.93 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 114.86 8.14 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 127.844 2.458 . . . . 0.0 105.311 169.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 m120 43.4 60.46 2.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.472 1.109 . . . . 0.0 111.03 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 64.95 6.25 3.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.465 1.906 . . . . 0.0 115.171 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.36 173.78 6.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.863 1.665 . . . . 0.0 108.879 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.1 -23.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 124.884 1.273 . . . . 0.0 113.597 -164.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.82 -77.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.715 1.206 . . . . 0.0 111.903 -155.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.54 172.17 19.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.881 2.072 . . . . 0.0 110.23 -161.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 mm -126.21 141.11 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 m -138.44 121.02 16.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.954 2.102 . . . . 0.0 106.296 166.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -137.02 79.14 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -88.28 158.21 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.41 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.88 162.7 15.79 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 167.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -100.17 99.84 10.38 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.46 -0.781 . . . . 0.0 108.926 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.91 -11.02 29.08 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.646 2.231 . . . . 0.0 114.444 -170.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.56 38.57 4.13 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.787 -1.196 . . . . 0.0 110.489 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.43 96.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.592 1.157 . . . . 0.0 110.477 168.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -129.32 5.25 5.22 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.262 1.025 . . . . 0.0 112.132 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -95.05 -99.3 0.16 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -84.83 -10.48 57.12 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 119.746 -1.846 . . . . 0.0 114.417 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.1 t 58.06 -86.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.592 1.557 . . . . 0.0 112.47 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -100.23 32.64 2.92 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 119.84 -1.787 . . . . 0.0 114.361 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.57 110.29 0.4 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 119.284 0.947 . . . . 0.0 111.124 172.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 97.07 -10.7 0.07 Allowed 'General case' 0 CA--C 1.536 0.419 1 C-N-CA 132.162 4.185 . . . . 0.0 114.906 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -46.51 -48.52 47.37 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 121.672 2.033 . . . . 0.0 110.989 161.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.17 -18.26 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 120.52 1.222 . . . . 0.0 113.081 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -68.34 -26.97 65.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.828 0.74 . . . . 0.0 111.15 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.01 -69.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.278 1.031 . . . . 0.0 108.849 165.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 m -62.02 -29.02 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -166.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -63.87 -35.99 82.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.292 1.405 . . . . 0.0 110.729 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -15.54 62.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.27 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -86.05 37.07 0.7 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.191 1.36 . . . . 0.0 110.856 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.46 25.72 4.64 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.841 2.163 . . . . 0.0 116.957 165.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.22 173.78 8.13 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -164.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 19.9 mt-10 -142.4 -33.62 0.47 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.768 1.627 . . . . 0.0 111.657 -178.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -138.14 156.19 47.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.461 1.104 . . . . 0.0 109.065 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -148.7 144.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.714 1.205 . . . . 0.0 108.587 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.45 115.48 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.96 177.14 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.116 0.966 . . . . 0.0 109.923 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.6 -80.45 0.39 Allowed 'General case' 0 C--O 1.226 -0.135 0 O-C-N 120.888 -1.133 . . . . 0.0 108.046 167.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.77 -19.01 8.47 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -164.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 74' ' ' GLY 0.289 5.5 tt 35.84 -126.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 127.517 2.327 . . . . 0.0 113.708 175.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 153.82 140.68 3.1 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.306 1.908 . . . . 0.0 109.461 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -48.51 -44.09 35.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 116.987 -1.482 . . . . 0.0 113.44 -166.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -31.18 55.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.756 1.616 . . . . 0.0 112.463 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.57 -25.57 22.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.712 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.93 -51.69 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 167.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.42 -26.63 13.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.557 1.543 . . . . 0.0 113.132 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.52 -57.15 4.38 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.649 0.659 . . . . 0.0 111.454 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -59.17 -34.6 72.3 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.003 1.321 . . . . 0.0 110.985 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -54.62 -32.5 59.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.949 0.899 . . . . 0.0 111.793 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.4 -10.65 59.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.77 0.714 . . . . 0.0 112.452 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 ptm -124.4 10.2 8.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.508 1.523 . . . . 0.0 111.026 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.05 21.94 64.31 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 118.584 0.629 . . . . 0.0 112.182 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -80.83 119.66 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.06 146.56 49.23 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 119.123 -0.465 . . . . 0.0 110.308 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 t -133.71 107.93 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.808 1.186 . . . . 0.0 111.545 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -96.52 147.76 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.871 1.668 . . . . 0.0 108.608 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -172.6 2.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.072 1.349 . . . . 0.0 110.316 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.25 9.87 73.24 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 163.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -167.87 2.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.793 1.796 . . . . 0.0 111.442 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.32 159.01 14.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.492 1.917 . . . . 0.0 106.845 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 117.24 -169.67 13.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 112.618 170.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 p -79.89 167.85 20.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.0 t -56.96 -54.03 35.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 123.718 0.807 . . . . 0.0 110.289 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -50.96 -40.81 58.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 -175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.85 -49.9 13.35 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.13 1.772 . . . . 0.0 109.307 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.3 t -50.44 -32.61 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.57 1.148 . . . . 0.0 110.867 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.2 t -82.98 -41.36 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -52.42 -48.89 65.48 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -58.71 -41.96 87.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.399 0.679 . . . . 0.0 111.693 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -65.37 -51.66 58.93 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.516 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -60.74 -26.71 67.39 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.944 0.778 . . . . 0.0 111.01 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.95 0.47 56.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 110.977 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.12 6.51 88.07 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 120.835 -1.165 . . . . 0.0 113.347 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -72.3 -48.71 40.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.77 1.285 . . . . 0.0 109.425 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 tp -81.52 134.69 35.55 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.11 1.364 . . . . 0.0 109.491 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -144.73 152.74 40.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.453 1.101 . . . . 0.0 111.086 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -91.21 13.86 15.95 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.195 2.198 . . . . 0.0 113.649 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 p -86.53 60.48 6.25 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.387 1.075 . . . . 0.0 111.398 -172.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.55 70.71 0.91 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.205 1.802 . . . . 0.0 106.929 -177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.43 173.5 9.87 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.47 -0.769 . . . . 0.0 112.136 178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 55.22 24.94 6.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.895 2.078 . . . . 0.0 113.959 173.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -105.83 47.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 127.01 2.124 . . . . 0.0 108.565 -167.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 69.55 92.45 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.582 1.953 . . . . 0.0 110.529 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -147.92 179.0 8.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.899 0.88 . . . . 0.0 110.998 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -153.65 -41.3 0.09 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.727 1.149 . . . . 0.0 113.592 167.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.9 m170 38.4 82.13 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.845 2.058 . . . . 0.0 114.27 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.65 169.45 8.58 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.947 -1.095 . . . . 0.0 111.681 172.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.36 -88.85 0.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 157.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -142.37 141.14 32.26 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.906 1.682 . . . . 0.0 108.293 -170.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -73.45 -174.42 1.67 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.616 1.098 . . . . 0.0 111.912 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 . . . . . 0 C--O 1.246 0.905 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 173.912 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 24.2 ttm . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.969 0.89 . . . . 0.0 112.07 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 mt -140.3 144.0 28.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.18 104.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.346 2.658 . . . . 0.0 105.981 -163.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.44 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -82.16 143.95 31.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.108 0.163 . . . . 0.0 111.091 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 mt -145.38 106.77 4.41 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.61 117.84 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.351 2.034 . . . . 0.0 107.929 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -112.18 159.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.719 1.608 . . . . 0.0 109.439 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -85.25 -11.55 54.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 117.548 -1.215 . . . . 0.0 112.389 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -150.88 170.16 19.96 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.701 1.201 . . . . 0.0 108.296 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -98.77 103.1 15.02 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -137.76 38.57 2.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.378 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.09 -123.78 2.68 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.695 -1.253 . . . . 0.0 111.516 -174.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -35.93 63.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.956 1.378 . . . . 0.0 113.7 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -6.27 50.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.531 1.133 . . . . 0.0 111.311 -175.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 m -52.6 111.33 2.49 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 120.302 1.41 . . . . 0.0 110.166 -175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -67.38 134.3 32.99 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.595 2.197 . . . . 0.0 108.541 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tt -64.75 142.82 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.161 0.437 . . . . 0.0 110.309 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -81.2 -173.79 4.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.826 0.85 . . . . 0.0 108.967 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.14 -46.97 6.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.469 1.128 . . . . 0.0 108.737 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -99.41 165.56 11.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.671 1.189 . . . . 0.0 109.436 -159.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -120.42 -49.41 2.26 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.264 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 16.72 5.06 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.177 0.894 . . . . 0.0 114.593 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.74 39.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 129.073 2.949 . . . . 0.0 107.863 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.48 150.88 82.72 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 170.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.63 -22.5 12.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.802 2.335 . . . . 0.0 114.359 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -145.84 172.28 13.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.431 1.892 . . . . 0.0 109.074 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -133.96 110.29 9.59 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.665 1.186 . . . . 0.0 108.034 162.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.72 101.75 8.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 165.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.44 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.3 m-85 -88.72 104.72 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.17 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -98.88 -165.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.006 -1.059 . . . . 0.0 108.637 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.12 147.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 162.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 123.08 15.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 161.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.94 20.5 11.58 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 t30 86.83 9.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.437 2.695 . . . . 0.0 112.27 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.59 170.22 8.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.54 -22.77 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.202 1.801 . . . . 0.0 112.304 -163.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 50.5 -72.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.48 1.912 . . . . 0.0 112.766 -160.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -157.06 156.45 32.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.135 0.574 . . . . 0.0 112.472 -166.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mm -121.68 127.81 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.141 1.777 . . . . 0.0 108.0 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 t -120.57 97.28 5.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.254 13.0 p -106.72 61.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 122.743 1.258 . . . . 0.0 108.636 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.6 149.62 31.28 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.48 163.34 16.09 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.0 115.63 60.89 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.85 -7.02 19.5 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.419 2.079 . . . . 0.0 112.515 -175.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mt -135.45 39.85 2.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.931 2.093 . . . . 0.0 107.687 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.48 -35.92 77.04 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.857 -1.152 . . . . 0.0 111.605 -173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -156.66 21.09 0.33 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.726 0.811 . . . . 0.0 111.338 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -89.58 -64.36 1.15 Allowed 'General case' 0 N--CA 1.462 0.131 0 O-C-N 122.021 -0.424 . . . . 0.0 110.517 -159.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -109.05 -1.92 18.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.683 1.193 . . . . 0.0 112.757 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m 28.85 58.15 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 131.532 3.933 . . . . 0.0 115.901 167.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.84 -61.61 0.57 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.744 0.818 . . . . 0.0 111.23 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.62 -148.08 5.39 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 105.143 -3.183 . . . . 0.0 105.143 -169.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.31 -20.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 128.102 2.561 . . . . 0.0 116.762 173.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.69 -49.18 27.56 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 126.131 1.772 . . . . 0.0 108.289 164.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.8 -25.0 17.4 Favored 'Trans proline' 0 C--N 1.359 1.096 0 CA-C-N 121.349 1.518 . . . . 0.0 111.367 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.415 ' HA ' ' HE3' ' A' ' 61' ' ' LYS . 10.2 t30 -71.36 -28.71 64.25 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 119.854 1.207 . . . . 0.0 111.237 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -60.85 -70.99 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 162.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -62.57 -21.9 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 58' ' ' ASN . 6.3 mtmp? -66.12 -22.9 66.41 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.555 -1.341 . . . . 0.0 112.746 170.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -26.33 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 120.267 1.394 . . . . 0.0 109.614 172.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -85.74 38.6 0.76 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.975 0.91 . . . . 0.0 111.118 -165.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.08 14.6 39.89 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.725 2.107 . . . . 0.0 116.017 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -69.32 167.64 16.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.242 1.521 . . . . 0.0 114.395 -160.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.479 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 32.3 mt-10 -142.68 -21.86 0.66 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.197 0.999 . . . . 0.0 112.486 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -142.47 155.03 45.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.73 1.212 . . . . 0.0 107.853 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -152.16 138.61 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.01 110.72 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 m -133.45 156.01 41.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.615 1.566 . . . . 0.0 108.931 -167.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -99.3 -52.4 3.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.199 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.97 -49.17 0.59 Allowed Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.542 1.068 . . . . 0.0 113.036 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.482 HG12 ' H ' ' A' ' 74' ' ' GLY 0.255 4.9 tt 41.42 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 127.077 2.151 . . . . 0.0 112.626 -173.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.482 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.74 158.18 21.69 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 127.153 2.311 . . . . 0.0 109.356 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -45.03 -40.0 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 128.793 2.837 . . . . 0.0 114.511 -168.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -58.81 -34.02 71.03 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.001 -1.062 . . . . 0.0 112.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.84 -31.58 22.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.312 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.8 -51.66 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 166.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 0.66 1.98 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.31 -51.95 5.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 119.983 -1.698 . . . . 0.0 111.736 163.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -60.9 -37.3 81.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.684 1.194 . . . . 0.0 110.02 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -63.06 -15.87 58.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.062 0.945 . . . . 0.0 112.675 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.32 -15.81 61.38 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.436 -1.415 . . . . 0.0 110.97 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.7 ptp -131.81 5.75 4.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.583 1.953 . . . . 0.0 112.519 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.34 41.62 55.21 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -79.1 119.64 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -66.47 136.73 56.12 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.453 -0.779 . . . . 0.0 109.09 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.82 110.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.0 mt -93.69 116.42 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 127.927 2.491 . . . . 0.0 106.126 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -117.04 135.12 53.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.785 0.434 . . . . 0.0 111.335 -173.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.04 2.29 13.94 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.671 1.605 . . . . 0.0 114.603 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 -177.96 5.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.458 1.629 . . . . 0.0 111.128 -168.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.4 p -164.61 153.76 13.18 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.925 -1.109 . . . . 0.0 108.383 -172.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.28 -144.65 15.43 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 112.106 -0.397 . . . . 0.0 112.106 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.7 p -105.94 173.0 6.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.194 1.398 . . . . 0.0 109.629 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.11 -57.82 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.59 -35.11 76.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.733 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.29 -51.7 41.91 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.64 1.176 . . . . 0.0 108.136 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.2 t -63.31 -29.5 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.186 0.995 . . . . 0.0 111.739 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.4 t -68.85 -51.34 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -56.22 -43.2 78.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.041 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -57.18 -51.21 70.22 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.708 1.14 . . . . 0.0 109.868 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.87 -43.64 57.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.124 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.43 -31.72 68.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.51 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 m -78.24 -12.66 60.01 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 113.271 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.6 5.87 68.6 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.272 0.942 . . . . 0.0 113.594 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -70.41 -37.11 74.4 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.792 1.296 . . . . 0.0 110.676 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mt -82.56 165.77 19.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.022 1.329 . . . . 0.0 112.432 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 110' ' ' ASP . 1.5 tptm -155.99 178.44 10.27 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.578 1.551 . . . . 0.0 111.91 175.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' A' ' 109' ' ' LYS . 2.0 p30 -136.06 37.08 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.17 2.188 . . . . 0.0 108.716 -156.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.91 -6.08 56.78 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -167.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -106.21 83.56 1.91 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.08 170.14 8.73 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.454 1.102 . . . . 0.0 110.16 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.08 113.54 2.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.915 0.78 . . . . 0.0 111.009 -173.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.3 m -75.51 177.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 126.747 2.019 . . . . 0.0 114.464 -166.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 60.8 72.54 0.52 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.279 1.832 . . . . 0.0 111.854 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -74.56 84.19 2.04 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.682 2.793 . . . . 0.0 112.573 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -57.33 -17.69 13.48 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -170.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 23.35 94.61 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.765 2.826 . . . . 0.0 114.855 164.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.43 157.5 42.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 55.5 m80 48.99 -155.91 0.08 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.165 0.986 . . . . 0.0 111.284 -167.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 28.63 95.86 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.559 3.144 . . . . 0.0 114.849 -175.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -89.85 -179.42 5.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.907 1.683 . . . . 0.0 110.46 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 30.2 p80 . . . . . 0 C--O 1.246 0.902 0 CA-C-O 117.615 -1.183 . . . . 0.0 109.893 159.373 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptm . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.16 141.15 47.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.5 mt -125.14 100.58 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.764 2.826 . . . . 0.0 106.384 -161.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.439 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -83.86 145.61 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.856 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.37 126.68 21.41 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 166.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -75.43 110.2 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 N-CA-C 106.252 -2.249 . . . . 0.0 106.252 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.98 161.73 8.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 122.465 1.126 . . . . 0.0 110.99 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -93.24 -22.91 18.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.848 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.1 165.21 32.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.661 1.119 . . . . 0.0 108.797 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -92.44 77.3 5.09 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.245 1.018 . . . . 0.0 109.475 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -124.01 57.7 1.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.77 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -24.72 119.52 0.02 OUTLIER Glycine 0 N--CA 1.47 0.931 0 C-N-CA 126.064 1.792 . . . . 0.0 112.655 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt 80.14 -58.02 0.34 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.779 3.232 . . . . 0.0 110.909 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.38 -6.23 9.6 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.627 1.171 . . . . 0.0 113.105 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 m -47.92 102.84 0.33 Allowed Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 130.3 3.44 . . . . 0.0 110.379 -167.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.23 123.62 7.31 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.203 1.936 . . . . 0.0 110.677 -170.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.3 tt -56.71 143.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 122.111 0.957 . . . . 0.0 109.406 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.08 168.77 9.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.79 1.236 . . . . 0.0 109.411 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.6 -40.49 18.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.779 -0.576 . . . . 0.0 111.899 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -101.05 172.51 6.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.765 1.226 . . . . 0.0 108.575 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -120.2 -51.79 2.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 173.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -7.05 7.57 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.132 171.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ttp-105 -144.32 39.43 1.3 Allowed 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 126.011 1.724 . . . . 0.0 109.625 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.91 123.95 87.46 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 163.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.95 -19.72 34.84 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 120.801 1.322 . . . . 0.0 112.669 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -148.04 161.49 41.28 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.153 0.888 . . . . 0.0 109.697 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -135.77 106.46 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 108.287 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.92 93.68 5.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.439 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -82.16 95.64 7.57 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 171.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -79.65 151.86 4.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.72 -174.37 2.53 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.694 -1.254 . . . . 0.0 110.16 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.19 137.69 19.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.53 -0.731 . . . . 0.0 109.098 165.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -142.68 125.97 16.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 53.06 39.61 29.8 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.836 0.744 . . . . 0.0 112.586 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.93 12.41 1.74 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.008 2.123 . . . . 0.0 114.487 -174.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.24 168.77 8.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.118 1.367 . . . . 0.0 108.223 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.42 -19.04 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.233 1.413 . . . . 0.0 112.076 -164.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 52.61 -66.71 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.16 2.184 . . . . 0.0 113.835 -167.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.79 178.72 9.5 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.977 1.311 . . . . 0.0 111.387 174.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.36 142.71 41.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.816 0.846 . . . . 0.0 108.798 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -113.18 88.92 2.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.875 2.47 . . . . 0.0 107.311 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.35 72.92 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 122.947 1.356 . . . . 0.0 107.626 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.67 151.0 22.72 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -73.77 150.74 40.91 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.099 1.359 . . . . 0.0 109.848 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -82.62 116.6 64.8 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.48 -8.8 24.14 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.722 2.281 . . . . 0.0 114.668 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.86 39.78 2.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.235 1.814 . . . . 0.0 109.464 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.91 -31.39 66.74 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 119.655 -1.903 . . . . 0.0 111.934 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.27 -12.77 1.86 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 118.078 -0.963 . . . . 0.0 113.071 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -98.7 116.48 31.03 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 120.698 1.59 . . . . 0.0 113.104 -156.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 37.09 47.96 0.68 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.91 2.084 . . . . 0.0 112.482 174.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.6 t -55.91 -43.88 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.475 1.11 . . . . 0.0 112.093 -149.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 46.25 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 129.477 3.111 . . . . 0.0 114.751 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.96 14.22 0.22 Allowed Glycine 0 CA--C 1.526 0.732 0 CA-C-O 117.84 -1.533 . . . . 0.0 112.802 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.19 -18.09 15.07 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.041 1.421 . . . . 0.0 114.48 -165.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -51.02 80.87 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 119.131 0.878 . . . . 0.0 109.775 170.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -72.64 -28.54 14.03 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.426 2.084 . . . . 0.0 111.688 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.84 -45.26 70.85 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.277 0.631 . . . . 0.0 109.675 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -57.97 -68.23 0.27 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.706 0.803 . . . . 0.0 111.274 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 m -61.41 -18.79 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 120.118 -1.614 . . . . 0.0 113.755 -171.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -68.68 -26.6 65.38 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.18 1.355 . . . . 0.0 111.766 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -23.32 62.91 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.809 1.186 . . . . 0.0 111.124 171.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -85.11 38.93 0.74 Allowed 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.949 -1.094 . . . . 0.0 111.408 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.53 28.32 4.84 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.891 2.186 . . . . 0.0 115.686 163.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.19 168.32 20.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.038 0.919 . . . . 0.0 113.054 -160.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -143.2 -33.35 0.44 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.323 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.1 152.66 45.58 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.203 0.91 . . . . 0.0 108.878 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.57 139.39 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 161.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.1 mt -115.66 121.79 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 172.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.31 162.6 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.823 1.249 . . . . 0.0 109.892 -170.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -91.65 -75.05 0.49 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.67 -27.17 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.187 -1.341 . . . . 0.0 114.849 -171.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.484 HG12 ' H ' ' A' ' 74' ' ' GLY 0.265 4.5 tt 37.27 -143.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.392 2.277 . . . . 0.0 112.603 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.484 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.44 156.01 20.1 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 127.785 2.612 . . . . 0.0 109.875 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.29 82.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.205 1.002 . . . . 0.0 112.081 -172.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -32.99 60.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.521 175.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.98 -40.59 16.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.99 -1.481 . . . . 0.0 111.193 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -44.82 -46.84 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 119.589 1.086 . . . . 0.0 108.886 166.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.73 -11.73 13.46 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 119.861 -1.774 . . . . 0.0 114.951 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.48 -32.88 14.72 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.123 1.329 . . . . 0.0 113.459 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.432 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -46.64 -55.94 6.9 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.748 -1.22 . . . . 0.0 109.07 154.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -69.66 -3.17 13.98 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 124.577 1.173 . . . . 0.0 110.294 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -10.16 48.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 119.507 1.049 . . . . 0.0 110.853 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.2 5.69 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.29 33.55 84.85 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.856 0.753 . . . . 0.0 111.767 -168.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 4.9 t -80.41 96.86 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.14 -1.212 . . . . 0.0 110.606 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -49.92 145.79 5.23 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.727 1.611 . . . . 0.0 111.94 -169.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' CG2' ' CD2' ' A' ' 81' ' ' PHE . 1.2 t -125.89 107.55 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.082 0.468 . . . . 0.0 111.283 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.8 mt -93.05 99.47 9.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -83.69 165.82 18.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.195 0.521 . . . . 0.0 110.119 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.86 17.77 69.37 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-O 118.522 -1.155 . . . . 0.0 114.044 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.44 166.61 19.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.609 1.205 . . . . 0.0 110.106 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -152.64 159.04 43.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.87 1.668 . . . . 0.0 106.917 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 -175.62 15.82 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.349 0.976 . . . . 0.0 113.093 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.1 p -79.68 160.67 26.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.622 -0.928 . . . . 0.0 109.029 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -46.67 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -171.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -27.35 67.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.29 -60.98 2.15 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.4 t -46.52 -56.06 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.306 1.443 . . . . 0.0 109.419 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.14 -52.87 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 125.334 1.454 . . . . 0.0 109.045 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -54.71 -42.84 71.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.893 0.77 . . . . 0.0 111.548 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -60.97 -44.54 97.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 112.285 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -63.79 -45.12 91.12 Favored 'General case' 0 CA--C 1.519 -0.219 0 O-C-N 121.333 -0.854 . . . . 0.0 113.273 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.5 -32.23 70.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.3 0.955 . . . . 0.0 110.498 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -74.79 -9.91 59.0 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.22 0.608 . . . . 0.0 111.707 174.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.98 3.84 87.48 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.386 1.469 . . . . 0.0 113.074 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -71.0 -50.49 33.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.743 1.772 . . . . 0.0 109.488 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.04 145.31 56.11 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.972 1.709 . . . . 0.0 110.618 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 161.54 39.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -106.93 13.66 27.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.864 2.065 . . . . 0.0 111.401 -175.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . 0.256 19.1 p 41.05 -154.29 0.01 OUTLIER 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 128.444 2.697 . . . . 0.0 114.628 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -134.78 111.25 9.77 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 -166.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.98 177.46 7.86 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.669 1.187 . . . . 0.0 109.152 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -70.11 89.4 0.63 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.3 m -79.69 43.86 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.055 1.342 . . . . 0.0 110.681 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -96.59 147.44 23.87 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.176 -0.953 . . . . 0.0 108.626 168.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -68.75 129.77 40.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 150.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -169.96 149.69 3.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.62 1.968 . . . . 0.0 110.438 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 61.54 165.87 0.09 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.624 2.37 . . . . 0.0 111.674 -176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.469 ' HD1' ' CD ' ' A' ' 122' ' ' GLU . 11.6 m-70 57.48 -178.32 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.292 1.037 . . . . 0.0 110.679 -167.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 154.41 83.71 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 130.709 3.604 . . . . 0.0 108.662 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.469 ' CD ' ' HD1' ' A' ' 120' ' ' HIS . 0.4 OUTLIER -165.79 153.62 10.72 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.391 1.076 . . . . 0.0 109.795 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -86.57 174.98 8.56 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.124 1.37 . . . . 0.0 109.648 171.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.7 p80 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 157.035 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' HA ' ' OE2' ' A' ' 66' ' ' GLU . 3.8 ptp . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 mt -136.03 148.06 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.5 mt -125.65 109.75 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 129.049 2.94 . . . . 0.0 106.271 -168.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.44 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -82.27 148.15 28.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.288 169.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 87.4 mt -140.47 116.71 7.78 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 167.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.33 125.25 12.14 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.269 1.979 . . . . 0.0 108.496 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.51 157.9 24.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 119.247 0.931 . . . . 0.0 111.541 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -90.8 -20.74 22.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 116.69 -1.624 . . . . 0.0 113.325 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -147.99 150.01 33.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.199 1.399 . . . . 0.0 107.67 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -80.55 39.35 0.47 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.128 1.771 . . . . 0.0 113.694 -166.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 -82.87 39.83 0.65 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.561 -1.337 . . . . 0.0 112.94 -166.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.74 -137.27 35.91 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 120.44 1.473 . . . . 0.0 111.493 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -28.66 29.31 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -4.86 57.37 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 112.482 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.9 m -51.72 115.14 6.04 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.082 1.353 . . . . 0.0 111.681 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.19 134.96 18.12 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.629 2.219 . . . . 0.0 110.318 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.22 141.56 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.272 1.029 . . . . 0.0 110.819 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.15 156.56 17.26 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.784 1.233 . . . . 0.0 110.195 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -70.14 -39.98 75.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.857 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -133.58 117.2 16.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.677 2.035 . . . . 0.0 109.706 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -41.82 -53.75 3.61 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 112.42 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.69 63.57 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.645 -164.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.55 38.99 2.23 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 120.504 2.152 . . . . 0.0 108.161 162.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.81 125.95 91.57 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.492 ' HA ' HD21 ' A' ' 45' ' ' ASN . 30.2 Cg_endo -63.51 -16.42 54.52 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.281 1.321 . . . . 0.0 113.017 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -150.39 149.03 29.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.283 1.033 . . . . 0.0 108.955 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.44 103.69 9.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.071 0.949 . . . . 0.0 108.643 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.82 106.8 13.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.44 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 1.7 m-85 -95.15 89.46 5.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.954 1.302 . . . . 0.0 107.532 171.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.69 147.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -89.2 -170.6 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.327 -0.858 . . . . 0.0 108.722 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -142.92 128.37 16.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 162.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -94.88 104.45 16.34 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.0 t30 59.25 -81.4 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.064 . . . . 0.0 110.533 -171.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -135.7 -0.27 2.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 130.449 3.5 . . . . 0.0 113.325 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.9 -179.29 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.049 1.74 . . . . 0.0 108.953 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.31 -22.18 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 121.413 1.915 . . . . 0.0 113.946 -169.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.22 -74.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.247 1.385 . . . . 0.0 112.331 -160.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -163.36 153.34 15.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.323 1.049 . . . . 0.0 110.302 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.0 mm -78.39 155.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.081 1.353 . . . . 0.0 107.854 168.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -127.73 154.88 44.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 141.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 70.53 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 122.8 1.286 . . . . 0.0 108.546 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.0 131.59 35.83 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.085 1.354 . . . . 0.0 108.759 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.12 162.65 27.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.375 0.607 . . . . 0.0 111.616 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.492 HD21 ' HA ' ' A' ' 25' ' ' PRO . 39.7 p-10 -78.42 95.39 0.17 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 131.461 3.904 . . . . 0.0 114.733 -168.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.89 -25.18 23.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.385 1.39 . . . . 0.0 114.307 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.24 39.64 3.24 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.881 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.72 74.85 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.007 1.323 . . . . 0.0 111.501 -171.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -139.59 0.04 1.8 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.052 0.941 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -111.39 115.75 29.79 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.379 -0.826 . . . . 0.0 109.904 -162.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 61.28 -49.37 0.12 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.198 2.199 . . . . 0.0 113.145 -168.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t 57.74 -87.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 128.624 2.769 . . . . 0.0 111.679 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 44.49 -71.19 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 130.106 3.362 . . . . 0.0 116.502 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.26 17.4 0.21 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.462 1.506 . . . . 0.0 111.905 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.48 -18.79 19.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.296 1.048 . . . . 0.0 113.489 -172.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -57.45 -51.67 80.0 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.69 -28.99 51.86 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.37 1.38 . . . . 0.0 112.416 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -32.54 74.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.584 1.084 . . . . 0.0 110.323 178.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -65.41 -61.99 1.79 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.4 m -61.87 -23.92 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 120.383 1.447 . . . . 0.0 113.261 -174.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -21.14 63.87 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 120.848 -1.158 . . . . 0.0 112.809 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.18 -19.36 54.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 120.665 1.575 . . . . 0.0 111.537 170.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -85.07 37.9 0.69 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.16 21.14 5.36 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.601 2.524 . . . . 0.0 115.735 169.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.05 167.47 13.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.011 1.405 . . . . 0.0 114.548 -163.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 9.5 mt-10 -137.96 -31.13 0.78 Allowed 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.504 1.122 . . . . 0.0 111.902 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.63 152.77 51.96 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.623 1.169 . . . . 0.0 108.783 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 t -139.11 146.5 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 168.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.4 mt -131.65 118.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -134.61 169.49 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 111.356 -168.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -112.69 -42.34 3.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.501 -1.374 . . . . 0.0 113.439 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.93 42.48 0.78 Allowed Glycine 0 N--CA 1.469 0.836 0 C-N-CA 125.197 1.38 . . . . 0.0 111.648 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.2 tt -58.97 166.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.744 1.217 . . . . 0.0 111.087 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.58 161.51 13.25 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.679 1.133 . . . . 0.0 110.744 170.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -30.09 59.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.275 1.43 . . . . 0.0 113.486 -174.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -53.63 -43.45 68.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 111.127 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.98 29.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.235 -1.364 . . . . 0.0 112.047 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.07 -49.48 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 120.337 1.426 . . . . 0.0 107.328 164.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -13.64 50.61 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.46 -60.77 2.12 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 110.07 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.77 -38.73 72.88 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.8 2.04 . . . . 0.0 109.553 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' CD ' ' HD1' ' A' ' 116' ' ' HIS . 39.0 mt-10 -59.92 -19.76 53.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.542 0.737 . . . . 0.0 112.944 172.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.85 -12.58 61.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.025 -1.672 . . . . 0.0 112.491 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.81 7.29 6.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.638 1.175 . . . . 0.0 114.064 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.15 24.76 74.68 Favored Glycine 0 C--O 1.241 0.558 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.972 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.11 116.33 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -69.99 141.76 52.91 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.78 97.82 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 110' ' ' ASP . 50.7 mt -75.64 144.85 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.636 1.174 . . . . 0.0 108.363 175.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.466 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 2.6 mppt? -125.38 173.19 9.03 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.075 1.75 . . . . 0.0 109.054 -175.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.37 57.78 16.95 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.899 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.14 165.53 12.81 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 124.368 0.687 . . . . 0.0 110.788 165.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.3 p -146.49 164.07 33.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.361 1.864 . . . . 0.0 108.436 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.38 -166.8 24.44 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 118.794 0.725 . . . . 0.0 113.486 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.4 p -85.18 165.7 17.19 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 121.547 -0.972 . . . . 0.0 111.7 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -50.41 -56.25 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 C-N-CA 124.523 1.129 . . . . 0.0 110.081 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -59.8 -27.46 66.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -82.83 -53.39 5.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.519 1.528 . . . . 0.0 107.893 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.84 -43.99 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.416 1.486 . . . . 0.0 110.145 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.07 -53.24 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.03 -39.66 90.63 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.301 -0.874 . . . . 0.0 111.91 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.46 -39.39 94.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.343 0.974 . . . . 0.0 110.645 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -64.32 -52.0 60.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.42 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -56.46 -36.03 68.6 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.006 0.922 . . . . 0.0 109.14 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.8 m -77.18 0.96 19.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.656 1.182 . . . . 0.0 112.697 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.5 9.91 84.59 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.894 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -80.0 -43.64 21.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 119.355 1.578 . . . . 0.0 109.84 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.32 141.38 48.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.33 171.82 19.11 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 127.538 2.335 . . . . 0.0 108.198 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 90' ' ' LYS . 12.4 p-10 -127.24 14.52 7.23 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.898 1.279 . . . . 0.0 112.22 169.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t 70.44 -168.25 0.16 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.425 1.89 . . . . 0.0 110.141 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -72.95 122.88 22.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.262 1.825 . . . . 0.0 106.562 161.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -114.27 172.04 7.25 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.775 1.23 . . . . 0.0 109.374 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -118.1 161.16 20.29 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.55 1.54 . . . . 0.0 110.503 -173.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.8 m -106.95 158.3 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.803 1.241 . . . . 0.0 109.528 -172.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.481 ' HD1' ' CD ' ' A' ' 82' ' ' GLU . 34.0 p-80 -80.67 96.35 6.86 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.763 -0.586 . . . . 0.0 111.351 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.16 -56.96 12.26 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.716 1.206 . . . . 0.0 110.489 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.38 122.75 21.72 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.684 -0.635 . . . . 0.0 110.347 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -129.92 -177.9 4.49 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.831 1.652 . . . . 0.0 107.871 160.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -157.42 72.81 0.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.097 0.959 . . . . 0.0 109.29 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.7 m170 37.4 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.098 2.159 . . . . 0.0 111.264 -165.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -56.39 156.72 5.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.288 1.435 . . . . 0.0 110.153 171.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -130.91 168.5 17.21 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.117 1.767 . . . . 0.0 106.466 168.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.566 0.209 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.0 mt -109.34 151.36 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 160.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.81 108.48 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 C-N-CA 130.011 3.324 . . . . 0.0 105.16 -169.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.433 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -79.68 153.73 29.11 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.272 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.9 mt -146.4 113.93 4.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.58 124.95 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 N-CA-C 106.852 -2.018 . . . . 0.0 106.852 170.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.43 155.47 15.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 -19.84 30.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 -177.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -149.43 153.37 37.22 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 -177.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -93.7 64.22 3.48 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.956 0.884 . . . . 0.0 111.537 -169.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -106.48 42.03 1.34 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.598 -166.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 24.38 80.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.701 1.619 . . . . 0.0 115.481 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 80.67 -46.26 0.26 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.153 2.981 . . . . 0.0 112.604 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -0.06 0.63 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.015 0.825 . . . . 0.0 112.169 162.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -51.0 107.97 0.94 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.713 2.805 . . . . 0.0 111.769 169.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.94 130.62 5.77 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.996 2.464 . . . . 0.0 110.209 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.41 134.35 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.951 1.301 . . . . 0.0 112.052 -175.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -70.15 169.42 13.6 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.85 1.66 . . . . 0.0 109.274 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -92.48 -23.11 19.24 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.324 -0.86 . . . . 0.0 111.12 174.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -108.48 171.23 7.53 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -170.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -120.76 -57.57 1.88 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.35 -3.14 11.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.731 -169.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -143.49 38.51 1.38 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.415 1.607 . . . . 0.0 108.703 169.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.86 152.57 96.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.96 -20.73 7.33 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.779 2.319 . . . . 0.0 113.606 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -152.85 157.1 40.23 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.868 1.267 . . . . 0.0 109.489 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -123.07 108.36 12.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.036 1.334 . . . . 0.0 107.893 174.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.42 87.5 5.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 165.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' CE1' ' CB ' ' A' ' 4' ' ' ALA . 2.2 m-85 -70.86 142.9 51.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 157.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -84.71 -168.48 2.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.102 0.865 . . . . 0.0 109.523 -179.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.63 143.12 26.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 162.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -139.45 133.91 31.61 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 127.428 2.291 . . . . 0.0 105.38 169.268 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 32.47 57.24 0.4 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.241 1.817 . . . . 0.0 112.702 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.53 12.98 5.83 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.982 2.513 . . . . 0.0 116.769 -178.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.03 -179.6 4.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.243 1.817 . . . . 0.0 109.586 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.33 -23.46 31.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 125.222 1.409 . . . . 0.0 113.611 -164.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.05 -74.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.105 1.32 . . . . 0.0 112.48 -160.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.17 160.25 39.71 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.533 1.933 . . . . 0.0 111.049 -160.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mm -124.87 134.62 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.507 1.923 . . . . 0.0 106.788 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 m -138.95 72.14 1.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.608 2.763 . . . . 0.0 106.941 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 2.2 t -77.22 97.75 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -96.27 159.84 14.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.886 173.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -57.41 163.51 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 110.848 167.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.33 95.93 3.28 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 159.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.51 3.46 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.217 2.612 . . . . 0.0 113.098 -176.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.26 39.11 2.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.016 1.326 . . . . 0.0 109.003 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.46 -37.15 72.42 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.751 -1.218 . . . . 0.0 111.489 -171.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -147.68 13.35 1.04 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 176.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -118.43 121.86 41.35 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.27 1.395 . . . . 0.0 111.998 -160.332 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 54.93 -27.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 131.02 3.728 . . . . 0.0 116.022 -172.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 50' ' ' ASP . 10.7 t 38.24 53.11 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 1 C-N-CA 131.821 4.048 . . . . 0.0 111.483 164.112 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.69 44.17 0.96 Allowed 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.366 -0.833 . . . . 0.0 110.291 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.09 28.53 70.73 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.527 -0.733 . . . . 0.0 112.649 -176.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.16 -15.2 20.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.283 1.033 . . . . 0.0 112.701 -172.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -50.13 -52.69 51.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 119.521 1.055 . . . . 0.0 109.665 173.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -71.05 -29.99 17.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.521 2.147 . . . . 0.0 111.974 178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.4 -32.78 74.59 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.428 -0.795 . . . . 0.0 110.596 -177.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -58.66 -65.69 0.62 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 109.925 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.81 -27.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -171.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -63.83 -19.96 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.984 0.913 . . . . 0.0 112.65 173.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -20.68 44.91 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.084 0.856 . . . . 0.0 111.984 169.131 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -86.83 38.03 0.78 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.677 -1.264 . . . . 0.0 111.419 -170.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.27 19.83 8.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.329 1.919 . . . . 0.0 115.918 166.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.46 168.43 19.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.185 1.492 . . . . 0.0 113.278 -163.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -143.38 -27.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.442 1.097 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 68' ' ' VAL . 41.9 tp -135.88 158.64 43.9 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.963 0.801 . . . . 0.0 110.241 176.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.421 ' H ' HD13 ' A' ' 67' ' ' LEU . 2.8 t -150.66 122.87 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -174.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 82.4 mt -114.59 107.67 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 108.628 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.43 176.07 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.729 2.012 . . . . 0.0 111.966 -174.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -96.5 -94.36 0.21 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 164.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.97 -40.52 8.03 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.588 -0.562 . . . . 0.0 114.072 -167.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.493 ' CG1' ' H ' ' A' ' 74' ' ' GLY 0.281 3.0 tt 44.55 -138.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.939 1.696 . . . . 0.0 112.537 -176.423 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.493 ' H ' ' CG1' ' A' ' 73' ' ' ILE . . . -179.42 155.37 15.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 129.61 3.481 . . . . 0.0 109.219 174.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.56 -34.15 73.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.989 1.394 . . . . 0.0 111.785 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -55.56 -23.41 26.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 171.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.84 13.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.205 0.911 . . . . 0.0 110.857 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.73 -46.35 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 166.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.53 -31.91 25.92 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.533 1.533 . . . . 0.0 114.566 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.5 -55.27 5.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.02 0.827 . . . . 0.0 110.526 -177.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -62.14 -31.45 71.93 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.436 1.094 . . . . 0.0 110.799 177.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -56.56 -32.58 65.31 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.196 -0.94 . . . . 0.0 112.302 170.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -18.69 61.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.713 0.688 . . . . 0.0 111.601 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.75 6.04 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.404 1.482 . . . . 0.0 110.785 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.81 23.67 69.33 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.941 -1.1 . . . . 0.0 111.982 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.0 t -79.4 117.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -58.72 145.12 41.39 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.429 1.492 . . . . 0.0 109.38 174.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.05 128.3 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 mt -115.16 131.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.325 2.65 . . . . 0.0 105.101 -178.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.481 ' H ' ' HA ' ' A' ' 110' ' ' ASP . 0.0 OUTLIER -134.2 135.86 43.32 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.769 1.228 . . . . 0.0 108.775 -170.681 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.14 2.95 6.38 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.673 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.78 173.64 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.079 1.44 . . . . 0.0 111.13 -173.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 p -161.99 165.13 27.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.198 1.799 . . . . 0.0 106.65 156.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.62 -163.05 16.42 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 122.264 0.924 . . . . 0.0 112.601 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 162.92 24.78 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.212 -1.169 . . . . 0.0 111.098 -178.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -53.05 -49.74 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 123.007 0.523 . . . . 0.0 109.605 174.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -62.22 -26.67 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -80.65 -54.61 5.49 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 107.828 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -53.84 -45.5 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -178.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.04 -42.8 92.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -58.0 -50.85 72.0 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.284 174.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -57.09 -41.72 79.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.197 0.908 . . . . 0.0 110.772 -172.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.25 -53.73 22.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.246 1.019 . . . . 0.0 112.134 174.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.2 -26.75 68.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.613 0.642 . . . . 0.0 110.822 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -82.54 -3.28 55.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 174.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.07 15.18 75.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 118.126 -1.374 . . . . 0.0 113.691 168.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -87.1 -30.08 21.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.984 1.392 . . . . 0.0 111.613 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 tp -74.86 166.53 23.48 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.152 -0.342 . . . . 0.0 111.347 -163.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.3 168.43 18.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.267 1.027 . . . . 0.0 111.748 -170.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.481 ' HA ' ' H ' ' A' ' 90' ' ' LYS . 40.0 p30 -121.2 13.99 11.27 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.021 1.728 . . . . 0.0 112.305 -175.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.6 p 32.78 54.44 0.38 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.473 2.309 . . . . 0.0 112.526 -171.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 49.11 33.1 4.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 129.192 2.997 . . . . 0.0 114.853 165.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.59 120.8 22.29 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.173 1.389 . . . . 0.0 108.935 173.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.06 116.14 8.35 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.781 171.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.63 71.5 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.57 0 O-C-N 121.085 -1.009 . . . . 0.0 110.147 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.05 113.36 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 127.306 2.242 . . . . 0.0 109.764 -164.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -56.9 110.03 0.74 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.198 0.999 . . . . 0.0 110.081 167.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.21 157.87 31.57 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.829 2.052 . . . . 0.0 108.392 172.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -41.63 123.28 2.19 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.756 1.223 . . . . 0.0 111.933 -174.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.47 71.56 3.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.137 1.375 . . . . 0.0 109.732 -176.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 56.86 -162.43 0.19 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.96 1.704 . . . . 0.0 109.797 -165.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -44.59 136.33 4.38 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 159.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -80.94 48.08 1.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.347 1.459 . . . . 0.0 109.699 -173.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.2 t60 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 116.298 -1.811 . . . . 0.0 110.336 -138.111 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.482 HD22 HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.06 70.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -145.05 22.53 1.56 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 175.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -117.57 129.23 55.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.899 0.772 . . . . 0.0 110.619 -163.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.5 m170 61.06 -40.04 0.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.685 2.794 . . . . 0.0 114.049 -168.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t 56.75 24.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.902 1.681 . . . . 0.0 111.531 173.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -64.23 -70.48 0.22 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 120.914 -1.116 . . . . 0.0 108.096 178.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.87 41.35 0.04 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -178.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.72 -14.37 14.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 -174.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.482 HG23 HD22 ' A' ' 45' ' ' ASN . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.443 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.75 158.85 40.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -135.74 45.56 2.41 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 126.48 1.912 . . . . 0.0 108.919 -164.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 m -44.2 152.06 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.498 1.919 . . . . 0.0 112.316 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.13 124.71 16.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -147.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.1 119.93 40.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.298 1.839 . . . . 0.0 110.3 -157.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.6 142.9 53.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 113.089 -173.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t 32.41 58.75 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 128.851 2.86 . . . . 0.0 111.739 174.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 t60 57.88 -77.09 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.836 2.054 . . . . 0.0 111.306 -170.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.91 -34.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.454 1.102 . . . . 0.0 111.577 171.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 67.97 -4.37 1.03 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.614 1.566 . . . . 0.0 114.993 171.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -82.63 148.36 28.02 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 121.093 1.77 . . . . 0.0 109.942 -171.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.3 m170 57.73 165.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.732 2.413 . . . . 0.0 111.197 -169.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -141.54 161.18 38.54 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.501 1.12 . . . . 0.0 108.728 164.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.75 -28.06 13.02 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 66.19 -24.97 0.1 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.099 2.16 . . . . 0.0 116.099 173.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 171.108 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.513 0.197 . . . . 0.0 110.841 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.412 HG22 ' CD1' ' A' ' 29' ' ' PHE . 7.2 mt -115.3 153.25 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 165.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 mt -134.51 105.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.132 2.173 . . . . 0.0 105.812 -164.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.924 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.52 145.59 31.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.191 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.483 HD12 HG13 ' A' ' 96' ' ' VAL . 51.3 mt -145.94 114.59 4.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.35 129.42 15.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.574 1.516 . . . . 0.0 108.372 171.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 15' ' ' SER . 4.9 m -122.88 150.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 118.739 0.7 . . . . 0.0 109.185 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -68.1 -27.06 66.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.318 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.59 156.1 39.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.648 1.579 . . . . 0.0 107.91 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -85.73 95.59 9.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -125.8 39.64 3.91 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 108.582 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.19 -127.88 29.94 Favored Glycine 0 C--N 1.34 0.76 0 O-C-N 120.775 -1.203 . . . . 0.0 111.434 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -58.4 -45.79 87.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.182 1.393 . . . . 0.0 111.665 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -1.87 4.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.774 2.43 . . . . 0.0 114.304 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.464 ' HB3' HG11 ' A' ' 7' ' ' VAL . 27.3 m -52.99 109.01 1.24 Allowed Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.975 174.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.92 135.47 14.11 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.357 1.371 . . . . 0.0 108.964 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.47 134.37 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.047 0.939 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.38 169.9 12.5 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.876 1.27 . . . . 0.0 107.876 166.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -88.1 -55.32 3.8 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 121.472 -0.768 . . . . 0.0 110.554 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.63 85.57 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 -152.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -37.49 -47.17 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.411 1.484 . . . . 0.0 112.908 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.42 -14.34 41.18 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 118.7 -1.055 . . . . 0.0 115.276 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.59 48.02 1.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.09 2.156 . . . . 0.0 108.74 173.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.65 137.77 54.77 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 167.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.74 -25.29 28.83 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.454 2.103 . . . . 0.0 114.494 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -146.27 158.17 43.86 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.29 103.9 8.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.51 1.524 . . . . 0.0 107.896 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.11 79.02 6.72 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.526 1.53 . . . . 0.0 107.585 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.924 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.31 3.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.458 HG13 HD13 ' A' ' 40' ' ' ILE . 3.9 t -83.08 164.15 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.034 171.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.874 -1.141 . . . . 0.0 108.97 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.413 HG12 ' HG2' ' A' ' 1' ' ' MET . 11.9 p -150.18 147.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 161.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -123.54 113.71 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 173.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t30 54.58 -86.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.718 1.207 . . . . 0.0 111.687 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.94 12.24 2.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.685 1.594 . . . . 0.0 111.969 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.11 156.36 38.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.784 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.26 -32.32 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.096 1.758 . . . . 0.0 112.932 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 59.13 -51.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 115.497 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.68 161.98 16.05 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.06 0.944 . . . . 0.0 110.8 -160.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.458 HD13 HG13 ' A' ' 30' ' ' VAL . 2.8 mm -135.74 140.45 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.226 1.81 . . . . 0.0 107.73 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.79 88.5 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.734 2.013 . . . . 0.0 107.714 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 4.7 t -89.8 93.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 164.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.69 152.6 19.47 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 mp0 -56.88 152.87 11.93 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.448 1.099 . . . . 0.0 110.496 168.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -79.77 133.6 58.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 164.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.92 -9.72 26.25 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 CA-C-N 121.12 1.436 . . . . 0.0 112.121 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.78 39.65 0.96 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.023 1.329 . . . . 0.0 110.062 -163.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 O-C-N 120.295 -1.503 . . . . 0.0 112.336 -169.088 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.08 -53.44 48.45 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 119.227 0.921 . . . . 0.0 109.515 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' HG22 ' A' ' 60' ' ' VAL . 29.0 Cg_endo -72.48 -32.05 10.41 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.012 1.808 . . . . 0.0 111.899 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.1 -38.33 73.22 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.052 0.842 . . . . 0.0 110.922 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.75 -65.58 0.61 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.902 1.281 . . . . 0.0 110.991 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.81 -22.34 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.751 1.16 . . . . 0.0 113.904 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.48 -12.36 61.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.304 -1.498 . . . . 0.0 114.002 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -19.01 23.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.809 1.186 . . . . 0.0 109.781 165.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.15 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.171 0 O-C-N 119.87 -1.768 . . . . 0.0 111.239 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.53 20.11 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 127.34 2.4 . . . . 0.0 116.214 161.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.23 176.84 9.3 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -159.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -144.1 -53.32 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 124.63 1.172 . . . . 0.0 110.642 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.08 157.01 19.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.6 1.16 . . . . 0.0 109.363 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.88 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -136.51 139.65 44.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.386 2.275 . . . . 0.0 105.071 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.573 HG21 HG13 ' A' ' 99' ' ' VAL . 94.5 mt -131.47 111.37 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 68' ' ' VAL . 3.1 m -137.31 155.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.685 -162.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' HE ' ' HB3' ' A' ' 93' ' ' SER . 17.6 ttt-85 -95.08 -62.14 1.36 Allowed 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.763 -1.211 . . . . 0.0 111.243 -176.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.85 -54.42 1.3 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.791 -0.568 . . . . 0.0 113.929 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.493 HG12 ' H ' ' A' ' 74' ' ' GLY 0.299 3.7 tt 44.26 -168.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 130.102 3.361 . . . . 0.0 115.14 -173.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.36 167.19 39.82 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.319 1.914 . . . . 0.0 110.445 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.61 -31.76 73.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -163.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -64.74 -36.33 83.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.198 1.817 . . . . 0.0 109.642 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.73 63.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.265 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.42 -43.96 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 119.764 1.165 . . . . 0.0 109.626 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.23 10.93 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.196 -1.565 . . . . 0.0 114.934 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 57' ' ' PRO . . . -80.16 -58.56 3.09 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.259 1.424 . . . . 0.0 110.453 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.47 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -35.62 -56.29 0.67 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 126.953 2.101 . . . . 0.0 109.159 160.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.42 -9.94 55.82 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 117.421 -1.276 . . . . 0.0 111.733 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.9 63.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.725 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.2 14.92 5.66 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.311 0.382 . . . . 0.0 111.504 -163.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.25 26.78 56.84 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.09 -0.381 . . . . 0.0 112.765 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 1.9 t -79.64 108.15 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -168.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.66 28.49 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.975 1.71 . . . . 0.0 110.336 -170.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.07 95.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.5 139.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.81 154.06 47.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.986 -0.446 . . . . 0.0 110.845 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.12 38.62 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.084 0.85 . . . . 0.0 114.799 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.5 157.53 37.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.427 1.113 . . . . 0.0 110.869 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.43 ' HB3' ' HE ' ' A' ' 71' ' ' ARG . 65.2 p -159.46 130.33 5.93 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.127 0.971 . . . . 0.0 108.414 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.65 -130.86 6.28 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.906 -172.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.35 159.61 39.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.041 1.737 . . . . 0.0 111.329 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.483 HG13 HD12 ' A' ' 5' ' ' ILE . 22.5 t -63.71 -45.1 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.861 -1.149 . . . . 0.0 111.272 -166.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.53 -12.01 48.97 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.38 -43.49 5.41 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.007 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.573 HG13 HG21 ' A' ' 69' ' ' ILE . 76.3 t -46.03 -49.8 4.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.432 1.469 . . . . 0.0 110.547 169.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.47 -38.47 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.478 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -62.01 -50.97 69.93 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 117.329 -1.32 . . . . 0.0 110.307 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.26 -37.22 69.5 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.379 1.445 . . . . 0.0 111.575 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.04 -50.42 41.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.723 1.209 . . . . 0.0 111.94 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.8 mt -62.88 -30.63 71.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.097 0.408 . . . . 0.0 110.139 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.9 m -74.77 -1.09 20.49 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.924 2.09 . . . . 0.0 112.508 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.91 75.0 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 125.39 1.472 . . . . 0.0 112.916 168.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.5 -45.78 51.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.914 0.864 . . . . 0.0 108.705 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.97 134.88 38.74 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.602 1.161 . . . . 0.0 108.373 -166.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.494 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.591 HG22 ' CD1' ' A' ' 29' ' ' PHE . 24.1 mt -111.7 141.7 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.428 HG12 HD12 ' A' ' 67' ' ' LEU . 18.9 mt -122.41 102.65 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 129.424 3.09 . . . . 0.0 107.246 -168.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.909 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -80.15 145.74 32.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.985 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mt -138.64 117.97 9.53 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.21 108.63 2.02 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 N-CA-C 107.121 -1.915 . . . . 0.0 107.121 166.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 26' ' ' TYR . 12.2 m -101.1 158.9 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 119.065 0.848 . . . . 0.0 110.33 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -77.03 -33.11 57.42 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.154 1.782 . . . . 0.0 112.392 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -147.13 146.58 29.96 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -86.54 90.03 8.1 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 167.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -111.62 39.44 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.487 -1.244 . . . . 0.0 110.306 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 25.05 91.36 0.01 OUTLIER Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.581 2.039 . . . . 0.0 115.174 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt 80.19 -45.7 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.791 2.436 . . . . 0.0 112.068 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -20.13 65.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -33.36 102.34 0.21 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.972 2.909 . . . . 0.0 111.974 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.29 137.13 36.05 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 109.349 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 93' ' ' SER . 14.6 tt -60.78 140.17 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 t -75.83 177.71 6.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.211 1.004 . . . . 0.0 109.039 170.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 -13.94 21.43 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.489 -0.757 . . . . 0.0 112.616 -173.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -142.25 -179.5 6.29 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.888 2.075 . . . . 0.0 108.861 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -119.6 -42.55 2.63 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.424 0.69 . . . . 0.0 111.777 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 -16.3 55.49 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 117.578 -1.679 . . . . 0.0 116.947 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 39.09 1.49 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.999 1.719 . . . . 0.0 109.794 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.39 146.7 97.83 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 37.6 Cg_endo -74.37 -22.22 16.55 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.565 1.51 . . . . 0.0 114.055 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.5 ' HB2' HG23 ' A' ' 7' ' ' VAL . 95.6 m-85 -153.18 153.03 31.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.694 1.134 . . . . 0.0 109.418 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -113.31 109.18 18.31 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.711 0.264 . . . . 0.0 111.711 164.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 96.58 6.52 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.906 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.1 m-85 -83.34 96.39 8.5 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 164.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 t -79.64 168.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.82 -164.21 1.32 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.24 -1.537 . . . . 0.0 109.246 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -147.11 133.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 O-C-N 121.74 -0.6 . . . . 0.0 109.768 170.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -105.27 102.09 11.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 168.454 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.4 t30 55.28 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 111.964 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -140.03 34.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.686 1.595 . . . . 0.0 109.996 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.19 169.89 12.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.518 1.127 . . . . 0.0 108.412 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.11 -23.12 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.573 1.533 . . . . 0.0 113.588 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.4 -68.68 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.367 1.867 . . . . 0.0 114.228 -162.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -168.32 146.38 4.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.752 0.821 . . . . 0.0 110.412 -150.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mm -111.89 126.53 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.005 2.122 . . . . 0.0 107.072 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.37 80.46 1.61 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.55 1.54 . . . . 0.0 107.39 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.266 7.2 p -91.82 75.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.976 0.893 . . . . 0.0 109.012 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.01 160.41 25.88 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.55 -178.44 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.754 1.222 . . . . 0.0 111.437 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 48' ' ' ALA . 33.7 p-10 -100.31 85.51 0.54 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.023 3.329 . . . . 0.0 114.671 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.69 -24.79 74.9 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.257 1.972 . . . . 0.0 113.39 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.587 HD12 ' H ' ' A' ' 56' ' ' VAL . 1.6 tm? -120.24 56.2 0.98 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 123.593 1.664 . . . . 0.0 107.74 173.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . . . . . . . . 0 C--O 1.238 0.484 0 C-N-CA 125.171 1.389 . . . . 0.0 109.904 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.587 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -46.41 -55.15 14.85 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 122.505 2.411 . . . . 0.0 110.288 -176.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.25 -17.11 11.86 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.319 2.013 . . . . 0.0 112.197 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.68 -48.8 68.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -52.95 -66.09 0.45 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.45 1.1 . . . . 0.0 111.278 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.64 -17.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 120.297 -1.502 . . . . 0.0 113.156 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.98 -31.87 61.54 Favored 'General case' 0 N--CA 1.458 -0.049 0 O-C-N 120.922 -1.111 . . . . 0.0 111.746 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -26.47 68.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.968 1.258 . . . . 0.0 110.981 170.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -82.48 38.13 0.54 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.859 0.863 . . . . 0.0 111.029 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 40.55 30.83 0.34 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 129.375 3.369 . . . . 0.0 116.903 165.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -73.74 175.46 7.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.551 1.175 . . . . 0.0 113.696 -167.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.56 -37.88 0.41 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.281 1.433 . . . . 0.0 110.052 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.8 tm? -132.02 154.76 49.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.698 1.199 . . . . 0.0 109.435 -173.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.909 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -148.76 140.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.544 HG21 ' CG1' ' A' ' 99' ' ' VAL . 71.6 mt -126.0 110.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.512 HG13 HG12 ' A' ' 68' ' ' VAL . 19.9 m -126.55 164.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 109.813 -172.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.36 -100.5 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.31 66.2 0.35 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 125.277 1.417 . . . . 0.0 110.606 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.7 tt -57.96 172.44 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.128 1.771 . . . . 0.0 111.215 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.72 154.2 20.82 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.716 1.151 . . . . 0.0 110.945 169.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -51.57 -35.5 41.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.921 2.089 . . . . 0.0 114.374 -165.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -59.06 -28.4 66.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.624 1.102 . . . . 0.0 112.448 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.03 -31.72 27.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.68 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.6 mm -54.44 -50.13 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.72 -26.78 10.07 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 114.851 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.76 -51.61 11.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.915 0.78 . . . . 0.0 111.29 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -58.51 -35.43 72.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.046 1.339 . . . . 0.0 110.293 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -65.23 -7.77 14.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.029 0.932 . . . . 0.0 113.383 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.69 -25.43 33.01 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.906 1.685 . . . . 0.0 110.942 170.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 ptm -118.28 1.75 11.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.913 1.685 . . . . 0.0 112.648 -167.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.87 76.47 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 118.722 0.692 . . . . 0.0 111.548 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 t -79.74 121.43 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.48 146.51 36.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 p -138.72 93.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 109' ' ' LYS . 51.1 mt -72.04 124.39 28.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 126.11 1.764 . . . . 0.0 107.161 173.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 166.94 12.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.603 0.761 . . . . 0.0 110.676 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.25 18.54 73.3 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.003 -0.887 . . . . 0.0 113.31 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.36 170.36 12.03 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.906 1.353 . . . . 0.0 110.913 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.416 ' HA ' HG21 ' A' ' 17' ' ' ILE . 1.1 t -161.91 147.93 13.52 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.444 1.098 . . . . 0.0 108.055 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.08 -172.53 19.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.156 1.36 . . . . 0.0 112.587 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.5 p -79.86 163.19 24.57 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.441 -1.035 . . . . 0.0 109.26 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.29 -51.38 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.931 0.893 . . . . 0.0 110.049 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.75 -38.41 72.38 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 123.334 0.396 . . . . 0.0 111.268 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -77.54 -54.73 6.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.159 0.984 . . . . 0.0 108.625 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.544 ' CG1' HG21 ' A' ' 69' ' ' ILE . 16.4 t -54.52 -46.84 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.109 1.364 . . . . 0.0 110.785 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.65 -51.43 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -56.63 -42.54 79.03 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.69 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -55.86 -39.39 71.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.673 1.124 . . . . 0.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.19 -45.64 47.09 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.092 0.557 . . . . 0.0 112.23 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.6 mp -56.99 -35.07 68.77 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.3 m -86.29 1.73 49.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.356 1.462 . . . . 0.0 113.129 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.64 13.87 61.71 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.494 1.045 . . . . 0.0 114.02 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -74.93 -36.54 62.13 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.823 1.312 . . . . 0.0 110.186 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.21 161.98 23.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.119 0.968 . . . . 0.0 109.041 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 89' ' ' ILE . 1.2 tptt . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 124.755 1.222 . . . . 0.0 108.384 -172.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.464 HG12 HD23 ' A' ' 67' ' ' LEU . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.804 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 60' ' ' VAL . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 3' ' ' ILE . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 4' ' ' ALA . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.553 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.482 HG21 ' HB ' ' A' ' 73' ' ' ILE . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' HG21 ' A' ' 70' ' ' VAL . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.553 ' CG1' HG21 ' A' ' 69' ' ' ILE . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 29' ' ' PHE . 10.2 mt -139.45 141.01 36.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.01 104.33 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 127.561 2.344 . . . . 0.0 107.428 -163.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.953 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -79.73 140.37 36.98 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.7 mt -139.71 107.51 7.05 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 129.32 14.5 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.152 1.901 . . . . 0.0 108.129 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 15' ' ' SER . 13.7 m -134.37 152.06 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.169 0.588 . . . . 0.0 110.132 -170.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -74.32 -13.27 60.73 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.94 170.41 21.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.9 1.227 . . . . 0.0 109.381 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.5 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 37.2 p-10 -82.12 39.67 0.59 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.014 1.326 . . . . 0.0 112.809 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -81.46 41.01 0.6 Allowed 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.631 -1.293 . . . . 0.0 112.285 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.7 124.7 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.396 2.427 . . . . 0.0 114.791 -170.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 18.3 mtmt 80.32 -67.28 0.13 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.998 2.919 . . . . 0.0 109.984 -165.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -10.61 48.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.592 2.357 . . . . 0.0 112.954 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.415 ' HB3' HG11 ' A' ' 7' ' ' VAL . 5.0 m -35.91 99.08 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 130.46 3.504 . . . . 0.0 111.628 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.22 128.68 15.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tt -62.04 131.87 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 170.27 14.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.103 1.361 . . . . 0.0 108.409 170.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -89.92 -56.08 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -99.6 135.41 41.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -67.9 -41.32 82.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.16 -5.24 53.03 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.119 -1.934 . . . . 0.0 115.444 -164.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -144.12 38.73 1.31 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.593 1.697 . . . . 0.0 109.181 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.27 132.67 75.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.29 -19.01 17.65 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.743 1.628 . . . . 0.0 113.502 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.5 ' CE2' ' HB3' ' A' ' 10' ' ' ASN . 96.7 m-85 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.935 1.294 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.17 107.75 10.29 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.684 1.194 . . . . 0.0 108.515 170.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.96 91.63 5.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.921 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.4 m-85 -77.98 95.91 4.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 160.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -79.84 164.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -112.42 -170.43 1.66 Allowed 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.851 -1.156 . . . . 0.0 110.017 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -141.56 151.53 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 156.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -111.74 106.32 15.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 160.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 t30 57.76 -62.63 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.376 2.27 . . . . 0.0 115.754 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.0 12.01 1.6 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.199 1.4 . . . . 0.0 112.791 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.23 -157.58 0.62 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.738 1.615 . . . . 0.0 112.802 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.11 -30.78 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.607 1.163 . . . . 0.0 111.316 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . . . 53.36 -71.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 113.828 -161.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.04 165.98 32.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.281 1.432 . . . . 0.0 110.42 -160.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.77 147.1 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.5 1.12 . . . . 0.0 110.071 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -129.71 117.7 20.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.009 2.523 . . . . 0.0 105.977 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.97 70.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -79.71 146.2 32.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -62.3 143.31 57.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.963 0.905 . . . . 0.0 109.513 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -81.06 121.04 80.25 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.71 -37.76 34.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.342 2.028 . . . . 0.0 112.666 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.53 ' HB2' HG23 ' A' ' 56' ' ' VAL . 8.6 mt -126.87 39.38 3.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.217 0.917 . . . . 0.0 110.08 -168.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.123 0 CA-C-N 119.01 0.823 . . . . 0.0 110.718 -173.019 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 117.21 -1.376 . . . . 0.0 114.376 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 47' ' ' LEU . 1.8 t -48.53 -52.35 44.66 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.397 1.453 . . . . 0.0 108.587 167.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.2 -30.27 25.14 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.056 1.17 . . . . 0.0 112.962 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -69.33 -22.49 63.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.086 -0.384 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.05 -64.4 0.87 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.078 -0.963 . . . . 0.0 108.973 164.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -60.94 -26.15 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 121.095 1.771 . . . . 0.0 114.472 -170.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -59.75 -26.57 65.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.189 1.359 . . . . 0.0 113.449 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -21.57 60.21 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.457 1.026 . . . . 0.0 110.324 172.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -84.56 38.19 0.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.252 0.933 . . . . 0.0 110.302 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 28.77 42.33 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 129.901 3.619 . . . . 0.0 115.042 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 172.48 8.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.394 1.097 . . . . 0.0 112.405 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HA ' HG22 ' A' ' 86' ' ' VAL . 18.3 mt-10 -139.0 -27.51 0.82 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.246 -166.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -141.57 154.47 45.46 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.69 0.796 . . . . 0.0 110.827 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.953 HG13 ' HB3' ' A' ' 4' ' ' ALA . 3.3 t -150.17 103.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 120.994 -1.066 . . . . 0.0 110.129 -172.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.526 HG21 ' CG1' ' A' ' 99' ' ' VAL . 89.6 mt -91.49 100.9 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 119.735 -1.853 . . . . 0.0 107.457 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.524 HG13 HG12 ' A' ' 68' ' ' VAL . 32.7 m -122.08 171.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.747 1.158 . . . . 0.0 111.948 -170.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -114.36 -100.06 0.43 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.49 54.42 4.95 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.806 1.67 . . . . 0.0 113.091 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.3 tt -58.02 -170.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 125.772 1.629 . . . . 0.0 111.603 165.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.87 164.81 31.91 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 119.051 -2.281 . . . . 0.0 109.38 171.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -53.28 -46.65 69.37 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.107 0.954 . . . . 0.0 113.554 -168.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -51.42 -21.61 2.45 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.31 -39.79 9.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.739 0.816 . . . . 0.0 110.584 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.7 mm -48.35 -47.6 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 166.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.56 -21.03 36.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.667 1.587 . . . . 0.0 114.672 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.16 -57.44 4.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.223 0.92 . . . . 0.0 108.925 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.516 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 15.4 m-85 -60.71 -38.86 86.47 Favored 'General case' 0 N--CA 1.424 -1.767 0 C-N-CA 124.936 1.294 . . . . 0.0 109.403 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.79 -14.14 30.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.683 -1.151 . . . . 0.0 113.962 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.65 64.64 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 121.421 1.919 . . . . 0.0 111.929 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.64 18.6 5.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.108 1.363 . . . . 0.0 112.998 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.14 25.78 60.38 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.81 -1.181 . . . . 0.0 113.001 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 66' ' ' GLU . 6.8 t -78.56 112.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 -170.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -65.95 148.88 51.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.23 -169.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.405 ' O ' ' HE2' ' A' ' 90' ' ' LYS . 3.7 p -144.36 98.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 109' ' ' LYS . 72.0 mt -72.75 134.48 29.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.77 2.028 . . . . 0.0 107.101 166.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HE2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -110.58 174.97 5.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.077 0.551 . . . . 0.0 110.34 169.201 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.52 -2.98 65.43 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.689 -1.617 . . . . 0.0 115.547 168.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.61 -174.48 0.72 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.025 1.912 . . . . 0.0 112.575 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 p -170.49 153.04 4.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.964 2.106 . . . . 0.0 106.455 165.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.65 -168.96 22.57 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.814 0.721 . . . . 0.0 111.878 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -82.74 169.29 16.33 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.54 -0.976 . . . . 0.0 110.393 166.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.18 -53.99 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 123.56 0.744 . . . . 0.0 109.817 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.01 -17.09 36.12 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -99.28 -52.06 3.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.275 1.43 . . . . 0.0 108.678 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 69' ' ' ILE . 25.7 t -55.33 -40.04 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.631 1.572 . . . . 0.0 111.714 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.37 -59.4 2.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -60.95 -41.09 95.62 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.517 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.27 -37.15 66.92 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.314 1.416 . . . . 0.0 110.584 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 21.2 t80 -77.12 -50.04 13.92 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.253 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.74 -25.64 65.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.816 0.697 . . . . 0.0 111.044 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -27.93 40.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.814 -0.613 . . . . 0.0 111.749 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.96 3.31 19.89 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.644 1.116 . . . . 0.0 113.693 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -42.67 65.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.171 1.486 . . . . 0.0 110.445 -173.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -66.47 147.93 52.6 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 122.957 0.503 . . . . 0.0 110.245 -172.33 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.671 ' O ' HG23 ' A' ' 89' ' ' ILE . 6.7 tptt . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 124.366 1.066 . . . . 0.0 110.671 -172.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mt -138.59 150.33 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.039 2.136 . . . . 0.0 105.971 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.41 HG23 HD23 ' A' ' 67' ' ' LEU . 3.7 mt -132.39 105.3 8.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 128.745 2.818 . . . . 0.0 108.112 -163.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.963 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -80.1 145.84 32.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 118.525 0.602 . . . . 0.0 110.401 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 53.4 mt -143.41 111.36 5.44 Favored Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.77 123.1 10.06 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 N-CA-C 106.715 -2.071 . . . . 0.0 106.715 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.86 158.85 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.784 0.72 . . . . 0.0 109.514 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.4 m -74.45 -34.9 63.3 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -146.52 154.06 41.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -80.21 115.32 19.7 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -138.34 39.64 2.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.399 0.545 . . . . 0.0 110.214 170.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.87 73.96 0.1 OUTLIER Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.326 -1.263 . . . . 0.0 115.058 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt 77.86 -28.35 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 130.6 3.56 . . . . 0.0 113.46 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.81 -8.3 53.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.502 0.721 . . . . 0.0 109.304 167.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -42.1 108.36 0.6 Allowed Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 130.224 3.41 . . . . 0.0 110.124 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.71 135.47 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.47 2.114 . . . . 0.0 109.102 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -58.53 146.38 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 118.854 0.752 . . . . 0.0 109.535 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 t -81.57 171.28 14.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 122.636 1.208 . . . . 0.0 109.159 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.62 -39.25 37.71 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.846 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -131.82 -174.03 3.3 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.792 -1.193 . . . . 0.0 108.6 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -119.83 -41.87 2.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.482 0.713 . . . . 0.0 110.208 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.39 64.79 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.936 -0.925 . . . . 0.0 113.739 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.43 72.68 1.44 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.26 1.824 . . . . 0.0 107.196 168.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.43 138.52 19.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 165.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.73 -20.97 8.82 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.641 2.894 . . . . 0.0 113.313 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -151.94 138.43 18.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.166 1.786 . . . . 0.0 107.038 -165.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.86 98.95 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.357 1.863 . . . . 0.0 107.953 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.41 78.0 5.94 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.204 1.402 . . . . 0.0 108.841 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.927 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -71.34 94.66 1.24 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.737 1.215 . . . . 0.0 109.285 174.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.98 167.88 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.528 1.531 . . . . 0.0 109.404 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -122.88 -171.53 2.31 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.694 -1.253 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.72 136.74 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 166.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.28 126.71 18.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 127.413 2.285 . . . . 0.0 105.759 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 52.75 42.38 31.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.145 0.978 . . . . 0.0 111.324 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.09 9.23 5.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.63 1.972 . . . . 0.0 113.729 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.05 167.89 10.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.659 1.184 . . . . 0.0 109.072 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.99 -26.21 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 113.673 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.514 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 57.78 -54.52 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.393 2.277 . . . . 0.0 115.937 -167.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -170.6 158.05 6.07 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.309 1.444 . . . . 0.0 108.787 -157.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.7 mt -138.82 137.87 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 125.303 1.441 . . . . 0.0 107.972 171.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 m -111.07 144.42 40.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.434 2.294 . . . . 0.0 105.855 160.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 16.0 t -140.74 68.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 167.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -80.18 136.65 36.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.14 150.04 49.69 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -88.85 107.74 19.28 Favored Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.199 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.17 -8.51 22.11 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.163 1.909 . . . . 0.0 112.083 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -128.41 37.75 4.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.11 0.964 . . . . 0.0 109.769 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.416 0 C-N-CA 126.146 1.778 . . . . 0.0 111.793 177.054 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -36.53 -51.19 1.9 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.162 2.185 . . . . 0.0 112.193 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.14 -24.64 12.41 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.257 1.485 . . . . 0.0 112.519 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -68.68 -38.36 80.3 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 119.874 1.215 . . . . 0.0 109.551 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.71 -65.62 0.54 Allowed 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.896 0.747 . . . . 0.0 109.557 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 m -59.91 -37.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 117.134 -1.412 . . . . 0.0 112.192 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -58.74 -17.56 24.06 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.02 2.191 . . . . 0.0 114.322 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -26.04 49.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.5 -1.375 . . . . 0.0 110.303 167.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -84.71 37.9 0.67 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.153 1.381 . . . . 0.0 111.164 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.06 26.63 1.32 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 128.287 2.851 . . . . 0.0 118.112 165.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -70.87 171.17 11.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.904 1.852 . . . . 0.0 115.21 -171.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -144.88 -27.24 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.042 1.737 . . . . 0.0 112.019 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.41 HD23 HG23 ' A' ' 3' ' ' ILE . 7.6 tp -132.18 156.21 46.84 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.378 1.471 . . . . 0.0 108.745 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.963 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -142.8 146.6 21.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.534 HG21 ' CG1' ' A' ' 99' ' ' VAL . 72.0 mt -130.6 113.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 173.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 68' ' ' VAL . 35.5 m -129.08 177.02 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.445 1.098 . . . . 0.0 109.542 -175.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.9 ttt-85 -112.55 -90.83 0.5 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.9 64.68 0.26 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.139 1.828 . . . . 0.0 112.37 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.48 176.62 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 125.639 1.576 . . . . 0.0 111.747 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.89 159.67 23.06 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.09 1.805 . . . . 0.0 111.141 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -60.01 -34.77 73.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -164.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -56.08 -40.76 74.11 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.267 1.394 . . . . 0.0 110.826 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.945 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.0 mm -61.47 -48.56 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 167.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.14 -20.49 58.67 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.71 -57.78 7.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.049 -1.032 . . . . 0.0 111.518 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -62.39 -37.86 87.41 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 126.438 1.895 . . . . 0.0 109.399 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.46 -30.0 59.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.53 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.29 -8.46 55.95 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.473 1.033 . . . . 0.0 112.297 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -134.97 12.82 3.62 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.175 1.79 . . . . 0.0 111.783 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.46 33.99 33.66 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 121.382 -0.824 . . . . 0.0 112.408 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.49 117.7 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 146.39 52.89 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.102 -0.998 . . . . 0.0 108.372 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.423 ' O ' ' HE2' ' A' ' 90' ' ' LYS . 2.5 p -133.69 110.17 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.467 0.651 . . . . 0.0 110.919 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mt -81.18 140.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.324 1.85 . . . . 0.0 106.135 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 88' ' ' VAL . 23.4 mtmt -124.48 174.07 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.727 1.211 . . . . 0.0 109.965 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.24 10.64 74.53 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.485 171.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 172.28 5.15 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.538 1.669 . . . . 0.0 111.345 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.0 p -159.38 153.91 24.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.054 1.742 . . . . 0.0 107.895 161.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.49 -166.52 25.8 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.759 0.709 . . . . 0.0 113.404 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 p -83.57 171.97 12.81 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.227 -1.16 . . . . 0.0 109.297 162.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.25 -55.1 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.341 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.18 -33.36 72.1 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.956 -173.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -71.57 -50.88 26.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.84 0.856 . . . . 0.0 110.388 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.534 ' CG1' HG21 ' A' ' 69' ' ' ILE . 38.0 t -58.99 -42.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.262 1.025 . . . . 0.0 110.218 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.62 -54.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -56.71 -42.04 78.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.004 0.82 . . . . 0.0 112.357 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -61.03 -32.85 72.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.266 0.939 . . . . 0.0 111.792 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -79.87 -42.13 24.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.414 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.53 -28.89 67.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.377 0.99 . . . . 0.0 110.754 173.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.2 m -74.12 -13.16 60.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.216 1.406 . . . . 0.0 112.896 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.8 12.77 65.19 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.946 1.26 . . . . 0.0 113.2 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -68.68 -50.84 47.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.131 1.466 . . . . 0.0 107.817 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.61 135.98 55.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.089 1.356 . . . . 0.0 110.109 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.259 0 C-N-CA 125.32 1.448 . . . . 0.0 109.373 171.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.447 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.146 0.022 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 mt -113.49 148.55 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 162.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.45 104.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 128.715 2.806 . . . . 0.0 105.604 -165.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.91 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.43 140.18 36.1 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.3 mt -131.94 118.59 16.53 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 167.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.9 121.22 8.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 107.099 -1.923 . . . . 0.0 107.099 168.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 m -116.13 147.6 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 119.013 0.824 . . . . 0.0 109.999 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -70.02 -30.93 68.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.993 -1.004 . . . . 0.0 111.429 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -146.4 156.33 43.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.429 1.892 . . . . 0.0 106.194 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -90.46 106.86 18.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -132.72 39.15 3.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.88 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.6 -76.12 0.01 OUTLIER Glycine 0 N--CA 1.469 0.864 0 C-N-CA 126.712 2.101 . . . . 0.0 115.849 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -110.33 -50.96 2.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.012 1.725 . . . . 0.0 107.069 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.88 -6.41 1.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 129.32 3.048 . . . . 0.0 113.77 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 m -47.95 109.7 1.2 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 129.864 3.266 . . . . 0.0 111.745 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.04 137.21 21.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.102 1.868 . . . . 0.0 110.317 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.14 137.26 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.643 1.211 . . . . 0.0 111.422 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -74.54 170.16 16.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.429 1.892 . . . . 0.0 109.614 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -109.87 -24.66 10.72 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.83 -1.169 . . . . 0.0 113.059 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -121.43 89.25 3.09 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.259 1.024 . . . . 0.0 109.897 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -39.86 -49.64 2.4 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.3 1.44 . . . . 0.0 113.23 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -15.07 48.38 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.22 52.48 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 173.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.93 153.36 69.74 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 161.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.62 -22.53 0.9 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.782 2.988 . . . . 0.0 113.955 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.11 160.93 39.25 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.793 1.237 . . . . 0.0 107.981 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -127.5 110.53 12.83 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.19 86.93 5.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.91 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -76.63 100.06 5.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.558 HG22 HD13 ' A' ' 40' ' ' ILE . 10.4 t -88.52 141.97 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 125.328 1.451 . . . . 0.0 107.847 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -93.18 -172.48 2.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.801 0.728 . . . . 0.0 109.277 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.2 t -145.42 134.31 17.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 34' ' ' ASN . 6.8 ttpt -133.0 118.52 18.92 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 126.061 1.744 . . . . 0.0 106.713 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.419 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 80.6 m-20 40.45 56.93 2.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.218 1.407 . . . . 0.0 112.62 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 39.93 62.81 1.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 112.985 -167.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.75 171.0 15.4 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.617 1.967 . . . . 0.0 107.968 159.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.63 -20.61 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.62 1.568 . . . . 0.0 112.985 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . . . 53.37 -59.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.737 2.415 . . . . 0.0 115.912 -165.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -170.88 164.29 7.76 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.718 2.407 . . . . 0.0 108.8 -164.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.558 HD13 HG22 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -136.02 129.05 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -173.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 m -124.35 89.03 3.0 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 127.177 2.191 . . . . 0.0 108.298 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 3.7 t -92.17 81.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.6 147.33 32.12 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.42 149.61 33.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.05 0.453 . . . . 0.0 110.115 162.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -95.51 107.98 36.65 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 117.802 -1.094 . . . . 0.0 108.61 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.27 -6.96 17.55 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.164 1.909 . . . . 0.0 113.372 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.46 38.18 4.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.157 1.783 . . . . 0.0 109.479 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.395 0 O-C-N 120.605 -1.309 . . . . 0.0 111.675 175.623 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -50.06 -48.28 79.38 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 120.48 1.491 . . . . 0.0 110.051 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HA ' HG22 ' A' ' 60' ' ' VAL . 58.2 Cg_endo -76.62 -29.61 5.63 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.847 1.698 . . . . 0.0 111.652 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.37 -40.59 71.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.325 0.966 . . . . 0.0 109.516 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.88 -71.74 0.09 Allowed 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.219 1.007 . . . . 0.0 110.516 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 57' ' ' PRO . 5.9 m -60.31 -14.47 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 O-C-N 119.542 -1.974 . . . . 0.0 114.549 -172.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -80.26 -18.26 49.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.878 1.671 . . . . 0.0 112.867 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.07 -27.82 61.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.775 1.17 . . . . 0.0 111.037 164.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -87.65 37.65 0.8 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.535 -0.728 . . . . 0.0 110.672 -162.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.03 27.09 4.87 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.717 2.103 . . . . 0.0 115.157 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.76 166.89 22.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.627 1.214 . . . . 0.0 112.89 -167.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 7.4 mt-10 -141.85 -28.37 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.906 0.882 . . . . 0.0 111.69 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -134.71 160.94 36.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.629 1.172 . . . . 0.0 109.444 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -140.24 148.84 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.606 1.562 . . . . 0.0 106.902 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.535 HG21 ' CG1' ' A' ' 99' ' ' VAL . 46.2 mt -132.41 113.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 68' ' ' VAL . 14.2 m -135.08 -175.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.343 1.057 . . . . 0.0 110.264 -170.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -118.01 -100.35 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.37 -24.17 59.49 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.565 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.302 2.4 tt 44.2 -97.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.577 2.351 . . . . 0.0 113.696 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.13 124.01 2.22 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 127.449 2.452 . . . . 0.0 109.93 -174.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.35 -40.73 17.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.726 1.61 . . . . 0.0 112.472 -169.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -58.05 -34.64 70.31 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.506 1.503 . . . . 0.0 112.69 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.79 -22.52 46.21 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.453 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.6 mm -54.72 -46.79 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.93 -11.76 14.8 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.56 -1.337 . . . . 0.0 114.311 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -57.09 4.76 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 121.26 1.846 . . . . 0.0 111.163 167.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -53.56 1.68 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.655 1.582 . . . . 0.0 110.659 167.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.47 -13.88 62.43 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.528 1.142 . . . . 0.0 111.49 -170.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.71 -22.45 40.3 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 119.212 0.915 . . . . 0.0 110.517 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.48 10.69 7.93 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.144 0.429 . . . . 0.0 111.856 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.66 23.62 58.78 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.399 0.999 . . . . 0.0 112.99 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.85 94.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.71 1.204 . . . . 0.0 110.909 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 127.99 34.55 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.567 . . . . 0.0 110.55 -166.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.63 103.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 122.57 1.176 . . . . 0.0 108.321 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.5 mt -85.67 134.38 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -118.56 179.42 4.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.83 0.452 . . . . 0.0 111.568 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.28 20.33 76.62 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.682 0.614 . . . . 0.0 112.106 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.93 175.04 6.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.224 1.012 . . . . 0.0 109.522 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.8 p -166.96 156.51 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.57 1.548 . . . . 0.0 107.323 166.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.57 -169.67 12.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -80.48 168.83 18.48 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.598 -0.942 . . . . 0.0 109.88 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.85 -49.96 76.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 O-C-N 121.752 -0.592 . . . . 0.0 109.592 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.1 -30.74 62.49 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -75.76 -64.44 1.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 69' ' ' ILE . 25.3 t -55.31 -44.24 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.746 1.618 . . . . 0.0 111.119 -171.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.1 t -59.15 -49.74 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.65 -33.67 76.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.565 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -60.76 -46.33 90.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.21 1.368 . . . . 0.0 110.426 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -59.14 -52.17 66.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.586 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -32.15 66.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.543 0.611 . . . . 0.0 110.856 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 m -76.98 -2.43 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.385 0.674 . . . . 0.0 111.882 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.8 8.92 87.21 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.911 -1.118 . . . . 0.0 112.718 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -75.33 -44.76 43.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.104 1.452 . . . . 0.0 110.405 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.53 151.81 37.88 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.852 1.261 . . . . 0.0 110.031 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 tptt . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 123.943 0.897 . . . . 0.0 111.949 -178.122 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 CA--C 1.507 -0.704 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 29' ' ' PHE . 1.3 mt -142.42 142.98 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.8 104.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 0.0 106.867 -170.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.938 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -81.39 140.27 34.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.307 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.18 113.14 9.56 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.54 108.09 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.493 2.129 . . . . 0.0 108.009 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -100.57 158.22 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.309 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.9 m -81.49 -25.62 35.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.503 -0.761 . . . . 0.0 111.524 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -152.29 157.83 41.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.567 1.076 . . . . 0.0 109.675 -174.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -95.23 84.25 4.03 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.841 1.257 . . . . 0.0 108.578 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -107.81 38.62 2.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 116.803 -1.57 . . . . 0.0 110.383 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 32.43 79.56 0.02 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 125.299 1.428 . . . . 0.0 112.958 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 78.08 -36.12 0.21 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 128.633 2.773 . . . . 0.0 113.249 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.35 -7.87 35.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.756 0.707 . . . . 0.0 110.549 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -39.55 106.6 0.4 Allowed Pre-proline 0 N--CA 1.448 -0.557 1 C-N-CA 131.845 4.058 . . . . 0.0 111.051 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.77 133.78 15.85 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.99 2.46 . . . . 0.0 110.778 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -64.44 127.16 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.493 0.663 . . . . 0.0 110.174 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -63.19 168.45 4.24 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.423 1.089 . . . . 0.0 109.321 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.78 -15.37 34.83 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.198 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -131.02 -177.72 4.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -120.36 -55.78 2.02 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.648 1.179 . . . . 0.0 108.531 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.02 -6.21 12.0 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 117.424 -1.764 . . . . 0.0 116.324 -166.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.8 39.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.799 2.3 . . . . 0.0 109.869 163.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 144.96 97.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.3 -18.47 20.6 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.203 1.936 . . . . 0.0 114.23 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.15 160.63 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.146 1.378 . . . . 0.0 109.811 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -133.56 104.75 6.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.945 1.698 . . . . 0.0 108.473 170.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.77 93.3 6.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.938 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.3 m-85 -81.98 101.34 10.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 167.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.2 160.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -111.14 -166.9 1.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.393 0.997 . . . . 0.0 108.518 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -157.07 144.44 10.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 164.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.0 124.22 23.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 128.401 2.68 . . . . 0.0 105.19 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 36.73 61.53 0.85 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.786 2.034 . . . . 0.0 111.729 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 64.95 11.16 6.82 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 128.458 2.703 . . . . 0.0 115.335 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.14 164.7 18.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 120.165 1.348 . . . . 0.0 109.639 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.36 -28.0 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 113.792 -162.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.45 -56.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.912 2.485 . . . . 0.0 114.398 -165.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -162.6 155.19 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.454 1.502 . . . . 0.0 110.34 -165.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mm -128.09 117.02 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.038 2.535 . . . . 0.0 106.088 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -109.7 98.39 7.75 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 165.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.54 86.81 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -93.55 153.71 18.28 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -64.91 167.44 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 109.329 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.22 109.97 29.65 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 158.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.13 -7.29 19.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.632 1.554 . . . . 0.0 112.946 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.38 39.39 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.722 1.209 . . . . 0.0 109.985 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.434 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -172.623 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.216 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -48.61 -50.9 56.73 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.439 1.018 . . . . 0.0 110.441 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -75.98 -19.96 15.4 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.347 1.365 . . . . 0.0 112.844 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -66.98 -40.59 87.44 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 119.421 1.01 . . . . 0.0 109.254 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -53.1 -64.4 0.83 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.039 0.936 . . . . 0.0 110.265 168.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.7 m -63.21 -29.22 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 119.952 1.251 . . . . 0.0 113.447 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -64.12 -23.28 67.26 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.76 -1.212 . . . . 0.0 112.791 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -24.71 61.23 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 121.245 1.839 . . . . 0.0 110.798 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.71 38.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.853 1.261 . . . . 0.0 111.102 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 38.63 37.09 0.51 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.735 2.588 . . . . 0.0 116.799 165.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -81.6 175.29 10.62 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.04 -31.56 0.54 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.792 1.637 . . . . 0.0 112.922 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 68' ' ' VAL . 64.8 tp -134.46 159.83 39.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.305 1.05 . . . . 0.0 109.552 175.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.87 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -141.9 130.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.501 HG21 HG13 ' A' ' 99' ' ' VAL . 76.4 mt -114.45 112.42 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.439 HG13 HG12 ' A' ' 68' ' ' VAL . 17.9 m -128.92 170.34 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.556 1.542 . . . . 0.0 109.277 -172.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -99.64 -93.64 0.26 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.32 -19.98 53.53 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.51 -1.161 . . . . 0.0 114.661 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 74' ' ' GLY 0.336 2.7 tt 29.55 -129.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 127.724 2.41 . . . . 0.0 112.978 -172.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.413 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -167.22 -162.99 20.27 Favored Glycine 0 CA--C 1.541 1.698 1 C-N-CA 131.227 4.251 . . . . 0.0 106.822 176.098 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -37.69 9.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 121.145 2.472 . . . . 0.0 111.106 165.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -60.84 -20.79 62.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.98 -4.49 17.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.383 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -56.18 -41.26 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 157.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.26 -18.27 15.62 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.64 7.09 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 120.811 -1.181 . . . . 0.0 108.826 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.02 -40.22 95.84 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 125.789 1.636 . . . . 0.0 109.054 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -56.49 -27.6 57.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.72 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.16 -11.95 61.24 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.186 1.357 . . . . 0.0 111.738 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.5 ptp -130.81 6.38 4.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.867 1.667 . . . . 0.0 111.851 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.56 37.15 66.28 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 120.653 -1.279 . . . . 0.0 110.906 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 121.01 34.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -59.08 147.87 33.23 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.878 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.57 126.21 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.03 119.87 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -113.4 158.78 20.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.935 1.294 . . . . 0.0 108.794 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 11.33 74.25 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.538 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.71 174.37 1.05 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.362 1.581 . . . . 0.0 113.322 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -161.74 148.61 14.2 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.663 -1.273 . . . . 0.0 109.768 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.06 -163.77 12.17 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 124.011 0.819 . . . . 0.0 112.618 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.9 p -81.1 174.73 11.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.936 0.894 . . . . 0.0 109.81 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.47 -54.92 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 O-C-N 121.028 -1.045 . . . . 0.0 109.756 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.78 -37.98 69.28 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.94 -49.87 40.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.508 0.723 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.501 HG13 HG21 ' A' ' 69' ' ' ILE . 39.9 t -57.54 -40.51 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.631 1.172 . . . . 0.0 110.513 176.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.21 -51.84 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -62.0 -44.88 95.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.028 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -52.91 -39.24 62.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.305 0.957 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -76.01 -43.2 45.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mp -62.31 -28.49 69.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.687 0.795 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.5 m -80.61 -37.44 31.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.38 1.072 . . . . 0.0 109.833 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.13 10.42 22.38 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.158 0.885 . . . . 0.0 112.986 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -61.72 -44.03 97.71 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.182 0.991 . . . . 0.0 108.664 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 137.74 57.19 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.123 1.369 . . . . 0.0 110.626 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tptm . . . . . 0 CA--C 1.518 -0.281 0 C-N-CA 124.635 1.174 . . . . 0.0 112.67 -170.081 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttm . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.152 0.025 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.7 142.8 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.75 107.41 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 129.779 3.232 . . . . 0.0 107.42 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.935 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -83.61 150.19 26.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.158 0.435 . . . . 0.0 111.367 175.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -142.77 120.01 7.02 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.19 123.17 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 108.75 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 15' ' ' SER . 10.0 m -118.54 156.89 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.158 0.583 . . . . 0.0 110.31 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -81.73 -21.49 37.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.524 -0.75 . . . . 0.0 112.123 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -142.77 161.36 38.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.621 1.1 . . . . 0.0 109.534 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -91.96 98.63 11.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -139.98 39.19 1.97 Allowed 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.77 -0.581 . . . . 0.0 110.473 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.408 ' HA2' HG11 ' A' ' 42' ' ' VAL . . . 52.02 -140.77 26.35 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-N 119.074 0.852 . . . . 0.0 112.347 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -56.61 -16.75 6.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.93 -2.7 55.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.535 1.534 . . . . 0.0 110.755 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.524 ' CB ' HG11 ' A' ' 7' ' ' VAL . 46.4 m -50.57 122.49 16.1 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.984 1.714 . . . . 0.0 110.991 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.91 130.99 15.09 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 123.021 2.481 . . . . 0.0 109.703 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.3 140.11 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.52 175.48 9.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.098 0.951 . . . . 0.0 108.906 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.72 -21.65 21.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 118.356 -0.83 . . . . 0.0 111.126 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -130.93 -175.14 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.118 2.167 . . . . 0.0 108.277 -173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.31 -48.13 2.33 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.527 1.131 . . . . 0.0 109.77 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -19.71 59.28 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -165.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.7 38.55 3.05 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.629 1.214 . . . . 0.0 110.57 168.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.49 129.2 89.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.62 -21.69 45.33 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.308 2.005 . . . . 0.0 114.888 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -145.33 164.37 31.66 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 119.359 0.981 . . . . 0.0 109.191 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -134.17 103.98 6.0 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.168 1.387 . . . . 0.0 108.608 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.75 91.15 5.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.935 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.5 m-85 -82.95 94.61 7.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.2 155.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -98.16 -172.2 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.819 -1.175 . . . . 0.0 110.475 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 t -138.79 157.18 29.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 153.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 21.1 ttpt -154.12 142.09 20.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.45 2.3 . . . . 0.0 104.969 162.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 47.62 47.8 17.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.727 1.149 . . . . 0.0 111.128 170.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.18 41.19 1.98 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.556 1.542 . . . . 0.0 115.029 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.6 169.09 18.4 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.283 0.633 . . . . 0.0 109.534 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.98 -31.38 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 113.484 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.441 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 53.69 -62.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.045 2.138 . . . . 0.0 114.789 -161.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.93 167.16 30.67 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.985 1.314 . . . . 0.0 111.525 -162.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.28 147.86 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.454 2.301 . . . . 0.0 107.86 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -145.21 97.51 3.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.408 HG11 ' HA2' ' A' ' 12' ' ' GLY . 4.0 p -105.09 65.89 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -89.1 150.26 22.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -170.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.78 148.67 49.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -80.1 122.28 82.85 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.297 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.98 -13.28 39.35 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.768 2.312 . . . . 0.0 114.789 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -134.05 39.91 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.499 1.52 . . . . 0.0 108.531 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 O-C-N 120.432 -1.417 . . . . 0.0 110.98 -179.757 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.51 -52.86 16.17 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.843 0.747 . . . . 0.0 109.989 172.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 60' ' ' VAL . 7.3 Cg_endo -75.67 -27.51 8.91 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.478 1.206 . . . . 0.0 113.199 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -55.82 -45.37 78.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.77 -66.48 0.49 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.185 0.994 . . . . 0.0 110.962 170.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.18 -21.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.871 1.668 . . . . 0.0 113.296 -171.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.39 -23.86 62.85 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.814 1.246 . . . . 0.0 112.187 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -79.81 -18.64 50.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.642 1.11 . . . . 0.0 112.079 168.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -85.88 39.32 0.8 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.459 1.104 . . . . 0.0 111.084 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.9 16.85 41.14 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 160.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.53 165.67 24.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.909 1.354 . . . . 0.0 114.552 -161.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.94 -34.16 1.01 Allowed 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.942 1.297 . . . . 0.0 111.189 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.5 tm? -137.34 154.19 50.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -171.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 4' ' ' ALA . 3.3 t -149.14 141.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.461 HG21 HG13 ' A' ' 99' ' ' VAL . 67.2 mt -132.91 111.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.15 -178.39 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.453 0.644 . . . . 0.0 110.592 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -114.0 -100.45 0.43 Allowed 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.3 61.96 1.25 Allowed Glycine 0 C--N 1.329 0.171 0 C-N-CA 125.688 1.613 . . . . 0.0 111.441 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.0 tt -59.96 172.46 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 125.462 1.505 . . . . 0.0 110.988 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 152.53 17.92 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -42.3 52.8 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 124.952 1.301 . . . . 0.0 112.418 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -56.95 -22.69 39.87 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.61 -31.71 13.15 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.311 1.045 . . . . 0.0 111.909 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.7 -45.77 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.1 -11.13 5.29 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.19 -57.14 3.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.551 1.069 . . . . 0.0 109.632 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -58.41 -39.15 78.95 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.008 1.723 . . . . 0.0 109.148 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -55.43 -29.26 58.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.526 1.131 . . . . 0.0 112.842 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.61 -6.53 55.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.696 1.135 . . . . 0.0 111.081 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -130.99 -0.78 4.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.13 1.372 . . . . 0.0 112.059 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.91 38.94 93.39 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.996 -1.065 . . . . 0.0 110.501 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.44 127.79 38.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 167.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -78.08 142.0 38.42 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 p -131.1 101.56 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 67' ' ' LEU . 56.3 mt -74.36 149.27 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 125.829 1.652 . . . . 0.0 107.399 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.41 176.17 7.93 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.62 19.21 77.74 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.34 -0.7 . . . . 0.0 113.295 165.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 179.78 6.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.279 1.04 . . . . 0.0 110.329 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 p -164.8 154.54 13.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.313 2.245 . . . . 0.0 107.091 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.86 -168.02 13.22 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 123.55 0.531 . . . . 0.0 112.885 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.7 p -79.68 173.38 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.775 -0.838 . . . . 0.0 109.966 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.58 -57.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.003 0.921 . . . . 0.0 108.955 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.08 -32.36 72.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.418 -173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.93 -54.23 20.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.21 1.404 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.461 HG13 HG21 ' A' ' 69' ' ' ILE . 50.4 t -57.33 -30.05 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.695 1.198 . . . . 0.0 111.139 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.8 -53.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -54.29 -44.59 72.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.617 0.767 . . . . 0.0 109.963 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -53.81 -38.8 64.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.544 0.738 . . . . 0.0 111.073 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.36 -39.44 32.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.927 0.891 . . . . 0.0 112.503 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.25 -26.29 68.3 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.402 1.456 . . . . 0.0 111.275 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -1.86 57.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.514 1.126 . . . . 0.0 111.802 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.64 69.25 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.328 -1.483 . . . . 0.0 113.226 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -78.13 -27.48 48.27 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.804 1.302 . . . . 0.0 110.538 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.55 152.88 22.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.099 0.96 . . . . 0.0 110.667 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 C-N-CA 124.413 1.085 . . . . 0.0 110.514 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 tpp . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 mt -139.05 142.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 mt -132.96 104.39 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 127.217 2.207 . . . . 0.0 105.9 -161.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.01 142.3 35.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.808 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.3 115.14 11.7 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.1 116.73 4.64 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.368 2.045 . . . . 0.0 106.878 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 26' ' ' TYR . 10.7 m -114.28 152.2 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 118.258 0.481 . . . . 0.0 109.843 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -77.34 -26.38 52.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.871 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -145.08 150.96 37.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.262 0.937 . . . . 0.0 109.516 -172.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 48.4 t-20 -85.78 64.75 8.79 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.239 1.816 . . . . 0.0 108.779 -168.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -111.2 39.24 2.33 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.495 -0.753 . . . . 0.0 109.319 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 42' ' ' VAL . . . 37.88 -108.05 0.07 OUTLIER Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.462 1.982 . . . . 0.0 112.953 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -20.53 46.51 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.69 -6.85 58.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.934 2.494 . . . . 0.0 110.674 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.0 m -51.7 119.93 14.63 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.622 1.969 . . . . 0.0 112.28 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.39 135.28 20.1 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.864 2.376 . . . . 0.0 110.893 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.02 139.55 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.951 0.5 . . . . 0.0 109.771 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.38 177.05 6.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.747 1.219 . . . . 0.0 110.032 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -96.06 -42.12 8.4 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.71 -0.619 . . . . 0.0 111.634 -171.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -100.18 178.49 4.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -120.43 -47.36 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.564 1.146 . . . . 0.0 109.672 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -12.03 34.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.69 1.138 . . . . 0.0 114.127 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.04 38.93 3.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.078 1.439 . . . . 0.0 110.848 168.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.71 130.18 82.02 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.3 -23.58 20.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.361 2.041 . . . . 0.0 113.338 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.517 ' HB2' HG23 ' A' ' 7' ' ' VAL . 69.3 m-85 -145.75 153.38 40.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.099 1.36 . . . . 0.0 107.761 -176.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -126.49 110.31 13.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.671 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -79.84 89.79 5.27 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.5 m-85 -81.72 93.02 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -79.74 153.73 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -103.14 -168.27 1.49 Allowed 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.646 -0.659 . . . . 0.0 109.769 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.29 138.69 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 163.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.16 96.43 6.22 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 164.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 71.02 -50.11 0.68 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.33 2.252 . . . . 0.0 114.328 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.91 -1.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.212 2.605 . . . . 0.0 112.543 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.84 178.22 4.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.257 1.423 . . . . 0.0 108.211 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.87 -18.76 23.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 120.206 1.366 . . . . 0.0 113.438 -162.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.22 -79.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.72 1.145 . . . . 0.0 110.383 -159.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -154.07 168.02 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 109.791 -168.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' HG23 ' A' ' 42' ' ' VAL . 5.9 mm -100.49 162.5 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 127.038 2.135 . . . . 0.0 106.691 170.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 m -148.61 84.66 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.677 1.591 . . . . 0.0 107.426 157.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.671 HG22 ' CB ' ' A' ' 28' ' ' ALA . 99.0 t -95.33 84.11 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -93.38 158.33 15.78 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -78.94 145.45 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.471 HD21 HG22 ' A' ' 56' ' ' VAL . 43.0 t-20 -84.59 108.8 16.08 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.34 -17.26 59.22 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.23 1.287 . . . . 0.0 111.929 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 55' ' ' ALA . 1.3 mm? -120.2 38.75 3.88 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.398 1.079 . . . . 0.0 110.258 -175.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.323 0 O-C-N 120.851 -1.155 . . . . 0.0 110.918 -178.787 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.823 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.471 HG22 HD21 ' A' ' 45' ' ' ASN . 1.8 t -48.38 -55.71 17.67 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 110.077 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.48 -20.93 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.963 1.776 . . . . 0.0 110.581 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.67 -44.67 85.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.296 0.638 . . . . 0.0 109.907 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -55.72 -66.91 0.34 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.274 1.43 . . . . 0.0 110.422 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.71 -22.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -0.94 8.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 113.374 171.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 -19.08 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.837 -1.165 . . . . 0.0 110.667 168.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -84.61 37.25 0.63 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.613 0.642 . . . . 0.0 111.375 -174.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 41.58 33.94 1.07 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.238 2.351 . . . . 0.0 114.492 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -68.19 166.73 15.65 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.613 1.707 . . . . 0.0 112.875 -168.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -139.14 -40.69 0.47 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.916 1.286 . . . . 0.0 110.923 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp -127.98 156.25 42.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.296 1.038 . . . . 0.0 108.664 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.814 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.7 t -138.56 142.88 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 172.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.492 HG21 ' CG1' ' A' ' 99' ' ' VAL . 94.4 mt -134.54 114.09 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.405 HG21 ' HB ' ' A' ' 73' ' ' ILE . 4.6 m -131.24 170.34 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.226 0.61 . . . . 0.0 110.065 -171.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -60.84 1.97 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.331 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.86 4.38 0.64 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 117.484 1.754 . . . . 0.0 117.484 -173.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 74' ' ' GLY 0.274 4.4 tt 31.83 -123.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 127.031 2.132 . . . . 0.0 114.994 162.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 156.75 155.76 7.58 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 128.039 2.733 . . . . 0.0 109.004 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -59.62 -31.96 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -164.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -30.32 71.16 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.466 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.66 -22.87 24.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.496 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.55 -42.61 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 121.005 1.73 . . . . 0.0 108.61 160.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.95 -10.6 22.24 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 120.453 -1.404 . . . . 0.0 113.118 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.66 -62.4 1.46 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 119.855 1.207 . . . . 0.0 111.333 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.478 ' CD2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -30.99 -57.88 0.22 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 128.027 2.531 . . . . 0.0 109.61 161.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.02 -13.17 62.29 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.959 0.787 . . . . 0.0 112.57 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.46 59.23 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.824 0.738 . . . . 0.0 111.759 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.416 ' SD ' HG21 ' A' ' 86' ' ' VAL . 3.0 ptt? -137.12 7.6 2.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.018 0.372 . . . . 0.0 111.811 -171.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.35 28.5 35.68 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.626 1.584 . . . . 0.0 112.39 -170.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.416 HG21 ' SD ' ' A' ' 84' ' ' MET . 2.3 t -80.06 99.52 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 124.341 1.057 . . . . 0.0 108.44 -172.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -64.34 128.44 35.8 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.392 -163.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 81' ' ' PHE . 7.0 p -110.77 112.25 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.0 mt -88.13 147.61 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -179.41 5.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.24 13.84 73.65 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-O 119.116 -0.824 . . . . 0.0 114.163 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.52 162.48 28.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.085 1.442 . . . . 0.0 109.936 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -146.14 160.1 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.053 2.141 . . . . 0.0 106.527 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.49 -161.06 17.95 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.469 0.577 . . . . 0.0 113.793 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -92.99 171.38 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 163.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -53.17 -54.97 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.883 0.873 . . . . 0.0 109.273 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.38 -31.0 71.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.047 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -70.87 -55.57 8.18 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 69' ' ' ILE . 55.7 t -54.08 -44.87 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.363 1.065 . . . . 0.0 110.599 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.59 -46.91 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -59.86 -42.14 93.02 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.887 0.767 . . . . 0.0 111.296 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -58.76 -52.5 65.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.863 0.865 . . . . 0.0 109.801 177.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.05 -46.66 83.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.11 -25.5 67.75 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.065 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 m -90.59 7.86 37.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 112.957 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.24 -1.28 88.96 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.177 1.37 . . . . 0.0 115.184 168.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -71.25 -44.06 66.04 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.367 1.084 . . . . 0.0 111.831 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.62 141.75 37.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.644 1.178 . . . . 0.0 108.473 -166.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 CA-C-O 123.482 1.61 . . . . 0.0 112.937 -173.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.521 0.201 . . . . 0.0 110.772 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.41 HG22 ' CD1' ' A' ' 29' ' ' PHE . 7.2 mt -115.31 153.13 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 165.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.48 105.29 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 127.16 2.184 . . . . 0.0 105.797 -164.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.921 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.47 145.56 31.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 118.623 -0.704 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.478 HD12 HG13 ' A' ' 96' ' ' VAL . 51.2 mt -145.93 114.59 4.66 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.38 129.55 16.05 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.523 1.482 . . . . 0.0 108.318 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 15' ' ' SER . 4.9 m -123.02 150.15 26.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.3 m -68.07 -27.02 66.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.337 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.63 156.07 39.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.663 1.585 . . . . 0.0 107.937 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 52.4 t-20 -85.71 95.52 9.41 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 173.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.69 39.67 3.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.072 0.949 . . . . 0.0 108.616 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.2 -127.96 30.08 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 120.751 -1.218 . . . . 0.0 111.464 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -58.29 -45.83 87.2 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.153 1.381 . . . . 0.0 111.736 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -1.87 4.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.751 2.42 . . . . 0.0 114.307 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.47 ' HB3' HG11 ' A' ' 7' ' ' VAL . 28.1 m -53.05 109.03 1.26 Allowed Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 125.201 1.4 . . . . 0.0 110.955 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.89 135.37 14.08 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.42 1.414 . . . . 0.0 108.932 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.43 134.37 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.978 0.911 . . . . 0.0 111.288 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.37 169.87 12.53 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.869 1.267 . . . . 0.0 107.91 166.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -88.09 -55.26 3.83 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 121.454 -0.779 . . . . 0.0 110.577 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.7 85.59 2.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -152.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -37.49 -47.22 0.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 112.908 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.35 40.98 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.773 -1.015 . . . . 0.0 115.341 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 47.96 1.56 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 108.737 173.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.63 137.79 54.84 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.76 -25.28 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.482 2.121 . . . . 0.0 114.457 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 10' ' ' ASN . 33.2 m-85 -146.3 158.18 43.86 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.28 103.92 8.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.523 1.529 . . . . 0.0 107.904 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.06 78.99 6.66 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.543 1.537 . . . . 0.0 107.624 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.921 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.28 3.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 170.188 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.461 HG13 HD13 ' A' ' 40' ' ' ILE . 3.8 t -83.05 164.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 123.682 0.793 . . . . 0.0 109.055 171.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.87 2.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.94 -1.1 . . . . 0.0 108.946 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.424 HG12 ' HG2' ' A' ' 1' ' ' MET . 11.9 p -150.19 147.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -123.65 113.76 19.08 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 173.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.8 t30 54.61 -86.86 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.716 1.206 . . . . 0.0 111.627 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.9 12.22 2.89 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.605 1.562 . . . . 0.0 111.917 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 156.32 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.821 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.21 -32.32 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.137 1.775 . . . . 0.0 112.938 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 59.17 -51.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.309 2.244 . . . . 0.0 115.48 -168.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.72 162.03 15.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 110.768 -160.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.461 HD13 HG13 ' A' ' 30' ' ' VAL . 2.8 mm -135.75 140.48 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.205 1.802 . . . . 0.0 107.683 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.84 88.55 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.741 2.016 . . . . 0.0 107.704 165.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 4.7 t -89.86 93.46 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 164.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.76 152.63 19.47 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -56.92 152.97 11.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.427 1.091 . . . . 0.0 110.439 168.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -79.86 133.66 58.09 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.94 -9.72 26.24 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 CA-C-N 121.128 1.439 . . . . 0.0 112.136 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.81 39.73 0.96 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.042 1.337 . . . . 0.0 110.082 -163.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.205 0 O-C-N 120.275 -1.516 . . . . 0.0 112.367 -169.135 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.06 -53.45 48.27 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 119.237 0.926 . . . . 0.0 109.515 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 60' ' ' VAL . 29.2 Cg_endo -72.43 -32.09 10.48 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.02 1.814 . . . . 0.0 111.925 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.09 -38.35 73.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.063 0.847 . . . . 0.0 110.884 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.77 -65.59 0.61 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.922 1.289 . . . . 0.0 110.971 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.74 -22.34 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 119.776 1.171 . . . . 0.0 113.952 -173.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.59 -12.34 61.51 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.368 -1.457 . . . . 0.0 113.946 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.78 -18.93 24.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.848 1.204 . . . . 0.0 109.813 165.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.22 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 119.84 -1.787 . . . . 0.0 111.221 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.51 20.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.337 2.398 . . . . 0.0 116.264 161.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.2 176.85 9.29 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -159.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -144.09 -53.31 0.33 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 110.661 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.02 157.03 19.73 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.618 1.167 . . . . 0.0 109.373 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -136.56 139.61 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 127.387 2.275 . . . . 0.0 105.084 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.58 HG21 HG13 ' A' ' 99' ' ' VAL . 94.5 mt -131.43 111.4 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.463 HG13 HG12 ' A' ' 68' ' ' VAL . 3.1 m -137.35 155.38 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.85 0.86 . . . . 0.0 110.657 -162.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.435 ' HE ' ' HB3' ' A' ' 93' ' ' SER . 17.6 ttt-85 -95.14 -62.1 1.36 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.66 -1.275 . . . . 0.0 111.195 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.82 -54.46 1.3 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 121.757 -0.589 . . . . 0.0 113.977 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.491 HG12 ' H ' ' A' ' 74' ' ' GLY 0.301 3.7 tt 44.38 -168.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 130.143 3.377 . . . . 0.0 115.093 -173.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.35 167.21 39.86 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.289 1.9 . . . . 0.0 110.42 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.8 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -64.74 -36.28 83.8 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 121.201 1.819 . . . . 0.0 109.638 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.66 -40.7 63.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.256 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.44 -43.89 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 119.732 1.151 . . . . 0.0 109.622 168.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.75 -11.25 11.32 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.131 -1.606 . . . . 0.0 114.89 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.407 ' HB2' ' CB ' ' A' ' 57' ' ' PRO . . . -80.18 -58.53 3.1 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.208 1.403 . . . . 0.0 110.441 175.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.457 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -35.63 -56.33 0.67 Allowed 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 126.958 2.103 . . . . 0.0 109.153 160.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.32 -10.05 56.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 117.441 -1.266 . . . . 0.0 111.763 -167.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.98 63.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.714 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.13 14.94 5.7 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.379 0.424 . . . . 0.0 111.476 -163.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.2 26.8 56.75 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.101 -0.374 . . . . 0.0 112.819 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 1.9 t -79.67 108.21 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -168.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.68 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.929 1.692 . . . . 0.0 110.349 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.05 95.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.51 139.47 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.87 154.06 47.68 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 -171.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.8 11.04 38.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.08 0.848 . . . . 0.0 114.751 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.48 157.58 37.58 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.48 1.14 . . . . 0.0 110.85 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.435 ' HB3' ' HE ' ' A' ' 71' ' ' ARG . 65.1 p -159.52 130.3 5.87 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.64 -130.77 6.25 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.95 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.41 159.55 39.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.044 1.738 . . . . 0.0 111.344 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.478 HG13 HD12 ' A' ' 5' ' ' ILE . 22.7 t -63.68 -45.1 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 120.909 -1.119 . . . . 0.0 111.304 -166.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.54 -11.91 48.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.43 -43.55 5.38 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 117.356 -1.307 . . . . 0.0 108.972 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.58 HG13 HG21 ' A' ' 69' ' ' ILE . 77.1 t -45.93 -49.88 4.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 120.412 1.46 . . . . 0.0 110.569 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.42 -38.48 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.471 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -61.99 -51.01 69.78 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 117.352 -1.309 . . . . 0.0 110.314 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.22 -37.26 69.46 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.374 1.443 . . . . 0.0 111.589 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.0 -50.38 42.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.724 1.21 . . . . 0.0 112.005 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.86 -30.72 71.72 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.128 0.422 . . . . 0.0 110.086 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.4 m -74.72 -1.13 20.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.884 2.074 . . . . 0.0 112.483 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 -8.9 74.98 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.356 1.455 . . . . 0.0 112.966 168.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.51 -45.79 51.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.95 134.85 38.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.34 -166.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.558 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 ttp . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.707 0.289 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -137.66 145.47 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.53 111.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 128.423 2.689 . . . . 0.0 106.827 -162.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.894 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -84.02 147.67 27.29 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.289 0.95 . . . . 0.0 111.599 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.4 mt -141.64 113.82 6.6 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.47 110.01 2.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.343 2.696 . . . . 0.0 108.824 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.527 HG23 ' HB2' ' A' ' 26' ' ' TYR . 18.6 m -106.82 146.26 13.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.496 0.718 . . . . 0.0 111.409 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.418 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -141.53 149.08 40.38 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.582 1.083 . . . . 0.0 109.389 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.68 100.04 11.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.95 39.02 1.8 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 27.23 80.89 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 126.76 2.124 . . . . 0.0 114.884 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 80.66 -29.78 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 1 C-N-CA 131.821 4.049 . . . . 0.0 113.445 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.5 -8.46 54.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.03 1.286 . . . . 0.0 110.263 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB3' HG21 ' A' ' 7' ' ' VAL . 7.4 m -45.82 108.64 0.83 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 128.401 2.681 . . . . 0.0 110.086 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.55 131.66 12.74 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.209 2.606 . . . . 0.0 110.104 -172.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 93' ' ' SER . 14.0 tt -62.11 140.75 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.404 1.002 . . . . 0.0 109.708 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -94.62 -173.32 2.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.982 1.313 . . . . 0.0 110.699 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -101.05 -42.72 6.28 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.729 1.212 . . . . 0.0 111.584 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -122.13 104.4 9.46 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.986 1.314 . . . . 0.0 109.901 -173.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -44.43 -44.57 8.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.126 1.37 . . . . 0.0 111.585 166.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.12 -3.09 51.14 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 117.943 -1.476 . . . . 0.0 116.233 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -148.16 63.16 1.1 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.03 124.31 32.53 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.69 1.996 . . . . 0.0 108.276 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.21 -23.71 24.13 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 CA-C-N 122.181 1.815 . . . . 0.0 114.214 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.527 ' HB2' HG23 ' A' ' 7' ' ' VAL . 77.7 m-85 -148.68 151.7 35.39 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.814 0.734 . . . . 0.0 109.041 -173.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -122.31 106.21 10.89 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.717 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.74 81.52 6.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.6 1.16 . . . . 0.0 107.94 169.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.894 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.6 m-85 -70.36 141.1 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 161.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.44 150.44 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -96.55 -169.83 1.97 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.374 0.67 . . . . 0.0 109.512 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.4 115.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.681 -0.637 . . . . 0.0 110.102 165.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' N ' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -81.82 91.94 6.59 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.305 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.39 -67.33 0.15 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.279 1.432 . . . . 0.0 112.69 174.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -145.71 12.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.138 1.775 . . . . 0.0 112.636 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.63 173.33 6.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.602 1.561 . . . . 0.0 109.389 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.91 -25.74 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 121.068 1.758 . . . . 0.0 114.229 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 53.53 -69.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.304 1.411 . . . . 0.0 112.989 -158.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -166.09 170.84 13.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.097 0.959 . . . . 0.0 112.071 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.2 mm -116.01 145.18 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.774 2.43 . . . . 0.0 106.56 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 m -147.35 68.36 1.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.025 2.53 . . . . 0.0 109.815 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 2.8 t -89.06 93.33 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -96.33 161.95 13.71 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.003 1.321 . . . . 0.0 109.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -71.5 149.36 45.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.66 1.584 . . . . 0.0 109.689 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.1 129.82 65.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 118.242 -0.885 . . . . 0.0 108.849 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.86 -27.26 26.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.168 1.246 . . . . 0.0 111.436 168.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.32 45.76 2.59 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.524 -1.36 . . . . 0.0 109.473 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.427 0 O-C-N 120.441 -1.412 . . . . 0.0 110.578 167.869 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 117.849 2.537 . . . . 0.0 117.849 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -51.49 -55.25 30.89 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 120.372 1.442 . . . . 0.0 109.254 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.62 -22.74 37.51 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 120.304 1.144 . . . . 0.0 110.36 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.82 -37.08 85.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.736 1.153 . . . . 0.0 110.485 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -61.42 -61.64 2.39 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.45 -27.72 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 120.603 -1.311 . . . . 0.0 113.674 -174.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -60.54 -22.63 63.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.199 1.0 . . . . 0.0 111.352 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.9 -18.64 58.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.945 1.702 . . . . 0.0 111.417 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -95.03 37.13 1.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.27 1.395 . . . . 0.0 112.195 -164.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 46.78 26.09 2.59 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.07 1.319 . . . . 0.0 115.357 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -75.32 171.8 13.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.112 1.456 . . . . 0.0 112.422 -168.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -143.89 -28.77 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.188 0.995 . . . . 0.0 112.965 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.409 HD22 ' H ' ' A' ' 68' ' ' VAL . 2.4 tm? -139.42 154.66 47.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.883 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.9 t -144.08 143.36 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.573 HG21 ' CG1' ' A' ' 99' ' ' VAL . 85.2 mt -133.22 115.93 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.62 175.43 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.468 1.107 . . . . 0.0 110.251 -172.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -99.43 0.18 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.89 -28.26 24.1 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 121.143 1.792 . . . . 0.0 116.217 -170.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.574 HG12 ' H ' ' A' ' 74' ' ' GLY 0.311 7.2 tt 39.9 -135.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 127.9 2.48 . . . . 0.0 113.41 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.28 154.99 18.09 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 127.78 2.609 . . . . 0.0 109.647 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -39.92 85.71 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.792 1.296 . . . . 0.0 111.645 -171.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -53.32 -38.22 63.0 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.793 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.87 -35.4 38.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 117.097 -1.43 . . . . 0.0 112.373 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.9 -48.07 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 120.604 1.547 . . . . 0.0 108.471 164.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 -10.02 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.281 -1.342 . . . . 0.0 114.479 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.08 -53.35 9.03 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 121.227 1.83 . . . . 0.0 109.904 167.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -60.86 -35.05 75.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.458 1.103 . . . . 0.0 110.385 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -60.32 -20.28 58.65 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.37 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.27 -10.77 57.03 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.665 1.575 . . . . 0.0 111.53 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.0 ptp -134.45 13.65 3.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.37 1.068 . . . . 0.0 112.782 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.2 33.08 44.88 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.628 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -79.45 113.0 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -71.95 146.44 47.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t -127.07 112.27 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -94.61 133.25 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.879 1.672 . . . . 0.0 106.624 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -129.28 167.98 16.9 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.982 1.713 . . . . 0.0 108.183 -172.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 12.45 67.21 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.765 -1.02 . . . . 0.0 113.781 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 171.89 10.38 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.05 1.425 . . . . 0.0 110.6 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.409 ' HA ' HG21 ' A' ' 17' ' ' ILE . 3.1 p -160.85 152.9 20.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 109.456 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.76 -173.13 16.52 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.381 0.515 . . . . 0.0 112.808 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p -82.43 172.94 12.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.621 -0.929 . . . . 0.0 109.752 168.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -60.81 -49.13 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 O-C-N 121.156 -0.965 . . . . 0.0 110.54 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -58.62 -37.5 76.0 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.499 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.42 -58.32 3.48 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.052 1.741 . . . . 0.0 107.867 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.573 ' CG1' HG21 ' A' ' 69' ' ' ILE . 46.2 t -54.4 -44.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.762 1.625 . . . . 0.0 110.636 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.59 -35.72 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.68 -40.6 88.64 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.788 1.176 . . . . 0.0 111.797 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -59.46 -44.26 93.04 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.013 0.824 . . . . 0.0 110.05 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.0 -45.33 74.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.961 0.905 . . . . 0.0 113.139 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.17 -28.02 69.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.85 0.75 . . . . 0.0 110.377 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.9 m -77.07 -3.23 38.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.36 56.08 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.141 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 -49.75 58.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.94 131.54 43.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.482 1.113 . . . . 0.0 110.743 -171.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttm . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.402 HG23 ' HG2' ' A' ' 31' ' ' LYS . 3.3 mt -127.45 135.72 62.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -132.85 101.59 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 127.001 2.12 . . . . 0.0 107.031 -156.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.811 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.04 144.22 33.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.078 0.399 . . . . 0.0 111.131 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.3 mt -134.54 115.87 12.69 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.51 114.59 4.07 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.15 2.567 . . . . 0.0 109.079 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.34 157.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.08 . . . . 0.0 112.699 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -74.46 -25.33 59.34 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.865 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -150.57 152.16 33.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.134 1.374 . . . . 0.0 107.819 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -85.12 110.95 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 164.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -126.37 39.46 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.473 166.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.07 -102.39 0.58 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 125.368 1.461 . . . . 0.0 109.532 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -98.49 -31.68 11.86 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.875 1.27 . . . . 0.0 110.628 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.78 -10.07 54.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.305 1.442 . . . . 0.0 111.445 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.6 m -40.71 106.44 0.42 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 129.911 3.284 . . . . 0.0 111.892 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 135.82 19.97 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.899 2.4 . . . . 0.0 110.927 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.43 138.65 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -77.67 -160.16 0.17 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 108.265 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.54 -52.81 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.977 1.37 . . . . 0.0 109.697 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.4 179.13 6.04 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.894 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 54.5 t80 -121.0 -46.7 2.32 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.843 -1.16 . . . . 0.0 110.889 159.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.14 -42.22 16.38 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 41.47 2.21 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.833 1.253 . . . . 0.0 111.825 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.29 118.01 65.11 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-O 115.927 -1.987 . . . . 0.0 106.373 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.25 -17.67 50.12 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 113.717 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -149.1 158.92 44.57 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.738 1.215 . . . . 0.0 108.782 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.409 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 25.1 m-85 -126.22 128.9 47.95 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.318 1.847 . . . . 0.0 107.485 170.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.42 89.13 3.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.7 m-85 -75.43 92.02 2.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.26 162.23 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 55.8 mttt -117.28 -167.64 1.35 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.81 -1.182 . . . . 0.0 108.714 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.33 136.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 120.872 -1.143 . . . . 0.0 109.751 165.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.05 91.82 3.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 168.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 56.68 -69.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.383 2.273 . . . . 0.0 114.345 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.25 11.81 3.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.555 1.542 . . . . 0.0 112.752 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.72 173.36 8.61 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.115 1.366 . . . . 0.0 110.207 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.45 -23.25 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.464 1.106 . . . . 0.0 112.994 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.05 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.593 1.557 . . . . 0.0 114.02 -162.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -162.24 167.16 24.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.367 1.467 . . . . 0.0 109.836 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 mm -124.28 138.6 53.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.897 2.079 . . . . 0.0 105.835 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 m -119.79 96.91 5.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.86 77.69 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 123.467 1.603 . . . . 0.0 107.523 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.6 127.99 32.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.585 1.554 . . . . 0.0 106.943 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -60.61 162.63 6.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.793 1.179 . . . . 0.0 108.681 158.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -78.2 153.38 79.59 Favored Pre-proline 0 N--CA 1.438 -1.059 0 O-C-N 121.496 -0.753 . . . . 0.0 109.428 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.12 -52.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.721 0.948 . . . . 0.0 110.916 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.24 38.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.332 -0.855 . . . . 0.0 111.278 -163.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.231 0 O-C-N 120.939 -1.101 . . . . 0.0 110.271 -160.293 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -46.98 -48.52 52.52 Favored Pre-proline 0 CA--C 1.556 1.204 0 CA-C-N 119.232 0.923 . . . . 0.0 110.398 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HA ' HG22 ' A' ' 60' ' ' VAL . 57.8 Cg_endo -74.73 -20.04 17.94 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.188 1.925 . . . . 0.0 112.385 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -64.96 -42.46 94.59 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -59.79 -62.14 2.1 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.0 m -63.91 -21.11 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.638 1.563 . . . . 0.0 112.545 -173.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -64.1 -13.21 46.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 116.862 -1.542 . . . . 0.0 112.654 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -11.19 32.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 121.237 1.835 . . . . 0.0 112.488 173.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -90.56 37.29 0.91 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.956 0.798 . . . . 0.0 111.647 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.77 28.05 5.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.836 1.684 . . . . 0.0 114.179 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -63.48 152.82 37.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.662 1.731 . . . . 0.0 112.796 -173.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -144.4 -21.84 0.54 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 111.738 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.3 166.39 23.23 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 109.019 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.5 t -142.31 150.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 165.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.482 HG21 ' CG1' ' A' ' 99' ' ' VAL . 39.6 mt -134.19 112.04 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.89 176.81 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.469 1.508 . . . . 0.0 109.679 -167.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -103.26 -97.19 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.237 -1.363 . . . . 0.0 107.838 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.12 -12.94 40.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 120.731 1.605 . . . . 0.0 115.638 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.532 HG12 ' H ' ' A' ' 74' ' ' GLY . 2.3 tt 38.51 -130.17 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.527 1.931 . . . . 0.0 114.159 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 168.82 158.46 12.79 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 129.437 3.398 . . . . 0.0 110.812 166.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -47.35 33.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.475 1.51 . . . . 0.0 112.492 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -55.9 -6.01 0.2 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.38 -40.45 3.64 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 116.785 -1.578 . . . . 0.0 110.235 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -42.44 -46.96 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.698 1.135 . . . . 0.0 108.958 161.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.36 -19.1 63.03 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.9 2.0 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -57.52 -44.52 85.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 124.013 0.925 . . . . 0.0 109.915 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.95 -14.14 59.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.495 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.98 72.62 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.015 1.734 . . . . 0.0 109.021 168.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -19.15 33.66 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.111 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.71 20.23 37.96 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.094 -1.004 . . . . 0.0 112.496 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.8 t -78.91 121.23 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -63.95 146.31 54.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.703 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 p -139.93 89.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.65 1.18 . . . . 0.0 107.989 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.12 131.58 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.21 171.86 7.35 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.012 1.325 . . . . 0.0 111.494 -173.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.76 4.05 38.1 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.003 1.287 . . . . 0.0 114.483 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.74 164.47 23.46 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.89 1.345 . . . . 0.0 110.324 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.3 p -162.17 124.87 2.91 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -159.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.29 -169.68 25.32 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 123.399 0.437 . . . . 0.0 112.618 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.3 p -79.92 170.56 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.929 0.865 . . . . 0.0 109.723 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.2 t -53.6 -59.83 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 C-N-CA 123.591 0.756 . . . . 0.0 109.425 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.01 -27.75 69.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.04 -54.26 8.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.812 1.645 . . . . 0.0 109.399 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 69' ' ' ILE . 19.8 t -56.35 -43.45 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.837 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 t -52.88 -58.35 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 107.993 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.61 -44.05 95.07 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.009 -0.996 . . . . 0.0 111.939 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.96 -46.01 78.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.347 0.976 . . . . 0.0 110.0 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -62.87 -52.64 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.034 0.534 . . . . 0.0 112.152 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 110.812 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.5 m -74.29 -39.56 62.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.68 35.23 1.09 Allowed Glycine 0 C--N 1.333 0.365 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.145 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.15 -35.12 10.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.068 0.934 . . . . 0.0 112.257 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.53 146.52 31.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.978 1.311 . . . . 0.0 108.871 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 tptm . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 123.409 0.684 . . . . 0.0 110.315 -159.143 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptm . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.54 HG22 ' CD1' ' A' ' 29' ' ' PHE . 6.8 mt -124.38 132.24 71.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -173.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.21 104.46 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 129.012 2.925 . . . . 0.0 106.079 -164.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.94 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.08 133.9 35.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mt -127.8 118.26 21.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.89 127.21 17.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 106.8 -2.039 . . . . 0.0 106.8 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 15' ' ' SER . 16.9 m -121.13 157.51 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 119.538 1.063 . . . . 0.0 110.691 177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.86 -34.45 60.03 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.991 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -146.16 169.35 18.91 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.183 0.993 . . . . 0.0 108.545 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -84.03 89.79 7.32 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 130.579 3.552 . . . . 0.0 108.599 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -128.67 38.91 3.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.717 -0.615 . . . . 0.0 110.794 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.41 -80.29 0.11 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 126.033 1.778 . . . . 0.0 113.351 167.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -120.93 -33.54 3.73 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.775 1.63 . . . . 0.0 111.393 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.67 -5.23 11.0 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.769 2.427 . . . . 0.0 112.177 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB3' HG11 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -49.24 109.62 1.28 Allowed Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 127.896 2.478 . . . . 0.0 108.318 176.305 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -83.04 137.37 8.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.181 1.92 . . . . 0.0 109.159 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.3 tt -58.92 133.99 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.012 0.91 . . . . 0.0 110.947 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 t -73.68 167.84 20.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.387 1.475 . . . . 0.0 109.137 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -90.82 -20.75 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.44 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -133.75 -176.7 4.26 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -120.33 -49.51 2.27 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 110.64 -176.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.6 -5.69 24.98 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 46.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.666 2.386 . . . . 0.0 106.852 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.04 143.4 94.31 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 162.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.76 -16.31 13.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.207 1.938 . . . . 0.0 113.089 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.427 ' HB2' HG23 ' A' ' 7' ' ' VAL . 96.5 m-85 -149.51 155.88 41.08 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.903 -1.123 . . . . 0.0 109.72 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.64 114.3 17.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 126.265 1.826 . . . . 0.0 107.684 170.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.95 88.49 5.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 161.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.94 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -75.19 92.42 2.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 160.457 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.94 148.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -97.23 -167.69 1.58 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -144.74 136.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 164.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.55 -139.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.31 1.844 . . . . 0.0 106.95 167.389 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.567 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 20.1 t-20 -59.34 -54.11 50.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.712 -1.242 . . . . 0.0 109.398 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.27 11.42 0.71 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.296 1.039 . . . . 0.0 112.701 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.08 171.35 7.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.336 1.455 . . . . 0.0 108.543 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.13 -22.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 126.375 1.87 . . . . 0.0 112.664 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.4 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 54.15 -70.9 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.943 1.697 . . . . 0.0 112.052 -162.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -159.1 162.05 36.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.244 1.818 . . . . 0.0 109.25 -155.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mm -126.87 126.03 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -173.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -112.87 94.76 5.06 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 163.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -91.65 88.83 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -97.55 136.37 38.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.825 1.25 . . . . 0.0 109.655 -169.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -75.91 143.57 41.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.338 1.055 . . . . 0.0 108.235 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.59 116.46 60.93 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.118 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.92 -22.9 30.69 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.834 1.69 . . . . 0.0 112.312 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.85 39.86 3.86 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.534 1.134 . . . . 0.0 109.356 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 123.518 0.727 . . . . 0.0 110.693 -179.819 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.454 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 1.9 t -43.2 -54.06 9.98 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 120.8 1.636 . . . . 0.0 111.456 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 6.1 Cg_exo -76.1 -31.24 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.969 2.446 . . . . 0.0 111.497 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -62.65 -41.55 99.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.924 -0.56 . . . . 0.0 109.559 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.16 -66.28 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.758 0.823 . . . . 0.0 109.679 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 m -60.56 -6.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE3' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -97.83 -20.03 17.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.502 -1.374 . . . . 0.0 112.432 175.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -64.3 -25.22 67.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.976 0.807 . . . . 0.0 110.753 158.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 36.25 0.74 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.306 0.957 . . . . 0.0 110.716 -165.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.69 4.39 0.04 OUTLIER Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.446 2.45 . . . . 0.0 116.741 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.427 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.78 158.46 25.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.086 -1.832 . . . . 0.0 112.736 -158.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 86' ' ' VAL . 21.6 mt-10 -131.65 -20.35 2.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.745 0.818 . . . . 0.0 111.852 -165.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.541 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.2 tm? -134.36 152.84 52.04 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.671 0.607 . . . . 0.0 109.558 -174.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.83 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.1 t -148.49 139.0 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.479 HG21 HG13 ' A' ' 99' ' ' VAL . 71.4 mt -130.55 111.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -131.05 -178.5 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.698 1.199 . . . . 0.0 111.685 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.31 -100.48 0.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.53 55.63 3.48 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 125.962 1.744 . . . . 0.0 112.503 -169.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.47 167.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 O-C-N 121.681 -0.893 . . . . 0.0 109.231 169.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.45 166.74 23.31 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.424 1.012 . . . . 0.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -36.31 46.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.302 1.441 . . . . 0.0 113.414 -166.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.82 -31.37 64.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.324 1.42 . . . . 0.0 112.449 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.18 -35.88 15.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.695 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -41.75 -54.29 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.981 1.264 . . . . 0.0 107.884 158.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.75 -14.21 42.04 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.52 -53.42 6.29 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.107 1.322 . . . . 0.0 110.566 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -57.78 -35.52 70.91 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.228 1.011 . . . . 0.0 110.807 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -49.76 -33.08 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.186 2.194 . . . . 0.0 114.043 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -18.94 64.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.172 0.896 . . . . 0.0 111.861 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.22 1.11 4.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.089 1.356 . . . . 0.0 113.551 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.05 39.16 97.23 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.052 -1.03 . . . . 0.0 112.246 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 66' ' ' GLU . 40.4 t -79.64 117.79 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -74.15 139.47 44.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.593 -0.692 . . . . 0.0 110.175 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.05 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.208 1.403 . . . . 0.0 109.295 -168.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.06 131.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -150.91 144.15 24.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.322 -0.861 . . . . 0.0 112.198 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.19 11.91 22.96 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.749 1.166 . . . . 0.0 112.073 -169.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.33 177.65 3.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.169 1.485 . . . . 0.0 110.043 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.2 p -162.2 156.72 22.11 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 119.806 1.184 . . . . 0.0 110.032 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.63 -153.26 21.95 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 121.643 0.579 . . . . 0.0 111.792 172.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.73 153.4 26.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.791 0.837 . . . . 0.0 111.154 -171.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 t -61.24 -45.56 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 122.932 0.493 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.83 -28.24 65.86 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.433 0.561 . . . . 0.0 111.939 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.28 -57.04 3.79 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 127.347 2.259 . . . . 0.0 109.008 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.479 HG13 HG21 ' A' ' 69' ' ' ILE . 25.6 t -52.95 -45.37 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.791 1.237 . . . . 0.0 110.72 -176.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.1 -50.38 79.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -55.88 -47.88 76.58 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.419 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -54.07 -38.2 65.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.123 1.329 . . . . 0.0 112.102 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -71.29 -51.29 25.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.506 0.723 . . . . 0.0 112.114 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.16 -38.92 68.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.5 m -78.98 -5.66 54.4 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.839 1.656 . . . . 0.0 112.025 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.8 4.28 82.61 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.848 1.214 . . . . 0.0 114.736 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -81.18 -35.16 31.76 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.765 1.283 . . . . 0.0 111.431 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.7 161.38 31.07 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.716 0.806 . . . . 0.0 110.845 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tptm . . . . . 0 C--O 1.232 0.173 0 C-N-CA 124.292 1.037 . . . . 0.0 109.821 -173.345 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ttp . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 mt -140.17 147.05 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.7 mt -132.56 103.1 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 127.38 2.272 . . . . 0.0 106.265 -162.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.977 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.09 154.42 28.1 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 119.61 -0.233 . . . . 0.0 110.845 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -146.18 115.89 4.7 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.22 123.4 9.91 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.497 2.131 . . . . 0.0 108.225 169.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 26' ' ' TYR . 17.5 m -119.81 157.93 21.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.448 0.567 . . . . 0.0 110.364 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.4 m -78.79 -27.84 44.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.078 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -148.75 148.94 30.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.111 0.869 . . . . 0.0 108.838 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -82.68 45.33 0.97 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.233 2.213 . . . . 0.0 112.987 -170.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -88.78 39.67 0.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.96 -1.713 . . . . 0.0 111.461 -167.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.51 -125.47 13.78 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.539 -1.35 . . . . 0.0 112.504 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -52.47 -45.82 66.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.648 1.579 . . . . 0.0 110.609 174.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -7.37 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.839 2.456 . . . . 0.0 111.834 -169.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -47.53 109.37 1.08 Allowed Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.151 1.78 . . . . 0.0 110.997 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.46 131.85 15.48 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.182 1.921 . . . . 0.0 109.975 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.94 142.93 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.488 1.115 . . . . 0.0 109.762 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.06 173.7 8.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.897 1.279 . . . . 0.0 108.735 174.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.34 -48.3 8.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 122.4 1.095 . . . . 0.0 109.196 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -86.88 166.39 15.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.486 -171.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -119.38 -52.27 2.27 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 123.862 0.865 . . . . 0.0 109.959 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -17.4 49.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.044 -0.864 . . . . 0.0 113.645 -172.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -139.2 39.3 2.1 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.283 1.833 . . . . 0.0 110.124 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.75 130.64 91.64 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 160.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.14 -17.87 35.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.445 1.43 . . . . 0.0 114.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.487 ' HB2' HG23 ' A' ' 7' ' ' VAL . 98.3 m-85 -146.69 156.34 43.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.516 1.126 . . . . 0.0 109.541 -171.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -134.18 106.42 7.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.039 1.736 . . . . 0.0 109.343 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.17 100.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.397 1.079 . . . . 0.0 108.662 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.977 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 4.5 m-85 -89.98 100.95 13.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 t -82.64 154.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 168.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 30.9 mtpt -102.67 -165.04 1.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.41 132.6 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 163.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.85 87.23 3.25 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 170.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 70.31 -75.01 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.125 1.37 . . . . 0.0 110.445 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -137.51 15.27 2.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.04 1.336 . . . . 0.0 112.197 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.34 174.79 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.981 1.313 . . . . 0.0 109.508 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.88 -22.87 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 121.217 1.826 . . . . 0.0 114.346 -166.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.76 -64.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.629 1.971 . . . . 0.0 115.084 -162.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.45 169.88 19.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.588 1.155 . . . . 0.0 108.823 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.2 mm -131.18 139.69 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 127.749 2.42 . . . . 0.0 105.32 -172.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.67 70.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.044 -1.035 . . . . 0.0 108.262 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.17 88.72 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 106.831 167.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.33 155.65 22.75 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.582 1.153 . . . . 0.0 108.25 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -82.34 166.34 19.56 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.994 -0.441 . . . . 0.0 109.991 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.9 110.77 37.83 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.203 173.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.44 -6.06 18.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.506 2.137 . . . . 0.0 113.275 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -134.99 38.17 3.0 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.06 0.944 . . . . 0.0 109.504 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 119.04 0.836 . . . . 0.0 110.475 -172.224 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.52 -53.09 38.63 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 119.467 1.03 . . . . 0.0 108.301 168.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.99 -28.19 24.44 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.571 1.514 . . . . 0.0 111.88 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.14 -42.69 99.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.05 1.295 . . . . 0.0 108.984 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.496 ' CZ ' ' HE2' ' A' ' 63' ' ' LYS . 4.6 t80 -53.39 -63.05 1.27 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.256 0.622 . . . . 0.0 110.256 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 m -61.91 -30.65 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.276 -0.89 . . . . 0.0 113.154 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -65.13 -17.52 64.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -30.88 66.31 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.089 165.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.496 ' HE2' ' CZ ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -86.27 37.32 0.72 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.912 1.687 . . . . 0.0 113.378 -167.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 36.6 42.36 0.66 Allowed Glycine 0 CA--C 1.541 1.683 0 C-N-CA 127.694 2.569 . . . . 0.0 117.208 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.79 168.9 4.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.63 1.715 . . . . 0.0 113.789 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -139.73 -25.98 0.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.031 1.732 . . . . 0.0 111.046 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 tp -142.53 150.22 40.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.379 0.99 . . . . 0.0 110.603 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' A' ' 4' ' ' ALA . 9.4 t -147.71 123.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.48 HG21 ' CG1' ' A' ' 99' ' ' VAL . 87.9 mt -111.54 112.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.61 -177.1 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.76 1.224 . . . . 0.0 110.272 -172.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -112.14 -87.08 0.55 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.428 -0.795 . . . . 0.0 108.919 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.51 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 124.365 0.983 . . . . 0.0 113.65 -167.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.483 HG12 ' H ' ' A' ' 74' ' ' GLY 0.257 4.6 tt 43.56 -153.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 126.876 2.07 . . . . 0.0 112.883 -176.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -168.66 156.55 28.04 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.606 2.527 . . . . 0.0 109.329 176.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -38.38 70.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.511 1.155 . . . . 0.0 111.547 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -55.69 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 175.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.44 12.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.261 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.63 -48.1 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 165.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.02 50.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.9 -51.06 17.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.265 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.68 -36.59 76.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 126.149 1.779 . . . . 0.0 110.123 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -61.62 -17.02 53.51 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.133 -0.979 . . . . 0.0 113.589 170.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.78 -13.63 53.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.478 1.49 . . . . 0.0 111.821 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -125.64 12.25 7.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.642 1.977 . . . . 0.0 110.854 -172.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 15.02 58.45 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 123.658 0.647 . . . . 0.0 112.924 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.406 ' CG1' HG23 ' A' ' 68' ' ' VAL . 55.9 t -79.26 113.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -67.85 147.71 52.16 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.31 108.45 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.106 0.962 . . . . 0.0 109.774 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.4 128.41 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 128.511 2.724 . . . . 0.0 106.868 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -108.21 179.54 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 108.812 169.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.72 8.08 87.28 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 115.079 0.791 . . . . 0.0 115.079 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 -176.73 1.58 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.544 1.172 . . . . 0.0 110.65 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.5 t -163.33 168.31 20.64 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 128.362 2.665 . . . . 0.0 106.588 164.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.82 -170.83 21.27 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 118.023 0.374 . . . . 0.0 113.804 168.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.5 p -79.52 163.0 25.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.453 -1.028 . . . . 0.0 111.337 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.09 -55.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.374 1.07 . . . . 0.0 110.164 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.19 -20.79 66.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.81 -54.07 4.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.871 1.668 . . . . 0.0 107.207 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 69' ' ' ILE . 54.3 t -52.49 -46.37 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.216 1.806 . . . . 0.0 110.886 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.38 -53.28 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -62.44 -37.68 86.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.15 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -59.88 -46.79 88.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.042 1.292 . . . . 0.0 110.259 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -61.28 -53.93 50.45 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -56.23 -31.3 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.609 0.64 . . . . 0.0 110.426 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.3 m -76.08 -22.31 55.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 112.726 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.23 8.99 58.43 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.408 1.004 . . . . 0.0 113.236 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -80.92 -22.6 39.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.426 1.613 . . . . 0.0 112.067 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.91 145.18 27.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 109.202 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.553 0 C-N-CA 124.27 1.028 . . . . 0.0 109.065 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttm . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.28 138.91 52.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 mt -125.66 105.42 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 127.586 2.354 . . . . 0.0 106.27 -159.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -79.65 144.09 34.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.365 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.9 mt -143.18 116.4 6.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 171.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.13 119.43 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 15' ' ' SER . 6.9 m -110.62 141.91 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.789 1.177 . . . . 0.0 110.21 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -69.28 -21.85 63.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 117.442 -1.266 . . . . 0.0 112.849 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -148.0 156.72 42.96 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 38.7 t-20 -90.42 97.75 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -132.24 38.21 3.5 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.25 -109.24 1.09 Allowed Glycine 0 C--N 1.342 0.891 0 C-N-CA 124.022 0.82 . . . . 0.0 112.487 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -80.62 -41.17 24.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.764 1.626 . . . . 0.0 109.603 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.27 -16.05 59.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.061 1.744 . . . . 0.0 112.408 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HG11 ' A' ' 7' ' ' VAL . 22.0 m -39.26 104.56 0.32 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.685 2.794 . . . . 0.0 112.416 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.37 135.94 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.056 1.837 . . . . 0.0 109.328 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -61.77 148.2 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.612 0.72 . . . . 0.0 110.338 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -78.47 178.35 7.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.905 2.482 . . . . 0.0 110.054 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -108.21 -30.22 8.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.816 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -133.88 90.59 2.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.694 1.134 . . . . 0.0 110.645 -164.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -43.32 -42.69 4.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.649 1.18 . . . . 0.0 112.986 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -1.53 40.02 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.023 -1.431 . . . . 0.0 115.925 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.45 46.86 1.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.442 1.621 . . . . 0.0 108.775 166.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 133.26 88.77 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 116.618 -1.658 . . . . 0.0 109.38 172.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -73.22 -22.55 18.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.756 2.304 . . . . 0.0 113.575 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 99.0 m-85 -147.1 154.04 40.66 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.022 0.929 . . . . 0.0 109.459 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.67 104.16 7.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 91.8 5.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.252 1.821 . . . . 0.0 108.913 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.907 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.6 m-85 -84.71 96.35 9.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.22 160.78 4.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -110.99 -170.08 1.57 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 119.993 -1.692 . . . . 0.0 108.798 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.1 144.24 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 162.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.691 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -80.05 -138.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.357 2.263 . . . . 0.0 105.598 167.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.691 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 21.4 t-20 -59.28 -62.63 1.74 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.471 1.908 . . . . 0.0 109.644 174.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -142.09 20.03 2.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.839 1.256 . . . . 0.0 111.678 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.91 161.71 26.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.117 1.367 . . . . 0.0 109.71 -170.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.75 -23.84 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.368 1.894 . . . . 0.0 112.608 -165.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.73 -65.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.032 2.133 . . . . 0.0 114.208 -166.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.24 165.88 21.53 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.069 0.948 . . . . 0.0 111.682 -165.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 152.07 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 127.229 2.212 . . . . 0.0 107.716 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.64 73.04 1.3 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.67 1.588 . . . . 0.0 109.467 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.256 8.3 p -90.63 84.77 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -96.66 154.46 17.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.707 1.203 . . . . 0.0 108.334 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.69 148.81 42.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.416 1.487 . . . . 0.0 110.564 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -92.19 115.08 64.05 Favored Pre-proline 0 CA--C 1.516 -0.345 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.806 -173.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 -21.97 53.59 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.989 1.793 . . . . 0.0 112.557 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -123.66 38.63 4.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.3 1.409 . . . . 0.0 111.049 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.339 0 CA-C-N 119.513 1.051 . . . . 0.0 110.693 175.208 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.8 -53.5 12.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.656 1.982 . . . . 0.0 109.501 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.456 ' HA ' HG22 ' A' ' 60' ' ' VAL . 56.3 Cg_endo -76.31 -30.73 5.14 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 120.581 1.243 . . . . 0.0 111.04 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.0 -24.97 67.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.06 0.544 . . . . 0.0 110.348 -177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -69.12 -73.2 0.16 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 124.472 1.109 . . . . 0.0 109.502 162.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.2 m -59.38 -28.76 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -58.82 -42.63 89.63 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.076 1.307 . . . . 0.0 108.836 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -17.86 54.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.761 0.824 . . . . 0.0 112.479 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -86.58 37.17 0.73 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.747 0.703 . . . . 0.0 109.853 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 29.27 44.27 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 128.688 3.042 . . . . 0.0 114.832 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.73 174.37 8.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.012 1.406 . . . . 0.0 113.635 -172.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -145.13 -28.09 0.46 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.024 0.93 . . . . 0.0 112.194 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.0 tm? -142.05 157.9 44.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.859 -173.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.008 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -150.77 143.6 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.811 1.644 . . . . 0.0 106.999 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.569 HG21 HG13 ' A' ' 99' ' ' VAL . 61.8 mt -131.59 113.38 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.61 -177.23 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.748 1.219 . . . . 0.0 110.418 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -104.05 -100.5 0.31 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 117.515 -1.231 . . . . 0.0 107.808 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.8 -18.27 32.83 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 120.355 1.434 . . . . 0.0 114.849 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.467 HG12 ' H ' ' A' ' 74' ' ' GLY 0.309 4.9 tt 41.22 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 126.98 2.112 . . . . 0.0 112.786 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -152.91 -138.74 2.76 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.977 2.227 . . . . 0.0 109.822 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.62 -31.6 4.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.748 1.274 . . . . 0.0 111.18 163.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -36.84 68.08 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.345 -1.472 . . . . 0.0 113.135 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 -31.71 43.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.219 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.23 -47.92 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.55 -12.74 34.97 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.07 -58.9 3.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.796 1.18 . . . . 0.0 109.403 172.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -58.49 -42.31 87.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.06 -20.87 66.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.53 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.43 -9.1 58.27 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.808 1.185 . . . . 0.0 112.222 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.49 -5.69 6.48 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.054 0.942 . . . . 0.0 112.434 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.39 28.87 69.0 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 119.589 1.086 . . . . 0.0 111.228 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.42 115.47 20.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -72.65 139.05 47.09 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.453 -0.779 . . . . 0.0 109.216 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.16 92.94 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 122.612 1.196 . . . . 0.0 109.637 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.9 147.48 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.173 1.789 . . . . 0.0 107.537 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -155.34 173.02 17.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.15 0.98 . . . . 0.0 109.38 -160.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.21 18.61 60.75 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.435 -0.647 . . . . 0.0 112.715 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.32 178.68 7.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.28 1.032 . . . . 0.0 109.784 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -158.27 160.4 37.03 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 106.05 -1.834 . . . . 0.0 106.05 160.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.37 -162.41 25.39 Favored Glycine 0 N--CA 1.463 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 112.665 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 p -84.93 165.33 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.65 -0.912 . . . . 0.0 109.134 165.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.2 t -53.74 -54.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.94 -22.52 62.57 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -89.63 -52.47 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.825 1.65 . . . . 0.0 107.658 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.569 HG13 HG21 ' A' ' 69' ' ' ILE . 43.0 t -55.16 -35.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 111.552 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.29 -53.99 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -54.91 -43.01 72.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.134 0.574 . . . . 0.0 111.214 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -58.86 -41.8 87.87 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.854 0.835 . . . . 0.0 111.005 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -72.5 -43.63 63.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.376 1.071 . . . . 0.0 111.778 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.26 -29.87 67.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.972 0.806 . . . . 0.0 110.601 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 m -78.33 -2.96 40.66 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.844 1.258 . . . . 0.0 113.138 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.68 20.65 68.39 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.534 1.061 . . . . 0.0 113.205 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -81.16 -56.18 4.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.344 1.072 . . . . 0.0 108.952 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.02 146.63 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 110.806 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 tptt . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 122.489 1.137 . . . . 0.0 112.379 -175.803 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.443 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.7 ttt . . . . . 0 C--O 1.235 0.342 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.409 HG12 ' HE3' ' A' ' 31' ' ' LYS . 3.9 mt -137.35 148.38 26.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 69' ' ' ILE . 13.8 mt -128.79 106.62 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 129.373 3.069 . . . . 0.0 105.561 -170.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.822 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.66 150.2 26.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.378 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.06 118.67 10.23 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.72 116.54 4.29 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 107.221 -1.876 . . . . 0.0 107.221 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 15' ' ' SER . 3.0 m -116.79 157.08 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.699 0.799 . . . . 0.0 110.488 -174.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 p -72.6 -35.45 67.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -142.2 156.44 45.33 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 120.355 1.434 . . . . 0.0 109.049 -167.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.52 88.88 6.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -132.41 38.41 3.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 109.719 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.26 -105.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 127.438 2.447 . . . . 0.0 111.25 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -79.92 -37.21 35.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.24 1.016 . . . . 0.0 110.216 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.66 -18.58 64.99 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.348 1.859 . . . . 0.0 112.175 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.584 ' HB3' HG11 ' A' ' 7' ' ' VAL . 3.7 m -37.97 105.06 0.31 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.42 2.288 . . . . 0.0 111.894 -175.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -68.87 132.64 25.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.578 1.519 . . . . 0.0 110.615 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.4 tt -62.13 142.0 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 119.781 -1.825 . . . . 0.0 110.67 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -81.03 -173.79 4.49 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.245 1.418 . . . . 0.0 108.977 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -109.12 -45.03 3.83 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.045 -1.034 . . . . 0.0 111.608 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -120.41 100.68 7.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.017 1.327 . . . . 0.0 107.851 -163.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -42.47 -45.35 4.4 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.141 1.376 . . . . 0.0 112.16 171.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.81 -20.2 59.46 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 117.888 -1.507 . . . . 0.0 114.303 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.32 38.91 3.58 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.415 1.608 . . . . 0.0 109.495 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.06 130.58 93.81 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.598 -1.192 . . . . 0.0 107.845 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.72 -20.74 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.605 2.203 . . . . 0.0 113.127 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -148.03 160.99 42.27 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.41 1.484 . . . . 0.0 108.378 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -126.94 112.11 14.9 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.68 88.41 7.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -78.12 98.6 5.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 108.179 169.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.42 136.82 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.465 1.106 . . . . 0.0 108.055 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HE3' HG12 ' A' ' 2' ' ' ILE . 9.6 mtpt -80.45 -164.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.13 -0.982 . . . . 0.0 109.549 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -156.25 147.86 11.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -146.06 122.08 10.72 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 53.96 34.46 19.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.079 0.952 . . . . 0.0 112.541 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 73.7 12.85 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.325 2.65 . . . . 0.0 114.337 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.06 172.49 7.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.0 108.402 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.85 -27.23 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 125.15 1.38 . . . . 0.0 112.436 -159.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.99 -67.42 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 C-N-CA 127.156 2.183 . . . . 0.0 112.753 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -164.86 157.17 16.02 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.751 -0.593 . . . . 0.0 112.011 -164.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.32 131.4 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.171 1.788 . . . . 0.0 106.848 -172.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.0 m -129.4 117.94 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 107.153 166.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 t -131.39 79.45 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -82.02 168.81 17.43 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -105.97 132.52 51.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 107.68 -168.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -79.59 123.73 84.04 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.591 -150.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.35 -10.77 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.427 2.752 . . . . 0.0 114.982 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.35 38.84 2.28 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.147 1.779 . . . . 0.0 109.895 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 O-C-N 120.599 -1.313 . . . . 0.0 112.429 -178.008 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -43.45 -52.02 14.1 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 121.404 1.911 . . . . 0.0 111.314 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.86 -27.39 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.277 1.985 . . . . 0.0 111.761 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.38 -41.79 90.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.729 1.149 . . . . 0.0 109.889 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.17 -68.15 0.2 Allowed 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 123.683 0.793 . . . . 0.0 109.654 167.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 m -64.47 -12.1 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -72.71 -22.26 60.92 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.59 1.156 . . . . 0.0 111.553 170.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.55 -12.95 50.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.838 0.745 . . . . 0.0 112.044 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -93.1 37.02 1.03 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.173 -0.954 . . . . 0.0 111.18 -164.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.28 18.27 34.95 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.796 1.188 . . . . 0.0 113.835 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -64.39 158.75 22.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.929 1.365 . . . . 0.0 112.422 -171.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 6.5 mt-10 -137.77 -19.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.327 1.451 . . . . 0.0 110.893 172.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.65 159.24 42.62 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.315 1.846 . . . . 0.0 109.042 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.571 HG12 HG13 ' A' ' 70' ' ' VAL . 3.5 t -137.62 139.82 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 158.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.523 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.5 mt -112.74 117.85 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.571 HG13 HG12 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -134.81 138.85 48.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 O-C-N 121.773 -0.58 . . . . 0.0 110.974 -164.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -77.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.598 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.87 -36.69 1.22 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.577 1.081 . . . . 0.0 115.459 -170.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.563 HD12 HG11 ' A' ' 70' ' ' VAL 0.252 6.2 tt 44.5 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 128.828 2.851 . . . . 0.0 113.971 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.85 169.67 40.61 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.296 1.903 . . . . 0.0 110.759 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -48.45 64.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.401 1.481 . . . . 0.0 114.007 -161.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.67 -24.03 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.02 -31.12 13.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.518 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mm -52.49 -46.95 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.25 54.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.62 -50.06 14.73 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.066 1.303 . . . . 0.0 111.279 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.447 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -38.09 -56.19 1.19 Allowed 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.806 1.643 . . . . 0.0 109.831 161.462 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -12.24 61.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 124.609 1.193 . . . . 0.0 112.081 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.8 -18.29 48.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.251 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.59 13.32 3.75 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.293 0.951 . . . . 0.0 113.3 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.98 27.54 59.76 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 121.347 -0.845 . . . . 0.0 111.847 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 2.1 t -79.67 110.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -170.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -57.16 151.85 14.73 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.863 0.465 . . . . 0.0 110.095 -168.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 90' ' ' LYS . 3.4 t -128.78 89.59 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-O 121.447 0.641 . . . . 0.0 110.543 -174.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . 0.258 36.7 mt -76.52 85.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 123.365 1.555 . . . . 0.0 109.591 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HG3' HG12 ' A' ' 88' ' ' VAL . 21.1 mtpt -80.75 142.01 34.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.896 2.079 . . . . 0.0 112.148 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.9 22.15 7.77 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.873 1.225 . . . . 0.0 112.484 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.78 165.98 24.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.567 1.683 . . . . 0.0 112.058 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -151.66 165.25 34.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.924 2.89 . . . . 0.0 105.136 158.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 125.36 175.45 14.22 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.953 0.797 . . . . 0.0 113.487 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 p -79.83 156.35 27.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.4 ' CG2' HG11 ' A' ' 7' ' ' VAL . 60.9 t -54.99 -47.87 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -54.69 -29.73 53.72 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.49 -45.84 8.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.651 1.981 . . . . 0.0 110.389 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' A' ' 69' ' ' ILE . 56.3 t -50.65 -45.69 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.977 1.311 . . . . 0.0 109.822 172.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.32 -48.39 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.756 0.822 . . . . 0.0 108.918 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.892 0.769 . . . . 0.0 111.188 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -54.9 -42.61 72.37 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.895 0.878 . . . . 0.0 110.272 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -69.48 -49.39 55.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.646 0.778 . . . . 0.0 113.067 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.71 -21.69 66.08 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.252 0.478 . . . . 0.0 111.121 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -81.25 -30.43 34.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.197 0.599 . . . . 0.0 109.72 171.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.37 2.0 17.98 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.48 1.514 . . . . 0.0 113.945 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -82.84 -30.31 28.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.83 0.815 . . . . 0.0 110.401 -165.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.94 136.74 45.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.823 1.249 . . . . 0.0 109.886 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 125.464 1.506 . . . . 0.0 112.279 -166.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.405 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 58.3 ttm . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.421 HG22 ' CD1' ' A' ' 29' ' ' PHE . 4.3 mt -131.59 143.67 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 172.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.474 HG12 HD12 ' A' ' 67' ' ' LEU . 46.2 mt -128.78 100.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 127.395 2.278 . . . . 0.0 106.844 -166.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 1.013 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -81.81 127.21 32.74 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.784 0.434 . . . . 0.0 110.71 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 96' ' ' VAL . 97.0 mt -130.24 116.82 17.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.83 127.01 9.82 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.262 1.975 . . . . 0.0 107.745 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 m -127.74 148.08 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.7 m -76.25 -22.01 55.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.526 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.48 171.75 13.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.218 1.407 . . . . 0.0 108.056 -173.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -113.69 40.4 2.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.818 1.647 . . . . 0.0 113.412 -165.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -86.0 39.01 0.79 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.982 0.513 . . . . 0.0 111.026 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.86 -95.82 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.954 2.216 . . . . 0.0 113.694 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -41.37 22.31 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.527 1.164 . . . . 0.0 112.315 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.56 -3.25 14.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.39 1.476 . . . . 0.0 111.205 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -49.68 117.63 7.43 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.603 1.961 . . . . 0.0 110.57 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.2 135.69 11.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.741 2.294 . . . . 0.0 111.655 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.59 129.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.485 0.659 . . . . 0.0 111.118 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.81 164.29 15.29 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.16 1.784 . . . . 0.0 108.979 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.37 -52.99 5.76 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 121.075 -1.016 . . . . 0.0 110.488 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -97.39 94.99 7.37 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -161.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -42.91 -52.41 5.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.586 0.63 . . . . 0.0 111.573 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.58 9.91 40.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.577 -176.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 -149.1 56.11 1.0 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.4 137.81 20.04 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.12 -20.25 19.29 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.939 1.759 . . . . 0.0 113.294 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -149.58 165.05 33.43 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.604 1.093 . . . . 0.0 109.558 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.02 106.76 8.23 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.368 1.467 . . . . 0.0 108.65 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 88.83 5.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 1.013 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -80.54 91.85 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.183 1.393 . . . . 0.0 108.298 166.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.49 155.5 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -99.69 -170.68 1.93 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.907 -1.121 . . . . 0.0 109.242 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 t -146.59 146.93 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 114.86 8.14 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 127.844 2.458 . . . . 0.0 105.311 169.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 m120 43.4 60.46 2.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.472 1.109 . . . . 0.0 111.03 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 64.95 6.25 3.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.465 1.906 . . . . 0.0 115.171 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.36 173.78 6.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.863 1.665 . . . . 0.0 108.879 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.1 -23.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 124.884 1.273 . . . . 0.0 113.597 -164.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.82 -77.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.715 1.206 . . . . 0.0 111.903 -155.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.54 172.17 19.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.881 2.072 . . . . 0.0 110.23 -161.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 mm -126.21 141.11 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 m -138.44 121.02 16.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.954 2.102 . . . . 0.0 106.296 166.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -137.02 79.14 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -88.28 158.21 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.41 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.88 162.7 15.79 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 167.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -100.17 99.84 10.38 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.46 -0.781 . . . . 0.0 108.926 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.91 -11.02 29.08 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.646 2.231 . . . . 0.0 114.444 -170.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.56 38.57 4.13 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.787 -1.196 . . . . 0.0 110.489 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 124.592 1.157 . . . . 0.0 110.477 168.624 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 116.72 -1.61 . . . . 0.0 114.906 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -46.51 -48.52 47.37 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 121.672 2.033 . . . . 0.0 110.989 161.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 60' ' ' VAL . 4.1 Cg_endo -67.17 -18.26 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 120.52 1.222 . . . . 0.0 113.081 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -68.34 -26.97 65.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.828 0.74 . . . . 0.0 111.15 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.01 -69.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.278 1.031 . . . . 0.0 108.849 165.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 57' ' ' PRO . 3.2 m -62.02 -29.02 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -166.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -63.87 -35.99 82.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.292 1.405 . . . . 0.0 110.729 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -15.54 62.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.27 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -86.05 37.07 0.7 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.191 1.36 . . . . 0.0 110.856 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.46 25.72 4.64 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.841 2.163 . . . . 0.0 116.957 165.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -72.22 173.78 8.13 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -164.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 19.9 mt-10 -142.4 -33.62 0.47 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.768 1.627 . . . . 0.0 111.657 -178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.5 tm? -138.14 156.19 47.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.461 1.104 . . . . 0.0 109.065 -173.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.782 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -148.7 144.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.714 1.205 . . . . 0.0 108.587 -177.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.423 HG21 HG13 ' A' ' 99' ' ' VAL . 52.1 mt -137.45 115.48 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.425 HG21 ' HB ' ' A' ' 73' ' ' ILE . 30.2 m -131.96 177.14 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.116 0.966 . . . . 0.0 109.923 -173.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.6 -80.45 0.39 Allowed 'General case' 0 C--O 1.226 -0.135 0 O-C-N 120.888 -1.133 . . . . 0.0 108.046 167.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.77 -19.01 8.47 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -164.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.425 ' HB ' HG21 ' A' ' 70' ' ' VAL 0.289 5.5 tt 35.84 -126.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 127.517 2.327 . . . . 0.0 113.708 175.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.82 140.68 3.1 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.306 1.908 . . . . 0.0 109.461 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -48.51 -44.09 35.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 116.987 -1.482 . . . . 0.0 113.44 -166.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -31.18 55.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.756 1.616 . . . . 0.0 112.463 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.57 -25.57 22.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.712 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.93 -51.69 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 167.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.42 -26.63 13.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.557 1.543 . . . . 0.0 113.132 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.52 -57.15 4.38 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.649 0.659 . . . . 0.0 111.454 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -59.17 -34.6 72.3 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.003 1.321 . . . . 0.0 110.985 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -54.62 -32.5 59.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.949 0.899 . . . . 0.0 111.793 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.4 -10.65 59.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.77 0.714 . . . . 0.0 112.452 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 ptm -124.4 10.2 8.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.508 1.523 . . . . 0.0 111.026 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.05 21.94 64.31 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 118.584 0.629 . . . . 0.0 112.182 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -80.83 119.66 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.06 146.56 49.23 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 119.123 -0.465 . . . . 0.0 110.308 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 t -133.71 107.93 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.808 1.186 . . . . 0.0 111.545 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -96.52 147.76 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.871 1.668 . . . . 0.0 108.608 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -172.6 2.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.072 1.349 . . . . 0.0 110.316 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.25 9.87 73.24 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 163.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -167.87 2.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.793 1.796 . . . . 0.0 111.442 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.32 159.01 14.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.492 1.917 . . . . 0.0 106.845 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 117.24 -169.67 13.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 112.618 170.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 p -79.89 167.85 20.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 5' ' ' ILE . 86.0 t -56.96 -54.03 35.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 123.718 0.807 . . . . 0.0 110.289 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -50.96 -40.81 58.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 -175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.85 -49.9 13.35 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.13 1.772 . . . . 0.0 109.307 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG13 HG21 ' A' ' 69' ' ' ILE . 24.3 t -50.44 -32.61 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.57 1.148 . . . . 0.0 110.867 173.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.2 t -82.98 -41.36 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -52.42 -48.89 65.48 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -58.71 -41.96 87.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.399 0.679 . . . . 0.0 111.693 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -65.37 -51.66 58.93 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.516 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -60.74 -26.71 67.39 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.944 0.778 . . . . 0.0 111.01 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.95 0.47 56.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 110.977 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.12 6.51 88.07 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 120.835 -1.165 . . . . 0.0 113.347 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -72.3 -48.71 40.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.77 1.285 . . . . 0.0 109.425 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 tp -81.52 134.69 35.55 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.11 1.364 . . . . 0.0 109.491 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 tptm . . . . . 0 C--N 1.33 -0.259 0 C-N-CA 124.453 1.101 . . . . 0.0 111.086 -176.778 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.513 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 24.2 ttm . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.969 0.89 . . . . 0.0 112.07 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.417 HG12 ' HE3' ' A' ' 31' ' ' LYS . 2.7 mt -140.3 144.0 28.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.18 104.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.346 2.658 . . . . 0.0 105.981 -163.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.957 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -82.16 143.95 31.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.108 0.163 . . . . 0.0 111.091 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 mt -145.38 106.77 4.41 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.61 117.84 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.351 2.034 . . . . 0.0 107.929 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.428 HG11 ' CB ' ' A' ' 15' ' ' SER . 1.5 m -112.18 159.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.719 1.608 . . . . 0.0 109.439 -174.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -85.25 -11.55 54.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 117.548 -1.215 . . . . 0.0 112.389 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -150.88 170.16 19.96 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.701 1.201 . . . . 0.0 108.296 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -98.77 103.1 15.02 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -137.76 38.57 2.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.378 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.09 -123.78 2.68 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.695 -1.253 . . . . 0.0 111.516 -174.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -35.93 63.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.956 1.378 . . . . 0.0 113.7 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -6.27 50.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.531 1.133 . . . . 0.0 111.311 -175.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.428 ' CB ' HG11 ' A' ' 7' ' ' VAL . 37.9 m -52.6 111.33 2.49 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 120.302 1.41 . . . . 0.0 110.166 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -67.38 134.3 32.99 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.595 2.197 . . . . 0.0 108.541 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tt -64.75 142.82 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.161 0.437 . . . . 0.0 110.309 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -81.2 -173.79 4.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.826 0.85 . . . . 0.0 108.967 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.14 -46.97 6.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.469 1.128 . . . . 0.0 108.737 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -99.41 165.56 11.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.671 1.189 . . . . 0.0 109.436 -159.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -120.42 -49.41 2.26 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.264 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 16.72 5.06 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.177 0.894 . . . . 0.0 114.593 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.74 39.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 129.073 2.949 . . . . 0.0 107.863 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.48 150.88 82.72 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 170.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.63 -22.5 12.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.802 2.335 . . . . 0.0 114.359 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -145.84 172.28 13.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.431 1.892 . . . . 0.0 109.074 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -133.96 110.29 9.59 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.665 1.186 . . . . 0.0 108.034 162.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.72 101.75 8.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 165.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.927 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.3 m-85 -88.72 104.72 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.17 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HE3' HG12 ' A' ' 2' ' ' ILE . 14.5 mtpt -98.88 -165.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.006 -1.059 . . . . 0.0 108.637 172.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.12 147.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 162.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 123.08 15.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 161.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.94 20.5 11.58 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 t30 86.83 9.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.437 2.695 . . . . 0.0 112.27 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.59 170.22 8.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.54 -22.77 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.202 1.801 . . . . 0.0 112.304 -163.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 50.5 -72.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.48 1.912 . . . . 0.0 112.766 -160.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -157.06 156.45 32.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.135 0.574 . . . . 0.0 112.472 -166.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mm -121.68 127.81 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.141 1.777 . . . . 0.0 108.0 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 t -120.57 97.28 5.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.254 13.0 p -106.72 61.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 122.743 1.258 . . . . 0.0 108.636 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.6 149.62 31.28 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.48 163.34 16.09 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.0 115.63 60.89 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.85 -7.02 19.5 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.419 2.079 . . . . 0.0 112.515 -175.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mt -135.45 39.85 2.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.931 2.093 . . . . 0.0 107.687 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.372 0 O-C-N 120.857 -1.152 . . . . 0.0 111.605 -173.803 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.69 -49.18 27.56 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 126.131 1.772 . . . . 0.0 108.289 164.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.8 -25.0 17.4 Favored 'Trans proline' 0 C--N 1.359 1.096 0 CA-C-N 121.349 1.518 . . . . 0.0 111.367 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.457 ' HA ' ' HE3' ' A' ' 61' ' ' LYS . 10.2 t30 -71.36 -28.71 64.25 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 119.854 1.207 . . . . 0.0 111.237 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -60.85 -70.99 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 162.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -62.57 -21.9 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 58' ' ' ASN . 6.3 mtmp? -66.12 -22.9 66.41 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.555 -1.341 . . . . 0.0 112.746 170.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -26.33 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 120.267 1.394 . . . . 0.0 109.614 172.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -85.74 38.6 0.76 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.975 0.91 . . . . 0.0 111.118 -165.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.08 14.6 39.89 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.725 2.107 . . . . 0.0 116.017 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -69.32 167.64 16.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.242 1.521 . . . . 0.0 114.395 -160.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 32.3 mt-10 -142.68 -21.86 0.66 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.197 0.999 . . . . 0.0 112.486 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 68' ' ' VAL . 1.9 tm? -142.47 155.03 45.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.73 1.212 . . . . 0.0 107.853 -171.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.957 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -152.16 138.61 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 99' ' ' VAL . 9.0 mt -130.01 110.72 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.556 HG13 HG12 ' A' ' 68' ' ' VAL . 19.1 m -133.45 156.01 41.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.615 1.566 . . . . 0.0 108.931 -167.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -99.3 -52.4 3.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.199 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.97 -49.17 0.59 Allowed Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.542 1.068 . . . . 0.0 113.036 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.506 HG12 ' H ' ' A' ' 74' ' ' GLY 0.255 4.9 tt 41.42 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 127.077 2.151 . . . . 0.0 112.626 -173.422 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.74 158.18 21.69 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 127.153 2.311 . . . . 0.0 109.356 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -45.03 -40.0 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 128.793 2.837 . . . . 0.0 114.511 -168.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -58.81 -34.02 71.03 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.001 -1.062 . . . . 0.0 112.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.84 -31.58 22.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.312 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.8 -51.66 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 166.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 0.66 1.98 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.31 -51.95 5.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 119.983 -1.698 . . . . 0.0 111.736 163.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -60.9 -37.3 81.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.684 1.194 . . . . 0.0 110.02 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -63.06 -15.87 58.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.062 0.945 . . . . 0.0 112.675 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.32 -15.81 61.38 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.436 -1.415 . . . . 0.0 110.97 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.7 ptp -131.81 5.75 4.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.583 1.953 . . . . 0.0 112.519 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.34 41.62 55.21 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -79.1 119.64 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -66.47 136.73 56.12 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.453 -0.779 . . . . 0.0 109.09 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.82 110.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 67' ' ' LEU . 24.0 mt -93.69 116.42 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 127.927 2.491 . . . . 0.0 106.126 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -117.04 135.12 53.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.785 0.434 . . . . 0.0 111.335 -173.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.04 2.29 13.94 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.671 1.605 . . . . 0.0 114.603 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 -177.96 5.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.458 1.629 . . . . 0.0 111.128 -168.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.4 p -164.61 153.76 13.18 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.925 -1.109 . . . . 0.0 108.383 -172.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.28 -144.65 15.43 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 112.106 -0.397 . . . . 0.0 112.106 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.7 p -105.94 173.0 6.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.194 1.398 . . . . 0.0 109.629 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.11 -57.82 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.59 -35.11 76.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.733 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.29 -51.7 41.91 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.64 1.176 . . . . 0.0 108.136 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.469 ' CG1' HG21 ' A' ' 69' ' ' ILE . 65.2 t -63.31 -29.5 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.186 0.995 . . . . 0.0 111.739 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.4 t -68.85 -51.34 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -56.22 -43.2 78.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.041 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -57.18 -51.21 70.22 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.708 1.14 . . . . 0.0 109.868 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.87 -43.64 57.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.124 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.43 -31.72 68.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.51 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 m -78.24 -12.66 60.01 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 113.271 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.6 5.87 68.6 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.272 0.942 . . . . 0.0 113.594 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -70.41 -37.11 74.4 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.792 1.296 . . . . 0.0 110.676 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mt -82.56 165.77 19.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.022 1.329 . . . . 0.0 112.432 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 tptm . . . . . 0 C--N 1.345 0.412 0 C-N-CA 125.578 1.551 . . . . 0.0 111.91 175.705 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.1 ptm . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.441 HG22 ' CD1' ' A' ' 29' ' ' PHE . 4.7 mt -130.16 141.15 47.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 175.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.483 HG23 HD12 ' A' ' 69' ' ' ILE . 35.5 mt -125.14 100.58 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.764 2.826 . . . . 0.0 106.384 -161.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.887 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -83.86 145.61 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.856 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.37 126.68 21.41 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 166.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -75.43 110.2 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 N-CA-C 106.252 -2.249 . . . . 0.0 106.252 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.98 161.73 8.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 122.465 1.126 . . . . 0.0 110.99 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -93.24 -22.91 18.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.848 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.1 165.21 32.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.661 1.119 . . . . 0.0 108.797 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -92.44 77.3 5.09 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.245 1.018 . . . . 0.0 109.475 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -124.01 57.7 1.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.77 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -24.72 119.52 0.02 OUTLIER Glycine 0 N--CA 1.47 0.931 0 C-N-CA 126.064 1.792 . . . . 0.0 112.655 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt 80.14 -58.02 0.34 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.779 3.232 . . . . 0.0 110.909 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.38 -6.23 9.6 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.627 1.171 . . . . 0.0 113.105 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 m -47.92 102.84 0.33 Allowed Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 130.3 3.44 . . . . 0.0 110.379 -167.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.23 123.62 7.31 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.203 1.936 . . . . 0.0 110.677 -170.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.481 HG21 ' HA ' ' A' ' 93' ' ' SER . 13.3 tt -56.71 143.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 122.111 0.957 . . . . 0.0 109.406 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.08 168.77 9.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.79 1.236 . . . . 0.0 109.411 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.6 -40.49 18.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.779 -0.576 . . . . 0.0 111.899 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -101.05 172.51 6.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.765 1.226 . . . . 0.0 108.575 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -120.2 -51.79 2.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 173.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -7.05 7.57 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.132 171.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ttp-105 -144.32 39.43 1.3 Allowed 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 126.011 1.724 . . . . 0.0 109.625 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.91 123.95 87.46 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 163.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.95 -19.72 34.84 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 120.801 1.322 . . . . 0.0 112.669 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -148.04 161.49 41.28 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.153 0.888 . . . . 0.0 109.697 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -135.77 106.46 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 108.287 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.92 93.68 5.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.887 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -82.16 95.64 7.57 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 171.768 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -79.65 151.86 4.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE3' HG12 ' A' ' 2' ' ' ILE . 16.7 mtpt -103.72 -174.37 2.53 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.694 -1.254 . . . . 0.0 110.16 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.19 137.69 19.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.53 -0.731 . . . . 0.0 109.098 165.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 7.4 ttpt -142.68 125.97 16.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 53.06 39.61 29.8 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.836 0.744 . . . . 0.0 112.586 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.93 12.41 1.74 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.008 2.123 . . . . 0.0 114.487 -174.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.24 168.77 8.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.118 1.367 . . . . 0.0 108.223 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.42 -19.04 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.233 1.413 . . . . 0.0 112.076 -164.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.419 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 52.61 -66.71 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.16 2.184 . . . . 0.0 113.835 -167.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.79 178.72 9.5 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.977 1.311 . . . . 0.0 111.387 174.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.36 142.71 41.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.816 0.846 . . . . 0.0 108.798 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -113.18 88.92 2.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.875 2.47 . . . . 0.0 107.311 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.35 72.92 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 122.947 1.356 . . . . 0.0 107.626 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.67 151.0 22.72 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -73.77 150.74 40.91 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.099 1.359 . . . . 0.0 109.848 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -82.62 116.6 64.8 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.48 -8.8 24.14 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.722 2.281 . . . . 0.0 114.668 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.86 39.78 2.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.235 1.814 . . . . 0.0 109.464 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.382 0 O-C-N 119.655 -1.903 . . . . 0.0 111.934 -179.42 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -51.02 80.87 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 119.131 0.878 . . . . 0.0 109.775 170.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' HG22 ' A' ' 60' ' ' VAL . 17.9 Cg_endo -72.64 -28.54 14.03 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.426 2.084 . . . . 0.0 111.688 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.84 -45.26 70.85 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.277 0.631 . . . . 0.0 109.675 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -57.97 -68.23 0.27 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.706 0.803 . . . . 0.0 111.274 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 57' ' ' PRO . 7.6 m -61.41 -18.79 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 120.118 -1.614 . . . . 0.0 113.755 -171.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -68.68 -26.6 65.38 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.18 1.355 . . . . 0.0 111.766 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -23.32 62.91 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.809 1.186 . . . . 0.0 111.124 171.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -85.11 38.93 0.74 Allowed 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.949 -1.094 . . . . 0.0 111.408 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.53 28.32 4.84 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.891 2.186 . . . . 0.0 115.686 163.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -76.19 168.32 20.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.038 0.919 . . . . 0.0 113.054 -160.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 17.9 mt-10 -143.2 -33.35 0.44 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.323 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 87' ' ' LYS . 5.7 tp -126.1 152.66 45.58 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.203 0.91 . . . . 0.0 108.878 175.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.9 t -136.57 139.39 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 161.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.513 HG21 ' CG1' ' A' ' 99' ' ' VAL . 4.1 mt -115.66 121.79 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 172.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 73' ' ' ILE . 24.2 m -133.31 162.6 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.823 1.249 . . . . 0.0 109.892 -170.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -91.65 -75.05 0.49 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.67 -27.17 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.187 -1.341 . . . . 0.0 114.849 -171.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.533 HG12 ' H ' ' A' ' 74' ' ' GLY 0.265 4.5 tt 37.27 -143.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.392 2.277 . . . . 0.0 112.603 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.533 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.44 156.01 20.1 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 127.785 2.612 . . . . 0.0 109.875 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.29 82.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.205 1.002 . . . . 0.0 112.081 -172.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -32.99 60.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.521 175.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.98 -40.59 16.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.99 -1.481 . . . . 0.0 111.193 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -44.82 -46.84 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 119.589 1.086 . . . . 0.0 108.886 166.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.73 -11.73 13.46 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 119.861 -1.774 . . . . 0.0 114.951 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.48 -32.88 14.72 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.123 1.329 . . . . 0.0 113.459 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.482 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -46.64 -55.94 6.9 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.748 -1.22 . . . . 0.0 109.07 154.531 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -69.66 -3.17 13.98 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 124.577 1.173 . . . . 0.0 110.294 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -10.16 48.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 119.507 1.049 . . . . 0.0 110.853 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.2 5.69 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.29 33.55 84.85 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.856 0.753 . . . . 0.0 111.767 -168.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 4.9 t -80.41 96.86 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.14 -1.212 . . . . 0.0 110.606 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.585 ' HB3' HD12 ' A' ' 67' ' ' LEU . 5.9 tttp -49.92 145.79 5.23 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.727 1.611 . . . . 0.0 111.94 -169.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' CG2' ' CD2' ' A' ' 81' ' ' PHE . 1.2 t -125.89 107.55 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.082 0.468 . . . . 0.0 111.283 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.8 mt -93.05 99.47 9.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -83.69 165.82 18.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.195 0.521 . . . . 0.0 110.119 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.86 17.77 69.37 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-O 118.522 -1.155 . . . . 0.0 114.044 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.44 166.61 19.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.609 1.205 . . . . 0.0 110.106 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.481 ' HA ' HG21 ' A' ' 17' ' ' ILE . 5.5 p -152.64 159.04 43.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.87 1.668 . . . . 0.0 106.917 169.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 -175.62 15.82 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.349 0.976 . . . . 0.0 113.093 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.1 p -79.68 160.67 26.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.622 -0.928 . . . . 0.0 109.029 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -46.67 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -171.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -27.35 67.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.29 -60.98 2.15 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 69' ' ' ILE . 53.4 t -46.52 -56.06 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.306 1.443 . . . . 0.0 109.419 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.14 -52.87 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 125.334 1.454 . . . . 0.0 109.045 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -54.71 -42.84 71.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.893 0.77 . . . . 0.0 111.548 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -60.97 -44.54 97.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 112.285 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -63.79 -45.12 91.12 Favored 'General case' 0 CA--C 1.519 -0.219 0 O-C-N 121.333 -0.854 . . . . 0.0 113.273 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.5 -32.23 70.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.3 0.955 . . . . 0.0 110.498 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -74.79 -9.91 59.0 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.22 0.608 . . . . 0.0 111.707 174.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.98 3.84 87.48 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.386 1.469 . . . . 0.0 113.074 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -71.0 -50.49 33.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.743 1.772 . . . . 0.0 109.488 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.04 145.31 56.11 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.972 1.709 . . . . 0.0 110.618 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.446 ' HA ' ' OE2' ' A' ' 66' ' ' GLU . 3.8 ptp . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 mt -136.03 148.06 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.5 mt -125.65 109.75 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 129.049 2.94 . . . . 0.0 106.271 -168.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.892 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.27 148.15 28.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.288 169.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 87.4 mt -140.47 116.71 7.78 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 167.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.33 125.25 12.14 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.269 1.979 . . . . 0.0 108.496 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.578 HG23 ' HB2' ' A' ' 26' ' ' TYR . 13.5 m -121.51 157.9 24.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 119.247 0.931 . . . . 0.0 111.541 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -90.8 -20.74 22.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 116.69 -1.624 . . . . 0.0 113.325 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -147.99 150.01 33.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.199 1.399 . . . . 0.0 107.67 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -80.55 39.35 0.47 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.128 1.771 . . . . 0.0 113.694 -166.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 -82.87 39.83 0.65 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.561 -1.337 . . . . 0.0 112.94 -166.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.74 -137.27 35.91 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 120.44 1.473 . . . . 0.0 111.493 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -28.66 29.31 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -4.86 57.37 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 112.482 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.414 ' HB3' HG21 ' A' ' 7' ' ' VAL . 29.9 m -51.72 115.14 6.04 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.082 1.353 . . . . 0.0 111.681 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.19 134.96 18.12 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.629 2.219 . . . . 0.0 110.318 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.22 141.56 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.272 1.029 . . . . 0.0 110.819 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.15 156.56 17.26 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.784 1.233 . . . . 0.0 110.195 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -70.14 -39.98 75.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.857 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -133.58 117.2 16.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.677 2.035 . . . . 0.0 109.706 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -41.82 -53.75 3.61 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 112.42 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.69 63.57 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.645 -164.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.55 38.99 2.23 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 120.504 2.152 . . . . 0.0 108.161 162.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.81 125.95 91.57 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.51 -16.42 54.52 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.281 1.321 . . . . 0.0 113.017 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.578 ' HB2' HG23 ' A' ' 7' ' ' VAL . 84.9 m-85 -150.39 149.03 29.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.283 1.033 . . . . 0.0 108.955 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.44 103.69 9.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.071 0.949 . . . . 0.0 108.643 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.82 106.8 13.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.892 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.7 m-85 -95.15 89.46 5.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.954 1.302 . . . . 0.0 107.532 171.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.69 147.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -89.2 -170.6 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.327 -0.858 . . . . 0.0 108.722 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 89.6 t -142.92 128.37 16.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 162.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 38' ' ' ALA . 7.1 ttpt -94.88 104.45 16.34 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.0 t30 59.25 -81.4 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.064 . . . . 0.0 110.533 -171.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -135.7 -0.27 2.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 130.449 3.5 . . . . 0.0 113.325 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' VAL . . . -111.9 -179.29 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.049 1.74 . . . . 0.0 108.953 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.31 -22.18 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 121.413 1.915 . . . . 0.0 113.946 -169.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 53.22 -74.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.247 1.385 . . . . 0.0 112.331 -160.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -163.36 153.34 15.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.323 1.049 . . . . 0.0 110.302 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.0 mm -78.39 155.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.081 1.353 . . . . 0.0 107.854 168.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -127.73 154.88 44.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 141.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 70.53 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 122.8 1.286 . . . . 0.0 108.546 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.0 131.59 35.83 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.085 1.354 . . . . 0.0 108.759 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.12 162.65 27.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.375 0.607 . . . . 0.0 111.616 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -78.42 95.39 0.17 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 131.461 3.904 . . . . 0.0 114.733 -168.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.89 -25.18 23.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.385 1.39 . . . . 0.0 114.307 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.24 39.64 3.24 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.881 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . . . . . . . . 0 C--O 1.235 0.335 0 C-N-CA 125.007 1.323 . . . . 0.0 111.501 -171.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.489 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.469 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 2.0 t -57.45 -51.67 80.0 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 5.2 Cg_exo -65.69 -28.99 51.86 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.37 1.38 . . . . 0.0 112.416 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -32.54 74.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.584 1.084 . . . . 0.0 110.323 178.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -65.41 -61.99 1.79 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 57' ' ' PRO . 5.4 m -61.87 -23.92 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 120.383 1.447 . . . . 0.0 113.261 -174.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -21.14 63.87 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 120.848 -1.158 . . . . 0.0 112.809 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.18 -19.36 54.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 120.665 1.575 . . . . 0.0 111.537 170.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -85.07 37.9 0.69 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.16 21.14 5.36 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.601 2.524 . . . . 0.0 115.735 169.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -68.05 167.47 13.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.011 1.405 . . . . 0.0 114.548 -163.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.446 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 9.5 mt-10 -137.96 -31.13 0.78 Allowed 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.504 1.122 . . . . 0.0 111.902 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.63 152.77 51.96 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.623 1.169 . . . . 0.0 108.783 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.857 HG13 ' HB3' ' A' ' 4' ' ' ALA . 4.9 t -139.11 146.5 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 168.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.51 HG21 ' CG1' ' A' ' 99' ' ' VAL . 53.4 mt -131.65 118.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -134.61 169.49 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 111.356 -168.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -112.69 -42.34 3.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.501 -1.374 . . . . 0.0 113.439 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.93 42.48 0.78 Allowed Glycine 0 N--CA 1.469 0.836 0 C-N-CA 125.197 1.38 . . . . 0.0 111.648 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.2 tt -58.97 166.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.744 1.217 . . . . 0.0 111.087 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.58 161.51 13.25 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.679 1.133 . . . . 0.0 110.744 170.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -30.09 59.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.275 1.43 . . . . 0.0 113.486 -174.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -53.63 -43.45 68.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 111.127 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.98 29.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.235 -1.364 . . . . 0.0 112.047 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.07 -49.48 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 120.337 1.426 . . . . 0.0 107.328 164.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -13.64 50.61 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.46 -60.77 2.12 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 110.07 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.77 -38.73 72.88 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.8 2.04 . . . . 0.0 109.553 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.92 -19.76 53.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.542 0.737 . . . . 0.0 112.944 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.85 -12.58 61.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.025 -1.672 . . . . 0.0 112.491 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.81 7.29 6.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.638 1.175 . . . . 0.0 114.064 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.15 24.76 74.68 Favored Glycine 0 C--O 1.241 0.558 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.972 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.11 116.33 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -69.99 141.76 52.91 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.78 97.82 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.7 mt -75.64 144.85 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.636 1.174 . . . . 0.0 108.363 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -125.38 173.19 9.03 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.075 1.75 . . . . 0.0 109.054 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.37 57.78 16.95 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.899 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.14 165.53 12.81 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 124.368 0.687 . . . . 0.0 110.788 165.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.3 p -146.49 164.07 33.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.361 1.864 . . . . 0.0 108.436 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.38 -166.8 24.44 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 118.794 0.725 . . . . 0.0 113.486 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.4 p -85.18 165.7 17.19 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 121.547 -0.972 . . . . 0.0 111.7 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -50.41 -56.25 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 C-N-CA 124.523 1.129 . . . . 0.0 110.081 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -59.8 -27.46 66.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -82.83 -53.39 5.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.519 1.528 . . . . 0.0 107.893 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.51 ' CG1' HG21 ' A' ' 69' ' ' ILE . 53.0 t -52.84 -43.99 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.416 1.486 . . . . 0.0 110.145 177.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.07 -53.24 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.03 -39.66 90.63 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.301 -0.874 . . . . 0.0 111.91 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.46 -39.39 94.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.343 0.974 . . . . 0.0 110.645 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -64.32 -52.0 60.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.42 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -56.46 -36.03 68.6 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.006 0.922 . . . . 0.0 109.14 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.8 m -77.18 0.96 19.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.656 1.182 . . . . 0.0 112.697 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.5 9.91 84.59 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.894 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -80.0 -43.64 21.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 119.355 1.578 . . . . 0.0 109.84 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.32 141.38 48.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.175 0 C-N-CA 127.538 2.335 . . . . 0.0 108.198 177.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.566 0.209 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 29' ' ' PHE . 23.0 mt -109.34 151.36 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 160.077 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.81 108.48 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 C-N-CA 130.011 3.324 . . . . 0.0 105.16 -169.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.895 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.68 153.73 29.11 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.272 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.9 mt -146.4 113.93 4.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.58 124.95 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 N-CA-C 106.852 -2.018 . . . . 0.0 106.852 170.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.43 155.47 15.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 -19.84 30.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 -177.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -149.43 153.37 37.22 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 -177.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -93.7 64.22 3.48 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.956 0.884 . . . . 0.0 111.537 -169.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -106.48 42.03 1.34 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.598 -166.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 24.38 80.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.701 1.619 . . . . 0.0 115.481 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 80.67 -46.26 0.26 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.153 2.981 . . . . 0.0 112.604 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -0.06 0.63 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.015 0.825 . . . . 0.0 112.169 162.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -51.0 107.97 0.94 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.713 2.805 . . . . 0.0 111.769 169.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.94 130.62 5.77 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.996 2.464 . . . . 0.0 110.209 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.41 134.35 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.951 1.301 . . . . 0.0 112.052 -175.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -70.15 169.42 13.6 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.85 1.66 . . . . 0.0 109.274 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -92.48 -23.11 19.24 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.324 -0.86 . . . . 0.0 111.12 174.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -108.48 171.23 7.53 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -170.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -120.76 -57.57 1.88 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.35 -3.14 11.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.731 -169.036 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -143.49 38.51 1.38 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.415 1.607 . . . . 0.0 108.703 169.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.86 152.57 96.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.96 -20.73 7.33 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.779 2.319 . . . . 0.0 113.606 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -152.85 157.1 40.23 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.868 1.267 . . . . 0.0 109.489 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -123.07 108.36 12.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.036 1.334 . . . . 0.0 107.893 174.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.42 87.5 5.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 165.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.895 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.2 m-85 -70.86 142.9 51.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 157.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 16.2 mtpt -84.71 -168.48 2.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.102 0.865 . . . . 0.0 109.523 -179.035 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.63 143.12 26.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 162.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -139.45 133.91 31.61 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 127.428 2.291 . . . . 0.0 105.38 169.268 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 32.47 57.24 0.4 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.241 1.817 . . . . 0.0 112.702 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.53 12.98 5.83 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.982 2.513 . . . . 0.0 116.769 -178.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.03 -179.6 4.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.243 1.817 . . . . 0.0 109.586 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.33 -23.46 31.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 125.222 1.409 . . . . 0.0 113.611 -164.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.05 -74.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.105 1.32 . . . . 0.0 112.48 -160.164 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.17 160.25 39.71 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.533 1.933 . . . . 0.0 111.049 -160.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mm -124.87 134.62 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.507 1.923 . . . . 0.0 106.788 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 m -138.95 72.14 1.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.608 2.763 . . . . 0.0 106.941 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 2.2 t -77.22 97.75 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.311 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -96.27 159.84 14.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.886 173.21 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -57.41 163.51 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 110.848 167.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.33 95.93 3.28 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 159.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.51 3.46 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.217 2.612 . . . . 0.0 113.098 -176.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.26 39.11 2.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.016 1.326 . . . . 0.0 109.003 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.582 0 O-C-N 120.751 -1.218 . . . . 0.0 111.489 -171.508 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 118.318 -0.848 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.416 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 2.0 t -50.13 -52.69 51.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 119.521 1.055 . . . . 0.0 109.665 173.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 1.8 Cg_endo -71.05 -29.99 17.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.521 2.147 . . . . 0.0 111.974 178.562 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.4 -32.78 74.59 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.428 -0.795 . . . . 0.0 110.596 -177.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -58.66 -65.69 0.62 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 109.925 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.81 -27.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -171.526 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -63.83 -19.96 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.984 0.913 . . . . 0.0 112.65 173.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -20.68 44.91 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.084 0.856 . . . . 0.0 111.984 169.131 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -86.83 38.03 0.78 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.677 -1.264 . . . . 0.0 111.419 -170.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.27 19.83 8.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.329 1.919 . . . . 0.0 115.918 166.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.46 168.43 19.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.185 1.492 . . . . 0.0 113.278 -163.415 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -143.38 -27.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.442 1.097 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.734 HD12 ' H ' ' A' ' 68' ' ' VAL . 41.9 tp -135.88 158.64 43.9 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.963 0.801 . . . . 0.0 110.241 176.012 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.861 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -150.66 122.87 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -174.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.446 HG21 ' CG1' ' A' ' 99' ' ' VAL . 82.4 mt -114.59 107.67 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 108.628 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.43 176.07 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.729 2.012 . . . . 0.0 111.966 -174.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -96.5 -94.36 0.21 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 164.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.97 -40.52 8.03 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.588 -0.562 . . . . 0.0 114.072 -167.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.529 HG12 ' H ' ' A' ' 74' ' ' GLY 0.281 3.0 tt 44.55 -138.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.939 1.696 . . . . 0.0 112.537 -176.423 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.42 155.37 15.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 129.61 3.481 . . . . 0.0 109.219 174.075 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.56 -34.15 73.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.989 1.394 . . . . 0.0 111.785 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -55.56 -23.41 26.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 171.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.84 13.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.205 0.911 . . . . 0.0 110.857 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.73 -46.35 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 166.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.53 -31.91 25.92 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.533 1.533 . . . . 0.0 114.566 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.5 -55.27 5.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.02 0.827 . . . . 0.0 110.526 -177.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.425 ' CD1' HG11 ' A' ' 86' ' ' VAL . 53.7 m-85 -62.14 -31.45 71.93 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.436 1.094 . . . . 0.0 110.799 177.03 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -56.56 -32.58 65.31 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.196 -0.94 . . . . 0.0 112.302 170.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -18.69 61.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.713 0.688 . . . . 0.0 111.601 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.487 ' SD ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -113.75 6.04 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.404 1.482 . . . . 0.0 110.785 -178.949 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.81 23.67 69.33 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.941 -1.1 . . . . 0.0 111.982 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' A' ' 84' ' ' MET . 56.0 t -79.4 117.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.021 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -58.72 145.12 41.39 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.429 1.492 . . . . 0.0 109.38 174.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.05 128.3 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 109' ' ' LYS . 13.5 mt -115.16 131.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.325 2.65 . . . . 0.0 105.101 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.2 135.86 43.32 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.769 1.228 . . . . 0.0 108.775 -170.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.14 2.95 6.38 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.673 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.78 173.64 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.079 1.44 . . . . 0.0 111.13 -173.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 p -161.99 165.13 27.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.198 1.799 . . . . 0.0 106.65 156.244 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.62 -163.05 16.42 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 122.264 0.924 . . . . 0.0 112.601 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 162.92 24.78 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.212 -1.169 . . . . 0.0 111.098 -178.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -53.05 -49.74 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 123.007 0.523 . . . . 0.0 109.605 174.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -62.22 -26.67 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -80.65 -54.61 5.49 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 107.828 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.446 ' CG1' HG21 ' A' ' 69' ' ' ILE . 54.7 t -53.84 -45.5 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -178.385 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.04 -42.8 92.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -58.0 -50.85 72.0 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.284 174.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -57.09 -41.72 79.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.197 0.908 . . . . 0.0 110.772 -172.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.25 -53.73 22.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.246 1.019 . . . . 0.0 112.134 174.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.2 -26.75 68.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.613 0.642 . . . . 0.0 110.822 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -82.54 -3.28 55.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 174.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.07 15.18 75.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 118.126 -1.374 . . . . 0.0 113.691 168.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -87.1 -30.08 21.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.984 1.392 . . . . 0.0 111.613 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 tp -74.86 166.53 23.48 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.152 -0.342 . . . . 0.0 111.347 -163.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.656 0 C-N-CA 124.267 1.027 . . . . 0.0 111.748 -170.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.464 HG12 HD23 ' A' ' 67' ' ' LEU . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.804 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 60' ' ' VAL . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 3' ' ' ILE . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 4' ' ' ALA . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.553 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.482 HG21 ' HB ' ' A' ' 73' ' ' ILE . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' HG21 ' A' ' 70' ' ' VAL . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.553 ' CG1' HG21 ' A' ' 69' ' ' ILE . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.513 0.197 . . . . 0.0 110.841 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.412 HG22 ' CD1' ' A' ' 29' ' ' PHE . 7.2 mt -115.3 153.25 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 165.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 mt -134.51 105.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.132 2.173 . . . . 0.0 105.812 -164.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.924 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.52 145.59 31.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.191 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.483 HD12 HG13 ' A' ' 96' ' ' VAL . 51.3 mt -145.94 114.59 4.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.35 129.42 15.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.574 1.516 . . . . 0.0 108.372 171.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 15' ' ' SER . 4.9 m -122.88 150.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 118.739 0.7 . . . . 0.0 109.185 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -68.1 -27.06 66.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.318 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.59 156.1 39.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.648 1.579 . . . . 0.0 107.91 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -85.73 95.59 9.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -125.8 39.64 3.91 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 108.582 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.19 -127.88 29.94 Favored Glycine 0 C--N 1.34 0.76 0 O-C-N 120.775 -1.203 . . . . 0.0 111.434 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -58.4 -45.79 87.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.182 1.393 . . . . 0.0 111.665 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -1.87 4.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.774 2.43 . . . . 0.0 114.304 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.464 ' HB3' HG11 ' A' ' 7' ' ' VAL . 27.3 m -52.99 109.01 1.24 Allowed Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.975 174.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.92 135.47 14.11 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.357 1.371 . . . . 0.0 108.964 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.47 134.37 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.047 0.939 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.38 169.9 12.5 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.876 1.27 . . . . 0.0 107.876 166.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -88.1 -55.32 3.8 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 121.472 -0.768 . . . . 0.0 110.554 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.63 85.57 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 -152.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -37.49 -47.17 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.411 1.484 . . . . 0.0 112.908 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.42 -14.34 41.18 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 118.7 -1.055 . . . . 0.0 115.276 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.59 48.02 1.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.09 2.156 . . . . 0.0 108.74 173.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.65 137.77 54.77 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 167.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.74 -25.29 28.83 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.454 2.103 . . . . 0.0 114.494 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -146.27 158.17 43.86 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.29 103.9 8.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.51 1.524 . . . . 0.0 107.896 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.11 79.02 6.72 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.526 1.53 . . . . 0.0 107.585 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.924 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.31 3.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.458 HG13 HD13 ' A' ' 40' ' ' ILE . 3.9 t -83.08 164.15 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.034 171.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.874 -1.141 . . . . 0.0 108.97 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG12 ' HG2' ' A' ' 1' ' ' MET . 11.9 p -150.18 147.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 161.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -123.54 113.71 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 173.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t30 54.58 -86.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.718 1.207 . . . . 0.0 111.687 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.94 12.24 2.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.685 1.594 . . . . 0.0 111.969 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.11 156.36 38.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.784 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.26 -32.32 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.096 1.758 . . . . 0.0 112.932 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 59.13 -51.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 115.497 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.68 161.98 16.05 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.06 0.944 . . . . 0.0 110.8 -160.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.458 HD13 HG13 ' A' ' 30' ' ' VAL . 2.8 mm -135.74 140.45 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.226 1.81 . . . . 0.0 107.73 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.79 88.5 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.734 2.013 . . . . 0.0 107.714 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 4.7 t -89.8 93.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 164.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.69 152.6 19.47 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 mp0 -56.88 152.87 11.93 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.448 1.099 . . . . 0.0 110.496 168.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -79.77 133.6 58.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 164.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.92 -9.72 26.25 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 CA-C-N 121.12 1.436 . . . . 0.0 112.121 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.78 39.65 0.96 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.023 1.329 . . . . 0.0 110.062 -163.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.47 85.84 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.295 -1.503 . . . . 0.0 112.336 -169.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.6 63.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 -171.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -144.29 -105.73 0.12 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.563 -161.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -64.93 -32.98 74.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.744 1.611 . . . . 0.0 112.991 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 t 49.97 84.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.626 1.97 . . . . 0.0 111.109 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.88 -176.76 5.65 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.211 -0.931 . . . . 0.0 109.981 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.96 21.39 0.28 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.509 1.052 . . . . 0.0 114.081 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.64 -20.24 17.1 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.602 1.701 . . . . 0.0 113.822 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.08 -53.44 48.45 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 119.227 0.921 . . . . 0.0 109.515 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' HG22 ' A' ' 60' ' ' VAL . 29.0 Cg_endo -72.48 -32.05 10.41 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.012 1.808 . . . . 0.0 111.899 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.1 -38.33 73.22 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.052 0.842 . . . . 0.0 110.922 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.75 -65.58 0.61 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.902 1.281 . . . . 0.0 110.991 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.81 -22.34 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.751 1.16 . . . . 0.0 113.904 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.48 -12.36 61.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.304 -1.498 . . . . 0.0 114.002 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -19.01 23.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.809 1.186 . . . . 0.0 109.781 165.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.15 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.171 0 O-C-N 119.87 -1.768 . . . . 0.0 111.239 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.53 20.11 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 127.34 2.4 . . . . 0.0 116.214 161.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.23 176.84 9.3 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -159.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -144.1 -53.32 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 124.63 1.172 . . . . 0.0 110.642 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.08 157.01 19.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.6 1.16 . . . . 0.0 109.363 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.88 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -136.51 139.65 44.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.386 2.275 . . . . 0.0 105.071 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.573 HG21 HG13 ' A' ' 99' ' ' VAL . 94.5 mt -131.47 111.37 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 68' ' ' VAL . 3.1 m -137.31 155.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.685 -162.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' HE ' ' HB3' ' A' ' 93' ' ' SER . 17.6 ttt-85 -95.08 -62.14 1.36 Allowed 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.763 -1.211 . . . . 0.0 111.243 -176.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.85 -54.42 1.3 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.791 -0.568 . . . . 0.0 113.929 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.493 HG12 ' H ' ' A' ' 74' ' ' GLY 0.299 3.7 tt 44.26 -168.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 130.102 3.361 . . . . 0.0 115.14 -173.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.36 167.19 39.82 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.319 1.914 . . . . 0.0 110.445 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.61 -31.76 73.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -163.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -64.74 -36.33 83.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.198 1.817 . . . . 0.0 109.642 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.73 63.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.265 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.42 -43.96 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 119.764 1.165 . . . . 0.0 109.626 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.23 10.93 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.196 -1.565 . . . . 0.0 114.934 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 57' ' ' PRO . . . -80.16 -58.56 3.09 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.259 1.424 . . . . 0.0 110.453 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.47 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -35.62 -56.29 0.67 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 126.953 2.101 . . . . 0.0 109.159 160.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.42 -9.94 55.82 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 117.421 -1.276 . . . . 0.0 111.733 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.9 63.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.725 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.2 14.92 5.66 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.311 0.382 . . . . 0.0 111.504 -163.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.25 26.78 56.84 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.09 -0.381 . . . . 0.0 112.765 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 1.9 t -79.64 108.15 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -168.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.66 28.49 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.975 1.71 . . . . 0.0 110.336 -170.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.07 95.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.5 139.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.81 154.06 47.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.986 -0.446 . . . . 0.0 110.845 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.12 38.62 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.084 0.85 . . . . 0.0 114.799 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.5 157.53 37.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.427 1.113 . . . . 0.0 110.869 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.43 ' HB3' ' HE ' ' A' ' 71' ' ' ARG . 65.2 p -159.46 130.33 5.93 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.127 0.971 . . . . 0.0 108.414 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.65 -130.86 6.28 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.906 -172.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.35 159.61 39.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.041 1.737 . . . . 0.0 111.329 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.483 HG13 HD12 ' A' ' 5' ' ' ILE . 22.5 t -63.71 -45.1 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.861 -1.149 . . . . 0.0 111.272 -166.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.53 -12.01 48.97 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.38 -43.49 5.41 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.007 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.573 HG13 HG21 ' A' ' 69' ' ' ILE . 76.3 t -46.03 -49.8 4.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.432 1.469 . . . . 0.0 110.547 169.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.47 -38.47 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.478 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -62.01 -50.97 69.93 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 117.329 -1.32 . . . . 0.0 110.307 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.26 -37.22 69.5 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.379 1.445 . . . . 0.0 111.575 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.04 -50.42 41.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.723 1.209 . . . . 0.0 111.94 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.8 mt -62.88 -30.63 71.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.097 0.408 . . . . 0.0 110.139 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.9 m -74.77 -1.09 20.49 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.924 2.09 . . . . 0.0 112.508 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.91 75.0 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 125.39 1.472 . . . . 0.0 112.916 168.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.5 -45.78 51.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.914 0.864 . . . . 0.0 108.705 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.97 134.88 38.74 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.602 1.161 . . . . 0.0 108.373 -166.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -158.72 178.78 9.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -124.55 14.12 8.78 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.089 2.156 . . . . 0.0 112.469 -162.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 t 49.34 -135.03 1.3 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.809 1.644 . . . . 0.0 111.456 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -146.68 113.95 6.26 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.974 1.71 . . . . 0.0 108.508 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -151.29 14.82 0.7 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -160.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -120.79 34.24 5.29 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.618 -1.302 . . . . 0.0 113.132 -166.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -45.82 137.06 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 125.182 1.393 . . . . 0.0 111.283 169.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -119.73 40.62 3.35 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.951 1.3 . . . . 0.0 111.41 -164.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -117.97 -26.52 6.41 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.614 1.566 . . . . 0.0 112.229 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -142.21 151.93 42.62 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.5 1.52 . . . . 0.0 108.33 -163.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -159.52 -171.25 3.23 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.518 1.527 . . . . 0.0 109.098 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -133.08 48.36 2.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.953 1.301 . . . . 0.0 109.028 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 54.23 173.65 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.092 1.357 . . . . 0.0 110.113 -141.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -71.53 -73.42 0.18 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 158.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 66.42 112.17 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.738 2.015 . . . . 0.0 109.187 -162.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 C--O 1.25 1.117 0 N-CA-C 104.567 -2.382 . . . . 0.0 104.567 160.755 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.591 HG22 ' CD1' ' A' ' 29' ' ' PHE . 24.1 mt -111.7 141.7 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.428 HG12 HD12 ' A' ' 67' ' ' LEU . 18.9 mt -122.41 102.65 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 129.424 3.09 . . . . 0.0 107.246 -168.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.909 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -80.15 145.74 32.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.985 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mt -138.64 117.97 9.53 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.21 108.63 2.02 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 N-CA-C 107.121 -1.915 . . . . 0.0 107.121 166.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 26' ' ' TYR . 12.2 m -101.1 158.9 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 119.065 0.848 . . . . 0.0 110.33 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -77.03 -33.11 57.42 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.154 1.782 . . . . 0.0 112.392 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -147.13 146.58 29.96 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -86.54 90.03 8.1 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 167.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -111.62 39.44 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.487 -1.244 . . . . 0.0 110.306 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 25.05 91.36 0.01 OUTLIER Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.581 2.039 . . . . 0.0 115.174 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt 80.19 -45.7 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.791 2.436 . . . . 0.0 112.068 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -20.13 65.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -33.36 102.34 0.21 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.972 2.909 . . . . 0.0 111.974 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.29 137.13 36.05 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 109.349 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 93' ' ' SER . 14.6 tt -60.78 140.17 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 t -75.83 177.71 6.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.211 1.004 . . . . 0.0 109.039 170.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 -13.94 21.43 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.489 -0.757 . . . . 0.0 112.616 -173.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -142.25 -179.5 6.29 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.888 2.075 . . . . 0.0 108.861 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -119.6 -42.55 2.63 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.424 0.69 . . . . 0.0 111.777 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 -16.3 55.49 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 117.578 -1.679 . . . . 0.0 116.947 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 39.09 1.49 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.999 1.719 . . . . 0.0 109.794 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.39 146.7 97.83 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 37.6 Cg_endo -74.37 -22.22 16.55 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.565 1.51 . . . . 0.0 114.055 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.5 ' HB2' HG23 ' A' ' 7' ' ' VAL . 95.6 m-85 -153.18 153.03 31.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.694 1.134 . . . . 0.0 109.418 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -113.31 109.18 18.31 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.711 0.264 . . . . 0.0 111.711 164.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 96.58 6.52 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.906 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.1 m-85 -83.34 96.39 8.5 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 164.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 t -79.64 168.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.82 -164.21 1.32 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.24 -1.537 . . . . 0.0 109.246 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -147.11 133.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 O-C-N 121.74 -0.6 . . . . 0.0 109.768 170.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -105.27 102.09 11.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 168.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.4 t30 55.28 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 111.964 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -140.03 34.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.686 1.595 . . . . 0.0 109.996 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.19 169.89 12.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.518 1.127 . . . . 0.0 108.412 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.11 -23.12 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.573 1.533 . . . . 0.0 113.588 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.4 -68.68 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.367 1.867 . . . . 0.0 114.228 -162.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -168.32 146.38 4.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.752 0.821 . . . . 0.0 110.412 -150.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mm -111.89 126.53 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.005 2.122 . . . . 0.0 107.072 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.37 80.46 1.61 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.55 1.54 . . . . 0.0 107.39 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.266 7.2 p -91.82 75.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.976 0.893 . . . . 0.0 109.012 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.01 160.41 25.88 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.55 -178.44 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.754 1.222 . . . . 0.0 111.437 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 48' ' ' ALA . 33.7 p-10 -100.31 85.51 0.54 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.023 3.329 . . . . 0.0 114.671 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.69 -24.79 74.9 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.257 1.972 . . . . 0.0 113.39 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.587 HD12 ' H ' ' A' ' 56' ' ' VAL . 1.6 tm? -120.24 56.2 0.98 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 123.593 1.664 . . . . 0.0 107.74 173.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . . . -59.2 -49.49 77.64 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.171 1.389 . . . . 0.0 109.904 162.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -145.6 5.93 1.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 116.833 -1.556 . . . . 0.0 112.659 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.44 97.6 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 121.558 1.981 . . . . 0.0 113.716 -166.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 41.76 26.53 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.71 2.404 . . . . 0.0 113.61 -166.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 m 33.12 55.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.625 2.77 . . . . 0.0 111.89 -169.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -117.51 -175.98 2.92 Favored 'General case' 0 C--O 1.242 0.683 0 O-C-N 121.49 -0.756 . . . . 0.0 110.491 -171.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.2 72.03 2.88 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 120.913 -1.117 . . . . 0.0 113.38 -163.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.41 -18.6 1.47 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.587 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -46.41 -55.15 14.85 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 122.505 2.411 . . . . 0.0 110.288 -176.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.25 -17.11 11.86 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.319 2.013 . . . . 0.0 112.197 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.68 -48.8 68.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -52.95 -66.09 0.45 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.45 1.1 . . . . 0.0 111.278 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.64 -17.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 120.297 -1.502 . . . . 0.0 113.156 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.98 -31.87 61.54 Favored 'General case' 0 N--CA 1.458 -0.049 0 O-C-N 120.922 -1.111 . . . . 0.0 111.746 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -26.47 68.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.968 1.258 . . . . 0.0 110.981 170.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -82.48 38.13 0.54 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.859 0.863 . . . . 0.0 111.029 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 40.55 30.83 0.34 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 129.375 3.369 . . . . 0.0 116.903 165.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -73.74 175.46 7.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.551 1.175 . . . . 0.0 113.696 -167.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.56 -37.88 0.41 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.281 1.433 . . . . 0.0 110.052 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.8 tm? -132.02 154.76 49.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.698 1.199 . . . . 0.0 109.435 -173.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.909 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -148.76 140.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.544 HG21 ' CG1' ' A' ' 99' ' ' VAL . 71.6 mt -126.0 110.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.512 HG13 HG12 ' A' ' 68' ' ' VAL . 19.9 m -126.55 164.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 109.813 -172.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.36 -100.5 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.31 66.2 0.35 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 125.277 1.417 . . . . 0.0 110.606 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.7 tt -57.96 172.44 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.128 1.771 . . . . 0.0 111.215 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.72 154.2 20.82 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.716 1.151 . . . . 0.0 110.945 169.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -51.57 -35.5 41.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.921 2.089 . . . . 0.0 114.374 -165.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -59.06 -28.4 66.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.624 1.102 . . . . 0.0 112.448 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.03 -31.72 27.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.68 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.6 mm -54.44 -50.13 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.72 -26.78 10.07 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 114.851 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.76 -51.61 11.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.915 0.78 . . . . 0.0 111.29 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -58.51 -35.43 72.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.046 1.339 . . . . 0.0 110.293 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -65.23 -7.77 14.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.029 0.932 . . . . 0.0 113.383 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.69 -25.43 33.01 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.906 1.685 . . . . 0.0 110.942 170.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 ptm -118.28 1.75 11.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.913 1.685 . . . . 0.0 112.648 -167.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.87 76.47 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 118.722 0.692 . . . . 0.0 111.548 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 t -79.74 121.43 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.48 146.51 36.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 p -138.72 93.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 109' ' ' LYS . 51.1 mt -72.04 124.39 28.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 126.11 1.764 . . . . 0.0 107.161 173.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 166.94 12.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.603 0.761 . . . . 0.0 110.676 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.25 18.54 73.3 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.003 -0.887 . . . . 0.0 113.31 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.36 170.36 12.03 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.906 1.353 . . . . 0.0 110.913 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.416 ' HA ' HG21 ' A' ' 17' ' ' ILE . 1.1 t -161.91 147.93 13.52 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.444 1.098 . . . . 0.0 108.055 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.08 -172.53 19.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.156 1.36 . . . . 0.0 112.587 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.5 p -79.86 163.19 24.57 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.441 -1.035 . . . . 0.0 109.26 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.29 -51.38 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.931 0.893 . . . . 0.0 110.049 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.75 -38.41 72.38 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 123.334 0.396 . . . . 0.0 111.268 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -77.54 -54.73 6.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.159 0.984 . . . . 0.0 108.625 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.544 ' CG1' HG21 ' A' ' 69' ' ' ILE . 16.4 t -54.52 -46.84 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.109 1.364 . . . . 0.0 110.785 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.65 -51.43 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -56.63 -42.54 79.03 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.69 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -55.86 -39.39 71.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.673 1.124 . . . . 0.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.19 -45.64 47.09 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.092 0.557 . . . . 0.0 112.23 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.6 mp -56.99 -35.07 68.77 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.3 m -86.29 1.73 49.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.356 1.462 . . . . 0.0 113.129 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.64 13.87 61.71 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.494 1.045 . . . . 0.0 114.02 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -74.93 -36.54 62.13 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.823 1.312 . . . . 0.0 110.186 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.21 161.98 23.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.119 0.968 . . . . 0.0 109.041 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 89' ' ' ILE . 1.2 tptt -129.61 179.67 5.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.755 1.222 . . . . 0.0 108.384 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -153.56 69.8 0.82 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -162.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.1 p -54.09 159.72 1.76 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.226 170.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -142.77 145.67 33.49 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -144.52 163.5 33.66 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.91 1.284 . . . . 0.0 108.782 -163.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -43.58 99.24 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 127.335 2.254 . . . . 0.0 112.165 -164.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.6 t -82.89 58.83 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 170.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -70.05 164.12 24.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 161.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -34.13 98.39 0.01 OUTLIER 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.667 2.387 . . . . 0.0 112.383 -168.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.88 159.72 31.53 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 122.209 -0.307 . . . . 0.0 110.377 170.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -144.99 149.91 35.99 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.022 -1.049 . . . . 0.0 111.838 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -156.9 129.68 7.68 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 125.637 1.575 . . . . 0.0 106.918 163.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.37 -177.54 5.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.095 0.958 . . . . 0.0 108.888 171.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 50.34 71.63 0.4 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.951 1.7 . . . . 0.0 112.261 170.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -162.45 168.7 21.6 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 161.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.902 0 C-N-CA 126.534 1.934 . . . . 0.0 106.866 140.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.464 HG12 HD23 ' A' ' 67' ' ' LEU . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.804 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.06 70.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -145.05 22.53 1.56 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -117.57 129.23 55.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.899 0.772 . . . . 0.0 110.619 -163.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.5 m170 61.06 -40.04 0.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.685 2.794 . . . . 0.0 114.049 -168.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t 56.75 24.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.902 1.681 . . . . 0.0 111.531 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -64.23 -70.48 0.22 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 120.914 -1.116 . . . . 0.0 108.096 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.87 41.35 0.04 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.72 -14.37 14.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 60' ' ' VAL . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 3' ' ' ILE . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 4' ' ' ALA . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.553 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.482 HG21 ' HB ' ' A' ' 73' ' ' ILE . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' HG21 ' A' ' 70' ' ' VAL . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.553 ' CG1' HG21 ' A' ' 69' ' ' ILE . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.75 158.85 40.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -135.74 45.56 2.41 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 126.48 1.912 . . . . 0.0 108.919 -164.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 m -44.2 152.06 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.498 1.919 . . . . 0.0 112.316 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.13 124.71 16.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -147.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.1 119.93 40.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.298 1.839 . . . . 0.0 110.3 -157.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.6 142.9 53.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 113.089 -173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t 32.41 58.75 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 128.851 2.86 . . . . 0.0 111.739 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 t60 57.88 -77.09 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.836 2.054 . . . . 0.0 111.306 -170.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.91 -34.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.454 1.102 . . . . 0.0 111.577 171.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 67.97 -4.37 1.03 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.614 1.566 . . . . 0.0 114.993 171.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -82.63 148.36 28.02 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 121.093 1.77 . . . . 0.0 109.942 -171.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.3 m170 57.73 165.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.732 2.413 . . . . 0.0 111.197 -169.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -141.54 161.18 38.54 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.501 1.12 . . . . 0.0 108.728 164.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.75 -28.06 13.02 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 66.19 -24.97 0.1 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.099 2.16 . . . . 0.0 116.099 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 171.108 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 29' ' ' PHE . 10.2 mt -139.45 141.01 36.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.01 104.33 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 127.561 2.344 . . . . 0.0 107.428 -163.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.953 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -79.73 140.37 36.98 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.7 mt -139.71 107.51 7.05 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 129.32 14.5 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.152 1.901 . . . . 0.0 108.129 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 15' ' ' SER . 13.7 m -134.37 152.06 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.169 0.588 . . . . 0.0 110.132 -170.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -74.32 -13.27 60.73 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.94 170.41 21.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.9 1.227 . . . . 0.0 109.381 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.5 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 37.2 p-10 -82.12 39.67 0.59 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.014 1.326 . . . . 0.0 112.809 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -81.46 41.01 0.6 Allowed 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.631 -1.293 . . . . 0.0 112.285 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.7 124.7 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.396 2.427 . . . . 0.0 114.791 -170.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 18.3 mtmt 80.32 -67.28 0.13 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.998 2.919 . . . . 0.0 109.984 -165.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -10.61 48.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.592 2.357 . . . . 0.0 112.954 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.415 ' HB3' HG11 ' A' ' 7' ' ' VAL . 5.0 m -35.91 99.08 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 130.46 3.504 . . . . 0.0 111.628 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.22 128.68 15.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tt -62.04 131.87 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 170.27 14.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.103 1.361 . . . . 0.0 108.409 170.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -89.92 -56.08 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -99.6 135.41 41.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -67.9 -41.32 82.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.16 -5.24 53.03 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.119 -1.934 . . . . 0.0 115.444 -164.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -144.12 38.73 1.31 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.593 1.697 . . . . 0.0 109.181 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.27 132.67 75.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.29 -19.01 17.65 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.743 1.628 . . . . 0.0 113.502 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.5 ' CE2' ' HB3' ' A' ' 10' ' ' ASN . 96.7 m-85 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.935 1.294 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.17 107.75 10.29 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.684 1.194 . . . . 0.0 108.515 170.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.96 91.63 5.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.921 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.4 m-85 -77.98 95.91 4.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 160.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -79.84 164.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -112.42 -170.43 1.66 Allowed 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.851 -1.156 . . . . 0.0 110.017 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -141.56 151.53 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 156.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -111.74 106.32 15.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 160.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 t30 57.76 -62.63 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.376 2.27 . . . . 0.0 115.754 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.0 12.01 1.6 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.199 1.4 . . . . 0.0 112.791 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.23 -157.58 0.62 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.738 1.615 . . . . 0.0 112.802 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.11 -30.78 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.607 1.163 . . . . 0.0 111.316 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . . . 53.36 -71.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 113.828 -161.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.04 165.98 32.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.281 1.432 . . . . 0.0 110.42 -160.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.77 147.1 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.5 1.12 . . . . 0.0 110.071 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -129.71 117.7 20.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.009 2.523 . . . . 0.0 105.977 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.97 70.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -79.71 146.2 32.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -62.3 143.31 57.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.963 0.905 . . . . 0.0 109.513 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -81.06 121.04 80.25 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.71 -37.76 34.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.342 2.028 . . . . 0.0 112.666 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.53 ' HB2' HG23 ' A' ' 56' ' ' VAL . 8.6 mt -126.87 39.38 3.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.217 0.917 . . . . 0.0 110.08 -168.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.03 87.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.01 0.823 . . . . 0.0 110.718 -173.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -139.8 60.16 1.57 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.252 1.021 . . . . 0.0 108.975 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -135.35 -154.28 0.57 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.229 -0.919 . . . . 0.0 110.545 -173.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -55.91 -16.5 4.78 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.474 1.488 . . . . 0.0 114.564 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.2 t 34.89 48.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 127.955 2.502 . . . . 0.0 113.356 165.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -92.37 41.1 1.06 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 119.705 -1.872 . . . . 0.0 108.336 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.81 30.96 45.87 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.906 -0.941 . . . . 0.0 113.529 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.75 -13.46 13.23 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.292 1.546 . . . . 0.0 114.376 -173.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 47' ' ' LEU . 1.8 t -48.53 -52.35 44.66 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.397 1.453 . . . . 0.0 108.587 167.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.2 -30.27 25.14 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.056 1.17 . . . . 0.0 112.962 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -69.33 -22.49 63.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.086 -0.384 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.05 -64.4 0.87 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.078 -0.963 . . . . 0.0 108.973 164.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -60.94 -26.15 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 121.095 1.771 . . . . 0.0 114.472 -170.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -59.75 -26.57 65.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.189 1.359 . . . . 0.0 113.449 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -21.57 60.21 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.457 1.026 . . . . 0.0 110.324 172.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -84.56 38.19 0.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.252 0.933 . . . . 0.0 110.302 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 28.77 42.33 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 129.901 3.619 . . . . 0.0 115.042 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 172.48 8.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.394 1.097 . . . . 0.0 112.405 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HA ' HG22 ' A' ' 86' ' ' VAL . 18.3 mt-10 -139.0 -27.51 0.82 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.246 -166.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -141.57 154.47 45.46 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.69 0.796 . . . . 0.0 110.827 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.953 HG13 ' HB3' ' A' ' 4' ' ' ALA . 3.3 t -150.17 103.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 120.994 -1.066 . . . . 0.0 110.129 -172.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.526 HG21 ' CG1' ' A' ' 99' ' ' VAL . 89.6 mt -91.49 100.9 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 119.735 -1.853 . . . . 0.0 107.457 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.524 HG13 HG12 ' A' ' 68' ' ' VAL . 32.7 m -122.08 171.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.747 1.158 . . . . 0.0 111.948 -170.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -114.36 -100.06 0.43 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.49 54.42 4.95 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.806 1.67 . . . . 0.0 113.091 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.3 tt -58.02 -170.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 125.772 1.629 . . . . 0.0 111.603 165.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.87 164.81 31.91 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 119.051 -2.281 . . . . 0.0 109.38 171.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -53.28 -46.65 69.37 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.107 0.954 . . . . 0.0 113.554 -168.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -51.42 -21.61 2.45 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.31 -39.79 9.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.739 0.816 . . . . 0.0 110.584 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.7 mm -48.35 -47.6 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 166.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.56 -21.03 36.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.667 1.587 . . . . 0.0 114.672 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.16 -57.44 4.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.223 0.92 . . . . 0.0 108.925 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.516 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 15.4 m-85 -60.71 -38.86 86.47 Favored 'General case' 0 N--CA 1.424 -1.767 0 C-N-CA 124.936 1.294 . . . . 0.0 109.403 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.79 -14.14 30.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.683 -1.151 . . . . 0.0 113.962 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.65 64.64 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 121.421 1.919 . . . . 0.0 111.929 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.64 18.6 5.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.108 1.363 . . . . 0.0 112.998 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.14 25.78 60.38 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.81 -1.181 . . . . 0.0 113.001 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 66' ' ' GLU . 6.8 t -78.56 112.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 -170.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -65.95 148.88 51.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.23 -169.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.405 ' O ' ' HE2' ' A' ' 90' ' ' LYS . 3.7 p -144.36 98.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 109' ' ' LYS . 72.0 mt -72.75 134.48 29.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.77 2.028 . . . . 0.0 107.101 166.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HE2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -110.58 174.97 5.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.077 0.551 . . . . 0.0 110.34 169.201 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.52 -2.98 65.43 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.689 -1.617 . . . . 0.0 115.547 168.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.61 -174.48 0.72 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.025 1.912 . . . . 0.0 112.575 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 p -170.49 153.04 4.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.964 2.106 . . . . 0.0 106.455 165.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.65 -168.96 22.57 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.814 0.721 . . . . 0.0 111.878 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -82.74 169.29 16.33 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.54 -0.976 . . . . 0.0 110.393 166.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.18 -53.99 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 123.56 0.744 . . . . 0.0 109.817 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.01 -17.09 36.12 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -99.28 -52.06 3.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.275 1.43 . . . . 0.0 108.678 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 69' ' ' ILE . 25.7 t -55.33 -40.04 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.631 1.572 . . . . 0.0 111.714 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.37 -59.4 2.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -60.95 -41.09 95.62 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.517 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.27 -37.15 66.92 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.314 1.416 . . . . 0.0 110.584 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 21.2 t80 -77.12 -50.04 13.92 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.253 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.74 -25.64 65.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.816 0.697 . . . . 0.0 111.044 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -27.93 40.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.814 -0.613 . . . . 0.0 111.749 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.96 3.31 19.89 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.644 1.116 . . . . 0.0 113.693 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -42.67 65.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.171 1.486 . . . . 0.0 110.445 -173.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -66.47 147.93 52.6 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 122.957 0.503 . . . . 0.0 110.245 -172.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.671 ' O ' HG23 ' A' ' 89' ' ' ILE . 6.7 tptt -111.01 146.19 37.13 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.366 1.066 . . . . 0.0 110.671 -172.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -126.37 56.68 1.44 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.791 1.636 . . . . 0.0 109.808 -166.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.5 t -60.39 163.55 5.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.006 1.322 . . . . 0.0 111.713 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -103.34 115.73 31.1 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.69 1.996 . . . . 0.0 106.988 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -87.89 152.78 21.83 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.431 1.092 . . . . 0.0 109.33 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -77.83 145.5 36.3 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.52 -174.01 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.466 1.506 . . . . 0.0 109.175 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -118.36 -66.56 1.06 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 119.535 -1.978 . . . . 0.0 109.465 -172.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -175.71 -87.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -162.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -160.07 173.03 16.44 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.135 1.774 . . . . 0.0 106.828 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -70.11 94.57 0.9 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 168.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 174.04 0.7 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 125.076 1.35 . . . . 0.0 109.732 172.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -73.94 69.54 1.43 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.029 0.932 . . . . 0.0 109.249 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.87 76.58 1.73 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.345 1.458 . . . . 0.0 107.126 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.86 160.98 17.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 117.645 -1.169 . . . . 0.0 112.124 175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 128.617 2.767 . . . . 0.0 108.358 -177.43 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mt -138.59 150.33 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.039 2.136 . . . . 0.0 105.971 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.41 HG23 HD23 ' A' ' 67' ' ' LEU . 3.7 mt -132.39 105.3 8.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 128.745 2.818 . . . . 0.0 108.112 -163.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.963 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -80.1 145.84 32.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 118.525 0.602 . . . . 0.0 110.401 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 53.4 mt -143.41 111.36 5.44 Favored Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.77 123.1 10.06 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 N-CA-C 106.715 -2.071 . . . . 0.0 106.715 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.86 158.85 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.784 0.72 . . . . 0.0 109.514 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.4 m -74.45 -34.9 63.3 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -146.52 154.06 41.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -80.21 115.32 19.7 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -138.34 39.64 2.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.399 0.545 . . . . 0.0 110.214 170.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.87 73.96 0.1 OUTLIER Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.326 -1.263 . . . . 0.0 115.058 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt 77.86 -28.35 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 130.6 3.56 . . . . 0.0 113.46 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.81 -8.3 53.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.502 0.721 . . . . 0.0 109.304 167.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -42.1 108.36 0.6 Allowed Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 130.224 3.41 . . . . 0.0 110.124 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.71 135.47 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.47 2.114 . . . . 0.0 109.102 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -58.53 146.38 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 118.854 0.752 . . . . 0.0 109.535 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 t -81.57 171.28 14.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 122.636 1.208 . . . . 0.0 109.159 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.62 -39.25 37.71 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.846 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -131.82 -174.03 3.3 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.792 -1.193 . . . . 0.0 108.6 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -119.83 -41.87 2.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.482 0.713 . . . . 0.0 110.208 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.39 64.79 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.936 -0.925 . . . . 0.0 113.739 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.43 72.68 1.44 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.26 1.824 . . . . 0.0 107.196 168.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.43 138.52 19.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 165.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.73 -20.97 8.82 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.641 2.894 . . . . 0.0 113.313 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -151.94 138.43 18.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.166 1.786 . . . . 0.0 107.038 -165.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.86 98.95 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.357 1.863 . . . . 0.0 107.953 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.41 78.0 5.94 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.204 1.402 . . . . 0.0 108.841 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.927 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -71.34 94.66 1.24 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.737 1.215 . . . . 0.0 109.285 174.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.98 167.88 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.528 1.531 . . . . 0.0 109.404 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -122.88 -171.53 2.31 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.694 -1.253 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.72 136.74 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 166.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.28 126.71 18.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 127.413 2.285 . . . . 0.0 105.759 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 52.75 42.38 31.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.145 0.978 . . . . 0.0 111.324 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.09 9.23 5.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.63 1.972 . . . . 0.0 113.729 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.05 167.89 10.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.659 1.184 . . . . 0.0 109.072 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.99 -26.21 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 113.673 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.514 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 57.78 -54.52 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.393 2.277 . . . . 0.0 115.937 -167.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -170.6 158.05 6.07 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.309 1.444 . . . . 0.0 108.787 -157.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.7 mt -138.82 137.87 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 125.303 1.441 . . . . 0.0 107.972 171.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 m -111.07 144.42 40.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.434 2.294 . . . . 0.0 105.855 160.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 16.0 t -140.74 68.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 167.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -80.18 136.65 36.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.14 150.04 49.69 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -88.85 107.74 19.28 Favored Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.199 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.17 -8.51 22.11 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.163 1.909 . . . . 0.0 112.083 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -128.41 37.75 4.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.11 0.964 . . . . 0.0 109.769 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.71 -28.19 58.5 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.146 1.778 . . . . 0.0 111.793 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -135.33 3.53 3.1 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.1 0.96 . . . . 0.0 113.365 -167.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -95.8 103.6 15.49 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.935 0.788 . . . . 0.0 109.369 173.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 51.89 -0.56 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.111 2.565 . . . . 0.0 116.399 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 t 53.16 23.04 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 126.135 1.774 . . . . 0.0 111.832 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -151.5 17.74 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.063 -1.648 . . . . 0.0 112.185 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.92 60.54 3.8 Favored Glycine 0 C--O 1.216 -1.012 0 O-C-N 120.4 -1.438 . . . . 0.0 111.291 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 53.05 26.77 5.08 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -36.53 -51.19 1.9 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.162 2.185 . . . . 0.0 112.193 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.14 -24.64 12.41 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.257 1.485 . . . . 0.0 112.519 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -68.68 -38.36 80.3 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 119.874 1.215 . . . . 0.0 109.551 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.71 -65.62 0.54 Allowed 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.896 0.747 . . . . 0.0 109.557 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 m -59.91 -37.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 117.134 -1.412 . . . . 0.0 112.192 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -58.74 -17.56 24.06 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.02 2.191 . . . . 0.0 114.322 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -26.04 49.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.5 -1.375 . . . . 0.0 110.303 167.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -84.71 37.9 0.67 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.153 1.381 . . . . 0.0 111.164 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.06 26.63 1.32 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 128.287 2.851 . . . . 0.0 118.112 165.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -70.87 171.17 11.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.904 1.852 . . . . 0.0 115.21 -171.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -144.88 -27.24 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.042 1.737 . . . . 0.0 112.019 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.41 HD23 HG23 ' A' ' 3' ' ' ILE . 7.6 tp -132.18 156.21 46.84 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.378 1.471 . . . . 0.0 108.745 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.963 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -142.8 146.6 21.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.534 HG21 ' CG1' ' A' ' 99' ' ' VAL . 72.0 mt -130.6 113.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 173.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 68' ' ' VAL . 35.5 m -129.08 177.02 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.445 1.098 . . . . 0.0 109.542 -175.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.9 ttt-85 -112.55 -90.83 0.5 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.9 64.68 0.26 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.139 1.828 . . . . 0.0 112.37 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.48 176.62 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 125.639 1.576 . . . . 0.0 111.747 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.89 159.67 23.06 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.09 1.805 . . . . 0.0 111.141 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -60.01 -34.77 73.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -164.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -56.08 -40.76 74.11 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.267 1.394 . . . . 0.0 110.826 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.945 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.0 mm -61.47 -48.56 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 167.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.14 -20.49 58.67 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.71 -57.78 7.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.049 -1.032 . . . . 0.0 111.518 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -62.39 -37.86 87.41 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 126.438 1.895 . . . . 0.0 109.399 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.46 -30.0 59.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.53 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.29 -8.46 55.95 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.473 1.033 . . . . 0.0 112.297 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -134.97 12.82 3.62 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.175 1.79 . . . . 0.0 111.783 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.46 33.99 33.66 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 121.382 -0.824 . . . . 0.0 112.408 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.49 117.7 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 146.39 52.89 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.102 -0.998 . . . . 0.0 108.372 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.423 ' O ' ' HE2' ' A' ' 90' ' ' LYS . 2.5 p -133.69 110.17 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.467 0.651 . . . . 0.0 110.919 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mt -81.18 140.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.324 1.85 . . . . 0.0 106.135 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 88' ' ' VAL . 23.4 mtmt -124.48 174.07 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.727 1.211 . . . . 0.0 109.965 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.24 10.64 74.53 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.485 171.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 172.28 5.15 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.538 1.669 . . . . 0.0 111.345 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.0 p -159.38 153.91 24.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.054 1.742 . . . . 0.0 107.895 161.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.49 -166.52 25.8 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.759 0.709 . . . . 0.0 113.404 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 p -83.57 171.97 12.81 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.227 -1.16 . . . . 0.0 109.297 162.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.25 -55.1 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.341 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.18 -33.36 72.1 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.956 -173.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -71.57 -50.88 26.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.84 0.856 . . . . 0.0 110.388 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.534 ' CG1' HG21 ' A' ' 69' ' ' ILE . 38.0 t -58.99 -42.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.262 1.025 . . . . 0.0 110.218 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.62 -54.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -56.71 -42.04 78.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.004 0.82 . . . . 0.0 112.357 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -61.03 -32.85 72.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.266 0.939 . . . . 0.0 111.792 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -79.87 -42.13 24.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.414 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.53 -28.89 67.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.377 0.99 . . . . 0.0 110.754 173.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.2 m -74.12 -13.16 60.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.216 1.406 . . . . 0.0 112.896 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.8 12.77 65.19 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.946 1.26 . . . . 0.0 113.2 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -68.68 -50.84 47.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.131 1.466 . . . . 0.0 107.817 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.61 135.98 55.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.089 1.356 . . . . 0.0 110.109 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.16 163.28 34.84 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.32 1.448 . . . . 0.0 109.373 171.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -80.16 101.57 8.88 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 160.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.8 p -127.51 54.12 1.7 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.447 159.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.01 75.24 1.48 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.17 -0.956 . . . . 0.0 109.714 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -162.61 136.72 6.37 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.951 1.301 . . . . 0.0 108.528 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.03 82.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.959 2.104 . . . . 0.0 109.375 160.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.9 t 62.15 173.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 C-N-CA 125.147 1.379 . . . . 0.0 110.113 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 119.64 0.64 Allowed 'General case' 0 N--CA 1.474 0.765 0 O-C-N 118.925 -2.36 . . . . 0.0 113.77 163.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.63 176.22 5.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.653 1.181 . . . . 0.0 110.79 165.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -167.6 -50.81 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.356 1.462 . . . . 0.0 109.388 162.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -85.37 169.41 13.72 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 161.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -114.44 177.89 4.48 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.584 1.554 . . . . 0.0 108.05 159.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -157.82 167.25 30.55 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.89 1.676 . . . . 0.0 107.325 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 64.71 -174.35 0.17 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.376 1.87 . . . . 0.0 111.205 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 62.41 -178.36 0.13 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.768 1.627 . . . . 0.0 111.25 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 . . . . . 0 C--O 1.239 0.538 0 N-CA-C 103.225 -2.879 . . . . 0.0 103.225 138.605 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.146 0.022 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 mt -113.49 148.55 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 162.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.45 104.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 128.715 2.806 . . . . 0.0 105.604 -165.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.91 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.43 140.18 36.1 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.3 mt -131.94 118.59 16.53 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 167.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.9 121.22 8.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 107.099 -1.923 . . . . 0.0 107.099 168.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 m -116.13 147.6 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 119.013 0.824 . . . . 0.0 109.999 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -70.02 -30.93 68.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.993 -1.004 . . . . 0.0 111.429 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -146.4 156.33 43.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.429 1.892 . . . . 0.0 106.194 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -90.46 106.86 18.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -132.72 39.15 3.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.88 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.6 -76.12 0.01 OUTLIER Glycine 0 N--CA 1.469 0.864 0 C-N-CA 126.712 2.101 . . . . 0.0 115.849 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -110.33 -50.96 2.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.012 1.725 . . . . 0.0 107.069 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.88 -6.41 1.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 129.32 3.048 . . . . 0.0 113.77 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 m -47.95 109.7 1.2 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 129.864 3.266 . . . . 0.0 111.745 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.04 137.21 21.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.102 1.868 . . . . 0.0 110.317 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.14 137.26 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.643 1.211 . . . . 0.0 111.422 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -74.54 170.16 16.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.429 1.892 . . . . 0.0 109.614 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -109.87 -24.66 10.72 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.83 -1.169 . . . . 0.0 113.059 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -121.43 89.25 3.09 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.259 1.024 . . . . 0.0 109.897 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -39.86 -49.64 2.4 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.3 1.44 . . . . 0.0 113.23 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -15.07 48.38 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.22 52.48 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 173.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.93 153.36 69.74 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 161.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.62 -22.53 0.9 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.782 2.988 . . . . 0.0 113.955 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.11 160.93 39.25 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.793 1.237 . . . . 0.0 107.981 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -127.5 110.53 12.83 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.19 86.93 5.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.91 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -76.63 100.06 5.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.558 HG22 HD13 ' A' ' 40' ' ' ILE . 10.4 t -88.52 141.97 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 125.328 1.451 . . . . 0.0 107.847 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -93.18 -172.48 2.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.801 0.728 . . . . 0.0 109.277 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.2 t -145.42 134.31 17.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 34' ' ' ASN . 6.8 ttpt -133.0 118.52 18.92 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 126.061 1.744 . . . . 0.0 106.713 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.419 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 80.6 m-20 40.45 56.93 2.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.218 1.407 . . . . 0.0 112.62 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 39.93 62.81 1.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 112.985 -167.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.75 171.0 15.4 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.617 1.967 . . . . 0.0 107.968 159.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.63 -20.61 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.62 1.568 . . . . 0.0 112.985 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . . . 53.37 -59.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.737 2.415 . . . . 0.0 115.912 -165.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -170.88 164.29 7.76 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.718 2.407 . . . . 0.0 108.8 -164.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.558 HD13 HG22 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -136.02 129.05 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -173.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 m -124.35 89.03 3.0 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 127.177 2.191 . . . . 0.0 108.298 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 3.7 t -92.17 81.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.6 147.33 32.12 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.42 149.61 33.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.05 0.453 . . . . 0.0 110.115 162.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -95.51 107.98 36.65 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 117.802 -1.094 . . . . 0.0 108.61 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.27 -6.96 17.55 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.164 1.909 . . . . 0.0 113.372 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.46 38.18 4.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.157 1.783 . . . . 0.0 109.479 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.75 -27.9 66.32 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.605 -1.309 . . . . 0.0 111.675 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -151.25 80.64 1.31 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.69 1.596 . . . . 0.0 107.714 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -145.4 -90.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 156.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -86.17 -17.13 35.73 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.274 1.03 . . . . 0.0 113.076 -167.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t 68.13 -22.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 128.484 2.714 . . . . 0.0 114.288 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -150.23 168.59 23.56 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.944 2.098 . . . . 0.0 106.374 162.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.82 -85.82 0.4 Allowed Glycine 0 N--CA 1.461 0.304 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -17.78 29.43 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -50.06 -48.28 79.38 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 120.48 1.491 . . . . 0.0 110.051 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HA ' HG22 ' A' ' 60' ' ' VAL . 58.2 Cg_endo -76.62 -29.61 5.63 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.847 1.698 . . . . 0.0 111.652 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.37 -40.59 71.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.325 0.966 . . . . 0.0 109.516 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.88 -71.74 0.09 Allowed 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.219 1.007 . . . . 0.0 110.516 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 57' ' ' PRO . 5.9 m -60.31 -14.47 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 O-C-N 119.542 -1.974 . . . . 0.0 114.549 -172.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -80.26 -18.26 49.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.878 1.671 . . . . 0.0 112.867 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.07 -27.82 61.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.775 1.17 . . . . 0.0 111.037 164.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -87.65 37.65 0.8 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.535 -0.728 . . . . 0.0 110.672 -162.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.03 27.09 4.87 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.717 2.103 . . . . 0.0 115.157 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.76 166.89 22.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.627 1.214 . . . . 0.0 112.89 -167.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 7.4 mt-10 -141.85 -28.37 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.906 0.882 . . . . 0.0 111.69 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -134.71 160.94 36.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.629 1.172 . . . . 0.0 109.444 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -140.24 148.84 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.606 1.562 . . . . 0.0 106.902 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.535 HG21 ' CG1' ' A' ' 99' ' ' VAL . 46.2 mt -132.41 113.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 68' ' ' VAL . 14.2 m -135.08 -175.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.343 1.057 . . . . 0.0 110.264 -170.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -118.01 -100.35 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.37 -24.17 59.49 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.565 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.302 2.4 tt 44.2 -97.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.577 2.351 . . . . 0.0 113.696 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.13 124.01 2.22 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 127.449 2.452 . . . . 0.0 109.93 -174.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.35 -40.73 17.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.726 1.61 . . . . 0.0 112.472 -169.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -58.05 -34.64 70.31 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.506 1.503 . . . . 0.0 112.69 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.79 -22.52 46.21 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.453 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.6 mm -54.72 -46.79 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.93 -11.76 14.8 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.56 -1.337 . . . . 0.0 114.311 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -57.09 4.76 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 121.26 1.846 . . . . 0.0 111.163 167.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -53.56 1.68 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.655 1.582 . . . . 0.0 110.659 167.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.47 -13.88 62.43 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.528 1.142 . . . . 0.0 111.49 -170.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.71 -22.45 40.3 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 119.212 0.915 . . . . 0.0 110.517 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.48 10.69 7.93 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.144 0.429 . . . . 0.0 111.856 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.66 23.62 58.78 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.399 0.999 . . . . 0.0 112.99 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.85 94.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.71 1.204 . . . . 0.0 110.909 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 127.99 34.55 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.567 . . . . 0.0 110.55 -166.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.63 103.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 122.57 1.176 . . . . 0.0 108.321 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.5 mt -85.67 134.38 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -118.56 179.42 4.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.83 0.452 . . . . 0.0 111.568 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.28 20.33 76.62 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.682 0.614 . . . . 0.0 112.106 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.93 175.04 6.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.224 1.012 . . . . 0.0 109.522 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.8 p -166.96 156.51 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.57 1.548 . . . . 0.0 107.323 166.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.57 -169.67 12.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -80.48 168.83 18.48 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.598 -0.942 . . . . 0.0 109.88 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.85 -49.96 76.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 O-C-N 121.752 -0.592 . . . . 0.0 109.592 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.1 -30.74 62.49 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -75.76 -64.44 1.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 69' ' ' ILE . 25.3 t -55.31 -44.24 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.746 1.618 . . . . 0.0 111.119 -171.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.1 t -59.15 -49.74 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.65 -33.67 76.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.565 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -60.76 -46.33 90.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.21 1.368 . . . . 0.0 110.426 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -59.14 -52.17 66.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.586 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -32.15 66.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.543 0.611 . . . . 0.0 110.856 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 m -76.98 -2.43 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.385 0.674 . . . . 0.0 111.882 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.8 8.92 87.21 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.911 -1.118 . . . . 0.0 112.718 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -75.33 -44.76 43.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.104 1.452 . . . . 0.0 110.405 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.53 151.81 37.88 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.852 1.261 . . . . 0.0 110.031 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.409 ' HG3' ' H ' ' A' ' 110' ' ' ASP . 4.8 tptt -160.22 165.74 30.95 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.943 0.897 . . . . 0.0 111.949 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.409 ' H ' ' HG3' ' A' ' 109' ' ' LYS . 9.1 p-10 -105.79 24.7 11.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 129.678 3.191 . . . . 0.0 112.096 -174.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.4 m -78.94 45.52 0.62 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.524 -1.36 . . . . 0.0 113.132 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -141.98 74.23 1.44 Allowed 'General case' 0 C--O 1.239 0.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.145 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -162.29 99.87 1.06 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -158.67 162.14 37.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.442 0.565 . . . . 0.0 109.792 160.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.273 8.9 m 45.77 5.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 130.676 3.59 . . . . 0.0 118.681 173.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -62.25 -64.88 0.79 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.968 1.258 . . . . 0.0 112.168 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -166.07 141.05 4.63 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.037 0.535 . . . . 0.0 109.697 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -111.63 114.06 26.86 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.494 1.518 . . . . 0.0 107.517 167.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -152.19 151.0 30.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 164.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.5 175.54 13.48 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.6 m80 62.67 163.54 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.433 2.293 . . . . 0.0 111.594 -170.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.67 -173.83 3.34 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 128.112 2.565 . . . . 0.0 107.154 169.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -148.02 52.11 1.03 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 130.71 3.604 . . . . 0.0 109.064 174.785 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 CA--C 1.507 -0.704 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 29' ' ' PHE . 1.3 mt -142.42 142.98 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.8 104.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 0.0 106.867 -170.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.938 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -81.39 140.27 34.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.307 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.18 113.14 9.56 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.54 108.09 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.493 2.129 . . . . 0.0 108.009 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -100.57 158.22 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.309 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.9 m -81.49 -25.62 35.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.503 -0.761 . . . . 0.0 111.524 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -152.29 157.83 41.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.567 1.076 . . . . 0.0 109.675 -174.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -95.23 84.25 4.03 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.841 1.257 . . . . 0.0 108.578 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -107.81 38.62 2.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 116.803 -1.57 . . . . 0.0 110.383 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 32.43 79.56 0.02 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 125.299 1.428 . . . . 0.0 112.958 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 78.08 -36.12 0.21 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 128.633 2.773 . . . . 0.0 113.249 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.35 -7.87 35.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.756 0.707 . . . . 0.0 110.549 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -39.55 106.6 0.4 Allowed Pre-proline 0 N--CA 1.448 -0.557 1 C-N-CA 131.845 4.058 . . . . 0.0 111.051 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.77 133.78 15.85 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.99 2.46 . . . . 0.0 110.778 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -64.44 127.16 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.493 0.663 . . . . 0.0 110.174 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -63.19 168.45 4.24 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.423 1.089 . . . . 0.0 109.321 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.78 -15.37 34.83 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.198 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -131.02 -177.72 4.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -120.36 -55.78 2.02 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.648 1.179 . . . . 0.0 108.531 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.02 -6.21 12.0 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 117.424 -1.764 . . . . 0.0 116.324 -166.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.8 39.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.799 2.3 . . . . 0.0 109.869 163.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 144.96 97.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.3 -18.47 20.6 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.203 1.936 . . . . 0.0 114.23 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.15 160.63 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.146 1.378 . . . . 0.0 109.811 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -133.56 104.75 6.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.945 1.698 . . . . 0.0 108.473 170.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.77 93.3 6.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.938 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.3 m-85 -81.98 101.34 10.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 167.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.2 160.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -111.14 -166.9 1.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.393 0.997 . . . . 0.0 108.518 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -157.07 144.44 10.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 164.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.0 124.22 23.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 128.401 2.68 . . . . 0.0 105.19 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 36.73 61.53 0.85 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.786 2.034 . . . . 0.0 111.729 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 64.95 11.16 6.82 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 128.458 2.703 . . . . 0.0 115.335 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.14 164.7 18.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 120.165 1.348 . . . . 0.0 109.639 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.36 -28.0 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 113.792 -162.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.45 -56.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.912 2.485 . . . . 0.0 114.398 -165.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -162.6 155.19 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.454 1.502 . . . . 0.0 110.34 -165.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mm -128.09 117.02 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.038 2.535 . . . . 0.0 106.088 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -109.7 98.39 7.75 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 165.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.54 86.81 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -93.55 153.71 18.28 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -64.91 167.44 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 109.329 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.22 109.97 29.65 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 158.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.13 -7.29 19.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.632 1.554 . . . . 0.0 112.946 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.38 39.39 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.722 1.209 . . . . 0.0 109.985 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.89 90.62 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.47 19.56 0.94 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.206 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -95.16 90.55 5.93 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 122.879 0.472 . . . . 0.0 110.488 -171.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 53.24 29.93 9.21 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.534 1.134 . . . . 0.0 111.649 172.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.69 117.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.581 1.152 . . . . 0.0 112.26 -145.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -143.21 97.55 3.11 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.574 1.149 . . . . 0.0 110.219 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.15 14.34 79.05 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.419 -1.211 . . . . 0.0 115.931 158.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.78 -17.71 7.3 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.858 1.829 . . . . 0.0 114.376 -172.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -48.61 -50.9 56.73 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.439 1.018 . . . . 0.0 110.441 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -75.98 -19.96 15.4 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.347 1.365 . . . . 0.0 112.844 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -66.98 -40.59 87.44 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 119.421 1.01 . . . . 0.0 109.254 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -53.1 -64.4 0.83 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.039 0.936 . . . . 0.0 110.265 168.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.7 m -63.21 -29.22 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 119.952 1.251 . . . . 0.0 113.447 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -64.12 -23.28 67.26 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.76 -1.212 . . . . 0.0 112.791 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -24.71 61.23 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 121.245 1.839 . . . . 0.0 110.798 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.71 38.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.853 1.261 . . . . 0.0 111.102 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 38.63 37.09 0.51 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.735 2.588 . . . . 0.0 116.799 165.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -81.6 175.29 10.62 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.04 -31.56 0.54 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.792 1.637 . . . . 0.0 112.922 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 68' ' ' VAL . 64.8 tp -134.46 159.83 39.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.305 1.05 . . . . 0.0 109.552 175.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.87 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -141.9 130.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.501 HG21 HG13 ' A' ' 99' ' ' VAL . 76.4 mt -114.45 112.42 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.439 HG13 HG12 ' A' ' 68' ' ' VAL . 17.9 m -128.92 170.34 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.556 1.542 . . . . 0.0 109.277 -172.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -99.64 -93.64 0.26 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.32 -19.98 53.53 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.51 -1.161 . . . . 0.0 114.661 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 74' ' ' GLY 0.336 2.7 tt 29.55 -129.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 127.724 2.41 . . . . 0.0 112.978 -172.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -167.22 -162.99 20.27 Favored Glycine 0 CA--C 1.541 1.698 1 C-N-CA 131.227 4.251 . . . . 0.0 106.822 176.098 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -37.69 9.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 121.145 2.472 . . . . 0.0 111.106 165.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -60.84 -20.79 62.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.98 -4.49 17.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.383 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -56.18 -41.26 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 157.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.26 -18.27 15.62 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.64 7.09 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 120.811 -1.181 . . . . 0.0 108.826 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.02 -40.22 95.84 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 125.789 1.636 . . . . 0.0 109.054 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -56.49 -27.6 57.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.72 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.16 -11.95 61.24 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.186 1.357 . . . . 0.0 111.738 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.5 ptp -130.81 6.38 4.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.867 1.667 . . . . 0.0 111.851 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.56 37.15 66.28 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 120.653 -1.279 . . . . 0.0 110.906 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 121.01 34.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -59.08 147.87 33.23 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.878 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.57 126.21 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.03 119.87 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -113.4 158.78 20.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.935 1.294 . . . . 0.0 108.794 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 11.33 74.25 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.538 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.71 174.37 1.05 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.362 1.581 . . . . 0.0 113.322 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -161.74 148.61 14.2 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.663 -1.273 . . . . 0.0 109.768 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.06 -163.77 12.17 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 124.011 0.819 . . . . 0.0 112.618 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.9 p -81.1 174.73 11.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.936 0.894 . . . . 0.0 109.81 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.47 -54.92 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 O-C-N 121.028 -1.045 . . . . 0.0 109.756 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.78 -37.98 69.28 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.94 -49.87 40.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.508 0.723 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.501 HG13 HG21 ' A' ' 69' ' ' ILE . 39.9 t -57.54 -40.51 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.631 1.172 . . . . 0.0 110.513 176.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.21 -51.84 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -62.0 -44.88 95.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.028 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -52.91 -39.24 62.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.305 0.957 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -76.01 -43.2 45.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mp -62.31 -28.49 69.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.687 0.795 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.5 m -80.61 -37.44 31.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.38 1.072 . . . . 0.0 109.833 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.13 10.42 22.38 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.158 0.885 . . . . 0.0 112.986 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -61.72 -44.03 97.71 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.182 0.991 . . . . 0.0 108.664 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 137.74 57.19 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.123 1.369 . . . . 0.0 110.626 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -115.24 148.7 38.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.635 1.174 . . . . 0.0 112.67 -170.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.71 58.38 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 127.802 2.441 . . . . 0.0 106.392 -169.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.9 t -58.42 150.09 23.27 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 158.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -116.03 169.91 8.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 148.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.64 12.38 2.3 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.249 1.019 . . . . 0.0 113.422 -176.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -94.61 175.81 6.52 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.153 -154.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.2 t -137.34 143.82 33.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -80.51 88.71 5.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 162.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.31 -76.12 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.962 2.105 . . . . 0.0 113.015 -172.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 174.69 -58.94 0.01 OUTLIER 'General case' 0 C--O 1.235 0.322 0 C-N-CA 129.041 2.936 . . . . 0.0 106.764 -168.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -139.68 -40.38 0.45 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.054 0.541 . . . . 0.0 111.968 171.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 44.79 94.21 0.01 OUTLIER 'General case' 0 C--O 1.233 0.192 0 C-N-CA 128.267 2.627 . . . . 0.0 112.863 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 32.1 t60 56.49 160.6 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.849 2.06 . . . . 0.0 110.545 -163.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -80.62 89.04 5.69 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 -163.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -71.13 88.22 0.8 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.965 1.306 . . . . 0.0 109.548 -164.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 . . . . . 0 C--O 1.25 1.113 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 156.528 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttm . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.152 0.025 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.7 142.8 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.75 107.41 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 129.779 3.232 . . . . 0.0 107.42 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.935 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -83.61 150.19 26.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.158 0.435 . . . . 0.0 111.367 175.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -142.77 120.01 7.02 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.19 123.17 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 108.75 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 15' ' ' SER . 10.0 m -118.54 156.89 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.158 0.583 . . . . 0.0 110.31 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -81.73 -21.49 37.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.524 -0.75 . . . . 0.0 112.123 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -142.77 161.36 38.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.621 1.1 . . . . 0.0 109.534 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -91.96 98.63 11.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -139.98 39.19 1.97 Allowed 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.77 -0.581 . . . . 0.0 110.473 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' HA2' HG11 ' A' ' 42' ' ' VAL . . . 52.02 -140.77 26.35 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-N 119.074 0.852 . . . . 0.0 112.347 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -56.61 -16.75 6.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.93 -2.7 55.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.535 1.534 . . . . 0.0 110.755 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.524 ' CB ' HG11 ' A' ' 7' ' ' VAL . 46.4 m -50.57 122.49 16.1 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.984 1.714 . . . . 0.0 110.991 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.91 130.99 15.09 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 123.021 2.481 . . . . 0.0 109.703 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.3 140.11 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.52 175.48 9.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.098 0.951 . . . . 0.0 108.906 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.72 -21.65 21.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 118.356 -0.83 . . . . 0.0 111.126 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -130.93 -175.14 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.118 2.167 . . . . 0.0 108.277 -173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.31 -48.13 2.33 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.527 1.131 . . . . 0.0 109.77 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -19.71 59.28 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -165.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.7 38.55 3.05 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.629 1.214 . . . . 0.0 110.57 168.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.49 129.2 89.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.62 -21.69 45.33 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.308 2.005 . . . . 0.0 114.888 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -145.33 164.37 31.66 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 119.359 0.981 . . . . 0.0 109.191 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -134.17 103.98 6.0 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.168 1.387 . . . . 0.0 108.608 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.75 91.15 5.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.935 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.5 m-85 -82.95 94.61 7.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.2 155.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -98.16 -172.2 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.819 -1.175 . . . . 0.0 110.475 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 t -138.79 157.18 29.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 153.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 21.1 ttpt -154.12 142.09 20.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.45 2.3 . . . . 0.0 104.969 162.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 47.62 47.8 17.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.727 1.149 . . . . 0.0 111.128 170.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.18 41.19 1.98 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.556 1.542 . . . . 0.0 115.029 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.6 169.09 18.4 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.283 0.633 . . . . 0.0 109.534 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.98 -31.38 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 113.484 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.441 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 53.69 -62.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.045 2.138 . . . . 0.0 114.789 -161.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.93 167.16 30.67 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.985 1.314 . . . . 0.0 111.525 -162.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.28 147.86 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.454 2.301 . . . . 0.0 107.86 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -145.21 97.51 3.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.408 HG11 ' HA2' ' A' ' 12' ' ' GLY . 4.0 p -105.09 65.89 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -89.1 150.26 22.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -170.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.78 148.67 49.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -80.1 122.28 82.85 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.297 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.98 -13.28 39.35 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.768 2.312 . . . . 0.0 114.789 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -134.05 39.91 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.499 1.52 . . . . 0.0 108.531 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.81 65.86 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 120.432 -1.417 . . . . 0.0 110.98 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -140.95 2.85 1.78 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -167.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 52' ' ' VAL . 3.9 t70 -127.94 154.11 45.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 119.409 1.004 . . . . 0.0 111.055 -156.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.6 m170 53.58 -31.11 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 129.583 3.153 . . . . 0.0 114.516 -162.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 50' ' ' ASP 0.265 21.2 m 36.16 3.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.83 1 C-N-CA 134.33 5.052 . . . . 0.0 116.959 -160.718 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -21.56 63.91 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.742 2.017 . . . . 0.0 112.345 -173.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.7 66.26 1.01 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -170.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.73 -6.4 19.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.181 154.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.51 -52.86 16.17 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.843 0.747 . . . . 0.0 109.989 172.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 60' ' ' VAL . 7.3 Cg_endo -75.67 -27.51 8.91 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.478 1.206 . . . . 0.0 113.199 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -55.82 -45.37 78.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.77 -66.48 0.49 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.185 0.994 . . . . 0.0 110.962 170.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.18 -21.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.871 1.668 . . . . 0.0 113.296 -171.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.39 -23.86 62.85 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.814 1.246 . . . . 0.0 112.187 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -79.81 -18.64 50.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.642 1.11 . . . . 0.0 112.079 168.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -85.88 39.32 0.8 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.459 1.104 . . . . 0.0 111.084 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.9 16.85 41.14 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 160.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.53 165.67 24.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.909 1.354 . . . . 0.0 114.552 -161.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.94 -34.16 1.01 Allowed 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.942 1.297 . . . . 0.0 111.189 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.5 tm? -137.34 154.19 50.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -171.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 4' ' ' ALA . 3.3 t -149.14 141.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.461 HG21 HG13 ' A' ' 99' ' ' VAL . 67.2 mt -132.91 111.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.15 -178.39 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.453 0.644 . . . . 0.0 110.592 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -114.0 -100.45 0.43 Allowed 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.3 61.96 1.25 Allowed Glycine 0 C--N 1.329 0.171 0 C-N-CA 125.688 1.613 . . . . 0.0 111.441 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.0 tt -59.96 172.46 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 125.462 1.505 . . . . 0.0 110.988 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 152.53 17.92 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -42.3 52.8 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 124.952 1.301 . . . . 0.0 112.418 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -56.95 -22.69 39.87 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.61 -31.71 13.15 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.311 1.045 . . . . 0.0 111.909 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.7 -45.77 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.1 -11.13 5.29 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.19 -57.14 3.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.551 1.069 . . . . 0.0 109.632 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -58.41 -39.15 78.95 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.008 1.723 . . . . 0.0 109.148 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -55.43 -29.26 58.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.526 1.131 . . . . 0.0 112.842 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.61 -6.53 55.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.696 1.135 . . . . 0.0 111.081 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -130.99 -0.78 4.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.13 1.372 . . . . 0.0 112.059 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.91 38.94 93.39 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.996 -1.065 . . . . 0.0 110.501 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.44 127.79 38.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 167.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -78.08 142.0 38.42 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 p -131.1 101.56 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 67' ' ' LEU . 56.3 mt -74.36 149.27 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 125.829 1.652 . . . . 0.0 107.399 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.41 176.17 7.93 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.62 19.21 77.74 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.34 -0.7 . . . . 0.0 113.295 165.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 179.78 6.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.279 1.04 . . . . 0.0 110.329 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 p -164.8 154.54 13.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.313 2.245 . . . . 0.0 107.091 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.86 -168.02 13.22 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 123.55 0.531 . . . . 0.0 112.885 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.7 p -79.68 173.38 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.775 -0.838 . . . . 0.0 109.966 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.58 -57.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.003 0.921 . . . . 0.0 108.955 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.08 -32.36 72.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.418 -173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.93 -54.23 20.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.21 1.404 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.461 HG13 HG21 ' A' ' 69' ' ' ILE . 50.4 t -57.33 -30.05 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.695 1.198 . . . . 0.0 111.139 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.8 -53.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -54.29 -44.59 72.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.617 0.767 . . . . 0.0 109.963 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -53.81 -38.8 64.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.544 0.738 . . . . 0.0 111.073 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.36 -39.44 32.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.927 0.891 . . . . 0.0 112.503 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.25 -26.29 68.3 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.402 1.456 . . . . 0.0 111.275 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -1.86 57.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.514 1.126 . . . . 0.0 111.802 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.64 69.25 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.328 -1.483 . . . . 0.0 113.226 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -78.13 -27.48 48.27 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.804 1.302 . . . . 0.0 110.538 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.55 152.88 22.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.099 0.96 . . . . 0.0 110.667 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 161.67 42.02 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.413 1.085 . . . . 0.0 110.514 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -87.65 89.99 8.2 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 167.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 55.9 p -133.55 176.19 8.76 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.977 1.711 . . . . 0.0 109.277 166.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 46.2 t0 74.33 94.24 0.07 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.492 2.717 . . . . 0.0 110.091 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -151.41 146.42 25.95 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.388 1.075 . . . . 0.0 110.66 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -103.67 147.52 27.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.768 1.227 . . . . 0.0 111.909 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -130.07 25.61 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 120.458 -1.401 . . . . 0.0 111.686 -171.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -131.47 24.95 4.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -156.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.74 142.71 49.92 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.49 1.041 . . . . 0.0 110.546 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 24.97 -121.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.388 2.275 . . . . 0.0 112.391 -169.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -172.05 -51.67 0.02 OUTLIER 'General case' 0 C--N 1.342 0.255 0 CA-C-O 117.737 -1.125 . . . . 0.0 110.849 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 24.03 75.94 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.799 2.839 . . . . 0.0 111.937 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -68.48 99.19 0.93 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 51.01 -90.86 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.02 2.128 . . . . 0.0 109.546 -165.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 68.9 73.8 0.26 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.555 1.942 . . . . 0.0 107.697 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.359 1.864 . . . . 0.0 106.564 -175.776 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 tpp . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 mt -139.05 142.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 mt -132.96 104.39 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 127.217 2.207 . . . . 0.0 105.9 -161.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.01 142.3 35.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.808 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.3 115.14 11.7 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.1 116.73 4.64 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.368 2.045 . . . . 0.0 106.878 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 26' ' ' TYR . 10.7 m -114.28 152.2 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 118.258 0.481 . . . . 0.0 109.843 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -77.34 -26.38 52.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.871 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -145.08 150.96 37.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.262 0.937 . . . . 0.0 109.516 -172.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 48.4 t-20 -85.78 64.75 8.79 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.239 1.816 . . . . 0.0 108.779 -168.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -111.2 39.24 2.33 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.495 -0.753 . . . . 0.0 109.319 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 42' ' ' VAL . . . 37.88 -108.05 0.07 OUTLIER Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.462 1.982 . . . . 0.0 112.953 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -20.53 46.51 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.69 -6.85 58.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.934 2.494 . . . . 0.0 110.674 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.0 m -51.7 119.93 14.63 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.622 1.969 . . . . 0.0 112.28 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.39 135.28 20.1 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.864 2.376 . . . . 0.0 110.893 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.02 139.55 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.951 0.5 . . . . 0.0 109.771 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.38 177.05 6.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.747 1.219 . . . . 0.0 110.032 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -96.06 -42.12 8.4 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.71 -0.619 . . . . 0.0 111.634 -171.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -100.18 178.49 4.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -120.43 -47.36 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.564 1.146 . . . . 0.0 109.672 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -12.03 34.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.69 1.138 . . . . 0.0 114.127 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.04 38.93 3.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.078 1.439 . . . . 0.0 110.848 168.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.71 130.18 82.02 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.3 -23.58 20.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.361 2.041 . . . . 0.0 113.338 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.517 ' HB2' HG23 ' A' ' 7' ' ' VAL . 69.3 m-85 -145.75 153.38 40.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.099 1.36 . . . . 0.0 107.761 -176.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -126.49 110.31 13.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.671 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -79.84 89.79 5.27 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.5 m-85 -81.72 93.02 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -79.74 153.73 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -103.14 -168.27 1.49 Allowed 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.646 -0.659 . . . . 0.0 109.769 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.29 138.69 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 163.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.16 96.43 6.22 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 164.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 71.02 -50.11 0.68 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.33 2.252 . . . . 0.0 114.328 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.91 -1.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.212 2.605 . . . . 0.0 112.543 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.84 178.22 4.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.257 1.423 . . . . 0.0 108.211 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.87 -18.76 23.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 120.206 1.366 . . . . 0.0 113.438 -162.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.22 -79.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.72 1.145 . . . . 0.0 110.383 -159.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -154.07 168.02 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 109.791 -168.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' HG23 ' A' ' 42' ' ' VAL . 5.9 mm -100.49 162.5 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 127.038 2.135 . . . . 0.0 106.691 170.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 m -148.61 84.66 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.677 1.591 . . . . 0.0 107.426 157.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.671 HG22 ' CB ' ' A' ' 28' ' ' ALA . 99.0 t -95.33 84.11 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -93.38 158.33 15.78 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -78.94 145.45 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.471 HD21 HG22 ' A' ' 56' ' ' VAL . 43.0 t-20 -84.59 108.8 16.08 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.34 -17.26 59.22 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.23 1.287 . . . . 0.0 111.929 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 55' ' ' ALA . 1.3 mm? -120.2 38.75 3.88 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.398 1.079 . . . . 0.0 110.258 -175.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.58 -21.89 65.4 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.851 -1.155 . . . . 0.0 110.918 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -145.67 -6.57 0.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.88 1.272 . . . . 0.0 112.786 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -69.7 89.4 0.55 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.17 1.388 . . . . 0.0 112.546 -157.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.1 m80 43.45 29.66 0.27 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.285 1.834 . . . . 0.0 112.973 -174.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t 36.11 44.78 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 129.435 3.094 . . . . 0.0 112.04 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -64.45 160.3 19.51 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.17 -1.581 . . . . 0.0 109.215 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.6 30.24 1.03 Allowed Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.714 -1.241 . . . . 0.0 112.946 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . . . -94.7 -19.01 20.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.823 -174.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.471 HG22 HD21 ' A' ' 45' ' ' ASN . 1.8 t -48.38 -55.71 17.67 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 110.077 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.48 -20.93 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.963 1.776 . . . . 0.0 110.581 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.67 -44.67 85.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.296 0.638 . . . . 0.0 109.907 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -55.72 -66.91 0.34 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.274 1.43 . . . . 0.0 110.422 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.71 -22.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -0.94 8.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 113.374 171.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 -19.08 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.837 -1.165 . . . . 0.0 110.667 168.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -84.61 37.25 0.63 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.613 0.642 . . . . 0.0 111.375 -174.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 41.58 33.94 1.07 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.238 2.351 . . . . 0.0 114.492 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -68.19 166.73 15.65 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.613 1.707 . . . . 0.0 112.875 -168.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -139.14 -40.69 0.47 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.916 1.286 . . . . 0.0 110.923 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp -127.98 156.25 42.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.296 1.038 . . . . 0.0 108.664 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.814 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.7 t -138.56 142.88 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 172.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.492 HG21 ' CG1' ' A' ' 99' ' ' VAL . 94.4 mt -134.54 114.09 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG21 ' HB ' ' A' ' 73' ' ' ILE . 4.6 m -131.24 170.34 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.226 0.61 . . . . 0.0 110.065 -171.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -60.84 1.97 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.331 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.86 4.38 0.64 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 117.484 1.754 . . . . 0.0 117.484 -173.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 74' ' ' GLY 0.274 4.4 tt 31.83 -123.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 127.031 2.132 . . . . 0.0 114.994 162.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 156.75 155.76 7.58 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 128.039 2.733 . . . . 0.0 109.004 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -59.62 -31.96 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -164.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -30.32 71.16 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.466 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.66 -22.87 24.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.496 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.55 -42.61 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 121.005 1.73 . . . . 0.0 108.61 160.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.95 -10.6 22.24 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 120.453 -1.404 . . . . 0.0 113.118 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.66 -62.4 1.46 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 119.855 1.207 . . . . 0.0 111.333 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.478 ' CD2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -30.99 -57.88 0.22 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 128.027 2.531 . . . . 0.0 109.61 161.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.02 -13.17 62.29 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.959 0.787 . . . . 0.0 112.57 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.46 59.23 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.824 0.738 . . . . 0.0 111.759 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.416 ' SD ' HG21 ' A' ' 86' ' ' VAL . 3.0 ptt? -137.12 7.6 2.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.018 0.372 . . . . 0.0 111.811 -171.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.35 28.5 35.68 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.626 1.584 . . . . 0.0 112.39 -170.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.416 HG21 ' SD ' ' A' ' 84' ' ' MET . 2.3 t -80.06 99.52 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 124.341 1.057 . . . . 0.0 108.44 -172.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -64.34 128.44 35.8 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.392 -163.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 81' ' ' PHE . 7.0 p -110.77 112.25 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.0 mt -88.13 147.61 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -179.41 5.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.24 13.84 73.65 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-O 119.116 -0.824 . . . . 0.0 114.163 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.52 162.48 28.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.085 1.442 . . . . 0.0 109.936 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -146.14 160.1 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.053 2.141 . . . . 0.0 106.527 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.49 -161.06 17.95 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.469 0.577 . . . . 0.0 113.793 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -92.99 171.38 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 163.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -53.17 -54.97 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.883 0.873 . . . . 0.0 109.273 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.38 -31.0 71.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.047 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -70.87 -55.57 8.18 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 69' ' ' ILE . 55.7 t -54.08 -44.87 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.363 1.065 . . . . 0.0 110.599 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.59 -46.91 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -59.86 -42.14 93.02 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.887 0.767 . . . . 0.0 111.296 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -58.76 -52.5 65.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.863 0.865 . . . . 0.0 109.801 177.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.05 -46.66 83.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.11 -25.5 67.75 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.065 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 m -90.59 7.86 37.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 112.957 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.24 -1.28 88.96 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.177 1.37 . . . . 0.0 115.184 168.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -71.25 -44.06 66.04 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.367 1.084 . . . . 0.0 111.831 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.62 141.75 37.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.644 1.178 . . . . 0.0 108.473 -166.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.71 161.51 41.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 123.482 1.61 . . . . 0.0 112.937 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.09 14.05 2.49 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.002 2.521 . . . . 0.0 112.926 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.7 m -87.14 61.23 6.62 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.972 1.309 . . . . 0.0 112.556 -173.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -157.48 82.45 0.9 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.922 -1.111 . . . . 0.0 108.502 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -124.93 162.25 24.84 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.119 0.968 . . . . 0.0 110.737 -167.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -121.82 163.54 18.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.322 1.449 . . . . 0.0 110.541 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.45 150.67 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 124.494 1.117 . . . . 0.0 108.357 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -160.77 -60.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 166.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 t70 66.03 113.69 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.282 2.633 . . . . 0.0 108.109 -168.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.24 47.23 0.52 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.411 -1.431 . . . . 0.0 112.258 -169.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -159.34 162.39 35.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.237 1.415 . . . . 0.0 108.752 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 61.83 78.5 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.41 2.284 . . . . 0.0 112.968 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.05 -82.63 0.53 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 158.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -51.51 0.65 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.64 1.176 . . . . 0.0 110.451 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -129.79 159.13 37.47 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.478 1.511 . . . . 0.0 108.998 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 p80 . . . . . 0 C--O 1.242 0.662 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 148.799 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.521 0.201 . . . . 0.0 110.772 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.41 HG22 ' CD1' ' A' ' 29' ' ' PHE . 7.2 mt -115.31 153.13 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 165.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.48 105.29 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 127.16 2.184 . . . . 0.0 105.797 -164.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.921 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.47 145.56 31.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 118.623 -0.704 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.478 HD12 HG13 ' A' ' 96' ' ' VAL . 51.2 mt -145.93 114.59 4.66 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.38 129.55 16.05 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.523 1.482 . . . . 0.0 108.318 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 15' ' ' SER . 4.9 m -123.02 150.15 26.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.3 m -68.07 -27.02 66.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.337 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.63 156.07 39.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.663 1.585 . . . . 0.0 107.937 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 52.4 t-20 -85.71 95.52 9.41 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 173.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.69 39.67 3.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.072 0.949 . . . . 0.0 108.616 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.2 -127.96 30.08 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 120.751 -1.218 . . . . 0.0 111.464 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -58.29 -45.83 87.2 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.153 1.381 . . . . 0.0 111.736 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -1.87 4.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.751 2.42 . . . . 0.0 114.307 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.47 ' HB3' HG11 ' A' ' 7' ' ' VAL . 28.1 m -53.05 109.03 1.26 Allowed Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 125.201 1.4 . . . . 0.0 110.955 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.89 135.37 14.08 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.42 1.414 . . . . 0.0 108.932 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.43 134.37 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.978 0.911 . . . . 0.0 111.288 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.37 169.87 12.53 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.869 1.267 . . . . 0.0 107.91 166.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -88.09 -55.26 3.83 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 121.454 -0.779 . . . . 0.0 110.577 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.7 85.59 2.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -152.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -37.49 -47.22 0.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 112.908 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.35 40.98 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.773 -1.015 . . . . 0.0 115.341 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 47.96 1.56 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 108.737 173.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.63 137.79 54.84 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.76 -25.28 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.482 2.121 . . . . 0.0 114.457 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 10' ' ' ASN . 33.2 m-85 -146.3 158.18 43.86 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.28 103.92 8.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.523 1.529 . . . . 0.0 107.904 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.06 78.99 6.66 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.543 1.537 . . . . 0.0 107.624 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.921 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.28 3.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 170.188 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG13 HD13 ' A' ' 40' ' ' ILE . 3.8 t -83.05 164.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 123.682 0.793 . . . . 0.0 109.055 171.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.87 2.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.94 -1.1 . . . . 0.0 108.946 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.424 HG12 ' HG2' ' A' ' 1' ' ' MET . 11.9 p -150.19 147.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -123.65 113.76 19.08 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 173.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.8 t30 54.61 -86.86 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.716 1.206 . . . . 0.0 111.627 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.9 12.22 2.89 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.605 1.562 . . . . 0.0 111.917 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 156.32 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.821 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.21 -32.32 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.137 1.775 . . . . 0.0 112.938 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 59.17 -51.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.309 2.244 . . . . 0.0 115.48 -168.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.72 162.03 15.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 110.768 -160.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.461 HD13 HG13 ' A' ' 30' ' ' VAL . 2.8 mm -135.75 140.48 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.205 1.802 . . . . 0.0 107.683 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.84 88.55 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.741 2.016 . . . . 0.0 107.704 165.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 4.7 t -89.86 93.46 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 164.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.76 152.63 19.47 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -56.92 152.97 11.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.427 1.091 . . . . 0.0 110.439 168.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -79.86 133.66 58.09 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.94 -9.72 26.24 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 CA-C-N 121.128 1.439 . . . . 0.0 112.136 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.81 39.73 0.96 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.042 1.337 . . . . 0.0 110.082 -163.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.41 85.84 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 120.275 -1.516 . . . . 0.0 112.367 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.63 63.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -171.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -144.32 -105.71 0.12 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.593 -161.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -65.04 -32.88 74.81 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.818 1.644 . . . . 0.0 112.978 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.1 t 49.87 84.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.632 1.973 . . . . 0.0 111.071 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.94 -176.79 5.67 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.026 0.931 . . . . 0.0 109.971 171.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.0 21.45 0.28 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.48 1.038 . . . . 0.0 114.005 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.63 -20.31 17.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.667 1.734 . . . . 0.0 113.813 -174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.06 -53.45 48.27 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 119.237 0.926 . . . . 0.0 109.515 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 60' ' ' VAL . 29.2 Cg_endo -72.43 -32.09 10.48 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.02 1.814 . . . . 0.0 111.925 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.09 -38.35 73.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.063 0.847 . . . . 0.0 110.884 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.77 -65.59 0.61 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.922 1.289 . . . . 0.0 110.971 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.74 -22.34 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 119.776 1.171 . . . . 0.0 113.952 -173.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.59 -12.34 61.51 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.368 -1.457 . . . . 0.0 113.946 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.78 -18.93 24.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.848 1.204 . . . . 0.0 109.813 165.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.22 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 119.84 -1.787 . . . . 0.0 111.221 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.51 20.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.337 2.398 . . . . 0.0 116.264 161.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.2 176.85 9.29 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -159.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -144.09 -53.31 0.33 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 110.661 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.02 157.03 19.73 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.618 1.167 . . . . 0.0 109.373 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -136.56 139.61 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 127.387 2.275 . . . . 0.0 105.084 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.58 HG21 HG13 ' A' ' 99' ' ' VAL . 94.5 mt -131.43 111.4 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.463 HG13 HG12 ' A' ' 68' ' ' VAL . 3.1 m -137.35 155.38 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.85 0.86 . . . . 0.0 110.657 -162.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.435 ' HE ' ' HB3' ' A' ' 93' ' ' SER . 17.6 ttt-85 -95.14 -62.1 1.36 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.66 -1.275 . . . . 0.0 111.195 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.82 -54.46 1.3 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 121.757 -0.589 . . . . 0.0 113.977 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.491 HG12 ' H ' ' A' ' 74' ' ' GLY 0.301 3.7 tt 44.38 -168.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 130.143 3.377 . . . . 0.0 115.093 -173.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.35 167.21 39.86 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.289 1.9 . . . . 0.0 110.42 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.8 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -64.74 -36.28 83.8 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 121.201 1.819 . . . . 0.0 109.638 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.66 -40.7 63.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.256 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.44 -43.89 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 119.732 1.151 . . . . 0.0 109.622 168.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.75 -11.25 11.32 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.131 -1.606 . . . . 0.0 114.89 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.407 ' HB2' ' CB ' ' A' ' 57' ' ' PRO . . . -80.18 -58.53 3.1 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.208 1.403 . . . . 0.0 110.441 175.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.457 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -35.63 -56.33 0.67 Allowed 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 126.958 2.103 . . . . 0.0 109.153 160.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.32 -10.05 56.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 117.441 -1.266 . . . . 0.0 111.763 -167.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.98 63.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.714 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.13 14.94 5.7 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.379 0.424 . . . . 0.0 111.476 -163.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.2 26.8 56.75 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.101 -0.374 . . . . 0.0 112.819 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 1.9 t -79.67 108.21 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -168.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.68 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.929 1.692 . . . . 0.0 110.349 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.05 95.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.51 139.47 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.87 154.06 47.68 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 -171.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.8 11.04 38.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.08 0.848 . . . . 0.0 114.751 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.48 157.58 37.58 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.48 1.14 . . . . 0.0 110.85 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.435 ' HB3' ' HE ' ' A' ' 71' ' ' ARG . 65.1 p -159.52 130.3 5.87 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.64 -130.77 6.25 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.95 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.41 159.55 39.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.044 1.738 . . . . 0.0 111.344 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.478 HG13 HD12 ' A' ' 5' ' ' ILE . 22.7 t -63.68 -45.1 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 120.909 -1.119 . . . . 0.0 111.304 -166.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.54 -11.91 48.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.43 -43.55 5.38 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 117.356 -1.307 . . . . 0.0 108.972 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.58 HG13 HG21 ' A' ' 69' ' ' ILE . 77.1 t -45.93 -49.88 4.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 120.412 1.46 . . . . 0.0 110.569 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.42 -38.48 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.471 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -61.99 -51.01 69.78 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 117.352 -1.309 . . . . 0.0 110.314 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.22 -37.26 69.46 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.374 1.443 . . . . 0.0 111.589 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.0 -50.38 42.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.724 1.21 . . . . 0.0 112.005 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.86 -30.72 71.72 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.128 0.422 . . . . 0.0 110.086 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.4 m -74.72 -1.13 20.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.884 2.074 . . . . 0.0 112.483 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 -8.9 74.98 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.356 1.455 . . . . 0.0 112.966 168.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.51 -45.79 51.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.95 134.85 38.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.34 -166.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -158.67 178.77 9.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -124.53 14.14 8.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.077 2.151 . . . . 0.0 112.436 -162.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 t 49.29 -134.98 1.3 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.795 1.638 . . . . 0.0 111.454 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -146.74 113.88 6.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.975 1.71 . . . . 0.0 108.575 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -151.23 14.82 0.7 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -160.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -120.79 34.36 5.24 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.603 -1.311 . . . . 0.0 113.146 -166.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.2 m -45.9 137.05 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.248 1.419 . . . . 0.0 111.234 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -119.73 40.67 3.34 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.936 1.294 . . . . 0.0 111.404 -164.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -118.01 -26.48 6.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.609 1.564 . . . . 0.0 112.237 -174.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -142.28 151.96 42.53 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.475 1.51 . . . . 0.0 108.31 -163.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -159.52 -171.32 3.26 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.525 1.53 . . . . 0.0 109.067 172.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -133.02 48.39 2.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.901 1.28 . . . . 0.0 109.052 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 54.25 173.67 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.114 1.366 . . . . 0.0 110.116 -141.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -71.5 -73.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 66.36 112.11 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.661 1.984 . . . . 0.0 109.234 -162.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.251 1.133 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 160.769 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 ttp . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.707 0.289 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -137.66 145.47 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.53 111.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 128.423 2.689 . . . . 0.0 106.827 -162.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.894 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -84.02 147.67 27.29 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.289 0.95 . . . . 0.0 111.599 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.4 mt -141.64 113.82 6.6 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.47 110.01 2.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.343 2.696 . . . . 0.0 108.824 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.527 HG23 ' HB2' ' A' ' 26' ' ' TYR . 18.6 m -106.82 146.26 13.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.496 0.718 . . . . 0.0 111.409 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.418 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -141.53 149.08 40.38 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.582 1.083 . . . . 0.0 109.389 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.68 100.04 11.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.95 39.02 1.8 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 27.23 80.89 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 126.76 2.124 . . . . 0.0 114.884 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 80.66 -29.78 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 1 C-N-CA 131.821 4.049 . . . . 0.0 113.445 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.5 -8.46 54.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.03 1.286 . . . . 0.0 110.263 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB3' HG21 ' A' ' 7' ' ' VAL . 7.4 m -45.82 108.64 0.83 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 128.401 2.681 . . . . 0.0 110.086 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.55 131.66 12.74 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.209 2.606 . . . . 0.0 110.104 -172.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 93' ' ' SER . 14.0 tt -62.11 140.75 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.404 1.002 . . . . 0.0 109.708 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -94.62 -173.32 2.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.982 1.313 . . . . 0.0 110.699 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -101.05 -42.72 6.28 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.729 1.212 . . . . 0.0 111.584 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -122.13 104.4 9.46 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.986 1.314 . . . . 0.0 109.901 -173.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -44.43 -44.57 8.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.126 1.37 . . . . 0.0 111.585 166.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.12 -3.09 51.14 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 117.943 -1.476 . . . . 0.0 116.233 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -148.16 63.16 1.1 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.03 124.31 32.53 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.69 1.996 . . . . 0.0 108.276 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.21 -23.71 24.13 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 CA-C-N 122.181 1.815 . . . . 0.0 114.214 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.527 ' HB2' HG23 ' A' ' 7' ' ' VAL . 77.7 m-85 -148.68 151.7 35.39 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.814 0.734 . . . . 0.0 109.041 -173.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -122.31 106.21 10.89 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.717 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.74 81.52 6.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.6 1.16 . . . . 0.0 107.94 169.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.894 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.6 m-85 -70.36 141.1 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 161.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.44 150.44 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -96.55 -169.83 1.97 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.374 0.67 . . . . 0.0 109.512 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.4 115.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.681 -0.637 . . . . 0.0 110.102 165.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' N ' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -81.82 91.94 6.59 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.39 -67.33 0.15 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.279 1.432 . . . . 0.0 112.69 174.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -145.71 12.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.138 1.775 . . . . 0.0 112.636 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.63 173.33 6.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.602 1.561 . . . . 0.0 109.389 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.91 -25.74 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 121.068 1.758 . . . . 0.0 114.229 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 53.53 -69.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.304 1.411 . . . . 0.0 112.989 -158.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -166.09 170.84 13.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.097 0.959 . . . . 0.0 112.071 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.2 mm -116.01 145.18 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.774 2.43 . . . . 0.0 106.56 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 m -147.35 68.36 1.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.025 2.53 . . . . 0.0 109.815 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 2.8 t -89.06 93.33 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -96.33 161.95 13.71 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.003 1.321 . . . . 0.0 109.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -71.5 149.36 45.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.66 1.584 . . . . 0.0 109.689 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.1 129.82 65.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 118.242 -0.885 . . . . 0.0 108.849 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.86 -27.26 26.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.168 1.246 . . . . 0.0 111.436 168.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.32 45.76 2.59 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.524 -1.36 . . . . 0.0 109.473 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.86 -51.72 68.79 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 120.441 -1.412 . . . . 0.0 110.578 167.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -152.25 70.91 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -164.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -146.88 -95.25 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -26.78 62.92 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.639 1.176 . . . . 0.0 112.487 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t 51.36 101.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 128.987 2.915 . . . . 0.0 109.888 -166.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 75.66 -35.58 0.27 Allowed 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 126.039 1.736 . . . . 0.0 112.99 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.62 154.58 45.54 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 162.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 49.29 -12.06 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 131.202 3.801 . . . . 0.0 117.849 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -51.49 -55.25 30.89 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 120.372 1.442 . . . . 0.0 109.254 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.62 -22.74 37.51 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 120.304 1.144 . . . . 0.0 110.36 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.82 -37.08 85.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.736 1.153 . . . . 0.0 110.485 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -61.42 -61.64 2.39 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.45 -27.72 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 120.603 -1.311 . . . . 0.0 113.674 -174.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -60.54 -22.63 63.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.199 1.0 . . . . 0.0 111.352 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.9 -18.64 58.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.945 1.702 . . . . 0.0 111.417 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -95.03 37.13 1.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.27 1.395 . . . . 0.0 112.195 -164.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 46.78 26.09 2.59 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.07 1.319 . . . . 0.0 115.357 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -75.32 171.8 13.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.112 1.456 . . . . 0.0 112.422 -168.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -143.89 -28.77 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.188 0.995 . . . . 0.0 112.965 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.409 HD22 ' H ' ' A' ' 68' ' ' VAL . 2.4 tm? -139.42 154.66 47.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.883 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.9 t -144.08 143.36 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.573 HG21 ' CG1' ' A' ' 99' ' ' VAL . 85.2 mt -133.22 115.93 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.62 175.43 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.468 1.107 . . . . 0.0 110.251 -172.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -99.43 0.18 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.89 -28.26 24.1 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 121.143 1.792 . . . . 0.0 116.217 -170.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.574 HG12 ' H ' ' A' ' 74' ' ' GLY 0.311 7.2 tt 39.9 -135.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 127.9 2.48 . . . . 0.0 113.41 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.28 154.99 18.09 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 127.78 2.609 . . . . 0.0 109.647 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -39.92 85.71 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.792 1.296 . . . . 0.0 111.645 -171.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -53.32 -38.22 63.0 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.793 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.87 -35.4 38.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 117.097 -1.43 . . . . 0.0 112.373 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.9 -48.07 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 120.604 1.547 . . . . 0.0 108.471 164.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 -10.02 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.281 -1.342 . . . . 0.0 114.479 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.08 -53.35 9.03 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 121.227 1.83 . . . . 0.0 109.904 167.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -60.86 -35.05 75.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.458 1.103 . . . . 0.0 110.385 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -60.32 -20.28 58.65 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.37 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.27 -10.77 57.03 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.665 1.575 . . . . 0.0 111.53 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.0 ptp -134.45 13.65 3.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.37 1.068 . . . . 0.0 112.782 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.2 33.08 44.88 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.628 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -79.45 113.0 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -71.95 146.44 47.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t -127.07 112.27 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 110' ' ' ASP . 63.7 mt -94.61 133.25 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.879 1.672 . . . . 0.0 106.624 170.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -129.28 167.98 16.9 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.982 1.713 . . . . 0.0 108.183 -172.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 12.45 67.21 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.765 -1.02 . . . . 0.0 113.781 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 171.89 10.38 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.05 1.425 . . . . 0.0 110.6 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.409 ' HA ' HG21 ' A' ' 17' ' ' ILE . 3.1 p -160.85 152.9 20.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 109.456 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.76 -173.13 16.52 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.381 0.515 . . . . 0.0 112.808 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p -82.43 172.94 12.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.621 -0.929 . . . . 0.0 109.752 168.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -60.81 -49.13 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 O-C-N 121.156 -0.965 . . . . 0.0 110.54 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -58.62 -37.5 76.0 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.499 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.42 -58.32 3.48 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.052 1.741 . . . . 0.0 107.867 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.573 ' CG1' HG21 ' A' ' 69' ' ' ILE . 46.2 t -54.4 -44.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.762 1.625 . . . . 0.0 110.636 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.59 -35.72 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.68 -40.6 88.64 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.788 1.176 . . . . 0.0 111.797 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -59.46 -44.26 93.04 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.013 0.824 . . . . 0.0 110.05 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.0 -45.33 74.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.961 0.905 . . . . 0.0 113.139 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.17 -28.02 69.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.85 0.75 . . . . 0.0 110.377 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.9 m -77.07 -3.23 38.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.36 56.08 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.141 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 -49.75 58.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.94 131.54 43.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.482 1.113 . . . . 0.0 110.743 -171.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.49 149.97 48.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 9.8 p-10 -82.36 29.15 0.43 Allowed 'General case' 0 C--N 1.324 -0.526 1 C-N-CA 132.068 4.147 . . . . 0.0 112.109 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.0 p -54.19 165.34 0.52 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.198 0.999 . . . . 0.0 112.199 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 67.72 86.29 0.13 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.19 1.796 . . . . 0.0 109.587 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -143.88 -177.47 5.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.378 1.071 . . . . 0.0 111.48 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.18 168.83 11.44 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.989 0.423 . . . . 0.0 111.098 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -141.78 -56.67 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.655 0.782 . . . . 0.0 109.897 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -142.49 -149.17 0.26 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.817 1.247 . . . . 0.0 108.429 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -54.21 134.45 44.65 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 120.098 1.317 . . . . 0.0 110.299 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -163.34 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.738 2.015 . . . . 0.0 107.028 170.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -149.14 168.57 22.87 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.871 1.214 . . . . 0.0 110.906 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -128.39 -66.55 0.84 Allowed 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.063 0.945 . . . . 0.0 110.3 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.4 -177.67 0.12 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.367 1.467 . . . . 0.0 110.643 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.253 0.2 OUTLIER 62.09 -71.61 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.322 1.849 . . . . 0.0 111.334 -168.163 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.2 t60 56.09 86.27 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.62 1.968 . . . . 0.0 111.178 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 . . . . . 0 C--O 1.242 0.678 0 C-N-CA 125.596 1.558 . . . . 0.0 108.998 169.439 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttm . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.402 HG23 ' HG2' ' A' ' 31' ' ' LYS . 3.3 mt -127.45 135.72 62.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -132.85 101.59 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 127.001 2.12 . . . . 0.0 107.031 -156.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.811 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.04 144.22 33.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.078 0.399 . . . . 0.0 111.131 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.3 mt -134.54 115.87 12.69 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.51 114.59 4.07 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.15 2.567 . . . . 0.0 109.079 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.34 157.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.08 . . . . 0.0 112.699 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -74.46 -25.33 59.34 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.865 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -150.57 152.16 33.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.134 1.374 . . . . 0.0 107.819 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -85.12 110.95 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 164.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -126.37 39.46 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.473 166.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.07 -102.39 0.58 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 125.368 1.461 . . . . 0.0 109.532 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -98.49 -31.68 11.86 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.875 1.27 . . . . 0.0 110.628 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.78 -10.07 54.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.305 1.442 . . . . 0.0 111.445 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.6 m -40.71 106.44 0.42 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 129.911 3.284 . . . . 0.0 111.892 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 135.82 19.97 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.899 2.4 . . . . 0.0 110.927 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.43 138.65 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -77.67 -160.16 0.17 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 108.265 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.54 -52.81 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.977 1.37 . . . . 0.0 109.697 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.4 179.13 6.04 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.894 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 54.5 t80 -121.0 -46.7 2.32 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.843 -1.16 . . . . 0.0 110.889 159.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.14 -42.22 16.38 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 41.47 2.21 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.833 1.253 . . . . 0.0 111.825 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.29 118.01 65.11 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-O 115.927 -1.987 . . . . 0.0 106.373 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.25 -17.67 50.12 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 113.717 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -149.1 158.92 44.57 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.738 1.215 . . . . 0.0 108.782 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.409 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 25.1 m-85 -126.22 128.9 47.95 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.318 1.847 . . . . 0.0 107.485 170.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.42 89.13 3.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.7 m-85 -75.43 92.02 2.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.26 162.23 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 55.8 mttt -117.28 -167.64 1.35 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.81 -1.182 . . . . 0.0 108.714 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.33 136.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 120.872 -1.143 . . . . 0.0 109.751 165.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.05 91.82 3.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 168.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 56.68 -69.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.383 2.273 . . . . 0.0 114.345 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.25 11.81 3.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.555 1.542 . . . . 0.0 112.752 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.72 173.36 8.61 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.115 1.366 . . . . 0.0 110.207 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.45 -23.25 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.464 1.106 . . . . 0.0 112.994 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.05 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.593 1.557 . . . . 0.0 114.02 -162.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -162.24 167.16 24.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.367 1.467 . . . . 0.0 109.836 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 mm -124.28 138.6 53.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.897 2.079 . . . . 0.0 105.835 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 m -119.79 96.91 5.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.86 77.69 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 123.467 1.603 . . . . 0.0 107.523 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.6 127.99 32.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.585 1.554 . . . . 0.0 106.943 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -60.61 162.63 6.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.793 1.179 . . . . 0.0 108.681 158.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -78.2 153.38 79.59 Favored Pre-proline 0 N--CA 1.438 -1.059 0 O-C-N 121.496 -0.753 . . . . 0.0 109.428 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.12 -52.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.721 0.948 . . . . 0.0 110.916 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.24 38.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.332 -0.855 . . . . 0.0 111.278 -163.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.33 97.21 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 120.939 -1.101 . . . . 0.0 110.271 -160.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.89 18.03 7.92 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -50.45 -67.0 0.29 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.616 2.367 . . . . 0.0 111.794 -167.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.26 24.0 1.15 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.581 1.553 . . . . 0.0 109.473 175.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.265 34.4 m 40.93 48.17 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 126.217 1.807 . . . . 0.0 111.656 -159.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -68.66 166.6 16.94 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.406 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.59 23.64 21.44 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.968 1.747 . . . . 0.0 111.624 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.27 -21.36 14.91 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.993 1.396 . . . . 0.0 113.276 -171.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -46.98 -48.52 52.52 Favored Pre-proline 0 CA--C 1.556 1.204 0 CA-C-N 119.232 0.923 . . . . 0.0 110.398 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HA ' HG22 ' A' ' 60' ' ' VAL . 57.8 Cg_endo -74.73 -20.04 17.94 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.188 1.925 . . . . 0.0 112.385 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -64.96 -42.46 94.59 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -59.79 -62.14 2.1 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.0 m -63.91 -21.11 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.638 1.563 . . . . 0.0 112.545 -173.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -64.1 -13.21 46.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 116.862 -1.542 . . . . 0.0 112.654 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -11.19 32.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 121.237 1.835 . . . . 0.0 112.488 173.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -90.56 37.29 0.91 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.956 0.798 . . . . 0.0 111.647 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.77 28.05 5.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.836 1.684 . . . . 0.0 114.179 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -63.48 152.82 37.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.662 1.731 . . . . 0.0 112.796 -173.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -144.4 -21.84 0.54 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 111.738 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.3 166.39 23.23 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 109.019 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.5 t -142.31 150.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 165.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.482 HG21 ' CG1' ' A' ' 99' ' ' VAL . 39.6 mt -134.19 112.04 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.89 176.81 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.469 1.508 . . . . 0.0 109.679 -167.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -103.26 -97.19 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.237 -1.363 . . . . 0.0 107.838 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.12 -12.94 40.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 120.731 1.605 . . . . 0.0 115.638 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.532 HG12 ' H ' ' A' ' 74' ' ' GLY . 2.3 tt 38.51 -130.17 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.527 1.931 . . . . 0.0 114.159 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 168.82 158.46 12.79 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 129.437 3.398 . . . . 0.0 110.812 166.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -47.35 33.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.475 1.51 . . . . 0.0 112.492 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -55.9 -6.01 0.2 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.38 -40.45 3.64 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 116.785 -1.578 . . . . 0.0 110.235 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -42.44 -46.96 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.698 1.135 . . . . 0.0 108.958 161.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.36 -19.1 63.03 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.9 2.0 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -57.52 -44.52 85.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 124.013 0.925 . . . . 0.0 109.915 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.95 -14.14 59.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.495 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.98 72.62 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.015 1.734 . . . . 0.0 109.021 168.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -19.15 33.66 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.111 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.71 20.23 37.96 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.094 -1.004 . . . . 0.0 112.496 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.8 t -78.91 121.23 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -63.95 146.31 54.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.703 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 p -139.93 89.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.65 1.18 . . . . 0.0 107.989 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.12 131.58 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.21 171.86 7.35 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.012 1.325 . . . . 0.0 111.494 -173.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.76 4.05 38.1 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.003 1.287 . . . . 0.0 114.483 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.74 164.47 23.46 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.89 1.345 . . . . 0.0 110.324 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.3 p -162.17 124.87 2.91 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -159.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.29 -169.68 25.32 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 123.399 0.437 . . . . 0.0 112.618 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.3 p -79.92 170.56 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.929 0.865 . . . . 0.0 109.723 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.2 t -53.6 -59.83 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 C-N-CA 123.591 0.756 . . . . 0.0 109.425 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.01 -27.75 69.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.04 -54.26 8.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.812 1.645 . . . . 0.0 109.399 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 69' ' ' ILE . 19.8 t -56.35 -43.45 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.837 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 t -52.88 -58.35 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 107.993 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.61 -44.05 95.07 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.009 -0.996 . . . . 0.0 111.939 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.96 -46.01 78.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.347 0.976 . . . . 0.0 110.0 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -62.87 -52.64 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.034 0.534 . . . . 0.0 112.152 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 110.812 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.5 m -74.29 -39.56 62.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.68 35.23 1.09 Allowed Glycine 0 C--N 1.333 0.365 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.145 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.15 -35.12 10.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.068 0.934 . . . . 0.0 112.257 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.53 146.52 31.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.978 1.311 . . . . 0.0 108.871 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -156.52 159.04 38.21 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.409 0.684 . . . . 0.0 110.315 -159.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -103.29 48.03 0.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.954 1.302 . . . . 0.0 109.23 -165.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.51 -4.03 24.51 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -164.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -114.71 88.2 2.81 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -162.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -121.56 153.99 37.29 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.148 0.579 . . . . 0.0 110.702 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.72 67.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.006 1.322 . . . . 0.0 111.244 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.5 t 62.07 -74.34 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 130.231 3.413 . . . . 0.0 112.46 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -162.23 177.38 9.69 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.792 1.178 . . . . 0.0 109.047 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -42.25 -46.59 4.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.13 1.772 . . . . 0.0 113.573 -172.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 38.87 64.86 0.72 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.331 2.252 . . . . 0.0 110.947 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -56.78 100.12 0.04 OUTLIER 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.47 1.508 . . . . 0.0 109.911 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -153.43 145.61 23.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 23.8 m170 77.87 156.09 0.16 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.946 2.098 . . . . 0.0 109.112 -162.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -150.35 -160.39 1.16 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.93 1.292 . . . . 0.0 109.018 -162.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -105.82 -47.09 3.96 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.012 1.725 . . . . 0.0 112.036 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.857 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 164.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptm . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.54 HG22 ' CD1' ' A' ' 29' ' ' PHE . 6.8 mt -124.38 132.24 71.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -173.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.21 104.46 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 129.012 2.925 . . . . 0.0 106.079 -164.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.94 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.08 133.9 35.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mt -127.8 118.26 21.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.89 127.21 17.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 106.8 -2.039 . . . . 0.0 106.8 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 15' ' ' SER . 16.9 m -121.13 157.51 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 119.538 1.063 . . . . 0.0 110.691 177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.86 -34.45 60.03 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.991 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -146.16 169.35 18.91 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.183 0.993 . . . . 0.0 108.545 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -84.03 89.79 7.32 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 130.579 3.552 . . . . 0.0 108.599 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -128.67 38.91 3.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.717 -0.615 . . . . 0.0 110.794 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.41 -80.29 0.11 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 126.033 1.778 . . . . 0.0 113.351 167.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -120.93 -33.54 3.73 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.775 1.63 . . . . 0.0 111.393 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.67 -5.23 11.0 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.769 2.427 . . . . 0.0 112.177 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB3' HG11 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -49.24 109.62 1.28 Allowed Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 127.896 2.478 . . . . 0.0 108.318 176.305 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -83.04 137.37 8.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.181 1.92 . . . . 0.0 109.159 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.3 tt -58.92 133.99 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.012 0.91 . . . . 0.0 110.947 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 t -73.68 167.84 20.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.387 1.475 . . . . 0.0 109.137 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -90.82 -20.75 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.44 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -133.75 -176.7 4.26 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -120.33 -49.51 2.27 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 110.64 -176.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.6 -5.69 24.98 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 46.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.666 2.386 . . . . 0.0 106.852 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.04 143.4 94.31 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 162.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.76 -16.31 13.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.207 1.938 . . . . 0.0 113.089 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.427 ' HB2' HG23 ' A' ' 7' ' ' VAL . 96.5 m-85 -149.51 155.88 41.08 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.903 -1.123 . . . . 0.0 109.72 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.64 114.3 17.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 126.265 1.826 . . . . 0.0 107.684 170.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.95 88.49 5.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 161.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.94 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -75.19 92.42 2.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 160.457 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.94 148.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -97.23 -167.69 1.58 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -144.74 136.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 164.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.55 -139.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.31 1.844 . . . . 0.0 106.95 167.389 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.567 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 20.1 t-20 -59.34 -54.11 50.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.712 -1.242 . . . . 0.0 109.398 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.27 11.42 0.71 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.296 1.039 . . . . 0.0 112.701 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.08 171.35 7.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.336 1.455 . . . . 0.0 108.543 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.13 -22.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 126.375 1.87 . . . . 0.0 112.664 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.4 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 54.15 -70.9 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.943 1.697 . . . . 0.0 112.052 -162.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -159.1 162.05 36.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.244 1.818 . . . . 0.0 109.25 -155.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mm -126.87 126.03 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -173.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -112.87 94.76 5.06 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 163.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -91.65 88.83 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -97.55 136.37 38.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.825 1.25 . . . . 0.0 109.655 -169.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -75.91 143.57 41.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.338 1.055 . . . . 0.0 108.235 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.59 116.46 60.93 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.118 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.92 -22.9 30.69 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.834 1.69 . . . . 0.0 112.312 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.85 39.86 3.86 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.534 1.134 . . . . 0.0 109.356 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.19 78.41 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.518 0.727 . . . . 0.0 110.693 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -141.87 18.7 2.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.446 1.098 . . . . 0.0 112.206 -170.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -76.77 73.94 3.42 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 120.98 -1.075 . . . . 0.0 108.675 172.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 53.25 29.96 9.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.686 1.594 . . . . 0.0 112.34 167.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.263 19.4 m 38.82 45.12 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.835 2.054 . . . . 0.0 113.065 -168.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -61.44 161.51 9.3 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.41 -29.5 75.27 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.622 -162.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.99 -1.82 33.98 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 -156.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.454 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 1.9 t -43.2 -54.06 9.98 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 120.8 1.636 . . . . 0.0 111.456 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 6.1 Cg_exo -76.1 -31.24 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.969 2.446 . . . . 0.0 111.497 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -62.65 -41.55 99.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.924 -0.56 . . . . 0.0 109.559 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.16 -66.28 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.758 0.823 . . . . 0.0 109.679 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 m -60.56 -6.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE3' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -97.83 -20.03 17.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.502 -1.374 . . . . 0.0 112.432 175.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -64.3 -25.22 67.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.976 0.807 . . . . 0.0 110.753 158.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 36.25 0.74 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.306 0.957 . . . . 0.0 110.716 -165.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.69 4.39 0.04 OUTLIER Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.446 2.45 . . . . 0.0 116.741 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.427 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.78 158.46 25.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.086 -1.832 . . . . 0.0 112.736 -158.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 86' ' ' VAL . 21.6 mt-10 -131.65 -20.35 2.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.745 0.818 . . . . 0.0 111.852 -165.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.541 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.2 tm? -134.36 152.84 52.04 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.671 0.607 . . . . 0.0 109.558 -174.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.83 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.1 t -148.49 139.0 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.479 HG21 HG13 ' A' ' 99' ' ' VAL . 71.4 mt -130.55 111.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -131.05 -178.5 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.698 1.199 . . . . 0.0 111.685 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.31 -100.48 0.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.53 55.63 3.48 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 125.962 1.744 . . . . 0.0 112.503 -169.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.47 167.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 O-C-N 121.681 -0.893 . . . . 0.0 109.231 169.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.45 166.74 23.31 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.424 1.012 . . . . 0.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -36.31 46.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.302 1.441 . . . . 0.0 113.414 -166.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.82 -31.37 64.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.324 1.42 . . . . 0.0 112.449 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.18 -35.88 15.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.695 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -41.75 -54.29 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.981 1.264 . . . . 0.0 107.884 158.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.75 -14.21 42.04 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.52 -53.42 6.29 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.107 1.322 . . . . 0.0 110.566 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -57.78 -35.52 70.91 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.228 1.011 . . . . 0.0 110.807 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -49.76 -33.08 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.186 2.194 . . . . 0.0 114.043 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -18.94 64.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.172 0.896 . . . . 0.0 111.861 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.22 1.11 4.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.089 1.356 . . . . 0.0 113.551 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.05 39.16 97.23 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.052 -1.03 . . . . 0.0 112.246 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 66' ' ' GLU . 40.4 t -79.64 117.79 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -74.15 139.47 44.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.593 -0.692 . . . . 0.0 110.175 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.05 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.208 1.403 . . . . 0.0 109.295 -168.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.06 131.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -150.91 144.15 24.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.322 -0.861 . . . . 0.0 112.198 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.19 11.91 22.96 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.749 1.166 . . . . 0.0 112.073 -169.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.33 177.65 3.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.169 1.485 . . . . 0.0 110.043 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.2 p -162.2 156.72 22.11 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 119.806 1.184 . . . . 0.0 110.032 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.63 -153.26 21.95 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 121.643 0.579 . . . . 0.0 111.792 172.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.73 153.4 26.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.791 0.837 . . . . 0.0 111.154 -171.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 t -61.24 -45.56 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 122.932 0.493 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.83 -28.24 65.86 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.433 0.561 . . . . 0.0 111.939 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.28 -57.04 3.79 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 127.347 2.259 . . . . 0.0 109.008 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.479 HG13 HG21 ' A' ' 69' ' ' ILE . 25.6 t -52.95 -45.37 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.791 1.237 . . . . 0.0 110.72 -176.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.1 -50.38 79.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -55.88 -47.88 76.58 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.419 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -54.07 -38.2 65.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.123 1.329 . . . . 0.0 112.102 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -71.29 -51.29 25.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.506 0.723 . . . . 0.0 112.114 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.16 -38.92 68.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.5 m -78.98 -5.66 54.4 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.839 1.656 . . . . 0.0 112.025 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.8 4.28 82.61 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.848 1.214 . . . . 0.0 114.736 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -81.18 -35.16 31.76 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.765 1.283 . . . . 0.0 111.431 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.7 161.38 31.07 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.716 0.806 . . . . 0.0 110.845 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -150.89 152.77 34.15 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.292 1.037 . . . . 0.0 109.821 -173.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -105.25 13.69 30.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.771 1.628 . . . . 0.0 111.442 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.0 t 51.77 -134.44 1.63 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.932 1.293 . . . . 0.0 108.628 176.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.23 110.8 15.1 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.843 1.657 . . . . 0.0 107.291 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.48 148.94 49.61 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -65.03 164.68 12.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.7 t -132.98 135.81 56.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 71.75 -164.7 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.636 1.574 . . . . 0.0 109.11 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 41.03 63.14 1.26 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.142 2.177 . . . . 0.0 113.429 -173.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -137.52 65.94 1.47 Allowed 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.622 -1.299 . . . . 0.0 109.303 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.23 158.37 24.33 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 121.373 -0.829 . . . . 0.0 110.743 174.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -149.23 138.5 21.51 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 170.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -168.83 -61.45 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.14 147.9 13.11 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 128.045 2.538 . . . . 0.0 104.787 174.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 161.13 -174.77 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 130.438 3.495 . . . . 0.0 107.411 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 31.1 m80 . . . . . 0 C--O 1.252 1.219 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 161.691 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ttp . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 mt -140.17 147.05 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.7 mt -132.56 103.1 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 127.38 2.272 . . . . 0.0 106.265 -162.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.977 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.09 154.42 28.1 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 119.61 -0.233 . . . . 0.0 110.845 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -146.18 115.89 4.7 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.22 123.4 9.91 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.497 2.131 . . . . 0.0 108.225 169.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 26' ' ' TYR . 17.5 m -119.81 157.93 21.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.448 0.567 . . . . 0.0 110.364 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.4 m -78.79 -27.84 44.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.078 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -148.75 148.94 30.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.111 0.869 . . . . 0.0 108.838 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -82.68 45.33 0.97 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.233 2.213 . . . . 0.0 112.987 -170.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -88.78 39.67 0.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.96 -1.713 . . . . 0.0 111.461 -167.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.51 -125.47 13.78 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.539 -1.35 . . . . 0.0 112.504 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -52.47 -45.82 66.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.648 1.579 . . . . 0.0 110.609 174.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -7.37 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.839 2.456 . . . . 0.0 111.834 -169.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -47.53 109.37 1.08 Allowed Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.151 1.78 . . . . 0.0 110.997 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.46 131.85 15.48 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.182 1.921 . . . . 0.0 109.975 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.94 142.93 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.488 1.115 . . . . 0.0 109.762 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.06 173.7 8.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.897 1.279 . . . . 0.0 108.735 174.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.34 -48.3 8.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 122.4 1.095 . . . . 0.0 109.196 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -86.88 166.39 15.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.486 -171.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -119.38 -52.27 2.27 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 123.862 0.865 . . . . 0.0 109.959 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -17.4 49.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.044 -0.864 . . . . 0.0 113.645 -172.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -139.2 39.3 2.1 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.283 1.833 . . . . 0.0 110.124 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.75 130.64 91.64 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 160.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.14 -17.87 35.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.445 1.43 . . . . 0.0 114.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.487 ' HB2' HG23 ' A' ' 7' ' ' VAL . 98.3 m-85 -146.69 156.34 43.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.516 1.126 . . . . 0.0 109.541 -171.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -134.18 106.42 7.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.039 1.736 . . . . 0.0 109.343 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.17 100.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.397 1.079 . . . . 0.0 108.662 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.977 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 4.5 m-85 -89.98 100.95 13.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 t -82.64 154.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 168.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 30.9 mtpt -102.67 -165.04 1.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.41 132.6 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 163.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.85 87.23 3.25 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 170.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 70.31 -75.01 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.125 1.37 . . . . 0.0 110.445 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -137.51 15.27 2.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.04 1.336 . . . . 0.0 112.197 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.34 174.79 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.981 1.313 . . . . 0.0 109.508 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.88 -22.87 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 121.217 1.826 . . . . 0.0 114.346 -166.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.76 -64.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.629 1.971 . . . . 0.0 115.084 -162.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.45 169.88 19.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.588 1.155 . . . . 0.0 108.823 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.2 mm -131.18 139.69 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 127.749 2.42 . . . . 0.0 105.32 -172.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.67 70.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.044 -1.035 . . . . 0.0 108.262 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.17 88.72 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 106.831 167.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.33 155.65 22.75 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.582 1.153 . . . . 0.0 108.25 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -82.34 166.34 19.56 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.994 -0.441 . . . . 0.0 109.991 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.9 110.77 37.83 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.203 173.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.44 -6.06 18.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.506 2.137 . . . . 0.0 113.275 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -134.99 38.17 3.0 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.06 0.944 . . . . 0.0 109.504 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.29 -35.62 77.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.04 0.836 . . . . 0.0 110.475 -172.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -144.2 41.17 1.37 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.039 1.335 . . . . 0.0 109.867 -168.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -134.76 -58.26 0.82 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.968 0.507 . . . . 0.0 111.999 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.11 -41.17 8.47 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.283 0.947 . . . . 0.0 111.057 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t 61.74 -71.93 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.848 1.659 . . . . 0.0 110.693 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 128.7 36.71 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.253 -1.529 . . . . 0.0 109.365 162.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.12 -21.41 6.15 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 117.918 -1.49 . . . . 0.0 115.827 159.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.93 -19.25 0.45 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.455 2.127 . . . . 0.0 115.035 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.52 -53.09 38.63 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 119.467 1.03 . . . . 0.0 108.301 168.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.99 -28.19 24.44 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.571 1.514 . . . . 0.0 111.88 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.14 -42.69 99.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.05 1.295 . . . . 0.0 108.984 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.496 ' CZ ' ' HE2' ' A' ' 63' ' ' LYS . 4.6 t80 -53.39 -63.05 1.27 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.256 0.622 . . . . 0.0 110.256 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 m -61.91 -30.65 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.276 -0.89 . . . . 0.0 113.154 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -65.13 -17.52 64.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -30.88 66.31 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.089 165.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.496 ' HE2' ' CZ ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -86.27 37.32 0.72 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.912 1.687 . . . . 0.0 113.378 -167.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 36.6 42.36 0.66 Allowed Glycine 0 CA--C 1.541 1.683 0 C-N-CA 127.694 2.569 . . . . 0.0 117.208 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.79 168.9 4.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.63 1.715 . . . . 0.0 113.789 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -139.73 -25.98 0.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.031 1.732 . . . . 0.0 111.046 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 tp -142.53 150.22 40.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.379 0.99 . . . . 0.0 110.603 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' A' ' 4' ' ' ALA . 9.4 t -147.71 123.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.48 HG21 ' CG1' ' A' ' 99' ' ' VAL . 87.9 mt -111.54 112.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.61 -177.1 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.76 1.224 . . . . 0.0 110.272 -172.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -112.14 -87.08 0.55 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.428 -0.795 . . . . 0.0 108.919 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.51 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 124.365 0.983 . . . . 0.0 113.65 -167.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.483 HG12 ' H ' ' A' ' 74' ' ' GLY 0.257 4.6 tt 43.56 -153.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 126.876 2.07 . . . . 0.0 112.883 -176.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -168.66 156.55 28.04 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.606 2.527 . . . . 0.0 109.329 176.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -38.38 70.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.511 1.155 . . . . 0.0 111.547 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -55.69 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 175.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.44 12.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.261 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.63 -48.1 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 165.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.02 50.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.9 -51.06 17.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.265 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.68 -36.59 76.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 126.149 1.779 . . . . 0.0 110.123 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -61.62 -17.02 53.51 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.133 -0.979 . . . . 0.0 113.589 170.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.78 -13.63 53.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.478 1.49 . . . . 0.0 111.821 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -125.64 12.25 7.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.642 1.977 . . . . 0.0 110.854 -172.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 15.02 58.45 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 123.658 0.647 . . . . 0.0 112.924 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.406 ' CG1' HG23 ' A' ' 68' ' ' VAL . 55.9 t -79.26 113.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -67.85 147.71 52.16 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.31 108.45 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.106 0.962 . . . . 0.0 109.774 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.4 128.41 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 128.511 2.724 . . . . 0.0 106.868 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -108.21 179.54 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 108.812 169.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.72 8.08 87.28 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 115.079 0.791 . . . . 0.0 115.079 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 -176.73 1.58 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.544 1.172 . . . . 0.0 110.65 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.5 t -163.33 168.31 20.64 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 128.362 2.665 . . . . 0.0 106.588 164.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.82 -170.83 21.27 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 118.023 0.374 . . . . 0.0 113.804 168.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.5 p -79.52 163.0 25.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.453 -1.028 . . . . 0.0 111.337 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.09 -55.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.374 1.07 . . . . 0.0 110.164 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.19 -20.79 66.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.81 -54.07 4.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.871 1.668 . . . . 0.0 107.207 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 69' ' ' ILE . 54.3 t -52.49 -46.37 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.216 1.806 . . . . 0.0 110.886 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.38 -53.28 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -62.44 -37.68 86.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.15 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -59.88 -46.79 88.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.042 1.292 . . . . 0.0 110.259 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -61.28 -53.93 50.45 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -56.23 -31.3 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.609 0.64 . . . . 0.0 110.426 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.3 m -76.08 -22.31 55.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 112.726 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.23 8.99 58.43 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.408 1.004 . . . . 0.0 113.236 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -80.92 -22.6 39.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.426 1.613 . . . . 0.0 112.067 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.91 145.18 27.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 109.202 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 165.46 28.27 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.27 1.028 . . . . 0.0 109.065 177.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.08 90.84 7.54 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 173.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.1 m -135.9 88.89 2.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.284 1.833 . . . . 0.0 108.725 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -165.37 101.59 0.72 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.498 1.519 . . . . 0.0 107.931 161.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.76 175.77 12.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 157.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -124.16 136.73 54.4 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 159.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 m -77.28 82.07 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 122.65 1.214 . . . . 0.0 108.757 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.81 174.24 11.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.451 1.5 . . . . 0.0 109.455 166.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.7 t70 62.99 173.92 0.15 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.099 2.56 . . . . 0.0 112.18 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -156.2 57.78 0.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.229 -0.919 . . . . 0.0 110.279 162.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -41.98 130.63 3.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.646 1.579 . . . . 0.0 111.916 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.34 178.12 7.64 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.813 -0.554 . . . . 0.0 111.022 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 65.56 175.87 0.21 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.219 1.408 . . . . 0.0 109.7 -167.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 72.11 111.78 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.701 2.4 . . . . 0.0 110.593 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -155.23 137.46 14.8 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.108 1.363 . . . . 0.0 107.632 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 C--O 1.253 1.282 0 CA-C-N 119.61 1.095 . . . . 0.0 110.662 -163.88 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttm . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.28 138.91 52.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 mt -125.66 105.42 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 127.586 2.354 . . . . 0.0 106.27 -159.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -79.65 144.09 34.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.365 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.9 mt -143.18 116.4 6.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 171.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.13 119.43 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 15' ' ' SER . 6.9 m -110.62 141.91 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.789 1.177 . . . . 0.0 110.21 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -69.28 -21.85 63.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 117.442 -1.266 . . . . 0.0 112.849 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -148.0 156.72 42.96 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 38.7 t-20 -90.42 97.75 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -132.24 38.21 3.5 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.25 -109.24 1.09 Allowed Glycine 0 C--N 1.342 0.891 0 C-N-CA 124.022 0.82 . . . . 0.0 112.487 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -80.62 -41.17 24.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.764 1.626 . . . . 0.0 109.603 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.27 -16.05 59.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.061 1.744 . . . . 0.0 112.408 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HG11 ' A' ' 7' ' ' VAL . 22.0 m -39.26 104.56 0.32 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.685 2.794 . . . . 0.0 112.416 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.37 135.94 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.056 1.837 . . . . 0.0 109.328 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -61.77 148.2 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.612 0.72 . . . . 0.0 110.338 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -78.47 178.35 7.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.905 2.482 . . . . 0.0 110.054 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -108.21 -30.22 8.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.816 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -133.88 90.59 2.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.694 1.134 . . . . 0.0 110.645 -164.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -43.32 -42.69 4.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.649 1.18 . . . . 0.0 112.986 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -1.53 40.02 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.023 -1.431 . . . . 0.0 115.925 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.45 46.86 1.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.442 1.621 . . . . 0.0 108.775 166.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 133.26 88.77 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 116.618 -1.658 . . . . 0.0 109.38 172.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -73.22 -22.55 18.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.756 2.304 . . . . 0.0 113.575 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 99.0 m-85 -147.1 154.04 40.66 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.022 0.929 . . . . 0.0 109.459 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.67 104.16 7.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 91.8 5.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.252 1.821 . . . . 0.0 108.913 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.907 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.6 m-85 -84.71 96.35 9.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.22 160.78 4.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -110.99 -170.08 1.57 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 119.993 -1.692 . . . . 0.0 108.798 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.1 144.24 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 162.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.691 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -80.05 -138.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.357 2.263 . . . . 0.0 105.598 167.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.691 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 21.4 t-20 -59.28 -62.63 1.74 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.471 1.908 . . . . 0.0 109.644 174.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -142.09 20.03 2.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.839 1.256 . . . . 0.0 111.678 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.91 161.71 26.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.117 1.367 . . . . 0.0 109.71 -170.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.75 -23.84 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.368 1.894 . . . . 0.0 112.608 -165.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.73 -65.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.032 2.133 . . . . 0.0 114.208 -166.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.24 165.88 21.53 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.069 0.948 . . . . 0.0 111.682 -165.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 152.07 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 127.229 2.212 . . . . 0.0 107.716 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.64 73.04 1.3 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.67 1.588 . . . . 0.0 109.467 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.256 8.3 p -90.63 84.77 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -96.66 154.46 17.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.707 1.203 . . . . 0.0 108.334 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.69 148.81 42.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.416 1.487 . . . . 0.0 110.564 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -92.19 115.08 64.05 Favored Pre-proline 0 CA--C 1.516 -0.345 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.806 -173.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 -21.97 53.59 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.989 1.793 . . . . 0.0 112.557 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -123.66 38.63 4.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.3 1.409 . . . . 0.0 111.049 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.71 63.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.513 1.051 . . . . 0.0 110.693 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -157.06 29.09 0.3 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.088 1.355 . . . . 0.0 110.448 -175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.48 -72.14 0.53 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.079 -1.013 . . . . 0.0 109.317 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -66.34 -23.37 66.34 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.943 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.7 t 39.0 52.26 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 126.534 1.934 . . . . 0.0 109.419 -174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -152.15 -58.02 0.15 Allowed 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.115 -0.991 . . . . 0.0 109.78 -165.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -176.62 -142.51 4.38 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -172.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.45 -14.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 129.997 3.319 . . . . 0.0 116.71 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.8 -53.5 12.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.656 1.982 . . . . 0.0 109.501 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.456 ' HA ' HG22 ' A' ' 60' ' ' VAL . 56.3 Cg_endo -76.31 -30.73 5.14 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 120.581 1.243 . . . . 0.0 111.04 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.0 -24.97 67.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.06 0.544 . . . . 0.0 110.348 -177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -69.12 -73.2 0.16 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 124.472 1.109 . . . . 0.0 109.502 162.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.2 m -59.38 -28.76 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -58.82 -42.63 89.63 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.076 1.307 . . . . 0.0 108.836 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -17.86 54.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.761 0.824 . . . . 0.0 112.479 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -86.58 37.17 0.73 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.747 0.703 . . . . 0.0 109.853 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 29.27 44.27 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 128.688 3.042 . . . . 0.0 114.832 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.73 174.37 8.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.012 1.406 . . . . 0.0 113.635 -172.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -145.13 -28.09 0.46 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.024 0.93 . . . . 0.0 112.194 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.0 tm? -142.05 157.9 44.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.859 -173.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.008 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -150.77 143.6 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.811 1.644 . . . . 0.0 106.999 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.569 HG21 HG13 ' A' ' 99' ' ' VAL . 61.8 mt -131.59 113.38 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.61 -177.23 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.748 1.219 . . . . 0.0 110.418 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -104.05 -100.5 0.31 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 117.515 -1.231 . . . . 0.0 107.808 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.8 -18.27 32.83 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 120.355 1.434 . . . . 0.0 114.849 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.467 HG12 ' H ' ' A' ' 74' ' ' GLY 0.309 4.9 tt 41.22 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 126.98 2.112 . . . . 0.0 112.786 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -152.91 -138.74 2.76 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.977 2.227 . . . . 0.0 109.822 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.62 -31.6 4.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.748 1.274 . . . . 0.0 111.18 163.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -36.84 68.08 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.345 -1.472 . . . . 0.0 113.135 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 -31.71 43.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.219 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.23 -47.92 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.55 -12.74 34.97 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.07 -58.9 3.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.796 1.18 . . . . 0.0 109.403 172.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -58.49 -42.31 87.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.06 -20.87 66.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.53 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.43 -9.1 58.27 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.808 1.185 . . . . 0.0 112.222 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.49 -5.69 6.48 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.054 0.942 . . . . 0.0 112.434 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.39 28.87 69.0 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 119.589 1.086 . . . . 0.0 111.228 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.42 115.47 20.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -72.65 139.05 47.09 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.453 -0.779 . . . . 0.0 109.216 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.16 92.94 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 122.612 1.196 . . . . 0.0 109.637 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.9 147.48 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.173 1.789 . . . . 0.0 107.537 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -155.34 173.02 17.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.15 0.98 . . . . 0.0 109.38 -160.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.21 18.61 60.75 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.435 -0.647 . . . . 0.0 112.715 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.32 178.68 7.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.28 1.032 . . . . 0.0 109.784 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -158.27 160.4 37.03 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 106.05 -1.834 . . . . 0.0 106.05 160.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.37 -162.41 25.39 Favored Glycine 0 N--CA 1.463 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 112.665 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 p -84.93 165.33 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.65 -0.912 . . . . 0.0 109.134 165.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.2 t -53.74 -54.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.94 -22.52 62.57 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -89.63 -52.47 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.825 1.65 . . . . 0.0 107.658 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.569 HG13 HG21 ' A' ' 69' ' ' ILE . 43.0 t -55.16 -35.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 111.552 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.29 -53.99 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -54.91 -43.01 72.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.134 0.574 . . . . 0.0 111.214 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -58.86 -41.8 87.87 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.854 0.835 . . . . 0.0 111.005 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -72.5 -43.63 63.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.376 1.071 . . . . 0.0 111.778 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.26 -29.87 67.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.972 0.806 . . . . 0.0 110.601 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 m -78.33 -2.96 40.66 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.844 1.258 . . . . 0.0 113.138 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.68 20.65 68.39 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.534 1.061 . . . . 0.0 113.205 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -81.16 -56.18 4.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.344 1.072 . . . . 0.0 108.952 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.02 146.63 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 110.806 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -150.4 164.61 35.41 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.489 1.137 . . . . 0.0 112.379 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -99.57 21.48 12.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 128.569 2.747 . . . . 0.0 110.414 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 p -74.52 5.33 4.85 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.685 1.994 . . . . 0.0 115.224 -164.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -123.22 74.1 1.21 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.309 1.528 . . . . 0.0 108.115 -150.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -163.55 86.02 0.5 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.094 -1.412 . . . . 0.0 107.371 -170.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.21 154.74 0.05 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 128.359 2.663 . . . . 0.0 108.882 164.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.9 t -141.43 -87.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 165.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -140.92 -57.04 0.51 Allowed 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 119.373 0.988 . . . . 0.0 112.26 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.41 -44.02 0.06 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.591 1.087 . . . . 0.0 112.177 175.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.49 -170.68 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 110.937 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -41.32 123.38 2.09 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.714 1.606 . . . . 0.0 111.894 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -92.25 119.73 32.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.42 147.05 52.29 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.08 0.854 . . . . 0.0 109.417 168.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -81.31 106.59 13.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.431 2.292 . . . . 0.0 108.212 171.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.19 146.74 25.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 162.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 . . . . . 0 C--O 1.234 0.262 0 O-C-N 126.881 2.613 . . . . 0.0 111.075 172.614 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.443 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.7 ttt . . . . . 0 C--O 1.235 0.342 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.409 HG12 ' HE3' ' A' ' 31' ' ' LYS . 3.9 mt -137.35 148.38 26.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 69' ' ' ILE . 13.8 mt -128.79 106.62 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 129.373 3.069 . . . . 0.0 105.561 -170.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.822 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.66 150.2 26.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.378 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.06 118.67 10.23 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.72 116.54 4.29 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 107.221 -1.876 . . . . 0.0 107.221 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 15' ' ' SER . 3.0 m -116.79 157.08 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.699 0.799 . . . . 0.0 110.488 -174.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 p -72.6 -35.45 67.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -142.2 156.44 45.33 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 120.355 1.434 . . . . 0.0 109.049 -167.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.52 88.88 6.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -132.41 38.41 3.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 109.719 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.26 -105.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 127.438 2.447 . . . . 0.0 111.25 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -79.92 -37.21 35.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.24 1.016 . . . . 0.0 110.216 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.66 -18.58 64.99 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.348 1.859 . . . . 0.0 112.175 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.584 ' HB3' HG11 ' A' ' 7' ' ' VAL . 3.7 m -37.97 105.06 0.31 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.42 2.288 . . . . 0.0 111.894 -175.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -68.87 132.64 25.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.578 1.519 . . . . 0.0 110.615 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.4 tt -62.13 142.0 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 119.781 -1.825 . . . . 0.0 110.67 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -81.03 -173.79 4.49 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.245 1.418 . . . . 0.0 108.977 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -109.12 -45.03 3.83 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.045 -1.034 . . . . 0.0 111.608 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -120.41 100.68 7.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.017 1.327 . . . . 0.0 107.851 -163.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -42.47 -45.35 4.4 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.141 1.376 . . . . 0.0 112.16 171.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.81 -20.2 59.46 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 117.888 -1.507 . . . . 0.0 114.303 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.32 38.91 3.58 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.415 1.608 . . . . 0.0 109.495 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.06 130.58 93.81 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.598 -1.192 . . . . 0.0 107.845 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.72 -20.74 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.605 2.203 . . . . 0.0 113.127 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -148.03 160.99 42.27 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.41 1.484 . . . . 0.0 108.378 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -126.94 112.11 14.9 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.68 88.41 7.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -78.12 98.6 5.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 108.179 169.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.42 136.82 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.465 1.106 . . . . 0.0 108.055 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HE3' HG12 ' A' ' 2' ' ' ILE . 9.6 mtpt -80.45 -164.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.13 -0.982 . . . . 0.0 109.549 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -156.25 147.86 11.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -146.06 122.08 10.72 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 53.96 34.46 19.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.079 0.952 . . . . 0.0 112.541 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 73.7 12.85 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.325 2.65 . . . . 0.0 114.337 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.06 172.49 7.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.0 108.402 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.85 -27.23 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 125.15 1.38 . . . . 0.0 112.436 -159.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.99 -67.42 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 C-N-CA 127.156 2.183 . . . . 0.0 112.753 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -164.86 157.17 16.02 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.751 -0.593 . . . . 0.0 112.011 -164.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.32 131.4 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.171 1.788 . . . . 0.0 106.848 -172.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.0 m -129.4 117.94 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 107.153 166.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 t -131.39 79.45 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -82.02 168.81 17.43 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -105.97 132.52 51.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 107.68 -168.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -79.59 123.73 84.04 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.591 -150.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.35 -10.77 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.427 2.752 . . . . 0.0 114.982 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.35 38.84 2.28 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.147 1.779 . . . . 0.0 109.895 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.44 68.68 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.599 -1.313 . . . . 0.0 112.429 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -130.14 -19.36 3.19 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.107 1.363 . . . . 0.0 111.869 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -100.28 128.97 46.23 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 60.05 -46.01 0.09 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.34 1.856 . . . . 0.0 113.719 -163.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.5 t 65.28 -80.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 127.49 2.316 . . . . 0.0 108.655 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -75.25 134.72 41.06 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 160.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.31 -151.91 21.29 Favored Glycine 0 C--N 1.322 -0.224 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -164.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.74 -1.1 1.72 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 -170.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -43.45 -52.02 14.1 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 121.404 1.911 . . . . 0.0 111.314 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.86 -27.39 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.277 1.985 . . . . 0.0 111.761 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.38 -41.79 90.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.729 1.149 . . . . 0.0 109.889 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.17 -68.15 0.2 Allowed 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 123.683 0.793 . . . . 0.0 109.654 167.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 m -64.47 -12.1 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -72.71 -22.26 60.92 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.59 1.156 . . . . 0.0 111.553 170.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.55 -12.95 50.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.838 0.745 . . . . 0.0 112.044 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -93.1 37.02 1.03 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.173 -0.954 . . . . 0.0 111.18 -164.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.28 18.27 34.95 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.796 1.188 . . . . 0.0 113.835 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -64.39 158.75 22.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.929 1.365 . . . . 0.0 112.422 -171.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 6.5 mt-10 -137.77 -19.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.327 1.451 . . . . 0.0 110.893 172.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.65 159.24 42.62 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.315 1.846 . . . . 0.0 109.042 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.571 HG12 HG13 ' A' ' 70' ' ' VAL . 3.5 t -137.62 139.82 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 158.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.523 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.5 mt -112.74 117.85 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.571 HG13 HG12 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -134.81 138.85 48.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 O-C-N 121.773 -0.58 . . . . 0.0 110.974 -164.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -77.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.598 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.87 -36.69 1.22 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.577 1.081 . . . . 0.0 115.459 -170.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.563 HD12 HG11 ' A' ' 70' ' ' VAL 0.252 6.2 tt 44.5 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 128.828 2.851 . . . . 0.0 113.971 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.85 169.67 40.61 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.296 1.903 . . . . 0.0 110.759 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -48.45 64.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.401 1.481 . . . . 0.0 114.007 -161.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.67 -24.03 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.02 -31.12 13.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.518 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mm -52.49 -46.95 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.25 54.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.62 -50.06 14.73 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.066 1.303 . . . . 0.0 111.279 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.447 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -38.09 -56.19 1.19 Allowed 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.806 1.643 . . . . 0.0 109.831 161.462 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -12.24 61.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 124.609 1.193 . . . . 0.0 112.081 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.8 -18.29 48.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.251 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.59 13.32 3.75 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.293 0.951 . . . . 0.0 113.3 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.98 27.54 59.76 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 121.347 -0.845 . . . . 0.0 111.847 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 2.1 t -79.67 110.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -170.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -57.16 151.85 14.73 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.863 0.465 . . . . 0.0 110.095 -168.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 90' ' ' LYS . 3.4 t -128.78 89.59 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-O 121.447 0.641 . . . . 0.0 110.543 -174.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . 0.258 36.7 mt -76.52 85.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 123.365 1.555 . . . . 0.0 109.591 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HG3' HG12 ' A' ' 88' ' ' VAL . 21.1 mtpt -80.75 142.01 34.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.896 2.079 . . . . 0.0 112.148 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.9 22.15 7.77 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.873 1.225 . . . . 0.0 112.484 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.78 165.98 24.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.567 1.683 . . . . 0.0 112.058 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -151.66 165.25 34.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.924 2.89 . . . . 0.0 105.136 158.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 125.36 175.45 14.22 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.953 0.797 . . . . 0.0 113.487 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 p -79.83 156.35 27.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.4 ' CG2' HG11 ' A' ' 7' ' ' VAL . 60.9 t -54.99 -47.87 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -54.69 -29.73 53.72 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.49 -45.84 8.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.651 1.981 . . . . 0.0 110.389 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' A' ' 69' ' ' ILE . 56.3 t -50.65 -45.69 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.977 1.311 . . . . 0.0 109.822 172.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.32 -48.39 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.756 0.822 . . . . 0.0 108.918 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.892 0.769 . . . . 0.0 111.188 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -54.9 -42.61 72.37 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.895 0.878 . . . . 0.0 110.272 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -69.48 -49.39 55.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.646 0.778 . . . . 0.0 113.067 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.71 -21.69 66.08 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.252 0.478 . . . . 0.0 111.121 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -81.25 -30.43 34.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.197 0.599 . . . . 0.0 109.72 171.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.37 2.0 17.98 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.48 1.514 . . . . 0.0 113.945 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -82.84 -30.31 28.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.83 0.815 . . . . 0.0 110.401 -165.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.94 136.74 45.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.823 1.249 . . . . 0.0 109.886 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.84 162.71 26.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.464 1.506 . . . . 0.0 112.279 -166.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -119.13 14.14 13.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.664 1.585 . . . . 0.0 111.367 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . 0.255 35.7 p 53.86 -159.98 0.15 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 126.047 1.739 . . . . 0.0 112.091 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.11 114.84 8.98 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -175.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.59 168.64 18.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.489 1.515 . . . . 0.0 109.552 -176.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -70.12 134.52 48.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.291 -163.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -58.61 126.21 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 160.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -46.57 109.58 0.21 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.038 2.135 . . . . 0.0 112.484 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -45.17 -48.43 12.36 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.843 1.657 . . . . 0.0 110.637 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.67 -11.03 6.16 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 28.64 51.76 0.06 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 129.84 3.256 . . . . 0.0 115.477 168.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -60.01 -29.03 68.21 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.887 -1.133 . . . . 0.0 112.623 -173.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 54.68 43.99 29.28 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.216 1.007 . . . . 0.0 110.983 167.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.99 73.76 6.77 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.519 1.128 . . . . 0.0 110.77 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 178.83 -7.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.829 0 N-CA-C 102.728 -3.064 . . . . 0.0 102.728 175.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 58.3 ttm . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.421 HG22 ' CD1' ' A' ' 29' ' ' PHE . 4.3 mt -131.59 143.67 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 172.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.474 HG12 HD12 ' A' ' 67' ' ' LEU . 46.2 mt -128.78 100.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 127.395 2.278 . . . . 0.0 106.844 -166.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.013 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -81.81 127.21 32.74 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.784 0.434 . . . . 0.0 110.71 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 96' ' ' VAL . 97.0 mt -130.24 116.82 17.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.83 127.01 9.82 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.262 1.975 . . . . 0.0 107.745 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 m -127.74 148.08 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.7 m -76.25 -22.01 55.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.526 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.48 171.75 13.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.218 1.407 . . . . 0.0 108.056 -173.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -113.69 40.4 2.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.818 1.647 . . . . 0.0 113.412 -165.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -86.0 39.01 0.79 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.982 0.513 . . . . 0.0 111.026 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.86 -95.82 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.954 2.216 . . . . 0.0 113.694 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -41.37 22.31 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.527 1.164 . . . . 0.0 112.315 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.56 -3.25 14.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.39 1.476 . . . . 0.0 111.205 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -49.68 117.63 7.43 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.603 1.961 . . . . 0.0 110.57 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.2 135.69 11.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.741 2.294 . . . . 0.0 111.655 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.59 129.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.485 0.659 . . . . 0.0 111.118 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.81 164.29 15.29 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.16 1.784 . . . . 0.0 108.979 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.37 -52.99 5.76 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 121.075 -1.016 . . . . 0.0 110.488 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -97.39 94.99 7.37 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -161.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -42.91 -52.41 5.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.586 0.63 . . . . 0.0 111.573 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.58 9.91 40.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.577 -176.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 -149.1 56.11 1.0 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.4 137.81 20.04 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.12 -20.25 19.29 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.939 1.759 . . . . 0.0 113.294 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -149.58 165.05 33.43 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.604 1.093 . . . . 0.0 109.558 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.02 106.76 8.23 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.368 1.467 . . . . 0.0 108.65 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 88.83 5.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 1.013 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -80.54 91.85 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.183 1.393 . . . . 0.0 108.298 166.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.49 155.5 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -99.69 -170.68 1.93 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.907 -1.121 . . . . 0.0 109.242 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 t -146.59 146.93 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 114.86 8.14 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 127.844 2.458 . . . . 0.0 105.311 169.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 m120 43.4 60.46 2.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.472 1.109 . . . . 0.0 111.03 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 64.95 6.25 3.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.465 1.906 . . . . 0.0 115.171 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.36 173.78 6.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.863 1.665 . . . . 0.0 108.879 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.1 -23.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 124.884 1.273 . . . . 0.0 113.597 -164.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.82 -77.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.715 1.206 . . . . 0.0 111.903 -155.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.54 172.17 19.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.881 2.072 . . . . 0.0 110.23 -161.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 mm -126.21 141.11 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 m -138.44 121.02 16.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.954 2.102 . . . . 0.0 106.296 166.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -137.02 79.14 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -88.28 158.21 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.41 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.88 162.7 15.79 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 167.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -100.17 99.84 10.38 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.46 -0.781 . . . . 0.0 108.926 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.91 -11.02 29.08 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.646 2.231 . . . . 0.0 114.444 -170.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.56 38.57 4.13 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.787 -1.196 . . . . 0.0 110.489 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.43 96.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.592 1.157 . . . . 0.0 110.477 168.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -129.32 5.25 5.22 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.262 1.025 . . . . 0.0 112.132 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -95.05 -99.3 0.16 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -84.83 -10.48 57.12 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 119.746 -1.846 . . . . 0.0 114.417 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.1 t 58.06 -86.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.592 1.557 . . . . 0.0 112.47 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -100.23 32.64 2.92 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 119.84 -1.787 . . . . 0.0 114.361 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.57 110.29 0.4 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 119.284 0.947 . . . . 0.0 111.124 172.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 97.07 -10.7 0.07 Allowed 'General case' 0 CA--C 1.536 0.419 1 C-N-CA 132.162 4.185 . . . . 0.0 114.906 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -46.51 -48.52 47.37 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 121.672 2.033 . . . . 0.0 110.989 161.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 60' ' ' VAL . 4.1 Cg_endo -67.17 -18.26 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 120.52 1.222 . . . . 0.0 113.081 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -68.34 -26.97 65.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.828 0.74 . . . . 0.0 111.15 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.01 -69.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.278 1.031 . . . . 0.0 108.849 165.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 57' ' ' PRO . 3.2 m -62.02 -29.02 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -166.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -63.87 -35.99 82.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.292 1.405 . . . . 0.0 110.729 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -15.54 62.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.27 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -86.05 37.07 0.7 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.191 1.36 . . . . 0.0 110.856 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.46 25.72 4.64 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.841 2.163 . . . . 0.0 116.957 165.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -72.22 173.78 8.13 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -164.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 19.9 mt-10 -142.4 -33.62 0.47 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.768 1.627 . . . . 0.0 111.657 -178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.5 tm? -138.14 156.19 47.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.461 1.104 . . . . 0.0 109.065 -173.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.782 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -148.7 144.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.714 1.205 . . . . 0.0 108.587 -177.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.423 HG21 HG13 ' A' ' 99' ' ' VAL . 52.1 mt -137.45 115.48 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.425 HG21 ' HB ' ' A' ' 73' ' ' ILE . 30.2 m -131.96 177.14 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.116 0.966 . . . . 0.0 109.923 -173.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.6 -80.45 0.39 Allowed 'General case' 0 C--O 1.226 -0.135 0 O-C-N 120.888 -1.133 . . . . 0.0 108.046 167.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.77 -19.01 8.47 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -164.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.425 ' HB ' HG21 ' A' ' 70' ' ' VAL 0.289 5.5 tt 35.84 -126.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 127.517 2.327 . . . . 0.0 113.708 175.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.82 140.68 3.1 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.306 1.908 . . . . 0.0 109.461 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -48.51 -44.09 35.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 116.987 -1.482 . . . . 0.0 113.44 -166.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -31.18 55.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.756 1.616 . . . . 0.0 112.463 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.57 -25.57 22.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.712 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.93 -51.69 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 167.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.42 -26.63 13.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.557 1.543 . . . . 0.0 113.132 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.52 -57.15 4.38 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.649 0.659 . . . . 0.0 111.454 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -59.17 -34.6 72.3 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.003 1.321 . . . . 0.0 110.985 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -54.62 -32.5 59.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.949 0.899 . . . . 0.0 111.793 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.4 -10.65 59.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.77 0.714 . . . . 0.0 112.452 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 ptm -124.4 10.2 8.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.508 1.523 . . . . 0.0 111.026 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.05 21.94 64.31 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 118.584 0.629 . . . . 0.0 112.182 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -80.83 119.66 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.06 146.56 49.23 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 119.123 -0.465 . . . . 0.0 110.308 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 t -133.71 107.93 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.808 1.186 . . . . 0.0 111.545 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -96.52 147.76 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.871 1.668 . . . . 0.0 108.608 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -172.6 2.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.072 1.349 . . . . 0.0 110.316 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.25 9.87 73.24 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 163.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -167.87 2.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.793 1.796 . . . . 0.0 111.442 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.32 159.01 14.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.492 1.917 . . . . 0.0 106.845 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 117.24 -169.67 13.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 112.618 170.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 p -79.89 167.85 20.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 5' ' ' ILE . 86.0 t -56.96 -54.03 35.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 123.718 0.807 . . . . 0.0 110.289 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -50.96 -40.81 58.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 -175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.85 -49.9 13.35 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.13 1.772 . . . . 0.0 109.307 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG13 HG21 ' A' ' 69' ' ' ILE . 24.3 t -50.44 -32.61 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.57 1.148 . . . . 0.0 110.867 173.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.2 t -82.98 -41.36 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -52.42 -48.89 65.48 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -58.71 -41.96 87.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.399 0.679 . . . . 0.0 111.693 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -65.37 -51.66 58.93 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.516 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -60.74 -26.71 67.39 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.944 0.778 . . . . 0.0 111.01 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.95 0.47 56.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 110.977 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.12 6.51 88.07 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 120.835 -1.165 . . . . 0.0 113.347 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -72.3 -48.71 40.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.77 1.285 . . . . 0.0 109.425 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 tp -81.52 134.69 35.55 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.11 1.364 . . . . 0.0 109.491 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -144.73 152.74 40.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.453 1.101 . . . . 0.0 111.086 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -91.21 13.86 15.95 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.195 2.198 . . . . 0.0 113.649 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 p -86.53 60.48 6.25 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.387 1.075 . . . . 0.0 111.398 -172.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.55 70.71 0.91 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.205 1.802 . . . . 0.0 106.929 -177.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.43 173.5 9.87 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.47 -0.769 . . . . 0.0 112.136 178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 55.22 24.94 6.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.895 2.078 . . . . 0.0 113.959 173.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -105.83 47.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 127.01 2.124 . . . . 0.0 108.565 -167.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 69.55 92.45 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.582 1.953 . . . . 0.0 110.529 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -147.92 179.0 8.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.899 0.88 . . . . 0.0 110.998 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -153.65 -41.3 0.09 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.727 1.149 . . . . 0.0 113.592 167.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.9 m170 38.4 82.13 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.845 2.058 . . . . 0.0 114.27 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.65 169.45 8.58 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.947 -1.095 . . . . 0.0 111.681 172.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.36 -88.85 0.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 157.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -142.37 141.14 32.26 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.906 1.682 . . . . 0.0 108.293 -170.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -73.45 -174.42 1.67 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.616 1.098 . . . . 0.0 111.912 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 . . . . . 0 C--O 1.246 0.905 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 173.912 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.513 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 24.2 ttm . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.969 0.89 . . . . 0.0 112.07 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.417 HG12 ' HE3' ' A' ' 31' ' ' LYS . 2.7 mt -140.3 144.0 28.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.18 104.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.346 2.658 . . . . 0.0 105.981 -163.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.957 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -82.16 143.95 31.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.108 0.163 . . . . 0.0 111.091 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 mt -145.38 106.77 4.41 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.61 117.84 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.351 2.034 . . . . 0.0 107.929 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.428 HG11 ' CB ' ' A' ' 15' ' ' SER . 1.5 m -112.18 159.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.719 1.608 . . . . 0.0 109.439 -174.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -85.25 -11.55 54.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 117.548 -1.215 . . . . 0.0 112.389 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -150.88 170.16 19.96 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.701 1.201 . . . . 0.0 108.296 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -98.77 103.1 15.02 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -137.76 38.57 2.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.378 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.09 -123.78 2.68 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.695 -1.253 . . . . 0.0 111.516 -174.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -35.93 63.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.956 1.378 . . . . 0.0 113.7 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -6.27 50.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.531 1.133 . . . . 0.0 111.311 -175.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.428 ' CB ' HG11 ' A' ' 7' ' ' VAL . 37.9 m -52.6 111.33 2.49 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 120.302 1.41 . . . . 0.0 110.166 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -67.38 134.3 32.99 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.595 2.197 . . . . 0.0 108.541 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tt -64.75 142.82 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.161 0.437 . . . . 0.0 110.309 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -81.2 -173.79 4.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.826 0.85 . . . . 0.0 108.967 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.14 -46.97 6.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.469 1.128 . . . . 0.0 108.737 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -99.41 165.56 11.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.671 1.189 . . . . 0.0 109.436 -159.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -120.42 -49.41 2.26 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.264 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 16.72 5.06 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.177 0.894 . . . . 0.0 114.593 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.74 39.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 129.073 2.949 . . . . 0.0 107.863 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.48 150.88 82.72 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 170.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.63 -22.5 12.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.802 2.335 . . . . 0.0 114.359 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -145.84 172.28 13.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.431 1.892 . . . . 0.0 109.074 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -133.96 110.29 9.59 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.665 1.186 . . . . 0.0 108.034 162.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.72 101.75 8.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 165.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.927 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.3 m-85 -88.72 104.72 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.17 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HE3' HG12 ' A' ' 2' ' ' ILE . 14.5 mtpt -98.88 -165.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.006 -1.059 . . . . 0.0 108.637 172.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.12 147.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 162.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 123.08 15.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 161.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.94 20.5 11.58 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 t30 86.83 9.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.437 2.695 . . . . 0.0 112.27 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.59 170.22 8.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.54 -22.77 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.202 1.801 . . . . 0.0 112.304 -163.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 50.5 -72.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.48 1.912 . . . . 0.0 112.766 -160.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -157.06 156.45 32.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.135 0.574 . . . . 0.0 112.472 -166.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mm -121.68 127.81 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.141 1.777 . . . . 0.0 108.0 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 t -120.57 97.28 5.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.254 13.0 p -106.72 61.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 122.743 1.258 . . . . 0.0 108.636 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.6 149.62 31.28 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.48 163.34 16.09 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.0 115.63 60.89 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.85 -7.02 19.5 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.419 2.079 . . . . 0.0 112.515 -175.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mt -135.45 39.85 2.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.931 2.093 . . . . 0.0 107.687 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.48 -35.92 77.04 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.857 -1.152 . . . . 0.0 111.605 -173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -156.66 21.09 0.33 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.726 0.811 . . . . 0.0 111.338 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -89.58 -64.36 1.15 Allowed 'General case' 0 N--CA 1.462 0.131 0 O-C-N 122.021 -0.424 . . . . 0.0 110.517 -159.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -109.05 -1.92 18.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.683 1.193 . . . . 0.0 112.757 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m 28.85 58.15 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 131.532 3.933 . . . . 0.0 115.901 167.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.84 -61.61 0.57 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.744 0.818 . . . . 0.0 111.23 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.62 -148.08 5.39 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 105.143 -3.183 . . . . 0.0 105.143 -169.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.31 -20.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 128.102 2.561 . . . . 0.0 116.762 173.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.69 -49.18 27.56 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 126.131 1.772 . . . . 0.0 108.289 164.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.8 -25.0 17.4 Favored 'Trans proline' 0 C--N 1.359 1.096 0 CA-C-N 121.349 1.518 . . . . 0.0 111.367 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.457 ' HA ' ' HE3' ' A' ' 61' ' ' LYS . 10.2 t30 -71.36 -28.71 64.25 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 119.854 1.207 . . . . 0.0 111.237 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -60.85 -70.99 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 162.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -62.57 -21.9 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 58' ' ' ASN . 6.3 mtmp? -66.12 -22.9 66.41 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.555 -1.341 . . . . 0.0 112.746 170.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -26.33 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 120.267 1.394 . . . . 0.0 109.614 172.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -85.74 38.6 0.76 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.975 0.91 . . . . 0.0 111.118 -165.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.08 14.6 39.89 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.725 2.107 . . . . 0.0 116.017 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -69.32 167.64 16.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.242 1.521 . . . . 0.0 114.395 -160.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 32.3 mt-10 -142.68 -21.86 0.66 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.197 0.999 . . . . 0.0 112.486 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 68' ' ' VAL . 1.9 tm? -142.47 155.03 45.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.73 1.212 . . . . 0.0 107.853 -171.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.957 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -152.16 138.61 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 99' ' ' VAL . 9.0 mt -130.01 110.72 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.556 HG13 HG12 ' A' ' 68' ' ' VAL . 19.1 m -133.45 156.01 41.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.615 1.566 . . . . 0.0 108.931 -167.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -99.3 -52.4 3.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.199 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.97 -49.17 0.59 Allowed Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.542 1.068 . . . . 0.0 113.036 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.506 HG12 ' H ' ' A' ' 74' ' ' GLY 0.255 4.9 tt 41.42 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 127.077 2.151 . . . . 0.0 112.626 -173.422 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.74 158.18 21.69 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 127.153 2.311 . . . . 0.0 109.356 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -45.03 -40.0 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 128.793 2.837 . . . . 0.0 114.511 -168.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -58.81 -34.02 71.03 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.001 -1.062 . . . . 0.0 112.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.84 -31.58 22.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.312 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.8 -51.66 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 166.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 0.66 1.98 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.31 -51.95 5.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 119.983 -1.698 . . . . 0.0 111.736 163.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -60.9 -37.3 81.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.684 1.194 . . . . 0.0 110.02 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -63.06 -15.87 58.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.062 0.945 . . . . 0.0 112.675 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.32 -15.81 61.38 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.436 -1.415 . . . . 0.0 110.97 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.7 ptp -131.81 5.75 4.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.583 1.953 . . . . 0.0 112.519 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.34 41.62 55.21 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -79.1 119.64 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -66.47 136.73 56.12 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.453 -0.779 . . . . 0.0 109.09 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.82 110.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 67' ' ' LEU . 24.0 mt -93.69 116.42 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 127.927 2.491 . . . . 0.0 106.126 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -117.04 135.12 53.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.785 0.434 . . . . 0.0 111.335 -173.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.04 2.29 13.94 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.671 1.605 . . . . 0.0 114.603 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 -177.96 5.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.458 1.629 . . . . 0.0 111.128 -168.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.4 p -164.61 153.76 13.18 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.925 -1.109 . . . . 0.0 108.383 -172.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.28 -144.65 15.43 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 112.106 -0.397 . . . . 0.0 112.106 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.7 p -105.94 173.0 6.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.194 1.398 . . . . 0.0 109.629 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.11 -57.82 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.59 -35.11 76.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.733 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.29 -51.7 41.91 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.64 1.176 . . . . 0.0 108.136 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.469 ' CG1' HG21 ' A' ' 69' ' ' ILE . 65.2 t -63.31 -29.5 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.186 0.995 . . . . 0.0 111.739 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.4 t -68.85 -51.34 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -56.22 -43.2 78.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.041 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -57.18 -51.21 70.22 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.708 1.14 . . . . 0.0 109.868 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.87 -43.64 57.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.124 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.43 -31.72 68.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.51 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 m -78.24 -12.66 60.01 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 113.271 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.6 5.87 68.6 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.272 0.942 . . . . 0.0 113.594 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -70.41 -37.11 74.4 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.792 1.296 . . . . 0.0 110.676 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mt -82.56 165.77 19.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.022 1.329 . . . . 0.0 112.432 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -155.99 178.44 10.27 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.578 1.551 . . . . 0.0 111.91 175.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -136.06 37.08 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.17 2.188 . . . . 0.0 108.716 -156.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.91 -6.08 56.78 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -167.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -106.21 83.56 1.91 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.08 170.14 8.73 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.454 1.102 . . . . 0.0 110.16 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.08 113.54 2.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.915 0.78 . . . . 0.0 111.009 -173.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.3 m -75.51 177.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 126.747 2.019 . . . . 0.0 114.464 -166.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 60.8 72.54 0.52 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.279 1.832 . . . . 0.0 111.854 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -74.56 84.19 2.04 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.682 2.793 . . . . 0.0 112.573 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -57.33 -17.69 13.48 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -170.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 23.35 94.61 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.765 2.826 . . . . 0.0 114.855 164.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.43 157.5 42.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 55.5 m80 48.99 -155.91 0.08 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.165 0.986 . . . . 0.0 111.284 -167.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 28.63 95.86 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.559 3.144 . . . . 0.0 114.849 -175.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -89.85 -179.42 5.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.907 1.683 . . . . 0.0 110.46 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 30.2 p80 . . . . . 0 C--O 1.246 0.902 0 CA-C-O 117.615 -1.183 . . . . 0.0 109.893 159.373 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.1 ptm . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.441 HG22 ' CD1' ' A' ' 29' ' ' PHE . 4.7 mt -130.16 141.15 47.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 175.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.483 HG23 HD12 ' A' ' 69' ' ' ILE . 35.5 mt -125.14 100.58 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.764 2.826 . . . . 0.0 106.384 -161.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.887 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -83.86 145.61 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.856 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.37 126.68 21.41 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 166.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -75.43 110.2 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 N-CA-C 106.252 -2.249 . . . . 0.0 106.252 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.98 161.73 8.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 122.465 1.126 . . . . 0.0 110.99 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -93.24 -22.91 18.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.848 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.1 165.21 32.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.661 1.119 . . . . 0.0 108.797 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -92.44 77.3 5.09 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.245 1.018 . . . . 0.0 109.475 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -124.01 57.7 1.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.77 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -24.72 119.52 0.02 OUTLIER Glycine 0 N--CA 1.47 0.931 0 C-N-CA 126.064 1.792 . . . . 0.0 112.655 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt 80.14 -58.02 0.34 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.779 3.232 . . . . 0.0 110.909 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.38 -6.23 9.6 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.627 1.171 . . . . 0.0 113.105 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 m -47.92 102.84 0.33 Allowed Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 130.3 3.44 . . . . 0.0 110.379 -167.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.23 123.62 7.31 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.203 1.936 . . . . 0.0 110.677 -170.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.481 HG21 ' HA ' ' A' ' 93' ' ' SER . 13.3 tt -56.71 143.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 122.111 0.957 . . . . 0.0 109.406 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.08 168.77 9.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.79 1.236 . . . . 0.0 109.411 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.6 -40.49 18.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.779 -0.576 . . . . 0.0 111.899 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -101.05 172.51 6.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.765 1.226 . . . . 0.0 108.575 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -120.2 -51.79 2.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 173.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -7.05 7.57 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.132 171.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ttp-105 -144.32 39.43 1.3 Allowed 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 126.011 1.724 . . . . 0.0 109.625 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.91 123.95 87.46 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 163.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.95 -19.72 34.84 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 120.801 1.322 . . . . 0.0 112.669 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -148.04 161.49 41.28 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.153 0.888 . . . . 0.0 109.697 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -135.77 106.46 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 108.287 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.92 93.68 5.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.887 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -82.16 95.64 7.57 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 171.768 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -79.65 151.86 4.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE3' HG12 ' A' ' 2' ' ' ILE . 16.7 mtpt -103.72 -174.37 2.53 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.694 -1.254 . . . . 0.0 110.16 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.19 137.69 19.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.53 -0.731 . . . . 0.0 109.098 165.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 7.4 ttpt -142.68 125.97 16.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 53.06 39.61 29.8 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.836 0.744 . . . . 0.0 112.586 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.93 12.41 1.74 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.008 2.123 . . . . 0.0 114.487 -174.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.24 168.77 8.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.118 1.367 . . . . 0.0 108.223 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.42 -19.04 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.233 1.413 . . . . 0.0 112.076 -164.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.419 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 52.61 -66.71 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.16 2.184 . . . . 0.0 113.835 -167.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.79 178.72 9.5 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.977 1.311 . . . . 0.0 111.387 174.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.36 142.71 41.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.816 0.846 . . . . 0.0 108.798 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -113.18 88.92 2.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.875 2.47 . . . . 0.0 107.311 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.35 72.92 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 122.947 1.356 . . . . 0.0 107.626 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.67 151.0 22.72 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -73.77 150.74 40.91 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.099 1.359 . . . . 0.0 109.848 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -82.62 116.6 64.8 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.48 -8.8 24.14 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.722 2.281 . . . . 0.0 114.668 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.86 39.78 2.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.235 1.814 . . . . 0.0 109.464 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.91 -31.39 66.74 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 119.655 -1.903 . . . . 0.0 111.934 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.27 -12.77 1.86 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 118.078 -0.963 . . . . 0.0 113.071 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -98.7 116.48 31.03 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 120.698 1.59 . . . . 0.0 113.104 -156.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 37.09 47.96 0.68 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.91 2.084 . . . . 0.0 112.482 174.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.6 t -55.91 -43.88 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.475 1.11 . . . . 0.0 112.093 -149.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 46.25 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 129.477 3.111 . . . . 0.0 114.751 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.96 14.22 0.22 Allowed Glycine 0 CA--C 1.526 0.732 0 CA-C-O 117.84 -1.533 . . . . 0.0 112.802 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.19 -18.09 15.07 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.041 1.421 . . . . 0.0 114.48 -165.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -51.02 80.87 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 119.131 0.878 . . . . 0.0 109.775 170.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' HG22 ' A' ' 60' ' ' VAL . 17.9 Cg_endo -72.64 -28.54 14.03 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.426 2.084 . . . . 0.0 111.688 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.84 -45.26 70.85 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.277 0.631 . . . . 0.0 109.675 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -57.97 -68.23 0.27 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.706 0.803 . . . . 0.0 111.274 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 57' ' ' PRO . 7.6 m -61.41 -18.79 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 120.118 -1.614 . . . . 0.0 113.755 -171.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -68.68 -26.6 65.38 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.18 1.355 . . . . 0.0 111.766 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -23.32 62.91 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.809 1.186 . . . . 0.0 111.124 171.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -85.11 38.93 0.74 Allowed 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.949 -1.094 . . . . 0.0 111.408 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.53 28.32 4.84 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.891 2.186 . . . . 0.0 115.686 163.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -76.19 168.32 20.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.038 0.919 . . . . 0.0 113.054 -160.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 17.9 mt-10 -143.2 -33.35 0.44 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.323 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 87' ' ' LYS . 5.7 tp -126.1 152.66 45.58 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.203 0.91 . . . . 0.0 108.878 175.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.9 t -136.57 139.39 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 161.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.513 HG21 ' CG1' ' A' ' 99' ' ' VAL . 4.1 mt -115.66 121.79 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 172.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 73' ' ' ILE . 24.2 m -133.31 162.6 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.823 1.249 . . . . 0.0 109.892 -170.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -91.65 -75.05 0.49 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.67 -27.17 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.187 -1.341 . . . . 0.0 114.849 -171.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.533 HG12 ' H ' ' A' ' 74' ' ' GLY 0.265 4.5 tt 37.27 -143.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.392 2.277 . . . . 0.0 112.603 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.533 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.44 156.01 20.1 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 127.785 2.612 . . . . 0.0 109.875 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.29 82.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.205 1.002 . . . . 0.0 112.081 -172.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -32.99 60.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.521 175.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.98 -40.59 16.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.99 -1.481 . . . . 0.0 111.193 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -44.82 -46.84 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 119.589 1.086 . . . . 0.0 108.886 166.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.73 -11.73 13.46 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 119.861 -1.774 . . . . 0.0 114.951 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.48 -32.88 14.72 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.123 1.329 . . . . 0.0 113.459 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.482 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -46.64 -55.94 6.9 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.748 -1.22 . . . . 0.0 109.07 154.531 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -69.66 -3.17 13.98 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 124.577 1.173 . . . . 0.0 110.294 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -10.16 48.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 119.507 1.049 . . . . 0.0 110.853 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.2 5.69 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.29 33.55 84.85 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.856 0.753 . . . . 0.0 111.767 -168.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 4.9 t -80.41 96.86 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.14 -1.212 . . . . 0.0 110.606 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.585 ' HB3' HD12 ' A' ' 67' ' ' LEU . 5.9 tttp -49.92 145.79 5.23 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.727 1.611 . . . . 0.0 111.94 -169.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' CG2' ' CD2' ' A' ' 81' ' ' PHE . 1.2 t -125.89 107.55 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.082 0.468 . . . . 0.0 111.283 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.8 mt -93.05 99.47 9.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -83.69 165.82 18.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.195 0.521 . . . . 0.0 110.119 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.86 17.77 69.37 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-O 118.522 -1.155 . . . . 0.0 114.044 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.44 166.61 19.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.609 1.205 . . . . 0.0 110.106 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.481 ' HA ' HG21 ' A' ' 17' ' ' ILE . 5.5 p -152.64 159.04 43.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.87 1.668 . . . . 0.0 106.917 169.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 -175.62 15.82 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.349 0.976 . . . . 0.0 113.093 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.1 p -79.68 160.67 26.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.622 -0.928 . . . . 0.0 109.029 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -46.67 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -171.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -27.35 67.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.29 -60.98 2.15 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 69' ' ' ILE . 53.4 t -46.52 -56.06 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.306 1.443 . . . . 0.0 109.419 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.14 -52.87 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 125.334 1.454 . . . . 0.0 109.045 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -54.71 -42.84 71.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.893 0.77 . . . . 0.0 111.548 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -60.97 -44.54 97.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 112.285 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -63.79 -45.12 91.12 Favored 'General case' 0 CA--C 1.519 -0.219 0 O-C-N 121.333 -0.854 . . . . 0.0 113.273 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.5 -32.23 70.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.3 0.955 . . . . 0.0 110.498 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -74.79 -9.91 59.0 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.22 0.608 . . . . 0.0 111.707 174.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.98 3.84 87.48 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.386 1.469 . . . . 0.0 113.074 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -71.0 -50.49 33.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.743 1.772 . . . . 0.0 109.488 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.04 145.31 56.11 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.972 1.709 . . . . 0.0 110.618 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 161.54 39.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -106.93 13.66 27.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.864 2.065 . . . . 0.0 111.401 -175.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . 0.256 19.1 p 41.05 -154.29 0.01 OUTLIER 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 128.444 2.697 . . . . 0.0 114.628 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -134.78 111.25 9.77 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 -166.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.98 177.46 7.86 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.669 1.187 . . . . 0.0 109.152 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -70.11 89.4 0.63 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.3 m -79.69 43.86 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.055 1.342 . . . . 0.0 110.681 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -96.59 147.44 23.87 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.176 -0.953 . . . . 0.0 108.626 168.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -68.75 129.77 40.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 150.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -169.96 149.69 3.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.62 1.968 . . . . 0.0 110.438 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 61.54 165.87 0.09 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.624 2.37 . . . . 0.0 111.674 -176.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 57.48 -178.32 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.292 1.037 . . . . 0.0 110.679 -167.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 154.41 83.71 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 130.709 3.604 . . . . 0.0 108.662 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.79 153.62 10.72 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.391 1.076 . . . . 0.0 109.795 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -86.57 174.98 8.56 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.124 1.37 . . . . 0.0 109.648 171.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.7 p80 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 157.035 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HA ' ' OE2' ' A' ' 66' ' ' GLU . 3.8 ptp . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 mt -136.03 148.06 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.5 mt -125.65 109.75 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 129.049 2.94 . . . . 0.0 106.271 -168.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.892 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.27 148.15 28.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.288 169.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 87.4 mt -140.47 116.71 7.78 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 167.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.33 125.25 12.14 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.269 1.979 . . . . 0.0 108.496 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.578 HG23 ' HB2' ' A' ' 26' ' ' TYR . 13.5 m -121.51 157.9 24.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 119.247 0.931 . . . . 0.0 111.541 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -90.8 -20.74 22.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 116.69 -1.624 . . . . 0.0 113.325 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -147.99 150.01 33.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.199 1.399 . . . . 0.0 107.67 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -80.55 39.35 0.47 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.128 1.771 . . . . 0.0 113.694 -166.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 -82.87 39.83 0.65 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.561 -1.337 . . . . 0.0 112.94 -166.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.74 -137.27 35.91 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 120.44 1.473 . . . . 0.0 111.493 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -28.66 29.31 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -4.86 57.37 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 112.482 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.414 ' HB3' HG21 ' A' ' 7' ' ' VAL . 29.9 m -51.72 115.14 6.04 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.082 1.353 . . . . 0.0 111.681 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.19 134.96 18.12 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.629 2.219 . . . . 0.0 110.318 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.22 141.56 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.272 1.029 . . . . 0.0 110.819 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.15 156.56 17.26 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.784 1.233 . . . . 0.0 110.195 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -70.14 -39.98 75.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.857 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -133.58 117.2 16.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.677 2.035 . . . . 0.0 109.706 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -41.82 -53.75 3.61 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 112.42 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.69 63.57 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.645 -164.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.55 38.99 2.23 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 120.504 2.152 . . . . 0.0 108.161 162.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.81 125.95 91.57 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.51 -16.42 54.52 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.281 1.321 . . . . 0.0 113.017 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.578 ' HB2' HG23 ' A' ' 7' ' ' VAL . 84.9 m-85 -150.39 149.03 29.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.283 1.033 . . . . 0.0 108.955 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.44 103.69 9.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.071 0.949 . . . . 0.0 108.643 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.82 106.8 13.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.892 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.7 m-85 -95.15 89.46 5.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.954 1.302 . . . . 0.0 107.532 171.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.69 147.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -89.2 -170.6 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.327 -0.858 . . . . 0.0 108.722 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 89.6 t -142.92 128.37 16.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 162.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 38' ' ' ALA . 7.1 ttpt -94.88 104.45 16.34 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.0 t30 59.25 -81.4 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.064 . . . . 0.0 110.533 -171.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -135.7 -0.27 2.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 130.449 3.5 . . . . 0.0 113.325 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' VAL . . . -111.9 -179.29 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.049 1.74 . . . . 0.0 108.953 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.31 -22.18 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 121.413 1.915 . . . . 0.0 113.946 -169.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 53.22 -74.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.247 1.385 . . . . 0.0 112.331 -160.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -163.36 153.34 15.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.323 1.049 . . . . 0.0 110.302 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.0 mm -78.39 155.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.081 1.353 . . . . 0.0 107.854 168.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -127.73 154.88 44.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 141.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 70.53 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 122.8 1.286 . . . . 0.0 108.546 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.0 131.59 35.83 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.085 1.354 . . . . 0.0 108.759 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.12 162.65 27.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.375 0.607 . . . . 0.0 111.616 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -78.42 95.39 0.17 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 131.461 3.904 . . . . 0.0 114.733 -168.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.89 -25.18 23.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.385 1.39 . . . . 0.0 114.307 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.24 39.64 3.24 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.881 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . . . -58.02 -37.72 74.85 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.007 1.323 . . . . 0.0 111.501 -171.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -139.59 0.04 1.8 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.052 0.941 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -111.39 115.75 29.79 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.379 -0.826 . . . . 0.0 109.904 -162.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 61.28 -49.37 0.12 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.198 2.199 . . . . 0.0 113.145 -168.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t 57.74 -87.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 128.624 2.769 . . . . 0.0 111.679 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 44.49 -71.19 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 130.106 3.362 . . . . 0.0 116.502 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.26 17.4 0.21 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.462 1.506 . . . . 0.0 111.905 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.48 -18.79 19.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.296 1.048 . . . . 0.0 113.489 -172.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.469 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 2.0 t -57.45 -51.67 80.0 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 5.2 Cg_exo -65.69 -28.99 51.86 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.37 1.38 . . . . 0.0 112.416 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -32.54 74.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.584 1.084 . . . . 0.0 110.323 178.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -65.41 -61.99 1.79 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 57' ' ' PRO . 5.4 m -61.87 -23.92 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 120.383 1.447 . . . . 0.0 113.261 -174.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -21.14 63.87 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 120.848 -1.158 . . . . 0.0 112.809 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.18 -19.36 54.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 120.665 1.575 . . . . 0.0 111.537 170.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -85.07 37.9 0.69 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.16 21.14 5.36 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.601 2.524 . . . . 0.0 115.735 169.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -68.05 167.47 13.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.011 1.405 . . . . 0.0 114.548 -163.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.446 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 9.5 mt-10 -137.96 -31.13 0.78 Allowed 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.504 1.122 . . . . 0.0 111.902 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.63 152.77 51.96 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.623 1.169 . . . . 0.0 108.783 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.857 HG13 ' HB3' ' A' ' 4' ' ' ALA . 4.9 t -139.11 146.5 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 168.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.51 HG21 ' CG1' ' A' ' 99' ' ' VAL . 53.4 mt -131.65 118.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -134.61 169.49 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 111.356 -168.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -112.69 -42.34 3.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.501 -1.374 . . . . 0.0 113.439 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.93 42.48 0.78 Allowed Glycine 0 N--CA 1.469 0.836 0 C-N-CA 125.197 1.38 . . . . 0.0 111.648 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.2 tt -58.97 166.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.744 1.217 . . . . 0.0 111.087 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.58 161.51 13.25 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.679 1.133 . . . . 0.0 110.744 170.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -30.09 59.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.275 1.43 . . . . 0.0 113.486 -174.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -53.63 -43.45 68.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 111.127 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.98 29.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.235 -1.364 . . . . 0.0 112.047 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.07 -49.48 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 120.337 1.426 . . . . 0.0 107.328 164.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -13.64 50.61 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.46 -60.77 2.12 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 110.07 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.77 -38.73 72.88 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.8 2.04 . . . . 0.0 109.553 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.92 -19.76 53.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.542 0.737 . . . . 0.0 112.944 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.85 -12.58 61.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.025 -1.672 . . . . 0.0 112.491 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.81 7.29 6.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.638 1.175 . . . . 0.0 114.064 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.15 24.76 74.68 Favored Glycine 0 C--O 1.241 0.558 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.972 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.11 116.33 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -69.99 141.76 52.91 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.78 97.82 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.507 ' HA ' ' HB3' ' A' ' 110' ' ' ASP . 50.7 mt -75.64 144.85 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.636 1.174 . . . . 0.0 108.363 175.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 2.6 mppt? -125.38 173.19 9.03 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.075 1.75 . . . . 0.0 109.054 -175.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.37 57.78 16.95 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.899 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.14 165.53 12.81 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 124.368 0.687 . . . . 0.0 110.788 165.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.3 p -146.49 164.07 33.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.361 1.864 . . . . 0.0 108.436 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.38 -166.8 24.44 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 118.794 0.725 . . . . 0.0 113.486 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.4 p -85.18 165.7 17.19 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 121.547 -0.972 . . . . 0.0 111.7 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -50.41 -56.25 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 C-N-CA 124.523 1.129 . . . . 0.0 110.081 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -59.8 -27.46 66.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -82.83 -53.39 5.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.519 1.528 . . . . 0.0 107.893 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.51 ' CG1' HG21 ' A' ' 69' ' ' ILE . 53.0 t -52.84 -43.99 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.416 1.486 . . . . 0.0 110.145 177.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.07 -53.24 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.03 -39.66 90.63 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.301 -0.874 . . . . 0.0 111.91 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.46 -39.39 94.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.343 0.974 . . . . 0.0 110.645 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -64.32 -52.0 60.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.42 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -56.46 -36.03 68.6 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.006 0.922 . . . . 0.0 109.14 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.8 m -77.18 0.96 19.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.656 1.182 . . . . 0.0 112.697 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.5 9.91 84.59 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.894 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -80.0 -43.64 21.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 119.355 1.578 . . . . 0.0 109.84 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.32 141.38 48.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.33 171.82 19.11 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 127.538 2.335 . . . . 0.0 108.198 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 89' ' ' ILE . 12.4 p-10 -127.24 14.52 7.23 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.898 1.279 . . . . 0.0 112.22 169.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t 70.44 -168.25 0.16 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.425 1.89 . . . . 0.0 110.141 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -72.95 122.88 22.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.262 1.825 . . . . 0.0 106.562 161.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -114.27 172.04 7.25 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.775 1.23 . . . . 0.0 109.374 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -118.1 161.16 20.29 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.55 1.54 . . . . 0.0 110.503 -173.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.8 m -106.95 158.3 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.803 1.241 . . . . 0.0 109.528 -172.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -80.67 96.35 6.86 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.763 -0.586 . . . . 0.0 111.351 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.16 -56.96 12.26 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.716 1.206 . . . . 0.0 110.489 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.38 122.75 21.72 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.684 -0.635 . . . . 0.0 110.347 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -129.92 -177.9 4.49 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.831 1.652 . . . . 0.0 107.871 160.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -157.42 72.81 0.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.097 0.959 . . . . 0.0 109.29 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.7 m170 37.4 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.098 2.159 . . . . 0.0 111.264 -165.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -56.39 156.72 5.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.288 1.435 . . . . 0.0 110.153 171.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -130.91 168.5 17.21 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.117 1.767 . . . . 0.0 106.466 168.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.566 0.209 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 29' ' ' PHE . 23.0 mt -109.34 151.36 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 160.077 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.81 108.48 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 C-N-CA 130.011 3.324 . . . . 0.0 105.16 -169.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.895 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.68 153.73 29.11 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.272 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.9 mt -146.4 113.93 4.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.58 124.95 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 N-CA-C 106.852 -2.018 . . . . 0.0 106.852 170.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.43 155.47 15.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 -19.84 30.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 -177.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -149.43 153.37 37.22 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 -177.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -93.7 64.22 3.48 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.956 0.884 . . . . 0.0 111.537 -169.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -106.48 42.03 1.34 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.598 -166.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 24.38 80.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.701 1.619 . . . . 0.0 115.481 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 80.67 -46.26 0.26 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.153 2.981 . . . . 0.0 112.604 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -0.06 0.63 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.015 0.825 . . . . 0.0 112.169 162.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -51.0 107.97 0.94 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.713 2.805 . . . . 0.0 111.769 169.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.94 130.62 5.77 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.996 2.464 . . . . 0.0 110.209 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.41 134.35 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.951 1.301 . . . . 0.0 112.052 -175.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -70.15 169.42 13.6 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.85 1.66 . . . . 0.0 109.274 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -92.48 -23.11 19.24 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.324 -0.86 . . . . 0.0 111.12 174.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -108.48 171.23 7.53 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -170.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -120.76 -57.57 1.88 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.35 -3.14 11.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.731 -169.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -143.49 38.51 1.38 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.415 1.607 . . . . 0.0 108.703 169.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.86 152.57 96.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.96 -20.73 7.33 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.779 2.319 . . . . 0.0 113.606 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -152.85 157.1 40.23 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.868 1.267 . . . . 0.0 109.489 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -123.07 108.36 12.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.036 1.334 . . . . 0.0 107.893 174.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.42 87.5 5.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 165.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.895 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.2 m-85 -70.86 142.9 51.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 157.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 16.2 mtpt -84.71 -168.48 2.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.102 0.865 . . . . 0.0 109.523 -179.035 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.63 143.12 26.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 162.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -139.45 133.91 31.61 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 127.428 2.291 . . . . 0.0 105.38 169.268 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 32.47 57.24 0.4 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.241 1.817 . . . . 0.0 112.702 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.53 12.98 5.83 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.982 2.513 . . . . 0.0 116.769 -178.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.03 -179.6 4.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.243 1.817 . . . . 0.0 109.586 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.33 -23.46 31.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 125.222 1.409 . . . . 0.0 113.611 -164.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.05 -74.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.105 1.32 . . . . 0.0 112.48 -160.164 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.17 160.25 39.71 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.533 1.933 . . . . 0.0 111.049 -160.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mm -124.87 134.62 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.507 1.923 . . . . 0.0 106.788 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 m -138.95 72.14 1.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.608 2.763 . . . . 0.0 106.941 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 2.2 t -77.22 97.75 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.311 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -96.27 159.84 14.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.886 173.21 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -57.41 163.51 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 110.848 167.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.33 95.93 3.28 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 159.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.51 3.46 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.217 2.612 . . . . 0.0 113.098 -176.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.26 39.11 2.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.016 1.326 . . . . 0.0 109.003 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.46 -37.15 72.42 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.751 -1.218 . . . . 0.0 111.489 -171.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -147.68 13.35 1.04 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 176.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.43 121.86 41.35 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.27 1.395 . . . . 0.0 111.998 -160.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 54.93 -27.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 131.02 3.728 . . . . 0.0 116.022 -172.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t 38.24 53.11 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 1 C-N-CA 131.821 4.048 . . . . 0.0 111.483 164.112 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.69 44.17 0.96 Allowed 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.366 -0.833 . . . . 0.0 110.291 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.09 28.53 70.73 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.527 -0.733 . . . . 0.0 112.649 -176.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.16 -15.2 20.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.283 1.033 . . . . 0.0 112.701 -172.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.416 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 2.0 t -50.13 -52.69 51.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 119.521 1.055 . . . . 0.0 109.665 173.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 1.8 Cg_endo -71.05 -29.99 17.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.521 2.147 . . . . 0.0 111.974 178.562 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.4 -32.78 74.59 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.428 -0.795 . . . . 0.0 110.596 -177.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -58.66 -65.69 0.62 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 109.925 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.81 -27.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -171.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -63.83 -19.96 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.984 0.913 . . . . 0.0 112.65 173.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -20.68 44.91 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.084 0.856 . . . . 0.0 111.984 169.131 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -86.83 38.03 0.78 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.677 -1.264 . . . . 0.0 111.419 -170.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.27 19.83 8.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.329 1.919 . . . . 0.0 115.918 166.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.46 168.43 19.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.185 1.492 . . . . 0.0 113.278 -163.415 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -143.38 -27.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.442 1.097 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.734 HD12 ' H ' ' A' ' 68' ' ' VAL . 41.9 tp -135.88 158.64 43.9 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.963 0.801 . . . . 0.0 110.241 176.012 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.861 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -150.66 122.87 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -174.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.446 HG21 ' CG1' ' A' ' 99' ' ' VAL . 82.4 mt -114.59 107.67 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 108.628 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.43 176.07 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.729 2.012 . . . . 0.0 111.966 -174.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -96.5 -94.36 0.21 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 164.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.97 -40.52 8.03 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.588 -0.562 . . . . 0.0 114.072 -167.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.529 HG12 ' H ' ' A' ' 74' ' ' GLY 0.281 3.0 tt 44.55 -138.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.939 1.696 . . . . 0.0 112.537 -176.423 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.42 155.37 15.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 129.61 3.481 . . . . 0.0 109.219 174.075 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.56 -34.15 73.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.989 1.394 . . . . 0.0 111.785 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -55.56 -23.41 26.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 171.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.84 13.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.205 0.911 . . . . 0.0 110.857 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.73 -46.35 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 166.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.53 -31.91 25.92 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.533 1.533 . . . . 0.0 114.566 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.5 -55.27 5.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.02 0.827 . . . . 0.0 110.526 -177.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.425 ' CD1' HG11 ' A' ' 86' ' ' VAL . 53.7 m-85 -62.14 -31.45 71.93 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.436 1.094 . . . . 0.0 110.799 177.03 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -56.56 -32.58 65.31 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.196 -0.94 . . . . 0.0 112.302 170.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -18.69 61.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.713 0.688 . . . . 0.0 111.601 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.487 ' SD ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -113.75 6.04 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.404 1.482 . . . . 0.0 110.785 -178.949 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.81 23.67 69.33 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.941 -1.1 . . . . 0.0 111.982 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' A' ' 84' ' ' MET . 56.0 t -79.4 117.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.021 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -58.72 145.12 41.39 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.429 1.492 . . . . 0.0 109.38 174.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.05 128.3 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 109' ' ' LYS . 13.5 mt -115.16 131.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.325 2.65 . . . . 0.0 105.101 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' H ' ' HA ' ' A' ' 110' ' ' ASP . 0.0 OUTLIER -134.2 135.86 43.32 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.769 1.228 . . . . 0.0 108.775 -170.681 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.14 2.95 6.38 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.673 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.78 173.64 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.079 1.44 . . . . 0.0 111.13 -173.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 p -161.99 165.13 27.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.198 1.799 . . . . 0.0 106.65 156.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.62 -163.05 16.42 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 122.264 0.924 . . . . 0.0 112.601 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 162.92 24.78 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.212 -1.169 . . . . 0.0 111.098 -178.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -53.05 -49.74 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 123.007 0.523 . . . . 0.0 109.605 174.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -62.22 -26.67 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -80.65 -54.61 5.49 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 107.828 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.446 ' CG1' HG21 ' A' ' 69' ' ' ILE . 54.7 t -53.84 -45.5 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -178.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.04 -42.8 92.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -58.0 -50.85 72.0 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.284 174.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -57.09 -41.72 79.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.197 0.908 . . . . 0.0 110.772 -172.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.25 -53.73 22.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.246 1.019 . . . . 0.0 112.134 174.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.2 -26.75 68.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.613 0.642 . . . . 0.0 110.822 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -82.54 -3.28 55.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 174.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.07 15.18 75.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 118.126 -1.374 . . . . 0.0 113.691 168.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -87.1 -30.08 21.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.984 1.392 . . . . 0.0 111.613 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 tp -74.86 166.53 23.48 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.152 -0.342 . . . . 0.0 111.347 -163.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -133.3 168.43 18.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.267 1.027 . . . . 0.0 111.748 -170.753 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.507 ' HA ' ' H ' ' A' ' 90' ' ' LYS . 40.0 p30 -121.2 13.99 11.27 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.021 1.728 . . . . 0.0 112.305 -175.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.6 p 32.78 54.44 0.38 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.473 2.309 . . . . 0.0 112.526 -171.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 49.11 33.1 4.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 129.192 2.997 . . . . 0.0 114.853 165.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.59 120.8 22.29 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.173 1.389 . . . . 0.0 108.935 173.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.06 116.14 8.35 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.781 171.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.63 71.5 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.57 0 O-C-N 121.085 -1.009 . . . . 0.0 110.147 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.05 113.36 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 127.306 2.242 . . . . 0.0 109.764 -164.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -56.9 110.03 0.74 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.198 0.999 . . . . 0.0 110.081 167.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.21 157.87 31.57 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.829 2.052 . . . . 0.0 108.392 172.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -41.63 123.28 2.19 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.756 1.223 . . . . 0.0 111.933 -174.035 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.47 71.56 3.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.137 1.375 . . . . 0.0 109.732 -176.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 56.86 -162.43 0.19 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.96 1.704 . . . . 0.0 109.797 -165.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -44.59 136.33 4.38 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 159.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -80.94 48.08 1.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.347 1.459 . . . . 0.0 109.699 -173.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.2 t60 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 116.298 -1.811 . . . . 0.0 110.336 -138.111 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.464 HG12 HD23 ' A' ' 67' ' ' LEU . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.804 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.06 70.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -145.05 22.53 1.56 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 175.099 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -117.57 129.23 55.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.899 0.772 . . . . 0.0 110.619 -163.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.5 m170 61.06 -40.04 0.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.685 2.794 . . . . 0.0 114.049 -168.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t 56.75 24.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.902 1.681 . . . . 0.0 111.531 173.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -64.23 -70.48 0.22 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 120.914 -1.116 . . . . 0.0 108.096 178.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.87 41.35 0.04 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -178.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.72 -14.37 14.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 -174.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 60' ' ' VAL . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 3' ' ' ILE . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 4' ' ' ALA . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.553 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.482 HG21 ' HB ' ' A' ' 73' ' ' ILE . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' HG21 ' A' ' 70' ' ' VAL . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.553 ' CG1' HG21 ' A' ' 69' ' ' ILE . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.75 158.85 40.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -135.74 45.56 2.41 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 126.48 1.912 . . . . 0.0 108.919 -164.398 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 m -44.2 152.06 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.498 1.919 . . . . 0.0 112.316 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.13 124.71 16.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -147.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.1 119.93 40.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.298 1.839 . . . . 0.0 110.3 -157.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.6 142.9 53.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 113.089 -173.512 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t 32.41 58.75 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 128.851 2.86 . . . . 0.0 111.739 174.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 t60 57.88 -77.09 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.836 2.054 . . . . 0.0 111.306 -170.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.91 -34.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.454 1.102 . . . . 0.0 111.577 171.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 67.97 -4.37 1.03 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.614 1.566 . . . . 0.0 114.993 171.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -82.63 148.36 28.02 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 121.093 1.77 . . . . 0.0 109.942 -171.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.3 m170 57.73 165.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.732 2.413 . . . . 0.0 111.197 -169.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -141.54 161.18 38.54 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.501 1.12 . . . . 0.0 108.728 164.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.75 -28.06 13.02 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 66.19 -24.97 0.1 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.099 2.16 . . . . 0.0 116.099 173.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 171.108 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.513 0.197 . . . . 0.0 110.841 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.412 HG22 ' CD1' ' A' ' 29' ' ' PHE . 7.2 mt -115.3 153.25 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 165.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 mt -134.51 105.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.132 2.173 . . . . 0.0 105.812 -164.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.924 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.52 145.59 31.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.191 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.483 HD12 HG13 ' A' ' 96' ' ' VAL . 51.3 mt -145.94 114.59 4.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.35 129.42 15.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.574 1.516 . . . . 0.0 108.372 171.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 15' ' ' SER . 4.9 m -122.88 150.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 118.739 0.7 . . . . 0.0 109.185 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -68.1 -27.06 66.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.318 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.59 156.1 39.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.648 1.579 . . . . 0.0 107.91 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -85.73 95.59 9.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -125.8 39.64 3.91 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 108.582 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.19 -127.88 29.94 Favored Glycine 0 C--N 1.34 0.76 0 O-C-N 120.775 -1.203 . . . . 0.0 111.434 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -58.4 -45.79 87.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.182 1.393 . . . . 0.0 111.665 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -1.87 4.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.774 2.43 . . . . 0.0 114.304 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.464 ' HB3' HG11 ' A' ' 7' ' ' VAL . 27.3 m -52.99 109.01 1.24 Allowed Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.975 174.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.92 135.47 14.11 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.357 1.371 . . . . 0.0 108.964 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.47 134.37 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.047 0.939 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.38 169.9 12.5 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.876 1.27 . . . . 0.0 107.876 166.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -88.1 -55.32 3.8 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 121.472 -0.768 . . . . 0.0 110.554 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.63 85.57 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 -152.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -37.49 -47.17 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.411 1.484 . . . . 0.0 112.908 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.42 -14.34 41.18 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 118.7 -1.055 . . . . 0.0 115.276 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.59 48.02 1.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.09 2.156 . . . . 0.0 108.74 173.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.65 137.77 54.77 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 167.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.74 -25.29 28.83 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.454 2.103 . . . . 0.0 114.494 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -146.27 158.17 43.86 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.29 103.9 8.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.51 1.524 . . . . 0.0 107.896 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.11 79.02 6.72 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.526 1.53 . . . . 0.0 107.585 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.924 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.31 3.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.458 HG13 HD13 ' A' ' 40' ' ' ILE . 3.9 t -83.08 164.15 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.034 171.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.874 -1.141 . . . . 0.0 108.97 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.413 HG12 ' HG2' ' A' ' 1' ' ' MET . 11.9 p -150.18 147.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 161.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -123.54 113.71 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 173.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t30 54.58 -86.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.718 1.207 . . . . 0.0 111.687 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.94 12.24 2.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.685 1.594 . . . . 0.0 111.969 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.11 156.36 38.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.784 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.26 -32.32 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.096 1.758 . . . . 0.0 112.932 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 59.13 -51.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 115.497 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.68 161.98 16.05 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.06 0.944 . . . . 0.0 110.8 -160.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.458 HD13 HG13 ' A' ' 30' ' ' VAL . 2.8 mm -135.74 140.45 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.226 1.81 . . . . 0.0 107.73 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.79 88.5 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.734 2.013 . . . . 0.0 107.714 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 4.7 t -89.8 93.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 164.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.69 152.6 19.47 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 mp0 -56.88 152.87 11.93 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.448 1.099 . . . . 0.0 110.496 168.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -79.77 133.6 58.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 164.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.92 -9.72 26.25 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 CA-C-N 121.12 1.436 . . . . 0.0 112.121 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.78 39.65 0.96 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.023 1.329 . . . . 0.0 110.062 -163.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 O-C-N 120.295 -1.503 . . . . 0.0 112.336 -169.088 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.08 -53.44 48.45 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 119.227 0.921 . . . . 0.0 109.515 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' HG22 ' A' ' 60' ' ' VAL . 29.0 Cg_endo -72.48 -32.05 10.41 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.012 1.808 . . . . 0.0 111.899 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.1 -38.33 73.22 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.052 0.842 . . . . 0.0 110.922 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.75 -65.58 0.61 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.902 1.281 . . . . 0.0 110.991 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.81 -22.34 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.751 1.16 . . . . 0.0 113.904 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.48 -12.36 61.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.304 -1.498 . . . . 0.0 114.002 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -19.01 23.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.809 1.186 . . . . 0.0 109.781 165.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.15 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.171 0 O-C-N 119.87 -1.768 . . . . 0.0 111.239 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.53 20.11 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 127.34 2.4 . . . . 0.0 116.214 161.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.23 176.84 9.3 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -159.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -144.1 -53.32 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 124.63 1.172 . . . . 0.0 110.642 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.08 157.01 19.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.6 1.16 . . . . 0.0 109.363 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.88 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -136.51 139.65 44.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.386 2.275 . . . . 0.0 105.071 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.573 HG21 HG13 ' A' ' 99' ' ' VAL . 94.5 mt -131.47 111.37 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 68' ' ' VAL . 3.1 m -137.31 155.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.685 -162.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' HE ' ' HB3' ' A' ' 93' ' ' SER . 17.6 ttt-85 -95.08 -62.14 1.36 Allowed 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.763 -1.211 . . . . 0.0 111.243 -176.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.85 -54.42 1.3 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.791 -0.568 . . . . 0.0 113.929 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.493 HG12 ' H ' ' A' ' 74' ' ' GLY 0.299 3.7 tt 44.26 -168.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 130.102 3.361 . . . . 0.0 115.14 -173.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.36 167.19 39.82 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.319 1.914 . . . . 0.0 110.445 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.61 -31.76 73.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -163.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -64.74 -36.33 83.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.198 1.817 . . . . 0.0 109.642 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.73 63.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.265 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.42 -43.96 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 119.764 1.165 . . . . 0.0 109.626 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.23 10.93 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.196 -1.565 . . . . 0.0 114.934 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 57' ' ' PRO . . . -80.16 -58.56 3.09 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.259 1.424 . . . . 0.0 110.453 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.47 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -35.62 -56.29 0.67 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 126.953 2.101 . . . . 0.0 109.159 160.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.42 -9.94 55.82 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 117.421 -1.276 . . . . 0.0 111.733 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.9 63.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.725 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.2 14.92 5.66 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.311 0.382 . . . . 0.0 111.504 -163.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.25 26.78 56.84 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.09 -0.381 . . . . 0.0 112.765 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 1.9 t -79.64 108.15 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -168.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.66 28.49 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.975 1.71 . . . . 0.0 110.336 -170.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.07 95.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.5 139.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.81 154.06 47.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.986 -0.446 . . . . 0.0 110.845 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.12 38.62 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.084 0.85 . . . . 0.0 114.799 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.5 157.53 37.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.427 1.113 . . . . 0.0 110.869 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.43 ' HB3' ' HE ' ' A' ' 71' ' ' ARG . 65.2 p -159.46 130.33 5.93 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.127 0.971 . . . . 0.0 108.414 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.65 -130.86 6.28 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.906 -172.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.35 159.61 39.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.041 1.737 . . . . 0.0 111.329 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.483 HG13 HD12 ' A' ' 5' ' ' ILE . 22.5 t -63.71 -45.1 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.861 -1.149 . . . . 0.0 111.272 -166.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.53 -12.01 48.97 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.38 -43.49 5.41 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.007 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.573 HG13 HG21 ' A' ' 69' ' ' ILE . 76.3 t -46.03 -49.8 4.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.432 1.469 . . . . 0.0 110.547 169.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.47 -38.47 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.478 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -62.01 -50.97 69.93 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 117.329 -1.32 . . . . 0.0 110.307 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.26 -37.22 69.5 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.379 1.445 . . . . 0.0 111.575 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.04 -50.42 41.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.723 1.209 . . . . 0.0 111.94 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.8 mt -62.88 -30.63 71.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.097 0.408 . . . . 0.0 110.139 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.9 m -74.77 -1.09 20.49 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.924 2.09 . . . . 0.0 112.508 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.91 75.0 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 125.39 1.472 . . . . 0.0 112.916 168.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.5 -45.78 51.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.914 0.864 . . . . 0.0 108.705 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.97 134.88 38.74 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.602 1.161 . . . . 0.0 108.373 -166.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.494 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.591 HG22 ' CD1' ' A' ' 29' ' ' PHE . 24.1 mt -111.7 141.7 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.428 HG12 HD12 ' A' ' 67' ' ' LEU . 18.9 mt -122.41 102.65 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 129.424 3.09 . . . . 0.0 107.246 -168.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.909 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -80.15 145.74 32.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.985 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mt -138.64 117.97 9.53 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.21 108.63 2.02 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 N-CA-C 107.121 -1.915 . . . . 0.0 107.121 166.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 26' ' ' TYR . 12.2 m -101.1 158.9 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 119.065 0.848 . . . . 0.0 110.33 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -77.03 -33.11 57.42 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.154 1.782 . . . . 0.0 112.392 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -147.13 146.58 29.96 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -86.54 90.03 8.1 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 167.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -111.62 39.44 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.487 -1.244 . . . . 0.0 110.306 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 25.05 91.36 0.01 OUTLIER Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.581 2.039 . . . . 0.0 115.174 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt 80.19 -45.7 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.791 2.436 . . . . 0.0 112.068 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -20.13 65.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -33.36 102.34 0.21 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.972 2.909 . . . . 0.0 111.974 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.29 137.13 36.05 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 109.349 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 93' ' ' SER . 14.6 tt -60.78 140.17 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 t -75.83 177.71 6.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.211 1.004 . . . . 0.0 109.039 170.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 -13.94 21.43 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.489 -0.757 . . . . 0.0 112.616 -173.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -142.25 -179.5 6.29 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.888 2.075 . . . . 0.0 108.861 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -119.6 -42.55 2.63 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.424 0.69 . . . . 0.0 111.777 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 -16.3 55.49 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 117.578 -1.679 . . . . 0.0 116.947 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 39.09 1.49 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.999 1.719 . . . . 0.0 109.794 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.39 146.7 97.83 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 37.6 Cg_endo -74.37 -22.22 16.55 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.565 1.51 . . . . 0.0 114.055 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.5 ' HB2' HG23 ' A' ' 7' ' ' VAL . 95.6 m-85 -153.18 153.03 31.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.694 1.134 . . . . 0.0 109.418 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -113.31 109.18 18.31 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.711 0.264 . . . . 0.0 111.711 164.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 96.58 6.52 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.906 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.1 m-85 -83.34 96.39 8.5 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 164.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 t -79.64 168.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.82 -164.21 1.32 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.24 -1.537 . . . . 0.0 109.246 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -147.11 133.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 O-C-N 121.74 -0.6 . . . . 0.0 109.768 170.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -105.27 102.09 11.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 168.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.4 t30 55.28 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 111.964 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -140.03 34.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.686 1.595 . . . . 0.0 109.996 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.19 169.89 12.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.518 1.127 . . . . 0.0 108.412 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.11 -23.12 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.573 1.533 . . . . 0.0 113.588 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.4 -68.68 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.367 1.867 . . . . 0.0 114.228 -162.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -168.32 146.38 4.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.752 0.821 . . . . 0.0 110.412 -150.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mm -111.89 126.53 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.005 2.122 . . . . 0.0 107.072 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.37 80.46 1.61 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.55 1.54 . . . . 0.0 107.39 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.266 7.2 p -91.82 75.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.976 0.893 . . . . 0.0 109.012 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.01 160.41 25.88 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.55 -178.44 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.754 1.222 . . . . 0.0 111.437 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 48' ' ' ALA . 33.7 p-10 -100.31 85.51 0.54 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.023 3.329 . . . . 0.0 114.671 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.69 -24.79 74.9 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.257 1.972 . . . . 0.0 113.39 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.587 HD12 ' H ' ' A' ' 56' ' ' VAL . 1.6 tm? -120.24 56.2 0.98 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 123.593 1.664 . . . . 0.0 107.74 173.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . . . . . . . . 0 C--O 1.238 0.484 0 C-N-CA 125.171 1.389 . . . . 0.0 109.904 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.587 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -46.41 -55.15 14.85 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 122.505 2.411 . . . . 0.0 110.288 -176.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.25 -17.11 11.86 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.319 2.013 . . . . 0.0 112.197 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.68 -48.8 68.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -52.95 -66.09 0.45 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.45 1.1 . . . . 0.0 111.278 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.64 -17.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 120.297 -1.502 . . . . 0.0 113.156 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.98 -31.87 61.54 Favored 'General case' 0 N--CA 1.458 -0.049 0 O-C-N 120.922 -1.111 . . . . 0.0 111.746 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -26.47 68.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.968 1.258 . . . . 0.0 110.981 170.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -82.48 38.13 0.54 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.859 0.863 . . . . 0.0 111.029 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 40.55 30.83 0.34 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 129.375 3.369 . . . . 0.0 116.903 165.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -73.74 175.46 7.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.551 1.175 . . . . 0.0 113.696 -167.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.56 -37.88 0.41 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.281 1.433 . . . . 0.0 110.052 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.8 tm? -132.02 154.76 49.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.698 1.199 . . . . 0.0 109.435 -173.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.909 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -148.76 140.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.544 HG21 ' CG1' ' A' ' 99' ' ' VAL . 71.6 mt -126.0 110.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.512 HG13 HG12 ' A' ' 68' ' ' VAL . 19.9 m -126.55 164.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 109.813 -172.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.36 -100.5 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.31 66.2 0.35 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 125.277 1.417 . . . . 0.0 110.606 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.7 tt -57.96 172.44 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.128 1.771 . . . . 0.0 111.215 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.72 154.2 20.82 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.716 1.151 . . . . 0.0 110.945 169.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -51.57 -35.5 41.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.921 2.089 . . . . 0.0 114.374 -165.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -59.06 -28.4 66.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.624 1.102 . . . . 0.0 112.448 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.03 -31.72 27.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.68 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.6 mm -54.44 -50.13 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.72 -26.78 10.07 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 114.851 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.76 -51.61 11.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.915 0.78 . . . . 0.0 111.29 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -58.51 -35.43 72.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.046 1.339 . . . . 0.0 110.293 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -65.23 -7.77 14.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.029 0.932 . . . . 0.0 113.383 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.69 -25.43 33.01 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.906 1.685 . . . . 0.0 110.942 170.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 ptm -118.28 1.75 11.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.913 1.685 . . . . 0.0 112.648 -167.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.87 76.47 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 118.722 0.692 . . . . 0.0 111.548 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 t -79.74 121.43 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.48 146.51 36.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 p -138.72 93.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 109' ' ' LYS . 51.1 mt -72.04 124.39 28.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 126.11 1.764 . . . . 0.0 107.161 173.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 166.94 12.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.603 0.761 . . . . 0.0 110.676 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.25 18.54 73.3 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.003 -0.887 . . . . 0.0 113.31 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.36 170.36 12.03 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.906 1.353 . . . . 0.0 110.913 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.416 ' HA ' HG21 ' A' ' 17' ' ' ILE . 1.1 t -161.91 147.93 13.52 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.444 1.098 . . . . 0.0 108.055 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.08 -172.53 19.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.156 1.36 . . . . 0.0 112.587 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.5 p -79.86 163.19 24.57 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.441 -1.035 . . . . 0.0 109.26 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.29 -51.38 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.931 0.893 . . . . 0.0 110.049 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.75 -38.41 72.38 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 123.334 0.396 . . . . 0.0 111.268 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -77.54 -54.73 6.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.159 0.984 . . . . 0.0 108.625 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.544 ' CG1' HG21 ' A' ' 69' ' ' ILE . 16.4 t -54.52 -46.84 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.109 1.364 . . . . 0.0 110.785 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.65 -51.43 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -56.63 -42.54 79.03 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.69 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -55.86 -39.39 71.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.673 1.124 . . . . 0.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.19 -45.64 47.09 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.092 0.557 . . . . 0.0 112.23 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.6 mp -56.99 -35.07 68.77 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.3 m -86.29 1.73 49.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.356 1.462 . . . . 0.0 113.129 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.64 13.87 61.71 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.494 1.045 . . . . 0.0 114.02 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -74.93 -36.54 62.13 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.823 1.312 . . . . 0.0 110.186 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.21 161.98 23.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.119 0.968 . . . . 0.0 109.041 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 89' ' ' ILE . 1.2 tptt . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 124.755 1.222 . . . . 0.0 108.384 -172.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.464 HG12 HD23 ' A' ' 67' ' ' LEU . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.804 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.531 HD21 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 45' ' ' ASN . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 60' ' ' VAL . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 3' ' ' ILE . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 4' ' ' ALA . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.553 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.482 HG21 ' HB ' ' A' ' 73' ' ' ILE . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' HG21 ' A' ' 70' ' ' VAL . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.553 ' CG1' HG21 ' A' ' 69' ' ' ILE . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 29' ' ' PHE . 10.2 mt -139.45 141.01 36.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.01 104.33 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 127.561 2.344 . . . . 0.0 107.428 -163.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.953 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -79.73 140.37 36.98 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.7 mt -139.71 107.51 7.05 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 129.32 14.5 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.152 1.901 . . . . 0.0 108.129 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 15' ' ' SER . 13.7 m -134.37 152.06 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.169 0.588 . . . . 0.0 110.132 -170.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -74.32 -13.27 60.73 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.94 170.41 21.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.9 1.227 . . . . 0.0 109.381 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.5 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 37.2 p-10 -82.12 39.67 0.59 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.014 1.326 . . . . 0.0 112.809 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -81.46 41.01 0.6 Allowed 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.631 -1.293 . . . . 0.0 112.285 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.7 124.7 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.396 2.427 . . . . 0.0 114.791 -170.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 18.3 mtmt 80.32 -67.28 0.13 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.998 2.919 . . . . 0.0 109.984 -165.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -10.61 48.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.592 2.357 . . . . 0.0 112.954 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.415 ' HB3' HG11 ' A' ' 7' ' ' VAL . 5.0 m -35.91 99.08 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 130.46 3.504 . . . . 0.0 111.628 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.22 128.68 15.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tt -62.04 131.87 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 170.27 14.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.103 1.361 . . . . 0.0 108.409 170.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -89.92 -56.08 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -99.6 135.41 41.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -67.9 -41.32 82.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.16 -5.24 53.03 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.119 -1.934 . . . . 0.0 115.444 -164.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -144.12 38.73 1.31 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.593 1.697 . . . . 0.0 109.181 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.27 132.67 75.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.29 -19.01 17.65 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.743 1.628 . . . . 0.0 113.502 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.5 ' CE2' ' HB3' ' A' ' 10' ' ' ASN . 96.7 m-85 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.935 1.294 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.17 107.75 10.29 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.684 1.194 . . . . 0.0 108.515 170.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.96 91.63 5.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.921 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.4 m-85 -77.98 95.91 4.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 160.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -79.84 164.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -112.42 -170.43 1.66 Allowed 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.851 -1.156 . . . . 0.0 110.017 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -141.56 151.53 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 156.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -111.74 106.32 15.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 160.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 t30 57.76 -62.63 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.376 2.27 . . . . 0.0 115.754 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.0 12.01 1.6 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.199 1.4 . . . . 0.0 112.791 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.23 -157.58 0.62 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.738 1.615 . . . . 0.0 112.802 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.11 -30.78 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.607 1.163 . . . . 0.0 111.316 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . . . 53.36 -71.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 113.828 -161.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.04 165.98 32.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.281 1.432 . . . . 0.0 110.42 -160.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.77 147.1 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.5 1.12 . . . . 0.0 110.071 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -129.71 117.7 20.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.009 2.523 . . . . 0.0 105.977 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.97 70.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -79.71 146.2 32.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -62.3 143.31 57.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.963 0.905 . . . . 0.0 109.513 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -81.06 121.04 80.25 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.71 -37.76 34.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.342 2.028 . . . . 0.0 112.666 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.53 ' HB2' HG23 ' A' ' 56' ' ' VAL . 8.6 mt -126.87 39.38 3.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.217 0.917 . . . . 0.0 110.08 -168.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.123 0 CA-C-N 119.01 0.823 . . . . 0.0 110.718 -173.019 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 117.21 -1.376 . . . . 0.0 114.376 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 47' ' ' LEU . 1.8 t -48.53 -52.35 44.66 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.397 1.453 . . . . 0.0 108.587 167.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.2 -30.27 25.14 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.056 1.17 . . . . 0.0 112.962 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -69.33 -22.49 63.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.086 -0.384 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.05 -64.4 0.87 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.078 -0.963 . . . . 0.0 108.973 164.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -60.94 -26.15 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 121.095 1.771 . . . . 0.0 114.472 -170.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -59.75 -26.57 65.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.189 1.359 . . . . 0.0 113.449 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -21.57 60.21 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.457 1.026 . . . . 0.0 110.324 172.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -84.56 38.19 0.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.252 0.933 . . . . 0.0 110.302 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 28.77 42.33 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 129.901 3.619 . . . . 0.0 115.042 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 172.48 8.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.394 1.097 . . . . 0.0 112.405 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HA ' HG22 ' A' ' 86' ' ' VAL . 18.3 mt-10 -139.0 -27.51 0.82 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.246 -166.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -141.57 154.47 45.46 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.69 0.796 . . . . 0.0 110.827 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.953 HG13 ' HB3' ' A' ' 4' ' ' ALA . 3.3 t -150.17 103.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 120.994 -1.066 . . . . 0.0 110.129 -172.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.526 HG21 ' CG1' ' A' ' 99' ' ' VAL . 89.6 mt -91.49 100.9 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 119.735 -1.853 . . . . 0.0 107.457 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.524 HG13 HG12 ' A' ' 68' ' ' VAL . 32.7 m -122.08 171.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.747 1.158 . . . . 0.0 111.948 -170.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -114.36 -100.06 0.43 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.49 54.42 4.95 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.806 1.67 . . . . 0.0 113.091 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.3 tt -58.02 -170.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 125.772 1.629 . . . . 0.0 111.603 165.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.87 164.81 31.91 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 119.051 -2.281 . . . . 0.0 109.38 171.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -53.28 -46.65 69.37 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.107 0.954 . . . . 0.0 113.554 -168.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -51.42 -21.61 2.45 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.31 -39.79 9.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.739 0.816 . . . . 0.0 110.584 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.7 mm -48.35 -47.6 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 166.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.56 -21.03 36.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.667 1.587 . . . . 0.0 114.672 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.16 -57.44 4.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.223 0.92 . . . . 0.0 108.925 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.516 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 15.4 m-85 -60.71 -38.86 86.47 Favored 'General case' 0 N--CA 1.424 -1.767 0 C-N-CA 124.936 1.294 . . . . 0.0 109.403 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.79 -14.14 30.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.683 -1.151 . . . . 0.0 113.962 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.65 64.64 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 121.421 1.919 . . . . 0.0 111.929 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.64 18.6 5.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.108 1.363 . . . . 0.0 112.998 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.14 25.78 60.38 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.81 -1.181 . . . . 0.0 113.001 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 66' ' ' GLU . 6.8 t -78.56 112.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 -170.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -65.95 148.88 51.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.23 -169.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.405 ' O ' ' HE2' ' A' ' 90' ' ' LYS . 3.7 p -144.36 98.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 109' ' ' LYS . 72.0 mt -72.75 134.48 29.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.77 2.028 . . . . 0.0 107.101 166.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HE2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -110.58 174.97 5.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.077 0.551 . . . . 0.0 110.34 169.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.52 -2.98 65.43 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.689 -1.617 . . . . 0.0 115.547 168.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.61 -174.48 0.72 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.025 1.912 . . . . 0.0 112.575 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 p -170.49 153.04 4.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.964 2.106 . . . . 0.0 106.455 165.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.65 -168.96 22.57 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.814 0.721 . . . . 0.0 111.878 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -82.74 169.29 16.33 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.54 -0.976 . . . . 0.0 110.393 166.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.18 -53.99 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 123.56 0.744 . . . . 0.0 109.817 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.01 -17.09 36.12 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -99.28 -52.06 3.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.275 1.43 . . . . 0.0 108.678 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 69' ' ' ILE . 25.7 t -55.33 -40.04 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.631 1.572 . . . . 0.0 111.714 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.37 -59.4 2.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -60.95 -41.09 95.62 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.517 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.27 -37.15 66.92 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.314 1.416 . . . . 0.0 110.584 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 21.2 t80 -77.12 -50.04 13.92 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.253 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.74 -25.64 65.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.816 0.697 . . . . 0.0 111.044 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -27.93 40.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.814 -0.613 . . . . 0.0 111.749 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.96 3.31 19.89 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.644 1.116 . . . . 0.0 113.693 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -42.67 65.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.171 1.486 . . . . 0.0 110.445 -173.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -66.47 147.93 52.6 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 122.957 0.503 . . . . 0.0 110.245 -172.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.671 ' O ' HG23 ' A' ' 89' ' ' ILE . 6.7 tptt . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 124.366 1.066 . . . . 0.0 110.671 -172.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mt -138.59 150.33 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.039 2.136 . . . . 0.0 105.971 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.41 HG23 HD23 ' A' ' 67' ' ' LEU . 3.7 mt -132.39 105.3 8.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 128.745 2.818 . . . . 0.0 108.112 -163.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.963 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -80.1 145.84 32.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 118.525 0.602 . . . . 0.0 110.401 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 53.4 mt -143.41 111.36 5.44 Favored Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.77 123.1 10.06 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 N-CA-C 106.715 -2.071 . . . . 0.0 106.715 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.86 158.85 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.784 0.72 . . . . 0.0 109.514 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.4 m -74.45 -34.9 63.3 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -146.52 154.06 41.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -80.21 115.32 19.7 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -138.34 39.64 2.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.399 0.545 . . . . 0.0 110.214 170.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.87 73.96 0.1 OUTLIER Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.326 -1.263 . . . . 0.0 115.058 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt 77.86 -28.35 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 130.6 3.56 . . . . 0.0 113.46 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.81 -8.3 53.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.502 0.721 . . . . 0.0 109.304 167.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -42.1 108.36 0.6 Allowed Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 130.224 3.41 . . . . 0.0 110.124 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.71 135.47 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.47 2.114 . . . . 0.0 109.102 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -58.53 146.38 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 118.854 0.752 . . . . 0.0 109.535 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 t -81.57 171.28 14.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 122.636 1.208 . . . . 0.0 109.159 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.62 -39.25 37.71 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.846 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -131.82 -174.03 3.3 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.792 -1.193 . . . . 0.0 108.6 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -119.83 -41.87 2.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.482 0.713 . . . . 0.0 110.208 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.39 64.79 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.936 -0.925 . . . . 0.0 113.739 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.43 72.68 1.44 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.26 1.824 . . . . 0.0 107.196 168.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.43 138.52 19.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 165.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.73 -20.97 8.82 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.641 2.894 . . . . 0.0 113.313 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -151.94 138.43 18.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.166 1.786 . . . . 0.0 107.038 -165.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.86 98.95 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.357 1.863 . . . . 0.0 107.953 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.41 78.0 5.94 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.204 1.402 . . . . 0.0 108.841 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.927 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -71.34 94.66 1.24 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.737 1.215 . . . . 0.0 109.285 174.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.98 167.88 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.528 1.531 . . . . 0.0 109.404 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -122.88 -171.53 2.31 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.694 -1.253 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.72 136.74 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 166.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.28 126.71 18.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 127.413 2.285 . . . . 0.0 105.759 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 52.75 42.38 31.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.145 0.978 . . . . 0.0 111.324 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.09 9.23 5.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.63 1.972 . . . . 0.0 113.729 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.05 167.89 10.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.659 1.184 . . . . 0.0 109.072 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.99 -26.21 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 113.673 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.514 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 57.78 -54.52 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.393 2.277 . . . . 0.0 115.937 -167.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -170.6 158.05 6.07 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.309 1.444 . . . . 0.0 108.787 -157.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.7 mt -138.82 137.87 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 125.303 1.441 . . . . 0.0 107.972 171.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 m -111.07 144.42 40.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.434 2.294 . . . . 0.0 105.855 160.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 16.0 t -140.74 68.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 167.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -80.18 136.65 36.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.14 150.04 49.69 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -88.85 107.74 19.28 Favored Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.199 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.17 -8.51 22.11 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.163 1.909 . . . . 0.0 112.083 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -128.41 37.75 4.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.11 0.964 . . . . 0.0 109.769 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.416 0 C-N-CA 126.146 1.778 . . . . 0.0 111.793 177.054 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -36.53 -51.19 1.9 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.162 2.185 . . . . 0.0 112.193 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.14 -24.64 12.41 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.257 1.485 . . . . 0.0 112.519 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -68.68 -38.36 80.3 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 119.874 1.215 . . . . 0.0 109.551 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.71 -65.62 0.54 Allowed 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.896 0.747 . . . . 0.0 109.557 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 m -59.91 -37.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 117.134 -1.412 . . . . 0.0 112.192 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -58.74 -17.56 24.06 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.02 2.191 . . . . 0.0 114.322 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -26.04 49.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.5 -1.375 . . . . 0.0 110.303 167.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -84.71 37.9 0.67 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.153 1.381 . . . . 0.0 111.164 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.06 26.63 1.32 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 128.287 2.851 . . . . 0.0 118.112 165.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -70.87 171.17 11.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.904 1.852 . . . . 0.0 115.21 -171.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -144.88 -27.24 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.042 1.737 . . . . 0.0 112.019 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.41 HD23 HG23 ' A' ' 3' ' ' ILE . 7.6 tp -132.18 156.21 46.84 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.378 1.471 . . . . 0.0 108.745 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.963 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -142.8 146.6 21.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.534 HG21 ' CG1' ' A' ' 99' ' ' VAL . 72.0 mt -130.6 113.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 173.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 68' ' ' VAL . 35.5 m -129.08 177.02 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.445 1.098 . . . . 0.0 109.542 -175.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.9 ttt-85 -112.55 -90.83 0.5 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.9 64.68 0.26 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.139 1.828 . . . . 0.0 112.37 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.48 176.62 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 125.639 1.576 . . . . 0.0 111.747 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.89 159.67 23.06 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.09 1.805 . . . . 0.0 111.141 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -60.01 -34.77 73.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -164.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -56.08 -40.76 74.11 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.267 1.394 . . . . 0.0 110.826 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.945 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.0 mm -61.47 -48.56 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 167.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.14 -20.49 58.67 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.71 -57.78 7.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.049 -1.032 . . . . 0.0 111.518 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -62.39 -37.86 87.41 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 126.438 1.895 . . . . 0.0 109.399 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.46 -30.0 59.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.53 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.29 -8.46 55.95 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.473 1.033 . . . . 0.0 112.297 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -134.97 12.82 3.62 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.175 1.79 . . . . 0.0 111.783 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.46 33.99 33.66 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 121.382 -0.824 . . . . 0.0 112.408 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.49 117.7 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 146.39 52.89 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.102 -0.998 . . . . 0.0 108.372 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.423 ' O ' ' HE2' ' A' ' 90' ' ' LYS . 2.5 p -133.69 110.17 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.467 0.651 . . . . 0.0 110.919 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mt -81.18 140.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.324 1.85 . . . . 0.0 106.135 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 88' ' ' VAL . 23.4 mtmt -124.48 174.07 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.727 1.211 . . . . 0.0 109.965 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.24 10.64 74.53 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.485 171.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 172.28 5.15 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.538 1.669 . . . . 0.0 111.345 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.0 p -159.38 153.91 24.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.054 1.742 . . . . 0.0 107.895 161.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.49 -166.52 25.8 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.759 0.709 . . . . 0.0 113.404 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 p -83.57 171.97 12.81 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.227 -1.16 . . . . 0.0 109.297 162.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.25 -55.1 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.341 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.18 -33.36 72.1 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.956 -173.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -71.57 -50.88 26.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.84 0.856 . . . . 0.0 110.388 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.534 ' CG1' HG21 ' A' ' 69' ' ' ILE . 38.0 t -58.99 -42.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.262 1.025 . . . . 0.0 110.218 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.62 -54.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -56.71 -42.04 78.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.004 0.82 . . . . 0.0 112.357 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -61.03 -32.85 72.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.266 0.939 . . . . 0.0 111.792 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -79.87 -42.13 24.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.414 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.53 -28.89 67.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.377 0.99 . . . . 0.0 110.754 173.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.2 m -74.12 -13.16 60.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.216 1.406 . . . . 0.0 112.896 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.8 12.77 65.19 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.946 1.26 . . . . 0.0 113.2 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -68.68 -50.84 47.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.131 1.466 . . . . 0.0 107.817 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.61 135.98 55.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.089 1.356 . . . . 0.0 110.109 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.259 0 C-N-CA 125.32 1.448 . . . . 0.0 109.373 171.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.447 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.146 0.022 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 mt -113.49 148.55 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 162.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.45 104.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 128.715 2.806 . . . . 0.0 105.604 -165.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.91 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.43 140.18 36.1 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.3 mt -131.94 118.59 16.53 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 167.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.9 121.22 8.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 107.099 -1.923 . . . . 0.0 107.099 168.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 m -116.13 147.6 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 119.013 0.824 . . . . 0.0 109.999 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -70.02 -30.93 68.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.993 -1.004 . . . . 0.0 111.429 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -146.4 156.33 43.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.429 1.892 . . . . 0.0 106.194 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -90.46 106.86 18.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -132.72 39.15 3.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.88 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.6 -76.12 0.01 OUTLIER Glycine 0 N--CA 1.469 0.864 0 C-N-CA 126.712 2.101 . . . . 0.0 115.849 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -110.33 -50.96 2.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.012 1.725 . . . . 0.0 107.069 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.88 -6.41 1.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 129.32 3.048 . . . . 0.0 113.77 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 m -47.95 109.7 1.2 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 129.864 3.266 . . . . 0.0 111.745 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.04 137.21 21.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.102 1.868 . . . . 0.0 110.317 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.14 137.26 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.643 1.211 . . . . 0.0 111.422 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -74.54 170.16 16.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.429 1.892 . . . . 0.0 109.614 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -109.87 -24.66 10.72 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.83 -1.169 . . . . 0.0 113.059 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -121.43 89.25 3.09 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.259 1.024 . . . . 0.0 109.897 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -39.86 -49.64 2.4 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.3 1.44 . . . . 0.0 113.23 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -15.07 48.38 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.22 52.48 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 173.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.93 153.36 69.74 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 161.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.62 -22.53 0.9 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.782 2.988 . . . . 0.0 113.955 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.11 160.93 39.25 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.793 1.237 . . . . 0.0 107.981 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -127.5 110.53 12.83 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.19 86.93 5.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.91 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -76.63 100.06 5.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.558 HG22 HD13 ' A' ' 40' ' ' ILE . 10.4 t -88.52 141.97 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 125.328 1.451 . . . . 0.0 107.847 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -93.18 -172.48 2.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.801 0.728 . . . . 0.0 109.277 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.2 t -145.42 134.31 17.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 34' ' ' ASN . 6.8 ttpt -133.0 118.52 18.92 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 126.061 1.744 . . . . 0.0 106.713 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.419 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 80.6 m-20 40.45 56.93 2.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.218 1.407 . . . . 0.0 112.62 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 39.93 62.81 1.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 112.985 -167.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.75 171.0 15.4 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.617 1.967 . . . . 0.0 107.968 159.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.63 -20.61 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.62 1.568 . . . . 0.0 112.985 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . . . 53.37 -59.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.737 2.415 . . . . 0.0 115.912 -165.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -170.88 164.29 7.76 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.718 2.407 . . . . 0.0 108.8 -164.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.558 HD13 HG22 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -136.02 129.05 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -173.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 m -124.35 89.03 3.0 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 127.177 2.191 . . . . 0.0 108.298 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 3.7 t -92.17 81.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.6 147.33 32.12 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.42 149.61 33.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.05 0.453 . . . . 0.0 110.115 162.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -95.51 107.98 36.65 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 117.802 -1.094 . . . . 0.0 108.61 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.27 -6.96 17.55 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.164 1.909 . . . . 0.0 113.372 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.46 38.18 4.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.157 1.783 . . . . 0.0 109.479 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.395 0 O-C-N 120.605 -1.309 . . . . 0.0 111.675 175.623 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -50.06 -48.28 79.38 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 120.48 1.491 . . . . 0.0 110.051 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HA ' HG22 ' A' ' 60' ' ' VAL . 58.2 Cg_endo -76.62 -29.61 5.63 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.847 1.698 . . . . 0.0 111.652 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.37 -40.59 71.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.325 0.966 . . . . 0.0 109.516 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.88 -71.74 0.09 Allowed 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.219 1.007 . . . . 0.0 110.516 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 57' ' ' PRO . 5.9 m -60.31 -14.47 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 O-C-N 119.542 -1.974 . . . . 0.0 114.549 -172.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -80.26 -18.26 49.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.878 1.671 . . . . 0.0 112.867 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.07 -27.82 61.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.775 1.17 . . . . 0.0 111.037 164.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -87.65 37.65 0.8 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.535 -0.728 . . . . 0.0 110.672 -162.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.03 27.09 4.87 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.717 2.103 . . . . 0.0 115.157 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.76 166.89 22.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.627 1.214 . . . . 0.0 112.89 -167.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 7.4 mt-10 -141.85 -28.37 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.906 0.882 . . . . 0.0 111.69 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -134.71 160.94 36.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.629 1.172 . . . . 0.0 109.444 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -140.24 148.84 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.606 1.562 . . . . 0.0 106.902 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.535 HG21 ' CG1' ' A' ' 99' ' ' VAL . 46.2 mt -132.41 113.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 68' ' ' VAL . 14.2 m -135.08 -175.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.343 1.057 . . . . 0.0 110.264 -170.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -118.01 -100.35 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.37 -24.17 59.49 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.565 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.302 2.4 tt 44.2 -97.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.577 2.351 . . . . 0.0 113.696 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.13 124.01 2.22 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 127.449 2.452 . . . . 0.0 109.93 -174.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.35 -40.73 17.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.726 1.61 . . . . 0.0 112.472 -169.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -58.05 -34.64 70.31 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.506 1.503 . . . . 0.0 112.69 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.79 -22.52 46.21 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.453 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.6 mm -54.72 -46.79 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.93 -11.76 14.8 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.56 -1.337 . . . . 0.0 114.311 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -57.09 4.76 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 121.26 1.846 . . . . 0.0 111.163 167.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -53.56 1.68 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.655 1.582 . . . . 0.0 110.659 167.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.47 -13.88 62.43 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.528 1.142 . . . . 0.0 111.49 -170.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.71 -22.45 40.3 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 119.212 0.915 . . . . 0.0 110.517 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.48 10.69 7.93 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.144 0.429 . . . . 0.0 111.856 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.66 23.62 58.78 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.399 0.999 . . . . 0.0 112.99 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.85 94.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.71 1.204 . . . . 0.0 110.909 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 127.99 34.55 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.567 . . . . 0.0 110.55 -166.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.63 103.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 122.57 1.176 . . . . 0.0 108.321 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.5 mt -85.67 134.38 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -118.56 179.42 4.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.83 0.452 . . . . 0.0 111.568 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.28 20.33 76.62 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.682 0.614 . . . . 0.0 112.106 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.93 175.04 6.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.224 1.012 . . . . 0.0 109.522 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.8 p -166.96 156.51 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.57 1.548 . . . . 0.0 107.323 166.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.57 -169.67 12.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -80.48 168.83 18.48 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.598 -0.942 . . . . 0.0 109.88 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.85 -49.96 76.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 O-C-N 121.752 -0.592 . . . . 0.0 109.592 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.1 -30.74 62.49 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -75.76 -64.44 1.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 69' ' ' ILE . 25.3 t -55.31 -44.24 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.746 1.618 . . . . 0.0 111.119 -171.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.1 t -59.15 -49.74 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.65 -33.67 76.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.565 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -60.76 -46.33 90.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.21 1.368 . . . . 0.0 110.426 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -59.14 -52.17 66.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.586 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -32.15 66.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.543 0.611 . . . . 0.0 110.856 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 m -76.98 -2.43 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.385 0.674 . . . . 0.0 111.882 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.8 8.92 87.21 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.911 -1.118 . . . . 0.0 112.718 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -75.33 -44.76 43.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.104 1.452 . . . . 0.0 110.405 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.53 151.81 37.88 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.852 1.261 . . . . 0.0 110.031 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 tptt . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 123.943 0.897 . . . . 0.0 111.949 -178.122 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 CA--C 1.507 -0.704 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 29' ' ' PHE . 1.3 mt -142.42 142.98 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.8 104.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 0.0 106.867 -170.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.938 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -81.39 140.27 34.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.307 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.18 113.14 9.56 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.54 108.09 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.493 2.129 . . . . 0.0 108.009 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -100.57 158.22 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.309 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.9 m -81.49 -25.62 35.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.503 -0.761 . . . . 0.0 111.524 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -152.29 157.83 41.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.567 1.076 . . . . 0.0 109.675 -174.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -95.23 84.25 4.03 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.841 1.257 . . . . 0.0 108.578 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -107.81 38.62 2.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 116.803 -1.57 . . . . 0.0 110.383 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 32.43 79.56 0.02 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 125.299 1.428 . . . . 0.0 112.958 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 78.08 -36.12 0.21 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 128.633 2.773 . . . . 0.0 113.249 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.35 -7.87 35.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.756 0.707 . . . . 0.0 110.549 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -39.55 106.6 0.4 Allowed Pre-proline 0 N--CA 1.448 -0.557 1 C-N-CA 131.845 4.058 . . . . 0.0 111.051 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.77 133.78 15.85 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.99 2.46 . . . . 0.0 110.778 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -64.44 127.16 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.493 0.663 . . . . 0.0 110.174 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -63.19 168.45 4.24 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.423 1.089 . . . . 0.0 109.321 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.78 -15.37 34.83 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.198 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -131.02 -177.72 4.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -120.36 -55.78 2.02 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.648 1.179 . . . . 0.0 108.531 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.02 -6.21 12.0 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 117.424 -1.764 . . . . 0.0 116.324 -166.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.8 39.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.799 2.3 . . . . 0.0 109.869 163.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 144.96 97.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.3 -18.47 20.6 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.203 1.936 . . . . 0.0 114.23 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.15 160.63 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.146 1.378 . . . . 0.0 109.811 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -133.56 104.75 6.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.945 1.698 . . . . 0.0 108.473 170.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.77 93.3 6.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.938 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.3 m-85 -81.98 101.34 10.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 167.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.2 160.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -111.14 -166.9 1.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.393 0.997 . . . . 0.0 108.518 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -157.07 144.44 10.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 164.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.0 124.22 23.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 128.401 2.68 . . . . 0.0 105.19 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 36.73 61.53 0.85 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.786 2.034 . . . . 0.0 111.729 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 64.95 11.16 6.82 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 128.458 2.703 . . . . 0.0 115.335 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.14 164.7 18.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 120.165 1.348 . . . . 0.0 109.639 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.36 -28.0 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 113.792 -162.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.45 -56.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.912 2.485 . . . . 0.0 114.398 -165.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -162.6 155.19 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.454 1.502 . . . . 0.0 110.34 -165.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mm -128.09 117.02 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.038 2.535 . . . . 0.0 106.088 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -109.7 98.39 7.75 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 165.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.54 86.81 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -93.55 153.71 18.28 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -64.91 167.44 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 109.329 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.22 109.97 29.65 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 158.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.13 -7.29 19.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.632 1.554 . . . . 0.0 112.946 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.38 39.39 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.722 1.209 . . . . 0.0 109.985 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.434 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -172.623 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.216 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -48.61 -50.9 56.73 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.439 1.018 . . . . 0.0 110.441 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -75.98 -19.96 15.4 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.347 1.365 . . . . 0.0 112.844 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -66.98 -40.59 87.44 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 119.421 1.01 . . . . 0.0 109.254 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -53.1 -64.4 0.83 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.039 0.936 . . . . 0.0 110.265 168.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.7 m -63.21 -29.22 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 119.952 1.251 . . . . 0.0 113.447 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -64.12 -23.28 67.26 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.76 -1.212 . . . . 0.0 112.791 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -24.71 61.23 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 121.245 1.839 . . . . 0.0 110.798 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.71 38.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.853 1.261 . . . . 0.0 111.102 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 38.63 37.09 0.51 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.735 2.588 . . . . 0.0 116.799 165.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -81.6 175.29 10.62 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.04 -31.56 0.54 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.792 1.637 . . . . 0.0 112.922 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 68' ' ' VAL . 64.8 tp -134.46 159.83 39.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.305 1.05 . . . . 0.0 109.552 175.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.87 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -141.9 130.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.501 HG21 HG13 ' A' ' 99' ' ' VAL . 76.4 mt -114.45 112.42 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.439 HG13 HG12 ' A' ' 68' ' ' VAL . 17.9 m -128.92 170.34 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.556 1.542 . . . . 0.0 109.277 -172.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -99.64 -93.64 0.26 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.32 -19.98 53.53 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.51 -1.161 . . . . 0.0 114.661 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 74' ' ' GLY 0.336 2.7 tt 29.55 -129.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 127.724 2.41 . . . . 0.0 112.978 -172.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.413 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -167.22 -162.99 20.27 Favored Glycine 0 CA--C 1.541 1.698 1 C-N-CA 131.227 4.251 . . . . 0.0 106.822 176.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -37.69 9.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 121.145 2.472 . . . . 0.0 111.106 165.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -60.84 -20.79 62.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.98 -4.49 17.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.383 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -56.18 -41.26 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 157.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.26 -18.27 15.62 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.64 7.09 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 120.811 -1.181 . . . . 0.0 108.826 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.02 -40.22 95.84 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 125.789 1.636 . . . . 0.0 109.054 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -56.49 -27.6 57.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.72 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.16 -11.95 61.24 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.186 1.357 . . . . 0.0 111.738 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.5 ptp -130.81 6.38 4.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.867 1.667 . . . . 0.0 111.851 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.56 37.15 66.28 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 120.653 -1.279 . . . . 0.0 110.906 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 121.01 34.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -59.08 147.87 33.23 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.878 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.57 126.21 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.03 119.87 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -113.4 158.78 20.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.935 1.294 . . . . 0.0 108.794 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 11.33 74.25 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.538 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.71 174.37 1.05 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.362 1.581 . . . . 0.0 113.322 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -161.74 148.61 14.2 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.663 -1.273 . . . . 0.0 109.768 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.06 -163.77 12.17 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 124.011 0.819 . . . . 0.0 112.618 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.9 p -81.1 174.73 11.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.936 0.894 . . . . 0.0 109.81 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.47 -54.92 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 O-C-N 121.028 -1.045 . . . . 0.0 109.756 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.78 -37.98 69.28 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.94 -49.87 40.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.508 0.723 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.501 HG13 HG21 ' A' ' 69' ' ' ILE . 39.9 t -57.54 -40.51 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.631 1.172 . . . . 0.0 110.513 176.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.21 -51.84 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -62.0 -44.88 95.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.028 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -52.91 -39.24 62.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.305 0.957 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -76.01 -43.2 45.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mp -62.31 -28.49 69.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.687 0.795 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.5 m -80.61 -37.44 31.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.38 1.072 . . . . 0.0 109.833 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.13 10.42 22.38 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.158 0.885 . . . . 0.0 112.986 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -61.72 -44.03 97.71 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.182 0.991 . . . . 0.0 108.664 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 137.74 57.19 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.123 1.369 . . . . 0.0 110.626 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tptm . . . . . 0 CA--C 1.518 -0.281 0 C-N-CA 124.635 1.174 . . . . 0.0 112.67 -170.081 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttm . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.152 0.025 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.7 142.8 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.75 107.41 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 129.779 3.232 . . . . 0.0 107.42 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.935 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -83.61 150.19 26.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.158 0.435 . . . . 0.0 111.367 175.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -142.77 120.01 7.02 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.19 123.17 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 108.75 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 15' ' ' SER . 10.0 m -118.54 156.89 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.158 0.583 . . . . 0.0 110.31 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -81.73 -21.49 37.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.524 -0.75 . . . . 0.0 112.123 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -142.77 161.36 38.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.621 1.1 . . . . 0.0 109.534 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -91.96 98.63 11.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -139.98 39.19 1.97 Allowed 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.77 -0.581 . . . . 0.0 110.473 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.408 ' HA2' HG11 ' A' ' 42' ' ' VAL . . . 52.02 -140.77 26.35 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-N 119.074 0.852 . . . . 0.0 112.347 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -56.61 -16.75 6.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.93 -2.7 55.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.535 1.534 . . . . 0.0 110.755 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.524 ' CB ' HG11 ' A' ' 7' ' ' VAL . 46.4 m -50.57 122.49 16.1 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.984 1.714 . . . . 0.0 110.991 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.91 130.99 15.09 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 123.021 2.481 . . . . 0.0 109.703 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.3 140.11 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.52 175.48 9.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.098 0.951 . . . . 0.0 108.906 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.72 -21.65 21.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 118.356 -0.83 . . . . 0.0 111.126 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -130.93 -175.14 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.118 2.167 . . . . 0.0 108.277 -173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.31 -48.13 2.33 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.527 1.131 . . . . 0.0 109.77 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -19.71 59.28 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -165.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.7 38.55 3.05 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.629 1.214 . . . . 0.0 110.57 168.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.49 129.2 89.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.62 -21.69 45.33 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.308 2.005 . . . . 0.0 114.888 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -145.33 164.37 31.66 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 119.359 0.981 . . . . 0.0 109.191 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -134.17 103.98 6.0 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.168 1.387 . . . . 0.0 108.608 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.75 91.15 5.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.935 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.5 m-85 -82.95 94.61 7.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.2 155.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -98.16 -172.2 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.819 -1.175 . . . . 0.0 110.475 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 t -138.79 157.18 29.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 153.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 21.1 ttpt -154.12 142.09 20.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.45 2.3 . . . . 0.0 104.969 162.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 47.62 47.8 17.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.727 1.149 . . . . 0.0 111.128 170.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.18 41.19 1.98 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.556 1.542 . . . . 0.0 115.029 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.6 169.09 18.4 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.283 0.633 . . . . 0.0 109.534 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.98 -31.38 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 113.484 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.441 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 53.69 -62.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.045 2.138 . . . . 0.0 114.789 -161.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.93 167.16 30.67 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.985 1.314 . . . . 0.0 111.525 -162.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.28 147.86 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.454 2.301 . . . . 0.0 107.86 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -145.21 97.51 3.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.408 HG11 ' HA2' ' A' ' 12' ' ' GLY . 4.0 p -105.09 65.89 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -89.1 150.26 22.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -170.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.78 148.67 49.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -80.1 122.28 82.85 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.297 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.98 -13.28 39.35 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.768 2.312 . . . . 0.0 114.789 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -134.05 39.91 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.499 1.52 . . . . 0.0 108.531 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 O-C-N 120.432 -1.417 . . . . 0.0 110.98 -179.757 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.51 -52.86 16.17 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.843 0.747 . . . . 0.0 109.989 172.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 60' ' ' VAL . 7.3 Cg_endo -75.67 -27.51 8.91 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.478 1.206 . . . . 0.0 113.199 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -55.82 -45.37 78.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.77 -66.48 0.49 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.185 0.994 . . . . 0.0 110.962 170.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.18 -21.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.871 1.668 . . . . 0.0 113.296 -171.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.39 -23.86 62.85 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.814 1.246 . . . . 0.0 112.187 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -79.81 -18.64 50.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.642 1.11 . . . . 0.0 112.079 168.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -85.88 39.32 0.8 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.459 1.104 . . . . 0.0 111.084 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.9 16.85 41.14 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 160.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.53 165.67 24.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.909 1.354 . . . . 0.0 114.552 -161.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.94 -34.16 1.01 Allowed 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.942 1.297 . . . . 0.0 111.189 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.5 tm? -137.34 154.19 50.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -171.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 4' ' ' ALA . 3.3 t -149.14 141.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.461 HG21 HG13 ' A' ' 99' ' ' VAL . 67.2 mt -132.91 111.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.15 -178.39 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.453 0.644 . . . . 0.0 110.592 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -114.0 -100.45 0.43 Allowed 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.3 61.96 1.25 Allowed Glycine 0 C--N 1.329 0.171 0 C-N-CA 125.688 1.613 . . . . 0.0 111.441 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.0 tt -59.96 172.46 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 125.462 1.505 . . . . 0.0 110.988 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 152.53 17.92 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -42.3 52.8 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 124.952 1.301 . . . . 0.0 112.418 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -56.95 -22.69 39.87 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.61 -31.71 13.15 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.311 1.045 . . . . 0.0 111.909 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.7 -45.77 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.1 -11.13 5.29 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.19 -57.14 3.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.551 1.069 . . . . 0.0 109.632 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -58.41 -39.15 78.95 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.008 1.723 . . . . 0.0 109.148 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -55.43 -29.26 58.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.526 1.131 . . . . 0.0 112.842 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.61 -6.53 55.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.696 1.135 . . . . 0.0 111.081 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -130.99 -0.78 4.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.13 1.372 . . . . 0.0 112.059 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.91 38.94 93.39 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.996 -1.065 . . . . 0.0 110.501 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.44 127.79 38.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 167.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -78.08 142.0 38.42 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 p -131.1 101.56 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 67' ' ' LEU . 56.3 mt -74.36 149.27 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 125.829 1.652 . . . . 0.0 107.399 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.41 176.17 7.93 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.62 19.21 77.74 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.34 -0.7 . . . . 0.0 113.295 165.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 179.78 6.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.279 1.04 . . . . 0.0 110.329 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 p -164.8 154.54 13.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.313 2.245 . . . . 0.0 107.091 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.86 -168.02 13.22 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 123.55 0.531 . . . . 0.0 112.885 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.7 p -79.68 173.38 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.775 -0.838 . . . . 0.0 109.966 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.58 -57.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.003 0.921 . . . . 0.0 108.955 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.08 -32.36 72.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.418 -173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.93 -54.23 20.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.21 1.404 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.461 HG13 HG21 ' A' ' 69' ' ' ILE . 50.4 t -57.33 -30.05 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.695 1.198 . . . . 0.0 111.139 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.8 -53.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -54.29 -44.59 72.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.617 0.767 . . . . 0.0 109.963 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -53.81 -38.8 64.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.544 0.738 . . . . 0.0 111.073 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.36 -39.44 32.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.927 0.891 . . . . 0.0 112.503 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.25 -26.29 68.3 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.402 1.456 . . . . 0.0 111.275 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -1.86 57.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.514 1.126 . . . . 0.0 111.802 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.64 69.25 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.328 -1.483 . . . . 0.0 113.226 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -78.13 -27.48 48.27 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.804 1.302 . . . . 0.0 110.538 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.55 152.88 22.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.099 0.96 . . . . 0.0 110.667 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 C-N-CA 124.413 1.085 . . . . 0.0 110.514 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 tpp . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 mt -139.05 142.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 mt -132.96 104.39 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 127.217 2.207 . . . . 0.0 105.9 -161.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.01 142.3 35.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.808 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.3 115.14 11.7 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.1 116.73 4.64 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.368 2.045 . . . . 0.0 106.878 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 26' ' ' TYR . 10.7 m -114.28 152.2 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 118.258 0.481 . . . . 0.0 109.843 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -77.34 -26.38 52.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.871 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -145.08 150.96 37.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.262 0.937 . . . . 0.0 109.516 -172.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 48.4 t-20 -85.78 64.75 8.79 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.239 1.816 . . . . 0.0 108.779 -168.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -111.2 39.24 2.33 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.495 -0.753 . . . . 0.0 109.319 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 42' ' ' VAL . . . 37.88 -108.05 0.07 OUTLIER Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.462 1.982 . . . . 0.0 112.953 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -20.53 46.51 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.69 -6.85 58.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.934 2.494 . . . . 0.0 110.674 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.0 m -51.7 119.93 14.63 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.622 1.969 . . . . 0.0 112.28 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.39 135.28 20.1 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.864 2.376 . . . . 0.0 110.893 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.02 139.55 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.951 0.5 . . . . 0.0 109.771 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.38 177.05 6.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.747 1.219 . . . . 0.0 110.032 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -96.06 -42.12 8.4 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.71 -0.619 . . . . 0.0 111.634 -171.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -100.18 178.49 4.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -120.43 -47.36 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.564 1.146 . . . . 0.0 109.672 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -12.03 34.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.69 1.138 . . . . 0.0 114.127 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.04 38.93 3.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.078 1.439 . . . . 0.0 110.848 168.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.71 130.18 82.02 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.3 -23.58 20.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.361 2.041 . . . . 0.0 113.338 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.517 ' HB2' HG23 ' A' ' 7' ' ' VAL . 69.3 m-85 -145.75 153.38 40.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.099 1.36 . . . . 0.0 107.761 -176.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -126.49 110.31 13.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.671 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -79.84 89.79 5.27 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.5 m-85 -81.72 93.02 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -79.74 153.73 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -103.14 -168.27 1.49 Allowed 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.646 -0.659 . . . . 0.0 109.769 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.29 138.69 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 163.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.16 96.43 6.22 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 164.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 71.02 -50.11 0.68 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.33 2.252 . . . . 0.0 114.328 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.91 -1.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.212 2.605 . . . . 0.0 112.543 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.84 178.22 4.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.257 1.423 . . . . 0.0 108.211 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.87 -18.76 23.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 120.206 1.366 . . . . 0.0 113.438 -162.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.22 -79.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.72 1.145 . . . . 0.0 110.383 -159.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -154.07 168.02 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 109.791 -168.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' HG23 ' A' ' 42' ' ' VAL . 5.9 mm -100.49 162.5 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 127.038 2.135 . . . . 0.0 106.691 170.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 m -148.61 84.66 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.677 1.591 . . . . 0.0 107.426 157.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.671 HG22 ' CB ' ' A' ' 28' ' ' ALA . 99.0 t -95.33 84.11 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -93.38 158.33 15.78 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -78.94 145.45 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.471 HD21 HG22 ' A' ' 56' ' ' VAL . 43.0 t-20 -84.59 108.8 16.08 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.34 -17.26 59.22 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.23 1.287 . . . . 0.0 111.929 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 55' ' ' ALA . 1.3 mm? -120.2 38.75 3.88 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.398 1.079 . . . . 0.0 110.258 -175.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.323 0 O-C-N 120.851 -1.155 . . . . 0.0 110.918 -178.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.823 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.471 HG22 HD21 ' A' ' 45' ' ' ASN . 1.8 t -48.38 -55.71 17.67 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 110.077 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.48 -20.93 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.963 1.776 . . . . 0.0 110.581 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.67 -44.67 85.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.296 0.638 . . . . 0.0 109.907 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -55.72 -66.91 0.34 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.274 1.43 . . . . 0.0 110.422 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.71 -22.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -0.94 8.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 113.374 171.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 -19.08 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.837 -1.165 . . . . 0.0 110.667 168.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -84.61 37.25 0.63 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.613 0.642 . . . . 0.0 111.375 -174.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 41.58 33.94 1.07 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.238 2.351 . . . . 0.0 114.492 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -68.19 166.73 15.65 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.613 1.707 . . . . 0.0 112.875 -168.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -139.14 -40.69 0.47 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.916 1.286 . . . . 0.0 110.923 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp -127.98 156.25 42.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.296 1.038 . . . . 0.0 108.664 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.814 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.7 t -138.56 142.88 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 172.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.492 HG21 ' CG1' ' A' ' 99' ' ' VAL . 94.4 mt -134.54 114.09 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.405 HG21 ' HB ' ' A' ' 73' ' ' ILE . 4.6 m -131.24 170.34 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.226 0.61 . . . . 0.0 110.065 -171.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -60.84 1.97 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.331 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.86 4.38 0.64 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 117.484 1.754 . . . . 0.0 117.484 -173.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 74' ' ' GLY 0.274 4.4 tt 31.83 -123.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 127.031 2.132 . . . . 0.0 114.994 162.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 156.75 155.76 7.58 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 128.039 2.733 . . . . 0.0 109.004 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -59.62 -31.96 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -164.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -30.32 71.16 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.466 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.66 -22.87 24.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.496 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.55 -42.61 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 121.005 1.73 . . . . 0.0 108.61 160.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.95 -10.6 22.24 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 120.453 -1.404 . . . . 0.0 113.118 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.66 -62.4 1.46 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 119.855 1.207 . . . . 0.0 111.333 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.478 ' CD2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -30.99 -57.88 0.22 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 128.027 2.531 . . . . 0.0 109.61 161.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.02 -13.17 62.29 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.959 0.787 . . . . 0.0 112.57 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.46 59.23 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.824 0.738 . . . . 0.0 111.759 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.416 ' SD ' HG21 ' A' ' 86' ' ' VAL . 3.0 ptt? -137.12 7.6 2.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.018 0.372 . . . . 0.0 111.811 -171.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.35 28.5 35.68 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.626 1.584 . . . . 0.0 112.39 -170.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.416 HG21 ' SD ' ' A' ' 84' ' ' MET . 2.3 t -80.06 99.52 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 124.341 1.057 . . . . 0.0 108.44 -172.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -64.34 128.44 35.8 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.392 -163.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 81' ' ' PHE . 7.0 p -110.77 112.25 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.0 mt -88.13 147.61 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -179.41 5.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.24 13.84 73.65 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-O 119.116 -0.824 . . . . 0.0 114.163 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.52 162.48 28.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.085 1.442 . . . . 0.0 109.936 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -146.14 160.1 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.053 2.141 . . . . 0.0 106.527 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.49 -161.06 17.95 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.469 0.577 . . . . 0.0 113.793 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -92.99 171.38 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 163.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -53.17 -54.97 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.883 0.873 . . . . 0.0 109.273 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.38 -31.0 71.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.047 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.418 ' HG2' HE21 ' A' ' 102' ' ' GLN . 42.4 tt0 -70.87 -55.57 8.18 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 69' ' ' ILE . 55.7 t -54.08 -44.87 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.363 1.065 . . . . 0.0 110.599 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.59 -46.91 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -59.86 -42.14 93.02 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.887 0.767 . . . . 0.0 111.296 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.418 HE21 ' HG2' ' A' ' 98' ' ' GLU . 72.3 mt-30 -58.76 -52.5 65.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.863 0.865 . . . . 0.0 109.801 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.05 -46.66 83.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.11 -25.5 67.75 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.065 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 m -90.59 7.86 37.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 112.957 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.24 -1.28 88.96 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.177 1.37 . . . . 0.0 115.184 168.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -71.25 -44.06 66.04 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.367 1.084 . . . . 0.0 111.831 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.62 141.75 37.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.644 1.178 . . . . 0.0 108.473 -166.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 CA-C-O 123.482 1.61 . . . . 0.0 112.937 -173.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.521 0.201 . . . . 0.0 110.772 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.41 HG22 ' CD1' ' A' ' 29' ' ' PHE . 7.2 mt -115.31 153.13 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 165.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.48 105.29 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 127.16 2.184 . . . . 0.0 105.797 -164.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.921 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.47 145.56 31.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 118.623 -0.704 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.478 HD12 HG13 ' A' ' 96' ' ' VAL . 51.2 mt -145.93 114.59 4.66 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.38 129.55 16.05 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.523 1.482 . . . . 0.0 108.318 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 15' ' ' SER . 4.9 m -123.02 150.15 26.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.3 m -68.07 -27.02 66.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.337 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.63 156.07 39.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.663 1.585 . . . . 0.0 107.937 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 52.4 t-20 -85.71 95.52 9.41 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 173.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.69 39.67 3.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.072 0.949 . . . . 0.0 108.616 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.2 -127.96 30.08 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 120.751 -1.218 . . . . 0.0 111.464 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -58.29 -45.83 87.2 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.153 1.381 . . . . 0.0 111.736 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -1.87 4.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.751 2.42 . . . . 0.0 114.307 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.47 ' HB3' HG11 ' A' ' 7' ' ' VAL . 28.1 m -53.05 109.03 1.26 Allowed Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 125.201 1.4 . . . . 0.0 110.955 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.89 135.37 14.08 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.42 1.414 . . . . 0.0 108.932 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.43 134.37 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.978 0.911 . . . . 0.0 111.288 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.37 169.87 12.53 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.869 1.267 . . . . 0.0 107.91 166.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -88.09 -55.26 3.83 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 121.454 -0.779 . . . . 0.0 110.577 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.7 85.59 2.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -152.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -37.49 -47.22 0.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 112.908 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.35 40.98 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.773 -1.015 . . . . 0.0 115.341 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 47.96 1.56 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 108.737 173.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.63 137.79 54.84 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.76 -25.28 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.482 2.121 . . . . 0.0 114.457 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 10' ' ' ASN . 33.2 m-85 -146.3 158.18 43.86 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.28 103.92 8.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.523 1.529 . . . . 0.0 107.904 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.06 78.99 6.66 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.543 1.537 . . . . 0.0 107.624 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.921 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.28 3.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 170.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.461 HG13 HD13 ' A' ' 40' ' ' ILE . 3.8 t -83.05 164.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 123.682 0.793 . . . . 0.0 109.055 171.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.87 2.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.94 -1.1 . . . . 0.0 108.946 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.424 HG12 ' HG2' ' A' ' 1' ' ' MET . 11.9 p -150.19 147.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -123.65 113.76 19.08 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 173.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.8 t30 54.61 -86.86 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.716 1.206 . . . . 0.0 111.627 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.9 12.22 2.89 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.605 1.562 . . . . 0.0 111.917 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 156.32 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.821 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.21 -32.32 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.137 1.775 . . . . 0.0 112.938 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 59.17 -51.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.309 2.244 . . . . 0.0 115.48 -168.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.72 162.03 15.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 110.768 -160.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.461 HD13 HG13 ' A' ' 30' ' ' VAL . 2.8 mm -135.75 140.48 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.205 1.802 . . . . 0.0 107.683 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.84 88.55 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.741 2.016 . . . . 0.0 107.704 165.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 4.7 t -89.86 93.46 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 164.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.76 152.63 19.47 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -56.92 152.97 11.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.427 1.091 . . . . 0.0 110.439 168.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -79.86 133.66 58.09 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.94 -9.72 26.24 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 CA-C-N 121.128 1.439 . . . . 0.0 112.136 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.81 39.73 0.96 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.042 1.337 . . . . 0.0 110.082 -163.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.205 0 O-C-N 120.275 -1.516 . . . . 0.0 112.367 -169.135 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.06 -53.45 48.27 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 119.237 0.926 . . . . 0.0 109.515 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 60' ' ' VAL . 29.2 Cg_endo -72.43 -32.09 10.48 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.02 1.814 . . . . 0.0 111.925 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.09 -38.35 73.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.063 0.847 . . . . 0.0 110.884 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.77 -65.59 0.61 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.922 1.289 . . . . 0.0 110.971 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.74 -22.34 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 119.776 1.171 . . . . 0.0 113.952 -173.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.59 -12.34 61.51 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.368 -1.457 . . . . 0.0 113.946 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.78 -18.93 24.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.848 1.204 . . . . 0.0 109.813 165.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.22 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 119.84 -1.787 . . . . 0.0 111.221 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.51 20.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.337 2.398 . . . . 0.0 116.264 161.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.2 176.85 9.29 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -159.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -144.09 -53.31 0.33 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 110.661 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.02 157.03 19.73 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.618 1.167 . . . . 0.0 109.373 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -136.56 139.61 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 127.387 2.275 . . . . 0.0 105.084 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.58 HG21 HG13 ' A' ' 99' ' ' VAL . 94.5 mt -131.43 111.4 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.463 HG13 HG12 ' A' ' 68' ' ' VAL . 3.1 m -137.35 155.38 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.85 0.86 . . . . 0.0 110.657 -162.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.435 ' HE ' ' HB3' ' A' ' 93' ' ' SER . 17.6 ttt-85 -95.14 -62.1 1.36 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.66 -1.275 . . . . 0.0 111.195 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.82 -54.46 1.3 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 121.757 -0.589 . . . . 0.0 113.977 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.491 HG12 ' H ' ' A' ' 74' ' ' GLY 0.301 3.7 tt 44.38 -168.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 130.143 3.377 . . . . 0.0 115.093 -173.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.35 167.21 39.86 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.289 1.9 . . . . 0.0 110.42 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.8 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -64.74 -36.28 83.8 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 121.201 1.819 . . . . 0.0 109.638 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.66 -40.7 63.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.256 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.44 -43.89 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 119.732 1.151 . . . . 0.0 109.622 168.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.75 -11.25 11.32 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.131 -1.606 . . . . 0.0 114.89 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.407 ' HB2' ' CB ' ' A' ' 57' ' ' PRO . . . -80.18 -58.53 3.1 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.208 1.403 . . . . 0.0 110.441 175.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.457 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -35.63 -56.33 0.67 Allowed 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 126.958 2.103 . . . . 0.0 109.153 160.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.32 -10.05 56.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 117.441 -1.266 . . . . 0.0 111.763 -167.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.98 63.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.714 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.13 14.94 5.7 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.379 0.424 . . . . 0.0 111.476 -163.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.2 26.8 56.75 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.101 -0.374 . . . . 0.0 112.819 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 1.9 t -79.67 108.21 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -168.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.68 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.929 1.692 . . . . 0.0 110.349 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.05 95.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.51 139.47 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.87 154.06 47.68 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 -171.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.8 11.04 38.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.08 0.848 . . . . 0.0 114.751 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.48 157.58 37.58 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.48 1.14 . . . . 0.0 110.85 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.435 ' HB3' ' HE ' ' A' ' 71' ' ' ARG . 65.1 p -159.52 130.3 5.87 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.64 -130.77 6.25 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.95 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.41 159.55 39.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.044 1.738 . . . . 0.0 111.344 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.478 HG13 HD12 ' A' ' 5' ' ' ILE . 22.7 t -63.68 -45.1 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 120.909 -1.119 . . . . 0.0 111.304 -166.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.54 -11.91 48.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.43 -43.55 5.38 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 117.356 -1.307 . . . . 0.0 108.972 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.58 HG13 HG21 ' A' ' 69' ' ' ILE . 77.1 t -45.93 -49.88 4.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 120.412 1.46 . . . . 0.0 110.569 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.42 -38.48 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.471 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -61.99 -51.01 69.78 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 117.352 -1.309 . . . . 0.0 110.314 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.22 -37.26 69.46 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.374 1.443 . . . . 0.0 111.589 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.0 -50.38 42.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.724 1.21 . . . . 0.0 112.005 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.86 -30.72 71.72 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.128 0.422 . . . . 0.0 110.086 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.4 m -74.72 -1.13 20.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.884 2.074 . . . . 0.0 112.483 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 -8.9 74.98 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.356 1.455 . . . . 0.0 112.966 168.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.51 -45.79 51.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.95 134.85 38.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.34 -166.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.558 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 ttp . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.707 0.289 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -137.66 145.47 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.53 111.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 128.423 2.689 . . . . 0.0 106.827 -162.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.894 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -84.02 147.67 27.29 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.289 0.95 . . . . 0.0 111.599 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.4 mt -141.64 113.82 6.6 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.47 110.01 2.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.343 2.696 . . . . 0.0 108.824 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.527 HG23 ' HB2' ' A' ' 26' ' ' TYR . 18.6 m -106.82 146.26 13.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.496 0.718 . . . . 0.0 111.409 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.418 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -141.53 149.08 40.38 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.582 1.083 . . . . 0.0 109.389 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.68 100.04 11.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.95 39.02 1.8 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 27.23 80.89 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 126.76 2.124 . . . . 0.0 114.884 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 80.66 -29.78 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 1 C-N-CA 131.821 4.049 . . . . 0.0 113.445 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.5 -8.46 54.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.03 1.286 . . . . 0.0 110.263 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB3' HG21 ' A' ' 7' ' ' VAL . 7.4 m -45.82 108.64 0.83 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 128.401 2.681 . . . . 0.0 110.086 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.55 131.66 12.74 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.209 2.606 . . . . 0.0 110.104 -172.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 93' ' ' SER . 14.0 tt -62.11 140.75 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.404 1.002 . . . . 0.0 109.708 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -94.62 -173.32 2.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.982 1.313 . . . . 0.0 110.699 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -101.05 -42.72 6.28 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.729 1.212 . . . . 0.0 111.584 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -122.13 104.4 9.46 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.986 1.314 . . . . 0.0 109.901 -173.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -44.43 -44.57 8.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.126 1.37 . . . . 0.0 111.585 166.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.12 -3.09 51.14 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 117.943 -1.476 . . . . 0.0 116.233 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -148.16 63.16 1.1 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.03 124.31 32.53 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.69 1.996 . . . . 0.0 108.276 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.21 -23.71 24.13 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 CA-C-N 122.181 1.815 . . . . 0.0 114.214 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.527 ' HB2' HG23 ' A' ' 7' ' ' VAL . 77.7 m-85 -148.68 151.7 35.39 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.814 0.734 . . . . 0.0 109.041 -173.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -122.31 106.21 10.89 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.717 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.74 81.52 6.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.6 1.16 . . . . 0.0 107.94 169.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.894 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.6 m-85 -70.36 141.1 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 161.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.44 150.44 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -96.55 -169.83 1.97 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.374 0.67 . . . . 0.0 109.512 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.4 115.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.681 -0.637 . . . . 0.0 110.102 165.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' N ' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -81.82 91.94 6.59 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.39 -67.33 0.15 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.279 1.432 . . . . 0.0 112.69 174.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -145.71 12.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.138 1.775 . . . . 0.0 112.636 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.63 173.33 6.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.602 1.561 . . . . 0.0 109.389 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.91 -25.74 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 121.068 1.758 . . . . 0.0 114.229 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 53.53 -69.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.304 1.411 . . . . 0.0 112.989 -158.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -166.09 170.84 13.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.097 0.959 . . . . 0.0 112.071 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.2 mm -116.01 145.18 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.774 2.43 . . . . 0.0 106.56 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 m -147.35 68.36 1.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.025 2.53 . . . . 0.0 109.815 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 2.8 t -89.06 93.33 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -96.33 161.95 13.71 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.003 1.321 . . . . 0.0 109.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -71.5 149.36 45.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.66 1.584 . . . . 0.0 109.689 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.1 129.82 65.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 118.242 -0.885 . . . . 0.0 108.849 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.86 -27.26 26.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.168 1.246 . . . . 0.0 111.436 168.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.32 45.76 2.59 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.524 -1.36 . . . . 0.0 109.473 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.427 0 O-C-N 120.441 -1.412 . . . . 0.0 110.578 167.869 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 117.849 2.537 . . . . 0.0 117.849 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -51.49 -55.25 30.89 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 120.372 1.442 . . . . 0.0 109.254 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.62 -22.74 37.51 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 120.304 1.144 . . . . 0.0 110.36 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.82 -37.08 85.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.736 1.153 . . . . 0.0 110.485 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -61.42 -61.64 2.39 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.45 -27.72 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 120.603 -1.311 . . . . 0.0 113.674 -174.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -60.54 -22.63 63.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.199 1.0 . . . . 0.0 111.352 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.9 -18.64 58.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.945 1.702 . . . . 0.0 111.417 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -95.03 37.13 1.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.27 1.395 . . . . 0.0 112.195 -164.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 46.78 26.09 2.59 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.07 1.319 . . . . 0.0 115.357 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -75.32 171.8 13.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.112 1.456 . . . . 0.0 112.422 -168.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -143.89 -28.77 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.188 0.995 . . . . 0.0 112.965 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.409 HD22 ' H ' ' A' ' 68' ' ' VAL . 2.4 tm? -139.42 154.66 47.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.883 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.9 t -144.08 143.36 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.573 HG21 ' CG1' ' A' ' 99' ' ' VAL . 85.2 mt -133.22 115.93 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.62 175.43 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.468 1.107 . . . . 0.0 110.251 -172.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -99.43 0.18 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.89 -28.26 24.1 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 121.143 1.792 . . . . 0.0 116.217 -170.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.574 HG12 ' H ' ' A' ' 74' ' ' GLY 0.311 7.2 tt 39.9 -135.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 127.9 2.48 . . . . 0.0 113.41 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.28 154.99 18.09 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 127.78 2.609 . . . . 0.0 109.647 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -39.92 85.71 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.792 1.296 . . . . 0.0 111.645 -171.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -53.32 -38.22 63.0 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.793 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.87 -35.4 38.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 117.097 -1.43 . . . . 0.0 112.373 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.9 -48.07 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 120.604 1.547 . . . . 0.0 108.471 164.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 -10.02 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.281 -1.342 . . . . 0.0 114.479 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.08 -53.35 9.03 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 121.227 1.83 . . . . 0.0 109.904 167.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -60.86 -35.05 75.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.458 1.103 . . . . 0.0 110.385 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -60.32 -20.28 58.65 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.37 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.27 -10.77 57.03 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.665 1.575 . . . . 0.0 111.53 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.0 ptp -134.45 13.65 3.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.37 1.068 . . . . 0.0 112.782 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.2 33.08 44.88 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.628 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -79.45 113.0 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -71.95 146.44 47.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t -127.07 112.27 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -94.61 133.25 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.879 1.672 . . . . 0.0 106.624 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -129.28 167.98 16.9 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.982 1.713 . . . . 0.0 108.183 -172.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 12.45 67.21 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.765 -1.02 . . . . 0.0 113.781 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 171.89 10.38 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.05 1.425 . . . . 0.0 110.6 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.409 ' HA ' HG21 ' A' ' 17' ' ' ILE . 3.1 p -160.85 152.9 20.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 109.456 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.76 -173.13 16.52 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.381 0.515 . . . . 0.0 112.808 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p -82.43 172.94 12.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.621 -0.929 . . . . 0.0 109.752 168.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -60.81 -49.13 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 O-C-N 121.156 -0.965 . . . . 0.0 110.54 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -58.62 -37.5 76.0 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.499 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.42 -58.32 3.48 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.052 1.741 . . . . 0.0 107.867 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.573 ' CG1' HG21 ' A' ' 69' ' ' ILE . 46.2 t -54.4 -44.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.762 1.625 . . . . 0.0 110.636 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.59 -35.72 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.68 -40.6 88.64 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.788 1.176 . . . . 0.0 111.797 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -59.46 -44.26 93.04 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.013 0.824 . . . . 0.0 110.05 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.0 -45.33 74.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.961 0.905 . . . . 0.0 113.139 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.17 -28.02 69.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.85 0.75 . . . . 0.0 110.377 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.9 m -77.07 -3.23 38.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.36 56.08 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.141 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 -49.75 58.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.94 131.54 43.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.482 1.113 . . . . 0.0 110.743 -171.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttm . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.402 HG23 ' HG2' ' A' ' 31' ' ' LYS . 3.3 mt -127.45 135.72 62.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -132.85 101.59 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 127.001 2.12 . . . . 0.0 107.031 -156.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.811 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.04 144.22 33.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.078 0.399 . . . . 0.0 111.131 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.3 mt -134.54 115.87 12.69 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.51 114.59 4.07 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.15 2.567 . . . . 0.0 109.079 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.34 157.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.08 . . . . 0.0 112.699 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -74.46 -25.33 59.34 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.865 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -150.57 152.16 33.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.134 1.374 . . . . 0.0 107.819 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -85.12 110.95 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 164.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -126.37 39.46 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.473 166.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.07 -102.39 0.58 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 125.368 1.461 . . . . 0.0 109.532 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -98.49 -31.68 11.86 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.875 1.27 . . . . 0.0 110.628 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.78 -10.07 54.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.305 1.442 . . . . 0.0 111.445 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.6 m -40.71 106.44 0.42 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 129.911 3.284 . . . . 0.0 111.892 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 135.82 19.97 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.899 2.4 . . . . 0.0 110.927 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.43 138.65 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -77.67 -160.16 0.17 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 108.265 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.54 -52.81 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.977 1.37 . . . . 0.0 109.697 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.4 179.13 6.04 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.894 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 54.5 t80 -121.0 -46.7 2.32 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.843 -1.16 . . . . 0.0 110.889 159.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.14 -42.22 16.38 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 41.47 2.21 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.833 1.253 . . . . 0.0 111.825 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.29 118.01 65.11 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-O 115.927 -1.987 . . . . 0.0 106.373 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.25 -17.67 50.12 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 113.717 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -149.1 158.92 44.57 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.738 1.215 . . . . 0.0 108.782 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.409 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 25.1 m-85 -126.22 128.9 47.95 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.318 1.847 . . . . 0.0 107.485 170.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.42 89.13 3.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.7 m-85 -75.43 92.02 2.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.26 162.23 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 55.8 mttt -117.28 -167.64 1.35 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.81 -1.182 . . . . 0.0 108.714 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.33 136.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 120.872 -1.143 . . . . 0.0 109.751 165.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.05 91.82 3.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 168.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 56.68 -69.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.383 2.273 . . . . 0.0 114.345 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.25 11.81 3.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.555 1.542 . . . . 0.0 112.752 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.72 173.36 8.61 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.115 1.366 . . . . 0.0 110.207 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.45 -23.25 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.464 1.106 . . . . 0.0 112.994 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.05 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.593 1.557 . . . . 0.0 114.02 -162.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -162.24 167.16 24.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.367 1.467 . . . . 0.0 109.836 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 mm -124.28 138.6 53.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.897 2.079 . . . . 0.0 105.835 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 m -119.79 96.91 5.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.86 77.69 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 123.467 1.603 . . . . 0.0 107.523 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.6 127.99 32.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.585 1.554 . . . . 0.0 106.943 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -60.61 162.63 6.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.793 1.179 . . . . 0.0 108.681 158.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -78.2 153.38 79.59 Favored Pre-proline 0 N--CA 1.438 -1.059 0 O-C-N 121.496 -0.753 . . . . 0.0 109.428 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.12 -52.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.721 0.948 . . . . 0.0 110.916 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.24 38.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.332 -0.855 . . . . 0.0 111.278 -163.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.231 0 O-C-N 120.939 -1.101 . . . . 0.0 110.271 -160.293 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -46.98 -48.52 52.52 Favored Pre-proline 0 CA--C 1.556 1.204 0 CA-C-N 119.232 0.923 . . . . 0.0 110.398 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HA ' HG22 ' A' ' 60' ' ' VAL . 57.8 Cg_endo -74.73 -20.04 17.94 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.188 1.925 . . . . 0.0 112.385 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -64.96 -42.46 94.59 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -59.79 -62.14 2.1 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.0 m -63.91 -21.11 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.638 1.563 . . . . 0.0 112.545 -173.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -64.1 -13.21 46.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 116.862 -1.542 . . . . 0.0 112.654 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -11.19 32.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 121.237 1.835 . . . . 0.0 112.488 173.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -90.56 37.29 0.91 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.956 0.798 . . . . 0.0 111.647 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.77 28.05 5.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.836 1.684 . . . . 0.0 114.179 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -63.48 152.82 37.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.662 1.731 . . . . 0.0 112.796 -173.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -144.4 -21.84 0.54 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 111.738 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.3 166.39 23.23 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 109.019 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.5 t -142.31 150.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 165.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.482 HG21 ' CG1' ' A' ' 99' ' ' VAL . 39.6 mt -134.19 112.04 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.89 176.81 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.469 1.508 . . . . 0.0 109.679 -167.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -103.26 -97.19 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.237 -1.363 . . . . 0.0 107.838 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.12 -12.94 40.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 120.731 1.605 . . . . 0.0 115.638 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.532 HG12 ' H ' ' A' ' 74' ' ' GLY . 2.3 tt 38.51 -130.17 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.527 1.931 . . . . 0.0 114.159 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 168.82 158.46 12.79 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 129.437 3.398 . . . . 0.0 110.812 166.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -47.35 33.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.475 1.51 . . . . 0.0 112.492 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -55.9 -6.01 0.2 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.38 -40.45 3.64 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 116.785 -1.578 . . . . 0.0 110.235 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -42.44 -46.96 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.698 1.135 . . . . 0.0 108.958 161.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.36 -19.1 63.03 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.9 2.0 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -57.52 -44.52 85.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 124.013 0.925 . . . . 0.0 109.915 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.95 -14.14 59.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.495 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.98 72.62 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.015 1.734 . . . . 0.0 109.021 168.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -19.15 33.66 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.111 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.71 20.23 37.96 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.094 -1.004 . . . . 0.0 112.496 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.8 t -78.91 121.23 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -63.95 146.31 54.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.703 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 p -139.93 89.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.65 1.18 . . . . 0.0 107.989 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.12 131.58 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.21 171.86 7.35 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.012 1.325 . . . . 0.0 111.494 -173.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.76 4.05 38.1 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.003 1.287 . . . . 0.0 114.483 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.74 164.47 23.46 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.89 1.345 . . . . 0.0 110.324 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.3 p -162.17 124.87 2.91 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -159.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.29 -169.68 25.32 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 123.399 0.437 . . . . 0.0 112.618 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.3 p -79.92 170.56 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.929 0.865 . . . . 0.0 109.723 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.2 t -53.6 -59.83 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 C-N-CA 123.591 0.756 . . . . 0.0 109.425 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.01 -27.75 69.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.04 -54.26 8.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.812 1.645 . . . . 0.0 109.399 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 69' ' ' ILE . 19.8 t -56.35 -43.45 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.837 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 t -52.88 -58.35 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 107.993 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.61 -44.05 95.07 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.009 -0.996 . . . . 0.0 111.939 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.96 -46.01 78.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.347 0.976 . . . . 0.0 110.0 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -62.87 -52.64 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.034 0.534 . . . . 0.0 112.152 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 110.812 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.5 m -74.29 -39.56 62.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.68 35.23 1.09 Allowed Glycine 0 C--N 1.333 0.365 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.145 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.15 -35.12 10.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.068 0.934 . . . . 0.0 112.257 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.53 146.52 31.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.978 1.311 . . . . 0.0 108.871 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 tptm . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 123.409 0.684 . . . . 0.0 110.315 -159.143 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptm . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.54 HG22 ' CD1' ' A' ' 29' ' ' PHE . 6.8 mt -124.38 132.24 71.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -173.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.21 104.46 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 129.012 2.925 . . . . 0.0 106.079 -164.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.94 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.08 133.9 35.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mt -127.8 118.26 21.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.89 127.21 17.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 106.8 -2.039 . . . . 0.0 106.8 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 15' ' ' SER . 16.9 m -121.13 157.51 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 119.538 1.063 . . . . 0.0 110.691 177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.86 -34.45 60.03 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.991 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -146.16 169.35 18.91 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.183 0.993 . . . . 0.0 108.545 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -84.03 89.79 7.32 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 130.579 3.552 . . . . 0.0 108.599 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -128.67 38.91 3.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.717 -0.615 . . . . 0.0 110.794 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.41 -80.29 0.11 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 126.033 1.778 . . . . 0.0 113.351 167.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -120.93 -33.54 3.73 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.775 1.63 . . . . 0.0 111.393 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.67 -5.23 11.0 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.769 2.427 . . . . 0.0 112.177 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB3' HG11 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -49.24 109.62 1.28 Allowed Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 127.896 2.478 . . . . 0.0 108.318 176.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -83.04 137.37 8.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.181 1.92 . . . . 0.0 109.159 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.3 tt -58.92 133.99 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.012 0.91 . . . . 0.0 110.947 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 t -73.68 167.84 20.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.387 1.475 . . . . 0.0 109.137 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -90.82 -20.75 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.44 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -133.75 -176.7 4.26 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -120.33 -49.51 2.27 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 110.64 -176.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.6 -5.69 24.98 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 46.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.666 2.386 . . . . 0.0 106.852 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.04 143.4 94.31 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 162.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.76 -16.31 13.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.207 1.938 . . . . 0.0 113.089 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.427 ' HB2' HG23 ' A' ' 7' ' ' VAL . 96.5 m-85 -149.51 155.88 41.08 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.903 -1.123 . . . . 0.0 109.72 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.64 114.3 17.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 126.265 1.826 . . . . 0.0 107.684 170.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.95 88.49 5.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 161.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.94 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -75.19 92.42 2.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 160.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.94 148.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -97.23 -167.69 1.58 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -144.74 136.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 164.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.55 -139.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.31 1.844 . . . . 0.0 106.95 167.389 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.567 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 20.1 t-20 -59.34 -54.11 50.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.712 -1.242 . . . . 0.0 109.398 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.27 11.42 0.71 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.296 1.039 . . . . 0.0 112.701 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.08 171.35 7.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.336 1.455 . . . . 0.0 108.543 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.13 -22.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 126.375 1.87 . . . . 0.0 112.664 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.4 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 54.15 -70.9 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.943 1.697 . . . . 0.0 112.052 -162.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -159.1 162.05 36.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.244 1.818 . . . . 0.0 109.25 -155.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mm -126.87 126.03 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -173.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -112.87 94.76 5.06 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 163.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -91.65 88.83 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -97.55 136.37 38.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.825 1.25 . . . . 0.0 109.655 -169.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -75.91 143.57 41.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.338 1.055 . . . . 0.0 108.235 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.59 116.46 60.93 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.118 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.92 -22.9 30.69 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.834 1.69 . . . . 0.0 112.312 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.85 39.86 3.86 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.534 1.134 . . . . 0.0 109.356 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 123.518 0.727 . . . . 0.0 110.693 -179.819 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.454 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 1.9 t -43.2 -54.06 9.98 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 120.8 1.636 . . . . 0.0 111.456 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 6.1 Cg_exo -76.1 -31.24 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.969 2.446 . . . . 0.0 111.497 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -62.65 -41.55 99.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.924 -0.56 . . . . 0.0 109.559 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.16 -66.28 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.758 0.823 . . . . 0.0 109.679 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 m -60.56 -6.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE3' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -97.83 -20.03 17.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.502 -1.374 . . . . 0.0 112.432 175.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -64.3 -25.22 67.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.976 0.807 . . . . 0.0 110.753 158.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 36.25 0.74 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.306 0.957 . . . . 0.0 110.716 -165.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.69 4.39 0.04 OUTLIER Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.446 2.45 . . . . 0.0 116.741 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.427 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.78 158.46 25.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.086 -1.832 . . . . 0.0 112.736 -158.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 86' ' ' VAL . 21.6 mt-10 -131.65 -20.35 2.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.745 0.818 . . . . 0.0 111.852 -165.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.541 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.2 tm? -134.36 152.84 52.04 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.671 0.607 . . . . 0.0 109.558 -174.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.83 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.1 t -148.49 139.0 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.479 HG21 HG13 ' A' ' 99' ' ' VAL . 71.4 mt -130.55 111.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -131.05 -178.5 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.698 1.199 . . . . 0.0 111.685 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.31 -100.48 0.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.53 55.63 3.48 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 125.962 1.744 . . . . 0.0 112.503 -169.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.47 167.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 O-C-N 121.681 -0.893 . . . . 0.0 109.231 169.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.45 166.74 23.31 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.424 1.012 . . . . 0.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -36.31 46.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.302 1.441 . . . . 0.0 113.414 -166.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.82 -31.37 64.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.324 1.42 . . . . 0.0 112.449 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.18 -35.88 15.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.695 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -41.75 -54.29 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.981 1.264 . . . . 0.0 107.884 158.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.75 -14.21 42.04 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.52 -53.42 6.29 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.107 1.322 . . . . 0.0 110.566 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -57.78 -35.52 70.91 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.228 1.011 . . . . 0.0 110.807 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -49.76 -33.08 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.186 2.194 . . . . 0.0 114.043 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -18.94 64.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.172 0.896 . . . . 0.0 111.861 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.22 1.11 4.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.089 1.356 . . . . 0.0 113.551 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.05 39.16 97.23 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.052 -1.03 . . . . 0.0 112.246 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 66' ' ' GLU . 40.4 t -79.64 117.79 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -74.15 139.47 44.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.593 -0.692 . . . . 0.0 110.175 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.05 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.208 1.403 . . . . 0.0 109.295 -168.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.06 131.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -150.91 144.15 24.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.322 -0.861 . . . . 0.0 112.198 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.19 11.91 22.96 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.749 1.166 . . . . 0.0 112.073 -169.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.33 177.65 3.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.169 1.485 . . . . 0.0 110.043 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.2 p -162.2 156.72 22.11 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 119.806 1.184 . . . . 0.0 110.032 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.63 -153.26 21.95 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 121.643 0.579 . . . . 0.0 111.792 172.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.73 153.4 26.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.791 0.837 . . . . 0.0 111.154 -171.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 t -61.24 -45.56 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 122.932 0.493 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.83 -28.24 65.86 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.433 0.561 . . . . 0.0 111.939 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.28 -57.04 3.79 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 127.347 2.259 . . . . 0.0 109.008 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.479 HG13 HG21 ' A' ' 69' ' ' ILE . 25.6 t -52.95 -45.37 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.791 1.237 . . . . 0.0 110.72 -176.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.1 -50.38 79.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -55.88 -47.88 76.58 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.419 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -54.07 -38.2 65.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.123 1.329 . . . . 0.0 112.102 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -71.29 -51.29 25.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.506 0.723 . . . . 0.0 112.114 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.16 -38.92 68.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.5 m -78.98 -5.66 54.4 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.839 1.656 . . . . 0.0 112.025 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.8 4.28 82.61 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.848 1.214 . . . . 0.0 114.736 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -81.18 -35.16 31.76 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.765 1.283 . . . . 0.0 111.431 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.7 161.38 31.07 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.716 0.806 . . . . 0.0 110.845 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tptm . . . . . 0 C--O 1.232 0.173 0 C-N-CA 124.292 1.037 . . . . 0.0 109.821 -173.345 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ttp . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 mt -140.17 147.05 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.7 mt -132.56 103.1 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 127.38 2.272 . . . . 0.0 106.265 -162.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.977 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.09 154.42 28.1 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 119.61 -0.233 . . . . 0.0 110.845 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -146.18 115.89 4.7 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.22 123.4 9.91 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.497 2.131 . . . . 0.0 108.225 169.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 26' ' ' TYR . 17.5 m -119.81 157.93 21.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.448 0.567 . . . . 0.0 110.364 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.4 m -78.79 -27.84 44.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.078 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -148.75 148.94 30.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.111 0.869 . . . . 0.0 108.838 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -82.68 45.33 0.97 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.233 2.213 . . . . 0.0 112.987 -170.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -88.78 39.67 0.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.96 -1.713 . . . . 0.0 111.461 -167.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.51 -125.47 13.78 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.539 -1.35 . . . . 0.0 112.504 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -52.47 -45.82 66.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.648 1.579 . . . . 0.0 110.609 174.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -7.37 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.839 2.456 . . . . 0.0 111.834 -169.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -47.53 109.37 1.08 Allowed Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.151 1.78 . . . . 0.0 110.997 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.46 131.85 15.48 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.182 1.921 . . . . 0.0 109.975 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.94 142.93 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.488 1.115 . . . . 0.0 109.762 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.06 173.7 8.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.897 1.279 . . . . 0.0 108.735 174.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.34 -48.3 8.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 122.4 1.095 . . . . 0.0 109.196 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -86.88 166.39 15.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.486 -171.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -119.38 -52.27 2.27 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 123.862 0.865 . . . . 0.0 109.959 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -17.4 49.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.044 -0.864 . . . . 0.0 113.645 -172.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -139.2 39.3 2.1 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.283 1.833 . . . . 0.0 110.124 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.75 130.64 91.64 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 160.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.14 -17.87 35.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.445 1.43 . . . . 0.0 114.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.487 ' HB2' HG23 ' A' ' 7' ' ' VAL . 98.3 m-85 -146.69 156.34 43.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.516 1.126 . . . . 0.0 109.541 -171.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -134.18 106.42 7.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.039 1.736 . . . . 0.0 109.343 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.17 100.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.397 1.079 . . . . 0.0 108.662 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.977 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 4.5 m-85 -89.98 100.95 13.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 t -82.64 154.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 168.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 30.9 mtpt -102.67 -165.04 1.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.41 132.6 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 163.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.85 87.23 3.25 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 170.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 70.31 -75.01 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.125 1.37 . . . . 0.0 110.445 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -137.51 15.27 2.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.04 1.336 . . . . 0.0 112.197 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.34 174.79 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.981 1.313 . . . . 0.0 109.508 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.88 -22.87 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 121.217 1.826 . . . . 0.0 114.346 -166.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.76 -64.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.629 1.971 . . . . 0.0 115.084 -162.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.45 169.88 19.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.588 1.155 . . . . 0.0 108.823 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.2 mm -131.18 139.69 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 127.749 2.42 . . . . 0.0 105.32 -172.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.67 70.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.044 -1.035 . . . . 0.0 108.262 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.17 88.72 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 106.831 167.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.33 155.65 22.75 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.582 1.153 . . . . 0.0 108.25 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -82.34 166.34 19.56 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.994 -0.441 . . . . 0.0 109.991 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.9 110.77 37.83 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.203 173.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.44 -6.06 18.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.506 2.137 . . . . 0.0 113.275 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -134.99 38.17 3.0 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.06 0.944 . . . . 0.0 109.504 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 119.04 0.836 . . . . 0.0 110.475 -172.224 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.52 -53.09 38.63 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 119.467 1.03 . . . . 0.0 108.301 168.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.99 -28.19 24.44 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.571 1.514 . . . . 0.0 111.88 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.14 -42.69 99.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.05 1.295 . . . . 0.0 108.984 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.496 ' CZ ' ' HE2' ' A' ' 63' ' ' LYS . 4.6 t80 -53.39 -63.05 1.27 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.256 0.622 . . . . 0.0 110.256 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 m -61.91 -30.65 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.276 -0.89 . . . . 0.0 113.154 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -65.13 -17.52 64.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -30.88 66.31 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.089 165.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.496 ' HE2' ' CZ ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -86.27 37.32 0.72 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.912 1.687 . . . . 0.0 113.378 -167.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 36.6 42.36 0.66 Allowed Glycine 0 CA--C 1.541 1.683 0 C-N-CA 127.694 2.569 . . . . 0.0 117.208 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.79 168.9 4.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.63 1.715 . . . . 0.0 113.789 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -139.73 -25.98 0.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.031 1.732 . . . . 0.0 111.046 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 tp -142.53 150.22 40.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.379 0.99 . . . . 0.0 110.603 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' A' ' 4' ' ' ALA . 9.4 t -147.71 123.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.48 HG21 ' CG1' ' A' ' 99' ' ' VAL . 87.9 mt -111.54 112.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.61 -177.1 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.76 1.224 . . . . 0.0 110.272 -172.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -112.14 -87.08 0.55 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.428 -0.795 . . . . 0.0 108.919 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.51 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 124.365 0.983 . . . . 0.0 113.65 -167.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.483 HG12 ' H ' ' A' ' 74' ' ' GLY 0.257 4.6 tt 43.56 -153.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 126.876 2.07 . . . . 0.0 112.883 -176.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -168.66 156.55 28.04 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.606 2.527 . . . . 0.0 109.329 176.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -38.38 70.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.511 1.155 . . . . 0.0 111.547 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -55.69 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 175.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.44 12.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.261 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.63 -48.1 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 165.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.02 50.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.9 -51.06 17.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.265 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.68 -36.59 76.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 126.149 1.779 . . . . 0.0 110.123 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -61.62 -17.02 53.51 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.133 -0.979 . . . . 0.0 113.589 170.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.78 -13.63 53.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.478 1.49 . . . . 0.0 111.821 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -125.64 12.25 7.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.642 1.977 . . . . 0.0 110.854 -172.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 15.02 58.45 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 123.658 0.647 . . . . 0.0 112.924 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.406 ' CG1' HG23 ' A' ' 68' ' ' VAL . 55.9 t -79.26 113.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -67.85 147.71 52.16 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.31 108.45 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.106 0.962 . . . . 0.0 109.774 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.4 128.41 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 128.511 2.724 . . . . 0.0 106.868 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -108.21 179.54 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 108.812 169.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.72 8.08 87.28 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 115.079 0.791 . . . . 0.0 115.079 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 -176.73 1.58 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.544 1.172 . . . . 0.0 110.65 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.5 t -163.33 168.31 20.64 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 128.362 2.665 . . . . 0.0 106.588 164.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.82 -170.83 21.27 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 118.023 0.374 . . . . 0.0 113.804 168.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.5 p -79.52 163.0 25.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.453 -1.028 . . . . 0.0 111.337 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.09 -55.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.374 1.07 . . . . 0.0 110.164 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.19 -20.79 66.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.81 -54.07 4.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.871 1.668 . . . . 0.0 107.207 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 69' ' ' ILE . 54.3 t -52.49 -46.37 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.216 1.806 . . . . 0.0 110.886 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.38 -53.28 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -62.44 -37.68 86.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.15 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -59.88 -46.79 88.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.042 1.292 . . . . 0.0 110.259 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -61.28 -53.93 50.45 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -56.23 -31.3 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.609 0.64 . . . . 0.0 110.426 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.3 m -76.08 -22.31 55.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 112.726 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.23 8.99 58.43 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.408 1.004 . . . . 0.0 113.236 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -80.92 -22.6 39.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.426 1.613 . . . . 0.0 112.067 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.91 145.18 27.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 109.202 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.553 0 C-N-CA 124.27 1.028 . . . . 0.0 109.065 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttm . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.28 138.91 52.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 mt -125.66 105.42 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 127.586 2.354 . . . . 0.0 106.27 -159.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -79.65 144.09 34.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.365 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.9 mt -143.18 116.4 6.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 171.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.13 119.43 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 15' ' ' SER . 6.9 m -110.62 141.91 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.789 1.177 . . . . 0.0 110.21 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -69.28 -21.85 63.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 117.442 -1.266 . . . . 0.0 112.849 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -148.0 156.72 42.96 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 38.7 t-20 -90.42 97.75 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -132.24 38.21 3.5 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.25 -109.24 1.09 Allowed Glycine 0 C--N 1.342 0.891 0 C-N-CA 124.022 0.82 . . . . 0.0 112.487 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -80.62 -41.17 24.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.764 1.626 . . . . 0.0 109.603 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.27 -16.05 59.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.061 1.744 . . . . 0.0 112.408 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HG11 ' A' ' 7' ' ' VAL . 22.0 m -39.26 104.56 0.32 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.685 2.794 . . . . 0.0 112.416 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.37 135.94 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.056 1.837 . . . . 0.0 109.328 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -61.77 148.2 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.612 0.72 . . . . 0.0 110.338 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -78.47 178.35 7.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.905 2.482 . . . . 0.0 110.054 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -108.21 -30.22 8.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.816 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -133.88 90.59 2.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.694 1.134 . . . . 0.0 110.645 -164.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -43.32 -42.69 4.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.649 1.18 . . . . 0.0 112.986 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -1.53 40.02 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.023 -1.431 . . . . 0.0 115.925 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.45 46.86 1.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.442 1.621 . . . . 0.0 108.775 166.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 133.26 88.77 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 116.618 -1.658 . . . . 0.0 109.38 172.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -73.22 -22.55 18.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.756 2.304 . . . . 0.0 113.575 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 99.0 m-85 -147.1 154.04 40.66 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.022 0.929 . . . . 0.0 109.459 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.67 104.16 7.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 91.8 5.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.252 1.821 . . . . 0.0 108.913 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.907 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.6 m-85 -84.71 96.35 9.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.22 160.78 4.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -110.99 -170.08 1.57 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 119.993 -1.692 . . . . 0.0 108.798 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.1 144.24 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 162.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.691 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -80.05 -138.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.357 2.263 . . . . 0.0 105.598 167.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.691 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 21.4 t-20 -59.28 -62.63 1.74 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.471 1.908 . . . . 0.0 109.644 174.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -142.09 20.03 2.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.839 1.256 . . . . 0.0 111.678 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.91 161.71 26.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.117 1.367 . . . . 0.0 109.71 -170.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.75 -23.84 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.368 1.894 . . . . 0.0 112.608 -165.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.73 -65.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.032 2.133 . . . . 0.0 114.208 -166.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.24 165.88 21.53 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.069 0.948 . . . . 0.0 111.682 -165.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 152.07 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 127.229 2.212 . . . . 0.0 107.716 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.64 73.04 1.3 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.67 1.588 . . . . 0.0 109.467 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.256 8.3 p -90.63 84.77 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -96.66 154.46 17.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.707 1.203 . . . . 0.0 108.334 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.69 148.81 42.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.416 1.487 . . . . 0.0 110.564 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -92.19 115.08 64.05 Favored Pre-proline 0 CA--C 1.516 -0.345 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.806 -173.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 -21.97 53.59 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.989 1.793 . . . . 0.0 112.557 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -123.66 38.63 4.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.3 1.409 . . . . 0.0 111.049 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.339 0 CA-C-N 119.513 1.051 . . . . 0.0 110.693 175.208 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.8 -53.5 12.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.656 1.982 . . . . 0.0 109.501 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.456 ' HA ' HG22 ' A' ' 60' ' ' VAL . 56.3 Cg_endo -76.31 -30.73 5.14 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 120.581 1.243 . . . . 0.0 111.04 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.0 -24.97 67.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.06 0.544 . . . . 0.0 110.348 -177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -69.12 -73.2 0.16 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 124.472 1.109 . . . . 0.0 109.502 162.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.2 m -59.38 -28.76 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -58.82 -42.63 89.63 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.076 1.307 . . . . 0.0 108.836 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -17.86 54.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.761 0.824 . . . . 0.0 112.479 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -86.58 37.17 0.73 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.747 0.703 . . . . 0.0 109.853 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 29.27 44.27 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 128.688 3.042 . . . . 0.0 114.832 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.73 174.37 8.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.012 1.406 . . . . 0.0 113.635 -172.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -145.13 -28.09 0.46 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.024 0.93 . . . . 0.0 112.194 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.0 tm? -142.05 157.9 44.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.859 -173.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.008 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -150.77 143.6 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.811 1.644 . . . . 0.0 106.999 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.569 HG21 HG13 ' A' ' 99' ' ' VAL . 61.8 mt -131.59 113.38 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.61 -177.23 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.748 1.219 . . . . 0.0 110.418 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -104.05 -100.5 0.31 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 117.515 -1.231 . . . . 0.0 107.808 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.8 -18.27 32.83 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 120.355 1.434 . . . . 0.0 114.849 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.467 HG12 ' H ' ' A' ' 74' ' ' GLY 0.309 4.9 tt 41.22 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 126.98 2.112 . . . . 0.0 112.786 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -152.91 -138.74 2.76 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.977 2.227 . . . . 0.0 109.822 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.62 -31.6 4.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.748 1.274 . . . . 0.0 111.18 163.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -36.84 68.08 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.345 -1.472 . . . . 0.0 113.135 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 -31.71 43.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.219 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.23 -47.92 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.55 -12.74 34.97 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.07 -58.9 3.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.796 1.18 . . . . 0.0 109.403 172.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -58.49 -42.31 87.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.06 -20.87 66.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.53 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.43 -9.1 58.27 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.808 1.185 . . . . 0.0 112.222 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.49 -5.69 6.48 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.054 0.942 . . . . 0.0 112.434 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.39 28.87 69.0 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 119.589 1.086 . . . . 0.0 111.228 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.42 115.47 20.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -72.65 139.05 47.09 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.453 -0.779 . . . . 0.0 109.216 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.16 92.94 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 122.612 1.196 . . . . 0.0 109.637 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.9 147.48 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.173 1.789 . . . . 0.0 107.537 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -155.34 173.02 17.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.15 0.98 . . . . 0.0 109.38 -160.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.21 18.61 60.75 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.435 -0.647 . . . . 0.0 112.715 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.32 178.68 7.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.28 1.032 . . . . 0.0 109.784 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -158.27 160.4 37.03 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 106.05 -1.834 . . . . 0.0 106.05 160.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.37 -162.41 25.39 Favored Glycine 0 N--CA 1.463 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 112.665 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 p -84.93 165.33 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.65 -0.912 . . . . 0.0 109.134 165.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.2 t -53.74 -54.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.94 -22.52 62.57 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -89.63 -52.47 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.825 1.65 . . . . 0.0 107.658 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.569 HG13 HG21 ' A' ' 69' ' ' ILE . 43.0 t -55.16 -35.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 111.552 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.29 -53.99 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -54.91 -43.01 72.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.134 0.574 . . . . 0.0 111.214 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -58.86 -41.8 87.87 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.854 0.835 . . . . 0.0 111.005 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -72.5 -43.63 63.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.376 1.071 . . . . 0.0 111.778 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.26 -29.87 67.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.972 0.806 . . . . 0.0 110.601 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 m -78.33 -2.96 40.66 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.844 1.258 . . . . 0.0 113.138 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.68 20.65 68.39 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.534 1.061 . . . . 0.0 113.205 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -81.16 -56.18 4.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.344 1.072 . . . . 0.0 108.952 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.02 146.63 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 110.806 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 tptt . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 122.489 1.137 . . . . 0.0 112.379 -175.803 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.443 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.7 ttt . . . . . 0 C--O 1.235 0.342 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.409 HG12 ' HE3' ' A' ' 31' ' ' LYS . 3.9 mt -137.35 148.38 26.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 69' ' ' ILE . 13.8 mt -128.79 106.62 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 129.373 3.069 . . . . 0.0 105.561 -170.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.822 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.66 150.2 26.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.378 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.06 118.67 10.23 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.72 116.54 4.29 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 107.221 -1.876 . . . . 0.0 107.221 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 15' ' ' SER . 3.0 m -116.79 157.08 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.699 0.799 . . . . 0.0 110.488 -174.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 p -72.6 -35.45 67.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -142.2 156.44 45.33 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 120.355 1.434 . . . . 0.0 109.049 -167.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.52 88.88 6.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -132.41 38.41 3.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 109.719 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.26 -105.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 127.438 2.447 . . . . 0.0 111.25 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -79.92 -37.21 35.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.24 1.016 . . . . 0.0 110.216 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.66 -18.58 64.99 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.348 1.859 . . . . 0.0 112.175 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.584 ' HB3' HG11 ' A' ' 7' ' ' VAL . 3.7 m -37.97 105.06 0.31 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.42 2.288 . . . . 0.0 111.894 -175.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -68.87 132.64 25.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.578 1.519 . . . . 0.0 110.615 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.4 tt -62.13 142.0 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 119.781 -1.825 . . . . 0.0 110.67 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -81.03 -173.79 4.49 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.245 1.418 . . . . 0.0 108.977 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -109.12 -45.03 3.83 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.045 -1.034 . . . . 0.0 111.608 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -120.41 100.68 7.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.017 1.327 . . . . 0.0 107.851 -163.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -42.47 -45.35 4.4 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.141 1.376 . . . . 0.0 112.16 171.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.81 -20.2 59.46 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 117.888 -1.507 . . . . 0.0 114.303 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.32 38.91 3.58 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.415 1.608 . . . . 0.0 109.495 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.06 130.58 93.81 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.598 -1.192 . . . . 0.0 107.845 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.72 -20.74 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.605 2.203 . . . . 0.0 113.127 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -148.03 160.99 42.27 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.41 1.484 . . . . 0.0 108.378 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -126.94 112.11 14.9 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.68 88.41 7.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -78.12 98.6 5.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 108.179 169.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.42 136.82 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.465 1.106 . . . . 0.0 108.055 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HE3' HG12 ' A' ' 2' ' ' ILE . 9.6 mtpt -80.45 -164.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.13 -0.982 . . . . 0.0 109.549 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -156.25 147.86 11.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -146.06 122.08 10.72 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 53.96 34.46 19.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.079 0.952 . . . . 0.0 112.541 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 73.7 12.85 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.325 2.65 . . . . 0.0 114.337 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.06 172.49 7.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.0 108.402 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.85 -27.23 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 125.15 1.38 . . . . 0.0 112.436 -159.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.99 -67.42 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 C-N-CA 127.156 2.183 . . . . 0.0 112.753 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -164.86 157.17 16.02 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.751 -0.593 . . . . 0.0 112.011 -164.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.32 131.4 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.171 1.788 . . . . 0.0 106.848 -172.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.0 m -129.4 117.94 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 107.153 166.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 t -131.39 79.45 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -82.02 168.81 17.43 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -105.97 132.52 51.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 107.68 -168.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -79.59 123.73 84.04 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.591 -150.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.35 -10.77 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.427 2.752 . . . . 0.0 114.982 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.35 38.84 2.28 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.147 1.779 . . . . 0.0 109.895 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 O-C-N 120.599 -1.313 . . . . 0.0 112.429 -178.008 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -43.45 -52.02 14.1 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 121.404 1.911 . . . . 0.0 111.314 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.86 -27.39 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.277 1.985 . . . . 0.0 111.761 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.38 -41.79 90.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.729 1.149 . . . . 0.0 109.889 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.17 -68.15 0.2 Allowed 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 123.683 0.793 . . . . 0.0 109.654 167.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 m -64.47 -12.1 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -72.71 -22.26 60.92 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.59 1.156 . . . . 0.0 111.553 170.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.55 -12.95 50.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.838 0.745 . . . . 0.0 112.044 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -93.1 37.02 1.03 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.173 -0.954 . . . . 0.0 111.18 -164.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.28 18.27 34.95 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.796 1.188 . . . . 0.0 113.835 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -64.39 158.75 22.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.929 1.365 . . . . 0.0 112.422 -171.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 6.5 mt-10 -137.77 -19.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.327 1.451 . . . . 0.0 110.893 172.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.65 159.24 42.62 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.315 1.846 . . . . 0.0 109.042 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.571 HG12 HG13 ' A' ' 70' ' ' VAL . 3.5 t -137.62 139.82 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 158.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.523 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.5 mt -112.74 117.85 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.571 HG13 HG12 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -134.81 138.85 48.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 O-C-N 121.773 -0.58 . . . . 0.0 110.974 -164.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -77.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.598 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.87 -36.69 1.22 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.577 1.081 . . . . 0.0 115.459 -170.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.563 HD12 HG11 ' A' ' 70' ' ' VAL 0.252 6.2 tt 44.5 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 128.828 2.851 . . . . 0.0 113.971 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.85 169.67 40.61 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.296 1.903 . . . . 0.0 110.759 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -48.45 64.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.401 1.481 . . . . 0.0 114.007 -161.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.67 -24.03 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.02 -31.12 13.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.518 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mm -52.49 -46.95 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.25 54.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.62 -50.06 14.73 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.066 1.303 . . . . 0.0 111.279 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.447 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -38.09 -56.19 1.19 Allowed 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.806 1.643 . . . . 0.0 109.831 161.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -12.24 61.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 124.609 1.193 . . . . 0.0 112.081 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.8 -18.29 48.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.251 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.59 13.32 3.75 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.293 0.951 . . . . 0.0 113.3 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.98 27.54 59.76 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 121.347 -0.845 . . . . 0.0 111.847 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 2.1 t -79.67 110.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -170.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -57.16 151.85 14.73 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.863 0.465 . . . . 0.0 110.095 -168.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 90' ' ' LYS . 3.4 t -128.78 89.59 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-O 121.447 0.641 . . . . 0.0 110.543 -174.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . 0.258 36.7 mt -76.52 85.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 123.365 1.555 . . . . 0.0 109.591 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HG3' HG12 ' A' ' 88' ' ' VAL . 21.1 mtpt -80.75 142.01 34.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.896 2.079 . . . . 0.0 112.148 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.9 22.15 7.77 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.873 1.225 . . . . 0.0 112.484 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.78 165.98 24.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.567 1.683 . . . . 0.0 112.058 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -151.66 165.25 34.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.924 2.89 . . . . 0.0 105.136 158.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 125.36 175.45 14.22 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.953 0.797 . . . . 0.0 113.487 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 p -79.83 156.35 27.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.4 ' CG2' HG11 ' A' ' 7' ' ' VAL . 60.9 t -54.99 -47.87 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -54.69 -29.73 53.72 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.49 -45.84 8.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.651 1.981 . . . . 0.0 110.389 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' A' ' 69' ' ' ILE . 56.3 t -50.65 -45.69 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.977 1.311 . . . . 0.0 109.822 172.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.32 -48.39 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.756 0.822 . . . . 0.0 108.918 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.892 0.769 . . . . 0.0 111.188 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -54.9 -42.61 72.37 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.895 0.878 . . . . 0.0 110.272 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -69.48 -49.39 55.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.646 0.778 . . . . 0.0 113.067 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.71 -21.69 66.08 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.252 0.478 . . . . 0.0 111.121 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -81.25 -30.43 34.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.197 0.599 . . . . 0.0 109.72 171.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.37 2.0 17.98 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.48 1.514 . . . . 0.0 113.945 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -82.84 -30.31 28.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.83 0.815 . . . . 0.0 110.401 -165.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.94 136.74 45.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.823 1.249 . . . . 0.0 109.886 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 125.464 1.506 . . . . 0.0 112.279 -166.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.405 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 58.3 ttm . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.421 HG22 ' CD1' ' A' ' 29' ' ' PHE . 4.3 mt -131.59 143.67 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 172.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.474 HG12 HD12 ' A' ' 67' ' ' LEU . 46.2 mt -128.78 100.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 127.395 2.278 . . . . 0.0 106.844 -166.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 1.013 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -81.81 127.21 32.74 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.784 0.434 . . . . 0.0 110.71 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 96' ' ' VAL . 97.0 mt -130.24 116.82 17.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.83 127.01 9.82 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.262 1.975 . . . . 0.0 107.745 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 m -127.74 148.08 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.7 m -76.25 -22.01 55.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.526 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.48 171.75 13.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.218 1.407 . . . . 0.0 108.056 -173.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -113.69 40.4 2.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.818 1.647 . . . . 0.0 113.412 -165.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -86.0 39.01 0.79 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.982 0.513 . . . . 0.0 111.026 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.86 -95.82 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.954 2.216 . . . . 0.0 113.694 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -41.37 22.31 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.527 1.164 . . . . 0.0 112.315 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.56 -3.25 14.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.39 1.476 . . . . 0.0 111.205 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -49.68 117.63 7.43 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.603 1.961 . . . . 0.0 110.57 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.2 135.69 11.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.741 2.294 . . . . 0.0 111.655 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.59 129.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.485 0.659 . . . . 0.0 111.118 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.81 164.29 15.29 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.16 1.784 . . . . 0.0 108.979 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.37 -52.99 5.76 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 121.075 -1.016 . . . . 0.0 110.488 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -97.39 94.99 7.37 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -161.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -42.91 -52.41 5.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.586 0.63 . . . . 0.0 111.573 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.58 9.91 40.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.577 -176.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 -149.1 56.11 1.0 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.4 137.81 20.04 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.12 -20.25 19.29 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.939 1.759 . . . . 0.0 113.294 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -149.58 165.05 33.43 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.604 1.093 . . . . 0.0 109.558 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.02 106.76 8.23 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.368 1.467 . . . . 0.0 108.65 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 88.83 5.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 1.013 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -80.54 91.85 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.183 1.393 . . . . 0.0 108.298 166.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.49 155.5 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -99.69 -170.68 1.93 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.907 -1.121 . . . . 0.0 109.242 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 t -146.59 146.93 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 114.86 8.14 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 127.844 2.458 . . . . 0.0 105.311 169.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 m120 43.4 60.46 2.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.472 1.109 . . . . 0.0 111.03 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 64.95 6.25 3.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.465 1.906 . . . . 0.0 115.171 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.36 173.78 6.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.863 1.665 . . . . 0.0 108.879 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.1 -23.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 124.884 1.273 . . . . 0.0 113.597 -164.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.82 -77.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.715 1.206 . . . . 0.0 111.903 -155.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.54 172.17 19.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.881 2.072 . . . . 0.0 110.23 -161.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 mm -126.21 141.11 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 m -138.44 121.02 16.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.954 2.102 . . . . 0.0 106.296 166.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -137.02 79.14 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -88.28 158.21 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.41 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.88 162.7 15.79 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 167.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -100.17 99.84 10.38 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.46 -0.781 . . . . 0.0 108.926 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.91 -11.02 29.08 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.646 2.231 . . . . 0.0 114.444 -170.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.56 38.57 4.13 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.787 -1.196 . . . . 0.0 110.489 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 124.592 1.157 . . . . 0.0 110.477 168.624 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 116.72 -1.61 . . . . 0.0 114.906 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -46.51 -48.52 47.37 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 121.672 2.033 . . . . 0.0 110.989 161.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 60' ' ' VAL . 4.1 Cg_endo -67.17 -18.26 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 120.52 1.222 . . . . 0.0 113.081 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -68.34 -26.97 65.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.828 0.74 . . . . 0.0 111.15 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.01 -69.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.278 1.031 . . . . 0.0 108.849 165.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 57' ' ' PRO . 3.2 m -62.02 -29.02 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -166.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -63.87 -35.99 82.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.292 1.405 . . . . 0.0 110.729 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -15.54 62.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.27 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -86.05 37.07 0.7 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.191 1.36 . . . . 0.0 110.856 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.46 25.72 4.64 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.841 2.163 . . . . 0.0 116.957 165.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -72.22 173.78 8.13 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -164.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 19.9 mt-10 -142.4 -33.62 0.47 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.768 1.627 . . . . 0.0 111.657 -178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.5 tm? -138.14 156.19 47.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.461 1.104 . . . . 0.0 109.065 -173.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.782 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -148.7 144.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.714 1.205 . . . . 0.0 108.587 -177.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.423 HG21 HG13 ' A' ' 99' ' ' VAL . 52.1 mt -137.45 115.48 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.425 HG21 ' HB ' ' A' ' 73' ' ' ILE . 30.2 m -131.96 177.14 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.116 0.966 . . . . 0.0 109.923 -173.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.6 -80.45 0.39 Allowed 'General case' 0 C--O 1.226 -0.135 0 O-C-N 120.888 -1.133 . . . . 0.0 108.046 167.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.77 -19.01 8.47 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -164.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.425 ' HB ' HG21 ' A' ' 70' ' ' VAL 0.289 5.5 tt 35.84 -126.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 127.517 2.327 . . . . 0.0 113.708 175.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.82 140.68 3.1 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.306 1.908 . . . . 0.0 109.461 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -48.51 -44.09 35.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 116.987 -1.482 . . . . 0.0 113.44 -166.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -31.18 55.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.756 1.616 . . . . 0.0 112.463 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.57 -25.57 22.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.712 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.93 -51.69 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 167.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.42 -26.63 13.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.557 1.543 . . . . 0.0 113.132 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.52 -57.15 4.38 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.649 0.659 . . . . 0.0 111.454 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -59.17 -34.6 72.3 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.003 1.321 . . . . 0.0 110.985 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -54.62 -32.5 59.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.949 0.899 . . . . 0.0 111.793 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.4 -10.65 59.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.77 0.714 . . . . 0.0 112.452 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 ptm -124.4 10.2 8.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.508 1.523 . . . . 0.0 111.026 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.05 21.94 64.31 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 118.584 0.629 . . . . 0.0 112.182 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -80.83 119.66 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.06 146.56 49.23 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 119.123 -0.465 . . . . 0.0 110.308 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 t -133.71 107.93 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.808 1.186 . . . . 0.0 111.545 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -96.52 147.76 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.871 1.668 . . . . 0.0 108.608 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -172.6 2.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.072 1.349 . . . . 0.0 110.316 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.25 9.87 73.24 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 163.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -167.87 2.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.793 1.796 . . . . 0.0 111.442 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.32 159.01 14.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.492 1.917 . . . . 0.0 106.845 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 117.24 -169.67 13.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 112.618 170.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 p -79.89 167.85 20.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 5' ' ' ILE . 86.0 t -56.96 -54.03 35.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 123.718 0.807 . . . . 0.0 110.289 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -50.96 -40.81 58.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 -175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.85 -49.9 13.35 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.13 1.772 . . . . 0.0 109.307 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG13 HG21 ' A' ' 69' ' ' ILE . 24.3 t -50.44 -32.61 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.57 1.148 . . . . 0.0 110.867 173.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.2 t -82.98 -41.36 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -52.42 -48.89 65.48 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -58.71 -41.96 87.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.399 0.679 . . . . 0.0 111.693 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -65.37 -51.66 58.93 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.516 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -60.74 -26.71 67.39 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.944 0.778 . . . . 0.0 111.01 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.95 0.47 56.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 110.977 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.12 6.51 88.07 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 120.835 -1.165 . . . . 0.0 113.347 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -72.3 -48.71 40.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.77 1.285 . . . . 0.0 109.425 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 tp -81.52 134.69 35.55 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.11 1.364 . . . . 0.0 109.491 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 tptm . . . . . 0 C--N 1.33 -0.259 0 C-N-CA 124.453 1.101 . . . . 0.0 111.086 -176.778 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.513 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 24.2 ttm . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.969 0.89 . . . . 0.0 112.07 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.417 HG12 ' HE3' ' A' ' 31' ' ' LYS . 2.7 mt -140.3 144.0 28.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.18 104.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.346 2.658 . . . . 0.0 105.981 -163.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.957 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -82.16 143.95 31.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.108 0.163 . . . . 0.0 111.091 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 mt -145.38 106.77 4.41 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.61 117.84 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.351 2.034 . . . . 0.0 107.929 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.428 HG11 ' CB ' ' A' ' 15' ' ' SER . 1.5 m -112.18 159.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.719 1.608 . . . . 0.0 109.439 -174.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -85.25 -11.55 54.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 117.548 -1.215 . . . . 0.0 112.389 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -150.88 170.16 19.96 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.701 1.201 . . . . 0.0 108.296 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -98.77 103.1 15.02 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -137.76 38.57 2.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.378 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.09 -123.78 2.68 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.695 -1.253 . . . . 0.0 111.516 -174.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -35.93 63.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.956 1.378 . . . . 0.0 113.7 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -6.27 50.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.531 1.133 . . . . 0.0 111.311 -175.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.428 ' CB ' HG11 ' A' ' 7' ' ' VAL . 37.9 m -52.6 111.33 2.49 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 120.302 1.41 . . . . 0.0 110.166 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -67.38 134.3 32.99 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.595 2.197 . . . . 0.0 108.541 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tt -64.75 142.82 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.161 0.437 . . . . 0.0 110.309 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -81.2 -173.79 4.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.826 0.85 . . . . 0.0 108.967 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.14 -46.97 6.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.469 1.128 . . . . 0.0 108.737 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -99.41 165.56 11.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.671 1.189 . . . . 0.0 109.436 -159.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -120.42 -49.41 2.26 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.264 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 16.72 5.06 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.177 0.894 . . . . 0.0 114.593 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.74 39.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 129.073 2.949 . . . . 0.0 107.863 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.48 150.88 82.72 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 170.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.63 -22.5 12.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.802 2.335 . . . . 0.0 114.359 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -145.84 172.28 13.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.431 1.892 . . . . 0.0 109.074 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -133.96 110.29 9.59 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.665 1.186 . . . . 0.0 108.034 162.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.72 101.75 8.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 165.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.927 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.3 m-85 -88.72 104.72 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.17 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HE3' HG12 ' A' ' 2' ' ' ILE . 14.5 mtpt -98.88 -165.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.006 -1.059 . . . . 0.0 108.637 172.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.12 147.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 162.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 123.08 15.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 161.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.94 20.5 11.58 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 t30 86.83 9.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.437 2.695 . . . . 0.0 112.27 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.59 170.22 8.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.54 -22.77 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.202 1.801 . . . . 0.0 112.304 -163.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 50.5 -72.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.48 1.912 . . . . 0.0 112.766 -160.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -157.06 156.45 32.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.135 0.574 . . . . 0.0 112.472 -166.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mm -121.68 127.81 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.141 1.777 . . . . 0.0 108.0 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 t -120.57 97.28 5.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.254 13.0 p -106.72 61.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 122.743 1.258 . . . . 0.0 108.636 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.6 149.62 31.28 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.48 163.34 16.09 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.0 115.63 60.89 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.85 -7.02 19.5 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.419 2.079 . . . . 0.0 112.515 -175.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mt -135.45 39.85 2.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.931 2.093 . . . . 0.0 107.687 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.372 0 O-C-N 120.857 -1.152 . . . . 0.0 111.605 -173.803 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.69 -49.18 27.56 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 126.131 1.772 . . . . 0.0 108.289 164.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.8 -25.0 17.4 Favored 'Trans proline' 0 C--N 1.359 1.096 0 CA-C-N 121.349 1.518 . . . . 0.0 111.367 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.457 ' HA ' ' HE3' ' A' ' 61' ' ' LYS . 10.2 t30 -71.36 -28.71 64.25 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 119.854 1.207 . . . . 0.0 111.237 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -60.85 -70.99 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 162.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -62.57 -21.9 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 58' ' ' ASN . 6.3 mtmp? -66.12 -22.9 66.41 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.555 -1.341 . . . . 0.0 112.746 170.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -26.33 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 120.267 1.394 . . . . 0.0 109.614 172.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -85.74 38.6 0.76 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.975 0.91 . . . . 0.0 111.118 -165.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.08 14.6 39.89 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.725 2.107 . . . . 0.0 116.017 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -69.32 167.64 16.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.242 1.521 . . . . 0.0 114.395 -160.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 32.3 mt-10 -142.68 -21.86 0.66 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.197 0.999 . . . . 0.0 112.486 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 68' ' ' VAL . 1.9 tm? -142.47 155.03 45.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.73 1.212 . . . . 0.0 107.853 -171.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.957 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -152.16 138.61 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 99' ' ' VAL . 9.0 mt -130.01 110.72 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.556 HG13 HG12 ' A' ' 68' ' ' VAL . 19.1 m -133.45 156.01 41.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.615 1.566 . . . . 0.0 108.931 -167.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -99.3 -52.4 3.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.199 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.97 -49.17 0.59 Allowed Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.542 1.068 . . . . 0.0 113.036 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.506 HG12 ' H ' ' A' ' 74' ' ' GLY 0.255 4.9 tt 41.42 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 127.077 2.151 . . . . 0.0 112.626 -173.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.74 158.18 21.69 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 127.153 2.311 . . . . 0.0 109.356 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -45.03 -40.0 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 128.793 2.837 . . . . 0.0 114.511 -168.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -58.81 -34.02 71.03 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.001 -1.062 . . . . 0.0 112.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.84 -31.58 22.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.312 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.8 -51.66 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 166.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 0.66 1.98 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.31 -51.95 5.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 119.983 -1.698 . . . . 0.0 111.736 163.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -60.9 -37.3 81.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.684 1.194 . . . . 0.0 110.02 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -63.06 -15.87 58.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.062 0.945 . . . . 0.0 112.675 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.32 -15.81 61.38 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.436 -1.415 . . . . 0.0 110.97 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.7 ptp -131.81 5.75 4.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.583 1.953 . . . . 0.0 112.519 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.34 41.62 55.21 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -79.1 119.64 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -66.47 136.73 56.12 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.453 -0.779 . . . . 0.0 109.09 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.82 110.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 67' ' ' LEU . 24.0 mt -93.69 116.42 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 127.927 2.491 . . . . 0.0 106.126 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -117.04 135.12 53.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.785 0.434 . . . . 0.0 111.335 -173.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.04 2.29 13.94 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.671 1.605 . . . . 0.0 114.603 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 -177.96 5.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.458 1.629 . . . . 0.0 111.128 -168.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.4 p -164.61 153.76 13.18 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.925 -1.109 . . . . 0.0 108.383 -172.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.28 -144.65 15.43 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 112.106 -0.397 . . . . 0.0 112.106 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.7 p -105.94 173.0 6.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.194 1.398 . . . . 0.0 109.629 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.11 -57.82 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.59 -35.11 76.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.733 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.29 -51.7 41.91 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.64 1.176 . . . . 0.0 108.136 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.469 ' CG1' HG21 ' A' ' 69' ' ' ILE . 65.2 t -63.31 -29.5 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.186 0.995 . . . . 0.0 111.739 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.4 t -68.85 -51.34 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -56.22 -43.2 78.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.041 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -57.18 -51.21 70.22 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.708 1.14 . . . . 0.0 109.868 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.87 -43.64 57.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.124 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.43 -31.72 68.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.51 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 m -78.24 -12.66 60.01 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 113.271 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.6 5.87 68.6 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.272 0.942 . . . . 0.0 113.594 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -70.41 -37.11 74.4 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.792 1.296 . . . . 0.0 110.676 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mt -82.56 165.77 19.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.022 1.329 . . . . 0.0 112.432 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 tptm . . . . . 0 C--N 1.345 0.412 0 C-N-CA 125.578 1.551 . . . . 0.0 111.91 175.705 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.1 ptm . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.441 HG22 ' CD1' ' A' ' 29' ' ' PHE . 4.7 mt -130.16 141.15 47.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 175.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.483 HG23 HD12 ' A' ' 69' ' ' ILE . 35.5 mt -125.14 100.58 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.764 2.826 . . . . 0.0 106.384 -161.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.887 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -83.86 145.61 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.856 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.37 126.68 21.41 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 166.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -75.43 110.2 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 N-CA-C 106.252 -2.249 . . . . 0.0 106.252 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.98 161.73 8.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 122.465 1.126 . . . . 0.0 110.99 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -93.24 -22.91 18.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.848 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.1 165.21 32.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.661 1.119 . . . . 0.0 108.797 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -92.44 77.3 5.09 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.245 1.018 . . . . 0.0 109.475 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -124.01 57.7 1.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.77 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -24.72 119.52 0.02 OUTLIER Glycine 0 N--CA 1.47 0.931 0 C-N-CA 126.064 1.792 . . . . 0.0 112.655 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt 80.14 -58.02 0.34 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.779 3.232 . . . . 0.0 110.909 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.38 -6.23 9.6 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.627 1.171 . . . . 0.0 113.105 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 m -47.92 102.84 0.33 Allowed Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 130.3 3.44 . . . . 0.0 110.379 -167.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.23 123.62 7.31 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.203 1.936 . . . . 0.0 110.677 -170.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.481 HG21 ' HA ' ' A' ' 93' ' ' SER . 13.3 tt -56.71 143.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 122.111 0.957 . . . . 0.0 109.406 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.08 168.77 9.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.79 1.236 . . . . 0.0 109.411 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.6 -40.49 18.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.779 -0.576 . . . . 0.0 111.899 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -101.05 172.51 6.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.765 1.226 . . . . 0.0 108.575 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -120.2 -51.79 2.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 173.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -7.05 7.57 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.132 171.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ttp-105 -144.32 39.43 1.3 Allowed 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 126.011 1.724 . . . . 0.0 109.625 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.91 123.95 87.46 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 163.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.95 -19.72 34.84 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 120.801 1.322 . . . . 0.0 112.669 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -148.04 161.49 41.28 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.153 0.888 . . . . 0.0 109.697 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -135.77 106.46 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 108.287 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.92 93.68 5.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.887 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -82.16 95.64 7.57 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 171.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -79.65 151.86 4.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE3' HG12 ' A' ' 2' ' ' ILE . 16.7 mtpt -103.72 -174.37 2.53 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.694 -1.254 . . . . 0.0 110.16 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.19 137.69 19.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.53 -0.731 . . . . 0.0 109.098 165.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 7.4 ttpt -142.68 125.97 16.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 53.06 39.61 29.8 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.836 0.744 . . . . 0.0 112.586 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.93 12.41 1.74 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.008 2.123 . . . . 0.0 114.487 -174.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.24 168.77 8.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.118 1.367 . . . . 0.0 108.223 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.42 -19.04 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.233 1.413 . . . . 0.0 112.076 -164.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.419 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 52.61 -66.71 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.16 2.184 . . . . 0.0 113.835 -167.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.79 178.72 9.5 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.977 1.311 . . . . 0.0 111.387 174.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.36 142.71 41.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.816 0.846 . . . . 0.0 108.798 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -113.18 88.92 2.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.875 2.47 . . . . 0.0 107.311 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.35 72.92 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 122.947 1.356 . . . . 0.0 107.626 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.67 151.0 22.72 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -73.77 150.74 40.91 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.099 1.359 . . . . 0.0 109.848 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -82.62 116.6 64.8 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.48 -8.8 24.14 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.722 2.281 . . . . 0.0 114.668 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.86 39.78 2.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.235 1.814 . . . . 0.0 109.464 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.382 0 O-C-N 119.655 -1.903 . . . . 0.0 111.934 -179.42 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -51.02 80.87 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 119.131 0.878 . . . . 0.0 109.775 170.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' HG22 ' A' ' 60' ' ' VAL . 17.9 Cg_endo -72.64 -28.54 14.03 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.426 2.084 . . . . 0.0 111.688 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.84 -45.26 70.85 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.277 0.631 . . . . 0.0 109.675 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -57.97 -68.23 0.27 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.706 0.803 . . . . 0.0 111.274 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 57' ' ' PRO . 7.6 m -61.41 -18.79 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 120.118 -1.614 . . . . 0.0 113.755 -171.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -68.68 -26.6 65.38 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.18 1.355 . . . . 0.0 111.766 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -23.32 62.91 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.809 1.186 . . . . 0.0 111.124 171.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -85.11 38.93 0.74 Allowed 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.949 -1.094 . . . . 0.0 111.408 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.53 28.32 4.84 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.891 2.186 . . . . 0.0 115.686 163.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -76.19 168.32 20.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.038 0.919 . . . . 0.0 113.054 -160.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 17.9 mt-10 -143.2 -33.35 0.44 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.323 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 87' ' ' LYS . 5.7 tp -126.1 152.66 45.58 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.203 0.91 . . . . 0.0 108.878 175.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.9 t -136.57 139.39 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 161.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.513 HG21 ' CG1' ' A' ' 99' ' ' VAL . 4.1 mt -115.66 121.79 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 172.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 73' ' ' ILE . 24.2 m -133.31 162.6 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.823 1.249 . . . . 0.0 109.892 -170.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -91.65 -75.05 0.49 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.67 -27.17 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.187 -1.341 . . . . 0.0 114.849 -171.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.533 HG12 ' H ' ' A' ' 74' ' ' GLY 0.265 4.5 tt 37.27 -143.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.392 2.277 . . . . 0.0 112.603 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.533 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.44 156.01 20.1 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 127.785 2.612 . . . . 0.0 109.875 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.29 82.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.205 1.002 . . . . 0.0 112.081 -172.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -32.99 60.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.521 175.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.98 -40.59 16.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.99 -1.481 . . . . 0.0 111.193 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -44.82 -46.84 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 119.589 1.086 . . . . 0.0 108.886 166.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.73 -11.73 13.46 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 119.861 -1.774 . . . . 0.0 114.951 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.48 -32.88 14.72 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.123 1.329 . . . . 0.0 113.459 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.482 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -46.64 -55.94 6.9 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.748 -1.22 . . . . 0.0 109.07 154.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -69.66 -3.17 13.98 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 124.577 1.173 . . . . 0.0 110.294 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -10.16 48.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 119.507 1.049 . . . . 0.0 110.853 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.2 5.69 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.29 33.55 84.85 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.856 0.753 . . . . 0.0 111.767 -168.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 4.9 t -80.41 96.86 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.14 -1.212 . . . . 0.0 110.606 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.585 ' HB3' HD12 ' A' ' 67' ' ' LEU . 5.9 tttp -49.92 145.79 5.23 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.727 1.611 . . . . 0.0 111.94 -169.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' CG2' ' CD2' ' A' ' 81' ' ' PHE . 1.2 t -125.89 107.55 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.082 0.468 . . . . 0.0 111.283 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.8 mt -93.05 99.47 9.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -83.69 165.82 18.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.195 0.521 . . . . 0.0 110.119 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.86 17.77 69.37 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-O 118.522 -1.155 . . . . 0.0 114.044 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.44 166.61 19.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.609 1.205 . . . . 0.0 110.106 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.481 ' HA ' HG21 ' A' ' 17' ' ' ILE . 5.5 p -152.64 159.04 43.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.87 1.668 . . . . 0.0 106.917 169.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 -175.62 15.82 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.349 0.976 . . . . 0.0 113.093 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.1 p -79.68 160.67 26.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.622 -0.928 . . . . 0.0 109.029 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -46.67 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -171.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -27.35 67.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.29 -60.98 2.15 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 69' ' ' ILE . 53.4 t -46.52 -56.06 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.306 1.443 . . . . 0.0 109.419 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.14 -52.87 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 125.334 1.454 . . . . 0.0 109.045 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -54.71 -42.84 71.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.893 0.77 . . . . 0.0 111.548 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -60.97 -44.54 97.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 112.285 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -63.79 -45.12 91.12 Favored 'General case' 0 CA--C 1.519 -0.219 0 O-C-N 121.333 -0.854 . . . . 0.0 113.273 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.5 -32.23 70.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.3 0.955 . . . . 0.0 110.498 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -74.79 -9.91 59.0 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.22 0.608 . . . . 0.0 111.707 174.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.98 3.84 87.48 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.386 1.469 . . . . 0.0 113.074 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -71.0 -50.49 33.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.743 1.772 . . . . 0.0 109.488 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.04 145.31 56.11 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.972 1.709 . . . . 0.0 110.618 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.446 ' HA ' ' OE2' ' A' ' 66' ' ' GLU . 3.8 ptp . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 mt -136.03 148.06 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.5 mt -125.65 109.75 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 129.049 2.94 . . . . 0.0 106.271 -168.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.892 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.27 148.15 28.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.288 169.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 87.4 mt -140.47 116.71 7.78 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 167.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.33 125.25 12.14 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.269 1.979 . . . . 0.0 108.496 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.578 HG23 ' HB2' ' A' ' 26' ' ' TYR . 13.5 m -121.51 157.9 24.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 119.247 0.931 . . . . 0.0 111.541 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -90.8 -20.74 22.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 116.69 -1.624 . . . . 0.0 113.325 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -147.99 150.01 33.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.199 1.399 . . . . 0.0 107.67 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -80.55 39.35 0.47 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.128 1.771 . . . . 0.0 113.694 -166.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 -82.87 39.83 0.65 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.561 -1.337 . . . . 0.0 112.94 -166.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.74 -137.27 35.91 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 120.44 1.473 . . . . 0.0 111.493 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -28.66 29.31 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -4.86 57.37 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 112.482 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.414 ' HB3' HG21 ' A' ' 7' ' ' VAL . 29.9 m -51.72 115.14 6.04 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.082 1.353 . . . . 0.0 111.681 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.19 134.96 18.12 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.629 2.219 . . . . 0.0 110.318 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.22 141.56 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.272 1.029 . . . . 0.0 110.819 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.15 156.56 17.26 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.784 1.233 . . . . 0.0 110.195 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -70.14 -39.98 75.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.857 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -133.58 117.2 16.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.677 2.035 . . . . 0.0 109.706 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -41.82 -53.75 3.61 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 112.42 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.69 63.57 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.645 -164.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.55 38.99 2.23 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 120.504 2.152 . . . . 0.0 108.161 162.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.81 125.95 91.57 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.516 ' HA ' HD22 ' A' ' 45' ' ' ASN . 30.2 Cg_endo -63.51 -16.42 54.52 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.281 1.321 . . . . 0.0 113.017 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.578 ' HB2' HG23 ' A' ' 7' ' ' VAL . 84.9 m-85 -150.39 149.03 29.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.283 1.033 . . . . 0.0 108.955 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.44 103.69 9.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.071 0.949 . . . . 0.0 108.643 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.82 106.8 13.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.892 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.7 m-85 -95.15 89.46 5.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.954 1.302 . . . . 0.0 107.532 171.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.69 147.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -89.2 -170.6 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.327 -0.858 . . . . 0.0 108.722 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 89.6 t -142.92 128.37 16.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 162.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 38' ' ' ALA . 7.1 ttpt -94.88 104.45 16.34 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.0 t30 59.25 -81.4 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.064 . . . . 0.0 110.533 -171.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -135.7 -0.27 2.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 130.449 3.5 . . . . 0.0 113.325 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' VAL . . . -111.9 -179.29 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.049 1.74 . . . . 0.0 108.953 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.31 -22.18 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 121.413 1.915 . . . . 0.0 113.946 -169.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 53.22 -74.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.247 1.385 . . . . 0.0 112.331 -160.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -163.36 153.34 15.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.323 1.049 . . . . 0.0 110.302 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.0 mm -78.39 155.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.081 1.353 . . . . 0.0 107.854 168.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -127.73 154.88 44.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 141.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 70.53 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 122.8 1.286 . . . . 0.0 108.546 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.0 131.59 35.83 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.085 1.354 . . . . 0.0 108.759 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.12 162.65 27.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.375 0.607 . . . . 0.0 111.616 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 39.7 p-10 -78.42 95.39 0.17 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 131.461 3.904 . . . . 0.0 114.733 -168.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.89 -25.18 23.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.385 1.39 . . . . 0.0 114.307 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.24 39.64 3.24 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.881 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . . . . . . . . 0 C--O 1.235 0.335 0 C-N-CA 125.007 1.323 . . . . 0.0 111.501 -171.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 118.145 -0.931 . . . . 0.0 113.489 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.469 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 2.0 t -57.45 -51.67 80.0 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 5.2 Cg_exo -65.69 -28.99 51.86 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.37 1.38 . . . . 0.0 112.416 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -32.54 74.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.584 1.084 . . . . 0.0 110.323 178.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -65.41 -61.99 1.79 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 57' ' ' PRO . 5.4 m -61.87 -23.92 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 120.383 1.447 . . . . 0.0 113.261 -174.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -21.14 63.87 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 120.848 -1.158 . . . . 0.0 112.809 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.18 -19.36 54.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 120.665 1.575 . . . . 0.0 111.537 170.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -85.07 37.9 0.69 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.16 21.14 5.36 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.601 2.524 . . . . 0.0 115.735 169.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -68.05 167.47 13.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.011 1.405 . . . . 0.0 114.548 -163.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.446 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 9.5 mt-10 -137.96 -31.13 0.78 Allowed 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.504 1.122 . . . . 0.0 111.902 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.63 152.77 51.96 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.623 1.169 . . . . 0.0 108.783 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.857 HG13 ' HB3' ' A' ' 4' ' ' ALA . 4.9 t -139.11 146.5 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 168.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.51 HG21 ' CG1' ' A' ' 99' ' ' VAL . 53.4 mt -131.65 118.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -134.61 169.49 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 111.356 -168.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -112.69 -42.34 3.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.501 -1.374 . . . . 0.0 113.439 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.93 42.48 0.78 Allowed Glycine 0 N--CA 1.469 0.836 0 C-N-CA 125.197 1.38 . . . . 0.0 111.648 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.2 tt -58.97 166.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.744 1.217 . . . . 0.0 111.087 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.58 161.51 13.25 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.679 1.133 . . . . 0.0 110.744 170.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -30.09 59.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.275 1.43 . . . . 0.0 113.486 -174.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -53.63 -43.45 68.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 111.127 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.98 29.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.235 -1.364 . . . . 0.0 112.047 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.07 -49.48 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 120.337 1.426 . . . . 0.0 107.328 164.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -13.64 50.61 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.46 -60.77 2.12 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 110.07 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.77 -38.73 72.88 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.8 2.04 . . . . 0.0 109.553 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.92 -19.76 53.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.542 0.737 . . . . 0.0 112.944 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.85 -12.58 61.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.025 -1.672 . . . . 0.0 112.491 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.81 7.29 6.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.638 1.175 . . . . 0.0 114.064 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.15 24.76 74.68 Favored Glycine 0 C--O 1.241 0.558 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.972 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.11 116.33 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -69.99 141.76 52.91 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.78 97.82 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.7 mt -75.64 144.85 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.636 1.174 . . . . 0.0 108.363 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -125.38 173.19 9.03 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.075 1.75 . . . . 0.0 109.054 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.37 57.78 16.95 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.899 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.14 165.53 12.81 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 124.368 0.687 . . . . 0.0 110.788 165.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.3 p -146.49 164.07 33.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.361 1.864 . . . . 0.0 108.436 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.38 -166.8 24.44 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 118.794 0.725 . . . . 0.0 113.486 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.4 p -85.18 165.7 17.19 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 121.547 -0.972 . . . . 0.0 111.7 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -50.41 -56.25 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 C-N-CA 124.523 1.129 . . . . 0.0 110.081 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -59.8 -27.46 66.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -82.83 -53.39 5.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.519 1.528 . . . . 0.0 107.893 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.51 ' CG1' HG21 ' A' ' 69' ' ' ILE . 53.0 t -52.84 -43.99 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.416 1.486 . . . . 0.0 110.145 177.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.07 -53.24 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.03 -39.66 90.63 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.301 -0.874 . . . . 0.0 111.91 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.46 -39.39 94.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.343 0.974 . . . . 0.0 110.645 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -64.32 -52.0 60.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.42 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -56.46 -36.03 68.6 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.006 0.922 . . . . 0.0 109.14 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.8 m -77.18 0.96 19.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.656 1.182 . . . . 0.0 112.697 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.5 9.91 84.59 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.894 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -80.0 -43.64 21.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 119.355 1.578 . . . . 0.0 109.84 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.32 141.38 48.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.175 0 C-N-CA 127.538 2.335 . . . . 0.0 108.198 177.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.566 0.209 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 29' ' ' PHE . 23.0 mt -109.34 151.36 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 160.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.81 108.48 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 C-N-CA 130.011 3.324 . . . . 0.0 105.16 -169.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.895 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.68 153.73 29.11 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.9 mt -146.4 113.93 4.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.58 124.95 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 N-CA-C 106.852 -2.018 . . . . 0.0 106.852 170.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.43 155.47 15.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 -19.84 30.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 -177.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -149.43 153.37 37.22 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 -177.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -93.7 64.22 3.48 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.956 0.884 . . . . 0.0 111.537 -169.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -106.48 42.03 1.34 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.598 -166.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 24.38 80.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.701 1.619 . . . . 0.0 115.481 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 80.67 -46.26 0.26 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.153 2.981 . . . . 0.0 112.604 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -0.06 0.63 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.015 0.825 . . . . 0.0 112.169 162.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -51.0 107.97 0.94 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.713 2.805 . . . . 0.0 111.769 169.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.94 130.62 5.77 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.996 2.464 . . . . 0.0 110.209 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.41 134.35 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.951 1.301 . . . . 0.0 112.052 -175.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -70.15 169.42 13.6 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.85 1.66 . . . . 0.0 109.274 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -92.48 -23.11 19.24 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.324 -0.86 . . . . 0.0 111.12 174.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -108.48 171.23 7.53 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -170.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -120.76 -57.57 1.88 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.35 -3.14 11.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.731 -169.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -143.49 38.51 1.38 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.415 1.607 . . . . 0.0 108.703 169.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.86 152.57 96.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.96 -20.73 7.33 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.779 2.319 . . . . 0.0 113.606 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -152.85 157.1 40.23 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.868 1.267 . . . . 0.0 109.489 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -123.07 108.36 12.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.036 1.334 . . . . 0.0 107.893 174.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.42 87.5 5.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 165.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.895 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.2 m-85 -70.86 142.9 51.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 157.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 16.2 mtpt -84.71 -168.48 2.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.102 0.865 . . . . 0.0 109.523 -179.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.63 143.12 26.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 162.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -139.45 133.91 31.61 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 127.428 2.291 . . . . 0.0 105.38 169.268 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 32.47 57.24 0.4 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.241 1.817 . . . . 0.0 112.702 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.53 12.98 5.83 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.982 2.513 . . . . 0.0 116.769 -178.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.03 -179.6 4.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.243 1.817 . . . . 0.0 109.586 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.33 -23.46 31.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 125.222 1.409 . . . . 0.0 113.611 -164.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.05 -74.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.105 1.32 . . . . 0.0 112.48 -160.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.17 160.25 39.71 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.533 1.933 . . . . 0.0 111.049 -160.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mm -124.87 134.62 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.507 1.923 . . . . 0.0 106.788 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 m -138.95 72.14 1.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.608 2.763 . . . . 0.0 106.941 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 2.2 t -77.22 97.75 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -96.27 159.84 14.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.886 173.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -57.41 163.51 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 110.848 167.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.33 95.93 3.28 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 159.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.51 3.46 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.217 2.612 . . . . 0.0 113.098 -176.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.26 39.11 2.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.016 1.326 . . . . 0.0 109.003 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.582 0 O-C-N 120.751 -1.218 . . . . 0.0 111.489 -171.508 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 118.318 -0.848 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.416 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 2.0 t -50.13 -52.69 51.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 119.521 1.055 . . . . 0.0 109.665 173.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 1.8 Cg_endo -71.05 -29.99 17.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.521 2.147 . . . . 0.0 111.974 178.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.4 -32.78 74.59 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.428 -0.795 . . . . 0.0 110.596 -177.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -58.66 -65.69 0.62 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 109.925 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.81 -27.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -171.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -63.83 -19.96 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.984 0.913 . . . . 0.0 112.65 173.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -20.68 44.91 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.084 0.856 . . . . 0.0 111.984 169.131 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -86.83 38.03 0.78 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.677 -1.264 . . . . 0.0 111.419 -170.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.27 19.83 8.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.329 1.919 . . . . 0.0 115.918 166.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.46 168.43 19.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.185 1.492 . . . . 0.0 113.278 -163.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -143.38 -27.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.442 1.097 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.734 HD12 ' H ' ' A' ' 68' ' ' VAL . 41.9 tp -135.88 158.64 43.9 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.963 0.801 . . . . 0.0 110.241 176.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.861 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -150.66 122.87 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -174.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.446 HG21 ' CG1' ' A' ' 99' ' ' VAL . 82.4 mt -114.59 107.67 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 108.628 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.43 176.07 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.729 2.012 . . . . 0.0 111.966 -174.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -96.5 -94.36 0.21 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 164.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.97 -40.52 8.03 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.588 -0.562 . . . . 0.0 114.072 -167.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.529 HG12 ' H ' ' A' ' 74' ' ' GLY 0.281 3.0 tt 44.55 -138.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.939 1.696 . . . . 0.0 112.537 -176.423 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.42 155.37 15.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 129.61 3.481 . . . . 0.0 109.219 174.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.56 -34.15 73.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.989 1.394 . . . . 0.0 111.785 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -55.56 -23.41 26.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 171.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.84 13.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.205 0.911 . . . . 0.0 110.857 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.73 -46.35 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 166.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.53 -31.91 25.92 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.533 1.533 . . . . 0.0 114.566 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.5 -55.27 5.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.02 0.827 . . . . 0.0 110.526 -177.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.425 ' CD1' HG11 ' A' ' 86' ' ' VAL . 53.7 m-85 -62.14 -31.45 71.93 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.436 1.094 . . . . 0.0 110.799 177.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -56.56 -32.58 65.31 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.196 -0.94 . . . . 0.0 112.302 170.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -18.69 61.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.713 0.688 . . . . 0.0 111.601 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.487 ' SD ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -113.75 6.04 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.404 1.482 . . . . 0.0 110.785 -178.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.81 23.67 69.33 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.941 -1.1 . . . . 0.0 111.982 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' A' ' 84' ' ' MET . 56.0 t -79.4 117.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.021 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -58.72 145.12 41.39 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.429 1.492 . . . . 0.0 109.38 174.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.05 128.3 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 109' ' ' LYS . 13.5 mt -115.16 131.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.325 2.65 . . . . 0.0 105.101 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.2 135.86 43.32 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.769 1.228 . . . . 0.0 108.775 -170.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.14 2.95 6.38 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.673 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.78 173.64 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.079 1.44 . . . . 0.0 111.13 -173.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 p -161.99 165.13 27.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.198 1.799 . . . . 0.0 106.65 156.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.62 -163.05 16.42 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 122.264 0.924 . . . . 0.0 112.601 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 162.92 24.78 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.212 -1.169 . . . . 0.0 111.098 -178.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -53.05 -49.74 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 123.007 0.523 . . . . 0.0 109.605 174.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -62.22 -26.67 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -80.65 -54.61 5.49 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 107.828 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.446 ' CG1' HG21 ' A' ' 69' ' ' ILE . 54.7 t -53.84 -45.5 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -178.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.04 -42.8 92.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -58.0 -50.85 72.0 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.284 174.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -57.09 -41.72 79.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.197 0.908 . . . . 0.0 110.772 -172.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.25 -53.73 22.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.246 1.019 . . . . 0.0 112.134 174.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.2 -26.75 68.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.613 0.642 . . . . 0.0 110.822 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -82.54 -3.28 55.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 174.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.07 15.18 75.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 118.126 -1.374 . . . . 0.0 113.691 168.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -87.1 -30.08 21.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.984 1.392 . . . . 0.0 111.613 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 tp -74.86 166.53 23.48 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.152 -0.342 . . . . 0.0 111.347 -163.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.656 0 C-N-CA 124.267 1.027 . . . . 0.0 111.748 -170.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.464 HG12 HD23 ' A' ' 67' ' ' LEU . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.804 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.531 HD21 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 45' ' ' ASN . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 60' ' ' VAL . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 3' ' ' ILE . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 4' ' ' ALA . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.553 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.482 HG21 ' HB ' ' A' ' 73' ' ' ILE . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' HG21 ' A' ' 70' ' ' VAL . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.553 ' CG1' HG21 ' A' ' 69' ' ' ILE . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.513 0.197 . . . . 0.0 110.841 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.412 HG22 ' CD1' ' A' ' 29' ' ' PHE . 7.2 mt -115.3 153.25 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 165.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 mt -134.51 105.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.132 2.173 . . . . 0.0 105.812 -164.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.924 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.52 145.59 31.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.191 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.483 HD12 HG13 ' A' ' 96' ' ' VAL . 51.3 mt -145.94 114.59 4.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.35 129.42 15.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.574 1.516 . . . . 0.0 108.372 171.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 15' ' ' SER . 4.9 m -122.88 150.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 118.739 0.7 . . . . 0.0 109.185 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -68.1 -27.06 66.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.318 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.59 156.1 39.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.648 1.579 . . . . 0.0 107.91 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -85.73 95.59 9.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -125.8 39.64 3.91 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 108.582 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.19 -127.88 29.94 Favored Glycine 0 C--N 1.34 0.76 0 O-C-N 120.775 -1.203 . . . . 0.0 111.434 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -58.4 -45.79 87.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.182 1.393 . . . . 0.0 111.665 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -1.87 4.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.774 2.43 . . . . 0.0 114.304 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.464 ' HB3' HG11 ' A' ' 7' ' ' VAL . 27.3 m -52.99 109.01 1.24 Allowed Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.975 174.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.92 135.47 14.11 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.357 1.371 . . . . 0.0 108.964 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.47 134.37 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.047 0.939 . . . . 0.0 111.245 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.38 169.9 12.5 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.876 1.27 . . . . 0.0 107.876 166.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -88.1 -55.32 3.8 Favored 'General case' 0 N--CA 1.438 -1.027 0 O-C-N 121.472 -0.768 . . . . 0.0 110.554 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.63 85.57 2.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 -152.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -37.49 -47.17 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.411 1.484 . . . . 0.0 112.908 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.42 -14.34 41.18 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 118.7 -1.055 . . . . 0.0 115.276 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.59 48.02 1.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.09 2.156 . . . . 0.0 108.74 173.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.65 137.77 54.77 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 167.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.74 -25.29 28.83 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.454 2.103 . . . . 0.0 114.494 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -146.27 158.17 43.86 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.29 103.9 8.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.51 1.524 . . . . 0.0 107.896 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.11 79.02 6.72 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.526 1.53 . . . . 0.0 107.585 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.924 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.31 3.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.458 HG13 HD13 ' A' ' 40' ' ' ILE . 3.9 t -83.08 164.15 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 123.682 0.793 . . . . 0.0 109.034 171.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.874 -1.141 . . . . 0.0 108.97 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG12 ' HG2' ' A' ' 1' ' ' MET . 11.9 p -150.18 147.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 161.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -123.54 113.71 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 173.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t30 54.58 -86.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.718 1.207 . . . . 0.0 111.687 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.94 12.24 2.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.685 1.594 . . . . 0.0 111.969 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.11 156.36 38.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.784 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.26 -32.32 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.096 1.758 . . . . 0.0 112.932 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 59.13 -51.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 115.497 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.68 161.98 16.05 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.06 0.944 . . . . 0.0 110.8 -160.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.458 HD13 HG13 ' A' ' 30' ' ' VAL . 2.8 mm -135.74 140.45 44.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.226 1.81 . . . . 0.0 107.73 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.79 88.5 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.734 2.013 . . . . 0.0 107.714 165.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 4.7 t -89.8 93.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 164.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.69 152.6 19.47 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 mp0 -56.88 152.87 11.93 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.448 1.099 . . . . 0.0 110.496 168.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -79.77 133.6 58.52 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 164.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.92 -9.72 26.25 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 CA-C-N 121.12 1.436 . . . . 0.0 112.121 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.78 39.65 0.96 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.023 1.329 . . . . 0.0 110.062 -163.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.47 85.84 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.295 -1.503 . . . . 0.0 112.336 -169.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.6 63.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 -171.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -144.29 -105.73 0.12 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.563 -161.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -64.93 -32.98 74.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.744 1.611 . . . . 0.0 112.991 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.8 t 49.97 84.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 126.626 1.97 . . . . 0.0 111.109 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.88 -176.76 5.65 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.211 -0.931 . . . . 0.0 109.981 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.96 21.39 0.28 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.509 1.052 . . . . 0.0 114.081 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.64 -20.24 17.1 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.602 1.701 . . . . 0.0 113.822 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.08 -53.44 48.45 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 119.227 0.921 . . . . 0.0 109.515 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' HG22 ' A' ' 60' ' ' VAL . 29.0 Cg_endo -72.48 -32.05 10.41 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.012 1.808 . . . . 0.0 111.899 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.1 -38.33 73.22 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.052 0.842 . . . . 0.0 110.922 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.75 -65.58 0.61 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.902 1.281 . . . . 0.0 110.991 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.81 -22.34 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 119.751 1.16 . . . . 0.0 113.904 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.48 -12.36 61.52 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.304 -1.498 . . . . 0.0 114.002 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -19.01 23.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.809 1.186 . . . . 0.0 109.781 165.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.15 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.171 0 O-C-N 119.87 -1.768 . . . . 0.0 111.239 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.53 20.11 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 127.34 2.4 . . . . 0.0 116.214 161.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.23 176.84 9.3 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -159.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -144.1 -53.32 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 124.63 1.172 . . . . 0.0 110.642 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.08 157.01 19.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.6 1.16 . . . . 0.0 109.363 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.88 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -136.51 139.65 44.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.386 2.275 . . . . 0.0 105.071 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.573 HG21 HG13 ' A' ' 99' ' ' VAL . 94.5 mt -131.47 111.37 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 68' ' ' VAL . 3.1 m -137.31 155.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.802 0.841 . . . . 0.0 110.685 -162.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' HE ' ' HB3' ' A' ' 93' ' ' SER . 17.6 ttt-85 -95.08 -62.14 1.36 Allowed 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.763 -1.211 . . . . 0.0 111.243 -176.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.85 -54.42 1.3 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.791 -0.568 . . . . 0.0 113.929 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.493 HG12 ' H ' ' A' ' 74' ' ' GLY 0.299 3.7 tt 44.26 -168.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 130.102 3.361 . . . . 0.0 115.14 -173.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.36 167.19 39.82 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.319 1.914 . . . . 0.0 110.445 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.61 -31.76 73.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -163.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -64.74 -36.33 83.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 121.198 1.817 . . . . 0.0 109.642 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.63 -40.73 63.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.265 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.42 -43.96 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 119.764 1.165 . . . . 0.0 109.626 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.23 10.93 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.196 -1.565 . . . . 0.0 114.934 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 57' ' ' PRO . . . -80.16 -58.56 3.09 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.259 1.424 . . . . 0.0 110.453 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.47 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -35.62 -56.29 0.67 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 126.953 2.101 . . . . 0.0 109.159 160.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.42 -9.94 55.82 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 117.421 -1.276 . . . . 0.0 111.733 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.9 63.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.725 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.2 14.92 5.66 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.311 0.382 . . . . 0.0 111.504 -163.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.25 26.78 56.84 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.09 -0.381 . . . . 0.0 112.765 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 1.9 t -79.64 108.15 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -168.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.66 28.49 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 125.975 1.71 . . . . 0.0 110.336 -170.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.07 95.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.5 139.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.81 154.06 47.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.986 -0.446 . . . . 0.0 110.845 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.12 38.62 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.084 0.85 . . . . 0.0 114.799 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.5 157.53 37.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.427 1.113 . . . . 0.0 110.869 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.43 ' HB3' ' HE ' ' A' ' 71' ' ' ARG . 65.2 p -159.46 130.33 5.93 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.127 0.971 . . . . 0.0 108.414 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.65 -130.86 6.28 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.906 -172.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.35 159.61 39.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.041 1.737 . . . . 0.0 111.329 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.483 HG13 HD12 ' A' ' 5' ' ' ILE . 22.5 t -63.71 -45.1 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 120.861 -1.149 . . . . 0.0 111.272 -166.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.53 -12.01 48.97 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.38 -43.49 5.41 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.007 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.573 HG13 HG21 ' A' ' 69' ' ' ILE . 76.3 t -46.03 -49.8 4.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 120.432 1.469 . . . . 0.0 110.547 169.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.47 -38.47 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.478 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -62.01 -50.97 69.93 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 117.329 -1.32 . . . . 0.0 110.307 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.26 -37.22 69.5 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.379 1.445 . . . . 0.0 111.575 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.04 -50.42 41.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.723 1.209 . . . . 0.0 111.94 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.8 mt -62.88 -30.63 71.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.097 0.408 . . . . 0.0 110.139 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.9 m -74.77 -1.09 20.49 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.924 2.09 . . . . 0.0 112.508 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.91 75.0 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 125.39 1.472 . . . . 0.0 112.916 168.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.5 -45.78 51.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.914 0.864 . . . . 0.0 108.705 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.97 134.88 38.74 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.602 1.161 . . . . 0.0 108.373 -166.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -158.72 178.78 9.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -124.55 14.12 8.78 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.089 2.156 . . . . 0.0 112.469 -162.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 t 49.34 -135.03 1.3 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.809 1.644 . . . . 0.0 111.456 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -146.68 113.95 6.26 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.974 1.71 . . . . 0.0 108.508 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -151.29 14.82 0.7 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -160.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -120.79 34.24 5.29 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.618 -1.302 . . . . 0.0 113.132 -166.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -45.82 137.06 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 125.182 1.393 . . . . 0.0 111.283 169.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -119.73 40.62 3.35 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.951 1.3 . . . . 0.0 111.41 -164.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -117.97 -26.52 6.41 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.614 1.566 . . . . 0.0 112.229 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -142.21 151.93 42.62 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.5 1.52 . . . . 0.0 108.33 -163.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -159.52 -171.25 3.23 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.518 1.527 . . . . 0.0 109.098 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -133.08 48.36 2.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.953 1.301 . . . . 0.0 109.028 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 54.23 173.65 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.092 1.357 . . . . 0.0 110.113 -141.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -71.53 -73.42 0.18 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 158.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 66.42 112.17 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.738 2.015 . . . . 0.0 109.187 -162.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 C--O 1.25 1.117 0 N-CA-C 104.567 -2.382 . . . . 0.0 104.567 160.755 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.591 HG22 ' CD1' ' A' ' 29' ' ' PHE . 24.1 mt -111.7 141.7 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.428 HG12 HD12 ' A' ' 67' ' ' LEU . 18.9 mt -122.41 102.65 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 129.424 3.09 . . . . 0.0 107.246 -168.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.909 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -80.15 145.74 32.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.985 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mt -138.64 117.97 9.53 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 170.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.21 108.63 2.02 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 N-CA-C 107.121 -1.915 . . . . 0.0 107.121 166.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 26' ' ' TYR . 12.2 m -101.1 158.9 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 119.065 0.848 . . . . 0.0 110.33 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -77.03 -33.11 57.42 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.154 1.782 . . . . 0.0 112.392 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -147.13 146.58 29.96 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -170.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -86.54 90.03 8.1 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 167.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -111.62 39.44 2.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.487 -1.244 . . . . 0.0 110.306 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 25.05 91.36 0.01 OUTLIER Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.581 2.039 . . . . 0.0 115.174 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt 80.19 -45.7 0.29 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.791 2.436 . . . . 0.0 112.068 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.24 -20.13 65.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -33.36 102.34 0.21 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.972 2.909 . . . . 0.0 111.974 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.29 137.13 36.05 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 109.349 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 93' ' ' SER . 14.6 tt -60.78 140.17 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.8 t -75.83 177.71 6.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.211 1.004 . . . . 0.0 109.039 170.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.48 -13.94 21.43 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.489 -0.757 . . . . 0.0 112.616 -173.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -142.25 -179.5 6.29 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.888 2.075 . . . . 0.0 108.861 -172.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -119.6 -42.55 2.63 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.424 0.69 . . . . 0.0 111.777 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 -16.3 55.49 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 117.578 -1.679 . . . . 0.0 116.947 -166.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 39.09 1.49 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.999 1.719 . . . . 0.0 109.794 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.39 146.7 97.83 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 37.6 Cg_endo -74.37 -22.22 16.55 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.565 1.51 . . . . 0.0 114.055 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.5 ' HB2' HG23 ' A' ' 7' ' ' VAL . 95.6 m-85 -153.18 153.03 31.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.694 1.134 . . . . 0.0 109.418 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -113.31 109.18 18.31 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.711 0.264 . . . . 0.0 111.711 164.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 96.58 6.52 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.906 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.1 m-85 -83.34 96.39 8.5 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 164.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 t -79.64 168.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.82 -164.21 1.32 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.24 -1.537 . . . . 0.0 109.246 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -147.11 133.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 O-C-N 121.74 -0.6 . . . . 0.0 109.768 170.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -105.27 102.09 11.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 168.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.4 t30 55.28 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.947 1.299 . . . . 0.0 111.964 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -140.03 34.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.686 1.595 . . . . 0.0 109.996 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.19 169.89 12.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.518 1.127 . . . . 0.0 108.412 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.11 -23.12 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.573 1.533 . . . . 0.0 113.588 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.4 -68.68 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.367 1.867 . . . . 0.0 114.228 -162.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -168.32 146.38 4.24 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.752 0.821 . . . . 0.0 110.412 -150.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 mm -111.89 126.53 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.005 2.122 . . . . 0.0 107.072 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.37 80.46 1.61 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.55 1.54 . . . . 0.0 107.39 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.266 7.2 p -91.82 75.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.976 0.893 . . . . 0.0 109.012 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.01 160.41 25.88 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.55 -178.44 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.754 1.222 . . . . 0.0 111.437 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 48' ' ' ALA . 33.7 p-10 -100.31 85.51 0.54 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.023 3.329 . . . . 0.0 114.671 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.69 -24.79 74.9 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.257 1.972 . . . . 0.0 113.39 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.587 HD12 ' H ' ' A' ' 56' ' ' VAL . 1.6 tm? -120.24 56.2 0.98 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 123.593 1.664 . . . . 0.0 107.74 173.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . . . -59.2 -49.49 77.64 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.171 1.389 . . . . 0.0 109.904 162.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -145.6 5.93 1.07 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 116.833 -1.556 . . . . 0.0 112.659 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.44 97.6 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 121.558 1.981 . . . . 0.0 113.716 -166.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 41.76 26.53 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.71 2.404 . . . . 0.0 113.61 -166.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 m 33.12 55.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.625 2.77 . . . . 0.0 111.89 -169.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -117.51 -175.98 2.92 Favored 'General case' 0 C--O 1.242 0.683 0 O-C-N 121.49 -0.756 . . . . 0.0 110.491 -171.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.2 72.03 2.88 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 120.913 -1.117 . . . . 0.0 113.38 -163.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.41 -18.6 1.47 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.587 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -46.41 -55.15 14.85 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 122.505 2.411 . . . . 0.0 110.288 -176.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -79.25 -17.11 11.86 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.319 2.013 . . . . 0.0 112.197 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.68 -48.8 68.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -52.95 -66.09 0.45 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.45 1.1 . . . . 0.0 111.278 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.64 -17.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 120.297 -1.502 . . . . 0.0 113.156 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.98 -31.87 61.54 Favored 'General case' 0 N--CA 1.458 -0.049 0 O-C-N 120.922 -1.111 . . . . 0.0 111.746 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -26.47 68.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.968 1.258 . . . . 0.0 110.981 170.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -82.48 38.13 0.54 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.859 0.863 . . . . 0.0 111.029 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 40.55 30.83 0.34 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 129.375 3.369 . . . . 0.0 116.903 165.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -73.74 175.46 7.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.551 1.175 . . . . 0.0 113.696 -167.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.56 -37.88 0.41 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.281 1.433 . . . . 0.0 110.052 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.8 tm? -132.02 154.76 49.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.698 1.199 . . . . 0.0 109.435 -173.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.909 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -148.76 140.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.544 HG21 ' CG1' ' A' ' 99' ' ' VAL . 71.6 mt -126.0 110.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.512 HG13 HG12 ' A' ' 68' ' ' VAL . 19.9 m -126.55 164.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 109.813 -172.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.36 -100.5 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.31 66.2 0.35 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 125.277 1.417 . . . . 0.0 110.606 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.7 tt -57.96 172.44 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.128 1.771 . . . . 0.0 111.215 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -131.72 154.2 20.82 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.716 1.151 . . . . 0.0 110.945 169.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -51.57 -35.5 41.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.921 2.089 . . . . 0.0 114.374 -165.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -59.06 -28.4 66.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.624 1.102 . . . . 0.0 112.448 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.03 -31.72 27.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.68 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.6 mm -54.44 -50.13 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.72 -26.78 10.07 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 114.851 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.76 -51.61 11.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.915 0.78 . . . . 0.0 111.29 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -58.51 -35.43 72.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.046 1.339 . . . . 0.0 110.293 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -65.23 -7.77 14.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.029 0.932 . . . . 0.0 113.383 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.69 -25.43 33.01 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.906 1.685 . . . . 0.0 110.942 170.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 ptm -118.28 1.75 11.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.913 1.685 . . . . 0.0 112.648 -167.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.87 76.47 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 118.722 0.692 . . . . 0.0 111.548 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 t -79.74 121.43 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.48 146.51 36.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 p -138.72 93.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 109' ' ' LYS . 51.1 mt -72.04 124.39 28.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 126.11 1.764 . . . . 0.0 107.161 173.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 166.94 12.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.603 0.761 . . . . 0.0 110.676 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.25 18.54 73.3 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.003 -0.887 . . . . 0.0 113.31 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.36 170.36 12.03 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.906 1.353 . . . . 0.0 110.913 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.416 ' HA ' HG21 ' A' ' 17' ' ' ILE . 1.1 t -161.91 147.93 13.52 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.444 1.098 . . . . 0.0 108.055 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.08 -172.53 19.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.156 1.36 . . . . 0.0 112.587 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.5 p -79.86 163.19 24.57 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.441 -1.035 . . . . 0.0 109.26 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.29 -51.38 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.931 0.893 . . . . 0.0 110.049 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.75 -38.41 72.38 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 123.334 0.396 . . . . 0.0 111.268 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -77.54 -54.73 6.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.159 0.984 . . . . 0.0 108.625 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.544 ' CG1' HG21 ' A' ' 69' ' ' ILE . 16.4 t -54.52 -46.84 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.109 1.364 . . . . 0.0 110.785 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.65 -51.43 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -56.63 -42.54 79.03 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.69 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -55.86 -39.39 71.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.673 1.124 . . . . 0.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -74.19 -45.64 47.09 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.092 0.557 . . . . 0.0 112.23 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.6 mp -56.99 -35.07 68.77 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.3 m -86.29 1.73 49.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.356 1.462 . . . . 0.0 113.129 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.64 13.87 61.71 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.494 1.045 . . . . 0.0 114.02 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -74.93 -36.54 62.13 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.823 1.312 . . . . 0.0 110.186 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.21 161.98 23.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.119 0.968 . . . . 0.0 109.041 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 89' ' ' ILE . 1.2 tptt -129.61 179.67 5.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.755 1.222 . . . . 0.0 108.384 -172.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -153.56 69.8 0.82 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -162.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.1 p -54.09 159.72 1.76 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.226 170.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -142.77 145.67 33.49 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -144.52 163.5 33.66 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.91 1.284 . . . . 0.0 108.782 -163.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -43.58 99.24 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 127.335 2.254 . . . . 0.0 112.165 -164.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.6 t -82.89 58.83 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 170.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -70.05 164.12 24.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 161.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -34.13 98.39 0.01 OUTLIER 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.667 2.387 . . . . 0.0 112.383 -168.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.88 159.72 31.53 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 122.209 -0.307 . . . . 0.0 110.377 170.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -144.99 149.91 35.99 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.022 -1.049 . . . . 0.0 111.838 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -156.9 129.68 7.68 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 125.637 1.575 . . . . 0.0 106.918 163.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.37 -177.54 5.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.095 0.958 . . . . 0.0 108.888 171.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 50.34 71.63 0.4 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.951 1.7 . . . . 0.0 112.261 170.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -162.45 168.7 21.6 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 161.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.902 0 C-N-CA 126.534 1.934 . . . . 0.0 106.866 140.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.464 HG12 HD23 ' A' ' 67' ' ' LEU . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.804 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.531 HD21 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.06 70.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -145.05 22.53 1.56 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -117.57 129.23 55.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.899 0.772 . . . . 0.0 110.619 -163.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.5 m170 61.06 -40.04 0.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.685 2.794 . . . . 0.0 114.049 -168.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t 56.75 24.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.902 1.681 . . . . 0.0 111.531 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -64.23 -70.48 0.22 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 120.914 -1.116 . . . . 0.0 108.096 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.87 41.35 0.04 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.72 -14.37 14.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 45' ' ' ASN . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 60' ' ' VAL . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 3' ' ' ILE . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 4' ' ' ALA . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.553 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.482 HG21 ' HB ' ' A' ' 73' ' ' ILE . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' HG21 ' A' ' 70' ' ' VAL . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.553 ' CG1' HG21 ' A' ' 69' ' ' ILE . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.75 158.85 40.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -135.74 45.56 2.41 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 126.48 1.912 . . . . 0.0 108.919 -164.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 m -44.2 152.06 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.498 1.919 . . . . 0.0 112.316 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.13 124.71 16.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -147.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.1 119.93 40.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.298 1.839 . . . . 0.0 110.3 -157.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.6 142.9 53.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 113.089 -173.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t 32.41 58.75 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 128.851 2.86 . . . . 0.0 111.739 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 t60 57.88 -77.09 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.836 2.054 . . . . 0.0 111.306 -170.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.91 -34.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.454 1.102 . . . . 0.0 111.577 171.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 67.97 -4.37 1.03 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.614 1.566 . . . . 0.0 114.993 171.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -82.63 148.36 28.02 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 121.093 1.77 . . . . 0.0 109.942 -171.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.3 m170 57.73 165.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.732 2.413 . . . . 0.0 111.197 -169.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -141.54 161.18 38.54 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.501 1.12 . . . . 0.0 108.728 164.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.75 -28.06 13.02 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 66.19 -24.97 0.1 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.099 2.16 . . . . 0.0 116.099 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 171.108 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 29' ' ' PHE . 10.2 mt -139.45 141.01 36.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.01 104.33 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 127.561 2.344 . . . . 0.0 107.428 -163.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.953 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -79.73 140.37 36.98 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.7 mt -139.71 107.51 7.05 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.59 129.32 14.5 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.152 1.901 . . . . 0.0 108.129 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 15' ' ' SER . 13.7 m -134.37 152.06 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.169 0.588 . . . . 0.0 110.132 -170.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -74.32 -13.27 60.73 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.94 170.41 21.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.9 1.227 . . . . 0.0 109.381 176.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.5 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 37.2 p-10 -82.12 39.67 0.59 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.014 1.326 . . . . 0.0 112.809 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -81.46 41.01 0.6 Allowed 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.631 -1.293 . . . . 0.0 112.285 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -22.7 124.7 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.396 2.427 . . . . 0.0 114.791 -170.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 18.3 mtmt 80.32 -67.28 0.13 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.998 2.919 . . . . 0.0 109.984 -165.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -10.61 48.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.592 2.357 . . . . 0.0 112.954 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.415 ' HB3' HG11 ' A' ' 7' ' ' VAL . 5.0 m -35.91 99.08 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 130.46 3.504 . . . . 0.0 111.628 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.22 128.68 15.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tt -62.04 131.87 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.44 170.27 14.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.103 1.361 . . . . 0.0 108.409 170.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -89.92 -56.08 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -99.6 135.41 41.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -169.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -67.9 -41.32 82.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.16 -5.24 53.03 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.119 -1.934 . . . . 0.0 115.444 -164.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -144.12 38.73 1.31 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.593 1.697 . . . . 0.0 109.181 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.27 132.67 75.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.29 -19.01 17.65 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.743 1.628 . . . . 0.0 113.502 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.5 ' CE2' ' HB3' ' A' ' 10' ' ' ASN . 96.7 m-85 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.935 1.294 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -127.17 107.75 10.29 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.684 1.194 . . . . 0.0 108.515 170.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.96 91.63 5.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 163.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.921 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.4 m-85 -77.98 95.91 4.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 160.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -79.84 164.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -112.42 -170.43 1.66 Allowed 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.851 -1.156 . . . . 0.0 110.017 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -141.56 151.53 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 156.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -111.74 106.32 15.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 160.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 t30 57.76 -62.63 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.376 2.27 . . . . 0.0 115.754 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.0 12.01 1.6 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.199 1.4 . . . . 0.0 112.791 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.23 -157.58 0.62 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.738 1.615 . . . . 0.0 112.802 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.11 -30.78 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.607 1.163 . . . . 0.0 111.316 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . . . 53.36 -71.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 113.828 -161.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.04 165.98 32.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.281 1.432 . . . . 0.0 110.42 -160.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.77 147.1 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.5 1.12 . . . . 0.0 110.071 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -129.71 117.7 20.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.009 2.523 . . . . 0.0 105.977 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.97 70.31 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -79.71 146.2 32.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -62.3 143.31 57.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.963 0.905 . . . . 0.0 109.513 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -81.06 121.04 80.25 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.71 -37.76 34.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.342 2.028 . . . . 0.0 112.666 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.53 ' HB2' HG23 ' A' ' 56' ' ' VAL . 8.6 mt -126.87 39.38 3.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.217 0.917 . . . . 0.0 110.08 -168.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.03 87.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.01 0.823 . . . . 0.0 110.718 -173.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -139.8 60.16 1.57 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.252 1.021 . . . . 0.0 108.975 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -135.35 -154.28 0.57 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.229 -0.919 . . . . 0.0 110.545 -173.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -55.91 -16.5 4.78 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.474 1.488 . . . . 0.0 114.564 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.2 t 34.89 48.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 127.955 2.502 . . . . 0.0 113.356 165.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -92.37 41.1 1.06 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 119.705 -1.872 . . . . 0.0 108.336 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.81 30.96 45.87 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.906 -0.941 . . . . 0.0 113.529 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.75 -13.46 13.23 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.292 1.546 . . . . 0.0 114.376 -173.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 47' ' ' LEU . 1.8 t -48.53 -52.35 44.66 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.397 1.453 . . . . 0.0 108.587 167.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.2 -30.27 25.14 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.056 1.17 . . . . 0.0 112.962 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -69.33 -22.49 63.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.086 -0.384 . . . . 0.0 110.936 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.05 -64.4 0.87 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 118.078 -0.963 . . . . 0.0 108.973 164.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -60.94 -26.15 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 121.095 1.771 . . . . 0.0 114.472 -170.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -59.75 -26.57 65.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.189 1.359 . . . . 0.0 113.449 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -21.57 60.21 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 119.457 1.026 . . . . 0.0 110.324 172.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -84.56 38.19 0.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.252 0.933 . . . . 0.0 110.302 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 28.77 42.33 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 129.901 3.619 . . . . 0.0 115.042 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.69 172.48 8.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.394 1.097 . . . . 0.0 112.405 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HA ' HG22 ' A' ' 86' ' ' VAL . 18.3 mt-10 -139.0 -27.51 0.82 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.246 -166.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -141.57 154.47 45.46 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.69 0.796 . . . . 0.0 110.827 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.953 HG13 ' HB3' ' A' ' 4' ' ' ALA . 3.3 t -150.17 103.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 120.994 -1.066 . . . . 0.0 110.129 -172.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.526 HG21 ' CG1' ' A' ' 99' ' ' VAL . 89.6 mt -91.49 100.9 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 119.735 -1.853 . . . . 0.0 107.457 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.524 HG13 HG12 ' A' ' 68' ' ' VAL . 32.7 m -122.08 171.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.747 1.158 . . . . 0.0 111.948 -170.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -114.36 -100.06 0.43 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.49 54.42 4.95 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.806 1.67 . . . . 0.0 113.091 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.3 tt -58.02 -170.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 125.772 1.629 . . . . 0.0 111.603 165.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.87 164.81 31.91 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 119.051 -2.281 . . . . 0.0 109.38 171.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -53.28 -46.65 69.37 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.107 0.954 . . . . 0.0 113.554 -168.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -51.42 -21.61 2.45 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.31 -39.79 9.87 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.739 0.816 . . . . 0.0 110.584 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.7 mm -48.35 -47.6 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 166.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.56 -21.03 36.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.667 1.587 . . . . 0.0 114.672 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.16 -57.44 4.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.223 0.92 . . . . 0.0 108.925 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.516 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 15.4 m-85 -60.71 -38.86 86.47 Favored 'General case' 0 N--CA 1.424 -1.767 0 C-N-CA 124.936 1.294 . . . . 0.0 109.403 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.79 -14.14 30.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.683 -1.151 . . . . 0.0 113.962 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.37 -22.65 64.64 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 121.421 1.919 . . . . 0.0 111.929 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.2 ptp -130.64 18.6 5.21 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.108 1.363 . . . . 0.0 112.998 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.14 25.78 60.38 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.81 -1.181 . . . . 0.0 113.001 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 66' ' ' GLU . 6.8 t -78.56 112.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 -170.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -65.95 148.88 51.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.23 -169.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.405 ' O ' ' HE2' ' A' ' 90' ' ' LYS . 3.7 p -144.36 98.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 109' ' ' LYS . 72.0 mt -72.75 134.48 29.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.77 2.028 . . . . 0.0 107.101 166.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HE2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -110.58 174.97 5.61 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.077 0.551 . . . . 0.0 110.34 169.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.52 -2.98 65.43 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.689 -1.617 . . . . 0.0 115.547 168.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.61 -174.48 0.72 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.025 1.912 . . . . 0.0 112.575 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 p -170.49 153.04 4.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.964 2.106 . . . . 0.0 106.455 165.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.65 -168.96 22.57 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.814 0.721 . . . . 0.0 111.878 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -82.74 169.29 16.33 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.54 -0.976 . . . . 0.0 110.393 166.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.18 -53.99 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 123.56 0.744 . . . . 0.0 109.817 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.01 -17.09 36.12 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -99.28 -52.06 3.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.275 1.43 . . . . 0.0 108.678 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 69' ' ' ILE . 25.7 t -55.33 -40.04 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.631 1.572 . . . . 0.0 111.714 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.37 -59.4 2.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -60.95 -41.09 95.62 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.517 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.27 -37.15 66.92 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.314 1.416 . . . . 0.0 110.584 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 21.2 t80 -77.12 -50.04 13.92 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.253 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.74 -25.64 65.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.816 0.697 . . . . 0.0 111.044 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -27.93 40.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.814 -0.613 . . . . 0.0 111.749 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.96 3.31 19.89 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.644 1.116 . . . . 0.0 113.693 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -42.67 65.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.171 1.486 . . . . 0.0 110.445 -173.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -66.47 147.93 52.6 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 122.957 0.503 . . . . 0.0 110.245 -172.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.671 ' O ' HG23 ' A' ' 89' ' ' ILE . 6.7 tptt -111.01 146.19 37.13 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.366 1.066 . . . . 0.0 110.671 -172.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -126.37 56.68 1.44 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.791 1.636 . . . . 0.0 109.808 -166.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.5 t -60.39 163.55 5.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.006 1.322 . . . . 0.0 111.713 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -103.34 115.73 31.1 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.69 1.996 . . . . 0.0 106.988 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -87.89 152.78 21.83 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.431 1.092 . . . . 0.0 109.33 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -77.83 145.5 36.3 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.52 -174.01 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.466 1.506 . . . . 0.0 109.175 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -118.36 -66.56 1.06 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 119.535 -1.978 . . . . 0.0 109.465 -172.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -175.71 -87.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -162.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -160.07 173.03 16.44 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.135 1.774 . . . . 0.0 106.828 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -70.11 94.57 0.9 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 168.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 174.04 0.7 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 125.076 1.35 . . . . 0.0 109.732 172.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -73.94 69.54 1.43 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.029 0.932 . . . . 0.0 109.249 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.87 76.58 1.73 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.345 1.458 . . . . 0.0 107.126 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.86 160.98 17.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 117.645 -1.169 . . . . 0.0 112.124 175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 128.617 2.767 . . . . 0.0 108.358 -177.43 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mt -138.59 150.33 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.039 2.136 . . . . 0.0 105.971 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.41 HG23 HD23 ' A' ' 67' ' ' LEU . 3.7 mt -132.39 105.3 8.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 128.745 2.818 . . . . 0.0 108.112 -163.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.963 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -80.1 145.84 32.19 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 118.525 0.602 . . . . 0.0 110.401 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 53.4 mt -143.41 111.36 5.44 Favored Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.77 123.1 10.06 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 N-CA-C 106.715 -2.071 . . . . 0.0 106.715 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.86 158.85 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.784 0.72 . . . . 0.0 109.514 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.4 m -74.45 -34.9 63.3 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -146.52 154.06 41.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -80.21 115.32 19.7 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -138.34 39.64 2.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.399 0.545 . . . . 0.0 110.214 170.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.87 73.96 0.1 OUTLIER Glycine 0 C--N 1.342 0.912 0 CA-C-O 118.326 -1.263 . . . . 0.0 115.058 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt 77.86 -28.35 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 130.6 3.56 . . . . 0.0 113.46 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -71.81 -8.3 53.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.502 0.721 . . . . 0.0 109.304 167.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -42.1 108.36 0.6 Allowed Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 130.224 3.41 . . . . 0.0 110.124 173.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.71 135.47 16.07 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.47 2.114 . . . . 0.0 109.102 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -58.53 146.38 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 118.854 0.752 . . . . 0.0 109.535 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 t -81.57 171.28 14.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 122.636 1.208 . . . . 0.0 109.159 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.62 -39.25 37.71 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.846 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -131.82 -174.03 3.3 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.792 -1.193 . . . . 0.0 108.6 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -119.83 -41.87 2.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.482 0.713 . . . . 0.0 110.208 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.39 64.79 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.936 -0.925 . . . . 0.0 113.739 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.43 72.68 1.44 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.26 1.824 . . . . 0.0 107.196 168.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.43 138.52 19.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 165.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.73 -20.97 8.82 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.641 2.894 . . . . 0.0 113.313 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -151.94 138.43 18.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.166 1.786 . . . . 0.0 107.038 -165.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -120.86 98.95 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.357 1.863 . . . . 0.0 107.953 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.41 78.0 5.94 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.204 1.402 . . . . 0.0 108.841 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.927 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -71.34 94.66 1.24 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.737 1.215 . . . . 0.0 109.285 174.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.98 167.88 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.528 1.531 . . . . 0.0 109.404 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -122.88 -171.53 2.31 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.694 -1.253 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.72 136.74 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 166.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.28 126.71 18.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 127.413 2.285 . . . . 0.0 105.759 178.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 52.75 42.38 31.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.145 0.978 . . . . 0.0 111.324 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.09 9.23 5.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.63 1.972 . . . . 0.0 113.729 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.05 167.89 10.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.659 1.184 . . . . 0.0 109.072 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.99 -26.21 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 113.673 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.514 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 57.78 -54.52 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.393 2.277 . . . . 0.0 115.937 -167.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -170.6 158.05 6.07 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.309 1.444 . . . . 0.0 108.787 -157.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.7 mt -138.82 137.87 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 125.303 1.441 . . . . 0.0 107.972 171.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 m -111.07 144.42 40.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 127.434 2.294 . . . . 0.0 105.855 160.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 16.0 t -140.74 68.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 167.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -80.18 136.65 36.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.14 150.04 49.69 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -88.85 107.74 19.28 Favored Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.199 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.17 -8.51 22.11 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.163 1.909 . . . . 0.0 112.083 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -128.41 37.75 4.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.11 0.964 . . . . 0.0 109.769 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.71 -28.19 58.5 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.146 1.778 . . . . 0.0 111.793 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -135.33 3.53 3.1 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.1 0.96 . . . . 0.0 113.365 -167.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -95.8 103.6 15.49 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.935 0.788 . . . . 0.0 109.369 173.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 51.89 -0.56 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.111 2.565 . . . . 0.0 116.399 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 t 53.16 23.04 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 126.135 1.774 . . . . 0.0 111.832 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -151.5 17.74 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.063 -1.648 . . . . 0.0 112.185 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.92 60.54 3.8 Favored Glycine 0 C--O 1.216 -1.012 0 O-C-N 120.4 -1.438 . . . . 0.0 111.291 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 53.05 26.77 5.08 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -36.53 -51.19 1.9 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.162 2.185 . . . . 0.0 112.193 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.14 -24.64 12.41 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.257 1.485 . . . . 0.0 112.519 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -68.68 -38.36 80.3 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 119.874 1.215 . . . . 0.0 109.551 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.71 -65.62 0.54 Allowed 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 123.896 0.747 . . . . 0.0 109.557 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 m -59.91 -37.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 117.134 -1.412 . . . . 0.0 112.192 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -58.74 -17.56 24.06 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.02 2.191 . . . . 0.0 114.322 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -26.04 49.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.5 -1.375 . . . . 0.0 110.303 167.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -84.71 37.9 0.67 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.153 1.381 . . . . 0.0 111.164 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.06 26.63 1.32 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 128.287 2.851 . . . . 0.0 118.112 165.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -70.87 171.17 11.13 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.904 1.852 . . . . 0.0 115.21 -171.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -144.88 -27.24 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.042 1.737 . . . . 0.0 112.019 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.41 HD23 HG23 ' A' ' 3' ' ' ILE . 7.6 tp -132.18 156.21 46.84 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.378 1.471 . . . . 0.0 108.745 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.963 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -142.8 146.6 21.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.534 HG21 ' CG1' ' A' ' 99' ' ' VAL . 72.0 mt -130.6 113.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 173.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 68' ' ' VAL . 35.5 m -129.08 177.02 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.445 1.098 . . . . 0.0 109.542 -175.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.9 ttt-85 -112.55 -90.83 0.5 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.9 64.68 0.26 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.139 1.828 . . . . 0.0 112.37 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.48 176.62 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 125.639 1.576 . . . . 0.0 111.747 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -130.89 159.67 23.06 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.09 1.805 . . . . 0.0 111.141 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -60.01 -34.77 73.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -164.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -56.08 -40.76 74.11 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.267 1.394 . . . . 0.0 110.826 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.91 -26.21 59.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.945 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.0 mm -61.47 -48.56 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 167.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.14 -20.49 58.67 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.71 -57.78 7.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.049 -1.032 . . . . 0.0 111.518 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -62.39 -37.86 87.41 Favored 'General case' 0 N--CA 1.428 -1.556 0 C-N-CA 126.438 1.895 . . . . 0.0 109.399 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.46 -30.0 59.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.53 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.29 -8.46 55.95 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.473 1.033 . . . . 0.0 112.297 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -134.97 12.82 3.62 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.175 1.79 . . . . 0.0 111.783 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.46 33.99 33.66 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 121.382 -0.824 . . . . 0.0 112.408 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -79.49 117.7 25.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 146.39 52.89 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.102 -0.998 . . . . 0.0 108.372 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.423 ' O ' ' HE2' ' A' ' 90' ' ' LYS . 2.5 p -133.69 110.17 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.467 0.651 . . . . 0.0 110.919 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mt -81.18 140.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.324 1.85 . . . . 0.0 106.135 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 88' ' ' VAL . 23.4 mtmt -124.48 174.07 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.727 1.211 . . . . 0.0 109.965 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.24 10.64 74.53 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.485 171.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 172.28 5.15 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.538 1.669 . . . . 0.0 111.345 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.0 p -159.38 153.91 24.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.054 1.742 . . . . 0.0 107.895 161.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.49 -166.52 25.8 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.759 0.709 . . . . 0.0 113.404 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 p -83.57 171.97 12.81 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.227 -1.16 . . . . 0.0 109.297 162.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.25 -55.1 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.341 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.18 -33.36 72.1 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.956 -173.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -71.57 -50.88 26.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.84 0.856 . . . . 0.0 110.388 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.534 ' CG1' HG21 ' A' ' 69' ' ' ILE . 38.0 t -58.99 -42.63 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.262 1.025 . . . . 0.0 110.218 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.62 -54.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -56.71 -42.04 78.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.004 0.82 . . . . 0.0 112.357 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -61.03 -32.85 72.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.266 0.939 . . . . 0.0 111.792 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -79.87 -42.13 24.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.414 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.53 -28.89 67.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.377 0.99 . . . . 0.0 110.754 173.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.2 m -74.12 -13.16 60.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.216 1.406 . . . . 0.0 112.896 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.8 12.77 65.19 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.946 1.26 . . . . 0.0 113.2 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -68.68 -50.84 47.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.131 1.466 . . . . 0.0 107.817 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.61 135.98 55.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.089 1.356 . . . . 0.0 110.109 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.16 163.28 34.84 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.32 1.448 . . . . 0.0 109.373 171.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -80.16 101.57 8.88 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 160.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.8 p -127.51 54.12 1.7 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.447 159.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.01 75.24 1.48 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.17 -0.956 . . . . 0.0 109.714 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -162.61 136.72 6.37 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.951 1.301 . . . . 0.0 108.528 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.03 82.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.959 2.104 . . . . 0.0 109.375 160.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.9 t 62.15 173.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 C-N-CA 125.147 1.379 . . . . 0.0 110.113 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 119.64 0.64 Allowed 'General case' 0 N--CA 1.474 0.765 0 O-C-N 118.925 -2.36 . . . . 0.0 113.77 163.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.63 176.22 5.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.653 1.181 . . . . 0.0 110.79 165.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -167.6 -50.81 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.356 1.462 . . . . 0.0 109.388 162.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -85.37 169.41 13.72 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 161.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -114.44 177.89 4.48 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.584 1.554 . . . . 0.0 108.05 159.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -157.82 167.25 30.55 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.89 1.676 . . . . 0.0 107.325 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 64.71 -174.35 0.17 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.376 1.87 . . . . 0.0 111.205 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 62.41 -178.36 0.13 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.768 1.627 . . . . 0.0 111.25 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 . . . . . 0 C--O 1.239 0.538 0 N-CA-C 103.225 -2.879 . . . . 0.0 103.225 138.605 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.146 0.022 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 mt -113.49 148.55 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 162.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.45 104.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 128.715 2.806 . . . . 0.0 105.604 -165.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.91 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.43 140.18 36.1 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.3 mt -131.94 118.59 16.53 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 167.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.9 121.22 8.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 107.099 -1.923 . . . . 0.0 107.099 168.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 m -116.13 147.6 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 119.013 0.824 . . . . 0.0 109.999 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -70.02 -30.93 68.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.993 -1.004 . . . . 0.0 111.429 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -146.4 156.33 43.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.429 1.892 . . . . 0.0 106.194 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -90.46 106.86 18.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -132.72 39.15 3.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.88 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.6 -76.12 0.01 OUTLIER Glycine 0 N--CA 1.469 0.864 0 C-N-CA 126.712 2.101 . . . . 0.0 115.849 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -110.33 -50.96 2.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.012 1.725 . . . . 0.0 107.069 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.88 -6.41 1.27 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 129.32 3.048 . . . . 0.0 113.77 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.9 m -47.95 109.7 1.2 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 129.864 3.266 . . . . 0.0 111.745 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -75.04 137.21 21.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.102 1.868 . . . . 0.0 110.317 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.14 137.26 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.643 1.211 . . . . 0.0 111.422 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -74.54 170.16 16.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.429 1.892 . . . . 0.0 109.614 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -109.87 -24.66 10.72 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.83 -1.169 . . . . 0.0 113.059 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -121.43 89.25 3.09 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.259 1.024 . . . . 0.0 109.897 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -39.86 -49.64 2.4 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.3 1.44 . . . . 0.0 113.23 175.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -15.07 48.38 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.22 52.48 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 173.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.93 153.36 69.74 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 161.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.62 -22.53 0.9 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.782 2.988 . . . . 0.0 113.955 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.11 160.93 39.25 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.793 1.237 . . . . 0.0 107.981 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -127.5 110.53 12.83 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.19 86.93 5.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.91 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -76.63 100.06 5.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.558 HG22 HD13 ' A' ' 40' ' ' ILE . 10.4 t -88.52 141.97 13.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 125.328 1.451 . . . . 0.0 107.847 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -93.18 -172.48 2.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.801 0.728 . . . . 0.0 109.277 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.2 t -145.42 134.31 17.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 34' ' ' ASN . 6.8 ttpt -133.0 118.52 18.92 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 126.061 1.744 . . . . 0.0 106.713 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.419 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 80.6 m-20 40.45 56.93 2.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.218 1.407 . . . . 0.0 112.62 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 39.93 62.81 1.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 112.985 -167.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.75 171.0 15.4 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.617 1.967 . . . . 0.0 107.968 159.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.63 -20.61 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.62 1.568 . . . . 0.0 112.985 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . . . 53.37 -59.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.737 2.415 . . . . 0.0 115.912 -165.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -170.88 164.29 7.76 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.718 2.407 . . . . 0.0 108.8 -164.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.558 HD13 HG22 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -136.02 129.05 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -173.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 m -124.35 89.03 3.0 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 127.177 2.191 . . . . 0.0 108.298 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 3.7 t -92.17 81.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.6 147.33 32.12 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.42 149.61 33.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.05 0.453 . . . . 0.0 110.115 162.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -95.51 107.98 36.65 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-O 117.802 -1.094 . . . . 0.0 108.61 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.27 -6.96 17.55 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.164 1.909 . . . . 0.0 113.372 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.46 38.18 4.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.157 1.783 . . . . 0.0 109.479 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.75 -27.9 66.32 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.605 -1.309 . . . . 0.0 111.675 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -151.25 80.64 1.31 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.69 1.596 . . . . 0.0 107.714 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -145.4 -90.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 156.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -86.17 -17.13 35.73 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.274 1.03 . . . . 0.0 113.076 -167.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t 68.13 -22.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 128.484 2.714 . . . . 0.0 114.288 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -150.23 168.59 23.56 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.944 2.098 . . . . 0.0 106.374 162.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.82 -85.82 0.4 Allowed Glycine 0 N--CA 1.461 0.304 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -17.78 29.43 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -50.06 -48.28 79.38 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 120.48 1.491 . . . . 0.0 110.051 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HA ' HG22 ' A' ' 60' ' ' VAL . 58.2 Cg_endo -76.62 -29.61 5.63 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.847 1.698 . . . . 0.0 111.652 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.37 -40.59 71.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.325 0.966 . . . . 0.0 109.516 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.88 -71.74 0.09 Allowed 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.219 1.007 . . . . 0.0 110.516 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 57' ' ' PRO . 5.9 m -60.31 -14.47 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 O-C-N 119.542 -1.974 . . . . 0.0 114.549 -172.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -80.26 -18.26 49.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.878 1.671 . . . . 0.0 112.867 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.07 -27.82 61.95 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.775 1.17 . . . . 0.0 111.037 164.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -87.65 37.65 0.8 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.535 -0.728 . . . . 0.0 110.672 -162.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.03 27.09 4.87 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.717 2.103 . . . . 0.0 115.157 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.76 166.89 22.85 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.627 1.214 . . . . 0.0 112.89 -167.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 7.4 mt-10 -141.85 -28.37 0.63 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.906 0.882 . . . . 0.0 111.69 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -134.71 160.94 36.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.629 1.172 . . . . 0.0 109.444 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -140.24 148.84 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.606 1.562 . . . . 0.0 106.902 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.535 HG21 ' CG1' ' A' ' 99' ' ' VAL . 46.2 mt -132.41 113.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 68' ' ' VAL . 14.2 m -135.08 -175.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.343 1.057 . . . . 0.0 110.264 -170.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -118.01 -100.35 0.44 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.37 -24.17 59.49 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.565 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.302 2.4 tt 44.2 -97.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.577 2.351 . . . . 0.0 113.696 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.13 124.01 2.22 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 127.449 2.452 . . . . 0.0 109.93 -174.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.35 -40.73 17.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.726 1.61 . . . . 0.0 112.472 -169.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -58.05 -34.64 70.31 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.506 1.503 . . . . 0.0 112.69 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.79 -22.52 46.21 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.453 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.6 mm -54.72 -46.79 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.93 -11.76 14.8 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.56 -1.337 . . . . 0.0 114.311 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -57.09 4.76 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 121.26 1.846 . . . . 0.0 111.163 167.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -53.56 1.68 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.655 1.582 . . . . 0.0 110.659 167.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.47 -13.88 62.43 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.528 1.142 . . . . 0.0 111.49 -170.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.71 -22.45 40.3 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 119.212 0.915 . . . . 0.0 110.517 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.48 10.69 7.93 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.144 0.429 . . . . 0.0 111.856 -172.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.66 23.62 58.78 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.399 0.999 . . . . 0.0 112.99 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.85 94.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.71 1.204 . . . . 0.0 110.909 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 127.99 34.55 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.794 -0.567 . . . . 0.0 110.55 -166.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.63 103.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 122.57 1.176 . . . . 0.0 108.321 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.5 mt -85.67 134.38 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -118.56 179.42 4.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.83 0.452 . . . . 0.0 111.568 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.28 20.33 76.62 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.682 0.614 . . . . 0.0 112.106 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.93 175.04 6.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.224 1.012 . . . . 0.0 109.522 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.8 p -166.96 156.51 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.57 1.548 . . . . 0.0 107.323 166.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.57 -169.67 12.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -80.48 168.83 18.48 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.598 -0.942 . . . . 0.0 109.88 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.85 -49.96 76.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 O-C-N 121.752 -0.592 . . . . 0.0 109.592 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.1 -30.74 62.49 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -75.76 -64.44 1.08 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 69' ' ' ILE . 25.3 t -55.31 -44.24 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.746 1.618 . . . . 0.0 111.119 -171.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.1 t -59.15 -49.74 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -65.65 -33.67 76.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.565 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -60.76 -46.33 90.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.21 1.368 . . . . 0.0 110.426 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -59.14 -52.17 66.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.586 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -32.15 66.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.543 0.611 . . . . 0.0 110.856 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 m -76.98 -2.43 33.8 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.385 0.674 . . . . 0.0 111.882 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.8 8.92 87.21 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 120.911 -1.118 . . . . 0.0 112.718 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -75.33 -44.76 43.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.104 1.452 . . . . 0.0 110.405 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.53 151.81 37.88 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.852 1.261 . . . . 0.0 110.031 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.409 ' HG3' ' H ' ' A' ' 110' ' ' ASP . 4.8 tptt -160.22 165.74 30.95 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.943 0.897 . . . . 0.0 111.949 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.409 ' H ' ' HG3' ' A' ' 109' ' ' LYS . 9.1 p-10 -105.79 24.7 11.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 129.678 3.191 . . . . 0.0 112.096 -174.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.4 m -78.94 45.52 0.62 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.524 -1.36 . . . . 0.0 113.132 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -141.98 74.23 1.44 Allowed 'General case' 0 C--O 1.239 0.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.145 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -162.29 99.87 1.06 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -158.67 162.14 37.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.442 0.565 . . . . 0.0 109.792 160.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.273 8.9 m 45.77 5.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 130.676 3.59 . . . . 0.0 118.681 173.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -62.25 -64.88 0.79 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.968 1.258 . . . . 0.0 112.168 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -166.07 141.05 4.63 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.037 0.535 . . . . 0.0 109.697 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -111.63 114.06 26.86 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.494 1.518 . . . . 0.0 107.517 167.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -152.19 151.0 30.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 164.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.5 175.54 13.48 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.6 m80 62.67 163.54 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.433 2.293 . . . . 0.0 111.594 -170.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.67 -173.83 3.34 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 128.112 2.565 . . . . 0.0 107.154 169.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -148.02 52.11 1.03 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.247 0.939 0 C-N-CA 130.71 3.604 . . . . 0.0 109.064 174.785 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 CA--C 1.507 -0.704 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 29' ' ' PHE . 1.3 mt -142.42 142.98 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.8 104.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 0.0 106.867 -170.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.938 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -81.39 140.27 34.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.307 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.18 113.14 9.56 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.54 108.09 2.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.493 2.129 . . . . 0.0 108.009 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -100.57 158.22 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.309 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.9 m -81.49 -25.62 35.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.503 -0.761 . . . . 0.0 111.524 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -152.29 157.83 41.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.567 1.076 . . . . 0.0 109.675 -174.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -95.23 84.25 4.03 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.841 1.257 . . . . 0.0 108.578 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -107.81 38.62 2.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 116.803 -1.57 . . . . 0.0 110.383 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 32.43 79.56 0.02 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 125.299 1.428 . . . . 0.0 112.958 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 78.08 -36.12 0.21 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 128.633 2.773 . . . . 0.0 113.249 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.35 -7.87 35.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.756 0.707 . . . . 0.0 110.549 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -39.55 106.6 0.4 Allowed Pre-proline 0 N--CA 1.448 -0.557 1 C-N-CA 131.845 4.058 . . . . 0.0 111.051 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.77 133.78 15.85 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.99 2.46 . . . . 0.0 110.778 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -64.44 127.16 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.493 0.663 . . . . 0.0 110.174 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -63.19 168.45 4.24 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.423 1.089 . . . . 0.0 109.321 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.78 -15.37 34.83 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.198 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -131.02 -177.72 4.5 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -120.36 -55.78 2.02 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.648 1.179 . . . . 0.0 108.531 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.02 -6.21 12.0 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-O 117.424 -1.764 . . . . 0.0 116.324 -166.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.8 39.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.799 2.3 . . . . 0.0 109.869 163.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 144.96 97.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.3 -18.47 20.6 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.203 1.936 . . . . 0.0 114.23 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -146.15 160.63 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.146 1.378 . . . . 0.0 109.811 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -133.56 104.75 6.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.945 1.698 . . . . 0.0 108.473 170.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.77 93.3 6.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.938 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.3 m-85 -81.98 101.34 10.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 167.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.2 160.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -111.14 -166.9 1.12 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.393 0.997 . . . . 0.0 108.518 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 p -157.07 144.44 10.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 164.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.0 124.22 23.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 128.401 2.68 . . . . 0.0 105.19 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 36.73 61.53 0.85 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.786 2.034 . . . . 0.0 111.729 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 64.95 11.16 6.82 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 128.458 2.703 . . . . 0.0 115.335 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.14 164.7 18.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 120.165 1.348 . . . . 0.0 109.639 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.36 -28.0 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 113.792 -162.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.45 -56.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.912 2.485 . . . . 0.0 114.398 -165.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -162.6 155.19 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.454 1.502 . . . . 0.0 110.34 -165.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 mm -128.09 117.02 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.038 2.535 . . . . 0.0 106.088 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -109.7 98.39 7.75 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 165.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.54 86.81 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -93.55 153.71 18.28 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -64.91 167.44 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.482 0.713 . . . . 0.0 109.329 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.22 109.97 29.65 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 158.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.13 -7.29 19.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.632 1.554 . . . . 0.0 112.946 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.38 39.39 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.722 1.209 . . . . 0.0 109.985 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.89 90.62 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.47 19.56 0.94 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.206 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -95.16 90.55 5.93 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 122.879 0.472 . . . . 0.0 110.488 -171.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 53.24 29.93 9.21 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.534 1.134 . . . . 0.0 111.649 172.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.69 117.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.581 1.152 . . . . 0.0 112.26 -145.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -143.21 97.55 3.11 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.574 1.149 . . . . 0.0 110.219 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.15 14.34 79.05 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.419 -1.211 . . . . 0.0 115.931 158.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.78 -17.71 7.3 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.858 1.829 . . . . 0.0 114.376 -172.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -48.61 -50.9 56.73 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.439 1.018 . . . . 0.0 110.441 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -75.98 -19.96 15.4 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.347 1.365 . . . . 0.0 112.844 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -66.98 -40.59 87.44 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 119.421 1.01 . . . . 0.0 109.254 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -53.1 -64.4 0.83 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.039 0.936 . . . . 0.0 110.265 168.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.7 m -63.21 -29.22 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 119.952 1.251 . . . . 0.0 113.447 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -64.12 -23.28 67.26 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.76 -1.212 . . . . 0.0 112.791 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -24.71 61.23 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 121.245 1.839 . . . . 0.0 110.798 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -87.71 38.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.853 1.261 . . . . 0.0 111.102 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 38.63 37.09 0.51 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.735 2.588 . . . . 0.0 116.799 165.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -81.6 175.29 10.62 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.04 -31.56 0.54 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.792 1.637 . . . . 0.0 112.922 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 68' ' ' VAL . 64.8 tp -134.46 159.83 39.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.305 1.05 . . . . 0.0 109.552 175.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.87 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -141.9 130.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.501 HG21 HG13 ' A' ' 99' ' ' VAL . 76.4 mt -114.45 112.42 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.439 HG13 HG12 ' A' ' 68' ' ' VAL . 17.9 m -128.92 170.34 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.556 1.542 . . . . 0.0 109.277 -172.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -99.64 -93.64 0.26 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.32 -19.98 53.53 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.51 -1.161 . . . . 0.0 114.661 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 74' ' ' GLY 0.336 2.7 tt 29.55 -129.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 127.724 2.41 . . . . 0.0 112.978 -172.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -167.22 -162.99 20.27 Favored Glycine 0 CA--C 1.541 1.698 1 C-N-CA 131.227 4.251 . . . . 0.0 106.822 176.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -37.69 9.09 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 121.145 2.472 . . . . 0.0 111.106 165.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -60.84 -20.79 62.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -167.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.98 -4.49 17.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.383 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -56.18 -41.26 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 157.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.26 -18.27 15.62 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.64 7.09 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 120.811 -1.181 . . . . 0.0 108.826 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.02 -40.22 95.84 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 125.789 1.636 . . . . 0.0 109.054 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -56.49 -27.6 57.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.72 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.16 -11.95 61.24 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.186 1.357 . . . . 0.0 111.738 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.5 ptp -130.81 6.38 4.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.867 1.667 . . . . 0.0 111.851 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.56 37.15 66.28 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 120.653 -1.279 . . . . 0.0 110.906 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.24 121.01 34.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -59.08 147.87 33.23 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.878 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.57 126.21 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.03 119.87 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -113.4 158.78 20.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.935 1.294 . . . . 0.0 108.794 -168.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 11.33 74.25 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.538 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.71 174.37 1.05 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.362 1.581 . . . . 0.0 113.322 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -161.74 148.61 14.2 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.663 -1.273 . . . . 0.0 109.768 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.06 -163.77 12.17 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 124.011 0.819 . . . . 0.0 112.618 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.9 p -81.1 174.73 11.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.936 0.894 . . . . 0.0 109.81 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.47 -54.92 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 O-C-N 121.028 -1.045 . . . . 0.0 109.756 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.78 -37.98 69.28 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -70.94 -49.87 40.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.508 0.723 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.501 HG13 HG21 ' A' ' 69' ' ' ILE . 39.9 t -57.54 -40.51 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.631 1.172 . . . . 0.0 110.513 176.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.21 -51.84 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -62.0 -44.88 95.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.028 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -52.91 -39.24 62.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.305 0.957 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -76.01 -43.2 45.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mp -62.31 -28.49 69.77 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.687 0.795 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.5 m -80.61 -37.44 31.14 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.38 1.072 . . . . 0.0 109.833 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.13 10.42 22.38 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.158 0.885 . . . . 0.0 112.986 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -61.72 -44.03 97.71 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.182 0.991 . . . . 0.0 108.664 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 137.74 57.19 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.123 1.369 . . . . 0.0 110.626 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -115.24 148.7 38.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.635 1.174 . . . . 0.0 112.67 -170.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.71 58.38 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 127.802 2.441 . . . . 0.0 106.392 -169.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.9 t -58.42 150.09 23.27 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 158.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -116.03 169.91 8.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 148.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.64 12.38 2.3 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.249 1.019 . . . . 0.0 113.422 -176.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -94.61 175.81 6.52 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.153 -154.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.2 t -137.34 143.82 33.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -80.51 88.71 5.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 162.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.31 -76.12 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.962 2.105 . . . . 0.0 113.015 -172.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 174.69 -58.94 0.01 OUTLIER 'General case' 0 C--O 1.235 0.322 0 C-N-CA 129.041 2.936 . . . . 0.0 106.764 -168.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -139.68 -40.38 0.45 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.054 0.541 . . . . 0.0 111.968 171.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 44.79 94.21 0.01 OUTLIER 'General case' 0 C--O 1.233 0.192 0 C-N-CA 128.267 2.627 . . . . 0.0 112.863 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 32.1 t60 56.49 160.6 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.849 2.06 . . . . 0.0 110.545 -163.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -80.62 89.04 5.69 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 -163.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -71.13 88.22 0.8 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.965 1.306 . . . . 0.0 109.548 -164.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 . . . . . 0 C--O 1.25 1.113 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 156.528 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttm . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.152 0.025 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.7 142.8 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.75 107.41 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 129.779 3.232 . . . . 0.0 107.42 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.935 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -83.61 150.19 26.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.158 0.435 . . . . 0.0 111.367 175.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -142.77 120.01 7.02 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.19 123.17 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 108.75 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 15' ' ' SER . 10.0 m -118.54 156.89 20.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.158 0.583 . . . . 0.0 110.31 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -81.73 -21.49 37.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.524 -0.75 . . . . 0.0 112.123 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -142.77 161.36 38.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.621 1.1 . . . . 0.0 109.534 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -91.96 98.63 11.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -139.98 39.19 1.97 Allowed 'General case' 0 C--O 1.226 -0.149 0 O-C-N 121.77 -0.581 . . . . 0.0 110.473 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' HA2' HG11 ' A' ' 42' ' ' VAL . . . 52.02 -140.77 26.35 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-N 119.074 0.852 . . . . 0.0 112.347 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -56.61 -16.75 6.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.93 -2.7 55.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.535 1.534 . . . . 0.0 110.755 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.524 ' CB ' HG11 ' A' ' 7' ' ' VAL . 46.4 m -50.57 122.49 16.1 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.984 1.714 . . . . 0.0 110.991 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.91 130.99 15.09 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 123.021 2.481 . . . . 0.0 109.703 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.3 140.11 18.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.52 175.48 9.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.098 0.951 . . . . 0.0 108.906 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.72 -21.65 21.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 118.356 -0.83 . . . . 0.0 111.126 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -130.93 -175.14 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.118 2.167 . . . . 0.0 108.277 -173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.31 -48.13 2.33 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.527 1.131 . . . . 0.0 109.77 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.98 -19.71 59.28 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -165.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.7 38.55 3.05 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.629 1.214 . . . . 0.0 110.57 168.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.49 129.2 89.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.62 -21.69 45.33 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.308 2.005 . . . . 0.0 114.888 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -145.33 164.37 31.66 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 119.359 0.981 . . . . 0.0 109.191 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -134.17 103.98 6.0 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.168 1.387 . . . . 0.0 108.608 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.75 91.15 5.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.935 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.5 m-85 -82.95 94.61 7.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.2 155.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -98.16 -172.2 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.819 -1.175 . . . . 0.0 110.475 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 t -138.79 157.18 29.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 153.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 21.1 ttpt -154.12 142.09 20.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.45 2.3 . . . . 0.0 104.969 162.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 47.62 47.8 17.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.727 1.149 . . . . 0.0 111.128 170.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.18 41.19 1.98 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.556 1.542 . . . . 0.0 115.029 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.6 169.09 18.4 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.283 0.633 . . . . 0.0 109.534 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.98 -31.38 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 113.484 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.441 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 53.69 -62.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.045 2.138 . . . . 0.0 114.789 -161.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.93 167.16 30.67 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.985 1.314 . . . . 0.0 111.525 -162.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.28 147.86 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.454 2.301 . . . . 0.0 107.86 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -145.21 97.51 3.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.408 HG11 ' HA2' ' A' ' 12' ' ' GLY . 4.0 p -105.09 65.89 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -89.1 150.26 22.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -170.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.78 148.67 49.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -80.1 122.28 82.85 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.297 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.98 -13.28 39.35 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.768 2.312 . . . . 0.0 114.789 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -134.05 39.91 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.499 1.52 . . . . 0.0 108.531 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.81 65.86 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 120.432 -1.417 . . . . 0.0 110.98 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -140.95 2.85 1.78 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -167.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 52' ' ' VAL . 3.9 t70 -127.94 154.11 45.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 119.409 1.004 . . . . 0.0 111.055 -156.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.6 m170 53.58 -31.11 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 129.583 3.153 . . . . 0.0 114.516 -162.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 50' ' ' ASP 0.265 21.2 m 36.16 3.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.83 1 C-N-CA 134.33 5.052 . . . . 0.0 116.959 -160.718 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -21.56 63.91 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.742 2.017 . . . . 0.0 112.345 -173.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.7 66.26 1.01 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -170.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.73 -6.4 19.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.181 154.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.51 -52.86 16.17 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 118.843 0.747 . . . . 0.0 109.989 172.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 60' ' ' VAL . 7.3 Cg_endo -75.67 -27.51 8.91 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.478 1.206 . . . . 0.0 113.199 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -55.82 -45.37 78.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.77 -66.48 0.49 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.185 0.994 . . . . 0.0 110.962 170.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.18 -21.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.871 1.668 . . . . 0.0 113.296 -171.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.39 -23.86 62.85 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.814 1.246 . . . . 0.0 112.187 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -79.81 -18.64 50.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.642 1.11 . . . . 0.0 112.079 168.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -85.88 39.32 0.8 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.459 1.104 . . . . 0.0 111.084 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.9 16.85 41.14 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 160.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.53 165.67 24.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.909 1.354 . . . . 0.0 114.552 -161.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.94 -34.16 1.01 Allowed 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.942 1.297 . . . . 0.0 111.189 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.5 tm? -137.34 154.19 50.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -171.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 4' ' ' ALA . 3.3 t -149.14 141.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.461 HG21 HG13 ' A' ' 99' ' ' VAL . 67.2 mt -132.91 111.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.15 -178.39 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.453 0.644 . . . . 0.0 110.592 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 -114.0 -100.45 0.43 Allowed 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.3 61.96 1.25 Allowed Glycine 0 C--N 1.329 0.171 0 C-N-CA 125.688 1.613 . . . . 0.0 111.441 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.0 tt -59.96 172.46 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 125.462 1.505 . . . . 0.0 110.988 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 152.53 17.92 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -42.3 52.8 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 124.952 1.301 . . . . 0.0 112.418 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -56.95 -22.69 39.87 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.61 -31.71 13.15 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.311 1.045 . . . . 0.0 111.909 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 mm -53.7 -45.77 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.1 -11.13 5.29 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.19 -57.14 3.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.551 1.069 . . . . 0.0 109.632 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -58.41 -39.15 78.95 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 126.008 1.723 . . . . 0.0 109.148 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -55.43 -29.26 58.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.526 1.131 . . . . 0.0 112.842 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.61 -6.53 55.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.696 1.135 . . . . 0.0 111.081 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -130.99 -0.78 4.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.13 1.372 . . . . 0.0 112.059 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.91 38.94 93.39 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.996 -1.065 . . . . 0.0 110.501 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.44 127.79 38.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 167.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -78.08 142.0 38.42 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 p -131.1 101.56 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 67' ' ' LEU . 56.3 mt -74.36 149.27 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 125.829 1.652 . . . . 0.0 107.399 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.41 176.17 7.93 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.62 19.21 77.74 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.34 -0.7 . . . . 0.0 113.295 165.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 179.78 6.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.279 1.04 . . . . 0.0 110.329 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.9 p -164.8 154.54 13.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.313 2.245 . . . . 0.0 107.091 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.86 -168.02 13.22 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 123.55 0.531 . . . . 0.0 112.885 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.7 p -79.68 173.38 12.64 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.775 -0.838 . . . . 0.0 109.966 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.58 -57.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.003 0.921 . . . . 0.0 108.955 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.08 -32.36 72.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.418 -173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.93 -54.23 20.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.21 1.404 . . . . 0.0 108.226 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.461 HG13 HG21 ' A' ' 69' ' ' ILE . 50.4 t -57.33 -30.05 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.695 1.198 . . . . 0.0 111.139 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.8 -53.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -54.29 -44.59 72.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.617 0.767 . . . . 0.0 109.963 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -53.81 -38.8 64.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.544 0.738 . . . . 0.0 111.073 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.36 -39.44 32.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.927 0.891 . . . . 0.0 112.503 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.25 -26.29 68.3 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.402 1.456 . . . . 0.0 111.275 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -1.86 57.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.514 1.126 . . . . 0.0 111.802 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.64 69.25 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.328 -1.483 . . . . 0.0 113.226 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -78.13 -27.48 48.27 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.804 1.302 . . . . 0.0 110.538 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.55 152.88 22.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.099 0.96 . . . . 0.0 110.667 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 161.67 42.02 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.413 1.085 . . . . 0.0 110.514 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -87.65 89.99 8.2 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 167.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 55.9 p -133.55 176.19 8.76 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.977 1.711 . . . . 0.0 109.277 166.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 46.2 t0 74.33 94.24 0.07 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.492 2.717 . . . . 0.0 110.091 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -151.41 146.42 25.95 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.388 1.075 . . . . 0.0 110.66 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -103.67 147.52 27.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.768 1.227 . . . . 0.0 111.909 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 p -130.07 25.61 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 120.458 -1.401 . . . . 0.0 111.686 -171.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -131.47 24.95 4.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -156.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.74 142.71 49.92 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.49 1.041 . . . . 0.0 110.546 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 24.97 -121.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.388 2.275 . . . . 0.0 112.391 -169.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -172.05 -51.67 0.02 OUTLIER 'General case' 0 C--N 1.342 0.255 0 CA-C-O 117.737 -1.125 . . . . 0.0 110.849 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 24.03 75.94 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.799 2.839 . . . . 0.0 111.937 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -68.48 99.19 0.93 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 51.01 -90.86 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.02 2.128 . . . . 0.0 109.546 -165.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 68.9 73.8 0.26 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.555 1.942 . . . . 0.0 107.697 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.359 1.864 . . . . 0.0 106.564 -175.776 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 tpp . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 mt -139.05 142.15 34.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 mt -132.96 104.39 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 127.217 2.207 . . . . 0.0 105.9 -161.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.01 142.3 35.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.808 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.3 115.14 11.7 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.1 116.73 4.64 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.368 2.045 . . . . 0.0 106.878 171.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 26' ' ' TYR . 10.7 m -114.28 152.2 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 118.258 0.481 . . . . 0.0 109.843 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.6 m -77.34 -26.38 52.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.871 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -145.08 150.96 37.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.262 0.937 . . . . 0.0 109.516 -172.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 48.4 t-20 -85.78 64.75 8.79 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.239 1.816 . . . . 0.0 108.779 -168.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -111.2 39.24 2.33 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.495 -0.753 . . . . 0.0 109.319 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 42' ' ' VAL . . . 37.88 -108.05 0.07 OUTLIER Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.462 1.982 . . . . 0.0 112.953 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -20.53 46.51 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.69 -6.85 58.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.934 2.494 . . . . 0.0 110.674 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.0 m -51.7 119.93 14.63 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.622 1.969 . . . . 0.0 112.28 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.39 135.28 20.1 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.864 2.376 . . . . 0.0 110.893 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt -62.02 139.55 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.951 0.5 . . . . 0.0 109.771 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.38 177.05 6.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.747 1.219 . . . . 0.0 110.032 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -96.06 -42.12 8.4 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.71 -0.619 . . . . 0.0 111.634 -171.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -100.18 178.49 4.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -120.43 -47.36 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.564 1.146 . . . . 0.0 109.672 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -12.03 34.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.69 1.138 . . . . 0.0 114.127 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.04 38.93 3.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.078 1.439 . . . . 0.0 110.848 168.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.71 130.18 82.02 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.3 -23.58 20.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.361 2.041 . . . . 0.0 113.338 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.517 ' HB2' HG23 ' A' ' 7' ' ' VAL . 69.3 m-85 -145.75 153.38 40.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.099 1.36 . . . . 0.0 107.761 -176.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -126.49 110.31 13.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.671 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -79.84 89.79 5.27 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.5 m-85 -81.72 93.02 6.71 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -79.74 153.73 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -103.14 -168.27 1.49 Allowed 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.646 -0.659 . . . . 0.0 109.769 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.29 138.69 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 163.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.16 96.43 6.22 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 164.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 71.02 -50.11 0.68 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 127.33 2.252 . . . . 0.0 114.328 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.91 -1.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.212 2.605 . . . . 0.0 112.543 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.84 178.22 4.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.257 1.423 . . . . 0.0 108.211 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.87 -18.76 23.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 120.206 1.366 . . . . 0.0 113.438 -162.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 53.22 -79.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.72 1.145 . . . . 0.0 110.383 -159.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -154.07 168.02 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 109.791 -168.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' HG23 ' A' ' 42' ' ' VAL . 5.9 mm -100.49 162.5 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 127.038 2.135 . . . . 0.0 106.691 170.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 m -148.61 84.66 1.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.677 1.591 . . . . 0.0 107.426 157.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.671 HG22 ' CB ' ' A' ' 28' ' ' ALA . 99.0 t -95.33 84.11 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -93.38 158.33 15.78 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -78.94 145.45 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.471 HD21 HG22 ' A' ' 56' ' ' VAL . 43.0 t-20 -84.59 108.8 16.08 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.34 -17.26 59.22 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.23 1.287 . . . . 0.0 111.929 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' A' ' 55' ' ' ALA . 1.3 mm? -120.2 38.75 3.88 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.398 1.079 . . . . 0.0 110.258 -175.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.58 -21.89 65.4 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.851 -1.155 . . . . 0.0 110.918 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -145.67 -6.57 0.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.88 1.272 . . . . 0.0 112.786 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -69.7 89.4 0.55 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.17 1.388 . . . . 0.0 112.546 -157.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.1 m80 43.45 29.66 0.27 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.285 1.834 . . . . 0.0 112.973 -174.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t 36.11 44.78 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 129.435 3.094 . . . . 0.0 112.04 -173.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -64.45 160.3 19.51 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.17 -1.581 . . . . 0.0 109.215 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.6 30.24 1.03 Allowed Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.714 -1.241 . . . . 0.0 112.946 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . . . -94.7 -19.01 20.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 117.757 -1.116 . . . . 0.0 112.823 -174.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.471 HG22 HD21 ' A' ' 45' ' ' ASN . 1.8 t -48.38 -55.71 17.67 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 110.077 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.48 -20.93 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.963 1.776 . . . . 0.0 110.581 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -65.67 -44.67 85.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.296 0.638 . . . . 0.0 109.907 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -55.72 -66.91 0.34 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.274 1.43 . . . . 0.0 110.422 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -63.71 -22.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -0.94 8.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 113.374 171.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 -19.08 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 120.837 -1.165 . . . . 0.0 110.667 168.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -84.61 37.25 0.63 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.613 0.642 . . . . 0.0 111.375 -174.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 41.58 33.94 1.07 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.238 2.351 . . . . 0.0 114.492 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -68.19 166.73 15.65 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.613 1.707 . . . . 0.0 112.875 -168.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -139.14 -40.69 0.47 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.916 1.286 . . . . 0.0 110.923 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp -127.98 156.25 42.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.296 1.038 . . . . 0.0 108.664 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.814 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.7 t -138.56 142.88 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 172.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.492 HG21 ' CG1' ' A' ' 99' ' ' VAL . 94.4 mt -134.54 114.09 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG21 ' HB ' ' A' ' 73' ' ' ILE . 4.6 m -131.24 170.34 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.226 0.61 . . . . 0.0 110.065 -171.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -60.84 1.97 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.331 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.86 4.38 0.64 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 117.484 1.754 . . . . 0.0 117.484 -173.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 74' ' ' GLY 0.274 4.4 tt 31.83 -123.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 127.031 2.132 . . . . 0.0 114.994 162.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 156.75 155.76 7.58 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 128.039 2.733 . . . . 0.0 109.004 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -59.62 -31.96 69.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -164.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -30.32 71.16 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.466 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.66 -22.87 24.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.496 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.55 -42.61 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 121.005 1.73 . . . . 0.0 108.61 160.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.95 -10.6 22.24 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 120.453 -1.404 . . . . 0.0 113.118 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.66 -62.4 1.46 Allowed 'General case' 0 C--N 1.347 0.481 0 CA-C-N 119.855 1.207 . . . . 0.0 111.333 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.478 ' CD2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -30.99 -57.88 0.22 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 128.027 2.531 . . . . 0.0 109.61 161.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.02 -13.17 62.29 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.959 0.787 . . . . 0.0 112.57 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.46 59.23 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.824 0.738 . . . . 0.0 111.759 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.416 ' SD ' HG21 ' A' ' 86' ' ' VAL . 3.0 ptt? -137.12 7.6 2.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.018 0.372 . . . . 0.0 111.811 -171.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.35 28.5 35.68 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.626 1.584 . . . . 0.0 112.39 -170.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.416 HG21 ' SD ' ' A' ' 84' ' ' MET . 2.3 t -80.06 99.52 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 124.341 1.057 . . . . 0.0 108.44 -172.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -64.34 128.44 35.8 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.392 -163.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 81' ' ' PHE . 7.0 p -110.77 112.25 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.0 mt -88.13 147.61 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -179.41 5.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.24 13.84 73.65 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-O 119.116 -0.824 . . . . 0.0 114.163 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.52 162.48 28.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.085 1.442 . . . . 0.0 109.936 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -146.14 160.1 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.053 2.141 . . . . 0.0 106.527 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.49 -161.06 17.95 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.469 0.577 . . . . 0.0 113.793 170.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.0 p -92.99 171.38 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 163.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -53.17 -54.97 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.883 0.873 . . . . 0.0 109.273 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.38 -31.0 71.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.047 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.418 ' HG2' HE21 ' A' ' 102' ' ' GLN . 42.4 tt0 -70.87 -55.57 8.18 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 69' ' ' ILE . 55.7 t -54.08 -44.87 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.363 1.065 . . . . 0.0 110.599 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.59 -46.91 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -59.86 -42.14 93.02 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.887 0.767 . . . . 0.0 111.296 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.418 HE21 ' HG2' ' A' ' 98' ' ' GLU . 72.3 mt-30 -58.76 -52.5 65.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.863 0.865 . . . . 0.0 109.801 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.05 -46.66 83.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.11 -25.5 67.75 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.065 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.1 m -90.59 7.86 37.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 112.957 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.24 -1.28 88.96 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.177 1.37 . . . . 0.0 115.184 168.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -71.25 -44.06 66.04 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.367 1.084 . . . . 0.0 111.831 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.62 141.75 37.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.644 1.178 . . . . 0.0 108.473 -166.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.71 161.51 41.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 123.482 1.61 . . . . 0.0 112.937 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.09 14.05 2.49 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.002 2.521 . . . . 0.0 112.926 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.7 m -87.14 61.23 6.62 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.972 1.309 . . . . 0.0 112.556 -173.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -157.48 82.45 0.9 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.922 -1.111 . . . . 0.0 108.502 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -124.93 162.25 24.84 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.119 0.968 . . . . 0.0 110.737 -167.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -121.82 163.54 18.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.322 1.449 . . . . 0.0 110.541 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.45 150.67 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 124.494 1.117 . . . . 0.0 108.357 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -160.77 -60.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 166.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 t70 66.03 113.69 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.282 2.633 . . . . 0.0 108.109 -168.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.24 47.23 0.52 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.411 -1.431 . . . . 0.0 112.258 -169.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -159.34 162.39 35.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.237 1.415 . . . . 0.0 108.752 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 61.83 78.5 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.41 2.284 . . . . 0.0 112.968 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.05 -82.63 0.53 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 158.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -51.51 0.65 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.64 1.176 . . . . 0.0 110.451 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -129.79 159.13 37.47 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.478 1.511 . . . . 0.0 108.998 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 p80 . . . . . 0 C--O 1.242 0.662 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 148.799 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.521 0.201 . . . . 0.0 110.772 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.41 HG22 ' CD1' ' A' ' 29' ' ' PHE . 7.2 mt -115.31 153.13 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 165.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.48 105.29 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 127.16 2.184 . . . . 0.0 105.797 -164.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.921 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.47 145.56 31.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 118.623 -0.704 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.478 HD12 HG13 ' A' ' 96' ' ' VAL . 51.2 mt -145.93 114.59 4.66 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.38 129.55 16.05 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.523 1.482 . . . . 0.0 108.318 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 15' ' ' SER . 4.9 m -123.02 150.15 26.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.3 m -68.07 -27.02 66.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.337 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -151.63 156.07 39.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.663 1.585 . . . . 0.0 107.937 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 52.4 t-20 -85.71 95.52 9.41 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 173.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.69 39.67 3.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.072 0.949 . . . . 0.0 108.616 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.2 -127.96 30.08 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 120.751 -1.218 . . . . 0.0 111.464 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -58.29 -45.83 87.2 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.153 1.381 . . . . 0.0 111.736 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -1.87 4.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.751 2.42 . . . . 0.0 114.307 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.47 ' HB3' HG11 ' A' ' 7' ' ' VAL . 28.1 m -53.05 109.03 1.26 Allowed Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 125.201 1.4 . . . . 0.0 110.955 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.89 135.37 14.08 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.42 1.414 . . . . 0.0 108.932 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 tt -55.43 134.37 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.978 0.911 . . . . 0.0 111.288 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -86.37 169.87 12.53 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.869 1.267 . . . . 0.0 107.91 166.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -88.09 -55.26 3.83 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 121.454 -0.779 . . . . 0.0 110.577 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -103.7 85.59 2.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -152.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -37.49 -47.22 0.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 112.908 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.35 40.98 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.773 -1.015 . . . . 0.0 115.341 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 47.96 1.56 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 108.737 173.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.63 137.79 54.84 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.76 -25.28 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.482 2.121 . . . . 0.0 114.457 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 10' ' ' ASN . 33.2 m-85 -146.3 158.18 43.86 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.28 103.92 8.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.523 1.529 . . . . 0.0 107.904 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.06 78.99 6.66 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 125.543 1.537 . . . . 0.0 107.624 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.921 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -74.81 97.28 3.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 170.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG13 HD13 ' A' ' 40' ' ' ILE . 3.8 t -83.05 164.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 123.682 0.793 . . . . 0.0 109.055 171.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -114.47 -171.87 2.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.94 -1.1 . . . . 0.0 108.946 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.424 HG12 ' HG2' ' A' ' 1' ' ' MET . 11.9 p -150.19 147.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 161.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -123.65 113.76 19.08 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 173.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.8 t30 54.61 -86.86 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.716 1.206 . . . . 0.0 111.627 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -137.9 12.22 2.89 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.605 1.562 . . . . 0.0 111.917 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 156.32 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.821 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.21 -32.32 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.137 1.775 . . . . 0.0 112.938 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 59.17 -51.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.309 2.244 . . . . 0.0 115.48 -168.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -166.72 162.03 15.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 110.768 -160.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.461 HD13 HG13 ' A' ' 30' ' ' VAL . 2.8 mm -135.75 140.48 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.205 1.802 . . . . 0.0 107.683 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -134.84 88.55 2.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.741 2.016 . . . . 0.0 107.704 165.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 4.7 t -89.86 93.46 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 164.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.76 152.63 19.47 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -56.92 152.97 11.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.427 1.091 . . . . 0.0 110.439 168.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -79.86 133.66 58.09 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.94 -9.72 26.24 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 CA-C-N 121.128 1.439 . . . . 0.0 112.136 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.3 mt -147.81 39.73 0.96 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.042 1.337 . . . . 0.0 110.082 -163.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.41 85.84 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 120.275 -1.516 . . . . 0.0 112.367 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.63 63.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -171.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -144.32 -105.71 0.12 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.593 -161.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -65.04 -32.88 74.81 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.818 1.644 . . . . 0.0 112.978 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.1 t 49.87 84.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.632 1.973 . . . . 0.0 111.071 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.94 -176.79 5.67 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.026 0.931 . . . . 0.0 109.971 171.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.0 21.45 0.28 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.48 1.038 . . . . 0.0 114.005 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.63 -20.31 17.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.667 1.734 . . . . 0.0 113.813 -174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.06 -53.45 48.27 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 119.237 0.926 . . . . 0.0 109.515 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 60' ' ' VAL . 29.2 Cg_endo -72.43 -32.09 10.48 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.02 1.814 . . . . 0.0 111.925 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.09 -38.35 73.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.063 0.847 . . . . 0.0 110.884 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -57.77 -65.59 0.61 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.922 1.289 . . . . 0.0 110.971 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.6 m -61.74 -22.34 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 119.776 1.171 . . . . 0.0 113.952 -173.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.59 -12.34 61.51 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.368 -1.457 . . . . 0.0 113.946 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.78 -18.93 24.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.848 1.204 . . . . 0.0 109.813 165.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -84.22 38.42 0.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 119.84 -1.787 . . . . 0.0 111.221 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.08 18.51 20.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.337 2.398 . . . . 0.0 116.264 161.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.2 176.85 9.29 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -159.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -144.09 -53.31 0.33 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 110.661 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.02 157.03 19.73 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.618 1.167 . . . . 0.0 109.373 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -136.56 139.61 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 127.387 2.275 . . . . 0.0 105.084 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.58 HG21 HG13 ' A' ' 99' ' ' VAL . 94.5 mt -131.43 111.4 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.463 HG13 HG12 ' A' ' 68' ' ' VAL . 3.1 m -137.35 155.38 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.85 0.86 . . . . 0.0 110.657 -162.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.435 ' HE ' ' HB3' ' A' ' 93' ' ' SER . 17.6 ttt-85 -95.14 -62.1 1.36 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.66 -1.275 . . . . 0.0 111.195 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.82 -54.46 1.3 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 121.757 -0.589 . . . . 0.0 113.977 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.491 HG12 ' H ' ' A' ' 74' ' ' GLY 0.301 3.7 tt 44.38 -168.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 130.143 3.377 . . . . 0.0 115.093 -173.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -173.35 167.21 39.86 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.289 1.9 . . . . 0.0 110.42 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.8 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -64.74 -36.28 83.8 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 121.201 1.819 . . . . 0.0 109.638 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.66 -40.7 63.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.256 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -50.44 -43.89 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 119.732 1.151 . . . . 0.0 109.622 168.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.75 -11.25 11.32 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.131 -1.606 . . . . 0.0 114.89 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.407 ' HB2' ' CB ' ' A' ' 57' ' ' PRO . . . -80.18 -58.53 3.1 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.208 1.403 . . . . 0.0 110.441 175.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.457 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -35.63 -56.33 0.67 Allowed 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 126.958 2.103 . . . . 0.0 109.153 160.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -69.32 -10.05 56.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 117.441 -1.266 . . . . 0.0 111.763 -167.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.5 -30.98 63.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.714 169.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.3 ptp -130.13 14.94 5.7 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.379 0.424 . . . . 0.0 111.476 -163.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.2 26.8 56.75 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.101 -0.374 . . . . 0.0 112.819 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 1.9 t -79.67 108.21 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -168.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.74 138.68 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.929 1.692 . . . . 0.0 110.349 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -124.05 95.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -80.51 139.47 18.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.87 154.06 47.68 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 -171.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.8 11.04 38.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.08 0.848 . . . . 0.0 114.751 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.48 157.58 37.58 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.48 1.14 . . . . 0.0 110.85 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.435 ' HB3' ' HE ' ' A' ' 71' ' ' ARG . 65.1 p -159.52 130.3 5.87 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 130.64 -130.77 6.25 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.95 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 p -133.41 159.55 39.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.044 1.738 . . . . 0.0 111.344 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.478 HG13 HD12 ' A' ' 5' ' ' ILE . 22.7 t -63.68 -45.1 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 O-C-N 120.909 -1.119 . . . . 0.0 111.304 -166.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -65.54 -11.91 48.11 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -103.43 -43.55 5.38 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 117.356 -1.307 . . . . 0.0 108.972 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.58 HG13 HG21 ' A' ' 69' ' ' ILE . 77.1 t -45.93 -49.88 4.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 120.412 1.46 . . . . 0.0 110.569 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 81.2 t -64.42 -38.48 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.471 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -61.99 -51.01 69.78 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 117.352 -1.309 . . . . 0.0 110.314 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -56.22 -37.26 69.46 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.374 1.443 . . . . 0.0 111.589 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -70.0 -50.38 42.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.724 1.21 . . . . 0.0 112.005 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.86 -30.72 71.72 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.128 0.422 . . . . 0.0 110.086 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.4 m -74.72 -1.13 20.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.884 2.074 . . . . 0.0 112.483 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 -8.9 74.98 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.356 1.455 . . . . 0.0 112.966 168.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -73.51 -45.79 51.76 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.4 tp -76.95 134.85 38.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.595 1.158 . . . . 0.0 108.34 -166.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -158.67 178.77 9.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -124.53 14.14 8.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.077 2.151 . . . . 0.0 112.436 -162.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.7 t 49.29 -134.98 1.3 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.795 1.638 . . . . 0.0 111.454 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -146.74 113.88 6.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.975 1.71 . . . . 0.0 108.575 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -151.23 14.82 0.7 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -160.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -120.79 34.36 5.24 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.603 -1.311 . . . . 0.0 113.146 -166.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.2 m -45.9 137.05 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.248 1.419 . . . . 0.0 111.234 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -119.73 40.67 3.34 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.936 1.294 . . . . 0.0 111.404 -164.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -118.01 -26.48 6.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.609 1.564 . . . . 0.0 112.237 -174.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -142.28 151.96 42.53 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 125.475 1.51 . . . . 0.0 108.31 -163.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -159.52 -171.32 3.26 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.525 1.53 . . . . 0.0 109.067 172.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -133.02 48.39 2.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.901 1.28 . . . . 0.0 109.052 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 54.25 173.67 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.114 1.366 . . . . 0.0 110.116 -141.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -71.5 -73.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 66.36 112.11 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.661 1.984 . . . . 0.0 109.234 -162.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.251 1.133 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 160.769 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.1 ttp . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.707 0.289 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mt -137.66 145.47 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.53 111.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 128.423 2.689 . . . . 0.0 106.827 -162.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.894 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -84.02 147.67 27.29 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.289 0.95 . . . . 0.0 111.599 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 85.4 mt -141.64 113.82 6.6 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.47 110.01 2.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.343 2.696 . . . . 0.0 108.824 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.527 HG23 ' HB2' ' A' ' 26' ' ' TYR . 18.6 m -106.82 146.26 13.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.496 0.718 . . . . 0.0 111.409 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.418 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -141.53 149.08 40.38 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.582 1.083 . . . . 0.0 109.389 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.68 100.04 11.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.95 39.02 1.8 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 27.23 80.89 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 126.76 2.124 . . . . 0.0 114.884 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 80.66 -29.78 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 1 C-N-CA 131.821 4.049 . . . . 0.0 113.445 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -71.5 -8.46 54.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.03 1.286 . . . . 0.0 110.263 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB3' HG21 ' A' ' 7' ' ' VAL . 7.4 m -45.82 108.64 0.83 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 128.401 2.681 . . . . 0.0 110.086 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.55 131.66 12.74 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.209 2.606 . . . . 0.0 110.104 -172.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 93' ' ' SER . 14.0 tt -62.11 140.75 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.404 1.002 . . . . 0.0 109.708 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -94.62 -173.32 2.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.982 1.313 . . . . 0.0 110.699 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -101.05 -42.72 6.28 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.729 1.212 . . . . 0.0 111.584 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -122.13 104.4 9.46 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.986 1.314 . . . . 0.0 109.901 -173.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -44.43 -44.57 8.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.126 1.37 . . . . 0.0 111.585 166.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.12 -3.09 51.14 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 117.943 -1.476 . . . . 0.0 116.233 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -148.16 63.16 1.1 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.03 124.31 32.53 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.69 1.996 . . . . 0.0 108.276 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.21 -23.71 24.13 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 CA-C-N 122.181 1.815 . . . . 0.0 114.214 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.527 ' HB2' HG23 ' A' ' 7' ' ' VAL . 77.7 m-85 -148.68 151.7 35.39 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.814 0.734 . . . . 0.0 109.041 -173.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -122.31 106.21 10.89 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.717 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -80.74 81.52 6.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.6 1.16 . . . . 0.0 107.94 169.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.894 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.6 m-85 -70.36 141.1 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 161.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.44 150.44 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -96.55 -169.83 1.97 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.374 0.67 . . . . 0.0 109.512 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.4 115.48 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.681 -0.637 . . . . 0.0 110.102 165.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' N ' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -81.82 91.94 6.59 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.39 -67.33 0.15 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.279 1.432 . . . . 0.0 112.69 174.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -145.71 12.64 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.138 1.775 . . . . 0.0 112.636 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.63 173.33 6.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.602 1.561 . . . . 0.0 109.389 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.91 -25.74 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 121.068 1.758 . . . . 0.0 114.229 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 53.53 -69.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.304 1.411 . . . . 0.0 112.989 -158.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -166.09 170.84 13.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.097 0.959 . . . . 0.0 112.071 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.2 mm -116.01 145.18 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.774 2.43 . . . . 0.0 106.56 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 m -147.35 68.36 1.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.025 2.53 . . . . 0.0 109.815 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 2.8 t -89.06 93.33 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -96.33 161.95 13.71 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.003 1.321 . . . . 0.0 109.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -71.5 149.36 45.87 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.66 1.584 . . . . 0.0 109.689 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.1 129.82 65.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 118.242 -0.885 . . . . 0.0 108.849 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.86 -27.26 26.2 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.168 1.246 . . . . 0.0 111.436 168.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.32 45.76 2.59 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.524 -1.36 . . . . 0.0 109.473 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.86 -51.72 68.79 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 120.441 -1.412 . . . . 0.0 110.578 167.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -152.25 70.91 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -164.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -146.88 -95.25 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -26.78 62.92 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.639 1.176 . . . . 0.0 112.487 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t 51.36 101.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 128.987 2.915 . . . . 0.0 109.888 -166.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 75.66 -35.58 0.27 Allowed 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 126.039 1.736 . . . . 0.0 112.99 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.62 154.58 45.54 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 162.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 49.29 -12.06 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 131.202 3.801 . . . . 0.0 117.849 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -51.49 -55.25 30.89 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 120.372 1.442 . . . . 0.0 109.254 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.62 -22.74 37.51 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 120.304 1.144 . . . . 0.0 110.36 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.82 -37.08 85.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.736 1.153 . . . . 0.0 110.485 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -61.42 -61.64 2.39 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.45 -27.72 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 120.603 -1.311 . . . . 0.0 113.674 -174.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -60.54 -22.63 63.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.199 1.0 . . . . 0.0 111.352 168.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.9 -18.64 58.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.945 1.702 . . . . 0.0 111.417 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -95.03 37.13 1.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.27 1.395 . . . . 0.0 112.195 -164.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 46.78 26.09 2.59 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.07 1.319 . . . . 0.0 115.357 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -75.32 171.8 13.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.112 1.456 . . . . 0.0 112.422 -168.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -143.89 -28.77 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.188 0.995 . . . . 0.0 112.965 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.409 HD22 ' H ' ' A' ' 68' ' ' VAL . 2.4 tm? -139.42 154.66 47.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.883 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.9 t -144.08 143.36 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.573 HG21 ' CG1' ' A' ' 99' ' ' VAL . 85.2 mt -133.22 115.93 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.62 175.43 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.468 1.107 . . . . 0.0 110.251 -172.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -99.43 0.18 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.89 -28.26 24.1 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 121.143 1.792 . . . . 0.0 116.217 -170.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.574 HG12 ' H ' ' A' ' 74' ' ' GLY 0.311 7.2 tt 39.9 -135.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 127.9 2.48 . . . . 0.0 113.41 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.28 154.99 18.09 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 127.78 2.609 . . . . 0.0 109.647 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -39.92 85.71 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.792 1.296 . . . . 0.0 111.645 -171.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -53.32 -38.22 63.0 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.793 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.87 -35.4 38.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 117.097 -1.43 . . . . 0.0 112.373 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.9 -48.07 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 120.604 1.547 . . . . 0.0 108.471 164.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 -10.02 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.281 -1.342 . . . . 0.0 114.479 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.08 -53.35 9.03 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 121.227 1.83 . . . . 0.0 109.904 167.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -60.86 -35.05 75.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.458 1.103 . . . . 0.0 110.385 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -60.32 -20.28 58.65 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.37 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.27 -10.77 57.03 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 120.665 1.575 . . . . 0.0 111.53 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.0 ptp -134.45 13.65 3.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.37 1.068 . . . . 0.0 112.782 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.2 33.08 44.88 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.628 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -79.45 113.0 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -71.95 146.44 47.78 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t -127.07 112.27 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 110' ' ' ASP . 63.7 mt -94.61 133.25 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.879 1.672 . . . . 0.0 106.624 170.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -129.28 167.98 16.9 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.982 1.713 . . . . 0.0 108.183 -172.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 12.45 67.21 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.765 -1.02 . . . . 0.0 113.781 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 171.89 10.38 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.05 1.425 . . . . 0.0 110.6 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.409 ' HA ' HG21 ' A' ' 17' ' ' ILE . 3.1 p -160.85 152.9 20.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 109.456 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.76 -173.13 16.52 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 123.381 0.515 . . . . 0.0 112.808 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p -82.43 172.94 12.49 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.621 -0.929 . . . . 0.0 109.752 168.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -60.81 -49.13 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 O-C-N 121.156 -0.965 . . . . 0.0 110.54 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -58.62 -37.5 76.0 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.499 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -72.42 -58.32 3.48 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.052 1.741 . . . . 0.0 107.867 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.573 ' CG1' HG21 ' A' ' 69' ' ' ILE . 46.2 t -54.4 -44.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.762 1.625 . . . . 0.0 110.636 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.59 -35.72 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.68 -40.6 88.64 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.788 1.176 . . . . 0.0 111.797 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -59.46 -44.26 93.04 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.013 0.824 . . . . 0.0 110.05 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -68.0 -45.33 74.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.961 0.905 . . . . 0.0 113.139 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.17 -28.02 69.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.85 0.75 . . . . 0.0 110.377 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.9 m -77.07 -3.23 38.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.36 56.08 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.141 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 -49.75 58.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.94 131.54 43.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.482 1.113 . . . . 0.0 110.743 -171.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.49 149.97 48.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 9.8 p-10 -82.36 29.15 0.43 Allowed 'General case' 0 C--N 1.324 -0.526 1 C-N-CA 132.068 4.147 . . . . 0.0 112.109 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.0 p -54.19 165.34 0.52 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.198 0.999 . . . . 0.0 112.199 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 67.72 86.29 0.13 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.19 1.796 . . . . 0.0 109.587 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -143.88 -177.47 5.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.378 1.071 . . . . 0.0 111.48 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.18 168.83 11.44 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.989 0.423 . . . . 0.0 111.098 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.8 p -141.78 -56.67 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.655 0.782 . . . . 0.0 109.897 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -142.49 -149.17 0.26 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.817 1.247 . . . . 0.0 108.429 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -54.21 134.45 44.65 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 120.098 1.317 . . . . 0.0 110.299 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -163.34 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.738 2.015 . . . . 0.0 107.028 170.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -149.14 168.57 22.87 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.871 1.214 . . . . 0.0 110.906 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -128.39 -66.55 0.84 Allowed 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 124.063 0.945 . . . . 0.0 110.3 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.4 -177.67 0.12 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.367 1.467 . . . . 0.0 110.643 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.253 0.2 OUTLIER 62.09 -71.61 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.322 1.849 . . . . 0.0 111.334 -168.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.2 t60 56.09 86.27 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.62 1.968 . . . . 0.0 111.178 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 . . . . . 0 C--O 1.242 0.678 0 C-N-CA 125.596 1.558 . . . . 0.0 108.998 169.439 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttm . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.402 HG23 ' HG2' ' A' ' 31' ' ' LYS . 3.3 mt -127.45 135.72 62.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -132.85 101.59 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 127.001 2.12 . . . . 0.0 107.031 -156.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.811 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.04 144.22 33.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.078 0.399 . . . . 0.0 111.131 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.3 mt -134.54 115.87 12.69 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.51 114.59 4.07 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.15 2.567 . . . . 0.0 109.079 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.34 157.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.08 . . . . 0.0 112.699 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -74.46 -25.33 59.34 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.865 173.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -150.57 152.16 33.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.134 1.374 . . . . 0.0 107.819 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -85.12 110.95 19.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 164.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -126.37 39.46 3.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.473 166.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.07 -102.39 0.58 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 125.368 1.461 . . . . 0.0 109.532 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -98.49 -31.68 11.86 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.875 1.27 . . . . 0.0 110.628 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.78 -10.07 54.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.305 1.442 . . . . 0.0 111.445 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.6 m -40.71 106.44 0.42 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 129.911 3.284 . . . . 0.0 111.892 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 135.82 19.97 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.899 2.4 . . . . 0.0 110.927 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.43 138.65 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -77.67 -160.16 0.17 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 108.265 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.54 -52.81 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 122.977 1.37 . . . . 0.0 109.697 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.4 179.13 6.04 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.894 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.409 ' CE2' ' CE1' ' A' ' 27' ' ' PHE . 54.5 t80 -121.0 -46.7 2.32 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.843 -1.16 . . . . 0.0 110.889 159.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.14 -42.22 16.38 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 41.47 2.21 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.833 1.253 . . . . 0.0 111.825 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.29 118.01 65.11 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-O 115.927 -1.987 . . . . 0.0 106.373 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.25 -17.67 50.12 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 113.717 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -149.1 158.92 44.57 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.738 1.215 . . . . 0.0 108.782 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.409 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 25.1 m-85 -126.22 128.9 47.95 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.318 1.847 . . . . 0.0 107.485 170.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.42 89.13 3.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.811 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.7 m-85 -75.43 92.02 2.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.26 162.23 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 55.8 mttt -117.28 -167.64 1.35 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.81 -1.182 . . . . 0.0 108.714 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.33 136.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 120.872 -1.143 . . . . 0.0 109.751 165.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.05 91.82 3.82 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 168.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 56.68 -69.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.383 2.273 . . . . 0.0 114.345 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.25 11.81 3.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.555 1.542 . . . . 0.0 112.752 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.72 173.36 8.61 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.115 1.366 . . . . 0.0 110.207 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.45 -23.25 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.464 1.106 . . . . 0.0 112.994 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.05 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.593 1.557 . . . . 0.0 114.02 -162.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -162.24 167.16 24.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.367 1.467 . . . . 0.0 109.836 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 mm -124.28 138.6 53.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.897 2.079 . . . . 0.0 105.835 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 m -119.79 96.91 5.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 p -92.86 77.69 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 123.467 1.603 . . . . 0.0 107.523 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.6 127.99 32.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.585 1.554 . . . . 0.0 106.943 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -60.61 162.63 6.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.793 1.179 . . . . 0.0 108.681 158.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -78.2 153.38 79.59 Favored Pre-proline 0 N--CA 1.438 -1.059 0 O-C-N 121.496 -0.753 . . . . 0.0 109.428 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.12 -52.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.721 0.948 . . . . 0.0 110.916 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.24 38.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.332 -0.855 . . . . 0.0 111.278 -163.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.33 97.21 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 120.939 -1.101 . . . . 0.0 110.271 -160.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.89 18.03 7.92 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -50.45 -67.0 0.29 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.616 2.367 . . . . 0.0 111.794 -167.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.26 24.0 1.15 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.581 1.553 . . . . 0.0 109.473 175.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.265 34.4 m 40.93 48.17 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 126.217 1.807 . . . . 0.0 111.656 -159.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -68.66 166.6 16.94 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.406 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.59 23.64 21.44 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.968 1.747 . . . . 0.0 111.624 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.27 -21.36 14.91 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.993 1.396 . . . . 0.0 113.276 -171.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -46.98 -48.52 52.52 Favored Pre-proline 0 CA--C 1.556 1.204 0 CA-C-N 119.232 0.923 . . . . 0.0 110.398 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HA ' HG22 ' A' ' 60' ' ' VAL . 57.8 Cg_endo -74.73 -20.04 17.94 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.188 1.925 . . . . 0.0 112.385 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -64.96 -42.46 94.59 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -59.79 -62.14 2.1 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.0 m -63.91 -21.11 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.638 1.563 . . . . 0.0 112.545 -173.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -64.1 -13.21 46.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 116.862 -1.542 . . . . 0.0 112.654 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.45 -11.19 32.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 121.237 1.835 . . . . 0.0 112.488 173.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -90.56 37.29 0.91 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.956 0.798 . . . . 0.0 111.647 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.77 28.05 5.1 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.836 1.684 . . . . 0.0 114.179 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -63.48 152.82 37.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.662 1.731 . . . . 0.0 112.796 -173.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -144.4 -21.84 0.54 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 111.738 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 tp -135.3 166.39 23.23 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 109.019 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.5 t -142.31 150.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 165.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.482 HG21 ' CG1' ' A' ' 99' ' ' VAL . 39.6 mt -134.19 112.04 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -134.89 176.81 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.469 1.508 . . . . 0.0 109.679 -167.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -103.26 -97.19 0.3 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.237 -1.363 . . . . 0.0 107.838 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.12 -12.94 40.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 120.731 1.605 . . . . 0.0 115.638 -171.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.532 HG12 ' H ' ' A' ' 74' ' ' GLY . 2.3 tt 38.51 -130.17 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.527 1.931 . . . . 0.0 114.159 169.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 73' ' ' ILE . . . 168.82 158.46 12.79 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 129.437 3.398 . . . . 0.0 110.812 166.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -48.06 -47.35 33.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.475 1.51 . . . . 0.0 112.492 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -55.9 -6.01 0.2 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.38 -40.45 3.64 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 116.785 -1.578 . . . . 0.0 110.235 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -42.44 -46.96 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.698 1.135 . . . . 0.0 108.958 161.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.36 -19.1 63.03 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.9 2.0 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -57.52 -44.52 85.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 124.013 0.925 . . . . 0.0 109.915 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.95 -14.14 59.28 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.495 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.09 -46.98 72.62 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 121.015 1.734 . . . . 0.0 109.021 168.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -19.15 33.66 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.111 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.71 20.23 37.96 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.094 -1.004 . . . . 0.0 112.496 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.8 t -78.91 121.23 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -63.95 146.31 54.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.703 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 p -139.93 89.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 124.65 1.18 . . . . 0.0 107.989 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.12 131.58 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.21 171.86 7.35 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.012 1.325 . . . . 0.0 111.494 -173.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.76 4.05 38.1 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.003 1.287 . . . . 0.0 114.483 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.74 164.47 23.46 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.89 1.345 . . . . 0.0 110.324 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.3 p -162.17 124.87 2.91 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -159.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.29 -169.68 25.32 Favored Glycine 0 CA--C 1.522 0.521 0 O-C-N 123.399 0.437 . . . . 0.0 112.618 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.3 p -79.92 170.56 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.929 0.865 . . . . 0.0 109.723 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.2 t -53.6 -59.83 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 C-N-CA 123.591 0.756 . . . . 0.0 109.425 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.01 -27.75 69.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.04 -54.26 8.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.812 1.645 . . . . 0.0 109.399 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 69' ' ' ILE . 19.8 t -56.35 -43.45 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.837 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 t -52.88 -58.35 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 107.993 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.61 -44.05 95.07 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.009 -0.996 . . . . 0.0 111.939 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -55.96 -46.01 78.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.347 0.976 . . . . 0.0 110.0 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -62.87 -52.64 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.034 0.534 . . . . 0.0 112.152 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 110.812 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.5 m -74.29 -39.56 62.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.68 35.23 1.09 Allowed Glycine 0 C--N 1.333 0.365 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.145 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.15 -35.12 10.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.068 0.934 . . . . 0.0 112.257 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.53 146.52 31.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.978 1.311 . . . . 0.0 108.871 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -156.52 159.04 38.21 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.409 0.684 . . . . 0.0 110.315 -159.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -103.29 48.03 0.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.954 1.302 . . . . 0.0 109.23 -165.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.51 -4.03 24.51 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -164.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -114.71 88.2 2.81 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -162.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -121.56 153.99 37.29 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.148 0.579 . . . . 0.0 110.702 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.72 67.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.006 1.322 . . . . 0.0 111.244 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.5 t 62.07 -74.34 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 130.231 3.413 . . . . 0.0 112.46 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -162.23 177.38 9.69 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.792 1.178 . . . . 0.0 109.047 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -42.25 -46.59 4.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.13 1.772 . . . . 0.0 113.573 -172.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 38.87 64.86 0.72 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.331 2.252 . . . . 0.0 110.947 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -56.78 100.12 0.04 OUTLIER 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.47 1.508 . . . . 0.0 109.911 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -153.43 145.61 23.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 23.8 m170 77.87 156.09 0.16 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.946 2.098 . . . . 0.0 109.112 -162.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -150.35 -160.39 1.16 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.93 1.292 . . . . 0.0 109.018 -162.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -105.82 -47.09 3.96 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.012 1.725 . . . . 0.0 112.036 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.857 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 164.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptm . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.54 HG22 ' CD1' ' A' ' 29' ' ' PHE . 6.8 mt -124.38 132.24 71.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -173.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.21 104.46 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 129.012 2.925 . . . . 0.0 106.079 -164.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.94 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.08 133.9 35.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mt -127.8 118.26 21.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.89 127.21 17.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 106.8 -2.039 . . . . 0.0 106.8 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 15' ' ' SER . 16.9 m -121.13 157.51 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 119.538 1.063 . . . . 0.0 110.691 177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.86 -34.45 60.03 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.991 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -146.16 169.35 18.91 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.183 0.993 . . . . 0.0 108.545 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -84.03 89.79 7.32 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 130.579 3.552 . . . . 0.0 108.599 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -128.67 38.91 3.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.717 -0.615 . . . . 0.0 110.794 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.41 -80.29 0.11 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 126.033 1.778 . . . . 0.0 113.351 167.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -120.93 -33.54 3.73 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.775 1.63 . . . . 0.0 111.393 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.67 -5.23 11.0 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.769 2.427 . . . . 0.0 112.177 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.515 ' HB3' HG11 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -49.24 109.62 1.28 Allowed Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 127.896 2.478 . . . . 0.0 108.318 176.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -83.04 137.37 8.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.181 1.92 . . . . 0.0 109.159 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.3 tt -58.92 133.99 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.012 0.91 . . . . 0.0 110.947 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.8 t -73.68 167.84 20.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.387 1.475 . . . . 0.0 109.137 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -90.82 -20.75 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.44 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -133.75 -176.7 4.26 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -120.33 -49.51 2.27 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 110.64 -176.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.6 -5.69 24.98 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -167.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 46.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.666 2.386 . . . . 0.0 106.852 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.04 143.4 94.31 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 162.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.76 -16.31 13.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.207 1.938 . . . . 0.0 113.089 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.427 ' HB2' HG23 ' A' ' 7' ' ' VAL . 96.5 m-85 -149.51 155.88 41.08 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.903 -1.123 . . . . 0.0 109.72 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.64 114.3 17.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 126.265 1.826 . . . . 0.0 107.684 170.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.95 88.49 5.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 161.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.94 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -75.19 92.42 2.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 160.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.94 148.75 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -97.23 -167.69 1.58 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -144.74 136.37 21.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 164.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.55 -139.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.31 1.844 . . . . 0.0 106.95 167.389 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.567 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 20.1 t-20 -59.34 -54.11 50.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.712 -1.242 . . . . 0.0 109.398 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.27 11.42 0.71 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.296 1.039 . . . . 0.0 112.701 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.08 171.35 7.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.336 1.455 . . . . 0.0 108.543 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.13 -22.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 126.375 1.87 . . . . 0.0 112.664 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.4 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 54.15 -70.9 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.943 1.697 . . . . 0.0 112.052 -162.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -159.1 162.05 36.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.244 1.818 . . . . 0.0 109.25 -155.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 mm -126.87 126.03 67.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -173.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -112.87 94.76 5.06 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 163.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 p -91.65 88.83 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -97.55 136.37 38.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.825 1.25 . . . . 0.0 109.655 -169.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -75.91 143.57 41.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.338 1.055 . . . . 0.0 108.235 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.59 116.46 60.93 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.118 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.92 -22.9 30.69 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.834 1.69 . . . . 0.0 112.312 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.85 39.86 3.86 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.534 1.134 . . . . 0.0 109.356 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.19 78.41 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.518 0.727 . . . . 0.0 110.693 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -141.87 18.7 2.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.446 1.098 . . . . 0.0 112.206 -170.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -76.77 73.94 3.42 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 120.98 -1.075 . . . . 0.0 108.675 172.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 53.25 29.96 9.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.686 1.594 . . . . 0.0 112.34 167.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.263 19.4 m 38.82 45.12 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.835 2.054 . . . . 0.0 113.065 -168.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -61.44 161.51 9.3 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.41 -29.5 75.27 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.622 -162.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.99 -1.82 33.98 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 -156.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.454 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 1.9 t -43.2 -54.06 9.98 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 120.8 1.636 . . . . 0.0 111.456 177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 6.1 Cg_exo -76.1 -31.24 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.969 2.446 . . . . 0.0 111.497 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -62.65 -41.55 99.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 118.924 -0.56 . . . . 0.0 109.559 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.16 -66.28 0.42 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.758 0.823 . . . . 0.0 109.679 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 m -60.56 -6.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE3' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -97.83 -20.03 17.77 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.502 -1.374 . . . . 0.0 112.432 175.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -64.3 -25.22 67.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.976 0.807 . . . . 0.0 110.753 158.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.54 36.25 0.74 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.306 0.957 . . . . 0.0 110.716 -165.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.69 4.39 0.04 OUTLIER Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.446 2.45 . . . . 0.0 116.741 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.427 ' CB ' ' CE1' ' A' ' 29' ' ' PHE . . . -80.78 158.46 25.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.086 -1.832 . . . . 0.0 112.736 -158.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 86' ' ' VAL . 21.6 mt-10 -131.65 -20.35 2.59 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.745 0.818 . . . . 0.0 111.852 -165.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.541 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.2 tm? -134.36 152.84 52.04 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 123.671 0.607 . . . . 0.0 109.558 -174.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.83 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.1 t -148.49 139.0 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.479 HG21 HG13 ' A' ' 99' ' ' VAL . 71.4 mt -130.55 111.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -131.05 -178.5 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.698 1.199 . . . . 0.0 111.685 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.31 -100.48 0.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.53 55.63 3.48 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 125.962 1.744 . . . . 0.0 112.503 -169.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.47 167.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 O-C-N 121.681 -0.893 . . . . 0.0 109.231 169.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.45 166.74 23.31 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.424 1.012 . . . . 0.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.71 -36.31 46.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.302 1.441 . . . . 0.0 113.414 -166.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.82 -31.37 64.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.324 1.42 . . . . 0.0 112.449 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.18 -35.88 15.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.695 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -41.75 -54.29 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.981 1.264 . . . . 0.0 107.884 158.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.75 -14.21 42.04 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.52 -53.42 6.29 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 120.107 1.322 . . . . 0.0 110.566 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -57.78 -35.52 70.91 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.228 1.011 . . . . 0.0 110.807 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -49.76 -33.08 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.186 2.194 . . . . 0.0 114.043 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.05 -18.94 64.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.172 0.896 . . . . 0.0 111.861 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.22 1.11 4.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.089 1.356 . . . . 0.0 113.551 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.05 39.16 97.23 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.052 -1.03 . . . . 0.0 112.246 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 66' ' ' GLU . 40.4 t -79.64 117.79 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -74.15 139.47 44.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.593 -0.692 . . . . 0.0 110.175 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.05 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.208 1.403 . . . . 0.0 109.295 -168.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.06 131.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -150.91 144.15 24.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.322 -0.861 . . . . 0.0 112.198 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.19 11.91 22.96 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.749 1.166 . . . . 0.0 112.073 -169.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.33 177.65 3.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.169 1.485 . . . . 0.0 110.043 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.2 p -162.2 156.72 22.11 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 119.806 1.184 . . . . 0.0 110.032 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.63 -153.26 21.95 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 121.643 0.579 . . . . 0.0 111.792 172.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.73 153.4 26.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.791 0.837 . . . . 0.0 111.154 -171.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 t -61.24 -45.56 98.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 122.932 0.493 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.83 -28.24 65.86 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.433 0.561 . . . . 0.0 111.939 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.28 -57.04 3.79 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 127.347 2.259 . . . . 0.0 109.008 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.479 HG13 HG21 ' A' ' 69' ' ' ILE . 25.6 t -52.95 -45.37 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.791 1.237 . . . . 0.0 110.72 -176.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.1 -50.38 79.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -55.88 -47.88 76.58 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.419 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -54.07 -38.2 65.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.123 1.329 . . . . 0.0 112.102 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -71.29 -51.29 25.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.506 0.723 . . . . 0.0 112.114 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.16 -38.92 68.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.5 m -78.98 -5.66 54.4 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.839 1.656 . . . . 0.0 112.025 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.8 4.28 82.61 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.848 1.214 . . . . 0.0 114.736 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -81.18 -35.16 31.76 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.765 1.283 . . . . 0.0 111.431 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.7 161.38 31.07 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.716 0.806 . . . . 0.0 110.845 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -150.89 152.77 34.15 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.292 1.037 . . . . 0.0 109.821 -173.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -105.25 13.69 30.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.771 1.628 . . . . 0.0 111.442 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.0 t 51.77 -134.44 1.63 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.932 1.293 . . . . 0.0 108.628 176.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.23 110.8 15.1 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.843 1.657 . . . . 0.0 107.291 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.48 148.94 49.61 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 169.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -65.03 164.68 12.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.7 t -132.98 135.81 56.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 71.75 -164.7 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.636 1.574 . . . . 0.0 109.11 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 41.03 63.14 1.26 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.142 2.177 . . . . 0.0 113.429 -173.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -137.52 65.94 1.47 Allowed 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.622 -1.299 . . . . 0.0 109.303 173.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.23 158.37 24.33 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 121.373 -0.829 . . . . 0.0 110.743 174.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -149.23 138.5 21.51 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 170.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -168.83 -61.45 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.14 147.9 13.11 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 128.045 2.538 . . . . 0.0 104.787 174.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 161.13 -174.77 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 130.438 3.495 . . . . 0.0 107.411 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 31.1 m80 . . . . . 0 C--O 1.252 1.219 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 161.691 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ttp . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 mt -140.17 147.05 23.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.7 mt -132.56 103.1 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 127.38 2.272 . . . . 0.0 106.265 -162.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.977 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -80.09 154.42 28.1 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 119.61 -0.233 . . . . 0.0 110.845 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -146.18 115.89 4.7 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.22 123.4 9.91 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.497 2.131 . . . . 0.0 108.225 169.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 26' ' ' TYR . 17.5 m -119.81 157.93 21.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.448 0.567 . . . . 0.0 110.364 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.4 m -78.79 -27.84 44.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.078 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -148.75 148.94 30.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.111 0.869 . . . . 0.0 108.838 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -82.68 45.33 0.97 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.233 2.213 . . . . 0.0 112.987 -170.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -88.78 39.67 0.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.96 -1.713 . . . . 0.0 111.461 -167.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.51 -125.47 13.78 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.539 -1.35 . . . . 0.0 112.504 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -52.47 -45.82 66.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.648 1.579 . . . . 0.0 110.609 174.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -7.37 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.839 2.456 . . . . 0.0 111.834 -169.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -47.53 109.37 1.08 Allowed Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.151 1.78 . . . . 0.0 110.997 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.46 131.85 15.48 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.182 1.921 . . . . 0.0 109.975 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.94 142.93 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.488 1.115 . . . . 0.0 109.762 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.06 173.7 8.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.897 1.279 . . . . 0.0 108.735 174.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.34 -48.3 8.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 122.4 1.095 . . . . 0.0 109.196 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -86.88 166.39 15.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.486 -171.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -119.38 -52.27 2.27 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 123.862 0.865 . . . . 0.0 109.959 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -17.4 49.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.044 -0.864 . . . . 0.0 113.645 -172.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -139.2 39.3 2.1 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.283 1.833 . . . . 0.0 110.124 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.75 130.64 91.64 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 160.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.14 -17.87 35.6 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.445 1.43 . . . . 0.0 114.195 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.487 ' HB2' HG23 ' A' ' 7' ' ' VAL . 98.3 m-85 -146.69 156.34 43.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.516 1.126 . . . . 0.0 109.541 -171.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -134.18 106.42 7.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.039 1.736 . . . . 0.0 109.343 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.17 100.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.397 1.079 . . . . 0.0 108.662 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.977 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 4.5 m-85 -89.98 100.95 13.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 166.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 t -82.64 154.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 168.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 30.9 mtpt -102.67 -165.04 1.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.41 132.6 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 163.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.85 87.23 3.25 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 170.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 70.31 -75.01 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.125 1.37 . . . . 0.0 110.445 174.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -137.51 15.27 2.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.04 1.336 . . . . 0.0 112.197 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.34 174.79 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.981 1.313 . . . . 0.0 109.508 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.88 -22.87 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 121.217 1.826 . . . . 0.0 114.346 -166.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.76 -64.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.629 1.971 . . . . 0.0 115.084 -162.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -162.45 169.88 19.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.588 1.155 . . . . 0.0 108.823 -169.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.2 mm -131.18 139.69 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 127.749 2.42 . . . . 0.0 105.32 -172.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.67 70.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.044 -1.035 . . . . 0.0 108.262 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.17 88.72 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 106.831 167.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.33 155.65 22.75 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.582 1.153 . . . . 0.0 108.25 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -82.34 166.34 19.56 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.994 -0.441 . . . . 0.0 109.991 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.9 110.77 37.83 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.203 173.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.44 -6.06 18.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.506 2.137 . . . . 0.0 113.275 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -134.99 38.17 3.0 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.06 0.944 . . . . 0.0 109.504 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.29 -35.62 77.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.04 0.836 . . . . 0.0 110.475 -172.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -144.2 41.17 1.37 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.039 1.335 . . . . 0.0 109.867 -168.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -134.76 -58.26 0.82 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.968 0.507 . . . . 0.0 111.999 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.11 -41.17 8.47 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.283 0.947 . . . . 0.0 111.057 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t 61.74 -71.93 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.848 1.659 . . . . 0.0 110.693 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 128.7 36.71 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.253 -1.529 . . . . 0.0 109.365 162.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.12 -21.41 6.15 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 117.918 -1.49 . . . . 0.0 115.827 159.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.93 -19.25 0.45 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.455 2.127 . . . . 0.0 115.035 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.52 -53.09 38.63 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 119.467 1.03 . . . . 0.0 108.301 168.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.99 -28.19 24.44 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.571 1.514 . . . . 0.0 111.88 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.14 -42.69 99.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.05 1.295 . . . . 0.0 108.984 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.496 ' CZ ' ' HE2' ' A' ' 63' ' ' LYS . 4.6 t80 -53.39 -63.05 1.27 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.256 0.622 . . . . 0.0 110.256 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 m -61.91 -30.65 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.276 -0.89 . . . . 0.0 113.154 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -65.13 -17.52 64.53 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -30.88 66.31 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.089 165.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.496 ' HE2' ' CZ ' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -86.27 37.32 0.72 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 120.912 1.687 . . . . 0.0 113.378 -167.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 36.6 42.36 0.66 Allowed Glycine 0 CA--C 1.541 1.683 0 C-N-CA 127.694 2.569 . . . . 0.0 117.208 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.79 168.9 4.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.63 1.715 . . . . 0.0 113.789 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -139.73 -25.98 0.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.031 1.732 . . . . 0.0 111.046 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 tp -142.53 150.22 40.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.379 0.99 . . . . 0.0 110.603 -173.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' A' ' 4' ' ' ALA . 9.4 t -147.71 123.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.48 HG21 ' CG1' ' A' ' 99' ' ' VAL . 87.9 mt -111.54 112.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.61 -177.1 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.76 1.224 . . . . 0.0 110.272 -172.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -112.14 -87.08 0.55 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.428 -0.795 . . . . 0.0 108.919 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.75 -53.51 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 124.365 0.983 . . . . 0.0 113.65 -167.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.483 HG12 ' H ' ' A' ' 74' ' ' GLY 0.257 4.6 tt 43.56 -153.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.293 0 C-N-CA 126.876 2.07 . . . . 0.0 112.883 -176.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -168.66 156.55 28.04 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.606 2.527 . . . . 0.0 109.329 176.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -38.38 70.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.511 1.155 . . . . 0.0 111.547 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -55.69 -21.98 21.05 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 175.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.44 12.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.261 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.63 -48.1 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 165.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.02 50.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.9 -51.06 17.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.265 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.68 -36.59 76.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 126.149 1.779 . . . . 0.0 110.123 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -61.62 -17.02 53.51 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.133 -0.979 . . . . 0.0 113.589 170.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.78 -13.63 53.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.478 1.49 . . . . 0.0 111.821 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -125.64 12.25 7.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.642 1.977 . . . . 0.0 110.854 -172.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 15.02 58.45 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 123.658 0.647 . . . . 0.0 112.924 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.406 ' CG1' HG23 ' A' ' 68' ' ' VAL . 55.9 t -79.26 113.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -67.85 147.71 52.16 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.31 108.45 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.106 0.962 . . . . 0.0 109.774 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.4 128.41 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 128.511 2.724 . . . . 0.0 106.868 169.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -108.21 179.54 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 108.812 169.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.72 8.08 87.28 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 115.079 0.791 . . . . 0.0 115.079 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.35 -176.73 1.58 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.544 1.172 . . . . 0.0 110.65 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.5 t -163.33 168.31 20.64 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 128.362 2.665 . . . . 0.0 106.588 164.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.82 -170.83 21.27 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 118.023 0.374 . . . . 0.0 113.804 168.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.5 p -79.52 163.0 25.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.453 -1.028 . . . . 0.0 111.337 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.09 -55.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.374 1.07 . . . . 0.0 110.164 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.19 -20.79 66.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.81 -54.07 4.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.871 1.668 . . . . 0.0 107.207 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 69' ' ' ILE . 54.3 t -52.49 -46.37 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.216 1.806 . . . . 0.0 110.886 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.38 -53.28 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -62.44 -37.68 86.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.15 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -59.88 -46.79 88.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.042 1.292 . . . . 0.0 110.259 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -61.28 -53.93 50.45 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mp -56.23 -31.3 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.609 0.64 . . . . 0.0 110.426 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.3 m -76.08 -22.31 55.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 112.726 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.23 8.99 58.43 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.408 1.004 . . . . 0.0 113.236 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -80.92 -22.6 39.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.426 1.613 . . . . 0.0 112.067 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.91 145.18 27.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 109.202 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 165.46 28.27 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.27 1.028 . . . . 0.0 109.065 177.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.08 90.84 7.54 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 173.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.1 m -135.9 88.89 2.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.284 1.833 . . . . 0.0 108.725 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -165.37 101.59 0.72 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.498 1.519 . . . . 0.0 107.931 161.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.76 175.77 12.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 157.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -124.16 136.73 54.4 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 159.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 m -77.28 82.07 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 122.65 1.214 . . . . 0.0 108.757 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.81 174.24 11.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.451 1.5 . . . . 0.0 109.455 166.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.7 t70 62.99 173.92 0.15 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.099 2.56 . . . . 0.0 112.18 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -156.2 57.78 0.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.229 -0.919 . . . . 0.0 110.279 162.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -41.98 130.63 3.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.646 1.579 . . . . 0.0 111.916 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.34 178.12 7.64 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.813 -0.554 . . . . 0.0 111.022 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 65.56 175.87 0.21 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.219 1.408 . . . . 0.0 109.7 -167.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 72.11 111.78 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.701 2.4 . . . . 0.0 110.593 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -155.23 137.46 14.8 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.108 1.363 . . . . 0.0 107.632 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 C--O 1.253 1.282 0 CA-C-N 119.61 1.095 . . . . 0.0 110.662 -163.88 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttm . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.28 138.91 52.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 mt -125.66 105.42 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 127.586 2.354 . . . . 0.0 106.27 -159.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -79.65 144.09 34.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.365 -177.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.9 mt -143.18 116.4 6.05 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 171.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.13 119.43 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 106.815 -2.033 . . . . 0.0 106.815 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 15' ' ' SER . 6.9 m -110.62 141.91 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.789 1.177 . . . . 0.0 110.21 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -69.28 -21.85 63.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 117.442 -1.266 . . . . 0.0 112.849 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -148.0 156.72 42.96 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 38.7 t-20 -90.42 97.75 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -132.24 38.21 3.5 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.25 -109.24 1.09 Allowed Glycine 0 C--N 1.342 0.891 0 C-N-CA 124.022 0.82 . . . . 0.0 112.487 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -80.62 -41.17 24.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.764 1.626 . . . . 0.0 109.603 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.27 -16.05 59.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.061 1.744 . . . . 0.0 112.408 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HG11 ' A' ' 7' ' ' VAL . 22.0 m -39.26 104.56 0.32 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.685 2.794 . . . . 0.0 112.416 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.37 135.94 27.78 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.056 1.837 . . . . 0.0 109.328 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -61.77 148.2 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.612 0.72 . . . . 0.0 110.338 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.9 t -78.47 178.35 7.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.905 2.482 . . . . 0.0 110.054 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -108.21 -30.22 8.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.816 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -133.88 90.59 2.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.694 1.134 . . . . 0.0 110.645 -164.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -43.32 -42.69 4.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.649 1.18 . . . . 0.0 112.986 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -1.53 40.02 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.023 -1.431 . . . . 0.0 115.925 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.45 46.86 1.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.442 1.621 . . . . 0.0 108.775 166.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 133.26 88.77 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 116.618 -1.658 . . . . 0.0 109.38 172.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -73.22 -22.55 18.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.756 2.304 . . . . 0.0 113.575 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 99.0 m-85 -147.1 154.04 40.66 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.022 0.929 . . . . 0.0 109.459 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.67 104.16 7.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 91.8 5.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.252 1.821 . . . . 0.0 108.913 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.907 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.6 m-85 -84.71 96.35 9.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.22 160.78 4.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -110.99 -170.08 1.57 Allowed 'General case' 0 C--N 1.319 -0.757 0 O-C-N 119.993 -1.692 . . . . 0.0 108.798 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.1 144.24 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 162.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.691 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -80.05 -138.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.357 2.263 . . . . 0.0 105.598 167.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.691 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 21.4 t-20 -59.28 -62.63 1.74 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.471 1.908 . . . . 0.0 109.644 174.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -142.09 20.03 2.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.839 1.256 . . . . 0.0 111.678 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.91 161.71 26.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.117 1.367 . . . . 0.0 109.71 -170.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.75 -23.84 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.368 1.894 . . . . 0.0 112.608 -165.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 54.73 -65.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.032 2.133 . . . . 0.0 114.208 -166.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.24 165.88 21.53 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.069 0.948 . . . . 0.0 111.682 -165.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 152.07 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 127.229 2.212 . . . . 0.0 107.716 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.64 73.04 1.3 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.67 1.588 . . . . 0.0 109.467 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.256 8.3 p -90.63 84.77 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -96.66 154.46 17.27 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.707 1.203 . . . . 0.0 108.334 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -73.69 148.81 42.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.416 1.487 . . . . 0.0 110.564 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -92.19 115.08 64.05 Favored Pre-proline 0 CA--C 1.516 -0.345 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.806 -173.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.32 -21.97 53.59 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.989 1.793 . . . . 0.0 112.557 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -123.66 38.63 4.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.3 1.409 . . . . 0.0 111.049 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.71 63.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.513 1.051 . . . . 0.0 110.693 175.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -157.06 29.09 0.3 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.088 1.355 . . . . 0.0 110.448 -175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.48 -72.14 0.53 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.079 -1.013 . . . . 0.0 109.317 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -66.34 -23.37 66.34 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.943 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.7 t 39.0 52.26 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 126.534 1.934 . . . . 0.0 109.419 -174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -152.15 -58.02 0.15 Allowed 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.115 -0.991 . . . . 0.0 109.78 -165.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -176.62 -142.51 4.38 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -172.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.45 -14.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 129.997 3.319 . . . . 0.0 116.71 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.8 -53.5 12.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.656 1.982 . . . . 0.0 109.501 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.456 ' HA ' HG22 ' A' ' 60' ' ' VAL . 56.3 Cg_endo -76.31 -30.73 5.14 Favored 'Trans proline' 0 C--N 1.356 0.935 0 CA-C-N 120.581 1.243 . . . . 0.0 111.04 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.0 -24.97 67.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.06 0.544 . . . . 0.0 110.348 -177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -69.12 -73.2 0.16 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 124.472 1.109 . . . . 0.0 109.502 162.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.2 m -59.38 -28.76 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -58.82 -42.63 89.63 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.076 1.307 . . . . 0.0 108.836 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -17.86 54.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.761 0.824 . . . . 0.0 112.479 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -86.58 37.17 0.73 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.747 0.703 . . . . 0.0 109.853 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 29.27 44.27 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 C-N-CA 128.688 3.042 . . . . 0.0 114.832 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.73 174.37 8.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.012 1.406 . . . . 0.0 113.635 -172.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -145.13 -28.09 0.46 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.024 0.93 . . . . 0.0 112.194 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.0 tm? -142.05 157.9 44.39 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.859 -173.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.008 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -150.77 143.6 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.811 1.644 . . . . 0.0 106.999 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.569 HG21 HG13 ' A' ' 99' ' ' VAL . 61.8 mt -131.59 113.38 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.61 -177.23 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.748 1.219 . . . . 0.0 110.418 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -104.05 -100.5 0.31 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 117.515 -1.231 . . . . 0.0 107.808 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.8 -18.27 32.83 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 120.355 1.434 . . . . 0.0 114.849 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.467 HG12 ' H ' ' A' ' 74' ' ' GLY 0.309 4.9 tt 41.22 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 126.98 2.112 . . . . 0.0 112.786 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -152.91 -138.74 2.76 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.977 2.227 . . . . 0.0 109.822 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.62 -31.6 4.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.748 1.274 . . . . 0.0 111.18 163.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -36.84 68.08 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 120.345 -1.472 . . . . 0.0 113.135 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 -31.71 43.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.219 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.23 -47.92 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.55 -12.74 34.97 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.07 -58.9 3.01 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.796 1.18 . . . . 0.0 109.403 172.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -58.49 -42.31 87.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.655 1.182 . . . . 0.0 110.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.06 -20.87 66.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.53 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.43 -9.1 58.27 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.808 1.185 . . . . 0.0 112.222 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.49 -5.69 6.48 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.054 0.942 . . . . 0.0 112.434 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.39 28.87 69.0 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 119.589 1.086 . . . . 0.0 111.228 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.42 115.47 20.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -72.65 139.05 47.09 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.453 -0.779 . . . . 0.0 109.216 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.16 92.94 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 122.612 1.196 . . . . 0.0 109.637 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.9 147.48 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.173 1.789 . . . . 0.0 107.537 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -155.34 173.02 17.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.15 0.98 . . . . 0.0 109.38 -160.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.21 18.61 60.75 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.435 -0.647 . . . . 0.0 112.715 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.32 178.68 7.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.28 1.032 . . . . 0.0 109.784 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 p -158.27 160.4 37.03 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 106.05 -1.834 . . . . 0.0 106.05 160.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.37 -162.41 25.39 Favored Glycine 0 N--CA 1.463 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 112.665 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 p -84.93 165.33 17.72 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.65 -0.912 . . . . 0.0 109.134 165.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.2 t -53.74 -54.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.94 -22.52 62.57 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -89.63 -52.47 4.99 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.825 1.65 . . . . 0.0 107.658 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.569 HG13 HG21 ' A' ' 69' ' ' ILE . 43.0 t -55.16 -35.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 111.552 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.29 -53.99 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -54.91 -43.01 72.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.134 0.574 . . . . 0.0 111.214 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -58.86 -41.8 87.87 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.854 0.835 . . . . 0.0 111.005 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -72.5 -43.63 63.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.376 1.071 . . . . 0.0 111.778 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.26 -29.87 67.88 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.972 0.806 . . . . 0.0 110.601 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 m -78.33 -2.96 40.66 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.844 1.258 . . . . 0.0 113.138 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.68 20.65 68.39 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.534 1.061 . . . . 0.0 113.205 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -81.16 -56.18 4.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.344 1.072 . . . . 0.0 108.952 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.02 146.63 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 110.806 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -150.4 164.61 35.41 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.489 1.137 . . . . 0.0 112.379 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -99.57 21.48 12.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 128.569 2.747 . . . . 0.0 110.414 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 p -74.52 5.33 4.85 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.685 1.994 . . . . 0.0 115.224 -164.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -123.22 74.1 1.21 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.309 1.528 . . . . 0.0 108.115 -150.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -163.55 86.02 0.5 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.094 -1.412 . . . . 0.0 107.371 -170.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.21 154.74 0.05 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 128.359 2.663 . . . . 0.0 108.882 164.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.9 t -141.43 -87.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 165.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -140.92 -57.04 0.51 Allowed 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 119.373 0.988 . . . . 0.0 112.26 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.41 -44.02 0.06 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.591 1.087 . . . . 0.0 112.177 175.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.49 -170.68 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 110.937 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -41.32 123.38 2.09 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.714 1.606 . . . . 0.0 111.894 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -92.25 119.73 32.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.42 147.05 52.29 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.08 0.854 . . . . 0.0 109.417 168.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -81.31 106.59 13.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.431 2.292 . . . . 0.0 108.212 171.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.19 146.74 25.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 162.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 . . . . . 0 C--O 1.234 0.262 0 O-C-N 126.881 2.613 . . . . 0.0 111.075 172.614 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.443 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.7 ttt . . . . . 0 C--O 1.235 0.342 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.409 HG12 ' HE3' ' A' ' 31' ' ' LYS . 3.9 mt -137.35 148.38 26.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 69' ' ' ILE . 13.8 mt -128.79 106.62 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 C-N-CA 129.373 3.069 . . . . 0.0 105.561 -170.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.822 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.66 150.2 26.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.378 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -138.06 118.67 10.23 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.72 116.54 4.29 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 107.221 -1.876 . . . . 0.0 107.221 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 15' ' ' SER . 3.0 m -116.79 157.08 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.699 0.799 . . . . 0.0 110.488 -174.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 p -72.6 -35.45 67.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -142.2 156.44 45.33 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 120.355 1.434 . . . . 0.0 109.049 -167.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.52 88.88 6.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -132.41 38.41 3.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.719 -0.613 . . . . 0.0 109.719 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.26 -105.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 127.438 2.447 . . . . 0.0 111.25 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -79.92 -37.21 35.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.24 1.016 . . . . 0.0 110.216 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.66 -18.58 64.99 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.348 1.859 . . . . 0.0 112.175 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.584 ' HB3' HG11 ' A' ' 7' ' ' VAL . 3.7 m -37.97 105.06 0.31 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.42 2.288 . . . . 0.0 111.894 -175.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -68.87 132.64 25.24 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.578 1.519 . . . . 0.0 110.615 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.4 tt -62.13 142.0 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 119.781 -1.825 . . . . 0.0 110.67 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 t -81.03 -173.79 4.49 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.245 1.418 . . . . 0.0 108.977 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -109.12 -45.03 3.83 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.045 -1.034 . . . . 0.0 111.608 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -120.41 100.68 7.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.017 1.327 . . . . 0.0 107.851 -163.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -42.47 -45.35 4.4 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.141 1.376 . . . . 0.0 112.16 171.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.81 -20.2 59.46 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 117.888 -1.507 . . . . 0.0 114.303 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.32 38.91 3.58 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.415 1.608 . . . . 0.0 109.495 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.06 130.58 93.81 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.598 -1.192 . . . . 0.0 107.845 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.72 -20.74 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.605 2.203 . . . . 0.0 113.127 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -148.03 160.99 42.27 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.41 1.484 . . . . 0.0 108.378 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -126.94 112.11 14.9 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.68 88.41 7.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -78.12 98.6 5.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 108.179 169.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.42 136.82 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.465 1.106 . . . . 0.0 108.055 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HE3' HG12 ' A' ' 2' ' ' ILE . 9.6 mtpt -80.45 -164.15 0.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.13 -0.982 . . . . 0.0 109.549 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -156.25 147.86 11.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -146.06 122.08 10.72 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 53.96 34.46 19.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.079 0.952 . . . . 0.0 112.541 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 73.7 12.85 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.325 2.65 . . . . 0.0 114.337 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.06 172.49 7.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.0 108.402 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.85 -27.23 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 125.15 1.38 . . . . 0.0 112.436 -159.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 56.99 -67.42 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 C-N-CA 127.156 2.183 . . . . 0.0 112.753 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -164.86 157.17 16.02 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.751 -0.593 . . . . 0.0 112.011 -164.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.32 131.4 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.171 1.788 . . . . 0.0 106.848 -172.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.0 m -129.4 117.94 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.24 1.816 . . . . 0.0 107.153 166.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 t -131.39 79.45 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -82.02 168.81 17.43 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -105.97 132.52 51.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 107.68 -168.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -79.59 123.73 84.04 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.591 -150.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.35 -10.77 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.427 2.752 . . . . 0.0 114.982 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.35 38.84 2.28 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.147 1.779 . . . . 0.0 109.895 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.44 68.68 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.599 -1.313 . . . . 0.0 112.429 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -130.14 -19.36 3.19 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.107 1.363 . . . . 0.0 111.869 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -100.28 128.97 46.23 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 60.05 -46.01 0.09 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.34 1.856 . . . . 0.0 113.719 -163.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.5 t 65.28 -80.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 127.49 2.316 . . . . 0.0 108.655 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -75.25 134.72 41.06 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 160.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.31 -151.91 21.29 Favored Glycine 0 C--N 1.322 -0.224 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -164.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.74 -1.1 1.72 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 -170.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -43.45 -52.02 14.1 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 121.404 1.911 . . . . 0.0 111.314 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.86 -27.39 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.277 1.985 . . . . 0.0 111.761 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.38 -41.79 90.14 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.729 1.149 . . . . 0.0 109.889 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.17 -68.15 0.2 Allowed 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 123.683 0.793 . . . . 0.0 109.654 167.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 m -64.47 -12.1 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -72.71 -22.26 60.92 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.59 1.156 . . . . 0.0 111.553 170.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.55 -12.95 50.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.838 0.745 . . . . 0.0 112.044 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -93.1 37.02 1.03 Allowed 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.173 -0.954 . . . . 0.0 111.18 -164.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.28 18.27 34.95 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.796 1.188 . . . . 0.0 113.835 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -64.39 158.75 22.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.929 1.365 . . . . 0.0 112.422 -171.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 6.5 mt-10 -137.77 -19.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.327 1.451 . . . . 0.0 110.893 172.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.65 159.24 42.62 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.315 1.846 . . . . 0.0 109.042 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.571 HG12 HG13 ' A' ' 70' ' ' VAL . 3.5 t -137.62 139.82 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 158.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.523 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.5 mt -112.74 117.85 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.571 HG13 HG12 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -134.81 138.85 48.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 O-C-N 121.773 -0.58 . . . . 0.0 110.974 -164.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -77.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.598 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.87 -36.69 1.22 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.577 1.081 . . . . 0.0 115.459 -170.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.563 HD12 HG11 ' A' ' 70' ' ' VAL 0.252 6.2 tt 44.5 -161.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 128.828 2.851 . . . . 0.0 113.971 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.85 169.67 40.61 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.296 1.903 . . . . 0.0 110.759 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -48.45 64.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.401 1.481 . . . . 0.0 114.007 -161.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.67 -24.03 31.66 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.02 -31.12 13.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.518 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mm -52.49 -46.95 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.25 54.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.62 -50.06 14.73 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.066 1.303 . . . . 0.0 111.279 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.447 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -38.09 -56.19 1.19 Allowed 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 125.806 1.643 . . . . 0.0 109.831 161.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -68.92 -12.24 61.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 124.609 1.193 . . . . 0.0 112.081 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.8 -18.29 48.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.251 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.59 13.32 3.75 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.293 0.951 . . . . 0.0 113.3 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.98 27.54 59.76 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 121.347 -0.845 . . . . 0.0 111.847 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 2.1 t -79.67 110.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -170.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -57.16 151.85 14.73 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.863 0.465 . . . . 0.0 110.095 -168.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 90' ' ' LYS . 3.4 t -128.78 89.59 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-O 121.447 0.641 . . . . 0.0 110.543 -174.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . 0.258 36.7 mt -76.52 85.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 123.365 1.555 . . . . 0.0 109.591 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HG3' HG12 ' A' ' 88' ' ' VAL . 21.1 mtpt -80.75 142.01 34.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.896 2.079 . . . . 0.0 112.148 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.9 22.15 7.77 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.873 1.225 . . . . 0.0 112.484 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.78 165.98 24.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.567 1.683 . . . . 0.0 112.058 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -151.66 165.25 34.92 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.924 2.89 . . . . 0.0 105.136 158.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 125.36 175.45 14.22 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.953 0.797 . . . . 0.0 113.487 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 p -79.83 156.35 27.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.4 ' CG2' HG11 ' A' ' 7' ' ' VAL . 60.9 t -54.99 -47.87 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -54.69 -29.73 53.72 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -91.49 -45.84 8.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.651 1.981 . . . . 0.0 110.389 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' A' ' 69' ' ' ILE . 56.3 t -50.65 -45.69 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.977 1.311 . . . . 0.0 109.822 172.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.32 -48.39 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.756 0.822 . . . . 0.0 108.918 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 118.892 0.769 . . . . 0.0 111.188 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -54.9 -42.61 72.37 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.895 0.878 . . . . 0.0 110.272 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -69.48 -49.39 55.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.646 0.778 . . . . 0.0 113.067 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.71 -21.69 66.08 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.252 0.478 . . . . 0.0 111.121 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -81.25 -30.43 34.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.197 0.599 . . . . 0.0 109.72 171.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.37 2.0 17.98 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.48 1.514 . . . . 0.0 113.945 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -82.84 -30.31 28.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.83 0.815 . . . . 0.0 110.401 -165.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.94 136.74 45.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.823 1.249 . . . . 0.0 109.886 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.84 162.71 26.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.464 1.506 . . . . 0.0 112.279 -166.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -119.13 14.14 13.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.664 1.585 . . . . 0.0 111.367 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . 0.255 35.7 p 53.86 -159.98 0.15 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 126.047 1.739 . . . . 0.0 112.091 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.11 114.84 8.98 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -175.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.59 168.64 18.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.489 1.515 . . . . 0.0 109.552 -176.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -70.12 134.52 48.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.291 -163.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -58.61 126.21 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 160.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -46.57 109.58 0.21 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.038 2.135 . . . . 0.0 112.484 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -45.17 -48.43 12.36 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.843 1.657 . . . . 0.0 110.637 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.67 -11.03 6.16 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 28.64 51.76 0.06 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 129.84 3.256 . . . . 0.0 115.477 168.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -60.01 -29.03 68.21 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.887 -1.133 . . . . 0.0 112.623 -173.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 54.68 43.99 29.28 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.216 1.007 . . . . 0.0 110.983 167.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.99 73.76 6.77 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.519 1.128 . . . . 0.0 110.77 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 178.83 -7.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.829 0 N-CA-C 102.728 -3.064 . . . . 0.0 102.728 175.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HA ' ' OE1' ' A' ' 66' ' ' GLU . 58.3 ttm . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.421 HG22 ' CD1' ' A' ' 29' ' ' PHE . 4.3 mt -131.59 143.67 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 172.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.474 HG12 HD12 ' A' ' 67' ' ' LEU . 46.2 mt -128.78 100.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 127.395 2.278 . . . . 0.0 106.844 -166.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.013 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -81.81 127.21 32.74 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.784 0.434 . . . . 0.0 110.71 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 96' ' ' VAL . 97.0 mt -130.24 116.82 17.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.83 127.01 9.82 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.262 1.975 . . . . 0.0 107.745 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 m -127.74 148.08 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.7 m -76.25 -22.01 55.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.526 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.48 171.75 13.63 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.218 1.407 . . . . 0.0 108.056 -173.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -113.69 40.4 2.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.818 1.647 . . . . 0.0 113.412 -165.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -86.0 39.01 0.79 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.982 0.513 . . . . 0.0 111.026 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.86 -95.82 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.954 2.216 . . . . 0.0 113.694 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -41.37 22.31 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.527 1.164 . . . . 0.0 112.315 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.56 -3.25 14.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.39 1.476 . . . . 0.0 111.205 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -49.68 117.63 7.43 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.603 1.961 . . . . 0.0 110.57 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.2 135.69 11.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.741 2.294 . . . . 0.0 111.655 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.59 129.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.485 0.659 . . . . 0.0 111.118 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.81 164.29 15.29 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.16 1.784 . . . . 0.0 108.979 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.37 -52.99 5.76 Favored 'General case' 0 N--CA 1.437 -1.111 0 O-C-N 121.075 -1.016 . . . . 0.0 110.488 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -97.39 94.99 7.37 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -161.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -42.91 -52.41 5.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.586 0.63 . . . . 0.0 111.573 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.58 9.91 40.44 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.577 -176.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 tpt85 -149.1 56.11 1.0 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.4 137.81 20.04 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.12 -20.25 19.29 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.939 1.759 . . . . 0.0 113.294 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -149.58 165.05 33.43 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.604 1.093 . . . . 0.0 109.558 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.02 106.76 8.23 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.368 1.467 . . . . 0.0 108.65 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 88.83 5.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 1.013 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -80.54 91.85 5.83 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.183 1.393 . . . . 0.0 108.298 166.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.49 155.5 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -99.69 -170.68 1.93 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.907 -1.121 . . . . 0.0 109.242 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.4 t -146.59 146.93 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 114.86 8.14 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 127.844 2.458 . . . . 0.0 105.311 169.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 m120 43.4 60.46 2.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.472 1.109 . . . . 0.0 111.03 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 64.95 6.25 3.31 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.465 1.906 . . . . 0.0 115.171 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.36 173.78 6.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.863 1.665 . . . . 0.0 108.879 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.1 -23.83 34.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 124.884 1.273 . . . . 0.0 113.597 -164.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.82 -77.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.715 1.206 . . . . 0.0 111.903 -155.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.54 172.17 19.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.881 2.072 . . . . 0.0 110.23 -161.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 mm -126.21 141.11 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 m -138.44 121.02 16.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.954 2.102 . . . . 0.0 106.296 166.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -137.02 79.14 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -88.28 158.21 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.41 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.88 162.7 15.79 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 167.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -100.17 99.84 10.38 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.46 -0.781 . . . . 0.0 108.926 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.91 -11.02 29.08 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.646 2.231 . . . . 0.0 114.444 -170.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.56 38.57 4.13 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.787 -1.196 . . . . 0.0 110.489 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.43 96.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.592 1.157 . . . . 0.0 110.477 168.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -129.32 5.25 5.22 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.262 1.025 . . . . 0.0 112.132 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -95.05 -99.3 0.16 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -84.83 -10.48 57.12 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 119.746 -1.846 . . . . 0.0 114.417 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.1 t 58.06 -86.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.592 1.557 . . . . 0.0 112.47 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -100.23 32.64 2.92 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 119.84 -1.787 . . . . 0.0 114.361 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.57 110.29 0.4 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 119.284 0.947 . . . . 0.0 111.124 172.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 97.07 -10.7 0.07 Allowed 'General case' 0 CA--C 1.536 0.419 1 C-N-CA 132.162 4.185 . . . . 0.0 114.906 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -46.51 -48.52 47.37 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 121.672 2.033 . . . . 0.0 110.989 161.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 60' ' ' VAL . 4.1 Cg_endo -67.17 -18.26 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 120.52 1.222 . . . . 0.0 113.081 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -68.34 -26.97 65.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.828 0.74 . . . . 0.0 111.15 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.01 -69.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.278 1.031 . . . . 0.0 108.849 165.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 57' ' ' PRO . 3.2 m -62.02 -29.02 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -166.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -63.87 -35.99 82.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.292 1.405 . . . . 0.0 110.729 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -15.54 62.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.27 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -86.05 37.07 0.7 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.191 1.36 . . . . 0.0 110.856 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.46 25.72 4.64 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.841 2.163 . . . . 0.0 116.957 165.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -72.22 173.78 8.13 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -164.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 19.9 mt-10 -142.4 -33.62 0.47 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.768 1.627 . . . . 0.0 111.657 -178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 68' ' ' VAL . 2.5 tm? -138.14 156.19 47.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.461 1.104 . . . . 0.0 109.065 -173.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.782 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -148.7 144.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.714 1.205 . . . . 0.0 108.587 -177.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.423 HG21 HG13 ' A' ' 99' ' ' VAL . 52.1 mt -137.45 115.48 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.425 HG21 ' HB ' ' A' ' 73' ' ' ILE . 30.2 m -131.96 177.14 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.116 0.966 . . . . 0.0 109.923 -173.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.6 -80.45 0.39 Allowed 'General case' 0 C--O 1.226 -0.135 0 O-C-N 120.888 -1.133 . . . . 0.0 108.046 167.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.77 -19.01 8.47 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -164.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.425 ' HB ' HG21 ' A' ' 70' ' ' VAL 0.289 5.5 tt 35.84 -126.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 127.517 2.327 . . . . 0.0 113.708 175.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.82 140.68 3.1 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.306 1.908 . . . . 0.0 109.461 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -48.51 -44.09 35.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 116.987 -1.482 . . . . 0.0 113.44 -166.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -31.18 55.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.756 1.616 . . . . 0.0 112.463 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.57 -25.57 22.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.712 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.93 -51.69 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 167.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.42 -26.63 13.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.557 1.543 . . . . 0.0 113.132 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.52 -57.15 4.38 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.649 0.659 . . . . 0.0 111.454 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -59.17 -34.6 72.3 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.003 1.321 . . . . 0.0 110.985 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -54.62 -32.5 59.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.949 0.899 . . . . 0.0 111.793 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.4 -10.65 59.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.77 0.714 . . . . 0.0 112.452 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.6 ptm -124.4 10.2 8.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.508 1.523 . . . . 0.0 111.026 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.05 21.94 64.31 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 118.584 0.629 . . . . 0.0 112.182 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -80.83 119.66 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.06 146.56 49.23 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 119.123 -0.465 . . . . 0.0 110.308 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 t -133.71 107.93 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.808 1.186 . . . . 0.0 111.545 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -96.52 147.76 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.871 1.668 . . . . 0.0 108.608 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -172.6 2.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.072 1.349 . . . . 0.0 110.316 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.25 9.87 73.24 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 163.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -167.87 2.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.793 1.796 . . . . 0.0 111.442 -175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.32 159.01 14.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.492 1.917 . . . . 0.0 106.845 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 117.24 -169.67 13.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 112.618 170.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 p -79.89 167.85 20.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 5' ' ' ILE . 86.0 t -56.96 -54.03 35.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 123.718 0.807 . . . . 0.0 110.289 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -50.96 -40.81 58.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.85 0.86 . . . . 0.0 110.593 -175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.85 -49.9 13.35 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.13 1.772 . . . . 0.0 109.307 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG13 HG21 ' A' ' 69' ' ' ILE . 24.3 t -50.44 -32.61 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.57 1.148 . . . . 0.0 110.867 173.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.2 t -82.98 -41.36 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -52.42 -48.89 65.48 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -58.71 -41.96 87.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.399 0.679 . . . . 0.0 111.693 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -65.37 -51.66 58.93 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.516 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -60.74 -26.71 67.39 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.944 0.778 . . . . 0.0 111.01 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.95 0.47 56.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.695 1.198 . . . . 0.0 110.977 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.12 6.51 88.07 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 120.835 -1.165 . . . . 0.0 113.347 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -72.3 -48.71 40.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.77 1.285 . . . . 0.0 109.425 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 tp -81.52 134.69 35.55 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.11 1.364 . . . . 0.0 109.491 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -144.73 152.74 40.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.453 1.101 . . . . 0.0 111.086 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -91.21 13.86 15.95 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.195 2.198 . . . . 0.0 113.649 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 p -86.53 60.48 6.25 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.387 1.075 . . . . 0.0 111.398 -172.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.55 70.71 0.91 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.205 1.802 . . . . 0.0 106.929 -177.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.43 173.5 9.87 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.47 -0.769 . . . . 0.0 112.136 178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 55.22 24.94 6.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.895 2.078 . . . . 0.0 113.959 173.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -105.83 47.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 127.01 2.124 . . . . 0.0 108.565 -167.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 69.55 92.45 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.582 1.953 . . . . 0.0 110.529 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -147.92 179.0 8.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.899 0.88 . . . . 0.0 110.998 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -153.65 -41.3 0.09 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.727 1.149 . . . . 0.0 113.592 167.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.9 m170 38.4 82.13 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.845 2.058 . . . . 0.0 114.27 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.65 169.45 8.58 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.947 -1.095 . . . . 0.0 111.681 172.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.36 -88.85 0.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 157.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -142.37 141.14 32.26 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.906 1.682 . . . . 0.0 108.293 -170.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -73.45 -174.42 1.67 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.616 1.098 . . . . 0.0 111.912 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 . . . . . 0 C--O 1.246 0.905 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 173.912 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.513 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 24.2 ttm . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.969 0.89 . . . . 0.0 112.07 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.417 HG12 ' HE3' ' A' ' 31' ' ' LYS . 2.7 mt -140.3 144.0 28.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.18 104.21 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.346 2.658 . . . . 0.0 105.981 -163.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.957 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -82.16 143.95 31.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.108 0.163 . . . . 0.0 111.091 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 mt -145.38 106.77 4.41 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.61 117.84 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.351 2.034 . . . . 0.0 107.929 171.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.428 HG11 ' CB ' ' A' ' 15' ' ' SER . 1.5 m -112.18 159.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.719 1.608 . . . . 0.0 109.439 -174.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -85.25 -11.55 54.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 117.548 -1.215 . . . . 0.0 112.389 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -150.88 170.16 19.96 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.701 1.201 . . . . 0.0 108.296 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -98.77 103.1 15.02 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.3 mtt-85 -137.76 38.57 2.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.378 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.09 -123.78 2.68 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.695 -1.253 . . . . 0.0 111.516 -174.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -35.93 63.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.956 1.378 . . . . 0.0 113.7 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -6.27 50.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.531 1.133 . . . . 0.0 111.311 -175.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.428 ' CB ' HG11 ' A' ' 7' ' ' VAL . 37.9 m -52.6 111.33 2.49 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 120.302 1.41 . . . . 0.0 110.166 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -67.38 134.3 32.99 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.595 2.197 . . . . 0.0 108.541 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tt -64.75 142.82 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.161 0.437 . . . . 0.0 110.309 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -81.2 -173.79 4.52 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.826 0.85 . . . . 0.0 108.967 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.14 -46.97 6.87 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.469 1.128 . . . . 0.0 108.737 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -99.41 165.56 11.6 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.671 1.189 . . . . 0.0 109.436 -159.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -120.42 -49.41 2.26 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.264 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.81 16.72 5.06 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.177 0.894 . . . . 0.0 114.593 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.74 39.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 129.073 2.949 . . . . 0.0 107.863 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.48 150.88 82.72 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 170.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.63 -22.5 12.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.802 2.335 . . . . 0.0 114.359 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -145.84 172.28 13.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.431 1.892 . . . . 0.0 109.074 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -133.96 110.29 9.59 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.665 1.186 . . . . 0.0 108.034 162.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.72 101.75 8.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 165.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.927 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.3 m-85 -88.72 104.72 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.17 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 170.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HE3' HG12 ' A' ' 2' ' ' ILE . 14.5 mtpt -98.88 -165.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.006 -1.059 . . . . 0.0 108.637 172.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.12 147.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 162.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 123.08 15.32 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 161.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.94 20.5 11.58 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 t30 86.83 9.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.437 2.695 . . . . 0.0 112.27 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.59 170.22 8.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.54 -22.77 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.202 1.801 . . . . 0.0 112.304 -163.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 50.5 -72.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.48 1.912 . . . . 0.0 112.766 -160.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -157.06 156.45 32.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.135 0.574 . . . . 0.0 112.472 -166.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mm -121.68 127.81 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.141 1.777 . . . . 0.0 108.0 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 t -120.57 97.28 5.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.254 13.0 p -106.72 61.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 122.743 1.258 . . . . 0.0 108.636 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.6 149.62 31.28 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.48 163.34 16.09 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.0 115.63 60.89 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.85 -7.02 19.5 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.419 2.079 . . . . 0.0 112.515 -175.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mt -135.45 39.85 2.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.931 2.093 . . . . 0.0 107.687 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.48 -35.92 77.04 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.857 -1.152 . . . . 0.0 111.605 -173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -156.66 21.09 0.33 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.726 0.811 . . . . 0.0 111.338 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -89.58 -64.36 1.15 Allowed 'General case' 0 N--CA 1.462 0.131 0 O-C-N 122.021 -0.424 . . . . 0.0 110.517 -159.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -109.05 -1.92 18.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.683 1.193 . . . . 0.0 112.757 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m 28.85 58.15 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 131.532 3.933 . . . . 0.0 115.901 167.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.84 -61.61 0.57 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.744 0.818 . . . . 0.0 111.23 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.62 -148.08 5.39 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 105.143 -3.183 . . . . 0.0 105.143 -169.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.31 -20.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 128.102 2.561 . . . . 0.0 116.762 173.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.69 -49.18 27.56 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 126.131 1.772 . . . . 0.0 108.289 164.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.8 -25.0 17.4 Favored 'Trans proline' 0 C--N 1.359 1.096 0 CA-C-N 121.349 1.518 . . . . 0.0 111.367 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.457 ' HA ' ' HE3' ' A' ' 61' ' ' LYS . 10.2 t30 -71.36 -28.71 64.25 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 119.854 1.207 . . . . 0.0 111.237 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -60.85 -70.99 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 162.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -62.57 -21.9 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 58' ' ' ASN . 6.3 mtmp? -66.12 -22.9 66.41 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.555 -1.341 . . . . 0.0 112.746 170.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -26.33 57.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 120.267 1.394 . . . . 0.0 109.614 172.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -85.74 38.6 0.76 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.975 0.91 . . . . 0.0 111.118 -165.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.08 14.6 39.89 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.725 2.107 . . . . 0.0 116.017 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -69.32 167.64 16.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.242 1.521 . . . . 0.0 114.395 -160.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 32.3 mt-10 -142.68 -21.86 0.66 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.197 0.999 . . . . 0.0 112.486 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 68' ' ' VAL . 1.9 tm? -142.47 155.03 45.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.73 1.212 . . . . 0.0 107.853 -171.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.957 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.2 t -152.16 138.61 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 99' ' ' VAL . 9.0 mt -130.01 110.72 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 176.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.556 HG13 HG12 ' A' ' 68' ' ' VAL . 19.1 m -133.45 156.01 41.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.615 1.566 . . . . 0.0 108.931 -167.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -99.3 -52.4 3.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.199 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.97 -49.17 0.59 Allowed Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.542 1.068 . . . . 0.0 113.036 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.506 HG12 ' H ' ' A' ' 74' ' ' GLY 0.255 4.9 tt 41.42 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 127.077 2.151 . . . . 0.0 112.626 -173.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.506 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.74 158.18 21.69 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 127.153 2.311 . . . . 0.0 109.356 170.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -45.03 -40.0 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 128.793 2.837 . . . . 0.0 114.511 -168.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -58.81 -34.02 71.03 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.001 -1.062 . . . . 0.0 112.132 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.84 -31.58 22.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.312 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.8 -51.66 26.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 166.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.33 0.66 1.98 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.31 -51.95 5.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 119.983 -1.698 . . . . 0.0 111.736 163.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -60.9 -37.3 81.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.684 1.194 . . . . 0.0 110.02 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -63.06 -15.87 58.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.062 0.945 . . . . 0.0 112.675 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.32 -15.81 61.38 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.436 -1.415 . . . . 0.0 110.97 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.7 ptp -131.81 5.75 4.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.583 1.953 . . . . 0.0 112.519 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.34 41.62 55.21 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.2 t -79.1 119.64 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -66.47 136.73 56.12 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 121.453 -0.779 . . . . 0.0 109.09 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.82 110.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 67' ' ' LEU . 24.0 mt -93.69 116.42 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 127.927 2.491 . . . . 0.0 106.126 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -117.04 135.12 53.95 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.785 0.434 . . . . 0.0 111.335 -173.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.04 2.29 13.94 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.671 1.605 . . . . 0.0 114.603 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 -177.96 5.04 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.458 1.629 . . . . 0.0 111.128 -168.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.4 p -164.61 153.76 13.18 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.925 -1.109 . . . . 0.0 108.383 -172.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.28 -144.65 15.43 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 112.106 -0.397 . . . . 0.0 112.106 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.7 p -105.94 173.0 6.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.194 1.398 . . . . 0.0 109.629 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.11 -57.82 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -61.59 -35.11 76.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.733 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.29 -51.7 41.91 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.64 1.176 . . . . 0.0 108.136 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.469 ' CG1' HG21 ' A' ' 69' ' ' ILE . 65.2 t -63.31 -29.5 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.186 0.995 . . . . 0.0 111.739 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.4 t -68.85 -51.34 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -56.22 -43.2 78.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.041 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -57.18 -51.21 70.22 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.708 1.14 . . . . 0.0 109.868 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.87 -43.64 57.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.124 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.43 -31.72 68.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.748 -0.644 . . . . 0.0 109.51 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 m -78.24 -12.66 60.01 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 113.271 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.6 5.87 68.6 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.272 0.942 . . . . 0.0 113.594 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -70.41 -37.11 74.4 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.792 1.296 . . . . 0.0 110.676 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mt -82.56 165.77 19.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.022 1.329 . . . . 0.0 112.432 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -155.99 178.44 10.27 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.578 1.551 . . . . 0.0 111.91 175.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -136.06 37.08 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.17 2.188 . . . . 0.0 108.716 -156.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.91 -6.08 56.78 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -167.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -106.21 83.56 1.91 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.08 170.14 8.73 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.454 1.102 . . . . 0.0 110.16 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.08 113.54 2.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.915 0.78 . . . . 0.0 111.009 -173.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.3 m -75.51 177.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 126.747 2.019 . . . . 0.0 114.464 -166.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 60.8 72.54 0.52 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.279 1.832 . . . . 0.0 111.854 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -74.56 84.19 2.04 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.682 2.793 . . . . 0.0 112.573 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -57.33 -17.69 13.48 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -170.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 23.35 94.61 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.765 2.826 . . . . 0.0 114.855 164.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.43 157.5 42.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 55.5 m80 48.99 -155.91 0.08 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.165 0.986 . . . . 0.0 111.284 -167.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 28.63 95.86 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.559 3.144 . . . . 0.0 114.849 -175.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -89.85 -179.42 5.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.907 1.683 . . . . 0.0 110.46 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 30.2 p80 . . . . . 0 C--O 1.246 0.902 0 CA-C-O 117.615 -1.183 . . . . 0.0 109.893 159.373 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.1 ptm . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.441 HG22 ' CD1' ' A' ' 29' ' ' PHE . 4.7 mt -130.16 141.15 47.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 175.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.483 HG23 HD12 ' A' ' 69' ' ' ILE . 35.5 mt -125.14 100.58 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.764 2.826 . . . . 0.0 106.384 -161.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.887 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -83.86 145.61 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.856 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.37 126.68 21.41 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 166.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -75.43 110.2 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 N-CA-C 106.252 -2.249 . . . . 0.0 106.252 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.98 161.73 8.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 122.465 1.126 . . . . 0.0 110.99 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -93.24 -22.91 18.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.084 -1.416 . . . . 0.0 111.848 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -149.1 165.21 32.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.661 1.119 . . . . 0.0 108.797 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -92.44 77.3 5.09 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.245 1.018 . . . . 0.0 109.475 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -124.01 57.7 1.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.77 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -24.72 119.52 0.02 OUTLIER Glycine 0 N--CA 1.47 0.931 0 C-N-CA 126.064 1.792 . . . . 0.0 112.655 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt 80.14 -58.02 0.34 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.779 3.232 . . . . 0.0 110.909 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.38 -6.23 9.6 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.627 1.171 . . . . 0.0 113.105 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 m -47.92 102.84 0.33 Allowed Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 130.3 3.44 . . . . 0.0 110.379 -167.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.23 123.62 7.31 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.203 1.936 . . . . 0.0 110.677 -170.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.481 HG21 ' HA ' ' A' ' 93' ' ' SER . 13.3 tt -56.71 143.45 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 122.111 0.957 . . . . 0.0 109.406 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.08 168.77 9.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.79 1.236 . . . . 0.0 109.411 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.6 -40.49 18.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.779 -0.576 . . . . 0.0 111.899 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -101.05 172.51 6.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.765 1.226 . . . . 0.0 108.575 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -120.2 -51.79 2.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 173.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -7.05 7.57 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.132 171.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ttp-105 -144.32 39.43 1.3 Allowed 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 126.011 1.724 . . . . 0.0 109.625 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.91 123.95 87.46 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 163.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -69.95 -19.72 34.84 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 120.801 1.322 . . . . 0.0 112.669 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -148.04 161.49 41.28 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.153 0.888 . . . . 0.0 109.697 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -135.77 106.46 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.662 1.585 . . . . 0.0 108.287 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.92 93.68 5.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.887 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -82.16 95.64 7.57 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 171.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -79.65 151.86 4.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE3' HG12 ' A' ' 2' ' ' ILE . 16.7 mtpt -103.72 -174.37 2.53 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.694 -1.254 . . . . 0.0 110.16 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.19 137.69 19.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 121.53 -0.731 . . . . 0.0 109.098 165.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 7.4 ttpt -142.68 125.97 16.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.9 t30 53.06 39.61 29.8 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.836 0.744 . . . . 0.0 112.586 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.93 12.41 1.74 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.008 2.123 . . . . 0.0 114.487 -174.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.24 168.77 8.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.118 1.367 . . . . 0.0 108.223 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.42 -19.04 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.233 1.413 . . . . 0.0 112.076 -164.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.419 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 52.61 -66.71 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.16 2.184 . . . . 0.0 113.835 -167.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.79 178.72 9.5 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.977 1.311 . . . . 0.0 111.387 174.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.36 142.71 41.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.816 0.846 . . . . 0.0 108.798 176.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -113.18 88.92 2.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.875 2.47 . . . . 0.0 107.311 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.0 p -87.35 72.92 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 122.947 1.356 . . . . 0.0 107.626 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -88.67 151.0 22.72 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -73.77 150.74 40.91 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.099 1.359 . . . . 0.0 109.848 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -82.62 116.6 64.8 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.48 -8.8 24.14 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.722 2.281 . . . . 0.0 114.668 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -135.86 39.78 2.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.235 1.814 . . . . 0.0 109.464 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.91 -31.39 66.74 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 119.655 -1.903 . . . . 0.0 111.934 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.27 -12.77 1.86 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 118.078 -0.963 . . . . 0.0 113.071 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -98.7 116.48 31.03 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 120.698 1.59 . . . . 0.0 113.104 -156.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 37.09 47.96 0.68 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.91 2.084 . . . . 0.0 112.482 174.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.6 t -55.91 -43.88 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.475 1.11 . . . . 0.0 112.093 -149.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 46.25 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 129.477 3.111 . . . . 0.0 114.751 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.96 14.22 0.22 Allowed Glycine 0 CA--C 1.526 0.732 0 CA-C-O 117.84 -1.533 . . . . 0.0 112.802 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.19 -18.09 15.07 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.041 1.421 . . . . 0.0 114.48 -165.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.0 -51.02 80.87 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 119.131 0.878 . . . . 0.0 109.775 170.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' HG22 ' A' ' 60' ' ' VAL . 17.9 Cg_endo -72.64 -28.54 14.03 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.426 2.084 . . . . 0.0 111.688 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.84 -45.26 70.85 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.277 0.631 . . . . 0.0 109.675 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -57.97 -68.23 0.27 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.706 0.803 . . . . 0.0 111.274 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 57' ' ' PRO . 7.6 m -61.41 -18.79 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 120.118 -1.614 . . . . 0.0 113.755 -171.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -68.68 -26.6 65.38 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.18 1.355 . . . . 0.0 111.766 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -23.32 62.91 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.809 1.186 . . . . 0.0 111.124 171.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -85.11 38.93 0.74 Allowed 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.949 -1.094 . . . . 0.0 111.408 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.53 28.32 4.84 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.891 2.186 . . . . 0.0 115.686 163.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -76.19 168.32 20.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.038 0.919 . . . . 0.0 113.054 -160.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 17.9 mt-10 -143.2 -33.35 0.44 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.323 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 87' ' ' LYS . 5.7 tp -126.1 152.66 45.58 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.203 0.91 . . . . 0.0 108.878 175.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.9 t -136.57 139.39 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 161.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.513 HG21 ' CG1' ' A' ' 99' ' ' VAL . 4.1 mt -115.66 121.79 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 172.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 73' ' ' ILE . 24.2 m -133.31 162.6 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.823 1.249 . . . . 0.0 109.892 -170.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -91.65 -75.05 0.49 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.67 -27.17 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.187 -1.341 . . . . 0.0 114.849 -171.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.533 HG12 ' H ' ' A' ' 74' ' ' GLY 0.265 4.5 tt 37.27 -143.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.392 2.277 . . . . 0.0 112.603 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.533 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -176.44 156.01 20.1 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 127.785 2.612 . . . . 0.0 109.875 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.29 82.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.205 1.002 . . . . 0.0 112.081 -172.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -32.99 60.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.521 175.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.98 -40.59 16.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.99 -1.481 . . . . 0.0 111.193 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -44.82 -46.84 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 119.589 1.086 . . . . 0.0 108.886 166.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.73 -11.73 13.46 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 119.861 -1.774 . . . . 0.0 114.951 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.48 -32.88 14.72 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.123 1.329 . . . . 0.0 113.459 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.482 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -46.64 -55.94 6.9 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 120.748 -1.22 . . . . 0.0 109.07 154.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -69.66 -3.17 13.98 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 124.577 1.173 . . . . 0.0 110.294 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -10.16 48.85 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 119.507 1.049 . . . . 0.0 110.853 169.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.2 5.69 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.29 33.55 84.85 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.856 0.753 . . . . 0.0 111.767 -168.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 81' ' ' PHE . 4.9 t -80.41 96.86 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.14 -1.212 . . . . 0.0 110.606 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.585 ' HB3' HD12 ' A' ' 67' ' ' LEU . 5.9 tttp -49.92 145.79 5.23 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.727 1.611 . . . . 0.0 111.94 -169.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' CG2' ' CD2' ' A' ' 81' ' ' PHE . 1.2 t -125.89 107.55 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.082 0.468 . . . . 0.0 111.283 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.8 mt -93.05 99.47 9.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -83.69 165.82 18.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.195 0.521 . . . . 0.0 110.119 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.86 17.77 69.37 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-O 118.522 -1.155 . . . . 0.0 114.044 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.44 166.61 19.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.609 1.205 . . . . 0.0 110.106 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.481 ' HA ' HG21 ' A' ' 17' ' ' ILE . 5.5 p -152.64 159.04 43.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.87 1.668 . . . . 0.0 106.917 169.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.82 -175.62 15.82 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.349 0.976 . . . . 0.0 113.093 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.1 p -79.68 160.67 26.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.622 -0.928 . . . . 0.0 109.029 175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -46.67 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -171.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -27.35 67.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.29 -60.98 2.15 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 69' ' ' ILE . 53.4 t -46.52 -56.06 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.306 1.443 . . . . 0.0 109.419 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.14 -52.87 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 125.334 1.454 . . . . 0.0 109.045 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -54.71 -42.84 71.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.893 0.77 . . . . 0.0 111.548 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -60.97 -44.54 97.2 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.952 0.882 . . . . 0.0 112.285 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -63.79 -45.12 91.12 Favored 'General case' 0 CA--C 1.519 -0.219 0 O-C-N 121.333 -0.854 . . . . 0.0 113.273 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.5 -32.23 70.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.3 0.955 . . . . 0.0 110.498 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.9 m -74.79 -9.91 59.0 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.22 0.608 . . . . 0.0 111.707 174.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.98 3.84 87.48 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.386 1.469 . . . . 0.0 113.074 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -71.0 -50.49 33.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.743 1.772 . . . . 0.0 109.488 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.04 145.31 56.11 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.972 1.709 . . . . 0.0 110.618 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 161.54 39.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -106.93 13.66 27.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.864 2.065 . . . . 0.0 111.401 -175.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . 0.256 19.1 p 41.05 -154.29 0.01 OUTLIER 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 128.444 2.697 . . . . 0.0 114.628 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -134.78 111.25 9.77 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 -166.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.98 177.46 7.86 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.669 1.187 . . . . 0.0 109.152 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -70.11 89.4 0.63 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.3 m -79.69 43.86 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.055 1.342 . . . . 0.0 110.681 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -96.59 147.44 23.87 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.176 -0.953 . . . . 0.0 108.626 168.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -68.75 129.77 40.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 150.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -169.96 149.69 3.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.62 1.968 . . . . 0.0 110.438 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 61.54 165.87 0.09 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.624 2.37 . . . . 0.0 111.674 -176.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 57.48 -178.32 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.292 1.037 . . . . 0.0 110.679 -167.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 154.41 83.71 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 130.709 3.604 . . . . 0.0 108.662 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.79 153.62 10.72 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.391 1.076 . . . . 0.0 109.795 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -86.57 174.98 8.56 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.124 1.37 . . . . 0.0 109.648 171.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.7 p80 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 157.035 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HA ' ' OE2' ' A' ' 66' ' ' GLU . 3.8 ptp . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 mt -136.03 148.06 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 65.5 mt -125.65 109.75 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 129.049 2.94 . . . . 0.0 106.271 -168.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.892 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -82.27 148.15 28.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.288 169.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 87.4 mt -140.47 116.71 7.78 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 167.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.33 125.25 12.14 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.269 1.979 . . . . 0.0 108.496 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.578 HG23 ' HB2' ' A' ' 26' ' ' TYR . 13.5 m -121.51 157.9 24.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 119.247 0.931 . . . . 0.0 111.541 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -90.8 -20.74 22.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 116.69 -1.624 . . . . 0.0 113.325 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -147.99 150.01 33.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.199 1.399 . . . . 0.0 107.67 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -80.55 39.35 0.47 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.128 1.771 . . . . 0.0 113.694 -166.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 -82.87 39.83 0.65 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.561 -1.337 . . . . 0.0 112.94 -166.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.74 -137.27 35.91 Favored Glycine 0 N--CA 1.475 1.278 0 CA-C-N 120.44 1.473 . . . . 0.0 111.493 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -28.66 29.31 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -4.86 57.37 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 112.482 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.414 ' HB3' HG21 ' A' ' 7' ' ' VAL . 29.9 m -51.72 115.14 6.04 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.082 1.353 . . . . 0.0 111.681 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.19 134.96 18.12 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.629 2.219 . . . . 0.0 110.318 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.22 141.56 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.272 1.029 . . . . 0.0 110.819 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.15 156.56 17.26 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.784 1.233 . . . . 0.0 110.195 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -70.14 -39.98 75.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.857 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -133.58 117.2 16.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.677 2.035 . . . . 0.0 109.706 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -41.82 -53.75 3.61 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 112.42 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.69 63.57 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.645 -164.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.55 38.99 2.23 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 120.504 2.152 . . . . 0.0 108.161 162.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.81 125.95 91.57 Favored Pre-proline 0 N--CA 1.45 -0.469 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.516 ' HA ' HD22 ' A' ' 45' ' ' ASN . 30.2 Cg_endo -63.51 -16.42 54.52 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.281 1.321 . . . . 0.0 113.017 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.578 ' HB2' HG23 ' A' ' 7' ' ' VAL . 84.9 m-85 -150.39 149.03 29.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.283 1.033 . . . . 0.0 108.955 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.44 103.69 9.12 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.071 0.949 . . . . 0.0 108.643 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.82 106.8 13.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.892 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 1.7 m-85 -95.15 89.46 5.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.954 1.302 . . . . 0.0 107.532 171.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.1 t -79.69 147.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -89.2 -170.6 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.327 -0.858 . . . . 0.0 108.722 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ALA . 89.6 t -142.92 128.37 16.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 162.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 38' ' ' ALA . 7.1 ttpt -94.88 104.45 16.34 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.0 t30 59.25 -81.4 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.064 . . . . 0.0 110.533 -171.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -135.7 -0.27 2.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 130.449 3.5 . . . . 0.0 113.325 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' VAL . . . -111.9 -179.29 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.049 1.74 . . . . 0.0 108.953 -178.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.31 -22.18 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 121.413 1.915 . . . . 0.0 113.946 -169.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB2' ' N ' ' A' ' 33' ' ' LYS . . . 53.22 -74.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.247 1.385 . . . . 0.0 112.331 -160.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -163.36 153.34 15.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.323 1.049 . . . . 0.0 110.302 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.0 mm -78.39 155.29 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.081 1.353 . . . . 0.0 107.854 168.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -127.73 154.88 44.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 141.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 70.53 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 122.8 1.286 . . . . 0.0 108.546 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.0 131.59 35.83 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.085 1.354 . . . . 0.0 108.759 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.12 162.65 27.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.375 0.607 . . . . 0.0 111.616 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 39.7 p-10 -78.42 95.39 0.17 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 131.461 3.904 . . . . 0.0 114.733 -168.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.89 -25.18 23.67 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.385 1.39 . . . . 0.0 114.307 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.24 39.64 3.24 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.881 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . . . -58.02 -37.72 74.85 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.007 1.323 . . . . 0.0 111.501 -171.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -139.59 0.04 1.8 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.052 0.941 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -111.39 115.75 29.79 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.379 -0.826 . . . . 0.0 109.904 -162.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 61.28 -49.37 0.12 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.198 2.199 . . . . 0.0 113.145 -168.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t 57.74 -87.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 128.624 2.769 . . . . 0.0 111.679 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 44.49 -71.19 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 130.106 3.362 . . . . 0.0 116.502 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.26 17.4 0.21 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.462 1.506 . . . . 0.0 111.905 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.48 -18.79 19.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.296 1.048 . . . . 0.0 113.489 -172.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.469 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 2.0 t -57.45 -51.67 80.0 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 5.2 Cg_exo -65.69 -28.99 51.86 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.37 1.38 . . . . 0.0 112.416 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -32.54 74.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.584 1.084 . . . . 0.0 110.323 178.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -65.41 -61.99 1.79 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 57' ' ' PRO . 5.4 m -61.87 -23.92 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 120.383 1.447 . . . . 0.0 113.261 -174.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -21.14 63.87 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 120.848 -1.158 . . . . 0.0 112.809 171.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -78.18 -19.36 54.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 120.665 1.575 . . . . 0.0 111.537 170.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -85.07 37.9 0.69 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.16 21.14 5.36 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.601 2.524 . . . . 0.0 115.735 169.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -68.05 167.47 13.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.011 1.405 . . . . 0.0 114.548 -163.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.446 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 9.5 mt-10 -137.96 -31.13 0.78 Allowed 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.504 1.122 . . . . 0.0 111.902 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.63 152.77 51.96 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.623 1.169 . . . . 0.0 108.783 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.857 HG13 ' HB3' ' A' ' 4' ' ' ALA . 4.9 t -139.11 146.5 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 168.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.51 HG21 ' CG1' ' A' ' 99' ' ' VAL . 53.4 mt -131.65 118.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -134.61 169.49 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 111.356 -168.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -112.69 -42.34 3.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.501 -1.374 . . . . 0.0 113.439 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.93 42.48 0.78 Allowed Glycine 0 N--CA 1.469 0.836 0 C-N-CA 125.197 1.38 . . . . 0.0 111.648 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.2 tt -58.97 166.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.744 1.217 . . . . 0.0 111.087 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.58 161.51 13.25 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.679 1.133 . . . . 0.0 110.744 170.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -30.09 59.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.275 1.43 . . . . 0.0 113.486 -174.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -53.63 -43.45 68.74 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 111.127 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.23 -27.98 29.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.235 -1.364 . . . . 0.0 112.047 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.07 -49.48 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 120.337 1.426 . . . . 0.0 107.328 164.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -13.64 50.61 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.46 -60.77 2.12 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 110.07 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.77 -38.73 72.88 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 126.8 2.04 . . . . 0.0 109.553 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.92 -19.76 53.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.542 0.737 . . . . 0.0 112.944 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.85 -12.58 61.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.025 -1.672 . . . . 0.0 112.491 174.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.81 7.29 6.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.638 1.175 . . . . 0.0 114.064 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.15 24.76 74.68 Favored Glycine 0 C--O 1.241 0.558 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.972 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.11 116.33 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -69.99 141.76 52.91 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.78 97.82 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.507 ' HA ' ' HB3' ' A' ' 110' ' ' ASP . 50.7 mt -75.64 144.85 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.636 1.174 . . . . 0.0 108.363 175.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 2.6 mppt? -125.38 173.19 9.03 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.075 1.75 . . . . 0.0 109.054 -175.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.37 57.78 16.95 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.899 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.14 165.53 12.81 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 124.368 0.687 . . . . 0.0 110.788 165.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.3 p -146.49 164.07 33.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.361 1.864 . . . . 0.0 108.436 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.38 -166.8 24.44 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 118.794 0.725 . . . . 0.0 113.486 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.4 p -85.18 165.7 17.19 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 121.547 -0.972 . . . . 0.0 111.7 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.7 t -50.41 -56.25 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 C-N-CA 124.523 1.129 . . . . 0.0 110.081 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -59.8 -27.46 66.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -82.83 -53.39 5.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.519 1.528 . . . . 0.0 107.893 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.51 ' CG1' HG21 ' A' ' 69' ' ' ILE . 53.0 t -52.84 -43.99 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.416 1.486 . . . . 0.0 110.145 177.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.07 -53.24 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.03 -39.66 90.63 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.301 -0.874 . . . . 0.0 111.91 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.46 -39.39 94.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.343 0.974 . . . . 0.0 110.645 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -64.32 -52.0 60.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.42 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.9 mp -56.46 -36.03 68.6 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.006 0.922 . . . . 0.0 109.14 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.8 m -77.18 0.96 19.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.656 1.182 . . . . 0.0 112.697 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.5 9.91 84.59 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.894 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -80.0 -43.64 21.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 119.355 1.578 . . . . 0.0 109.84 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.32 141.38 48.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.012 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.33 171.82 19.11 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 127.538 2.335 . . . . 0.0 108.198 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 89' ' ' ILE . 12.4 p-10 -127.24 14.52 7.23 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.898 1.279 . . . . 0.0 112.22 169.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t 70.44 -168.25 0.16 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.425 1.89 . . . . 0.0 110.141 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -72.95 122.88 22.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.262 1.825 . . . . 0.0 106.562 161.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -114.27 172.04 7.25 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.775 1.23 . . . . 0.0 109.374 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -118.1 161.16 20.29 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.55 1.54 . . . . 0.0 110.503 -173.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.8 m -106.95 158.3 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.803 1.241 . . . . 0.0 109.528 -172.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -80.67 96.35 6.86 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.763 -0.586 . . . . 0.0 111.351 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.16 -56.96 12.26 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.716 1.206 . . . . 0.0 110.489 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.38 122.75 21.72 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.684 -0.635 . . . . 0.0 110.347 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -129.92 -177.9 4.49 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.831 1.652 . . . . 0.0 107.871 160.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -157.42 72.81 0.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.097 0.959 . . . . 0.0 109.29 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.7 m170 37.4 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.098 2.159 . . . . 0.0 111.264 -165.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -56.39 156.72 5.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.288 1.435 . . . . 0.0 110.153 171.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -130.91 168.5 17.21 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 126.117 1.767 . . . . 0.0 106.466 168.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.566 0.209 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 29' ' ' PHE . 23.0 mt -109.34 151.36 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 160.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.81 108.48 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 C-N-CA 130.011 3.324 . . . . 0.0 105.16 -169.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.895 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.68 153.73 29.11 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 172.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.9 mt -146.4 113.93 4.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 171.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.58 124.95 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 N-CA-C 106.852 -2.018 . . . . 0.0 106.852 170.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.43 155.47 15.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 -19.84 30.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.761 -177.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -149.43 153.37 37.22 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 -177.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -93.7 64.22 3.48 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.956 0.884 . . . . 0.0 111.537 -169.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -106.48 42.03 1.34 Allowed 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.598 -166.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 24.38 80.37 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.701 1.619 . . . . 0.0 115.481 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 80.67 -46.26 0.26 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.153 2.981 . . . . 0.0 112.604 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -0.06 0.63 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.015 0.825 . . . . 0.0 112.169 162.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -51.0 107.97 0.94 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.713 2.805 . . . . 0.0 111.769 169.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.94 130.62 5.77 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.996 2.464 . . . . 0.0 110.209 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.41 134.35 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.951 1.301 . . . . 0.0 112.052 -175.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -70.15 169.42 13.6 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.85 1.66 . . . . 0.0 109.274 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -92.48 -23.11 19.24 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.324 -0.86 . . . . 0.0 111.12 174.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -108.48 171.23 7.53 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -170.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -120.76 -57.57 1.88 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.35 -3.14 11.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.731 -169.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -143.49 38.51 1.38 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.415 1.607 . . . . 0.0 108.703 169.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.86 152.57 96.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.96 -20.73 7.33 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.779 2.319 . . . . 0.0 113.606 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -152.85 157.1 40.23 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.868 1.267 . . . . 0.0 109.489 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -123.07 108.36 12.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.036 1.334 . . . . 0.0 107.893 174.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -79.42 87.5 5.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 165.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.895 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 2.2 m-85 -70.86 142.9 51.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 157.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -138.27 138.53 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 16.2 mtpt -84.71 -168.48 2.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.102 0.865 . . . . 0.0 109.523 -179.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.63 143.12 26.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 162.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -139.45 133.91 31.61 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 127.428 2.291 . . . . 0.0 105.38 169.268 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 32.47 57.24 0.4 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.241 1.817 . . . . 0.0 112.702 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.53 12.98 5.83 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.982 2.513 . . . . 0.0 116.769 -178.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.03 -179.6 4.33 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.243 1.817 . . . . 0.0 109.586 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.33 -23.46 31.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 125.222 1.409 . . . . 0.0 113.611 -164.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . . . 54.05 -74.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.105 1.32 . . . . 0.0 112.48 -160.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.17 160.25 39.71 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.533 1.933 . . . . 0.0 111.049 -160.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mm -124.87 134.62 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.507 1.923 . . . . 0.0 106.788 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 m -138.95 72.14 1.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.608 2.763 . . . . 0.0 106.941 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . 2.2 t -77.22 97.75 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -96.27 159.84 14.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.886 173.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -57.41 163.51 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 110.848 167.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.33 95.93 3.28 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 159.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.51 3.46 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.217 2.612 . . . . 0.0 113.098 -176.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.26 39.11 2.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.016 1.326 . . . . 0.0 109.003 172.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.46 -37.15 72.42 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.751 -1.218 . . . . 0.0 111.489 -171.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -147.68 13.35 1.04 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 176.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.43 121.86 41.35 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.27 1.395 . . . . 0.0 111.998 -160.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 54.93 -27.02 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 131.02 3.728 . . . . 0.0 116.022 -172.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t 38.24 53.11 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 1 C-N-CA 131.821 4.048 . . . . 0.0 111.483 164.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.69 44.17 0.96 Allowed 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.366 -0.833 . . . . 0.0 110.291 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.09 28.53 70.73 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.527 -0.733 . . . . 0.0 112.649 -176.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.16 -15.2 20.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.283 1.033 . . . . 0.0 112.701 -172.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.416 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 2.0 t -50.13 -52.69 51.09 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 119.521 1.055 . . . . 0.0 109.665 173.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 1.8 Cg_endo -71.05 -29.99 17.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.521 2.147 . . . . 0.0 111.974 178.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.4 -32.78 74.59 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.428 -0.795 . . . . 0.0 110.596 -177.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -58.66 -65.69 0.62 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 109.925 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.81 -27.36 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -171.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -63.83 -19.96 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.984 0.913 . . . . 0.0 112.65 173.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -20.68 44.91 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.084 0.856 . . . . 0.0 111.984 169.131 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -86.83 38.03 0.78 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.677 -1.264 . . . . 0.0 111.419 -170.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.27 19.83 8.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.329 1.919 . . . . 0.0 115.918 166.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -74.46 168.43 19.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.185 1.492 . . . . 0.0 113.278 -163.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -143.38 -27.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.442 1.097 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.734 HD12 ' H ' ' A' ' 68' ' ' VAL . 41.9 tp -135.88 158.64 43.9 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.963 0.801 . . . . 0.0 110.241 176.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.861 HG13 ' HB3' ' A' ' 4' ' ' ALA . 2.8 t -150.66 122.87 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -174.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.446 HG21 ' CG1' ' A' ' 99' ' ' VAL . 82.4 mt -114.59 107.67 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 108.628 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.43 176.07 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.729 2.012 . . . . 0.0 111.966 -174.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -96.5 -94.36 0.21 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 164.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.97 -40.52 8.03 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.588 -0.562 . . . . 0.0 114.072 -167.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.529 HG12 ' H ' ' A' ' 74' ' ' GLY 0.281 3.0 tt 44.55 -138.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.939 1.696 . . . . 0.0 112.537 -176.423 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 73' ' ' ILE . . . -179.42 155.37 15.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 129.61 3.481 . . . . 0.0 109.219 174.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.56 -34.15 73.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.989 1.394 . . . . 0.0 111.785 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -55.56 -23.41 26.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 171.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.84 13.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.205 0.911 . . . . 0.0 110.857 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.73 -46.35 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 166.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.53 -31.91 25.92 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.533 1.533 . . . . 0.0 114.566 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.5 -55.27 5.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.02 0.827 . . . . 0.0 110.526 -177.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.425 ' CD1' HG11 ' A' ' 86' ' ' VAL . 53.7 m-85 -62.14 -31.45 71.93 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.436 1.094 . . . . 0.0 110.799 177.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -56.56 -32.58 65.31 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.196 -0.94 . . . . 0.0 112.302 170.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -18.69 61.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.713 0.688 . . . . 0.0 111.601 -175.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.487 ' SD ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -113.75 6.04 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.404 1.482 . . . . 0.0 110.785 -178.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.81 23.67 69.33 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.941 -1.1 . . . . 0.0 111.982 -175.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' A' ' 84' ' ' MET . 56.0 t -79.4 117.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.021 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -58.72 145.12 41.39 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.429 1.492 . . . . 0.0 109.38 174.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.05 128.3 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 109' ' ' LYS . 13.5 mt -115.16 131.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.325 2.65 . . . . 0.0 105.101 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' H ' ' HA ' ' A' ' 110' ' ' ASP . 0.0 OUTLIER -134.2 135.86 43.32 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.769 1.228 . . . . 0.0 108.775 -170.681 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.14 2.95 6.38 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.673 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.78 173.64 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.079 1.44 . . . . 0.0 111.13 -173.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 p -161.99 165.13 27.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.198 1.799 . . . . 0.0 106.65 156.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.62 -163.05 16.42 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 122.264 0.924 . . . . 0.0 112.601 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 162.92 24.78 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.212 -1.169 . . . . 0.0 111.098 -178.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -53.05 -49.74 48.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 123.007 0.523 . . . . 0.0 109.605 174.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -62.22 -26.67 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -80.65 -54.61 5.49 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 107.828 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.446 ' CG1' HG21 ' A' ' 69' ' ' ILE . 54.7 t -53.84 -45.5 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -178.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.3 t -66.04 -42.8 92.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -58.0 -50.85 72.0 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.284 174.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -57.09 -41.72 79.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.197 0.908 . . . . 0.0 110.772 -172.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.25 -53.73 22.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.246 1.019 . . . . 0.0 112.134 174.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.2 -26.75 68.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.613 0.642 . . . . 0.0 110.822 -176.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -82.54 -3.28 55.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 174.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.07 15.18 75.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-O 118.126 -1.374 . . . . 0.0 113.691 168.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -87.1 -30.08 21.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.984 1.392 . . . . 0.0 111.613 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 tp -74.86 166.53 23.48 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.152 -0.342 . . . . 0.0 111.347 -163.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -133.3 168.43 18.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.267 1.027 . . . . 0.0 111.748 -170.753 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.507 ' HA ' ' H ' ' A' ' 90' ' ' LYS . 40.0 p30 -121.2 13.99 11.27 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.021 1.728 . . . . 0.0 112.305 -175.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.6 p 32.78 54.44 0.38 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.473 2.309 . . . . 0.0 112.526 -171.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 49.11 33.1 4.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 129.192 2.997 . . . . 0.0 114.853 165.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.59 120.8 22.29 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.173 1.389 . . . . 0.0 108.935 173.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.06 116.14 8.35 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.781 171.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.63 71.5 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.57 0 O-C-N 121.085 -1.009 . . . . 0.0 110.147 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.05 113.36 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 127.306 2.242 . . . . 0.0 109.764 -164.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -56.9 110.03 0.74 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.198 0.999 . . . . 0.0 110.081 167.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.21 157.87 31.57 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.829 2.052 . . . . 0.0 108.392 172.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -41.63 123.28 2.19 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.756 1.223 . . . . 0.0 111.933 -174.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.47 71.56 3.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.137 1.375 . . . . 0.0 109.732 -176.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 56.86 -162.43 0.19 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.96 1.704 . . . . 0.0 109.797 -165.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -44.59 136.33 4.38 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 159.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -80.94 48.08 1.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.347 1.459 . . . . 0.0 109.699 -173.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.2 t60 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 116.298 -1.811 . . . . 0.0 110.336 -138.111 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' CD ' ' A' ' 66' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.67 144.85 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 165.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.464 HG12 HD23 ' A' ' 67' ' ' LEU . 24.5 mt -131.04 103.68 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 C-N-CA 128.825 2.85 . . . . 0.0 105.506 -162.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . . . -79.81 141.57 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.064 172.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.92 116.77 17.02 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 168.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.52 131.45 23.08 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.765 1.643 . . . . 0.0 107.889 171.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.41 160.89 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 118.78 0.718 . . . . 0.0 110.413 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.72 -29.91 23.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.488 -174.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -148.79 154.36 39.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.751 2.02 . . . . 0.0 108.205 -174.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.05 67.15 9.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.883 2.473 . . . . 0.0 109.367 -173.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -108.39 39.16 2.04 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.699 -0.625 . . . . 0.0 110.639 -174.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.69 -83.9 0.01 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 126.214 1.864 . . . . 0.0 113.144 -174.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -120.03 -38.5 2.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 127.355 2.262 . . . . 0.0 109.837 -166.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -1.39 2.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.528 1.531 . . . . 0.0 112.497 162.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -45.79 107.7 0.7 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 127.182 2.193 . . . . 0.0 111.107 170.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.01 126.31 9.23 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.595 1.53 . . . . 0.0 109.848 -176.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 tt -54.8 134.84 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.628 0.728 . . . . 0.0 110.841 -177.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -75.29 171.68 13.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.78 1.276 . . . . 0.0 110.007 178.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -81.24 -31.19 33.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.39 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -131.78 -170.58 2.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.716 1.606 . . . . 0.0 107.103 -168.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.21 -41.53 2.62 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.683 0.393 . . . . 0.0 110.555 175.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.71 4.61 86.1 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 118.486 -1.175 . . . . 0.0 115.126 -166.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 45.99 1.34 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.774 1.23 . . . . 0.0 108.325 161.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.04 138.1 56.92 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 167.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.97 -24.71 14.86 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.385 2.057 . . . . 0.0 113.353 174.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -146.1 158.54 43.88 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.298 0.954 . . . . 0.0 109.401 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.89 119.25 31.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 126.098 1.759 . . . . 0.0 106.304 170.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.15 89.44 7.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 164.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.804 ' CE1' ' HB2' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -77.61 88.0 3.91 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 166.054 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.64 143.28 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -90.7 -169.05 2.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.6 t -140.94 145.15 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 161.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' HB2' ' A' ' 38' ' ' ALA . 2.5 ttpt -142.27 128.83 20.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 171.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 37.69 61.12 1.06 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.608 1.163 . . . . 0.0 112.298 177.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.54 14.4 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.575 2.35 . . . . 0.0 116.524 -178.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.56 172.09 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.02 1.328 . . . . 0.0 108.757 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.48 -23.15 29.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 C-N-CA 125.632 1.573 . . . . 0.0 113.387 -166.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . . . 54.5 -73.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.623 1.569 . . . . 0.0 112.817 -162.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.48 156.74 42.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.646 2.778 . . . . 0.0 107.707 -153.213 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.84 153.58 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 173.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 80.76 1.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 163.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.87 99.44 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 167.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -113.12 133.03 55.21 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.768 1.227 . . . . 0.0 108.829 -171.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -69.0 137.53 53.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.545 1.538 . . . . 0.0 109.582 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.531 HD21 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.48 105.25 3.93 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.108 0.963 . . . . 0.0 110.374 -173.497 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.42 -14.66 45.04 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.232 1.955 . . . . 0.0 114.687 -171.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.88 38.98 3.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.476 1.035 . . . . 0.0 111.354 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.06 70.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.909 1.686 . . . . 0.0 111.766 -165.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -145.05 22.53 1.56 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 175.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -117.57 129.23 55.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.899 0.772 . . . . 0.0 110.619 -163.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.5 m170 61.06 -40.04 0.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.685 2.794 . . . . 0.0 114.049 -168.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t 56.75 24.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.902 1.681 . . . . 0.0 111.531 173.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -64.23 -70.48 0.22 Allowed 'General case' 0 C--N 1.343 0.311 0 O-C-N 120.914 -1.116 . . . . 0.0 108.096 178.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.87 41.35 0.04 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -178.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.72 -14.37 14.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.465 -174.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 45' ' ' ASN . 1.8 t -50.27 -52.96 49.43 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.771 1.169 . . . . 0.0 109.965 167.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 60' ' ' VAL . 31.6 Cg_endo -72.63 -23.36 19.77 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.343 1.362 . . . . 0.0 111.899 -177.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -73.12 -24.42 60.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.953 0.501 . . . . 0.0 111.559 -175.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.56 -66.1 0.61 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.394 1.078 . . . . 0.0 109.477 162.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 57' ' ' PRO . 4.8 m -58.85 -25.98 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.757 1.617 . . . . 0.0 114.984 -170.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -66.18 -10.44 41.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.412 1.006 . . . . 0.0 113.403 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -16.33 31.19 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.124 -0.985 . . . . 0.0 111.355 171.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -93.44 36.55 1.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.258 -0.902 . . . . 0.0 112.316 -166.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.62 29.27 7.53 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.705 1.622 . . . . 0.0 114.476 173.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -67.73 164.37 19.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.809 1.304 . . . . 0.0 112.788 -172.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 3.3 mt-10 -146.7 -35.95 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.445 1.098 . . . . 0.0 110.826 -178.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 3' ' ' ILE . 21.7 tp -129.22 155.1 46.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.407 1.483 . . . . 0.0 108.42 175.367 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 4' ' ' ALA . 10.5 t -137.3 147.21 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 162.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.553 HG21 ' CG1' ' A' ' 99' ' ' VAL . 97.7 mt -125.28 115.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.482 HG21 ' HB ' ' A' ' 73' ' ' ILE . 10.0 m -126.53 174.75 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.394 0.677 . . . . 0.0 110.197 -177.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.16 -67.56 0.85 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.871 174.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -137.35 67.6 0.53 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.283 1.421 . . . . 0.0 112.558 -175.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' HG21 ' A' ' 70' ' ' VAL . 9.7 tt -63.87 -174.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 127.951 2.5 . . . . 0.0 112.129 170.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.27 169.19 30.26 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.871 1.224 . . . . 0.0 111.958 163.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.92 -34.11 58.61 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -165.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -58.5 -29.35 66.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.384 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.79 -33.7 15.6 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.644 -1.17 . . . . 0.0 110.581 176.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.5 mm -54.09 -45.03 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 120.199 1.363 . . . . 0.0 108.705 172.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.01 -18.43 57.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.044 -0.979 . . . . 0.0 113.138 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.02 4.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.298 0.954 . . . . 0.0 110.527 173.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -60.4 -34.05 73.37 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.417 1.887 . . . . 0.0 111.15 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.91 -37.22 60.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.265 0.626 . . . . 0.0 112.592 167.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -10.88 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.595 -1.316 . . . . 0.0 113.246 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -129.0 6.89 5.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.327 . . . . 0.0 110.586 -174.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.05 16.81 64.81 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.005 0.812 . . . . 0.0 113.586 -177.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.47 116.85 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -169.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.59 146.0 54.58 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.0 t -124.29 105.9 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.112 0.965 . . . . 0.0 108.522 -175.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.9 mt -84.2 144.52 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 167.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 174.03 8.03 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.725 1.61 . . . . 0.0 108.772 176.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.92 11.11 84.92 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.458 -1.19 . . . . 0.0 115.712 166.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.4 165.38 22.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.251 1.026 . . . . 0.0 110.925 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.4 p -157.47 148.26 21.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.555 1.542 . . . . 0.0 107.136 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.16 -156.59 21.31 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 118.537 0.608 . . . . 0.0 113.283 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p -85.67 179.47 7.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.666 0.786 . . . . 0.0 109.411 167.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.05 -58.13 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 121.63 -0.669 . . . . 0.0 109.379 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.71 -21.5 65.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.103 -172.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.37 -57.13 5.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.125 168.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.553 ' CG1' HG21 ' A' ' 69' ' ' ILE . 20.2 t -57.95 -41.22 79.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 120.9 1.682 . . . . 0.0 111.17 -176.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.5 -42.34 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -63.19 -41.77 99.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.529 1.059 . . . . 0.0 111.552 177.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -56.75 -47.75 79.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.997 1.271 . . . . 0.0 109.268 177.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -72.95 -42.66 63.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.498 -0.751 . . . . 0.0 111.762 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.96 -20.57 65.92 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.971 0.805 . . . . 0.0 110.742 177.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -76.92 -10.31 59.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.181 0.992 . . . . 0.0 112.4 169.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.17 76.24 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.201 1.382 . . . . 0.0 113.867 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.29 -40.84 94.38 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.066 1.433 . . . . 0.0 112.348 -172.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.37 168.19 16.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 111.632 -162.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.75 158.85 40.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.887 -1.133 . . . . 0.0 111.578 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -135.74 45.56 2.41 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 126.48 1.912 . . . . 0.0 108.919 -164.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.5 m -44.2 152.06 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.498 1.919 . . . . 0.0 112.316 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.13 124.71 16.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -147.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.1 119.93 40.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.298 1.839 . . . . 0.0 110.3 -157.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.6 142.9 53.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 113.089 -173.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t 32.41 58.75 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 128.851 2.86 . . . . 0.0 111.739 174.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 t60 57.88 -77.09 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.836 2.054 . . . . 0.0 111.306 -170.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.91 -34.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.454 1.102 . . . . 0.0 111.577 171.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 67.97 -4.37 1.03 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.614 1.566 . . . . 0.0 114.993 171.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -82.63 148.36 28.02 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 121.093 1.77 . . . . 0.0 109.942 -171.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.3 m170 57.73 165.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.732 2.413 . . . . 0.0 111.197 -169.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -141.54 161.18 38.54 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.501 1.12 . . . . 0.0 108.728 164.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.75 -28.06 13.02 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 66.19 -24.97 0.1 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.099 2.16 . . . . 0.0 116.099 173.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 171.108 . . . . . . . . 0 0 . 1 stop_ save_